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AXON‐GLIA INTERACTIONS: ROLE OF NEUROFILAMENT ASSOCIATED PROTEINS {#sec2-1}
-----------------------------------------------------------------

### Fressinaud C.,^1^ Berges R.,^2^ Eyer J.^2^ {#sec3-1}

#### ^1^Neurology Department, UPRES EA3143, University Hospital, Angers, France; ^2^UPRES EA 3143, Faculty of Medicine, Angers, France {#sec4-1}

INTRODUCTION: In multiple sclerosis (MS) axon remyelination by oligodendrocytes (OL) is incomplete. Axonal lesions, such as abnormal non phosphorylated forms of neurofilaments (NF), and decrease in NF, and b tubulin (TUB) also occur (Fressinaud et al., 2005), which might, in turn, render axons unproper for remyelination. NF fractions, obtained by successive purification from rat brain (Fasani et al., 2004), copurify with small amounts of other proteins, such as TUB. We have assessed whether these proteins modulate the development of OL in pure secondary cultures. Although these proteins are physiologically intracellular, they might interact with membrane proteins mediating their signal, or, in case of axonal damage, their release in the extracellular space could alter remyelination.

MATERIAL AND METHODS: Newborn rat OL secondary cultures grown in chemically‐defined medium (Fressinaud et al., 1993) were treated for 1‐3 days with purified TUB, MAPs, Tau, spectrin 2, and synaptophysin 2 (0.05‐0.1 μg/ml).

RESULTS: Purified TUB, MAPs, Tau, spectrin 2, as well as synaptophysin 2 (0.05‐0.1 μg/ml) enhanced OL progenitor proliferation by 2‐5 fold compared to controls. Differentiation increased by 70‐110%. Indeed CNP+ OL with a very complex morphology and numerous thinly branched processes were significantly increased compared to controls. Moreover, maturation was not delayed, and the relative percentage of OL expressing myelin basic protein (MBP+) was similar to control values.

DISCUSSION: Our results suggest that axon cytoskeleton proteins increase myelination in vitro. We project to analyze their expression in MS lesions, already characterized by a strong decrease in TUB (Fressinaud et al., 2005). A decrease in the other proteins, resulting from successive relapses, might participate in remyelination failure. Identification of the role of axon cytoskeleton proteins on remyelination is a prerequisite to define putative therapeutic targets in demyelinating diseases.

Supported by a grant from the University of Angers (PHRC).

P‐002 {#sec1-2}
=====

PURINERGIC SIGNALING IN TERMINAL SCHWANN CELLS ASSOCIATED WITH LANCEOLATE SENSORY ENDINGS {#sec2-2}
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### Takahashi‐Iwanaga H. {#sec3-2}

#### Hokkaido University Graduate School of Medicine, Sapporo, Japan {#sec4-2}

Accumulating reports have shown neurons and many non‐excitatory cells including glia to interact with one another through the signal substance adenosine 5\'‐triphosphate (ATP) that activates purinoceptors on the cells to elevate the cytoplasmic Ca2+ concentration (\[Ca2+\]i). The lanceolate sensory endings, motion detectors that form palisades around the hair follicle, contain specialized glial elements, terminal Schwann cells. These cells extend long thin processes or connecting stalks, which branch into lamellar end feet resting on different axon terminals. We previously reported the branched Schwann cells to express the purinoceptor subtype P2Y2. This work aims to define spatiotemporal properties of the ATP‐dependent glial signals in the mechanoreceptor palisades. Lanceolate endings were isolated from rat vibrissal follicles with collagenase and subjected to Ca2+ image recording by confocal microscopy while a local ATP release was induced by gently touching the specimen with the tip of a glass micropipette. The mechanical stimulation triggered a \[Ca2+\]i elevation in the Schwann lamellae covering the probe‐contacted lanceolate, and subsequently induced glial Ca2+ responses in 2‐4 neighboring lanceolates. These secondary signals were generated at specific foci in individual glial lamellae after an increasing latency by the distance from the stimulation point, rapidly spread along the lamellae, and acutely collapsed around the junction with the connecting stalk. The antipurinergic agents suramin and apyrase significantly suppressed the activation ofthese signals. The observations characterize each lamellar process of the terminal Schwann cell as a functional compartment that can independently respond to local purinergic stimuli to modulate the activity of its accompanying mechanoreceptor axon based on its own Ca2+ signal. Morphological backgrounds for the subcellular compartmentalization in the glial purinergic signaling will be discussed.
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SUSTAINED AXON‐GLIAL SIGNALLING INDUCES SCHWANN CELL HYPERPROLIFERATION, REMAK BUNDLE MYELINATION AND TUMORIGENESIS {#sec2-3}
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### Gomez‐Sanchez J.A.,^1^ Lopez de Armentia M.,^1^ Lujan R.,^2^ Kessaris N.,^3^ Richardson W.D.,^3^ Cabedo H.^1^ {#sec3-3}
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Type III neuregulins exposed on axon surfaces control myelination of the peripheral nervous system. It has been shown, for example, that threshold levelsof type IIIß 1a neuregulin dictate not only the myelination fate of axons but also myelin thickness. Here we show that another neuregulin isoform, type IIIß 3, plays a distinct role in myelination. Neuronal overexpression of this isoform in mice stimulates Schwann cell proliferation and dramatically enlarges peripheral nerves and ganglia ‐ which come to resemble plexiform neurofibromas‐ but have no effect on myelin thickness. The nerves display other neurofibroma‐like properties such as abundant collagen fibrils and abundant dissociated Schwann cells that in some cases produce big tumours. Moreover, the organization of Remak bundles is dramatically altered; the small‐calibre axons of each bundle are no longer segregated from one another within the cytoplasm of a non‐myelinating Schwann cell, but instead are close‐packed and the whole bundle wrapped as a single unit, frequently by a compact myelin sheath. Because Schwann cell hyperproliferation and Remak bundle degeneration are early hallmarks of type I neurofibromatosis, we suggest that sustained activation of the neuregulin pathway in Remak bundles can contribute to neurofibroma development.
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IS TISSUE TYPE PLASMINOGEN ACTIVATOR A KEY ACTOR OF GLUTAMATERGIC COMMUNICATION BETWEEN ASTROCYTES AND NEURONS? {#sec2-4}
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### Cassé F. {#sec3-4}

#### INSERM U919, Caen, France {#sec4-4}

Tissue‐type plasminogen activator (tPA) is a serine protease synthesized in the brain parenchyma, involved in a number of physiological and pathological functions. Extracellular tPA could be recaptured by astrocytes through a low‐density lipoprotein (LDL) receptor‐related protein (LRP)‐dependent mechanism1. The aim of our study was to further investigate the mechanisms controlling the uptake of tPA by astrocytes and to determine its possible influence in pathological conditions.

By using tPA labelled with a fluorochrome (alexa‐555), we have determined that tPA was recaptured by astrocytes through a LRP‐dependent mechanism. In addition, we have evidenced that after recapture, cytoplasmic tPA remained proteolytic activity. We previously described that tPA potentiates N‐methyl‐D‐aspartate mediated neuronal calcium influx2 leading to an increased neuronal death. Although tPA potentiated NMDA induced neuronal death in primary cultures of neurones, it failed to do so in mixed cultures of neurones and astrocytes.

We hypothesized that the ability of astrocytes to recapture exogenous tPA could be influenced by the extracellular concentration of glutamate. Indeed, capture of tPA by astrocytes is dramatically increased by a competitive blocker of excitatory amino acid transporters (DL‐threo‐β‐Benzyloxyaspartic acid) or increasing concentrations of glutamate (0.1, 0.5 and 1mM).

Thus, astrocytic tPA uptake could be a critical mechanism to control synaptic neurotransmission and the ability of tPA to promote NMDA‐receptor signalling both in physiological and pathological conditions.

1\. Fernández Monreal M. et al. (2004) Mol. Cell. Neurosci 25, 594--601.

2\. Nicole et al. (2001) Nat Med 7:59--64.

Key words: tPA, glutamate, astrocytes, LRP
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A ROLE FOR EPHA4 IN THE DEVELOPING AND INJURED VISUAL CORTEX {#sec2-5}
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### Goldshmit Y., Bourne J. {#sec3-5}

#### Monash University, Melbourne, Australia {#sec4-5}

Eph/ephrin tyrosine kinase receptors and ligands are predominantly expressed in the brain during development. These molecules mediate cell migration and axonal pathfinding in the developing CNS mainly through repulsive signal.

In this study, we demonstrate the involvement of the EphA4 receptor in both the embryonic and postnatal development of the non‐human primate (marmoset monkey) visual cortex, as well as following injury of this cortical locus, through specific expression patterns.

Coronal and sagittal sections from brains of animals aged ED 130 (before cortical lamination is complete; n=1), PD 0 (n=2), PD14 (n=2) and 12 months (adult; n=2) were processed immunohistochemically for EphA4 expression. Nissl substance staining and nonphosphorylated neurofilament (NNF) expression were used to assist in the demarcation of laminar and areal boundaries. GFAP and vimentin were used to confirm EphA4 expression on astrocytes during development and after injury.

Between the late embryonic stage (ED 130) and birth, EphA4 was expressed on the radial processes of the astrocytes in V1, which are involved in guiding neurons to their target layer. At PD0, in area V2, where the neuronal cells have not been differentiated yet and their interconnections not present, EphA4 is still expressed on the radial processes of glia cells. However, in V1 EphA4 is already expressed on neuronal cell bodies. At PD14, EphA4 is strongly expressed on neuronal cells and their processes in layers 2/3, 4 and 5, which may suggest a role in establishment of local networks. In adult brain, EphA4 is downregulated from neuronal cells and mainly expressed on astrocytes around blood vessels, which may be important for the blood‐brain barrier maintenance.

In adult animals which received an injury (ablation) of V1, EphA4 is strongly upregulated on reactive astrocytes around the lesion site creating the glial scar (n=2) 3 weeks post‐lesion.

This study demonstrates that EphA4 is mediating neuronal guidance during visual cortex development and is important for formation of cortical boundaries. After neurotrauma EphA4 is mediating glial scar formation in nonhuman primate brain.
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INVESTIGATING THE EXPRESSION AND FUNCTION OF CPEB PROTEINS IN ASTROCYTES {#sec2-6}
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#### Institute of Cellular Neurosciences, Bonn, Germany {#sec4-6}

Cytoplasmic polyadenylation element binding proteins (CPEBs) are a family of translational regulators expressed in brain. They bind to mRNAs which contain the cytoplasmic polyadenylation element (CPE) and control protein synthesis. Using transgenic mice expressing a dominant negative CPEB in forebrain neurons we previously found a role for CPEBs in synaptic plasticity, learning and memory. We now ask the question whether CPEBs are relevant also in astroglia. CPEBs (2, 3 and 4) were detected in distinct astroglial subpopulations of mouse hippocampus by immunofluorescence, single cell RT‐PCR and nonradioactive in situ hybridisation (ISH). Their expression varied with respect to different astroglial subpopulations (GluT and GluR cells) of the mouse hippocampus. In addition, all the CPEB transcripts and proteins (1‐4) were detected in rat primary astrocyte cultures. The presence of CPEBs in astrocytes could be explained by their possible translational regulation of different mRNAs present in astroglial cells, such as GLT1 and connexins (Cx43 and Cx30). By reporter gene assays in cultured astrocytes, we are testing this hypothesis. To study the role of CPEBs in astrocytes, we have generated a transgenic mice expressing CPEB3 in astrocytes under GFAP promoter control (GFAP‐tTA; tetO‐CPEB3EGFP). The fluorescent CPEB3 protein was localized in the peripheral astrocytic processes, where it may modulate local protein synthesis of selected astrocytic gene products. Such mice exhibit enlarged ventricles and overt behavioural anomalies. We now further study the developmental effect of astrocytic CPEB3 overexpression. In parallel, we block transgene expression until adulthood by application of doxycycline and study the acute role of astrocytic CPEBs in the adult brain.
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ENDOCANNABINOIDS POTENTIATE SYNAPTIC TRANSMISSION THROUGH ASTROCYTE STIMULATION {#sec2-7}
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### Navarrete M., Araque A. {#sec3-7}

#### Instituto Cajal, CSIC, Madrid, Spain {#sec4-7}

We have investigated the effects of the ECB‐mediated neuron‐astrocyte signalling on synaptic transmission. Using electrophysiological and Ca2+ imaging techniques in mouse hippocampal slices, we performed paired recordings from CA1 pyramidal neurons and simultaneously monitored astrocyte Ca2+ levels. We stimulated Schaffer collateral single synapses using the minimal stimulation method, and we quantified the synaptic transmission properties. ECBs were released by depolarizing one pyramidal neuron (ND) while EPSCs were monitored in the adjacent neuron. We found: 1) ND transiently increased the probability of transmitter release (Pr) in 40% of the synapses, without affecting EPSC amplitudes, which resulted in a short‐term potentiation (e‐SP). These effects were abolished by the CB1R antagonist AM251, and were absent in CB1R‐/‐ mice. 2) In 27% of the synapses, ND evoked a transient decrease of Pr without changes in EPSC amplitudes. This was blocked by AM251 and was absent in CB1R‐/‐ mice. 3) ND evoked Ca2+ elevations in astrocytes that were abolished by AM251 and were absent in CB1R‐/‐ mice, indicating that they were due to astrocytic CB1R activation. 4) Both the ND‐evoked ECB‐mediated e‐SP and the astrocyte Ca2+ signal were unafected by pertussis toxin, but were blocked by phospholipase‐C antagonists and thapsigargin, indicating that they were not mediated by Gi/o proteins, but they were due to activation of Gq/11 proteins and phospholipase‐C‐mediated Ca2+ mobilization from internal stores. 5) After loading astrocytes with BAPTA, DSE was unaffected, but ND failed to induce e‐SP, indicating that it required astrocyte Ca2+ elevations. 6) The ND‐evoked e‐SP was abolished by the type I mGluR antagonists without affecting the astrocyte Ca2+ signal. Therefore, e‐SP was mediated by ECB‐induced Ca2+‐dependent release of glutamate from astrocytes, which activated presynaptic type I mGluR. 7) Synapses that showed ND‐evoked synaptic potentiation were depressed after perfusion with the CB1R agonist, indicating that they expressed CB1Rs that can lead to synaptic depression. We conclude that endocannabinoids potentiate excitatory synaptic transmission through stimulation of Ca2+‐dependent release of glutamate from astrocytes.

Funded by MICINN (BFU2007‐064764) Spain, and EU (HEALTH‐F2‐2007‐202167).
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CHANGES OF RELEASE PROPERTIES ON CA3‐CA1 SYNAPSES INDUCED BY METABOLIC ARREST OF ASTROCYTES IN HIPPOCAMPAL SLICES {#sec2-8}
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The glutamate released from stimulated astrocytes selectively increases the probability of neurotransmitter release (*Pr*) in the glutamatergic terminals of hippocampus by activation of metabotropic glutamate receptors. Astrocytes in situ exhibit spontaneous calcium oscillations, which appear to be necessary and sufficient to trigger gliotransmission of glutamate. However, it is unknown whether this spontaneous signalling from astrocytes could determine a basal state of *Pr* in synapses. Using electrophysiological approach in hippocampal slices, we evaluated *Pr* at CA3‐CA1 synapses in presence of gliotoxine fluorocitrate (FC). Excitatory postsynaptic currents were evoked by conventional stimulation (~e~EPSC) and by single fiber stimulation (~me~EPSC), and recorded in CA1 pyramidal neurons. FC reduced the amplitude and synaptic efficacy of ~e~EPSCs, as well as the *Pr*and synaptic potency of meEPSC. These effects occurred in parallel with increasing of paired pulse facilitation (PPF). Although the addition of glutamine (Gln) blocked the effects of FC on the ~me~EPSC potency, the PPF remained high due to a decrease in the rate of success. Parallely, FC decreased the frequency of spontaneous miniature postsynaptic currents (~m~EPSCs, TTX‐insensitive), independently of the addition of Gln. However, in the presence of FC plus Gln, the ~m~EPSCs amplitude did not change significantly. These results demonstrate that the astroglial inhibition induces: 1) a decrease in *Pr*, probably due to inhibition of astroglial signalling spontaneous and 2) a decrease of vesicular contents in glutamatergic terminals, due to the interruption of glutamine/glutamate cycle. We suggest that astroglial spontaneous signalling participates in determining a basal state of the release properties that characterize each synapse.

*Grants; FONDECYT ‐ CONICYT Chile 1061074; CID 01/2006; DIPUV 40/46‐2007.*
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TRANSIENT INFLAMMATION CAUSES CHRONIC TACTILE HYPERSENSITIVITY IN MICE: THE ROLE OF GAP JUNCTIONS {#sec2-9}
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### Hanani M.,^1^ Huang T.Y.,^1^ Dublin P.,^1^ Kushnir R.,^1^ Zuckerman J.,^1^ Gulinello M.,^2^ Spray D.C.^2^ {#sec3-9}

#### ^1^Hadassah University Hospital, Jerusalem, Israel; ^2^Albert Einstein College of Medicine. Dept of Neuroscience, Bronx, NY, United States {#sec4-9}

There is increasing evidence for the important role of glial cells in chronic pain. Satellite glial cells (SGCs) are the main type of glial cells in sensory ganglia, but still little is known about their role in pain states. We used a simple, but effective model for studying chronic orofacial pain in mice. Transient inflammation was induced in the submandibular region using complete Freund\'s adjuvant (CFA), and 3‐28 days later trigeminal ganglia were removed and examined in vitro. Coupling between cells was tested by intracellular injection of the fluorescent dye Lucifer yellow, and electrical activity of sensory neurons was monitored by intracellular electrodes. Sensitivity of mice to tactile stimulation was quantified using von Frey hairs. We found that CFA induced inflammation, which was resolved after 14 days, but hypersensitivity to tactile stimulation persisted for at least 53 days, consistent with post‐inflammatory, chronic pain. Dye coupling between SGCs was followed for up to 28 days and was found to increase 4.2‐6.8‐fold compared with controls, (p\<0.01). Dye coupling from neuron to neuron and from neuron to SGCs was also increased. Electrical recordings from neurons showed that 6‐7 days after CFA injection, the threshold for firing an action potential was 50% of that in controls. Also, spontaneous action potentials and subthreshold activity were greatly increased after CFA injection. These findings indicate an augmented excitability of the neurons. These changes were significantly reduced in the presence of the gap junction blocker carbenoxolone (50 μM). Injection of carbenoxolone to CFA‐treated mice largely reversed the behavioral changes. We conclude that inflammation induced augmented gap junction‐mediated coupling among trigeminal ganglion cells, and that this coupling contributes to neuronal hyperexcitability and chronic tactile hypersensitivity.
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CROSSTALK BETWEEN SPINAL ASTROCYTES AND NEURONS CONTRIBUTES TO NEUROPATHIC PAIN {#sec2-10}
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### Wang W., Wang W., Wu S.X., Li Y.Q. {#sec3-10}

#### The Fourth Military Medical university, Xi\'an, China {#sec4-10}

Emerging research implicates the participation of spinal dorsal horn (SDH) neurons and astrocytes in nerve injury‐induced neuropathic pain. However, whether they orchestrate together and how to contribute to neuropathic pain are not clear. Using a lumbar 5 (L5) spinal nerve ligation (SNL) pain model, we testified our hypothesis that SDH neurons and astrocytes reciprocally regulate each other to maintain the persistent neuropathic pain states. Glial fibrillary acidic protein (GFAP) was used as the astrocytic specific marker and Fos, protein of the protooncogene c‐fos, was used as a marker for activated neurons. SNL induced a significant mechanical allodynia as well as activated SDH neurons indicated by the Fos expression at the early phase and activated astrocytes with the increased expression of GFAP during the late phase of pain, respectively. Intrathecal administration of c‐fos antisense oligodeoxynucleotides (ASO) or astroglial toxin L‐α‐aminoadipate (L‐AA) reversed the mechanical allodynia, respectively. Immunofluorescent histochemistry revealed that intrathecal administration of c‐fos ASO significantly suppressed activation of not only neurons but also astrocytes induced by SNL. Meanwhile, L‐AA shortened the duration of neuronal activation by SNL. Our data offers direct evidence that neuronal and astrocytic activations are closely related with the maintenance of neuropathic pain through a reciprocal "crosstalk". The current study suggests that neuronal and non‐neuronal elements should be taken integrally into consideration for nociceptive transmission, and that the intervention of such interaction may offer some novel pain therapeutic strategies.
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DIFFERENTIAL GENE EXPRESSION IN TWO SPINAL CORD REGIONS WITH DISTINCT GROWTH‐INHIBITORY PROPERTIES {#sec2-11}
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### Waselle L., Quaglia X., Zurn A. {#sec3-11}

#### CHUV, Lausanne, Switzerland {#sec4-11}

Dorsal root injury leads to reactive gliosis and to disintegration of axons and myelin sheaths (Wallerian degeneration) in the dorsal root entry zone (DREZ) and in the spinal cord dorsal column beyond the DREZ, two regions that have distinct growth‐inhibitory properties. This disparity could be due to differences in glial cell activation, and/or to differential gene expression. Laser capture microdissection followed by quantitative analysis of mRNA expression by real‐time PCR as well as immunohistochemical analysis revealed that glial markers were differentially expressed post‐injury. In addition, the number of glial cells undergoing cell division was different, and the proportion of microglia/macrophages amongst dividing cells was higher in the dorsal column than the DREZ. Furthermore, transcripts for the chondroitin sulfate proteoglycans Brevican and Versican were found to be preferentially up‐regulated in the DREZ and not the dorsal column. These results clearly identify two proteoglycans as potential key molecules participating in the highly inhibitory properties of the DREZ and reveal distinct glial activation in the two regions. They provide the first molecular evidence in support of earlier work indicating that the dorsal column is less inhibitory to sensory axonal growth after injury than the DREZ. Strategies to selectively decrease the expression of these CSPGs by RNA interference could therefore provide novel tools to promote repair following spinal cord or brachial plexus injury. This comparative strategy may allow to discover additional molecules such as cytokines and chemokines involved in inflammation as potential highly selective targets for ameliorating axonal regeneration post‐injury.
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GPR126 IS ESSENTIAL FOR SCHWANN CELL MYELINATION {#sec2-12}
------------------------------------------------

### Monk K., Naylor S., Glenn T., Mercurio S., Perlin J., Dominguez C., Talbot W. {#sec3-12}

#### Stanford University, Stanford, United States {#sec4-12}

During the development of myelinated axons, promyelinating Schwann cells associate with one segment of an axon, and later become mature Schwann cells that repeatedly wrap their membranes around axons to form the myelin sheath. Incompletely understood axonal signals activate specific transcription factors, including Oct6 and Krox20, that initiate myelination in Schwann cells. Elevation of cAMP can mimic axonal contact in vitro, but the mechanisms that regulate cAMP levels in vivo are unknown. Using mutational analysis in zebrafish, we report that *gpr126*, which encodes a member of the G protein‐coupled receptor superfamily with no previously defined function, is required autonomously in Schwann cells for myelination. In *gpr126* mutants, Schwann cells fail to express *oct6* and *krox20*, and ultrastructural analyses demonstrate that Schwann cells do not progress beyond the promyelinating stage. Elevation of cAMP in *gpr126* mutants rescues Mbp expression, and genetic studies show that Gpr126 activates *oct6* expression in parallel with Neuregulin/ErbB signaling. Ongoing experiments to understand the role of Gpr126 in myelination will be discussed.
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ORGANIC CATION TRANSPORTER MRNA EXPRESSION IN CULTURED ADULT AND NEONATAL RAT ASTROCYTES AND THEIR POSSIBLE FUNCTIONAL ROLE {#sec2-13}
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### Perdan ‐ Pirkmajer K.,^1^ Pirkmajer S.,^2^ Mars T.,^2^ Grubic Z.,^2^ Krzan M.^1^ {#sec3-13}
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Astrocytes have been shown to play an important role in the inactivation of various neurotransmitters, including histamine. Although a number of transporters has been identified on astrocytes, a specific histamine transporter remains an unresolved issue. Organic cation transporters (OCT1, 2 and 3) are often mentioned as possible participants in histamine transport, but their expression pattern and functional role in astrocytes remain to be elucidated.

The goal of our present work was to establish whether OCTs might participate in histamine uptake in cultured rat astrocytes. We first assessed the expression pattern of OCT mRNA (real‐time PCR) in cultured rat astrocytes and rat cortical tissue samples. All three types of OCTs were expressed both in astrocyte cultures and cortical tissue, but their relative levels were significantly different. While OCT3 was most prominently expressed in neonatal and adult cortical tissue samples, it was barely detectable in cultured neonatal astrocytes, while the expression level was more than 20‐fold lower than OCT2 in adult astrocyte cultures. On the other hand the level of OCT1 mRNA was almost undetectable in cortical tissue (more than 1000‐fold lower than OCT3), but was expressed at a level comparable to OCT2 in astrocyte cultures. The OCT2/OCT1 ratio reached 2 in adult astrocytes (N=4, p\<0.05) and 30 in neonatal astrocytes (N=4, p\<0.001).

To assess the possible functional role of OCTs in histamine transport in cultured astrocytes, we carried out a preliminary \[3H\]‐histamine uptake study. Decynium 22 (D22), a specific OCT inhibitor, in a concentration range of 0.1--50 microM notably lowered histamine uptake in neonatal and adult astrocyte cultures, however the observed effect was statistically significant only in the adult astrocyte cultures (p\<0.001, ANOVA).

Our preliminary results imply that astrocytes not only express mRNA for OCTs but are also possible candidates for histamine uptake into astrocytes. Further studies are needed.
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THYROID HORMONE REGULATES BORG4 AND SEPTIN‐4 EXPRESSION DURING BERGMANN GLIA DIFFERENTIATION {#sec2-14}
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### Horn S.,^1^ Kaether C.,^1^ Mittag J.,^2^ Schäfer M.K.,^3^ Baader S.L.,^4^ Heuer H.^1^ {#sec3-14}
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Absence of thyroid hormone has a devastating impact on brain development by affecting processes such as neuronal migration and differentiation, myelination and synaptogenesis. As the most prominent consequence of congenital hypothyroidism cerebellar development is severely impaired with a striking reduction of Purkinje cell dendritic growth and branching as a prominent hallmark. Since Purkinje cells dendrites are structurally and functionally closely associated with Bergmann glia processes one would expect an impaired Bergmann glia differentiation under hypothyroid conditions as well. Yet, the importance of thyroid hormone for proper Bergmann glia development still remains rather enigmatic.

Our analysis of congenital athyroid Pax8‐/‐ mice that express GFP in glia cells revealed indeed a pronounced reduction in the formation of the lateral Bergmann glia appendages while the formation of the radial glia fibers was unaltered. By studying the expression levels of gene products putatively involved in the formation of the glial lamellate processes we found a decreased expression of Septin‐4, a cytoskeletal protein with GTPase activity, and Borg4, a downstream target of Cdc42/Rho GTPases, specifically in Bergmann glia cells of hypothyroid animals. Thyroid hormone treatment restored normal Borg4 and Septin‐4 expression levels via activation of the thyroid hormone receptor TRalpha1. Most intriguingly, overexpression of Borg4 in primary cerebellar astrocytes resulted not only in an altered subcellular Septin‐4 localization but also lead to the formation of long filamentous protrusions. Based on our findings we speculate that a Borg4/Septin‐4 pathway plays an important role in the thyroid hormone induced Bergmann glia development.
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SUBTHALAMIC ELECTRICAL STIMULATION EVOKES CALCIUM SIGNALS IN GLIAL CELLS OF THE SUBSTANTIA NIGRA PARS RETICULATA {#sec2-15}
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### Barat E., Bouyssieres C., Boisseau S., Savasta M., Albrieux M. {#sec3-15}

#### Inserm U836 ‐ Université Joseph Fourier, Grenoble, France {#sec4-15}

The subthalamic nucleus (STN) is a key component of the basal ganglia network, influencing its output structures, including the substantia nigra pars reticulata (SNr). High‐frequency stimulation of the subthalamic nucleus (STN‐HFS) is an effective treatment for alleviating the motor symptoms of parkinsonian patients. However, the neurobiological mechanisms by which STN‐HFS improves these motor symptoms remain unclear. Electrophysiological and neurochemical in vivo studies on Parkinson\'s disease animal models are beginning to understand the impact of STN‐HFS on SNr neuronal cells; however, the involvement of glial cells in the HFS mechanisms remains unclear. We used calcium imaging to investigate the impact of STN electrical stimulation on the glial cell response within the SNr in rat brain slices. Immunohistochemical analyses showed that the rat SNr contains about 70% glial cells. During STN electrical stimulation, calcium levels increased in 12% of the loaded SNr glial cells. Applications of ATP, glutamate and GABA also induced Ca2+ transients in some SNr glial cells. We investigated the role of gliotransmitters and neurotransmitters in the observed STN‐HFS calcium response, using purinergic (suramin), glutamate (CNQX, LAP‐3, D‐AP5) and GABA (bicuculline, saclofen) receptor inhibitors. All these inhibitors strongly and significantly affected the calcium response observed under STN electrical stimulation, demonstrating the involvement of ATP, glutamate and GABA in the STN‐HFS‐induced glial calcium response. These data provide insight into the mechanisms involved in the functional impact of STN‐HFS, implicating glial cells as a new actor in the SNr response, involving ATP, glutamate and GABA transmission in particular.
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OLFACTORY ENSHEATHING CELLS AND SCHWANN CELLS INTERACT WITH GLIAL CELLS AND NEURONS VIA HIGHLY MOTILE LAMELLIPODIAL WAVES {#sec2-16}
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### Ekberg J., Windus L., Scott S., Lineburg K., Cornock J., Mackay‐Sim A., St John J. {#sec3-16}

#### National Centre for Adult Stem Cell Research, Nathan, Australia {#sec4-16}

Implantation of olfactory ensheathing cells (OECs) or Schwann cells (SCs) into damaged CNS tracts have led to axonal regeneration but the results are not optimal and the favorable glial type may vary depending on the site of injury. Therefore it is crucial to investigate the functional differences between OECs and SCs in terms of modulation of different types of neurons, and to determine how these glial cells interact with neurons. We have previously shown that OECs display highly motile peripheral membrane protrusions termed lamellipodial waves, which mediate cell‐cell contact between OECs and may potentially also mediate OEC‐axon contacts.

Using high‐speed, high‐resolution time lapse imaging of fluorescently labeled cells, we have for the first time demonstrated the presence of dynamic lamellipodial waves in SCs. The waves were similar to those in OECs in terms of number of waves/cell and wave area (n = 14‐15) but traveled ∼2‐fold faster (n = 20; p ≤ 0.01, t‐test). As previously shown for OECs, the number of waves and wave area of SCs correlated positively with whole‐cell migration rate (p ≤ 0.0001 and 0.005, respectively). Both OECs and SCs interacted directly with DRG axons via lamellipodial waves and selectively migrated along DRG axons rather than on the surrounding substrate. Contact with axons increased the migration‐rate of glial cells ∼2‐fold (p ≤ 0.0001), most likely as a result of increased wave area in SCs (p ≤ 0.05). Finally, we showed that both SCs and OECs promote survival of DRG neurons. In a nutrient‐free medium, neuronal survival after 3 days was increased from 40 % to 67 % by SCs (p ≤ 0.05) and to 77 % by OECs (p ≤ 0.01) (n = 8‐16 wells containing ∼200 neurons; one‐way Anova, Tukey\'s post test).

In summary, we have demonstrated that similarly to OECs, SCs exhibit lamellipodial waves, and that contact with axons leads to increased wave activity and resulting increased migration. Both OECs and SCs promoted neuronal survival with no difference between the two glial cell types, suggesting that transplantation of both SCs and OECs may promote regeneration of damaged sensory neurons.
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GLIAL CELL POPULATION DYNAMICS IN VITRO {#sec2-17}
---------------------------------------

### Szabo M., Gulya K. {#sec3-17}

#### University of Szeged, Szeged, Hungary {#sec4-17}

The population dynamics of different glial cell types (astroglia, oligodendroglia and microglia) and neurons were investigated and correlated to a selected group of EF‐hand‐type calcium (Ca)‐binding/buffer proteins in rat primary cortical cell cultures by immunohistochemistry and Western blot analysis. Primary cortical cell cultures were established from E18 wild‐type rat embryos and maintained routinely in cultures for up to 28 days. A massive expansion of the microglial cell type was observed in vitro as Iba1 immunoreactivity, demonstrated by Western analysis, was steadily increased about 800‐fold between DIV1 and DIV28, while the number of Iba1‐immunoreactive microglial cells during the same culturing period rose at least 66‐fold. However, another microglial marker, HLA‐DRalpha, detected by immunocytochemistry, was expressed in only a few microglial cells shortly after seeding. The amount of the astrocytic marker GFAP increased 85‐fold from DIV1 to DIV7, and remained steady thereafter. A smaller (about 10‐fold) increase in CNPase immunoreactivity, an oligodendrocyte marker, was also noted throughout in vitro culturing. The in vitro development of the selected Ca‐binding/buffer proteins displayed a differential expression during the culturing period. While the immunoreactivity of CaM (the prototypic EF‐hand‐type intracellular Ca sensor protein abundant in neurons, but also present in glial cells) did not change significantly from DIV1 to DIV28, the immunoreactivities of CB‐D28K and S100, markers characteristic of neuronal and astroglial cells, respectively, displayed marked increases from DIV10 to DIV 28; they were in excess of 30‐ and 50‐fold for CB‐D28K and S100, respectively. Interestingly, the amount of a neuron‐specific marker (TU‐20) decreased steadily during the same culturing period. Our finding that many of the CB‐D28K‐positive cells survived the massive neuronal cell loss starting at DIV7 can be explained by the protective effects of this protein against apoptotic cell death, and thus by the high survival rate of the CB‐D28K‐containing neurons. Studies of population dynamics combined with phenotypic characterization, using multiple cell‐specific markers in cell cultures, can be of importance when different pathophysiological situations are modeled in vitro.
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INTRACELLULAR SODIUM SIGNALS INDUCED BY SYNAPTIC ACTIVITY IN ASTROCYTES IN SITU {#sec2-18}
-------------------------------------------------------------------------------

### Langer J., Rose C.R. {#sec3-18}

#### University of Duesseldorf, Duesseldorf, Germany {#sec4-18}

In the central nervous system, astrocytes are in close contact to excitatory synapses and express transporters which mediate the sodium‐ dependent uptake of glutamate. In cultured astrocytes, activation of glutamate uptake results in sodium elevations which stimulate Na^+^/K^+^‐ATPase and metabolism. Sodium increases can also induce the clustering of glutamate transporters, indicating that sodium might serve a signalling function in glial cells.

Here, we analysed sodium transients evoked by synaptic stimulation in SR101‐positive, passive astrocytes and pyramidal neurons in acute hippocampal slices of juvenile mouse brain using whole‐cell patch‐clamp and quantitative sodium imaging with the fluorescent dye SBFI. We found that short bursts of afferent Schaffer collateral stimulation (5‐10 pulses at 50 Hz) evoke sodium transients in the mM range in the somata of neurons and astrocytes. Pharmacological analysis revealed that neuronal sodium signals were mainly attributable to sodium influx through ionotropic glutamate receptors. Activation of ionotropic receptors also contributed to glial sodium transients, while TBOA‐sensitive glutamate uptake was the major pathway responsible for sodium influx into astrocytes following synaptic activation. Upon selective activation of glutamate uptake by D‐aspartate as well as following synaptic stimulation, we found that glial sodium transients were defined to 1‐2 primary branches and adjacent fine processes and only weakly invaded the soma with low stimulation intensities. More intense stimulation, in contrast, elicited global sodium transients throughout the entire cell.

Our results establish that glutamatergic synaptic transmission in the hippocampus results in either local or global sodium transients in astrocytes that are mainly mediated by activation of glutamate uptake. They also suggest the existence of microdomains for sodium signalling, in which sodium‐dependent processes could be modulated independently.

Supported by the Deutsche Forschungsgemeinschaft (SPP1172: neuron‐glia interaction at synapses; Ro2327/4‐3).
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CORTICAL ASTROCYTES EXPRESS FUNCTIONAL ENDOCANNABINOID RECEPTORS {#sec2-19}
----------------------------------------------------------------

### Maglio L., Araque A. {#sec3-19}

#### Instituto Cajal, Madrid, Spain {#sec4-19}

Accumulating evidence have demonstrated the existence of bidirectional communication between astrocytes and neurons.

Although, the functional expression of CB1 receptors (CB1Rs) has been demonstrated in hippocampal astrocytes, their expression in astrocytes from other brain regions remains unknown. We have studied if cortical astrocytes express functional CB1 receptors. Using electrophysiological and calcium imaging techniques from mice primary somatosensory cortical slices, we have recorded the intracellular Ca2+ signal in astrocytes located in layer I and II/III. We locally applied the CB1R agonist WIN 55,212‐2 by pressure pulses (2 s duration) in the presence of TTX (1 μM).

We have found that:1‐Cortical astrocytes in layer I and II/III respond with transient intracellular Ca2+ elevations to local application of WIN.2‐The astrocytic intracellular Ca2+ increases were blocked by the selective antagonist of CB1Rs, AM251 (2 μM).3‐WIN‐evoked astrocytic Ca2+ elevations were abolished by thapsigargin (1 μM), that depletes the intracellular calcium stores.4‐The phospholipase (PLC) antagonist U73122 (4 μM) prevent the WIN‐evoked Ca2+ elevations in astrocytes.5‐Ca2+ elevations evoked by WIN were absent in astrocytes from transgenic mice lacking CB1R expression (CB1R‐/‐).

Therefore, these results indicate that cortical astrocytes of layers I and II/III express functional CB1Rs, which activate the phospholipase C lead the mobilization of Ca2+ from internal stores.

We thank A. Zimmer for the generous gift of the CB1R‐/‐ mice.

Supported by: MICINN (BFU2007‐64764) and European Union (Health‐F2‐2007‐202167) and Cajal Blue Brain to AA.
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THE DIRECT AND INDIRECT ROLE OF CYTOSOLIC PHOSPHOLIPASE A2A IN NEURO‐DEGENERATION IN RAT GLIA‐NEURON MIXED CULTURES {#sec2-20}
-------------------------------------------------------------------------------------------------------------------

### Levy R., Szaingurten‐Solodkin I., Sagy‐Bross C., Hadad N., Moshayev Z. {#sec3-20}

#### Ben‐Gurion University of the Negev, Beer‐Sheva, Israel {#sec4-20}

In Alzheimer\'s disease the progressive loss of neuronal cells is associated with extracellular plaques mainly composed of the b‐amyloid peptides. The role of cytosolic Phospholipase A2a (cPLA~2~a) in either microglia, neuron and glia‐neuron mixed cultures exposed to aggregated Ab (Ab) was studied using antisense technology which specifically inhibited its production and activity. Addition of Ab to either primary rat microglia or rat cortical neuron caused an elevation in cPLA~2~a activity and protein expression. Exposure of microglia to aggregated Ab caused an activation of cPLA~2~a and of NOX2‐ NADPH oxidase, which is under cPLA2a regulation. In turn, released superoxides induced the elevation of both cPLA~2~a and COX‐2 protein expression, probably through activation of the redox sensitive NF‐kB as detected by its phosphorylation of Ser‐536. The high levels of PGE~2~ secreted extracellularly induce iNOS protein upregulation by activating the PKA‐CREB pathway resulting in NO production. Exposure of primary rat cortical neurons to Ab for 24 h caused apoptotic cell death of about 20%. The apoptotic process involves activation of caspase‐8 and caspase‐3 dependent on cPLA~2~a activity but not caspase‐9. Exposure of rat glia‐neuron mixed cultures (containing 6‐8% microglia) to Ab 42 for 24 h resulted with a higher apoptotic cell death of about 35%, which was prevented by inhibition of cPLA~2~a up‐regulation. The results suggest that both microglia cPLA~2~a indirectly and neuronal cPLA2a directly contribute to neuro‐degeneration and that cPLA~2~a may serve as an efficient target for treatment of Alzheimer\'s disease.
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NEUROGLIAL CONTACTS IN THE CRAYFISH STRETCH RECEPTOR AT THE ULTRASTRUCTURAL LEVEL {#sec2-21}
---------------------------------------------------------------------------------

### Uzdensky A.,^1^ Fedorenko G.^2^ {#sec3-21}

#### ^1^Southern Federal University, Rostov‐on‐Don, Russian Federation; ^2^Southern Scientific Center RAN, Rostov‐on‐Don, Russian Federation {#sec4-21}

Crayfish stretch receptor neuron (SRN) enwrapped by satellite glial cells (GC) is a simplest system for study of neuroglial interactions. Its glial envelope consists of 10‐30 layers separated by collagen. The space between neuronal and adjacent glial membrane is usually less than 15 nm width. This facilitates intercellular diffusion but limits neuron communication with the external medium. Microtubule and neurofilament bundles passing from dendrites to axon form the fibrillar capsule around the neuron perikarion, which reduces vesicular transport between the perikarion and the plasma membrane. Numerous glial invaginations into the neuron cytoplasm up to 1 μm deep across the fibrillar layer shorten the diffusion pathway between GC and SRN perikarion. They also mechanically strengthen GC binding to SRN. Double‐wall vesicles, which may represent the captured tips of these invaginations, are numerous at the periphery of the neuron cytoplasm. Their cytoplasm is typical for neuronal but not glial cell. Specific structural triads consisting of flat subsurface cisterns, ER vesicles and mitochondria are present in the neuron regions contacting to glial cells. These triads are presumably involved in formation of glial invaginations and double‐wall vesicles and in the neuroglial exchange. The tubular lattice found in glial cells can participate in the transfer of ions and metabolites between glial layers. Sometimes, the local impairments of integrity of the neuronal and glial membranes were observed. However, free neuroglial passage between these cells was possibly prevented by the diffuse material accumulated in these regions. Thus, the neuroglial exchange with some cell components may be mediated by diffusion through glial invaginations and submembrane cisterns, by double‐walled vesicles, in which big glial masses are captured, and by transfer through tubular lattices.

The work is supported by RFBR (grant 08‐04‐01322) and Minobrnauki RF (grant 2.1.1/6185).
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CHARACTERIZATION OF THE MORPHOLOGICAL AND MOLECULAR CHANGES ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES {#sec2-22}
-----------------------------------------------------------------------------------------------------------------------------

### Zenker J., de Preux Charles A.S., Arnaud E., Médard J.J., Chrast R. {#sec3-22}

#### University of Lausanne, Lausanne, Switzerland {#sec4-22}

More than 246 million individuals worldwide are affected by diabetes mellitus (DM) and this number is rapidly increasing (<http://www.eatlas>. idf.org). 90% of all diabetic patients have type 2 DM, which is characterized by insulin resistance and β‐cell dysfunction. Even though diabetic peripheral neuropathy (DPN) is the major chronic complication of DM its underlying pathophysiological mechanisms still remain unknown.

To get more insight into the DPN associated with type 2 DM, we characterized the rodent model of this form of diabetes, the db/db mice. The progression of pathological changes in db/db mice mimics the ones observed in humans: increase of the body weight, insulin insensitivity, elevated blood glucose level and reduction in nerve conduction velocity (NCV). Decreased NCV, present in many peripheral neuropathies, is usually associated with demyelination of peripheral nerves. However, our detailed analysis of the sciatic nerves of db/db mice exposed for 4 months to hyperglycemia, failed to reveal any signs of demyelination in spite of significantly reduced NCV in these animals. We therefore currently focus our analysis on the structure of Nodes of Ranvier, regions of intense axo‐glial interactions, which also play a crucial role in rapid saltatory impulse conduction. In addition we are also evaluating molecular changes in somas of sensory neurons projecting through sciatic nerve, which are localized in the dorsal root ganglia. We hope that the combination of these approaches will shed light on molecular alterations leading to DPN as a consequence of type 2 DM.

P‐023 {#sec1-23}
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IMPACT OF GLIAL NEUROTRANSMITTERS UPTAKE ON CORTICOSTRIATAL INFORMATION PROCESSING {#sec2-23}
----------------------------------------------------------------------------------

### Goubard V., Fino E., Deniau J.M., Venance L. {#sec3-23}

#### Collège de France, Paris, France {#sec4-23}

Basal ganglia are involved in learning of contextual cognitive and motor sequences related to environmental stimuli. Striatum, the main input nucleus of basal ganglia, receives glutamatergic inputs from the whole cerebral cortex. The striatal output neurons (medium‐sized spiny neurons, MSNs), act as detectors of distributed patterns of cortical activity. Glial modulation of uptake of neurotransmitters constitutes a key step in the information processing. However, the impact of astrocytes on corticostriatal transmission and synaptic plasticity remains to be determined. We performed electrical stimulation in layer V of the somatosensory cortex while recording MSNs and astrocytes by double patch‐clamp in the dorsal striatum. Cortical stimulations evoked reliable glutamatergic excitatory postsynaptic currents (EPSCs) in MSNs and efficient inward currents in astrocytes. Such astrocytic evoked‐currents displayed latency of 4.74±0.32 ms, amplitude of 55.4±7.0 pA and rise time of 11.9±0.8 ms (n=29). Astrocytic evoked‐currents originated mainly from the activities of glutamate and GABA transporters. Indeed, dihydrokainic acid, an inhibitor of glutamate transporter‐1 and nipecotic acid, a non‐specific GABA transporter inhibitor, inhibited cortically astrocytic evoked‐currents by 30.3±7.5 % and 29.2±5.5 % (n=12 and n=10) respectively, and 47.8±6.0 % (n=5) when applied together. Inhibition of glutamate and GABA transporters led to significant decreases of the cortically MSN‐evoked responses: 20.2±7.5 % (n=8) and 41.7±12.7 % (n=5), respectively. We have determined the characteristics of short‐term plasticity in MSNs and astrocytes. Namely, we have observed some facilitation and depression of the MSN EPSCs as well as astrocytic transporter currents, depending on the paired‐pulses intervals. Finally, we have observed that these plasticities are modified after glutamate or GABA uptakes inhibitions.

In conclusion, our experiments indicate that neurotransmitters uptake by astrocytes is particularly efficient in the corticostriatal axis and have a strong impact on transmission and synaptic plasticity. Such astrocytic properties could play a determinant role in the MSN coincidence detection of cortical activities.

P‐024 {#sec1-24}
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D‐SERINE GOVERNS NMDA RECEPTORS‐DEPENDENT SYNAPTIC ACTIVITY IN THE PREFRONTAL CORTEX OF ADULT RATS {#sec2-24}
--------------------------------------------------------------------------------------------------

### Turpin F.R.,^1^ Fossat P.,^1^ Dulong J.R.,^1^ Rivet J.M.,^2^ Sacchi S.,^3^ Pollegioni L.,^3^ Millan M.J.,^2^ Oliet S.H.,^1^ Mothet J.P.^1^ {#sec3-24}

#### ^1^Neurocentre Magendie, Inserm U862, Université de Bordeaux, Bordeaux, France; ^2^Department of Psychopharmacology, Institut de Recherches Servier, Croissy SUR Seine, France; ^3^Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, Italy {#sec4-24}

Ionotropic N‐methyl D‐aspartate (NMDA) glutamate receptors mediate fast synaptic transmission in the brain and play a crucial role in learning and memory. Their dysfunction is believed to be associated with a number of neuropsychiatric disorders, including schizophrenia. Though not all data agree, genetic linkage studies have incriminated genes coding for enzymes associated with D‐serine metabolism as risk factors for schizophrenia. Interestingly, D‐serine is a major endogenous co‐agonist of NMDA receptors in many brain regions. However, its role in governing NMDA receptor functions in the prefrontal cortex (PFC) has not yet been defined. We have developed a slice preparation of adult PFC for studying the control by D‐serine of NMDA receptor‐mediated activity. Using patch‐clamp recordings of pyramidal neurons in layers V/VI, we show that specific enzymatic degradation of D‐serine with D‐amino acid oxidase (DAAO) attenuates NMDA receptor‐mediated currents, whereas degradation of glycine with glycine oxydase (GO) exerts no effect. The cellular origin(s) of D‐serine were evaluated. Immunohistochemistry revealed that in the PFC, D‐serine is predominantly present in glial cells, as well as in a subpopulation of neurons whereas serine racemase is localised exclusively in glia. Recordings made in the presence of fluoroacetate (FAC), a glial metabolic inhibitor, blunted NMDA currents without affecting activity at AMPA receptors. The addition of D‐serine restored the NMDA receptor‐mediated currents in FAC‐treated slices, supporting the idea that D‐serine originates from glial cells. Finally, we show that glia‐derived D‐serine controls NMDA receptor‐dependent long term synaptic potentiation (LTP) since application of DAAO occluded the LTP. Furthermore treatment of PFC slices with FAC blocked the LTP which was rescued by adding D‐serine. These data provide compelling evidence that D‐serine rather than glycine controls activity at NMDA receptors in the PFC of adult rats. This reinforces interest in strategies for modulating D‐serine in the treatment of schizophrenia.
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CXCL10/CXCR3 SIGNALING IN GLIA CELLS DIFFERENTIALLY AFFECTS NMDA‐INDUCED CELL DEATH IN CA AND DG NEURONS OF THE MOUSE HIPPOCAMPUS {#sec2-25}
---------------------------------------------------------------------------------------------------------------------------------

### Vinet J.,^1^ Van Weering H.,^1^ de Haas S.,^1^ Brouwer N.,^1^ Van Rooijen N.,^2^ Thomsen A.,^3^ Boddeke E.,^1^ Biber K.^1^ {#sec3-25}

#### ^1^University Medical Center Groningen, Groningen, Netherlands; ^2^Free University Medical Hospital, Amsterdam, Netherlands; ^3^University of Copenhagen, Copenhagen, Netherlands {#sec4-25}

The chemokine CXCL10 and its receptor CXCR3 have been implicated in various CNS pathologies and their expression has been demonstrated in both neurons and glia cells. Interference with CXCL10/CXCR3 signaling alters the onset and progression of pathological signs in various CNS disease models. However, the mechanism and cell‐types involved in CXCL10/CXCR3 signaling under pathological conditions are far from understood. Here, we investigated the potential role for CXCL10/CXCR3 signaling in neuronal cell death and glia activation in response to N‐methyl‐D‐aspartic acid (NMDA)‐induced excitotoxicity in mouse organotypic hippocampal slice cultures (OHSCs). Our findings demonstrate that astrocytes rapidly express CXCL10 in response to NMDA‐induced excitotoxicity. To determine the effect of CXCL10 on NMDA‐induced neuronal cell death we prepared OHSCs derived from CXCL10‐deficient (CXCL10‐/‐) and CXCR3‐deficient (CXCR3‐/‐) mice and subsequently exposed these slice cultures to 0 (control), 10, 15, 25 or 50 μM NMDA. In the absence of CXCL10 or CXCR3, neuronal cell death in the hippocampal regions CA1 and CA3 was attenuated in response to NMDA‐treatment when compared to wild type conditions. In contrast, neuronal cell death in the DG region was enhanced in both CXCL10‐/‐ and CXCR3‐/‐ OHSCs in response to a high (50 μM) NMDA‐concentration. Furthermore, we show that in the absence of microglia these differential changes in neuronal vulnerability between CXCR3‐/‐ and wild type OHSCs are fully abrogated, suggesting a prominent role for microglia in this process. Taken together, our results identify a region‐specific role for CXCL10/CXCR3 signaling in neuron‐glia and glia‐glia interactions under pathological conditions.
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LOSS OF PEROXISOMAL FUNCTION FROM ALL NEURAL CELLS BUT NOT FROM ASTROCYTES OR NEURONS CAUSES AXONAL DEGENERATION AND DYSMYELINATION {#sec2-26}
-----------------------------------------------------------------------------------------------------------------------------------

### Bottelbergs A.,^1^ Hulshagen L.,^1^ Goebbels S.,^2^ Nave K.A.,^2^ Baes M.^1^ {#sec3-26}

#### ^1^Kuleuven, Leuven, Belgium; ^2^Max Planck Institute, Goettingen, Germany {#sec4-26}

We previously showed that elimination of functional peroxisomes from all neural cells (Nestin--Pex5 knockout mice) causes dys‐ and demyelination, axonal damage, lipid accumulations, astrogliosis and microgliosis. Macroscopically the mice suffer from coordination and cognitive problems and they all die before the age of six months (Hulshagen et al, J. Neurosci., April 9, 2008, 28(15):4015‐4027). A mouse model which only lacks peroxisomes in oligodendrocytes (CNPase‐Pex5) shows a similar pathology, but with a later onset and slower progression (Kassman et al., Nat. Genet. 2008, 39, 969 ‐ 976).

In view of the axonal degeneration and the fact that peroxisomes are important players in intermediary metabolism, which is primarily performed by astrocytes in the brain, we now studied the phenotype of mice with neuron or astrocyte selective inactivation of peroxisomal function (NEX‐Pex5 and GFAP‐Pex5 knockout mice respectively).

Macroscopically, neither the GFAP‐Pex5 nor the NEX‐Pex5 knockout mice showed any alterations in motoric performance and they had a normal life span. Microscopically and metabolically no abnormalities were noticed in the NEX‐Pex5 knockout mice, indicating that these organelles are not essential within neurons, if they are still present in glial cells. The GFAP‐Pex5 knockout mice showed several metabolic alterations such as accumulation of neutral lipids in Bergmann glial cells and around the lateral ventricle, colocalising with an overexpression of the peroxisomal anti‐oxidative enzyme catalase. The very long chain fatty acid C26 was elevated and plasmalogen levels were significantly decreased in GFAP‐Pex5 knockout mice, indicating that astrocytes do participate importantly in peroxisomal metabolism in brain. Surprisingly, these lipid alterations were even more pronounced in isolated myelin, compared to whole brain extracts.

In conclusion, the lipid abnormalities in GFAP‐Pex5 knockout mice do not trigger pathological abnormalities. Comparison of the different mouse models with peroxisome deficiency in brain indicates that there is metabolic crosstalk at the level of peroxisomes between brain cell types.
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SECRETION PROPERTIES OF NEURONAL CCL21 {#sec2-27}
--------------------------------------

### Vinet J., Boddeke E., Biber K. {#sec3-27}

#### UMCG, Groningen, Netherlands {#sec4-27}

Neuronal CCL21 is a microglia‐activating chemokine, which in brain is solely found in endangered neurons. Recently, we have demonstrated that CCL21 is sorted in large dense‐core vesicles and transported into every neuronal compartment making a good candidate for directed communication between neuron and microglia. However, no data exist regarding which stimuli can induce CCL21 release from vesicles. Here we have used CCL21‐pHluorin construct transfected into NG‐108 cells (neuron‐like cells) and live‐cell imaging to study the release properties of CCL21. We show that glutamate but not KCl induces release of CCL21. After stimulation with glutamate, we observed an increase in the frequency of release events which was more prominent in the cell body than in neurites. Moreover, these release events appeared several seconds‐minutes after stimulation suggesting involvement of a slow molecular pathway. Furthermore, we observed various durations of release events ranging from 2‐3 sec up to minutes after initial fusion, which is in line with recent data published by de Wit et al (2009). Our data suggest that preferential stimuli, which are not necessarily linked to membrane depolarization, are implicated in CCL21 release.
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INTERLEUKIN (IL)‐6‐TYPE CYTOKINES IN NEUROPROTECTION: IL‐6 AND OSM PROTECT NEURONS AGAINST EXCITOTOXICITY DIFFERENTLY FROM LIF {#sec2-28}
------------------------------------------------------------------------------------------------------------------------------

### Moidunny S.,^1^ Boddeke E.,^1^ Limatola C.,^2^ Enrique E.,^2^ Biber K.^1^ {#sec3-28}

#### ^1^University Medical Center Groningen, Groningen, Netherlands; ^2^Universita di Roma, Rome, Italy {#sec4-28}

Toxicity induced by the neurotransmitter glutamate (excitotoxicity) has been described as the major cause of neuronal death in diseases like ischemic stroke, Spinal cord trauma, Multiple sclerosis, Parkinson\'s and Alzheimer\'s disease. Excitotoxicity has been shown to be associated with high amounts of adenosine accumulation in the extracellular space. Extracellular adenosine are well known for their endogenous neuroprotective properties, which is largely mediated through the Adenosine A1 receptors (ADORA1) on neurons. Our group recently showed that IL‐6, a soluble cytokine produced in the brain mainly by glial cells, increased the ADORA1 levels in mouse cortical neurons in vitro. Moreover, neuronal cultures that were pre‐incubated with IL‐6 showed an increased survival against excitotoxicity, which was completely abolished when the neuronal Adenosine A1 receptors were pharmacologically blocked. This strongly indicates that the neuroprotection induced by IL‐6 is mediated through neuronal Adenosine A1 receptors. IL‐6 has been shown to have overlapping biological actvities with other members of the IL‐6‐type cytokine family. We therefore investigated the protective functions of Leukemia inhibitory factor (LIF), and Oncostatin M (OSM) in cortical and hippocampal neurons in vitro. Pharmacological blockade of ADORA1 in wild‐type neurons abolished the protection induced by OSM against excitotoxicity, while it did not affect the protective functions of LIF. Parallel experiments in ADORA1 knock‐out (‐/‐) mice suggest that LIF‐induced neuroprotection was independent of the A1 receptors, unlike IL‐6 and OSM. Understanding the intracellular signaling pathways involved in their neuroprotective mechanisms is crucial for their putative use in treatment of neurodegenerative diseases. In addition, this may also add to our understanding of neuron‐glia interaction in neuroprotection.
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PROPERTIES OF REGULATED EXOCYTOSIS AND VESICLE TRAFFICKING IN ASTROCYTES {#sec2-29}
------------------------------------------------------------------------

### Kreft M.,^1^ Potokar M.,^1^ Pangrsic T.,^1^ Stenovec M.,^2^ Zorec R.^1^ {#sec3-29}

#### ^1^Inst. pathophysiol., Faculty of Medicine, Uni. Ljubljana, Ljubljana, Slovenia; ^2^Celica Biomedical Center, Ljubljana, Slovenia {#sec4-29}

The important process of communication between astrocytes and neurons is exocytotic release of gliotransmitters (such as glutamate, neuroactive peptides and ATP) from membrane‐bound vesicles into the extracellular space. To explore whether stimuli that increase \[Ca2+\]i trigger vesicular ATP release from astrocytes, we used HEK‐293T cells transfected with P2X3 receptor, used as sniffers for ATP release from astrocytes. Glutamate stimulation of astrocytes was followed by an increase in the incidence of small transient inward currents in sniffers, reminiscent of postsynaptic quantal events observed at synapses. Their incidence was highly dependent on extracellular Ca2+. This indicates that glutamate‐stimulated ATP release from astrocytes was most likely exocytotic. Prior fusing with the plasma membrane in the process of exocytosis, membrane‐bound vesicles are transported through the cytoplasm. Their trafficking and consequently release of their content may be changed in altered physiological conditions, therefore affecting the physiological status of neurons. We studied the prefusion mobility of fluorescently labeled peptidergic ANP vesicles (atrial natriuretic peptide; ANP) in the cytoplasm of single rat and mouse astrocytes in culture. We found out that delivery of vesicles to the plasma membrane for exocytosis involves an interaction with the cytoskeleton, in particular microtubules and actin filaments, which is similar to neurons and excitable secretory cells. Some of the membrane‐bound vesicles are retrieved from the plasma membrane to be recycled back into the cytosol. Postfusion transport of glutamatergic and peptidergic vesicles was studied by labeling vesicles with antibodies against specific membrane or luminal vesicle proteins. Trafficking velocity of prefusion and postfusion (recycling) vesicles differ in velocity for one order of magnitude and the traffic of diverse vesicles appears to be differently regulated by calcium ions.
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SPONTANEOUS AND EVOKED CALCIUM SIGNALING IN HIPPOCAMPAL ASTROCYTES AND NG2‐CELLS {#sec2-30}
--------------------------------------------------------------------------------

### Honsek S.D., Walz C., Rose C.R. {#sec3-30}

#### Institute for Neurobiology, Heinrich‐Heine‐University, Duesseldorf, Germany {#sec4-30}

Glial cells actively participate in synaptic transmission and respond to neuronal activity by transient increases in their intracellular calcium concentration. These calcium transients can result in the release of neuroactive substances, so‐called gliotransmitters, which in turn influence the neuronal network. While it is well established that neuronal synapses are plastic and alter their strength depending on previous activity, very little is known about activity‐induced alterations of glial calcium signaling. In the present study we characterized spontaneous calcium signaling properties of hippocampal glial cells in juvenile mice, focussing on astrocytes as well as NG2‐positive glial cells (NG2‐cells). In addition, we applied different stimulation paradigms and compared changes in the amplitudes of glial calcium transients with those in field potential recordings. Employing high‐resolution 2‐photon imaging with the calcium‐sensitive dye Fluo‐5F, we found spontaneous calcium oscillations occurring in the absence of electrical stimulation in more than 90 % of classical astrocytes. Most of these calcium oscillations were restricted to cellular subdomains within small astrocytic processes and did not invade the soma. In contrast, spontaneous calcium oscillations were only rarely observed in NG2‐cells. Short burst Schaffer collateral stimulation (3 pulses, 50 Hz) elicited calcium transients in astrocytes as well as NG2‐cells. Calcium transients in NG2‐cells were highly variable and, on average, exhibited a strong run‐down with repetitive stimulations. Astrocytes consistently responded to repetitive stimulations and the amplitudes of astrocytic calcium transients correlated with the stimulation intensity. In contrast, after induction of synaptic potentiation by a theta‐burst stimulation protocol, astrocytic calcium transients evoked by short burst stimulation were not significantly altered. Our data thus demonstrate pronounced differences in calcium signaling properties between astrocytes and NG2‐cells, both concerning spontaneous activity as well as evoked activity. Our results also suggest that the amplitudes of astrocytic calcium transients reflect the number of activated fibers but not the degree of synaptic potentiation.

*This work was supported by the DFG (Ro2327/3‐2).*
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IDENTIFICATION OF NEURON‐INDUCED ASTROCYTE GENES {#sec2-31}
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### Goudriaan A., Camargo N., Smit A.B., Verheijen M. {#sec3-31}

#### CNCR, Neuroscience Campus Amsterdam, VU Univ. (Amsterdam), Amsterdam, Netherlands {#sec4-31}

During the last decade, the importance of astrocyte‐neuron communication in neuronal development and synaptic plasticity has become increasingly clear. Astrocytes support neurons during development and maintenance and recently it was found that they also function as active partners in synaptic function in a so‐called "tripartite synapse". However, only for a few astrocyte‐derived genes their roles in neuronal development and synaptic function have been identified. Since neuron‐glia interactions represent highly dynamic and reciprocal processes, we hypothesized that astrocytic genes may be regulated as a consequence of interactions with maturing and synaptically active neurons. We set out to identify neuronal contact dependent astrocyte‐expressed genes. For this we developed a new method to separate neurons from astrocyte monolayers, and performed a microarray experiment in which RNA derived from astrocyte monolayers was compared with astrocyte RNA derived from 8‐day astrocyte‐neuron co‐cultures. We showed that approximately 90% of the neuronal RNA could be removed by our treatment. This represents an important finding, because cytotoxic or apoptosis‐inducing drug treatment as used in other cell purification methods could be avoided, thereby preventing side effects and assuring the integrity of the RNA before microarray hybridization. Analysis of the regulated genes revealed involvement of possible novel mechanisms. Many of these factors, as Eif1ay, Trim25 and TPPP3, were associated with general changes in cell activity, as translation, transcription and cytoskeleton reorganization. However, genes implicated in more specific processes, including axon/neurite development, apoptosis, phagocytosis, cell cycling, ROS metabolism and neuropeptide signalling, were identified as well. In order to correlate gene expression patterns with different stages in neuronal development, the same approach was taken on a time‐series during neuronal outgrowth and synaptogenesis. Some regulated genes and their protein localization in the co‐cultures as determined by immunocytochemistry will be discussed.

A. Goudriaan and N. Camargo contributed equally to the work.
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ASTROCYTE‐NEURON INTERACTION: CHELATION OF ASTROCYTIC CA2+ INCREASES EXCITABILITY IN MOUSE BARREL CORTEX NEURONS {#sec2-32}
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### Benedetti B., Matyash V., Nolte C., Kettenmann H. {#sec3-32}

#### MDC, Berlin, Germany {#sec4-32}

Electrical stimulation in barrel cortex layer 4 triggers neuronal and astrocytic cytosolic Ca2+ increase. While the neuronal Ca2+ signal spreads also across the barrel borders, the astrocytic response is delayed and restricted to the stimulated column (Schipke et al., Cereb Cortex 18:2450‐9, 2008). We now addressed the question whether the astrocyte Ca2+ response has any impact on neuronal activity. To affect astrocytic Ca2+ signaling, we dialyzed these cells with 40 mM BAPTA using whole‐cell patch clamp. We assume that BAPTA had spread via gap junctions into a network of astrocytes. After dialysis, L4 electrical stimulation still triggered Ca2+ responses in neurons. However, it completely inhibited Ca2+ responses in astrocytes within 100 ± 40 micro meters from the BAPTA injection site. Surprisingly, more distant astrocytes, which had not responded before, started to show Ca2+ responses to neuronal stimulation. We also patch clamped 32 granular and pyramidal neurons in the layers 3 and 4 of a barrel column. In control conditions, L4 electrical stimulation (30 pulses of 1ms, 400 microA at 10Hz) triggered a neuronal depolarization for 5.8 ± 2.7s with trains of action potentials during the recovery phase. When the astrocyte Ca2+ signaling was suppressed, the same stimulation paradigm triggered multiple de‐ and repolarizing responses within a period of 12s. Chronical depolarization by 20 ± 5 mV led to a repetitive spiking activity. In control conditions the spiking frequency decreased during the recovery phase following electrical stimulation. Astrocyte Ca2+ chelation prevented this decrease in the neuronal firing frequency. Our findings indicate that astrocyte activity in the barrel cortex has an inhibitory influence on the activity of L3 and L4 neurons.
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MLC1 TRAFFICKING AND MEMBRANE EXPRESSION IN ASTROCYTES. ROLE OF CAVEOLIN‐1 AND MLC1 PHOSPHORYLATION {#sec2-33}
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### Lanciotti A., Brignone M.S., Camerini S., Serafini B., Macchia G.F., Macioce P., Raggi C., Molinari P., Aloisi F., Petrucci T.C., Ambrosini E. {#sec3-33}

#### Istituto superiore di Sanità, Rome, Italy {#sec4-33}

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare congenital autosomal recessive form of leukodistrophy characterized by macrocephaly, diffuse white matter swelling and subcortical cysts. Brain histological examinations revealed that white matter swelling is due to liquid vacuoles localized between the outer lamellae of the myelin sheaths associated to alterations in the blood brain barrier (BBB) and enlargement of extracellular spaces. Mutations in a gene named MLC1 have been associated to MLC disease. MLC1 gene product is a membrane protein with unknown function, which is mainly expressed in astrocyte end--feet forming the BBB and glia limitans. The presence of MLC1 in astrocytes, but not in oligodendrocytes, suggests that white matter damage seen in MLC disease might result from astrocyte dysfunction. We previously showed that in astrocytes MLC1 localizes in lipid rafts and associates with the dystrophin glycoprotein complex (DGC). Using pull‐down assays and co‐fractionation techniques, we now show that MLC1 intracellular domains interact with DGC proteins (syntrophin, dystrobrevin and Kir4.1) and caveolin‐1 (cav‐1), the structural protein of caveolae that binds dystroglycan and is involved in the compartimentalization of signal transduction components, lipid metabolism, endocytosis and intracellular trafficking of some membrane proteins. Based on recent data suggesting that pathological mutations prevent the localization of MLC1 to the plasma membrane, we have studied the role of cav‐1 in MLC1 intracellular trafficking and membrane expression in astrocytes. Using fractionationprocedures of brain tissue from WT and cav‐1 KO mice and of cultured astrocytes treated with agents able to modulate intracellular trafficking, we show that MLC1 is expressed in intracellular vesicles and endoplasmic reticulum and undergoes caveolar mediated endocytosis and recycling pathway. Inhibition of raft‐mediated endocytosis and cav‐1 deletion favour MLC1 membrane expression. We have also found that MLC1 is phosphorylated by protein kinases A and C and that its phosphorylation increases MLC1 membrane expression. These data suggest that pharmacological treatments affecting MLC1 trafficking should be considered as potential therapeutic strategies for MLC patients.
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GLIA‐DEPENDENT PHYSIOLOGICAL SWITCH IN KAINATE RECEPTOR ACTIVITY {#sec2-34}
----------------------------------------------------------------

### Bonfardin V.D.J., Fossat P., Theodosis D.T., Oliet S.H.R. {#sec3-34}

#### INSERM U862, Bordeaux, France {#sec4-34}

The release of oxytocin (OT) and vasopressin (VP) from the neurohypophysis is controlled by the electrical activity of hypothalamic magnocellular neurons, which is itself regulated by excitatory and inhibitory afferent synaptic inputs. The presence of functional glutamatergic kainate receptors (KARs) on GABA terminals in the supraoptic nucleus (SON) remains to be determined. To address this issue, we combined whole‐cell patch clamp recordings and immunohistochemical identification of SON neurons in acute hypothalamic slices. Miniatures GABA‐A receptor‐mediated currents (mIPSCs) were investigated. Bath applications of UBP 302 (10 microM), a specific antagonist of GluR5‐containing KARs, decreased the frequency of mIPSCs (‐27.05 ± 2.41 %; n = 13) without affecting their amplitude. This result argued in favor of a tonic activation of presynaptic GluR5‐containing KARs by ambient glutamate, thereby facilitating GABA release on SON neurons. In other structures, the regulatory effect of presynaptic KARs on transmitter release can be switched from facilitation to inhibition by an increased KAR agonist concentration. This hypothesis was verified in the SON of lactating rats, where reduction in astrocytic coverage of OT neurons is associated with an increased glutamate concentration in the extracellular space, and in the SON of virgin rats in the presence of a glutamate transporter blocker. Under theses two conditions, activation of presynaptic GluR5‐containing KARs switched from facilitating into inhibiting GABA transmission. These results reveal that glial cells, through the control of glutamate clearance, influence KAR activity. The mechanisms of facilitation and inhibition of GABA release by KARs in these two different physiological conditions are under investigation.
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REGULATORY ROLE OF MONOAMINE NEUROTRANSMITTERS IN ASTROCYTIC NT‐3 SYNTHESIS {#sec2-35}
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### Mele T., Čarman‐Krzan M., Jurič D.M. {#sec3-35}

#### Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia {#sec4-35}

Astrocytes actively control neuronal activity and synaptic transmission and by producing various neurotrophic factors represent an important local source of trophic support in the normal and diseased brain. In our present study we examined the ability of cultured neonatal rat cortical astrocytes to synthesize NT‐3 and the active involvement of the monoamine neurotransmitters noradrenaline, adrenaline, dopamine, histamine and serotonin, as well as basic intracellular second messenger systems, in the regulation of astrocytic NT‐3 intracellular levels.

Neonatal rat cortical astrocytes are able to synthesize NT‐3; basal cellular content of NT‐3 protein was 23.2 ± 0.4 pg NT‐3/mg cell protein. The examined neurotransmitters, with the exception of serotonin, were able to potently and transiently increase NT‐3 cellular contents; their maximal effects were dose‐ and time‐dependent. The catecholamines noradrenaline (1 μM), adrenaline (1 μM) and dopamine (100 μM) maximally increased NT‐3 cellular content after 6 h treatment causing 1.9‐, 1.8‐ and 2.7‐fold elevation, respectively. The maximal increase in response to histamine (1 μM) was also observed at 6 h of incubation causing a 2.1‐fold elevation in NT‐3 cellular content, whereas serotonin showed no effect. The initial increase in NT‐3 levels returned to basal levels when incubation with monoamines was extended beyond 12 h (for dopamine) or 24 h (for noradrenaline, adrenaline, and histamine). Screening different activators of basic intracellular second messenger systems for their influence on NT‐3 synthesis revealed that forskolin (20 μM), dibutyryl cAMP (dBcAMP) (100 μM), as well as calcimycin (1μM) (Ca2+ ionophore A23187) and phorbol 12‐myristate 13‐acetate (TPA) (100 nM) markedly increased the cellular level of NT‐3 protein, which led us to conclude that downstream signaling responsible for the stimulation of NT‐3 synthesis in astrocytes by monoamines consists of multiple, complex intracellular mechanisms involving the cAMP/protein kinase A pathway, as well as mobilization of Ca2+ ions and activation of protein kinase C.

Our results have confirmed for the first time that monoaminergic neurotransmitters play an important role in the regulation of neurotropic neurotrophin‐3 (NT‐3) activity in cultured rat astrocytes.
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ASTROGLIAL NETWORKS DEPRESS HIPPOCAMPAL NEUROTRANSMISSION {#sec2-36}
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### Pannasch U., Ezan P., Giaume C., Rouach N. {#sec3-36}

#### INSERM College de France, Paris, France {#sec4-36}

Up to now, the involvement of astrocytes in central functions has only been considered to result from the activity of individual astrocytes. However, a typical feature of astrocytes is their network organizationprovided by numerous gap junctions. To investigate the role of astroglial connectivity in neuronal transmission, we took advantage of the double knockout mice for astroglial connexins, Cx30 and Cx43 (Cx30‐/‐Cx43‐/‐), in which gap junctional communication is totally disrupted.

Here we show that the absence of astrocytic gap junctional coupling enhances hippocampal synaptic transmission and alters synaptic plasticity of CA1 pyramidal neurons. Although these mice have normal hippocampal morphology, they exhibit pre‐ and postsynaptic changes. Indeed, excitability of CA1 pyramidal neurons is increased in Cx30‐/‐Cx43‐/‐ mice, due to a lower spike threshold. In addition, release probability is increased, as indicated by decreased paired‐pulse facilitation. The number or activity of postsynaptic AMPA receptors is also enhanced in these mice, because AMPA‐NMDA current ratios, as well as AMPA currents induced by an exogenous saturating AMPA application are increased. These alterations lead to a 40% increase in field excitatory postsynaptic potentials, evoked by Schaffer collaterals stimulation in Cx30‐/‐Cx43‐/‐ mice compared to wild type animals. Furthermore long‐term potentiation, induced by tetanic stimulation, is absent in Cx30‐/‐Cx43‐/‐ mice. These effects are not due to altered gliotransmitter (glutamate, ATP) release from astrocytes, since inhibition of NMDA or adenosine‐1 receptors in Cx30‐/‐Cx43‐/‐ mice revealed no difference compared to wild type mice. However, disconnected astrocytes display increased synaptically‐evoked potassium currents, suggesting higher extracellular potassium levels. Altogether these results indicate that astroglial gap junctions control neuronal excitability and synaptic strength of excitatory terminals. This suggests that connexin‐mediated astroglial networks play an active role in information processing.
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ASTROGLIAL CALCIUM SIGNALING INHIBITS NEURONAL EPILEPTIFORM ACTIVITY {#sec2-37}
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### Derangeon M., Giaume C., Rouach N. {#sec3-37}

#### College de France, INSERM U840, Paris, France {#sec4-37}

Epilepsy comprises a group of neurological disorders associated with periodic intense neuronal discharges generated by hypersynchronous firing. Epileptiform activity is usually assumed to be generated exclusively in and by neurons. However, astrocytes have recently been proposed to contribute to epileptiform activity, as it initiates astrocytic calcium transients and glutamate‐mediated gliotransmission which may lead to increased neuronal excitability. These results are controversial due to the lack of a selective astroglial pharmacology and the mechanisms of glial modulation of neuronal seizures are not yet well understood. Therefore the goal of this study was to determine the role of neuroglial network interactions in epileptiform activity by using a pharmacological approach targeted specifically to astrocytes. We found that neuronal epileptic bursts, induced chemically in hippocampal slices (0 Mg^2+^ + picrotoxin model), trigger synchronized calcium oscillations in populations of astrocytes. Chelation of intracellular calcium specifically in astroglial networks, by including BAPTA in the patch pipette, increases the frequency of neuronal epileptic discharges. This effect depends on two astroglial gap‐junction proteins, connexin 43 and connexin 30, as it is abolished in knockout mice for these two proteins. Inhibition of calcium signaling in astrocytes also results in an increase in release probability at presynaptic terminals. The nature of the gliotransmitter was identified using pharmacological tools. Degradation of ATP by apyrase, as well as inhibition of A1 adenosine receptors by DPCPX, both increased the frequency of neuronal epileptic bursts, therefore mimicking the BAPTA effect. Moreover, inhibition of adenosine receptors occludes the BAPTA effect. These data suggest that during epileptiform activity, astrocytes release in a calcium‐dependent manner ATP, converted into adenosine, which inhibits neuronal seizures by decreasing neurotransmitter release.
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GLIA MODULATION OF TISSUE PH IN CHEMOSENSITIVE REGIONS OF THE MEDULLA OF RODENTS {#sec2-38}
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### Erlichman J.,^1^ Leiter J.^2^ {#sec3-38}

#### ^1^St. Lawrence University, Canton, United States; ^2^Dartmouth Medical School, Hanover, United States {#sec4-38}

Astrocytes have a dynamic role in a variety of cellular processes including neurotransmitter uptake, K+ siphoning, metabolic coupling and extracellular pH (pHe) regulation. Blood and brain tissue pH are maintained at constant levels by respiratory centers located in the medulla. The retrotrapezoid nucleus (RTN) is located within the ventral respiratory group, and RTN neurons increase their activity linearly with physiological changes in both CO2 and pH. Moreover, ventilation tracks tissue pH changes in the RTN: focal acidosis increases ventilation whereas focal alkalinization decreases breathing. We studied glial processes that are capable of modulating pHe in the medulla and therefore capable of modulating ventilation. Electrogenic, sodium bicarbonate co‐transport (NBCe) is widely expressed by glia in the RTN. Selective activation of sodium bicarbonate co‐transport in astrocytes decreased pHe ∼‐0.3 pH units and this drop in pH was DIDS sensitive. Hypercapnic acidosis (HA) depolarized glia, presumably activated sodium bicarbonate transport, and decreased pHe ∼30% more than that predicted by physical‐chemical buffering alone. Intracellular pH (pHi) measurements of astrocytes in the RTN showed that ∼ 62% of the glia defend pHi in response to HA (termed GR cells) whereas 38% do not (termed GNR cells). Slope recovery GR cells was unaffected by the addition of Na+‐H+ exchange (NHE) inhibitors, slowed in 0 Cl‐ solutions and was eliminated by the addition of DIDS. Moreover, the addition of elevated K+ in GR cells resulted in a robust alkalinization of pHi implicating an important role for NBCe. In contrast, GNR cells showed little recovery during HA. The addition of NHE inhibitors or DIDS during HA resulted in a slight acid shift in pHi in GNR cells. The addition of elevated K+ in GNR cells had a small but signficant alkalinizing effect. These findings suggest there are two populations of astrocytes in the RTN that utilize different pHi regulatory mechanisms. In addition, these data suggest GR cells may modulate neuronal activity in the brain via changes in pHe.

Supported by NSF grant IOB‐0517698.
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ALTERATIONS OF ASTROGLIAL CONNEXIN EXPRESSION AROUND B‐AMYLOID PLAQUES IN MOUSE MODELS OF ALZHEIMER {#sec2-39}
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### Mei X., Giaume C., Koulakoff A. {#sec3-39}

#### College de France, Paris, France {#sec4-39}

Astrocytes are organized in networks of communicating cells, thanks to their high content in 2 connexins (Cx), Cx43 and Cx30, the gap junction forming proteins. The expression of Cx43 in cultured astrocytes is up‐regulated by neurons, an effect reversed by neuronal death (Koulakoff et al., 2008) and down‐regulated by activated microglia (Même et al., 2006). This inhibitory effect, mimicked by proinflammatory cytokines and potentiated by b‐amyloid peptide (Ab), results in an inhibition of junctional communication but an activation of hemichannels (Retamal et al, 2007). As neuronal death and inflammatory situation occur in Alzheimer\'s disease (AD), we have analyzed the expression pattern of astrocytic Cxs in two models of AD, the APPSL/PS1M146L and APPswe/PS1dE9 mice, by using immunohistochemistry and confocal microscopy approaches. In young mice, before the emergence of Ab deposits, the distribution of Cx43 and Cx30 was similar to that of control mice. In both models, although with a different time‐course, Ab deposits forming dense core plaques surrounded by reactive astrocytes were detected in the cortex and the hippocampus. The expression of both Cxs was specifically modified in the peri‐plaque areas. In most cases, increases in the size and density of Cx immunoreactive puncta were detected. Activated microglial cells did not contribute to the elevated Cx immunoreactivity that was concentrated in the widened astroglial processes infiltrating the plaques. Interestingly, down‐regulation of Cx43 and Cx30 expression was also observed in a small but significant proportion of plaques (5‐10%). The nature of Cx changes was not correlated with the size of the plaques but could be linked to the local inflammatory status. Therefore, the functional consequences of these Cx modifications are currently analyzed, using ethidium bromide uptake in slices from APPswe/PS1dE9 mice to assess hemichannel activity.

This work was supported by the CRPCEN.
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GLIAL GLUCOKINASE EXPRESSION IN ADULT AND POST‐NATAL DEVELOPMENT OF HYPOTHALAMIC REGION {#sec2-40}
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### Garcia M.A.,^1^ Millan C.,^1^ Martinez F.,^1^ Cortes‐Campos C.,^1^ Yañez M.J.,^1^ Llanos P.,^1^ Tarifeño E.,^1^ Reinicke K.,^1^ Peruzzo B.,^2^ Nualart F.^1^ {#sec3-40}

#### ^1^Departamento de Biología Celular, Universidad de Concepción, Concepcion, Chile; ^2^Universidad Austral de Chile, Valdivia, Chile {#sec4-40}

Studies support the hypothesis that the brain works as coordinated system of interaction between glial cells and neurons. It has recently been proposed that the hypothalamic glial cells sense the levels of glucose and release lactate as a signal to activate adjacent neurons. Glucokinase, the hexokinase involved in glucose sensing in pancreatic β cells, is also expressed in the hypothalamus. However, it has not been clearly determined if glial and/or neuron cells express this protein. Interestingly, the glia that cover the ventricular walls of the hypothalamus, termed tanycytes, are in contact with cerebrospinal fluid, the capillaries of arcuate nucleus, and adjacent neurons, which would be expected for a system that can detect and communicate changes in glucose concentration. Previously, we demonstrated the localization and function of glucose transporter 2 (GLUT2) in hypothalamic tanycytes, proposing that these glial cells are part of the glucosensor system. Here, we demonstrated by Western blot analysis, QRT‐PCR, and in situ hybridization that glucokinase is expressed in tanycytes. Confocal microscopy and immunoultrastructural analysis revealed that GK is localized in the nucleus and cytoplasm of β1 tanycytes. Furthermore, glucokinase expression was increased in these cells during the second week of post‐natal development by QRT‐PCR analysis. Based on this evidence, we propose that tanycytes mediate, at least in part, the mechanism by which the hypothalamus detects changes in glucose concentrations.

Supported by grant CONICYT‐World Bank ACT02.
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MECHANISMS OF COMMUNICATION BETWEEN DEVELOPING SENSORY AXONS AND GLIAL CELLS IN THE OLFACTORY BULB {#sec2-41}
--------------------------------------------------------------------------------------------------

### Hirnet D.,^1^ Rieger A.,^2^ Deitmer J.W.,^2^ Lohr C.^1^ {#sec3-41}

#### ^1^University of Muenster, Muenster, Germany; ^2^University of Kaiserslautern, Kaiserslautern, Germany {#sec4-41}

The olfactory system of mammals comprises a unique type of glial cells, the olfactory ensheathing cells (OEC). During development, OECs migrate along with the outgrowing axons of the olfactory sensory neurons towards the central nervous system, ensheathing axon bundles and preceding the growth cones of the axons with their processes. The OECs are crucial for axon pathfinding not only during the development of the sensory network, but also during the lifelong renewal of olfactory sensory neurons. However, the mechanisms of this neuron‐glia communication are still unknown. We investigated interactions between olfactory receptor axons and OECs in olfactory bulbs of postnatal mice by monitoring calcium signalling in OECs. Electrical stimulation of the axons evoked calcium increases in OECs mediated by mGluR1 and P2Y1 receptors, suggesting the extra‐synaptic release of neurotransmitters along olfactory receptor axons. Extra‐synaptic release of ATP was confirmed by recording ATP‐mediated currents in P2X2‐expressing HEK cells ("sniffer cells") seeded onto receptor axon bundles. Antibody stainings against VGluT2 and synaptophysin indicated the presence of these synaptic vesicle marker proteins along the axons, and ultrastructural studies of the olfactory nerve showed the presence of vesicles within axons adjacent to the OECs. In addition, we monitored vesicle fusion along the receptor axons upon electrical stimulation in a transgenic mouse line, expressing the vesicle fusion marker synapto‐pHluorin. Suppressing vesicular release with bafilomycin A1 and botulinum toxin abolished stimulation‐induced calcium transients in OEC. Hence, our results indicate a communication pathway, in which axonal activity leads to vesicular release of glutamate and ATP, activating calcium signalling in OECs. P2Y1 and mGluR1‐mediated calcium transients as well as mGluR1 immunoreactivity in OECs decreased upon maturation of the olfactory bulb, suggesting that ATP‐ and glutamate‐mediated axon‐glia interactions are prominent during the initial formation of the olfactory map.

Supported by the DFG LO779 and SFB 530, TP B1.
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ENGINEERED LENTIVIRAL VECTOR TARGETING ASTROCYTES IN VIVO {#sec2-42}
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### Bonvento G., Colin A., Faideau M., Dufour N., Auregan G., Escartin C., Hantraye P., Deglon N. {#sec3-42}

#### CEA, Fontenay‐Aux‐Roses, France {#sec4-42}

Astrocytes are involved in key physiological brain processes, such as glutamatergic transmission and energy metabolism, often altered in neurodegenerative diseases. Targeted gene expression in astrocytes is needed to assess the contribution of these cells to physiological processes and for the development of new therapeutic strategies. However, most of the viral vectors currently used for gene transfer in the central nervous system (CNS) are highly neurotropic. We used mokola pseudotyping to shift the tropism of lentiviral vectors toward astrocytes and a detargeting strategy with miRNA to eliminate residual expression in neuronal cells. In primary cultures, we showed that incorporating target sequences for the neuron‐specific miR124 effectively abolished transgene expression in neurons post‐transcriptionally. Targeted expression of the LacZ reporter gene in astrocytes was achieved in the hippocampus, striatum, and cerebellum of the adult mouse in vivo. As a proof‐of‐principle, this new lentiviral vector was used to either overexpress or downregulate (RNA interference) the glial glutamate transporter GLAST into striatal astrocytes in vivo. These vectors provide new opportunities for cell type‐specific gene transfer in the CNS.
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TEMPORALLY CONTROLLED ABLATION OF AMPA‐TYPE GLUTAMATE RECEPTORS IN BERGMANN GLIA {#sec2-43}
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Bergmann glial cells possess arborized processes which irregularly extend lamellae toward synapses on Purkinje‐cell spines formed either by parallel or climbing fibers. The glial appendages do not only seal the synaptic cleft, they also constitute microdomains for signalling pathways. On these membranes, Bergmann glia expresses highly localized either glutamate transporters (GLAST close to the synaptic cleft) or AMPA‐type glutamate receptors (GluR A and GluR D close to the shaft of the presynaptic terminal). While the role of GLAST in controlling extracellular glutamate levels is rather obvious, we have only a limited knowledge of glial AMPA receptor function.

To investigate the particular impact of glial transmitter receptors in vivo, we implemented a conditional knockout approach by crossbreeding mouse lines in which astrocytes express the tamoxifen inducible variant of the Cre recombinase CreERT2 under the control of the human GFAP promoter or from the murine GLAST gene, respectively, with genetically modified mice in which exons 11 of the GluR A and GluR D genes, respectively, were flanked by loxP sites.

Here, we demonstrate that in vivo GluR A and D can be ablated from Bergmann glial processes using the cre/loxP system in an inducible and timely controlled manner. The astroglia‐specific deletion of GluR A and D reveals ultrastructural changes in the cerebellum in which the Bergmann glial lamellae retract from Purkinje‐cell synapses. Although physiological consequences of these ultrastructural alterations have to be determined yet, alteration of the cerebellar network result in impaired hind‐ and forelimb coordination. This study shows that astrocytes play a functional role as an element of communication within the central nervous system, and therewith substantiating the physiological impact of the neuron‐glia interaction.
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BIDIRECTIONAL NEURON‐GLIAL SIGNALING BY PANNEXINS AND CONNEXINS IN TRIGEMINAL GANGLIA {#sec2-44}
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### Spray D.C.,^1^ Iglesias R.,^1^ Suadicani S.O.,^1^ Scemes E.,^1^ Zuckerman J.,^2^ Hanstein R.,^1^ Smith D.O.,^1^ Hanani M.^2^ {#sec3-44}

#### ^1^Albert Einstein College of Medicine, Bronx, United States; ^2^Hadassah Medical School, Hebrew U, Jerusalem, Israel {#sec4-44}

Neuronal somata in sensory ganglia are closely apposed by Satellite Glial Cells (SGCs) that possess many characteristics of CNS astrocytes, including expression of the gap junction protein Cx43 and P2 receptors. We have explored communication between neurons, between SGCs and between these two cell types using dual whole cell recording and Ca2+ imaging methods on dissociated mouse trigeminal ganglia. Focal electrical or mechanical stimulation of neurons led to Ca2+ elevation that spread to SGCs, and mechanical stimulation of SGC led to Ca2+ elevations in both adjacent glia and neurons. Intercellular calcium wave spread was largely blocked by either suramin or carbenoxolone, suggesting the participation of both gap junctions and purinergic reeptors in the signal propagation. Dual whole cell recordings from SGC cell pairs revealed strong gap junction‐mediated coupling, while neuron‐neuron coupling was much weaker. Paired recordings from neurons and SGCs in response to voltage ramps from holding potential (‐60 mV) to +100 mV revealed the presence of a moderate degree of direct bidirectional electrical coupling mediated by gap junction channels as well as paracrine pathway that originated from the depolarized cell (either neuron or SGC). Because gap junction channel blockers prevented both junctional and paracrine bi‐directional communication, we attribute the non‐junctional, paracrine, pathway to pannexons. Moreover, since this non‐junctional chemical response is blocked by P2 receptor antagonists, ATP is likely the transmitter released from the stimulated cell. Thus, bi‐directional communication between neurons and glia in the sensory ganglia appears to involve both connexin gap junctions and pannexin "hemichannels".
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DIFFERENTIAL EFFECTS OF UNDIFFERENTIATED AND DIFFERENTIATED ASTROCYTES DYSFUNCTION ON DELAYED NEURONAL DEATH FOLLOWING PERINATAL HYPOXIC/ISCHEMIC INSULTS {#sec2-45}
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#### ^1^Institut de Biologie du Développement de Marseille Luminy, Marseille, France; ^2^Cyceron CNRS UMR 6232 CiNAPS‐ Université de Caen Basse Normandie, Caen, France {#sec4-45}

Both experimental and clinical observations indicate that encephalopathy due to perinatal hypoxia‐ischemia (HI) is an evolving process. Alzheimer type II astrocytes are commonly found in human neonatal ischemic brain. PDC, a glutamate uptake inhibitor that mimics glutamate transport reversal observed in HI and decreases the intracellular contents of both glutamate and the main brain antioxidant glutathione, transforms undifferentiated striatal astrocytes in primary culture into Alzheimer type II ones. To test the effects of this astrocyte dysfunction on neuronal viability, coverslips of naïve neurons have been placed on control or transformed astrocytes, either PDC‐treated or obtained after an oxygen glucose deprivation (OGD, an in vitro HI), with medium change following PDC/OGD to eliminate primary toxins and maintained in co‐culture for 6 days. These transformed astrocytes are no longer able to support neuron survival suggesting that such an astrocytic dysfunction could be a primary cause of the delayed neuronal death observed in human after perinatal HI insults. Different pharmacological treatments have been used to test the mechanisms involved and the antioxidant N‐acetyl‐cysteine seems to be among the most protective three days after HI. Surprisingly, in co‐culture with dBcAMP‐differentiated astrocytes, which are dying after PDC treatment or OGD and during the co‐culture, neuronal viability is higher than in co‐culture with undifferentiated treated ones. As cells dying by apoptosis are known to release glutathione, we are testing the hypothesis that this release is higher in differentiated astrocytes than in undifferentiated ones after the different treatments. Altogether these results highlight the importance of glial glutathione homeostasis for neuronal survival.

E. Gouix is supported by fellowships from the "Fondation Motrice".
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#### ^1^Albert Einstein College of Medicine, Bronx, NY, United States; ^2^Haddassah Medical School, Jerusalem, Israel {#sec4-46}

In sensory ganglia, individual neurons are completely surrounded by envelopes of glial cells, termed satellite glial cells (SGCs). Therefore, the neuron and its surrounding SGCs form a distinct morphological unit with likely functional consequences. Although this arrangement differs from that seen in the CNS, where astrocytic processes make contact with several neurons, SGCs exhibit many characteristics of CNS astrocytes, including the expression of the gap junction protein Cx43 and the enzyme glutamine synthetase. SGCs around a given neuron and adjacent neurons are functionally coupled via gap junctions. In addition, whole cell recordings and Ca2+ imaging experiments indicate a bidirectional neuronal‐glial signaling by pannexins and connexins in trigeminal ganglia (see Poster by Spray et al.).

We characterized the expression and distribution of pannexin and connexin proteins as well as purinergic receptor subtypes that contribute to glial and neuron‐glia communication by immunohistochemistry in vitro and in vivo. As nerve injury causes glial activation and an increase in glial coupling, we have additionally analyzed changes in pannexin, connexin and P2R expression levels and their arrangement in trigeminal ganglia in a model of inflammatory pain in vivo.
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INVESTIGATION OF GLIA‐NEURONAL INTERACTIONS AND MYELINATION IN ZEBRAFISH (DANIO RERIO) {#sec2-47}
--------------------------------------------------------------------------------------

### Stahl K. {#sec3-47}

#### Deutsches Zentrum für Neurodegenerative Erkrankungen, München, Germany {#sec4-47}

Myelination is a tightly regulated process that requires communication between neurons, myelinating and non‐myelinating glia. To illuminate these communication processes, we use the zebrafish as model organism. Due to its transparent, fast and extra‐maternally developing larva, this species is particularly suitable to visualize complex cellular interactions through live imaging. We follow two strategies to investigate the contribution of astrocytes to the formation and maintenance of myelin.

In the first approach, we aim to genetically ablate astrocytes at specific time points. We created transgenic zebrafish expressing diphtheria toxin subunit A (DTA) under the control of an astrocyte specific promoter. Expression of the toxic protein is induced via the cre/loxP system which in turn is heat inducible. Ablation of astrocytes resulted in deformation of the body axis and characteristic "curly tail" phenotypes, as well as an increased level of cell death in deformed zebrafish. Currently, we are investigating the ablated larvae via immunohistochemistry to investigate effects on neurons and glia after DTA induction in astrocytes.

In a second approach, we use the zebrafish as model organism for the leukodystrophy Alexander disease (AXD), a very rare but severe human genetic disease. AXD is characterized by rapid and widespread white matter degeneration. On a molecular level, mutations in the gene for glial fibrillary acidic protein (GFAP), an astrocyte specific protein, are causal for the disease. It is unknown how a primary defect in astrocytes causes extensive loss of white matter. In AXD patients, mutated GFAP is the main component of intracellular aggregates called Rosenthal fibers. To monitor aggregation dynamics and possible clearance mechanisms, we established transgenic zebrafish lines expressing wildtype and mutant GFAP fused to eGFP as a reporter. GFP positive aggregates were detectable with onset of GFAP expression. We found that formation of the aggregates is a dynamic process: aggregates are mobile in astrocytes, dissolve and re‐aggregate during cytokinesis. Currently, we are investigating effects of various drugs on clearance of the aggregates. Additionally, we are performing biochemical and EM analysis to show different aggregation states and potential degradation products.
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A "HUMANIZED" MOUSE MODEL FOR THE PLP1 GENE {#sec2-48}
-------------------------------------------

### Sarret C.,^1^ Werner H.B.,^2^ Begou M.,^1^ Boespflug‐Tanguy O.,^1^ Nave K.A.,^2^ Vaurs‐Barriere C.^1^ {#sec3-48}

#### ^1^GReD UMR INSERM U931 CNRS6247, Medicine School, Clermont‐Ferrand, France; ^2^Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Gottingen, Germany {#sec4-48}

The proteolipid protein 1 (PLP1) gene is highly conserved among species and encodes, by alternative splicing of its exon 3b, two protein isoforms: PLP and DM20. New mRNA variants of the human PLP1 (hPLP1) gene, emerging by alternative splicing of two novel exons located in intron 1, have recently been identified with some of those new transcripts encoding new protein isoforms. The new transcripts are human‐specific and, although classical PLP/DM20 are expressed specifically in oligodendrocytes, the new variants display a neuronal expression pattern. Those observations suggest that the hPLP1 gene may have a function not only in oligodendrocytes but also in neurons and that the neuronal isoforms could be implicated in oligodendrocyte‐to‐axon interactions.

To analyze the role of those new isoforms in the central nervous system, we have developed an "hPLP1‐humanized" mouse model using BAC transgenesis. One mouse line was established from a F0 female carrying five BAC copies. All copies are present in tandem on the same chromosome. This BAC mouse line was backcrossed with mPlp null mice in order to obtain "humanized" animals expressing only the hPLP1 gene. After nine months, no abnormal phenotype was noticed in "hPLP1‐humanized" animals. By RT‐PCR, the new transcripts were found expressed in the brains of "humanized" animals, with both alternatively spliced PLP/DM20 isoforms. Backcrosses to obtain homozygous mice over‐expressing the hPLP1 gene (10 copies) are under realization to establish whether the expression of the human‐specific variants could mediate a toxic gain of function. The "hPLP1‐humanized" mouse model will be helpful afterwards to better assess the function of the new isoforms by in vivo and in vitro experiments.
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RETINOIC ACID IN THE POSTNATAL BRAIN {#sec2-49}
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### Vőfély G., Orsolits B., Madarász E., Környei Z. {#sec3-49}

#### Institute of Experimental Medicine, Budapest, Hungary {#sec4-49}

Retinoids represent a family of compounds derived from vitamin A that perform a large number of functions, many via the vitamin A product, retinoic acid (RA). Recently, emerging evidence supports the view, that retinoid signaling is required for several aspects of postnatal brain function. Though the location of retinod producing foci in the mature brain had roughly been described, little is known about the exact cellular sources of active retinoid compounds. In the present work we describe the distribution and identify some retinoid responsive and/or retinoid producing cell populations in the postnatal brain. We show, that ependymal cell both in the choroid plexi and in the walls of lateral ventricles express RALDH2, one of the key enzymes of RA synthesis. RA‐reporter assays reveal that both meningeal cells, choroid tissue and cultured astrocytes produce significant amounts of RA. We identify a RA‐responsive subpopulation of astrocytes within the hippocampus. We show, that some of these astroglial cells are located in the subgranularlayer of dentate gyrus, which is one of the major sites of adult neurogenesis.
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SUBCELLULAR ANTIGEN LOCALIZATION IN PERIPHERAL ASTROCYTE PROCESSES AFTER ISOLATION OF MORPHOLOGICALLY INTACT CELLS (IMIC) {#sec2-50}
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### Haseleu J., Steinhäuser C., Derouiche A. {#sec3-50}

#### Institute of Cellular Neurosciences, Bonn, Germany {#sec4-50}

In the astrocyte, most of its membrane is in its PERIPHERAL processes, which often have a diameter comparable to vesicles and small organelles. These processes are hardly studied, since they are not directly accessible to electrophysiology, they cannot be isolated for biochemistry, and microscopically they are at the limit of light microscopic resolution. Yet it is at the peripheral process where the astrocyte contacts the synapse, and this process also preferentially displays membrane receptors and transporters relevant for glia‐synaptic interaction. Based on the dimensions of these processes, unambiguous antigen localization in them requires immuno‐electron microscopy or subresolution light microscopy, rather complex procedures. A tool is developed here to investigate the peripheral astrocyte processes by conventional light microscopy.

We have isolated astrocytes from juvenile rat cortex (p13‐15), applying papain dissociation, and cytospin centrifugation to attach the cells to a slide. In this way the cells and their complete process tree including the peripheral processes becomes nicely projected in 2D; after fixation they are ready for immunostaining. The entire procedure does not take longer than three hours, and protein expression is assumed to reflect the in vivo situation. The low cell numbers and the procedure are incompatible with biochemistry. However, this IMIC procedure reveals the fine detail of the astrocyte\'s main and peripheral processes, the latter is extensively preserved and visualized by anti‐ezrin or stains for actin, in combination with anti‐GFAP.

In contrast to cell culture, results derived from this procedure allow for direct conclusions relating to (i) the presence of an antigen in cortical astrocytes, (ii) its subcellular distribution, in particular when localized in the paripheral astrocyte processes. We exemplify the advantages by localizing vesicle‐bound molecules related to stimulated exocytosis from astrocytes, and actin‐binding proteins contributing to the plasticity of the peripheral processes, which are actin‐based.
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INVOLVEMENT OF GLIAL CELLS DURING EPILEPTOGENESIS IN A GENETIC MODEL OF ABSENCE EPILEPSY {#sec2-51}
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### Girod S., Laharie A.M., Depaulis A., Guillemain I. {#sec3-51}

#### Grenoble‐Institut des Neurosciences, Grenoble, France {#sec4-51}

Recent studies have suggested that glial cells are critical in the synchronization of cortical neurons during the onset of epileptic seizures. However, this hypothesis has never been investigated in models with spontaneous seizures. In the present study, we have examined the role of the cortical glial network in a genetic model of absence epilepsy: a non convulsive epileptic syndrome characterized by brief episodes of unresponsiveness to environmental stimuli (absence) and cessation of activity associated with spike and waves discharges (SWD) on the electroencephalogram.

In this animal model (Genetic Absence Epilepsy Rat from Strasbourg or GAERS) we have shown that SWDs start in the region of the somatosensory cortex coding for the peri‐oral field of the body then generalize to other parts of the cortex and the thalamus. We hypothesized that the maturation of the cortical glial network is different in GAERS, as compared to non epileptic controls, in the area of the "cortical focus", during the first 4‐5 weeks postnatal that precede the onset of the first SWD, i.e., the period of epileptogenesis. Significant differences in both the number and maturation state of astrocytes were observed in the somatosensory cortex of GAERS, as compared to control rats. Using immunohistochemical labeling of the expression of GFAP, the data suggest that radial glia‐like cells are still present at P7 in GAERS, whereas they have almost disappeared in controls. Furthermore, at P14, a greater number of GFAP‐positive cells are observed in GAERS. This quantitative difference persists in adulthood when SWDs are well established. These data are in agreement with our hypothesis that an anomaly in the maturation of the somatosensory cortex of GAERS could be implicated in the epileptogenetic mechanism of absence epilepsy.
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THE ROLE OF MITOCHONDRIAL DYSFUNCTION IN ASTROCYTES A MOUSE MODEL FOR BRAIN AGEING {#sec2-52}
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### Ebert B., Steib K., Jagasia R., Lie C. {#sec3-52}

#### Helmholtz Zentrum Muenchen, Muenchen/Neuherberg, Germany {#sec4-52}

The cellular and molecular mechanisms underlying age‐related neurodegeneration and dysfunction of the brain are not fully understood. Impairment of mitochondrial function is a factor for ageing in many tissues. Importantly, there is increasing evidence that mitochondrial dysfunction in neurons may be causally linked to neuronal dysfunction and death. Astrocytes are the most abundant cell type in the adult brain. It is well established that astrocytes are important for neuronal homeostasis, survival, and synaptic plasticity. In addition, one of the most surprising findings of the past decade was that specialized astrocytes contribute to cellular plasticity by generating new neurons in discrete regions of the adult brain. Despite this large variety of functions in the adult brain, surprisingly little attention has been paid to the contribution of astrocytes to brain dysfunction during ageing and to the impact of age‐related mitochondrial dysfunctionon astrocytes. In a pilot study we have found strong evidence that the maturation and integration of new neurons generated from astrocytes is highly dependent on intact mitochondrial function and dynamics.

We now hypothesize that mitochondrial dysfunction in adult astrocytes will negatively affect neuronal function and survival, will decrease the generation of new functional neurons, and will ultimately lead to a premature ageing phenotype. To test this hypothesis, we have generated a genetic mouse model (GLAST::CreERT2 x TfamloxP/TfamloxP x CAG‐CAT‐EGFP), which allows the conditional induction of mitochondrial dysfunction specifically in adult astrocytes through deletion of the mitochondrial transcription factor A (TFAM). These conditional KO mice have previously been used to induce mitochondrial dysfunction in other cell types including neurons. Behavioral, neuropathological and histological analysis are currently being performed to determine, whether mitochondrial dysfunction in astrocytes will have an impact on the brain homeostasis. In addition, we are setting up co‐culture systems, which allows the in vitro analysis of the interaction of dysfunctional astrocytes and neurons.

We expect that this research will provide new insights into the role of astrocytes and mitochondria, in the process of brain ageing and plasticity.

P‐053 {#sec1-53}
=====

OLIGODENDROCYTE‐SPECIFIC EXPRESSION OF THE ADHESION MOLECULE TAG‐1 IN THE ORGANIZATION OF MYELINATED FIBERS {#sec2-53}
-----------------------------------------------------------------------------------------------------------

### Karagogeos D., Savvaki M., Theodorakis K., Zoupi L., Tivodar S. {#sec3-53}

#### Univ Crete & IMBB, Heraklion, Crete, Greece {#sec4-53}

TAG‐1 is a neural cell adhesion molecule of the Ig superfamily that is implicated in neuronal migration, neurite outgrowth and extension during development. In adulthood, TAG‐1 is expressed by both glial cells and axons and is localized in the juxtaparanodal region of myelinated fibers of both the CNS and PNS. It is required for the proper clustering of Caspr2 and Shaker‐type voltage gated potassium channels (VGKCs) at the juxtaparanodes in various areas of the CNS and in peripheral nerves. TAG‐1 homozygous mutant mice (Tag‐1‐/‐) also appear to have shorter internodal lengths of myelinated fibers. Recently, TAG‐1 has been identified as an autoantigen in multiple sclerosis patients.

We would like to test whether TAG‐1 originating from oligodendrocytes only is adequate for the rescue of the juxtaparanodal phenotype of Tag‐1‐/‐ mice, or if both axonal and glial expression is necessary.

For this purpose, we generated mice that express the rat homolog of TAG‐1 under the proteolipid protein (PLP) promoter, driving the expression of TAG‐1 in oligodendrocytes specifically, in a Tag‐1‐/‐ background. Phenotype analysis, emphasizing the molecular profiles of the juxtaparanodes at the cellular and ultrastructural level, is in progress. We will assay for the glial specific expression of the protein by biochemical and immunohistochemical assays. We will also examine the proper localization of Caspr2 and VGKCs. In addition we plan to measure the expression levels of glial proteins in myelin‐enriched brain extracts from normal, Tag‐1‐/‐ and PLP transgenic mice. Finally we will examine whether the internodal length defects, present in Tag‐1‐/‐ mice, are rescued due to the glial‐specific expression of the molecule.

Funding by: ELA 2007‐025I2, Special Accounts of the Univ. of Crete, Graduate programs in Molecular Biology‐Biomedicine and The Molecular Basis of Human Disease, University of Crete and IMBB.
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DOK4 IS INVOLVED IN SCHWANN CELL MYELINATION AND MEDIATES GDNF SIGNALING {#sec2-54}
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### Decker L.,^1^ Blugeon C.,^2^ Le Crom S.,^3^ Charnay P.^1^ {#sec3-54}

#### ^1^INSERM U784, Paris, France; ^2^IFR36, Paris, France; ^3^INSERM U784, IFR36, Paris, France {#sec4-54}

In the peripheral nervous system, myelination is carried out by Schwann cells and relies on complex interactions between the Schwann cell and the neuron, involving bidirectional communication between the two cell types. Little is known on the molecules mediating the initial Schwann cell/axon interaction and on the early events following this contact. To investigate this issue, we performed an RNA profiling analysis designed to identify genes regulated in Schwann cell upon axonal contact. 30 genes were recovered, including several genes already known to be involved in myelination. Among the novel genes, we focused on Dok4, which encodes a tyrosine kinase substrate required in neuron for neurite outgrowth following GDNF stimulation. To investigate the possible function of Dok4 in myelination, we first performed loss‐of‐function experiments, using siRNA, in an in vitro myelination system. Transfection of the Dok4 siRNA led to a significant decrease in myelination. Furthermore we showed that siRNA‐mediated Dok4 silencing led to a reduction of GDNF‐mediated phosphorylation of ERK and CREB. Together these data indicate that Dok4 is induced in Schwann cell upon axonal contact and that the protein is involved in myelination and is likely to act by mediating GDNF‐signaling, which is already known to enhance myelination.
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DIFFERENTIAL TRANSPORT AND METABOLISM OF FLUORESCENT GLUCOSE IN CEREBELLAR SLICES {#sec2-55}
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### Jakoby P.,^1^ Courjaret R.,^1^ Loaiza A.,^2^ Lohr C.,^3^ Barros L.F.,^2^ Deitmer J.W.^1^ {#sec3-55}

#### ^1^TU Kaiserslautern, Kaiserslautern, Germany; ^2^CECS, Valdivia, Chile; ^3^IZKF, Münster, Germany {#sec4-55}

Glucose is an essential energy requirement to maintain brain metabolism. It is believed that the supply of energy is adjusted to energy demand in the brain, and that different cell types may have their individual glucose handling. In a previous study, the uptake of glucose was studied in real‐time using fluorescent tracers and confocal microscopy in brain cells in culture1. Here, we have adapted this technique to acute slices prepared from rodent cerebellum studied with multiphoton microscopy. The transport of the fluorescent glucose analogs (N‐7‐ nitrobenz‐2‐oxa‐1,3‐diazol‐4‐yl‐amino)‐deoxy‐D‐glucose, 2‐NBDG and 6‐NBDG, was up to three times faster in the molecular layer of the cerebellar cortex than in granular cell layer. After washout of the free dye, the majority of the 2‐NBDG appeared to be confined to Bergmann glia. This was confirmed by using monomeric red fluorescent protein1 (GFAP‐mRFP1) knock‐in mice (obtained from F. Kirchhoff, Homburg/Saar), which reveals Bergmann glial cells. The recovery of fluorescence after locally defined photobleaching showed that phosphorylated 2‐NBDG can diffuse horizontally across the molecular layer, presumably through gap junctions between Bergmann glial cells. The dye calcein, which is not taken up by living cells, served as control for diffusion kinetics of dye in the extracellular spaces and in the experimental chamber. Our results suggest that in acute cerebellar slices, the glucose transport capacity and glycolytic rate of Bergmann glia are considerably higher than those of neurons. Since the cerebellum, like other parts of the brain, is largely fueled by glucose, and as neurons are estimated to spend significantly more energy than Bergmann glia, these results suggest substantial shuttling of energy‐rich metabolites, for example lactate and/or pyruvate via monocarboxylate transporters, between glial cells and neurons.

1\. Loaiza, A., Porras, O.H. & Barros, L.F. (2003) J Neurosci, 23, 7337‐7342.

Supported by Fondecyt, Conicyt, and Deutsche Forschungsgemeinschaft to J.W.D. and L.F.B.
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INJURY‐INDUCED REGULATION OF NEUROGENESIS {#sec2-56}
-----------------------------------------

### Andersen R.K., Owens T. {#sec3-56}

#### University of Southern Denmark, Odense C, Denmark {#sec4-56}

Neurogenesis in the brain is an ongoing process throughout life, and is implicated in diverse functions including learning, sense of smell, and potentially also in neurological disease. The hippocampus dentate gyrus sub‐granular zone (DG SGZ) is a major site of adult neurogenesis, generating neurons that incorporate into the granule cell layer. This constitutive production of new neurons can be modulated by a variety of factors, including hormones, growth factors, and neurotrophins. Many of these factors are produced by glial cells, in inflamed, infected or injured brain. It remains unclear whether and how glial response affects neurogenesis.

Brain trauma results in neuronal death, axonal damage and loss of synaptic connections, with accompanying glial response. Although regeneration and repair via activation of neural precursor cells (NPCs) and increase in neurogenesis is plausible, it has not been clearly demonstrated. We are investigating whether transection of perforant path axons has an effect on neurogenesis in the DG SGZ, measuring newly developed neurons as doublecortin/bromodeoxyuridine positive cells.

Members of the Toll‐like receptor (TLR) family are induced and triggered by endogenous ligands in the CNS in response to injury. Interestingly, studies by others have shown that doublecortin‐positive NPCs in the hippocampus express TLR2 and TLR4. Furthermore, TLR2‐deficiency impairs neurogenesis, while absence of TLR4 promotes proliferation and neuronal differentiation from NPCs. These findings point towards distinct roles of TLR2 and TLR4, which have yet to be investigated during injury. Data will be presented from experiments that compare basal and injury‐induced glial response and neurogenesis in wild‐type mice and mice deficient in TLR signaling.

Understanding mechanisms involved in injury‐induced glial‐neuron signaling leading to neurogenesis, is of relevance for potential regenerative therapy in neurodegenerative diseases, like Alzheimers disease, as well as in neuroinflammatory conditions such as MS.
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TWO ASTROGLIAL NETWORKS ARE DIFFERENTLY REGULATED BY NEURONAL ACTIVITY IN THE OLFACTORY GLOMERULAR LAYER {#sec2-57}
--------------------------------------------------------------------------------------------------------

### Roux L., Giaume C. {#sec3-57}

#### Collège de France, Paris, France {#sec4-57}

An important feature of astrocytes is their network organization due to the expression of a large number of gap junction channels formed by two connexins (Cxs): Cx43 and Cx30. Thus, dynamic neuroglial interactions may not only occur at individual cell level, but could also involve collaboration between cellular networks. Thanks to their specific compartmentalized neuronal organization, olfactory glomeruli provide a suitable model to study the basis of such an interaction. The analysis of dye coupling experiments performed with sulforhodamine B in acute slices from P15‐P22 mouse olfactory bulbs show that two types of astroglial networks with restricted communication coexist in the glomerular layer: intraglomerular and extraglomerular networks. This distinction tends to reflect neuronal organization and is reinforced by the fact that these networks are differently regulated by neuronal activity. Indeed, inhibition of spontaneous neuronal activity by TTX application reduces the number of coupled cells by 56% (n=12) in glomerular networks whereas TTX has no effect on extraglomerular networks (n=9). Interestingly, immunohistochemistry and confocal analysis indicate that Cx43 is preferentially expressed at the periphery of the glomeruli and Cx30 within the glomeruli. The differential activity‐dependent regulation of astroglial networks could then be linked to the distinct localization of these two Cxs. To test whether Cx30 is more sensible to neuronal activity than Cx43, knock‐out mice for each Cxs were used. Indeed, short term inhibition of neuronal activity by TTX had no significant effect in Cx30 KO mouse (7% inhibition, n=7) compared to the control mouse (56% inhibition, n=12). In contrast, an inhibition stronger than in control conditions is observed in Cx43fl/fl GFAP‐Cre mouse (66%, n=10). Also with a long term inhibition of neuronal activity performed by neonatal naris closure, no effect was observed in Cx30 KO mouse 20 days after deprivation (12% increase, n=7), whereas control and Cx43fl/fl GFAP‐Cre mice showed a significant decrease in the level of coupling (62%, n=10, and 79%, n=5, respectively). Altogether these observations demonstrate that astroglial networks in olfactory glomeruli are compartmentalized and controlled by neuronal activity in connexin‐dependent manner.
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DEVELOPMENTAL CHANGES OF GABAERGIC SYNAPTIC INPUTS RECEIVED BY NG2 CELLS IN THE MOUSE SOMATOSENSORY CORTEX {#sec2-58}
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### Velez Fort M., Maldonado Rojas P., Audinat E., Angulo M.C. {#sec3-58}

#### INSERM U603, CNRS UMR 8154, Univ. Paris Descartes, Paris, France {#sec4-58}

NG2 cells, considered as a fourth major type of glia, received functional glutamatergic and GABAergic synaptic contacts from neurons. In the present work, we analysed the intrinsic properties and synaptic activity of NG2 cells in acute slices of the barrel cortex of NG2‐DsRed transgenic mice during postnatal development (from PN3 to PN28). We observed that voltage‐dependent potassium conductances increased in cortical NG2 cells, whereas sodium conductances decreased during the first postnatal month. Spontaneous synaptic activity of cortical NG2 cells was mainly GABAergic, sensitive to the GABA‐A receptor antagonist GABAzine. In control as well as in the presence of 10mM extracellular KCl, which increases neuronal activity, a drastic frequency decrease of GABAergic synaptic events occurred after PN14 (control: 45.6±14.8 events/min at PN7‐14 vs 2.8±0.6 events/min at PN21‐28; KCl: 113.6±75.4 vs 5.8±2.3 events/min). Moreover, miniature postsynaptic currents (mPSCs) were not detected at PN21‐28, even when the potent secretagogue ruthenium red was bath applied. In contrast, mPSCs having fast rise times and slow decay times (0.9±0.2 msec and 26.9±2,7msec, respectively) were easily observed at PN7‐14. Ca2+ imaging experiments revealed increases in the intracellular Ca2+ concentration of NG2 cells at different developmental stages upon bath applications of saturating concentrations of GABA (500 microM) or muscimol (50 microM), suggesting a depolarising action of GABA‐A receptor activation. However, the number of cells showing intracellular Ca2+ responses was larger at PN7‐14 than at PN21‐28 (75% vs 30%). Also, a significant decrease of GABA and muscimol induced currents were observed during development (700±46 pA at PN7‐14 vs 331±143pA at PN21‐28 for muscimol). All together, these results suggest a decrease in the number of GABAergic synaptic inputs onto NG2 cells during postnatal development accompanied with a decrease in the expression of GABA‐A receptors.
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INFLUENCE OF MELANIN‐CONCENTRATING HORMONE ON GLUTAMATE HOMEOSTASIS {#sec2-59}
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### Harray S.,^1^ Massie A.,^2^ Abarca C.,^2^ Beguin A.C.,^3^ Smolders I.,^2^ Vanhoutte N.,^4^ Hermans E.,^4^ Grisar T.,^1^ Lakaye B.^1^ {#sec3-59}

#### ^1^ULG, Sart‐Tilman Liège, Belgium; ^2^VUB, Bruxelles, Belgium; ^3^FUNDP, Namur, Belgium; ^4^UCL, Bruxelles, Belgium {#sec4-59}

MCH, a 19 amino acids cyclic peptide, is produced by neurons located in lateral hypothalamus and zona incerta which project axons to almost brain. In the same way, MCH receptor 1 (MCHR1) is expressed in many cerebral structures and particularly in limbic structures with a strong density in the shell of the nucleus accumbens (NAc).

By microdialysis, we observed an increase of basal glutamate level in the nucleus accumbens (NAc) of MCHR1 KO mice compared to WT. However, experiments of 3H‐aspartate uptake in synaptosomal fractions prepared from the lower half of striatum has revealed a higher uptake in KO mice. By using specific inhibitors, we showed that GLAST should be responsible for this difference. A higher uptake was also observed in KO mice compared to WT in synaptosomal fractions of cortex and no difference was observed in cerebellum which agrees with the fact that MCHR1 is not expressed in this structure. By Western blot, a significant increase of GLAST levels was observed in the NAc of KO compared to WT.

Because astrocytes are the principal regulators of glutamate homeostasis, we first demonstrated, by RT‐PCR, that these cells expressed mRNA encoding MCHR1 in vitro. Next, we performed 3H‐aspartate uptake experiments. We showed a lower uptake in astrocytes treated 6 minutes with MCH 1 μM compared to the non treated one. By using specific inhibitors, we demonstrated that the effect is largely mediated by GLT‐1. The effect of MCH was also completely blocked in the presence of the MCHR1 receptor antagonist PMC‐3881. Finally, knowing that MCHR1 receptor is principally coupled to the Gi/Go pathway, we tested PTX influence on 3H‐aspartate uptake. We demonstrated that a 16h PTX incubation partially inhibited MCH effect, showing that Gi/Go pathway is implicated in the uptake regulation with the contribution of another pathway, certainly Gq.

These results show that MCH acts directly on astrocytes via MCHR1 tomodulate glutamate homeostasis. These data will have to betaken into account when studying the effect of MCH on synaptic transmission.

P‐060 {#sec1-60}
=====

EFFECT OF N‐3 POLYUNSATURATED FATTY ACIDS (PUFA) ON ASTROGLIAL FUNCTION DURING AGING {#sec2-60}
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### Grintal B.,^1^ Champeil‐Potokar G.,^1^ Harbeby E.,^1^ Guesnet P.,^1^ Latour A.,^1^ Vancassel S.,^1^ Billard J.M.,^2^ Renault A.,^3^ Lavialle M.,^1^ Denis I.^1^ {#sec3-60}

#### ^1^INRA, JOUY‐EN‐Josas, France; ^2^INSERM U 894, Paris, France; ^3^Saint‐Hubert, Rungis, France {#sec4-60}

n‐3PUFA must be provided to the diet in sufficient amount to allow the optimal incorporation of docosahexaenoic acid (DHA, the main n‐3PUFA), in brain cell membranes (neurons and astrocytes). The unbalance between n‐3 and n‐6PUFA in western diet may therefore result in a low brain DHA status that is supposed to participate to the decline of brain function with aging and to the occurrence of associated neuropathologies (Alzheimer, depression...). However, the mechanisms linking DHA status in brain cells and brain disorders are still questioning.

We have shown that DHA is involved in the regulation of astroglial gapjunctional coupling and glutamate transport (Champeil‐Potokar et al 06, Grintal et al 09). Because astrocytes play a key role in maintaining a safe microenvironment for neurons, we have investigated the possible consequences of an n‐3PUFA deficiency on several features of astroglial function in aging rats, focusing primarily on glutamate scavenging.

Astroglial glutamate transport was investigated by measuring D‐3H‐Aspartate uptake by freshly isolated brain membrane suspensions (from cortex and CA1) and by quantifying astroglial transporters (GLAST and GLT‐1) by western blotting in these suspensions. Astrogliosis was also evaluated by immunohistological and western blotting determination of GFAP. These parameters were compared in young (2‐4 month‐old) and old (20‐24 month‐old) male Wistar rats receiving an n‐3PUFA balanced or deficient diet (from their conception). Their brain fatty acid status was evaluated in the main cell membrane phospholipid classes by gas chromatography.

Old rats exhibited a 30% reduction of their glutamate transport activity as compared to young ones, and a marked increase in GFAP, in cortex and CA1. All the measured astroglial parameters were similar in n‐3PUFA balanced and deficient young rats. However n‐3PUFA deficient old rats exhibited a decrease in glutamate transport and an increased GFAP as compared to n‐3PUFA balanced old rats.

These results indicate that n‐3PUFA deficiency aggravates the impairment of astroglial glutamate transport and the astrogliosis occurring in aged rats. They suggest that a low brain DHA status contributes to the alteration of astrocyte function associated to brain aging.
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FUNCTIONAL VALIDATION OF GENES IDENTIFIED IN SCHWANN CELLS BY MICROARRAYS UPON AXONAL CONTACT {#sec2-61}
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### Blugeon C.,^1^ Decker L.,^2^ Charnay P.,^2^ Le Crom S.^3^ {#sec3-61}

#### ^1^IFR36,Plate‐forme transcriptome, Paris, France; ^2^INSERM U784, Paris, France; ^3^IFR36,Plate‐forme transcriptome, INSERM U784, Paris, France {#sec4-61}

Validation of candidate genes obtained by microarrays is a challenging task. As classical RT‐PCR approach is only a confirmation of the results obtained form biochips, there is a real interest for functional validation assays. Here we report a set of validation tests for genes detected during the interaction between Schwann cells (SCs) and axons. We performed comparative gene analysis using microarrays between SCs and SCs co‐cultured with dorsal root ganglia (DRG) neurons and obtained a list of genes regulated in SCs in early stage of neuron‐ SCs contact.

In order to validate our microarray data and to investigate the functional relevance of the interaction, we have performed different experimental tests. We first used RT‐PCR on gene candidates for the confirmation of induction or repression of gene expression. Then we performed in situ hybridization on cell cultures in order to localize mRNA expression in cells. Finally, we have combined an in vitro model of myelination with 2 loss‐of‐function approaches using either an available neutralizing antibody to block the activity of protein of interest ora siRNA‐mediated gene silencing. The results of these tests underline advantages and drawbacks of each methodology and allow for the selection of the most useful approach. In addition, the entire test performed clearly identifies Schwann cell markers regulated upon axonal contact.
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INTRODUCTION: Several studies suggest that docosahexaenoic acid (DHA, 22:6ω3), the main omega‐3 PUFA of brain membranes, may be an important regulator of brain energy metabolism by affecting glucose utilization, its transporter GLUT1 and mitochondrial oxidative phosphorylation (Ximenes et al., J Neurochem 2002; Pifferi et al., J. Nutr 2005). Because DHA may regulate gene expression via different transcription factors, we investigated the impact of dietary omega‐3 PUFA on the expression of GLUT1 gene and key neuroenergetics genes in fronto‐parietal cortex of rats under basal and neuronal activated state.

MATERIAL AND METHODS: Nine‐week‐old male rats, fed either an omega‐3 PUFA‐adequate (control, n = 12) or an omega‐3 PUFA‐deficient (omega‐3 def, n = 12) diet, were randomly divided into two subgroups: normal environment (naïve) and enriched environment (activated). FA content in phospholipid classes was determined by gas chromatography and the mRNA expression of 45 key metabolic genes was quantified by a multiple gene expression analysis using real‐time PCR (TaqMan low‐density array, TLDA).

RESULTS: Omega‐3 PUFA‐deficient rats had reduced DHA amount in their membrane phospholipids (‐ 67%). Under basal condition, omega‐3 PUFA deficiency induced alteration of the expression of ten genes including MCT2, LDH5, catalytic subunit of the Na+/K+‐ATPase pump, and complexes of the oxidative phosphorylation (OXPHOS)(II, III, IV and V). The gene expression of GLUT1 was also decreased by the deficiency under basal condition (‐33%). Though enriched environment induced a similar activation of GLUT1 expression in the two dietary groups, the level of GLUT1 expression remained significantly lower in deficient rats but similar to that of naïve control rats.

CONCLUSION: Our data indicate that the lower GLUT1 density in cerebral cortex in omega‐3 PUFA‐deficient rats is consistent with a reduction in GLUT1 gene expression. This alteration persists under brain activation, confirming our hypothesis of a consequent impairment of glucose metabolism. Changes in the gene expression of MCT2 LDH5, Na+/K+‐ATPase and complexes of OXPHOS indicate that the metabolism of lactate and ATP synthesis are also disturbed by the lack of omega‐3 PUFA in the diet.
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METABOLIC REGULATION AND NEURONAL OSCILLATIONS IN THE OLFACTORY BULB ARE UNDER THE INFLUENCE OF ASTROCYTIC NETWORKS {#sec2-63}
-------------------------------------------------------------------------------------------------------------------

### Martin C.,^1^ Houitte D.,^2^ Guillermier M.,^2^ Roux L.,^3^ Giaume C.,^3^ Bonvento G.,^2^ Gurden H.^1^ {#sec3-63}

#### ^1^Labo. IMNC CNRS UMR8165, Orsay, France; ^2^MIRCen CNRS‐CEA URA2210, Fontenay‐Aux‐Roses, France; ^3^Inserm 840 Collège de France, Paris, France {#sec4-63}

Neuron‐astrocyte crosstalk is an essential feature of brain networks. Via glutamate transporters (GLAST and GLT1), astrocytes can detect neuronal activity and regulate the level of glutamate in the synaptic cleft. Besides, astrocytes are organized in networks, bound together via connexins (Cx43, 30), the constituents of gap junction channels. These keys astrocytic molecules play a crucial role in metabolic regulation in response to neuronal activity but their functional implication in a defined and physiologically activated network is unclear. In this context, we use the sensory activation of olfactory glomeruli ‐the olfactory bulb (OB) functional units‐ as a model for the study of astrocytic glutamate transporters and connexins in neuroenergetics.

Odor‐evoked changes of activity in the OB were measured in mice lacking either glutamate transporters or Cx30 using: 1) \[14C\]‐2‐Deoxy‐D‐Glucose (2DG) uptake; 2) local field potential (LFP) recording of neuronal activity; 3) behavior to examine olfactory capabilities of animals.

For 2DG uptake in olfactory glomeruli in response to a benzaldehyde odor (2%), we found no significant changes between GLT1‐KO and wild type (WT) mice while GLAST‐KO mice presented a 20% decrease. Contrary to GLAST‐KO, in Cx30‐KO mice, 2DG glucose uptake was markedly amplified in activated glomeruli by more than 50%. In addition, more glomeruli are activated in Cx30‐KO mice. To check whether these metabolic changes impair neuronal activity, we examine properties of LFP activities recorded in the OB. We also test the odor detection threshold of these mice and their capacity to discriminate between similar odorants. Electrophysiological and behavioral data are under process. In conclusion, our results show for the first time that GLAST and Cx30 are controlling glucose input into odor‐activated glomerular networks and that the absence of these astrocytic elements has an impact on neuronal activity.

Support: ANR‐06‐NEURO‐004‐01 Astroglo.
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GLUCOSE STIMULATES THE EXPRESSION OF ENDOZEPINES IN GLIAL CELLS: POTENTIAL INVOLVEMENT IN BRAIN GLUCOSE SENSING AND FEEDING BEHAVIOUR {#sec2-64}
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#### ^1^EA4310, DC2N Laboratory of Neuronal and Neuroendocrine Cell Differenciation and Communication, Rouen, France; ^2^Oncology and Molecular Endocrinology Research Center, Laval University Hospital, Quebec, Canada {#sec4-64}

Diazepam‐binding inhibitor (DBI), a polypeptide exclusively produced by astroglial cells in the central nervous system, has been isolated for its ability to displace benzodiazepines from their receptors. DBI and its processing products, including the octadecaneuropeptide (ODN), are collectively termed endozepines. Central administration of ODN markedly inhibits food intake and this effect is mediated through activation/inactivation of POMC/NPY pathways. It is well known that glucose is involved in the regulation of feeding and several studies suggest a direct implication of glial cells in central glucose sensing. Using real‐time quantitative PCR, we show that glucose induces a 2‐fold increase of DBI mRNA levels in cultured rat astrocytes and C6 glioma cells. Promoter/reporter experiments indicate that this effect is mediated by activation of the DBI gene promoter. The effect of glucose on DBI mRNA levels is neither mimicked by pyruvate, substrate of the ATP‐generating Krebbs cycle, nor blocked by pharmacological activation of the "metabolic sensor" AMP‐dependent protein kinase, suggesting that the signal for DBI induction is independent of ATP/AMP levels. The effects of glucose on DBI induction is suppressed by DON, a specific inibitor of the hexosamine biosynthesis pathway (HBP), a branch pathway of glycolysis which is able to modulate gene expression through the O‐glycosylation of transcription factors. The stimulatory effect of glucose on DBI expression is abolished by inhibition of the transcription factor Sp1, a well‐recognized target of the HBP. We finally demonstrate, using in situ hybridization, that i.c.v. injection of glucose increases DBI mRNA levels in rat mediobasal hypothalamus. Altogether, these data support the view that inhibition of food intake by glucose might involve, at least in part, stimulation of endozepine production in glial cells.
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UPTAKE AND RECYCLING OF PRO‐BDNF FOR TRANSMITTER‐INDUCED SECRETION BY CORTICAL ASTROCYTES {#sec2-65}
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Activity‐dependent secretion of brain‐derived neurotrophic factor(BDNF) is thought to enhance synaptic plasticity, but the mechanisms controlling extracellular availability and clearance of secreted BDNF are poorly understood. We show that BDNF is secreted in its precursor form (pro‐BDNF) and is then cleared from the extracellular space through rapid uptake by nearby astrocytes after theta‐burst stimulation in layer II/III of cortical slices, a paradigm resulting in long‐term potentiation of synaptic transmission. Internalization of pro‐BDNF occurs via the formation of a complex with the pan‐neurotrophin receptor p75 and subsequent clathrindependent endocytosis. Fluorescence‐tagged pro‐BDNF and real‐time total internal reflection fluorescence microscopy in cultured astrocytes is used to monitor single endocytic vesicles in response to the neurotransmitter glutamate. We find that endocytosed pro‐BDNF is routed into a fast recycling pathway for subsequent soluble SNARE‐dependent secretion. Thus, astrocytes contain an endocytic compartment competent for pro‐BDNF recycling, suggesting a specialized form of bidirectional communication between neurons and glia.
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The vulnerability of motor neurons to excitotoxicity is mediated by Ca^2+^influx through AMPA receptors and is implicated in the selective motor neuron loss typical for amyotrophic lateral sclerosis (ALS). The Ca^2+^ permeability of the AMPA receptor depends on the subunit composition. If the GluR2 subunit is present in the receptor complex, the AMPA receptor is impermeable to Ca^2+^. We have previously shown that astrocytes secrete factors that can upregulate the expression of the GluR2 subunit in motor neurons and can determine the sensitivity of these cells to excitotoxicity, both *in vitro* and *in vivo*. One of the factors secreted by astrocytes is vascular endothelial growth factor (VEGF). VEGF treatment of motor neurons results in AMPA receptor currents with a low sensitivity to 1‐naphthyl acetyl spermine (NAS), a high rectification index and a low relative Ca^2+^ permeability, all functional parameters linked to high GluR2 expression. The stimulating effect of VEGF is mediated through the VEGFR2 present on motor neurons and is due to activation of GluR2 transcription. Intracerebroventricular treatment of rats with VEGF induces GluR2 expression in the ventral spinal cord. In conclusion, we identified VEGF as an inducer of the GluR2 subunit of the AMPA receptor leading to AMPA receptors with a lower Ca^2+^ permeability. This mechanism could contribute to the protective effect of VEGF on motor neurons.
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After demyelination of the corpus callosum, repopulation of the lesion and remyelination are not only ensured by local oligodendrocyte progenitor cells (OPCs), but also by NG2‐expressing OPCs generated de novo in the subventricular zone (SVZ) and migrating into the lesion. It has recently been shown that most NG2+ cells present in the white matter are contacted by glutamatergic synapses after the first postnatal week. However, it is still debated whether synaptic interaction represents an early step during myelination, or is a property of NG2+ cells that persist in the adult white matter and are not engaged in myelination. It is also unknown whether demyelinated axons in the adult brain retain the potential to form new synapses with OPCs repopulating a lesion. We performed whole‐cell recordings on retrovirally‐labeled SVZ‐derived progenitors at different time points after focal demyelination of the adult mouse corpus callosum (CC). This system allowed us to selectively focus on NG2+ OPCs that are engaged in oligodendrogenesis and remyelination after demyelination. At 3 days post‐lesion (DPL), GFP+ cells were observed not only in the SVZ, but also migrating at the border between the SVZ and the CC, and inside the CC itself. At this stage, approximately 48% of GFP+NG2+ cells in the demyelinated CC (n = 12/25) exhibited evoked glutamatergic EPSC (eEPSC) and spontaneous EPSCs (sEPSC). At 7 DPL, this percentage increased to 91% (n=11/12), indicating that almost all SVZ‐born NG2+ cells are synaptically connected after 1 week. By contrast, we never observed any EPSC in the few GFP+Dcx+ neuroblasts migrating into the CC (n = 0/6), demonstrating that glutamatergic synapses are specifically formed onto SVZ‐derived NG2+ progenitor. Between 7 and 10 DPL, we observed a significant decrease in the percentage of GFP+NG2+ OPCs in favor of GFP+CC1+ oligodendrocytes, suggesting that synaptically connected GFP+NG2+ at 7DPL do convert into CC1+ cells. This conversion was confirmed by the observation that 28% of GFP+/CC1+ cells still exhibited sEPSCs between 7 and 10 DPL (n = 4/14). In conclusion, we demonstrate here that axon‐OP synapse formation is a specific and transient step that occurs during remyelination of callosal axons, and that both demyelinated axons and adult OPs retain the potential to form synapses.
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The last decade has presented studies providing evidence for astrocytic exocytosis of glutamate potentiating nerve signals. To make further investigations into this astrocytic attribute we investigated the localization of the vesicular glutamate transporter 1 (VGLUT1) in small processes of astrocytes close to glutamatergic terminals in frontal cortex, striatum, molecular layer of hippocampus and stratum radiatum of hippocampus. According to the importance of VGLUT1 in glutamate exocytosis the presence of VGLUT1 in astrocytic processes indicates the ability to exocytose glutamate.

METHODS: For qualitative analysis we used immunoflourescence histochemistry. Sections from rat frontal cortex, striatum, molecular layer of hippocampus and stratum radiatum of hippocampus were labeled with antibodies against glutamine synthetase (an astrocytic marker) and VGLUT1. Z‐stacks of 4.5‐5 μm obtained by confocal microscopy from each section were deconvolved and 3D reconstructed in Amira. Small astrocytic processes were analysed for the presence of VGLUT1 inside the processes. The quantitative analysis was done by immunogold labeling. Ultrathin sections from each brain region were labeled for GLT (an astrocytic marker) and VGLUT1. Pictures obtained by electron microscopy were analysed and the point density (gold particles/nm^2^) for VGLUT1 in astrocytic processes was measured.

RESULTS: Using confocal 3D reconstructions we were qualitatively able to identify VGLUT1 within small processes of astrocytes in all four brain regions. Reflecting our qualitative findings the electron microscopical immunogold quantifications showed a significant density of gold particles signaling VGLUT1 in astrocytic processes in all four brain regions.

CONCLUSION: We extend the results of previous studies on glutamate release from astrocytes, which have focused on the hippocampus, proposing that astrocytic exocytosis of glutamate is a global phenomenon in the brain.
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Accumulating evidence suggests that during neuroinflammation activated glial cells can produce neurotoxic factors contributing to the progression of neurodegeneration. One such factor might be a CX3C chemokine Fractalkine (FKN), known to possess cell adhesion and chemoattractive properties. FKN is expressed in the CNS by various cell types, including astroglia, and reported to exhibit both neuroprotective and neurotoxic effects. Full length FKN is a membrane‐bound protein containing a chemokine domain, which upon proteolytic cleavage is released and secreted as a soluble form. The present study was designed to examine the effects of cytokine‐activated primary human astrocytes, potentially expressing and secreting soluble FKN, on the viability of human NT2‐derived neurons. We have established that a combination of TNF‐alpha and IFN‐gamma brought about the morphological and biochemical changes (star‐shaped morphology, upregulated GFAP expression and production of IL‐6) in primary human astrocytes, consistent with their activated phenotype. These activated astrocytes also up‐regulated the expression of FKN, which was rapidly cleaved into the 80 kDa fragment and secreted to the culture medium. The activated astrocyte conditioned medium (ACM), when added to pure cultures of neurons, caused neuronal cell death, suggesting that it contained a potentially neurotoxic factor(s). A direct treatment of neuronal cultures with the combination of TNF‐alpha, IFN‐gamma or IL‐6 did not have any adverse effects on the neurons; however, exposure to the recombinant full‐length FKN or its chemokine domain resulted in outcomes similar to the treatment with ACM. Taken together, our results strongly suggest that under neuroinflammatory conditions, FKN produced and secreted by activated astrocytes, could adversely affect the viability of neurons; thus, contributing to the progressive nature of neurodegenerative diseases, known to be associated with chronic inflammatory processes.
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All but the smallest‐diameter axons in the CNS are myelinated, but the signals that initiate myelination are unknown. Our prior work has shown that integrin signaling forms part of the cell‐cell interactions that ensure only those oligodendrocytes contacting axons survive. Here therefore we have asked whether integrins regulate the interactions that lead to myelination. Using homologous recombination to insert a single‐copy transgene into the hprt locus, we find that mice expressing a dominant negative beta1 integrin in myelinating oligodendrocytes require a larger axon diameter to initiate timely myelination. Mice with a conditional deletion of focal adhesion kinase (a signaling molecule activated by integrins) exhibit a similar phenotype. Conversely, transgenic mice expressing dominant negative beta3 integrin in oligodendrocytes display no myelination abnormalities. We conclude that beta1 integrin plays a key role in the axoglial interactions that sense axon size and initiate myelination, such that loss of integrin signaling leads to a delay in myelination of small‐diameter axons.
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Myelin formation and maintenance requires intense communication between neurons and oligodendrocytes. In human myelin disease as well as in transgenic mice, secondary axonal degeneration develops in response to a primary glial defect suggesting signalling mechanisms between oligodendrocytes and axons independent of myelin formation. We have shown recently that oligodendrocytes secrete small microvesicles called exosomes implicated in cell communication. In addition to exosome specific cargo, these vesicles carry myelin proteins such as PLP and proteins with potential neuroprotective functions. Treatment of primary oligodendrocytes with the Ca2+‐ionophore ionomycin stimulates oligodendroglial exosome release, indicating that exosome secretion is triggered by elevation of cytoplasmic Ca2+‐levels. Ca2+‐signalling in oligodendrocytes is mediated by neurotransmitters such as glutamate. Indeed, administration of glutamate triggers exosome release from cultured oligodendrocytes, which is further potentiated by the astroglia‐derived gliotransmitter D‐serine. Application of NMDA‐ and AMPA‐receptor inhibitors interferes with exosome release, indicating that both of these receptors are able to transmit the signal. Immunocytochemical and western blot analysis confirmed expression of the NMDA‐receptor subunits NR1, NR2A and NR2B by cultured oligodendrocytes. Thus, oligodendroglial exosome release is stimulated by neurotransmitters most likely coupling this process to neuronal electrical activity. Oligodendroglial exosomes may be part of a transcellular signalling loop between neurons and glia.

Supported by ELA, IFSN University of Mainz.
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DELETION OF SCAP IN ASTROCYTES: THE IMPLICATION OF COMPROMISED LIPID METABOLISM IN THE MOUSE BRAIN {#sec2-72}
--------------------------------------------------------------------------------------------------

### Camargo N., Smit A.B., Verheijen M.H.G. {#sec3-72}

#### Center for Neurogenomics and Cognitive Research. Neurosciences Campus, Amsterdam, Netherlands {#sec4-72}

The brain is remarkably different in lipid composition than other organs. It is enriched in poly‐unsaturated fatty acids (PUFAs) and cholesterol; the human brain with 2% of the total body weight contains about one quarter of the total amount of cholesterol in the body. Many neurodevelopmental and neurodegenerative diseases are associated with disrupted lipid metabolism in the brain, e.g. Niemann‐Pick Disease and Alzheimer Disease. Astrocytes have been shown to play a pivotal role in the maturation of neuronal circuitry and in synaptic function. Here, we ask the question whether lipid supply by astrocytes plays a role in these processes.

The synthesis of cholesterol and fatty acids is controlled by a family of transcription factors called Sterol Regulatory Element Binding Proteins (SREBPs). Activation of these transcription factors is dependent on the activity of SCAP (SREBP cleavage‐activating protein). In this study, we generated Cre‐lox SCAP mice, from which the SCAP gene was deleted in astrocytes by driving Cre from the human GFAP promoter (from E14 on). These animals were used to study the role of SCAP‐mediated activation of SREBPs in the supply of lipids from astrocytes to neurons during development and in the adult brain.

We found that SCAP knockout animals show an inducible startle‐like behavior (hyperekplexia/dystonia) with an onset at 2 months. The number of startles increased with age and was correlated with a decrease in survival. In addition, SCAP mutant mice had smaller brains, whereas no difference was found in overall body weight. Current research is aimed at revealing the cellular and synaptic changes that occur in SCAP mutant brains, in more detail.
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Neuregulin expressed by axons can regulate myelination by signalling to ErbB receptors on myelinating cells. Furthermore, in CNS grey matter, neuregulin increases the expression of NMDA receptors. Oligodendrocytes at all developmental stages in the white matter exhibit NMDA evoked currents, mediated by receptors which show very weak magnesium block and are expressed in the myelin (Káradóttir et al., 2005, 2008), indicating that they might play a role in myelination.

We now use an assay in which cortical oligodendrocytes ensheath dorsal root ganglion cells (Wang et. al., 2006) to show that neuregulin and NMDA receptors interact to regulate myelination. Without neuregulin, blocking NMDA receptors had no effect on myelination. Adding neuregulin (in the form of the extracellular domain of NRG1‐ß1, 10ng/ml) increased myelination by 60%, and led to the majority of myelination being dependent on activation of NMDA receptors: NMDA receptor block decreased myelination by 80%. Blocking action potentials with TTX also had no effect in the absence of neuregulin, but greatly reduced myelination in the presence of neuregulin. Neuregulin\'s effect was associated with a 4‐fold increase in NMDA receptor current in oligodendrocyte lineage cells. Thus, neuregulin apparently switches myelination from a default programme, that is independent of neuronal activity, to a mechanism that is regulated by glutamate released from active axons.

These data reveal a function for oligodendrocyte NMDA receptors, and could provide a novel white matter explanation for how the linkage of neuregulin to schizophrenia can be reconciled with schizophrenia involving a malfunction of NMDA receptors. The absence of neuregulin in multiple sclerosis lesions, and enhanced remyelination by added neuregulin, suggest a role for neuregulin/NMDA receptor dependent remyelination after pathology.

Káradóttir R, Cavelier P, Bergersen L & Attwell D (2005) Nature 438, 1162‐1166.

Káradóttir R, Hamilton N, Bakiri Y & Attwell D (2008) Nature Neuroscience 11, 450‐456.

Wang Z, Colognato H & ffrench‐Constant C (2006) Glia 55, 537‐45.

Supported by the Wellcome Trust, MRC, Axregen, Action Medical Research, and the Royal Society.
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NF1 patients characteristically develop Schwann cell derived, benign and malignant, tumours resulting from loss of the Ras‐GAP, neurofibromin. Schwann cells are normally found tightly associated with axons, which are thought to maintain the Schwann cells out of the cell‐cycle in specialised differentiation states important for nerve function. In contrast, loss of axonal contact is a frequent and important early event in neurofibroma development. However, the molecular basis of this physical interaction or how it is disrupted in cancer remains unclear. Here we show that loss of neurofibromin in Schwann cells is sufficient to disrupt Schwann cell/axonal interactions via upregulation of the Ras/Raf/ERK signaling pathway. Importantly, we identify downregulation of semaphorin 4F (Sema4F) as the molecular mechanism responsible for the Ras‐mediated loss of interactions. In heterotypic co‐cultures, Sema4F knock‐down induced Schwann cell proliferation by relieving axonal contact‐inhibitory signals, providing a mechanism through which loss of axonal contact contributes to tumourigenesis. Importantly, Sema4F levels were strongly reduced in a panel of human neurofibromas, confirming the relevance of these findings to the human disease. This work identifies a novel role for the guidance‐molecules semaphorins in the mediation of Schwann cell/axonal interactions, and provides a molecular mechanism by which heterotypic cell‐cell contacts control cell proliferation and suppress tumourigenesis. Finally, it provides a new approach for the development of therapies for NF1.
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Astroglial processes enclose ∼60 % of CA1 hippocampal synapses to form the tripartite synapse. Although astrocytes express ionic channels, neurotransmitter receptors and transporters to detect neuronal activity, the nature, properties and plasticity of the extrasynaptic currents induced by neuronal activity is unclear in hippocampal astrocytes. We found that single stimulation of Schaffer collaterals in hippocampal slices evokes in CA1 astrocytes a slow depolarization of 1.6 ± 0.4 mV (n = 8), associated to a complex prolonged inward current of ‐30 ± 12 pA (n = 8) that activates rapidly and inactivates slowly. These astrocytic responses are synchronized to fast field excitatory postsynaptic potentials in CA1 neurons. Pharmacological dissection of this astroglial current indicates that it is composed of three components, including a long‐lasting potassium current (‐24 ± 9 pA, ∼10 sec, n = 10) sensitive to kynurenic acid, a transient glutamate transporter current (‐14 ± 5 pA, ∼20 msec, n = 10) sensitive to TBOA and a slow residual current (‐8 ± 2 pA, ∼10 sec, n = 10). The three currents are sensitive to neuronal activity, as their amplitude increases in proportion to the fiber volley amplitude. However the sensitivity of the residual current to the recruited fibers is lower compared to the potassium and glutamate transporter currents. Astroglial extrasynaptic currents also exhibit activity‐dependent short‐term plasticity, i.e. facilitation during paired‐pulse stimulation at various frequencies (0.5 to 50 Hz). The facilitation is higher for elevated frequencies and peaks at 50 Hz, unlike the facilitation of synaptic currents, which peaks at 25 Hz. At this frequency, paired‐pulse facilitation (PPF) of potassium current was 3‐fold, while PPF of the glutamate transporter current and residual current was 1.5‐fold, similar to synaptic PPF. The strength of neuron to glial signaling in the hippocampus is therefore dynamically regulated by the frequency of schaffer collaterals stimulation. This pattern of short‐term plasticity may be important for astrocytes to detect and support synapses with high frequency input.
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The multidrug resistance‐associated protein 1 (Mrp1) is an efflux pump from the ABC transporter family that exports neurotoxic molecules from the brain. Interestingly, the regulation of neural development by ABC transporters has been a valuable tool for studying neural stem cell (NSC) self‐renewal and differentiation,^1^ but there is a lack of information regarding Mrp1. Thus, in this work we aimed to determine: (i) Mrp1 expression throughout NSC proliferation and differentiation; (ii) Mrp1 expression along maturation of neurons and astrocytes; and (iii) Mrp1 neuronal expression during neuron‐glia interactions.

Neurospheres, obtained from committed neural progenitors, were used to evaluate Mrp1 by Western blot analysis. Differentiation of neurons was induced by plating NS onto PLL‐coated plates, in the presence of 5 ng/mL bFGF, which was replaced after 2 days by Neurobasal medium with B‐27, glutamine and gentamicin. Mrp1 expression was determined after 4, 8 and 18 days in vitro (DIV). We have also evaluated Mrp1 expression in rat astrocytes with 5, 10 and 20 DIV and in neurons with 4, 8 and 18 DIV. Furthermore, astrocytes with 10 DIV were seeded onto transwells for 24 h and co‐cultured with 8 DIV neurons. After 48 h we evaluated Mrp1 expression.

Our first data indicate that Mrp1 was greatly expressed in NS, decreasing during neuronal differentiation to 75% at 4 DIV, to 58% at 8 DIV and 88% at 18 DIV. Thus, although increasing during maturation, Mrp1 expression never reached that obtained in proliferating NS. In primary cultures we also have observed that Mrp1 increased throughout maturation both in neurons (1.9‐ and 2.6‐folds at 8 and 18 DIV, respectively, vs. 4 DIV) and glial cells (3.1‐ and 5.8‐folds at 10 and 20 DIV, respectively, vs. 5 DIV). In the co‐cultures, we have observed an increase in neuronal Mrp1 (11%) indicating that glial signaling molecules may have induced its expression.

In conclusion: (i) Mrp1 may have an important role in NSC proliferation/differentiation decisions; (ii) a lower Mrp1 expression in immature cells will contribute to their higher susceptibility to neurotoxins; and (iii) astrocytes may increase intrinsic neuronal defense mechanisms.

^1^Lin et al. Cell Research 2006;16:857‐871.

Funded by FCT‐POCI/SAU‐MMO/55955/2004, FCT‐PTDC/SAU‐NEU/64385/2006, POCI 2010/FEDER (to DB).
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### Ben Achour S., Silm K., Bessis A., Pascual O. {#sec3-77}

#### ENS, Paris, France {#sec4-77}

Inflammation is a common feature of most central nervous system (CNS) diseases exhibiting loss of synapses and/or altered synaptic transmission. However, very little is known on the inflammatory mechanisms that impacts synaptic transmission and neuronal activity. Microglia are the main effectors of inflammation in the CNS, they originate from the myeloid lineage and are mainly described as the immunocompetent cells of the brain. They release multiple factors such as cytokines, chemokines, nitric oxide and growth factors in inflammatory conditions that could impact neuronal transmission. In addition to the release of immune related molecules, microglia have been more recently described as a potent source of neurotransmitters (glutamate, ATP, GABA...).

Our aim was to assess microglial impact on neuronal activity upon inflammation. We studied neuronal activity of CA1 hippocampal neurons by patch clamp recording in voltage clamp configuration on acute mouse slices. Microglia were selectively stimulated by bath application of lipopolysacharide (LPS) (500 ng/ml), a Toll Like Receptor‐4 (TLR4) ligand. CA1 neuronal recordings indicated that LPS induced a rapid increase of postsynaptic currents (PSC) frequency within the first minute of application with no change in amplitude. This PSC frequency increase was blocked by application of kainate/AMPA receptor antagonist NBQX but was neither affected by D‐APV nor picrotoxine. Altogether, these results suggest that microglial activation by LPS increases the probability of glutamate release at the presynaptic level.

Microglial signaling pathway was tested using slices from TLR4‐/‐ and anti‐inflammatory drug minocycline. In both cases, PSC increase was abolished, providing evidence that LPS action was due to its usual inflammatory transduction pathway. To investigate the molecular signaling between microglia and neurons, we tested signaling pathways involving TNF‐alpha and ATP respectively, two molecules described for their presynaptic action. While LPS effect was still present in TNF‐alpha ‐/‐ animals the PSC frequency was totally abolished by broad spectrum purinergic antagonist RB‐2 or PPADS.

Overall our data suggest that microglia rapidly modulates glutamatergic neuronal activity through a purinergic signaling at the onset of inflammation.
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Mutations in the proteolipoprotein (*PLP*) gene cause a spectrum of X‐linked dysmyelinating disorders, spanning in clinical severity from the severe developmental disorder Pelizaeus‐Merzbacher disease (PMD) to mild forms of spastic paraplegia (SPG2). While motor signs with ataxia and spasticity are the classical manifestations of PMD/SPG2, cognitive disturbances have been reported in PLP mutated male patients as well as in some heterozygote female carriers. Plp transgenic mice are reliable models of the human pathology: the Plp overexpressing (+PLP Tg) mice exhibit a severe myelin defect similar to PMD patients with PLP duplication; the Plp knockout (KPLP) mice exhibit mainly a late onset axonal degenerescence, similar to SPG2 patients with a PLP depletion. In order to further investigate the cognitive and behavioral abnormalities related to dysmyelinating disorders, we initiated a longitudinal study in affected KPLP males as well as in KPLP and +PLP Tg female carriers (from 3 to 12 months). Affected +PLP Tg males have not been studied due to their premature death.. The pattern and temporal evolution of motor, cognitive and sensitive behaviors have been assessed. Results show that KPLP males mice exhibit mainly motor dysfunction (grip strength and motor coordination defects) with also some cognitive and sensitive dysfunctions. In both strains of mice, the heterozygous females develop minor locomotor abnormalities but severe cognitive and sensitive disturbances with age, KPLP female carriers being more impaired than +PLP Tg female carriers. Results obtained in this animal study are in accordance with the preliminary results observed in our PMD/SPG families. Further analysis using in vivo 1H MRS and neuropathological investigations will try to identify the anatomical substrates and biochemical changes underlying these behavioral abnormalities.
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Extracellular nucleotides are known to function as important neuron‐glia mediators in the physiological and pathological conditions in the CNS. When neurons are injured by kainate (KA), they leak a pyrimidine nucleotide UDP, an endogenous agonist to P2Y~6~ receptors, and inform microglia of their crisis. Although resting microglia express no or little P2Y6 receptors, they upregulate their P2Y~6~ receptors upon neuronal injury. Once microglia sense UDP by the P2Y~6~ receptors, they start to phagocytose dead neurons to remove (Koizumi et al., Nature 2007). However, so far, the precise mechanism underlying microglia‐specific upregulation of P2Y~6~receptors remains unknown. Here, we show that transforming growth factor (TGF)‐β1 is an essential factor for this response. Exogenously applied TGF‐β1 caused significant increases in P2Y~6~ receptors (mRNA and protein) in a concentration dependent fashion in microglia, which was abolished by an inhibitor of TGF‐β type I receptors. This upregulation was mimicked by endogenous TGF‐β1 because (1) the supernatant of KA‐treated neurons‐glia mixed cultures increased microglial P2Y~6~ receptors, which was inhibited by anti‐TGF‐β1 antibody and (2) TGF‐β was increased in the KA‐treated supernatant. Interestingly, TGF‐β1 was not produced when neurons alone or individual glial cells alone were stimulated with KA, suggesting importance of neuron‐glia communications for TGF‐β1 production. We next asked which molecules are responsible for the TGF‐β1 production, and which cells produce TGF‐β1 when neurons are damaged by KA. We performed cytokine array analysis in the mixed cultures and picked out several molecules increased in response to KA. Among candidate molecules, we found that TNF‐α was responsible for induction of TGF‐β1. We also found that astrocytes are the main source of TGF‐β1. Taken together, we demonstrated that TGF‐β1 is a key molecule that upregulates P2Y~6~ receptors and transforms resting microglia into phagocytes. It should be noted that for the upregulation, communication of neuron‐astrocyte‐microglia is required.
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During the last decade, the discovery that astrocytes possess a non‐electrical form of excitability (Ca^2+^‐excitability) that leads to the release of chemical transmitters, an activity called "gliotransmission", indicates that these cells may have additional important roles in brain function. Elucidating the stimulus‐secretion coupling leading to the exocytic release of chemical transmitters (such as glutamate, Bezzi et al., Nature Neurosci, 2004) may therefore clarify i) whether astrocytes represent in full a new class of secretory cells in the brain and ii) whether they can participate to the fast brain signaling in the brain. Here by using a recently developed approach for studying vesicle recycling dynamics at synapses (Voglmaier et al., Neuron, 2006; Balaji and Ryan, PNAS, 2007) combined with epifluorescence and total internal reflection fluorescence (TIRF) imaging, we investigated the spatiotemporal characteristics of stimulus‐secretion coupling leading glutamate exocytosis of synaptic‐like microvesicles (SLMVs) in astrocytes. We performed the analysis at both the whole‐cell and single‐vesicle levels providing the first system for comparing exo‐endocytic processes in astrocytes with those in neurons. Both the time course and modalities of secretion in astrocytes present more similarities to neurons then previously expected. We found that 1. the G‐protein‐coupled receptor (GPCR)‐evoked exocytosis reached the maximum on a ms time scale and that 2. ER tubuli formed sub‐micrometer domains beneath the plasma membrane in close proximity to exocytic vesicles, where fusion events were spatiotemporally correlated with fast Ca^2+^ events.

*Supported by grant FBM UNIL2006.*

P‐081 {#sec1-81}
=====
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In the interphase nucleus, the DNA of higher eukaryotes is organized in supercoiled loops anchored to a nuclear matrix (NM). Such loops are topologically constrained and supercoiled. Several important processes of nuclear physiology, such as replication, transcription and processing of primary transcripts seem to occur at macromolecular complexes located at discrete sites upon the NM. The DNA loops plus the NM constitute a "nucleoid", a very large nucleoprotein aggregate. Cortical neurons become postmitotic since their early embryonic development is in contrast to that of Schwann cells, which have a high proliferative potential. In this study we isolate and compare the nuclei and NM shape, as well as the DNA loop‐NM interaction between cortical neurons and Schwann cells of seven days postnatal rats (P7). The results show that the nuclei of Schwann cells have an ovoid shape which is maintained in the NM. The neuronal nuclei, in contrast, have an overall spherical shape that is maintained in the NM. The interaction between the DNA loop and the NM in the nucleoids of P7 Schwann cells is very fragile, since exposure to high ethidium bromide (EtBr) concentration (80ug/ml) leads to a complete release of the DNA and irreversible disintegration of the NM framework. In contrast, nucleoids of P7 cortical neurons exposed to the same EtBr concentration produce a DNA halo, symmetrically organized around a well defined NM contour, which appears as a stable structure that is not affected by the forces resulting from the EtBr‐induced release and unwinding of the DNA loop. These results suggest that the NM maintains the nuclear shape and that great differences in the stability of the nucleiods are observed between Schwann cells and cortical neurons.
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In the CNS, the NG2 proteoglycan is expressed by oligodendrocyte precursor cells. NG2‐expressing cells are distributed in white and grey matter. In developing cerebellum and hippocampus, and also in the cortex NG2+ cells make morphologically identifiable and electrophysiologically characterised synapses with neurons or axons (Bergles et al. 2000, Jabs et al. 2005, Kukley et al. 2008). These synapses between NG2 cells and neurons may indeed be present throughout the CNS. The components and function of these glial‐neuron synapses are unelucidated but they are thought to modulate activity of the neuronal network.

We have examined the presence of pre and post synaptic components expressed by or adjacent to the EYFP‐fluorescent cells in brain sections from the NG2‐EYFP knock‐in mouse (Karram et al. 2008). Close contact between NG2+ cells and NeuN+ neurones is observed in grey matter areas and the presynaptic markers Bassoon and Piccolo stain structures looking like synaptic contacts on NG2+ cells in the cortex. An NG2 signal is present in synaptosomes and post synaptic density fractions prepared from different brain regions of developing and adult mice, suggesting that the glial‐neuron synaptic components are included in preparations of synaptosomes.
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Astrocytes are one type of glial cell in the brain essential for the structural and metabolic support of neurons. In addition, astrocytes contribute to signal processing. A prerequisite for this functional interaction between astrocytes and neurons is a close spatial relationship as well as tightly regulated cell contact sites. Astrocytic processes ensheath numerous synapses and are highly motile; however, the mechanism and function of this structural plasticity remains unclear. The aim of this study is to elucidate the mechanisms controlling structural plasticity of astrocytes with regard to motility of processes in vivo. This motility is regulated by a dynamic interplay between cell adhesion proteins and the actin cytoskeleton. Vinculin is a central component of the cell adhesion complex that structurally and functionally links cell adhesion receptors to the actin cytoskeleton and is crucial for regulation of adhesion sites. To study vinculin function in astrocytes in vivo we first analysed the localisation of vinculin in mouse brain slices using immunohistochemistry and confocal microscopy. Vinculin is present in the somata as well as in the processes of astrocytes, where it shows a punctate pattern as expected for localization in adhesion sites. Using time‐lapse two‐photon laser scanning microscopy to image astrocytes and neurons in acutely isolated brain slices we confirmed that astrocytes form and retract filopodial and lamellipodial structures within minutes contacting neuronal processes. Furthermore, we generated a mouse line with an astrocyte‐specific and inducible knock‐out for vinculin. Results obtained by genotyping single astrocytes isolated from brains of those mice demonstrate successful recombination of the floxed vinculin gene in vivo indicating a successful cell‐type specific knock‐out. Using this mouse model the consequences of vinculin‐deficiency on astroglial morphology and motility in brain slices was analyzed providing new insights in the relevance of vinculin function for astroglial process motility in vivo.
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The first step in the time‐dependent, multi‐step process of myelination begins with accurate contact between an oligodendrocyte and the axon of a neuron. Oligodendrocytes express a repertoire of adhesion molecules on their surface such as integrins, neurofascins, NCAM, and N‐cadherins. In order to determine which of these factors are essential for contact, we used fluorophore‐assisted light inactivation (FALI), in which a labeled antibody binds to a specific protein and damages it upon illumination. When ß1‐integrin was inactivated with FALI on oligodendrocyte precursor cells, a perturbation in adhesion behaviour on extracellular matrix was observed. This result was confirmed with both siRNA knockdown of ß1‐integrin on a cell line and a ß1‐integrin blocking antibody on primary cells. In addition, this effect is specific, as illuminating oligodendrocyte precursor cells with a labeled IgG or ß5‐integrin antibody did not show any difference in adhesion. As the main goal is to evaluate adhesion molecules involved in oligodendrocyte‐axon contact, a simplified coculture system of dorsal root ganglion neurons and oligodendrocyte precursor cells was used, so that the quantity, timing, and type of cells could be precisely controlled. Oligodendrocyte precursor cells were added to a neuron culture and their adhesion to axons was followed via time‐lapse imaging. After optimizing the timing of the coculture system, ß1‐integrin on oligodendrocyte precursors was again suppressed through either FALI or siRNA and their adhesion to axons was followed via time‐lapse imaging. No changes were observed and this suggests that ß1‐integrin, although perhaps a significant participant in the process of myelination, is not necessary for initial axoglial adhesion.
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ACh and its receptors are expressed at early stages of nervous system development suggesting that it may have alternative roles during neurogenesis, independent on its synaptic function as neurotransmitter. ACh receptors have been also found in several glial cells such as astrocytes, oligodendrocytes and Schwann cells suggesting a role for ACh in the maturation and physiology of glial cells.

Rat Schwann cells express different muscarinic receptor subtypes. M2 receptor is the most abundant subtype in Schwann cells and its activation causes a reversible arrest of cell cycle in G1 phase. The negative effect of M2 agonist on Schwann cell proliferation was accompanied by significant modifications in cell morphology, cytoskeleton protein organization and adhesion molecule redistribution. Moreover we demonstrated that M2 receptor activation is able to induce an up‐regulation of transcription for some myelin proteins such as P0 and PMP22. These data suggest that ACh may be a signal required to stimulate Schwann cell differentiation via M2 receptor.

We have further characterized the pattern of expression of muscarinic receptor subtypes both in progenitor and mature oligodendrocytes and we have studies the effects dependent on their activation. The exposure of pre‐OLs to muscarine enhanced cell proliferation; this is specifically prevented by the subtype specific antagonists 4‐DAMP, pirenzepine and tropicamide, indicating that M3, M1 and M4 subtypes are the receptors involved in the control of pre‐OL proliferation. On the other hand M2 receptors did not appear to be involved in the control of OL proliferation, although their stimulation with high doses of M2 agonist arecaidine impaired OL survival. Moreover the expression of several myelin proteins such as MBP, MAG, MAL and CX32 in both pre‐OLs and mature OLs is downregulated by muscarinic receptors. These data suggest that ACh may influence the development of OLs by preventing their maturation to myelin producing cells and by promoting the maintenance of immature proliferating OLs.

The data obtained demonstrate that ACh, through the activation of different muscarinic receptor subtypes, induces opposite effects on glial cells involved in myelin sheath formation in the central and peripheral nervous system.
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It is now accepted that astrocytes are excitable cells capable to detect and modulate synaptic transmission. However, even though these cells are considered functional elements at tripartite synapses, evidence of such a role at the level of single synapse in the CNS is largely indirect. Thus, the idea that astrocytes detect activity at individual synapses and consequently, actively regulate basal synaptic transmission in central synaptic networks remains controversial. Hence, the goal of this study was to unravel the morphological and functional substrate of the tripartite synapse and test whether astrocytes regulate basal transmission at single hippocampal synapses. We used simultaneous whole cell patch‐clamp recordings and line scan calcium imaging in acute hippocampal slices from pyramidal cells and astrocytes in stratum radiatum of the CA1 area. We uncovered a functional astrocytic compartment, the gliosynaptic element. 3D reconstruction of confocal images showed that this compartment was associated with dendritic spines and corresponded to an enlargement of the astrocytic process. Interestingly, local and precise glutamatergic application by two‐photon uncaging of MNI‐glutamate revealed that the astrocytic activation only occurred in restricted membrane compartments of the gliosynaptic element. Importantly, rapid Ca2+ elevations were elicited in this compartment by single minimal stimulation. This glial detection was blocked by TTX and was dependent on the activation of metabotropic glutamatergic receptors subtype 5 (mGluR5). Finally, we uncovered an mGluR5‐dependent potentiation of basal synaptic transmission in pyramidal cells, as revealed by an increase in the failure rate of minimally evoked synaptic responses by MPEP, a specific mGluR5 antagonist. This effect was entirely due to a glial modulation since it was completely abolished by introducing the Ca2+ buffer BAPTA in astrocytes. In conclusion, astrocytes possess specialized morphological and functional synaptic compartments that detect basal synaptic activity at the single synapse level and, in turn, regulate transmitter release, unraveling a novel fundamental role of astrocytes in information processing in the CNS.
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The detection of olfactory nutritive cues is crucial for survival and implies modifications of activities in the olfactory system. This nutritional regulation has a hormonal (leptin) as well as a neuropeptidergic (orexins) origin. Olfactory glomeruli are thought to be a major target for this modulation since they are the first stage of olfactory coding in the brain. They are constituted of the excitatory synapses formed by axon terminals of the olfactory receptor neurons located in the mucosa and the apical dendrites of mitral cells. These synapses are surrounded and contacted by inhibitory interneurons and astrocytes. We previously showed that glomerular astrocytes express leptin receptors and are triggers of odor‐induced functional optical signals. In addition, they play a crucial role in the glomerular neuro‐metabolic coupling (see C. Martin\'s poster in this meeting). Here, we propose to study the impact of the nutritional state on glomerular neuro‐astrocytic activities in fasted *versus ad‐libitum* rats.

Using *fos*activity, we first showed that cellular responses to familiar odors of glomerular cells in fasted rats were significantly increased compared to ad‐libitum rats. Then, injecting an orexin receptor antagonist or leptin, we restored control *fos* responses in fasted rats. In parallel, we mapped glomerular activities *in vivo* induced by nutritive odors in anesthetized rats using intrinsic optical signals (IOS) imaging. IOS are due to activity‐dependent vascular changes and reliably map olfactory glomeruli. We report specific glomerular maps induced by peanut butter presentation in control animals. In our preliminary experiments in fasted rats using the same odor, we observe further odor‐activated glomeruli. We are currently studying the nutritional modulation of specific astrocytic molecules such as GFAP, connexins 30 and leptin receptors by western blot, RT‐qPCR and immunohistochemistry.

Supported by IFR144 NeuroSud‐Paris; CNRS and INRA for M. Bendahmane\'s PhD Fellowship.
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In contrast to the central nervous system, peripheral nerves regenerate spontaneously after injury. Functional recovery involves Wallerian degeneration followed by axon regrowth and remyelination of the regenerated axons by Schwann cells.

In this study, we investigated the role of Neuregulin1 signaling for peripheral nerve remyelination after crush injury of the sciatic nerve. Neuregulin1 belongs to a family of transmembrane and secreted growth factors interacting with ErbB receptor tyrosine kinases. The Neuregulin1 gene encodes more than 15 isoforms belonging to three classes according to their extracellular domain structures. During myelination, Neuregulin1 isoforms are essential for survival and proliferation of Schwann cells. Moreover, Neuregulin1 type III has been shown to regulate myelin sheath thickness in the peripheral nervous system.

We analysed previously generated mouse mutants for Neuregulin1 isoforms at different time points after nerve crush injury. Four weeks after nerve crush injury, mice heterozygous for Neuregulin1 (n=3) show reduced myelin sheath thickness compared to wildtype animals (n=6) as measured by g‐ratio analysis on electron microscopic level. In contrast, transgenic mice overexpressing Neuregulin1 type III (n=5) show thicker myelin sheaths compared to control animals. Interestingly, also Neuregulin1 type I overexpressing mice (n=3) depict improved remyelination compared to wildtype mice. Neuregulin1 type I does not influence myelin sheath thickness during myelination, suggesting distinct roles of Neuregulin1 isoforms during myelination and remyelination of the peripheral nervous system.

We conclude that Neuregulin1 signaling is required for peripheral nerve remyelination after injury.
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GABAergic striatal output neurons (SONs) undergo cell death when mutation of huntingtin results in excessive accumulation of polyglutamine‐containing proteins (Huntington\'s disease). Deficits in the regulation of ambient GABA and the resulting changes in tonic and/or phasic inhibition may contribute to excitotoxic cell death, but the role of GABA transporters (GATs) is not well elucidated in the striatum. The present study aimed at clarifying the differential function GAT‐1 versus GAT‐3, as they were reported to display preferential expression in neurons and astrocytes. The relative strength of the two transporters was assessed by using the respective blockers, NO711 (10 μM) and SNAP4114 (40 μM). Based on patch‐clamp recordings from SONs between postnatal days (P) 7 and 34, we demonstrate that the tonic GABA(A) receptor‐mediated current (I(GABA)tonic) is weak or absent during the first 2 postnatal weeks but then significantly increases towards adulthood. At P28‐34 block of GAT‐1 produced an about 10fold increase of I(GABA)tonic, whereas SNAP4114 hat little effect on it. The dependency of phasic GABA(A) receptor‐mediated synaptic transmission on ambient GABA concentration was estimated on the basis of GABA(B) receptor‐mediated suppression of stimulus‐induced GABA release and changes in the amplitude/kinetics of quantal postsynaptic responses. It was found that in the adult striatum block of GAT‐1 affected pre‐ and postsynaptic sites, as it decreased the amplitudes of evoked IPSCs (eIPSCs) and mIPSCs, prolonged eIPSCs and increased their paired‐pulse ratio (PPR). Block of GAT‐3 also produced a similar GABA(B) receptor‐dependent effect on GABA release, but this effect has only been observed in the presence of NO711, i.e. when GAT‐1 activity was blocked. In contrast to I(GABA)tonic, an age‐dependency of GAT‐ or GAT‐3 action on phasic GABAergic synaptic transmission has not been revealed. We conclude that in the murine striatum GAT‐1, and possibly GAT‐3, operate in the uptake mode and thereby keep extracellular GABA at a level excluding persistent activation presynaptic GABA(B) and postsynaptic GABA(A) receptors. The astrocytic GABA transporter GAT‐3 may provide an additional uptake capacity when neuronal GAT‐1 is insufficient, but this concerns phasic rather than tonic inhibition of SONs.
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ANTIDEPRESSANT DRUGS ALTER THE PHENOTYPE OF ACTIVATED MICROGLIA THEREBY AFFECTING NEURONAL FATE {#sec2-90}
-----------------------------------------------------------------------------------------------

### Dhami K.S., Dibal C.D., Todd K.G. {#sec3-90}

#### University of Alberta, Edmonton, Canada {#sec4-90}

Microglial cells undergo morphological and functional changes in various neurodegenerative diseases and brain injuries or by stimulation from activating factors such as bacteria. Often, patients suffering from neurodegenerative diseases or brain injuries are comorbid for depressive disorders. However, there have been relatively few investigations on the role of microglia in the pathogenesis of mood disorders. The objectives of this study were to determine the effects of different classes of antidepressants on the microglial release of various mediators including nitric oxide (NO), tumor necrosis factor‐alpha (TNF‐α), interleukin 1‐beta (IL1‐β), and brain‐derived neurotrophic factor (BDNF) and to investigate whether there was any subsequent effect on the fate of injured neurons. The antidepressants used were tricyclics (imipramine and clomipramine), monoamine oxidase inhibitors (phenelzine and tranylcypromine) and selective‐serotonin reuptake inhibitors (fluoxetine and citalopram). We pre‐treated primary microglial cultures with the antidepressants, activated the cultures with lipopolysaccharide (LPS) for 24 hrs and measured the mediators released in media. Our results show that most antidepressants investigated attenuated LPS‐induced microglial release of NO, TNF‐α, IL1‐β. In addition, we utilized a co‐culture model consisting of microglia (treated with antidepressants and stimulated with LPS) and cortical neurons (control and oxygen‐glucose deprived) to show that inhibiting the activity of NO using aminoguanidine had no effect on the survival of injured neurons; however, blocking the activity of TNF‐α using an anti‐TNF‐α neutralizing antibody increased survival of injured neurons.

Our data also show that some antidepressants increase the release of BDNF from microglia. Increased microglial release of BDNF may underlie the neuroprotective effects of some antidepressants. Taken together, our data show that microglial release of TNF‐α affects neuronal fate more than release of NO and that antidepressant‐induced microglial release of BDNF is an important contributor to neuronal survival.

Funding acknowledgement: Canadian Institues of Health Research, Heart & Stroke Foundation of Canada, and Davey Endowment for Brain Research.
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THE ASTROGLIAL NAD+/NADH REDOX STATE IS A CRUCIAL CONNECTION OF METABOLISM AND CELLULAR SIGNALLING {#sec2-91}
--------------------------------------------------------------------------------------------------

### Wilhelm F., Hirrlinger J. {#sec3-91}

#### IZKF Leipzig, Leipzig, Germany {#sec4-91}

Astrocytes form a highly connected cellular system enabling them to build up long‐distance transport and signalling networks. As they are a vital part of neural communication, astrocytic metabolic activity is directly linked to neuronal signalling. Additional, more and more evidence emerges that astrocytes are also actively modulating neuronal function. One kind of astrocytic metabolic supply has been described in the model of the lactate shuttle. Thereby the NAD+/NADH redox state is directly coupled between astrocytes and neurons via the LDH reaction. Since the proportion of NAD+ to NADH is influencing the activity of several redox sensitive proteins, changing the redox state in one of those cells might have a direct influence on enzymatic activities or gene expression. However, surprisingly little is known about the NAD+/NADH redox state and its regulation in astrocytes. Therefore, the aim of this study was a precise analysis of the levels of both nucleotides. First, we took advantage of the endogenous fluorescence of NADH to investigate rapid changes in NADH level upon interference with astrocytic metabolism and application of neurotransmitters. To likewise assess the non‐fluorescent oxidized form, we adapted an enzymatic cycling method to analyse the levels of both NAD+ and NADH in cultured primary cortical astrocytes, thereby determining cellular NAD+/NADH redox ratio. This assay can detect as little as 5 pmol of NAD+ or NADH with high specificity and reproducibility. The biochemical method also correlates well with the imaging‐experiments showing quick changes in NADH levels of cultured cortical astrocytes in response to modulation of the metabolic state as well as substrate availability. Pharmacological interference with glycolysis induces a shift of the NAD+/NADH redox state to the oxidized side whereas blockade of the electron transport chain causes a more reduced redox state. Interestingly, cellular NAD+ concentrations seem to be tightly controlled. Finally, we provide evidence that a changed NAD+/NADH redox state influences astroglial Ca2+ signalling. In conclusion these findings support the idea of a fine‐tuned NAD+/NADH redox state integrating metabolism and signalling to control cellular functions.
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PURKINJE CELL MATURATION CONTROLS OLIGODENDROCYTE PRECURSOR DIFFERENTIATION THROUGH DEVELOPMENTAL REGULATED SONIC HEDGEHOG AND VITRONECTIN EXPRESSIONS {#sec2-92}
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### Bouslama‐Oueghlani L., Wehrle R., Lebrun C., Lemaigre‐Dubreuil Y., Doulazmi M., Sotelo C., Dusart I. {#sec3-92}

#### UPMC and CNRS UMR7102, Laboratoire Neurobiologie des Processus Adaptatifs, Paris, France {#sec4-92}

Differentiation of oligodendrocyte precursor cells (OPC) is timely regulated during development. Using mouse organotypic slice cultures, we provided evidence that the timing of cerebellar OPC differentiation is controlled by factors whose expression depends upon Purkinje cell maturation. Co‐culture experiments showed that mature cerebellar slices release factors that increase OPC differentiation in more immature slices, whereas immature slices inhibit OPC differentiation in mature ones. To confirm the existence of diffusible factors controlling OPC differentiation we showed that conditioned media from mature slices are able to stimulate OPC differentiation in immature slices. Moreover, we showed that the secretion of these factors depends on the number of Purkinje cells. In order to identify these diffusible factors we performed a transcriptome analysis using affymetrix array on cerebellar cortices enriched in Purkinje cells at P0, P3, P5, P7 and P10. This transcriptome analysis revealed a down‐regulation of Sonic hedgehog and an upregulation of Vitronectin during cortical cerebellar development. We showed that Sonic hedgehog stimulates OPC proliferation, delays their differentiation and inhibits their differentiation in organotypic cerebellar slices. We also showed that Vitronectin stimulates OPC differentiation and more importantly the neutralization of Vitronectin using blocking antibodies abolishes the conditioned media effects. Altogether, these results suggest that in the cerebellum Purkinje cells participate to the timing of OPC differentiation through the developmental regulated expression of extracellular molecules such as Sonic hedgehog and Vitronectin.
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ALTERED AXON‐GLIA INTERACTION IN CHARCOT‐MARIE‐TOOTH 1A POLYNEUROPATHY {#sec2-93}
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### Kinter J.,^1^ Geidl‐Flück B.,^1^ Erne B.,^1^ Lazzati T.,^1^ Stalder A.,^1^ Lützelschwab R.,^1^ Pareyson D.,^2^ Peles E.,^3^ Steck A.,^1^ Schaeren‐Wiemers N.^1^ {#sec3-93}

#### ^1^University Hospital Basel, Basel, Switzerland; ^2^Biochemistry and Genetic Unit, C. Besta Neurological Institute, Milan, Italy; ^3^Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel {#sec4-93}

Similarities in the axonal pathology of CMT1A murine models with myelin‐associated glycoprotein (MAG) deficient mice in respect to the decrease in neurofilament phosphorylation suggests that in the CMT1A disease the MAG signaling pathway might be disrupted. In this study we investigated the axon‐glia interaction in the primary demyelinating polyneuropathy CMT1A. We investigated molecular pathways involved in axon‐glial signaling in a mouse model of CMT1A (C22 mouse line) and in nerve biopsies from CMT1A patients. We found an increase in MAG expression in CMT1A patients as well as in C22 mice. The activity of the axonal effector kinase cdk5 was also increased, although a reduction of phosphorylated neurofilament heavy chain was evident. In contrast to MAG, we identified an other adhesion molecule involved in axon‐glia interaction, namely Necl4, which was strongly reduced in peripheral nerves of C22 mice as well as in sural nerve biopsies of CMT1A patients. Our data propose that there is an additional Schwann cell mediated, but MAG‐independent, signaling pathway involved in neurofilament phosphorylation. Since the axonal pathology of CMT1A is much more pronounced than in MAG deficient mice, this pathway might be critical for maintaining axonal integrity. Still MAG might play an important neuroprotective role, since C22 mice lacking MAG show an even more pronounced axonal pathology.
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ROLES OF OLIGODENDROCTYE‐DERIVED CONTACTIN IN CENTRAL MYELIN {#sec2-94}
------------------------------------------------------------

### Fernandes F., Bergstrom‐Tyrberg U., Ranscht B. {#sec3-94}

#### Burnham Institute for Medical Research, United States {#sec4-94}

The rapid propagation of action potentials along the nerve is accomplished by the electrical insulation of axons with myelin produced by oligodendrocytes in the central nervous system (CNS) and Schwann cells in the periphery. The terminal loops of each myelin segment attach to the axon through septate‐like junctions adjacent to the nodes of Ranvier. Contactin is expressed by neurons in both the CNS and PNS and by oligodendrocytes, but not Schwann cells. Neuronal Contactin in association with Contactin‐associated protein (Caspr/paranodin) accumulates at paranodes to regulate axoglial junction formation (Boyle et al, 2001). We here assess the contribution of oligodendrocyte‐derived Contactin in central myelination. Analyses of optic nerves from P7--P18 Contactin null mice revealed a significant reduction of myelin profiles and reduced numbers of oligodendrocytes compared to controls (the mutation is lethal by P18). These defects are not observed in peripheral myelin and exceed the phenotype of the Caspr/paranodin null mice suggesting a contribution of oligodendrocyte‐derived Contactin in central myelination. We started out by asking where oligodendrocyte‐derived Contactin is expressed in central myelin. We generated a GFP‐tagged Contactin that we inserted in a Semliki Forest Virus vector strain that preferentially promotes gene expression in glial cells. In organotypic cerebellar slices the vector strain reliably targeted oligodendrocytes as judged by cell morphology and co‐immunostaining for myelin markers. GFP‐Contactin was expressed on the outer membrane of compact myelin where it co‐localized with myelin‐oligodendrocyte glycoprotein. Co‐immunostaining for paranodal components revealed that oligodendrocyte‐derived Contactin also localizes to paranodes where it is positioned to contribute to paranodal junction formation. We are now investigating the ability of Contactin null oligodendrocytes to form paranodal junctions with wild type axons in in vitro myelination experiments in brain slices. We have also generated mice with the conditional Contactin allele to create mice specifically lacking Contactin in oligodendrocyte populations for a more global analysis of Contactin in oligodendrocyte development. In sum, our work suggests that Contactin produced by oligodendrocytes partakes in central myelin formation and/or function.

Grant support: NIH NS038297.
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GENE EXPRESSION AND TRANSCRIPTION FACTORS
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GENE EXPRESSION PROFILE IN THE BRAIN OF A MOUSE MODEL FOR CACH/VWM DISEASE DUE TO A POINT MUTATION IN EIF2B5 {#sec2-95}
------------------------------------------------------------------------------------------------------------

### Marom L., Geva M., Elroy‐Stein O. {#sec3-95}

#### Tel‐Aviv University, Tel‐Aviv, Israel {#sec4-95}

Childhood Ataxia with CNS Hypomyelination (CACH) / Vanishing White Matter (VWM) is an autosomal recessive genetic disease caused by mutations in each of the five genes encoding eukaryotic translation initiation factor 2B (eIF2B) subunits. The disease is manifested by loss of motor and cognitive functions which deteriorate upon physiological and environmental stress. The course of the disease is chronic progressive towards death at early adolescence.

We recently generated the first knocked‐in (KI) mouse model for the disease by introducing a point mutation into the mouse genome, leading to R132H replacement in the catalytic subunit of eIF2B. This mutation corresponds to the human R136H mutation that leads to a classical form of the disease.

Eukaryotic translation initiation factor 2B (eIF2B) is a major regulator of protein synthesis under normal and stress conditions. Distortion of translational control of regulatory genes is expected to affect the expression level of downstream genes. Using Affymetrix GeneChip arrays we have compared expression profiles in the brains of WT (eIF2B5+/+) and KI (eIF2B5mut/mut) mice at two ages. The newborn (P1) brain represents basal gene expression level at birth whereas the P18 brain represents gene expression at a stage of active myelination.

A significant change in gene expression in the KI mice brains was detected. The expression level of 255 genes was different in the P1 brains (fold change\>1.3, p‐value\<0.05) implying slow‐down of cell‐cycle and down regulation of cell junction and membrane trafficking related genes. The expression level of 208 genes was different in P18 brains (fold change\>1.25, p‐value\<0.05) implying down regulation of biological processes related to metabolism of lipids, fatty acids, steroids and amino acids; apoptosis, proliferation and differentiation. Altered expression of 16 genes was common to P1 and P18 brains, among which are two ribosomal proteins.
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CHARACTERIZATION OF RORASG/SG MUTANT MOUSE ASTROGLIOSIS AND INVOLVEMENT OF THE NUCLEAR RETINOIC ACID RECEPTOR‐RELATED ORPHAN RECEPTOR ALPHA (RORALPHA) IN MOLECULAR MECHANISMS OF ASTROCYTE ACTIVATION {#sec2-96}
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### Journiac N.,^1^ Jolly S.,^1^ Gautheron V.,^1^ Rogard M.,^1^ Mariani J.,^2^ Vernet‐Der Garabedian B.^1^ {#sec3-96}

#### ^1^UMR7102 CNRS‐University P. and M. Curie, Paris, France; ^2^UMR7102 CNRS‐UPMC & Hopital Charles Foix, Paris, France {#sec4-96}

Reactive gliosis is a common hallmark of brain damage and can be both detrimental or beneficial for neuron survival. We are interested in the role of RORalpha in molecular mechanisms of astrocyte activation. RORalpha is a nuclear receptor with anti‐inflammatory properties exerted via inhibition of the NF‐kB pathway (Delerive et al., 2001). Up to now, RORalpha expression has been identified in different structures in the CNS, and was specified as exclusively neuronal. We recently demonstrated that RORalpha is also expressed in astrocytes. We examined in vitro the relation of RORalpha to astrocytes and IL‐6. We show that RORalpha exerts bi‐directional control of Il‐6: we identified the Il‐6 gene as a RORalpha target that requires RORalpha for the activation of its basal expression while in an inflammatory context, RORalpha indirectly repress IL‐6 expression through the inhibition of the NF‐κB pathway.

Studies of the roles of RORalpha in vivo are facilitated by the availability of staggerer mutant mouse carrying a mutation in the Rora gene that leads to a massive cerebellar neuronal loss during the first month of life associated with an inflammatory process. The aim of our current study is to determine if the ongoing of the astroglial reaction of the Rorasg/sg mouse is normal or disregulated. We examined the duration of the astrocyte activation. In that way we followed the expression of the GFAP gene in a double mutant Rorasg/sg;GFAP‐LacZ using immunohistochemistry, biochemistry and molecular biology. We show that the reporter gene under the control of a truncated GFAP promoter is expressed during neuron loss and up to 12 months. Using the Cre‐Lox system, we will also study the phenotypes of mouse carrying selective inactivation of RORalpha either in the astrocytes (Glast‐cre; Roralox/lox) or in the Purkinje cells (L7‐cre; Roralox/lox).

In conclusion, these results demonstrate that activation of astrocytes is protracted in Rorasg/sg cerebellum. The role of RORalpha in the mechanism will be discussed.
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THE INVERTEBRATE SOXE HMG BOX CONTAINING TRANSCRIPTION FACTOR SOX100B CAN COMPENSATE FOR THE LOSS OF SOX10 PROTEIN DURING OLIGODENDROCYTE AND EARLY NEURAL CREST CELL DEVELOPMENT IN MICE {#sec2-97}
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### Cossais F.,^1^ Schreiner S.,^1^ Kellerer S.,^1^ Bösl M.R.,^2^ Sock E.,^1^ Wegner M.^1^ {#sec3-97}

#### ^1^Institut fur biochemie, Erlangen, Germany; ^2^Max‐Planck‐Institut für Neurobiologie, Martinsried, Germany {#sec4-97}

In higher vertebrates, HMG‐ box containing transcription factors of the SoxE group, and more specifically the Sox10 protein, are known to be important regulators of both neural crest cell and oligodendrocyte development. The invention of both neural crest cells and oligodendrocytes is assumed to have played an essential role during vertebrate evolution. Still, little is known about how these cell types arose during evolution and how their developmental processes and their main regulators co‐evolved. To better understand the role of SoxE proteins in the evolution of neural crest cells and oligodendrocytes, we generated a knock‐in mouse model where the Sox10 gene was replaced by the open reading frame of an invertebrate SoxE gene, namely the Sox100b gene from Drosophila. Surprisingly, mice carrying two Sox100b replacement alleles showed a relatively mild phenotype. We see no defect in oligodendrocyte development and differentiation. Moreover, we show that the Sox100b protein is able to induce neural crest fate. Among neural crest cell derivatives, both glial cells and neurons of the PNS were generated in the mutant mice. However, adrenal gland, melanocyte, enteric nervous system and sympathetic nervous system development were mildly to severely disturbed, causing death of newborns within a few hours. Sox100b protein is thus capable of compensation for the loss of Sox10 during early neural crest and oligodendrocyte development. These results suggest that co‐option of an ancestral invertebrate SoxE protein may have played an important role in the appearance of neural crest cells and oligodendrocytes in early vertebrates and that some functional mutations within the SoxE proteins may then have been required for allowing the full set of neural crest cell derivatives to form.
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EPIGENETIC CONTROL OF CCR5 TRANSCRIPTION {#sec2-98}
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### Van Den Elsen P.J.,^1^ Van Eggermond M.,^2^ Benard A.,^2^ Van Leeuwen J.C.,^2^ Marquez V.E.,^3^ Wierda R.J.,^2^ Kuipers H.F.^2^ {#sec3-98}

#### ^1^VU University medical center, Amsterdam, Netherlands; ^2^Leiden University Medical Center, Leiden, Netherlands; ^3^Center for Cancer Research, NCI‐Frederick, Frederick, MD, United States {#sec4-98}

The chemokine receptor CCR5 is implicated in the pathogenesis of various inflammatory diseases such as Multiple Sclerosis (MS). Previously, we have shown that CCR5 expression is regulated by the transcription factor CREB‐1 and not by the transcription factors IRF‐1 and NK‐κB (Kuipers et al. Blood 2008; 112: 1610‐1619). For these studies we have employed human cultured microglia, dendritic cells and activated T cells, which express CCR5 while cultured astrocytes and Jurkat T leukemia cells lack CCR5 expression. However, the ubiquitous pattern of CREB‐1 expression suggests the involvement of additional regulatory mechanisms in cell type‐specific expression of CCR5. We now show that changes in DNA methylation, and histone acetylation and methylation modifications within the context of the CCR5 promoter region correlate with upregulation of CCR5 transcription in CD4+ T cells upon activation. Moreover, interference in the epigenetic repressive mechanisms that account for the lack of CCR5 transcription in Jurkat T leukemia cells results in re‐expression of CCR5. Together, these data indicate that epigenetic modifications of DNA and histones contribute to the control of CCR5 transcription in CD4+ T cells.
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THE INTERACTION OF SOX10 AND OCT6 DURING PERIPHERAL MYELINATION {#sec2-99}
---------------------------------------------------------------

### Reiprich S., Kriesch J., Weider M., Wegner M. {#sec3-99}

#### Institute for Biochemistry, Erlangen, Germany {#sec4-99}

In the peripheral nervous system, Schwann cells myelinate nerve axons. Among the transcription factors involved in the formation of peripheral myelin are the POU domain proteins Oct6 and Brn2, the Sry‐box protein Sox10 and the zinc‐finger protein Krox20. Sox10 expression persists throughout Schwann cell development and overlaps with the transient expression of Oct6 and Brn2. Sox10 and Oct6 are known to synergistically activate expression of Krox20, the master regulator of myelination. Krox20 expression in myelinating Schwann cells is driven by a conserved 1.3 kb enhancer element, the Myelinating Schwann Cell Element MSE, located 35 kb downstream of the transcriptional start of Krox20 (Ghislain et al., 2002). Besides the known Oct6 binding sites, we identified several conserved Sox binding sites within this cis‐acting element and analyzed their contribution to Krox20 expression.

The detailed analysis of the synergism of Sox and POU proteins indicates that synergistic activation of this enhancer element is specific for class III POU proteins and Sox proteins of subgroup E. On the part of the Sox10 protein the transactivation domain and the DNA‐binding HMG domain are necessary, whereas the isolated POU domain of Oct6 is sufficient to sustain at least part of the synergism. Additionally, loss of the highly conserved K2 domain in Sox10 leads to a disruption of the synergism, marking it as a further domain essentially involved in the interaction with the Oct6 protein. Recently, a hypomorphic Sox10 mutant mouse was generated, in which the Sox10 protein lacks the K2 domain. In this mutant, immature Schwann cells develop, but fail to initiate myelination. In agreement with this, we observe that mutant Schwann cells along peripheral nerves express Oct6, but not Krox20. These observations in vivo confirm the importance of the K2 domain for the interaction with Oct6, which is subject of our further investigations.
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DIFFERENT MICROGLIA PHENOTYPES IN WHITE AND GREY MATTER OF THE CENTRAL NERVOUS SYSTEM {#sec2-100}
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### Olah M., Brouwer N., Biber K., Boddeke E. {#sec3-100}

#### University Medical Center Groningen, Groningen, Netherlands {#sec4-100}

It has been suggested that microglia in different central nervous sytem (CNS) compartments display different phenotypes and these regional differences in microglia phenotype might contribute to a certain extent to the ethiology and pathophysiology of different CNS disease and disorders. Indeed recent studies have shown that the regional differences in microglia in different CNS compartments go beyond the morphology of these cells and can be readily detected also as the different level of surface expression of immunologically relevant molecules, such as CD86 and CD11b. It has been suggested that these regional differences in microglia phenotype are of significant importance, since they might contribute to the etiology and pathophysiology of different CNS disease and disorders. Our aim was to investigate the anticipated regional differences in microglia phenotype in detail with the help of microarray gene expression analysis. We focused on microglia residing in the white (corpus callosum) and the grey matter (cerebral cortex). Our findings suggest, that white matter microglia are phenotypicaly different from grey matter microglia in the adult murine brain even under physiological conditions. Based on the differentially regulated genes (which included genes involved in both innate and adaptive immune responses) microglia within the white matter seemed to exist in a higher basal level of activation. Nonetheless, in an endotoxemia model white matter microglia responded to systemic inflammation to a greater extent than their grey matter counterparts. Our results thus point to a phenotypic difference between white and grey matter microglia that might have functional consequences in respect of several pathological conditions in the CNS.
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TRANSCRIPTIONAL REGULATORY NETWORKS UNDERLYING THE SPECIFICATION OF OLIGODENDROCYTE PRECURSOR CELLS {#sec2-101}
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### Galinanes‐Garcia L., Castro D., Guillemot F. {#sec3-101}

#### National Institute for Medical Research, London, United Kingdom {#sec4-101}

Members of the bHLH proneural family of proteins, including Mash1, are crucial transcription factors (TFs) that play pivotal roles in neurogenesis. Interestingly, although Mash1 is more commonly recognized for its function in neurogenesis, it is also required for the specification of oligodendrocyte precursor cells (OPCs). We are interested in the role of Mash1 in lineage commitment of neural progenitors, and specifically the mechanisms underlying Mash1 activity in oligodendrocyte commitment.

To begin to identify novel target genes of Mash1 in the specification of OPCs we opted for an in vitro cell culture system, since in the developing embryo OPC populations are relatively small, they are not easily accessible and exist in mixture with other populations, thus making their isolation for biochemical/genomic purposes unpractical. We culture mouse OPCs as oligospheres to generate OPCs, which express Olig2, PDGFRalpha and Sox10. We use this material to perform Mash1 locational analysis using ChIP‐on chip, and find that Mash1 protein is bound to early and late OPC genes, Olig1/Sox8 and Mog/Omg respectively. Other molecular determinants of oligodendrocyte cell fate specification have been identified; the bHLH TFs Olig1 and Olig2, and the HMG TF Sox9. We hypothesise that Mash1 interacts with either neuronal‐ or oligodendrocyte‐specific cofactors, and that these interactions modulate Mash1 activity. We are interested to ask whether Mash1 bound elements are also bound by these other TFs.
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DEVELOPMENTAL GENES ARE SPECIFICALLY INVOLVED IN SEVERE FORMS OF EIF2B‐PATHIES {#sec2-102}
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### Horzinski L.,^1^ Henaut A.,^2^ Bertini E.,^3^ Schiffmann R.,^4^ Rodriguez D.,^5^ Dantal Y.,^2^ Boespflug‐Tanguy O.,^1^ Fogli A.^1^ {#sec3-102}

#### ^1^GReD UMR INSERM U931 CNRS 6247, Clermont‐Ferrand, France; ^2^Soluscience, Clermont‐Ferrand, France; ^3^Bambino Gesu\'Hospital, Roma, Italy; ^4^Baylor Research Institute, Dallas, United States; ^5^Hôpital Armand Trousseau, Paris, France {#sec4-102}

Among the demyelinated inherited disorders, eIF2B‐pathies represent a clinical heterogenous group, from severe congenital cases to asymptomatic adult forms caused by mutations in the ubiquitous eukaryotic initiation factor 2B (eIF2B). This ubiquitous expressed factor is involved in translation initiation regulation under cellular stress by activating the eIF2 tanks to its guanine exchange factor activity (GEF). The pathophysiological processes seem to involve i) a defect in glial cells maturation and ii) a hyper‐activation of the ER‐stress response mediated by ATF4, as observed in eIF2B‐mutated patients\' fibroblasts (Fb), oligodendrocytes and brains. A correlation between the GEF‐eIF2B activity and the disease severity has been established.

In order to identify metabolic pathways involved in eIF2B‐pathies, we performed a differential transcriptomic analysis in Fb from severe eIF2B‐mutated patients (GEF activity \<50%) in comparison to controls and to patients with other type of leikodystrophies, at basal state and after ER‐stress. We demonstrated equivalent stress responses between the different groups, suggesting that ER‐ stress response is not specific to eIF2B‐pathies. We identified 72 genes specifically differentially expressed in eIF2B‐mutated Fb, mainly relative to development process. We selected 10 genes thanks to their potential involvement in the pathophysiology: HNRNPH1, HNRNPF, HNRNPL and HNRNPC (transcription or mRNA stabilization and splicing), MRPS26, MRPL28, HCCS, VDAC3 and KIF5B (mitochondria) and DIAPH3 (development) genes. We confirmed underexpression of these genes in disease by QRT‐PCR in Fb as well as in human foetus brain. These results suggest that the severe forms of eIF2B‐pathies are primary developmental disorders that could explain WM susceptibility to eIF2B mutations.
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REST, THE TRANSCRIPTION REPRESSOR THAT GOVERNS NEUROSECRETION, APPEARS TO HAVE A ROLE ALSO IN THE EXPRESSION OF GLIOSECRETION {#sec2-103}
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### Prada I.,^1^ D\'Alessandro R.,^1^ Stucchi L.,^1^ Meldolesi J.^2^ {#sec3-103}

#### ^1^Vita‐Salute San Raffaele University, Milan, Italy; ^2^Scientific Institute San Raffaele, Milan, Italy, Milan, Italy {#sec4-103}

REST (RE‐1 silencing transcription factor) is a repressor of transcription known to govern the expression of hundreds of neuron‐specific genes, inducing their repression in the non‐nerve and their fine regulation in the nerve cells. Our previous studies in neurosecretory rat PC12 cells identified REST as the critical factor governing the expression not only of individual genes, but also of the whole neurosecretory process via multiple, direct and indirect mechanisms (D\'Alessandro et al., J. Neurochem., 2008; Klajn et al., J. Neurosci. 2009, in press). In view of the similarity of neurosecretion with gliosecretion, the process by which astrocytes release glutamate and other transmitters (D‐serine, ATP, peptides), we wondered whether gliosecretion is also governed by REST. Our data on astrocyte primary cultures, expressing REST mRNA and protein, suggest that this might be the case. Transient transfections of the dominant‐negative construct ofREST combined to treatment with trichostatinA (TSA), a blocker of the REST‐associated histone deacetylases, induced the appearance of SNAP25 and synaptotagmin1, two key proteins of neuro‐exocytosis lacking in untransfected cells. Moreover **Ch**romatin **I**mmuno**P**recipitation experiments showed the binding of REST to the RE‐1 region of SNAP25, one of the genes most sensitive to the repressor. The modulation of the secretory proteins expression, although of different extent, suggests that REST exerts a general regulatory action on neurosecretory gene expression even in astrocytes. Ongoing molecular, morphological and functional studies will clarify in more detail the role of the repressor in control and properties of the gliosecretory process. This new observation might be of great interest for the understanding of astrocyte physiology and pathology. Indeed, astrocyte dysfunctions are known to play a role in the pathogenesis of neurological disorders, such as Huntington\'s, ALS and Rett\'s syndromes, in which REST‐based disregulations of epigenetic mechanisms have also been reported.
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LIVER X RECEPTORS IN CHOLESTEROL HOMEOSTASIS IN PRIMARY RAT OLIGODENDROCYTES {#sec2-104}
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### Nelissen K.,^1^ Hendriks J.,^1^ Smets I.,^2^ Smeets K.,^1^ Mulder M.,^3^ Ameloot M.^1^ {#sec3-104}

#### ^1^Hasselt University, Diepenbeek, Belgium; ^2^PHL University College, Diepenbeek, Belgium; ^3^Rotterdam University, Rotterdam, Netherlands {#sec4-104}

Liver X receptors (LXRs) are nuclear oxysterol receptors that regulate genes involved in cholesterol homeostasis. Although both subtypes (LXR‐α and LXR‐β) are expressed in the brain, their presence in oligodendrocytes and their function in oligodendrocyte cholesterol homeostasis remain largely unexplored. Cholesterol homeostasis in oligodendrocytes is important, since a high cholesterol level in oligodendrocytes is essential for myelin membrane growth during maturation of the central nervous system and during remyelination in pathological conditions such as multiple sclerosis. In order to gain insight into the cholesterol homeostasis in oligodendrocytes, cultures of oligodendrocytes derived from either neonatal or mature rats were used. mRNA expression levels of the LXRs and their target genes were investigated using quantitative real time PCR. Reliable quantification, however, depends on a proper normalization strategy. Therefore we first determined the stability of various reference genes. For the cell cultures in our study, CycA, Pgk1, Rpl13A, YWHAZ or HPRT appear to be the most appropriate reference genes for normalization. Standard reference genes such as ActB, GAPDH and 18S are not recommended as they appear to be relatively unstable under the experimental conditions used. The LXRs, as well as the LXR target genes (ApoE, ABCG1, ABCA1, LDLR) are expressed in both primary oligodendrocyte cell types. Treatment of primary neonatal rat oligodendrocytes with the LXR agonist T0901317 induced the expression of several established LXR target genes, including ApoE, ABCG1, ABCA1, LDLR and LXR‐α itself. Our work indicates that LXRs and their target genes are present in oligodendrocytes and provides strong evidence that the LXRs play an important role in cholesterol homeostasis in oligodendrocytes.
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EXPRESSION OF STEROL 27‐HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING {#sec2-105}
---------------------------------------------------------------------------------------------------

### de Fabiani E., Gilardi F., Galmozzi A., Boraso M., Bartesaghi S., Torri A., Caruso D., Crestani M., Marinovich M. {#sec3-105}

#### Università degli Studi di Milano, Milano, Italy {#sec4-105}

Cholesterol is required in the brain for synaptogenesis and its turnover is critical for cerebral functions. Several proteins involved in cholesterol handling and metabolism are transcriptionally regulated by the nuclear liver X receptor (LXR) α and β. Sterol 27‐hydroxylase (CYP27) is a ubiquitously expressed enzyme involved in cholesterol metabolism. Notably, its deficiency causes a disease characterized by progressive neurologic impairment. With the final goal to understand the pathophysiological role of CYP27A1 in the central nervous system, we studied the expression pattern of Cyp27a1 and other related genes in primary cultures of rat glia and neurons. Secondly, given the pivotal role of LXR in the regulation of cholesterol homeostasis, we investigated the effects of its activation on the expression of Cyp27a1. We found that primary astrocytes express different sterol hydroxylases and are able to uptake exogenous 27−hydroxycholesterol. We found that both microglia and astrocytes express preferentially Lxrβ. However, despite this similarity, we observed cell−specific responsiveness of known and novel (including Cyp27a1) target genes to LXR activation. The increase of mRNA and protein levels in treated astrocytes is paralleled by transactivation of the proximal Cyp27a1 promoter in transfected astrocytes. We suggest that the astrocyte−restricted up‐regulation of Cyp27a1 may be ascribable to differential expression of transcriptional co‐activators. Given the role of astrocytes in maintaining brain homeostasis, we hypothesize that impairment of CYP27 activity in these cells may alter critical features of the astrocytes, from the handling and delivery of cholesterol to neurons to the release of signaling molecules.
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OLIG1 FUNCTION IN OLIGODENDROCYTE DEVELOPMENT {#sec2-106}
---------------------------------------------

### Paes de Faria J., Li H., Richardson W.D. {#sec3-106}

#### Wolfson Institute for Biomedical Research and Research Department of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, London, United Kingdom {#sec4-106}

OLIG1 is one of the helix‐loop‐helix family of transcription factors that includes OLIG2, NGN1/2 and MASH1. Olig1 and Olig2 were first identified in a screen for regulators of oligodendrocyte (OL) development and are both expressed in oligodendrocyte precursors (OLPs) and in myelinating OLs. OLIG1 was initially reported as having a subtle role in OL development in the spinal cord. Accordingly, Olig1 nulls exhibited a very mild phenotype and were viable (Lu *et al.* ^1^). In the brain, OLIG1 could partially compensate for loss of OLIG2.

A second Olig1 null mouse was described by Xin *et al.* ^2^. This mouse was derived from the original Olig1 null mouse by removing the PGK‐neomycin (PGK‐neo) cassette. In contrast with the first Olig1 null mouse, this new mutant exhibited severe neurological defects and although OLPs formed normally they failed to differentiate into myelinating OLs, leading to axonal degeneration, gliosis and death at postnatal day 14. To explain the divergence between the two Olig1(‐/‐) phenotypes, Xin *et al.* ^2^ proposed that there was a compensatory up‐regulation of Olig2 in the original mutant, caused by a cis‐acting effect of PGK‐neo. However, this idea was not tested.

In this study we aimed to clarify the role of Olig1. In a first approach, we are using a knock‐in mouse, in which the Olig1 ORF was replaced by a DNA fragment including an inverted PGK‐neo cassette. In this Olig1(‐/‐) background, we observed that 1) Olig2 expression is NOT up‐regulated in the forebrain of 18.5 days embryos (E18.5) but is significantly decreased, and 2) the Olig1(‐/‐) mice are viable and fertile. We also found that Sox10 expression was decreased in these mice. As a second approach, mice carrying an Olig2 BAC transgene were crossed with Olig1/Olig2 double null mice. This approach creates an Olig1(‐/‐) null in a PGK‐neo free background. So far, the results show that Olig1 deletion is not lethal in an Olig2 multi‐copy genetic background. We are now testing whether a single copy of the Olig2 BAC can rescue Olig1/Olig2 double mutants.

In summary, we find that mice lacking Olig1 have no developmental phenotype and their viability is not likely to depend on compensatory up‐regulation of Olig2.

^1^ Lu et al. (2002) Cell 109: 75--86.

^2^ Xin et al. (2005) J Neurosci 25: 1354--136.
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ROLE OF OLIG2 PHOSPHORYLATION IN VENTRAL SPINAL CORD DEVELOPMENT {#sec2-107}
----------------------------------------------------------------

### Li H., Andrew P., Richardson W.D. {#sec3-107}

#### Wolfson Institute for Biomedical Research, University College London, London, United Kingdom {#sec4-107}

OLIG2, a bHLH transcription factor, is a master regulator of motor neuron (MN) and oligodendrocyte (OL) development. At early developmental stages (E9.5‐11.5), OLIG2 promotes MN identity by repressing alternative neuronal cell fates; later on (E12.5), OLIG2 specifies OL precursors (OLPs) from the same pool of progenitors. In the spinal cord and brainstem of OLIG2 null mice, MN and OL development are completely disrupted. Given OLIG2\'s pivotal role in both MN and OLP specification, we speculated that OLIG2 might be at the centre of the fate switch from MN to OLP production. Post‐translational modification of OLIG2 -- for example, phosphorylation -- might control the affinity of OLIG2 for different co‐factors, and thereby switch its specificity for downstream transcriptional targets, resulting in a fate switch. We identified a PKA phosphorylation site at Serine147 in helix 2 of the OLIG2 bHLH domain that is conserved among species and between OLIG1 and OLIG2 ‐ but is not found in other bHLH proteins including neurogenins. We immunoprecipitated OLIG2 from mouse embryonic spinal cord homogenates and Western blotted the precipitate with an S147‐Phosphate specific antibody. We found that S147 was phosphorylated during MN development, but not after E12.5 when OLP production had started. Mutation of S147 to Alanine (S147A) inhibited the formation of OLIG2 homodimers but enhanced formation of OLIG2‐NGN2 heterodimers in co‐transfected Cos7 cells. We generated an OLIG2 BAC transgenic mouse line carrying the S147A mutation and crossed these with OLIG2 (‐/‐) mice to produce OLIG2(S17A); OLIG2(‐/‐) embryos. In these animals both ventral patterning and MN development were disrupted. Despite this, a decreased number of OLPs developed by E18.5. Consistent with these experiments, electroporation of an OLIG2(S147A) expression vector into chick neural tube induced ectopic OLPs but no ectopic MNs. In summary, our data suggest that the phosphorylation status of OLIG2 at S147 might be critical for the MN ‐\> OL fate switch.
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CREB DEPENDENT REGULATION OF ASTROCYTE PLASTICITY {#sec2-108}
-------------------------------------------------

### Carriba P., Lichtenstein M., Galea E. {#sec3-108}

#### Institute of Neuroscience, Bellaterra (Cerdanyola del Vallés), Spain {#sec4-108}

We define astrocyte plasticity as changes, either morphological or functional, that affect synaptic efficiency, which is finally determined by the amount of neurotransmitter present at the synaptic cleft, and/or the content or activity of synaptic receptors. Although numerous studies implicate CREB in synaptic plasticity the nature of the genes transcribed upon CREB activation, and whether they are in astrocytes has not been established. The general goal of this project is to explore how CREB may regulate astrocyte plasticity thus affecting synaptic plasticity that, in turn, underlies learning and memory. Key initial questions are: 1. Do neurotransmitters stimulate CREB‐dependent transcription in astrocytes?; 2. What are the consequences of this, that is, does CREB cause expression in astrocytes of molecules that regulate synaptic plasticity such as glutamate transporters (EAAT1 and EAAT2), which would ultimately influence the level of glutamate at the synaptic cleft?. Using the CRE‐luciferase reporter assay we report that glutamate, forskolin, noradrenaline, and ATP increase to different extents CREB‐dependent transcription in rat cortical primary astrocyte cultures. Other neurotransmitters are under exploration. CREB activation appears to be dependent on CREB phosphorylation mediated, in turn, by calcium and ERK activation. The expression of EAAT2 but not EAAT1 assessed by western blots is increased 3‐6h after the treatment with ATP or forskolin caused the greatest increase and glutamate the lowest. Ongoing studies are aimed at determining whether the increased EAAT2 expression: 1) is dependent on CREB transcription (blockade of CREB with a dominant negative form); 2) is dependent on Rho‐GTPases for the correct docking in membranes (experiments with adenoviral expression of dominant negative and constitutively active forms RhoA, Rac, and Cdc42); and 3) correlates with increased transporter activity (aspartate uptake experiments). Comparison of different neurotransmitters will indicate whether CREB dependent regulation of astrocyte plasticity is neurotransmitter‐specific.
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GLUCOCORTICOID RECEPTOR TRANSCRIPTIONAL COMPLEX IN GLIAL CELLS: CELL‐SPECIFIC AND PROMOTER DEPENDENT RECRUITMENT OF THE P160S, REPRESSIVE EFFECT OF P300, AND IMPLICATION OF BETA‐CATENIN {#sec2-109}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Grenier J.,^1^ Fonte C.,^2^ Trousson A.,^1^ Schumacher M.,^2^ Massaad C.^1^ {#sec3-109}

#### ^1^Cnrs, Paris, France; ^2^Inserm, le Kremlin‐Bicetre, France {#sec4-109}

In the nervous system, glucocorticoids (GC) exert beneficial or noxious effects, depending on their concentration and the duration of hormonal stimulation. Their target is the GC receptor (GR), which recruits the p160 coactivator members (SRC‐1, SRC‐2 and SRC‐3) and CBP/p300. We investigated the molecular pathways used by GR in astrocytes and Schwann cells.

First, we showed that the recruitment of the p160s by the GR is dependent on the promoter context. We also demonstrated a cell‐specific intracellular distribution of the p160s, dependent on the duration of the hormonal induction: within astrocytes, SRC‐1 and SRC‐2 were mainly nuclear, while SRC‐3 unexpectedly localized in the Golgi apparatus. In contrast, in Schwann cells, SRC‐1 showed a nucleocytoplasmic shuttling depending on hormonal stimulation, while SRC‐2 remained nuclear and SRC‐3 cytoplasmic. We demonstrated by overexpression and siRNA knock down, that depending on the glial cell type, GR differentially recruits p160 family members. Moreover, interaction between SRC‐1a and GR is unusual: the C‐terminal nuclear receptor interacting domain of SRC‐1a participates in its exclusion from the GR complex in astrocytes, while in Schwann cells SRC‐1a interacts with GR via its two nuclear receptor binding domains. This atypical interaction altered the action of CBP and p300. CBP is not implicated in GR complex, and p300 unexpectedly repressed GR transactivation. Functional and pull‐down assays in Schwann cells showed that beta‐catenin is the coactivator replacing CBP.

Altogether, these results highlight the promoter‐, cell‐specificity and time‐dependence of p160s recruitment by the GR in glial cells, revealing that the recruitment of coactivators by the GR is a multiparametric event. Moreover the implication of beta‐catenin in GC signalling could reflect the importance of wnt signalling pathway in the regulation of glial‐specific genes within the peripheral nervous system.
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ANALYSIS OF SULFATASE1 FUNCTION IN SHH‐DEPENDANT OLIGODENDROCYTE SPECIFICATION IN THE VENTRAL SPINAL CORD {#sec2-110}
---------------------------------------------------------------------------------------------------------

### Danesin C., Soula C. {#sec3-110}

#### Centre de Biologie du Developpement, Toulouse, France {#sec4-110}

Neurons and glial cells (astrocytes and oligodendrocytes) composing the adult central nervous system, arise from neural progenitors during embryonic development. The spinal cord is a simple model to study the emergence of the diverse neural populations. In the ventral region, the Sonic Hedgehog (Shh) morphogenetic gradient, originating from notochord and floor plate, establishes the formation of distinct neural domains generating different neuronal subpopulations. Subsequently to neuronal production, Shh induces the specification of oligodendrocyte precursors (OPC) in the ventral spinal cord, raising the question of the molecular mechanisms underlying this temporal change of neural progenitor response to the same signal. The sulfatase Sulf1 is a potential player involved in these events. Indeed, its expression starts after the main waves of neuronal production in the floor plate and later expands into the ventral neural progenitors just prior to OPC specification in this domain. This spatio‐temporal pattern of expression is strongly conserved among vertebrates, including chick and zebrafish. Sulf1 encodes for an enzyme hydrolysing sulphate groups at specific position from Heparan Sulfate Proteoglycans (HSPG) at the cell surface. This modification of HSPG sulfation pattern modulates their affinity for extracellular ligands and therefore their activity in regulating signalling pathways. Studies from Drosophila and Vertebrates have shown that transport and activity of ligands from Hedgehog family depends on HSPG. Gain of function studies in chick and recent functional analysis in Drosophila indicate that Sulf1 regulates Shh extracellular distribution and signalling. We tested sulf1 function in zebrafish by morpholino loss of function experiments. In sulf1 morphants, expression of Shh target genes is downregulated in the ventral neural tube. Our preliminary results indicate that production of ventral neurons is not impaired whereas OPC are absent in sulf1 morphants. These findings suggest that Sulf1 is a positive regulator of Shh activity required for OPC specification in the ventral spinal cord. We propose that Sulf1 triggers a temporal modulation of Shh activity in the ventral progenitors that induce their switch from producing neuron to oligodendrocyte in the vertebrate spinal cord.

Keywords: HSPG, sulf, Shh, oligodendrocyte
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ESTROGEN RECEPTOR AND INFLAMMATORY GENE TRANSCRIPTION IN MICROGLIA AND BRAIN {#sec2-111}
----------------------------------------------------------------------------

### Vegeto E., Maggi A. {#sec3-111}

#### University of Milan, Milan, Italy {#sec4-111}

Clinical evidence suggests that a decrease in the levels of circulating estrogen hormone, as it occurs in women at menopause, is associated with a higher incidence of inflammatory disorders; accordingly, estrogen administration correlates with a protective effect against inflammatory pathologies. We thus hypothesized that estrogen may exert its beneficial effects by acting as an anti‐inflammatory agent. We initially showed that inflammatory cells, including microglia, express the estrogen receptors, ERalpha and ERbeta, and that estrogen inhibits the transcription of inflammatory genes. Using an experimental model of acute brain inflammation, we demonstrated that hormone reduces the activation of brain inflammatory cells in vivo and that this effect is specifically mediated by ERalpha. In parallel, using the APP23 mice, an animal model of Alzheimer\'s Disease, we observed that the endogenous estrogen status clearly regulates the brain inflammatory response associated with this chronic neuroinflamamtory disease. At the molecular level we observed that estrogen activity is associated the inhibition of the intracellular transport of NF‐kB, a transcription factor for inflammatory genes. This immediate‐early event of the inflammatory response is down‐regulated by estrogen through the selective involvement of ERalpha and a nongenomic signalling mechanism. Our most recent data on hormone withdrawal and/or replacement with selective estrogen receptor modulators and brain inflammation will be discussed. Altogether, our studies show that estrogen acts as an anti‐inflammatory agent in brain through a unique mechanism of action that is not shared by conventional anti‐inflammatory drugs. These results may be useful to identify more selective ligands and appropriate therapeutic interventions for the prevention of inflammatory pathologies in the aging women.

P‐112 {#sec1-112}
=====

REGULATION OF SCHWANN CELL DIFFERENTIATION AND PROLIFERATION BY THE PAX‐3 TRANSCRIPTION FACTOR {#sec2-112}
----------------------------------------------------------------------------------------------

### Parkinson D.B.,^1^ Heupel K.,^2^ Mirsky R.,^2^ Jessen K.R.^2^ {#sec3-112}

#### ^1^Peninsula Medical School, Plymouth, United Kingdom; ^2^University College London, London, United Kingdom {#sec4-112}

Pax‐3 is a paired domain transcription factor which plays many roles during vertebrate development. In the Schwann cell lineage, Pax‐3 is expressed at an early stage in Schwann cells precursors of the embryonic nerve, is maintained in the non‐myelinating cells of the adult nerve, and is up‐regulated after peripheral nerve injury. Consistent with this expression pattern, Pax‐3 has previously been shown to play a role in repressing the expression of the myelin basic protein gene in Schwann cells. We have extensively studied the role of Pax‐3 in Schwann cells and have found that in vitro it completely opposes the ability of Krox‐20 (Egr2), the physiological regulator of myelination in the peripheral nervous system, to induce myelin gene expression. In contrast to inhibition of myelination by the c‐Jun N‐terminal kinase (JNK) pathway, we find that Pax‐3 represses myelin gene expression in a c‐Jun independent manner. In addition to this we find that Pax‐3 expression is sufficient to promote Schwann cell survival and to inhibit TGF‐beta induced apoptosis in vitro. Additional experiments have shown that Pax‐3 expression, in the absence of added growth factors, is sufficient to drive Schwann cell proliferation and expression of Pax‐3 can overcome the cell cycle arrest induced by Krox‐20. These findings indicate new roles for the Pax‐3 transcription factor in controlling the differentiation and proliferation of Schwann cells during development and after peripheral nerve injury.
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TEMPORAL LOBE EPILEPSY: OVER‐EXPRESSION OF ASTROGLIAL CONNEXIN CX43 IN THE RODENT PILOCARPINE MODEL IS PREVENTED BY CARBENOXOLONE {#sec2-113}
---------------------------------------------------------------------------------------------------------------------------------

### Stastna D., Laschet J., Boudria S., Chali F., Louvel J. {#sec3-113}

#### Inserm, Paris, France {#sec4-113}

INTRODUCTION: The astrocytes are connected by gap junctions (GJ). GJs are intercellular aqueous channels composed of subunits, called connexins (Cx). Connexin 43 (Cx43) is the most expressed subunit in the astroglial syncytium. An increase of Cx 43 expression has been observed in hippocampus, both in animal epilepsy models and in epileptic patients. Our aim was to study the changes in expression of Cx43 in temporo‐parietal cortex of pilocarpine (Pilo) treated rats, a model appropriate for human mesio‐temporal lobe epilepsy (MTLE).

METHODS: in rats Pilo induces an initial status epilpeticus (SE) and after a latent period of several days the development of recurrent spontaneous seizures. We studied acute behavioral responses, survival rate, quantitative expression of Cx43 as a function of administred Pilo dose and the protective effect of the GJ blocker carbenoxolone (CBX) and of the antiepileptic drug diazepam (DZP) on these parameters. Rats were sacrificied 12 days after SE, before development of spontaneous seizures. RT‐QPCR was used to quantify the expression ratio (ER) of Cx43 (houskeeping gene: βactin), in the temporo‐parietal cortex.

RESULTS: Convulsive doses of Pilo (280 or 360 mg/kg) induced acute SE and delayed spontaneous epileptic seizures. CBX and DZP administration both reduced gravity of acute seizures and mortality. At time of sacrifice, expression of Cx43 significantly increased in Pilo treated animals vs native controls. Administration of CBX or DZP significantly decreased seizure gravity and mortality and suppressed the delayed increase of ER of Cx43 in Pilo treated groups.

CONCLUSIONS: The increased synthesis of gap junction could be the response of astrocytes to the initial SE. If the increase in Cx43 expression is instrumental in the generation of the delayed seizures, then Gjs blockers specific for Cx43 could have a potential therapeutical role.
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HOX PROTEIN CONTRIBUTION TO OLIGODENDROCYTE DEVELOPMENT IN THE MOUSE HINDBRAIN {#sec2-114}
------------------------------------------------------------------------------

### Miguez A.,^1^ Vidal M.,^1^ Ducret S.,^2^ Kerever A.,^1^ Zalc B.,^1^ Rijli F.,^2^ Thomas J.L.^1^ {#sec3-114}

#### ^1^CRICM, Paris, France; ^2^FMI, Basel, Switzerland {#sec4-114}

Distinct pools of oligodendrocyte precursors arise from ventral and dorsal domains of the developing neural tube and express distinct combinations of bHLH and homeodomain (HD) transcription factors. However, little is known about oligodendrocyte diversity along the rostro‐caudal axis. Here, we focus on the mouse hindbrain that, at early embryonic stages, is segmented along the rostro‐caudal axis into a series of rhombomeres. The HD transcription factors of the Hox gene family are expressed with spatially restricted expression patterns conferring rhombomere‐specific identities. In addition, recent evidence supports the idea that Hox factors play important roles in late aspects of topographic neuronal circuit development, both in sensory and motor systems. One possibility is that, in the developing hindbrain, oligodendrocytes may develop according to rhombomere‐specific patterns and may be labeled by Hox‐specific positional codes according to their rostro‐caudal origin and final position. To start addressing this issue, we have investigated the developmental pattern of generation and dispersion of oligodendrocyte precursors specifically originated in rhombomere 2 (R2), and analysed the role of Hoxa2, the only Hox gene expressed in R2. By means of ad hoc genetic tools, we have started to gather information concerning: i) the spatial segregation and long‐term fate mapping of R2‐derived oligodendrocytes in the developing and mature brain; ii) the expression of Hoxa2 in R2‐derived oligodendrocytes; iii) Hoxa2 function in R2‐specific oligodendrogenesis. Our preliminary observations will be presented and discussed.

Support: FRC, ARSEP, Novartis Research Foundation.
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ISCHEMIA AND HYPOXIA
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CELL CYCLE INHIBITION ATTENUATES MICROGLIAL PROLIFERATION AND ITS ASSOCIATED IL‐1β, MIP‐1α AND NO PRODUCTION IN RAT LOCAL CEREBRAL ISCHEMIA MODEL {#sec2-115}
-------------------------------------------------------------------------------------------------------------------------------------------------

### Yu Z., Zhang Q., Chen C., Xie M., Wang W. {#sec3-115}

#### Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China {#sec4-115}

We recently showed that suppressing cell cycle progression inhibited reactive astrogliosis and promoted neuronal survival in an acute focal cerebral ischemia rat model. However, it remains unclear whether and to what extent the bene?cial effects of cell cycle inhibition might also be attributed to the inhibition of microglial proliferation and cytokine/chemokine production. In this study, we showed that application of the cell cycle inhibitor roscovitine before middle carotid artery occlusion (MCAO) in the rat inhibited microglial proliferation and cytokine/ chemokine production, and reduced the number of cell‐cycle‐related proteins including cyclin A, cyclin B, and cyclin E. All of these microglia‐related changes may contribute to roscovitine\'s effect on reducing neuronal apoptosis and infarct volume, thus improving neurological scores. Using the BV‐2 microglia cell line, we showed that roscovitine not only inhibited oxygen‐glucose deprivation (OGD) induced cell cycle activation by arresting the cells at G1/S and G2/M in a dose‐dependent manner, but it also inhibited interleukin‐1 beta (IL‐1b), macrophage in ammatory protein‐1a (MIP‐1a), and nitric oxide (NO) production. These results suggest that cell cycle modulation results in neuroprotection in ischemia, mediated at least in part through inhibition of microglia proliferation and production of in?ammatory cytokines such as IL‐1b, MIP‐1a, and NO.
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TARGETING ASTROCYTES TO REDUCE LOSS OF CA1 HIPPOCAMPAL NEURONS IN FOREBRAIN ISCHEMIA {#sec2-116}
------------------------------------------------------------------------------------

### Giffard R.G., Xu L., Ouyang Y.B., Emery J.F. {#sec3-116}

#### Stanford University, Stanford, United States {#sec4-116}

Brief forebrain ischemia is known to result in delayed loss of CA1 hippocampal neurons. We previously showed that increasing expression of glutamate transporter 1 (GLT 1) in astrocytes reduces loss of neurons in this paradigm. To improve astrocyte function as a method to prevent neuron loss in forebrain ischemia we targeted expression of the protective chaperone heat shock protein 72 (Hsp72) to astrocytes in the hippocampus prior to ischemia.. An expression construct with the Hsp72 coding sequence undercontrol of the GFAP promoter was made and injected stereotactically into the hippocampus unilaterally in adult male Sprague Dawley rats. Forebrain ischemia was performed 3 days later, and neuronal survival assessed 7 days later. Selective astrocytic expression of Hsp72 expression was confirmed by double labeling experiments. Selective loss of CA1 neurons was observed at 7 days reperfusion after 10 min transient forebrain ischemia with hypotension by cresyl violet staining. The construct or control DNA was injected 3 d before ischemia, loss of CA1 hippocampal neurons was significantly reduced on theHsp72 injection side but not on the non‐injection side of the hippocampus. Our previous study showed that early loss of GLT‐1 contributes to delayed neuronal loss. Targeted Hsp72 over‐expression in astrocytes was associated with much better preservation of GLT‐1 immunoreactivity at 5 hr reperfusion after 10 min transient forebrain ischemia. Hsp72 over‐expressing astrocyte cultures were subjected to oxygen glucose deprivation (OGD) and activities of the mitochondrial respiratory complexes I and IV decreased significantly at 18 hr recovery following 1 hr OGD in astrocytes; over‐expressing Hsp72 protected from these decreases. Thus, Hsp72 might protect neurons by maintaining glutamate transport and mitochondrial function in the nearby astrocytes. Thus suggests that preserving astrocyte function is a possible method for reducing neuron loss following forebrain ischemia.
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ROLE OF REGULATOR OF CALCINEURIN 1 (RCAN1) IN BRAIN ISCHEMIA/ REPERFUSION INJURY {#sec2-117}
--------------------------------------------------------------------------------

### Cano E.,^1^ Sobrado M.,^2^ Ramirez B.,^1^ Lizasoain I.,^2^ Moro M.A.^2^ {#sec3-117}

#### ^1^Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain; ^2^Universidad Complutense de Madrid, Madrid, Spain {#sec4-117}

Brain ischemia leads to an overload of intracellular calcium \[Ca2+\]i. This elevation in calcium levels is one of the first events to take place after stroke (reviewed in \[1\]. A key element of the cellular response to Ca2+ signals is the action of the phosphatase calcineurin (CN). We recently showed that primary cortical astrocytes express all components of the Ca/CN/NFAT pathway and that this pathway is activated by pharmacological and physiological Ca2+‐mobilizing agents. Based on the results of a targeted microarray screen, we also identified the pro‐inflammatory response gene Cox‐2 and the calcineurin regulator Rcan1‐4 as neurologically‐relevant target genes that are up‐regulated by this pathway in astrocytes \[2\] Rcan1‐4 belongs to a family of calcineurin inhibitors (Regulator of Calcineurin), previously named DSCR, MCIP, calcipressin, and Adapt78 in humans \[3, 4\].

In the lab, we explore the expression and role of Rcan1 protein in a model of brain ischemia/reperfusion (I/R) injury. We show that Rcan1‐4 protein and mRNA accumulate in brain cortex at early stages after ischemia/reperfusion. Studies with Rcan1‐/‐ mice showed that the absence of this protein is detrimental for the final outcome of stroke, and that expression of inflammatory‐associated genes is increased. Furthermore, the absence of Rcan1 causes a marked increase in the number of GFAP positive cells, and gliosis around the infarcted region. Our findings suggest that Rcan1‐4 expression can be considered an endogenous mechanism for controlling the spiral of brain inflammation after injury, and may have important implications for the initiation and progression of neuroinflammatory disease.

1\. Takano, T., et al., Astrocytes and ischemic injury. Stroke, 2009. 40(3 Suppl): p. S8--12.

2\. Canellada, A., et al., Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1‐4 and cyclooxygenase‐2 as NFAT target genes. Glia, 2008. 56(7): p. 709‐22.

3\. Davies, K.J., et al., Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J, 2007. 21(12): p. 3023--8.

4\. Rothermel, B.A., R.B. Vega, and R.S. Williams, The role of modulatory calcineurin‐interacting proteins in calcineurin signaling. Trends Cardiovasc Med, 2003. 13(1): p. 15--21.
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EVALUATION OF THE TSPO (18KDA)/PBR RADIOLIGAND \[18F\] DPA‐714 IN A RAT MODEL OF FOCAL CEREBRAL ISCHEMIA {#sec2-118}
--------------------------------------------------------------------------------------------------------

### Martin A.,^1^ Boisgard R.,^1^ Dolle F.,^1^ Theze B.,^1^ Van Camp N.,^1^ Kassiou M.,^2^ Tavitian B.^1^ {#sec3-118}

#### ^1^CEA, DSV, I^2^BM, SHFJ, Orsay Cedex (France), France; ^2^University of Sydney, Sydney, Australia {#sec4-118}

Focal cerebral ischemia leads to an inflammatory reaction which involves an over‐expression of the translocator protein, TSPO (18KDa), that is expressed in the monocytic lineage (microglia and monocyte) and astrocytes under such situation. Here, the new peripheral‐type benzodiazepine receptor (PBR) tracer \[18F\] DPA‐714 was evaluated in vivo in a stroke model using PET imaging.

\[18F\] DPA‐714 was administered in a rat model of 2 hours transient middle cerebral artery occlusion (tMCAO) using 1, 4, 7, 11, 15, 21 and 30 days of reperfusion. We performed in vitro binding using autoradiography, and in vivo dynamic imaging using μPET, including displacement studies, and analyzed the stroke lesion with several markers using immunohistochemistry at different time points.

In vivo PET imaging showed a significant increase at day 7, day 11, day 15 (P\<0.01) and day 21 (P\<0.05) in the stroke area with respect to the contralateral area. The highest binding value was reached at 11 days after ischemia relatively to 7 and 15 days (P\<0.05). \[18F\] DPA‐714 uptake decreased at 21 days and 30 days with respect to uptake at 11 days (P\<0.001). In vitro binding using DPA‐714 was performed at 1, 4, 7, 11 and 15 days after ischemia in order to confirm the results obtained in vivo with PET. An increase in binding was observed at 4 days (P\<0.05), followed by a further increase from day 7 to day 15 (P\<0.001). Binding was maximal at 11 days after ischemia in relation to day 4 (P\<0.05) and day 7 (P\<0.01) but not significantly higher than at day 15.

Displacement studies using in vivo PET imaging and in vitro binding with PK11195 and DPA‐714 showed a rapid and complete displacement of \[18F\] DPA‐714 binding from the lesion.

The immunohistochemistry studies showed an increase of TSPO expression in amoeboid cells (monocytic lineage) in the core of infarction, and in astrocytes in the periphery of the infarcted area from days 7 to 15 after ischemia. At day 30, the presence of astrocytes increased in the core, thus indicating the presence of an astrocytic scar.

\[18F\] DPA‐714 appears as a good tracer for the study of the inflammatory reaction following stroke. This tracer will be further evaluated for its potential to document the effect of different anti‐inflammatory strategies on TSPO expression.
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FUNCTIONAL SIGNIFICANCE OF THE TRANSIENT ENHANCED EXPRESSION OF PANNEXIN1 EARLY IN THE REPERFUSION AFTER ISCHEMIA IN CULTURED ASTROCYTES {#sec2-119}
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### Iwabuchi S., Kawahara K. {#sec3-119}

#### Hokkaido University, Sapporo, Japan {#sec4-119}

One of the mechanisms for neuronal cell death under ischemic insult is caused by the massive Ca^2+^ influx into neurons through the excessive activation of ATP‐P2X~7~receptors. It was reported that ATP is released to the extracellular space in an *in vitro* ischemic model, and astrocytic maxi‐anion channels are considered as a primary pathway for releasing ATP. Previously, we reported that sublethal oxygen‐glucose deprivation (sOGD) increases the concentration of extracellular ATP (\[ATP\]~e~) during and after sOGD in cultured astrocytes. The increase in \[ATP\]~e~ resulted in the development of OGD tolerance via ERK1/2 and PI3K/Akt signaling. In this study, we addressed the question as to the reason why ATP was released during and after sOGD. Neonatal rat‐derived primary astrocytes were maintained with a culture medium (CM) for 14 day. To simulate ischemic conditions, CM was replaced with the glucose‐free buffer, and cultures were placed in an anaerobic chamber containing the de‐oxygenation reagent. After 2 h of sOGD, cultures were incubated with fresh CM (reperfusion) from 1 h to 1 day. The increase in the \[ATP\]~e~during sOGD was attenuated by treatment with an inhibitor of maxi‐anion channels, but not with an inhibitor of hemichannels. In contrast, the increase of \[ATP\]~e~early in the reperfusion was attenuated by treatment with an inhibitor of either maxi‐anion channels or hemichannels. The expression of pannexin1, which is the part of the P2X~7~ receptor‐channel complex, was transiently enhanced early in the reperfusion after sOGD. When the cultures were treated with hemichannel inhibitors during reperfusion for 1 day, the sOGD‐induced tolerance against subsequent lethal OGD was significantly attenuated. However, the pannexin1 expression was significantly decreased as compared with that in the control groups at 1 day later. Such a decrease was probably involved in the decreased release of ATP during subsequent lethal OGD, contributing to the development of OGD tolerance. Taken together, the present study demonstrated a possibility that astrocytes would actively released ATP early in the reperfusion, and this enhanced release possibly contributed to the recurrent suppression in the expression of hemichannels at 1 day later, suggesting the existence of a negative‐feedback pathway regulating the expression of hemichannels.
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#### College of medicine, The Catholic University of Korea, Seoul, Republic of Korea {#sec4-120}

Suppressor of cytokine signaling‐2 (SOCS‐2) has recently identified as an important regulator that is involved in neuronal differentiation and maturation. However, the role of SOCS‐2 in ischemia‐induced hippocampal neurogenesis still remains to be clarified. Here, we investigated spatiotemporal expression of SOCS‐2 in the rat hippocampus following transient forebrain ischemia, and particular attention was paid to its changes in the dentate gyrus. SOCS‐2 mRNA was constitutively expressed in hippocampal neurons and astrocytes in control animals, however, its upregulation occurred specifically in reactive astrocytes in the hippocampus proper, in particular CA1 and the dentate hilar regions by day 3 after reperfusion, and was sustained for more than two weeks. This was compatible with the postischemic upregulation of SOCS‐2 in the CA1 region as detected by the semi‐quantitative reverse transcriptase--polymerase chain reaction analysis. In addition to the CA1 and hilar regions, SOCS‐2 was transiently increased in the subgranular zone (SGZ) of the dentate gyrus on days 3‐7 days after reperfusion. Most of the SOCS‐2 expressing cells in the SGZ were colabeled with glial fibrillary acidic protein (GFAP), and a subpopulation of GFAP/SOCS‐2 double labeled cells in the SGZ coexpressed neural progenitor marker nestin or proliferation marker proliferating cellular nuclear antigen. In addition, a subset of SOCS‐2 labeled cells in the SGZ expressed immature neuronal marker polysialylic acid‐neural cell adhesion molecule. These data suggest that SOCS‐2 may be involved in glial reaction, and possibly in adult hippocampal neurogenesis during ischemic insults.

This research was supported by a grant from the Ministry of Knowledge Economy, The Republic of Korea (10029970), and by a grant (M103KV010010‐08K2201‐01010) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, The Republic of Korea.
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The cerebellum is a structure of the nervous system that plays a crucial role in several motor and even cognitive processes in mammals, so that alterations in its functionality result mainly in distortions in the execution and coordination of movement. Glial fibrillary acidic protein (GFAP) is a specific astrocyte marker which expression has been demonstrated to increase during aging. The pathologies related to hypoxic processes, which are characterized by a diminished oxygen contribution to tissues, occur with the highest incidence in old individuals. In this study we have analyzed by means of western blotting technique the expression of GFAP in cerebellum homogenates of adult (4 months) and old (26 months) rats submitted to a model of acute hypobaric hypoxia followed by several reoxygenation periods compressed between 0 hours and 5 days. Rats of both ages but submitted to normobaric normoxia were used as control group. Thus, this study reproduces hypoxic situations which have not been studied previously in old individuals. The analysis of the band pattern reveals a significant increase in GFAP expression in adult animals after 2 hours of reoxygenation. On the other hand, in the old animals we have found an augmented GFAP expression as well, but in this case, it occurs at 0h immediately after the hypoxic insult. After this initial increase, in both experimental groups, GFAP expression levels suffer a decrease back to basal (control group) levels, followed by an new increase after 48 hours of reoxigenation, before coming back to basal levels again. These increases in GFAP expression could be interpreted as an augmented glial reactivity, which could trigger a beneficial effect protecting neurons from the hypoxic insult.
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Neurons are highly dependent on astrocyte survival during brain damage. To identify genes involved in astrocyte function during ischemia, we performed mRNA differential display in astrocytes after oxygen and glucose deprivation. We detected a robust downregulation of S6 kinase mRNA that was accompanied by a sharp decrease in protein levels and activity. OGD‐induced apoptosis was increased by the combined deletion of S6K1 and S6K2 genes, as well as by treatment with rapamycin that inhibits S6K1 activity by acting on the upstream regulator mTOR. Astrocytes lacking S6K1 and S6K2 displayed a defect in BAD phosphorylation and in the expression of the anti‐apoptotic factors Bcl‐2 and Bcl‐xL. Furthermore reactive oxygen species were increased while translation recovery was impaired in S6K deficient astrocytes following OGD. Rescue of either S6K1 or S6K2 expression by adenoviral infection revealed that protective functions were specifically mediated by S6K1, as this isoform selectively promoted resistance to OGD and reduction of ROS levels. Finally, "in vivo" effects of S6K suppression were analyzed in the permanent middle cerebral artery occlusion model of ischemia, in which absence of S6K expression increased mortality and infarct volume. In summary, this article uncovers a protective role for astrocyte S6K1 against brain ischemia, indicating a functional pathway that senses nutrient and oxygen levels and may be beneficial for neuronal survival.
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Recent evidences show that the acute ischemic damage is followed by a delayed injury phase affecting the so‐called peri‐ischemic area. This area surrounding the damaged tissue undergoes substantial matrix remodelling while inflammatory responses and apoptotic programs further contribute to injury development. Although these late structural and functional changes are of key importance for the final stroke outcome, knowledge of the underlying pathophysiological is still incomplete. It has been shown that Neural stem/precursor cells (NPCs) are able to release at the site of injury a milieu of regulatory molecules and ameliorate functional outcome when transplanted in the acute phase after stroke.

Aim of this work was to investigate whether delayed transplantation of NPCs (i.e. 72 hours after stroke) could influence the detrimental effect of these late pathophysiological processes.

Adult mice submitted to transient left middle cerebral artery occlusion, were randomized in two treatment groups. One group received intravenous transplantation of adult NPCs (106 cells/mouse), while the latter group was sham‐treated with the carrier solution. The effects of the delayed systemic NPCs transplantation on neurological recovery, gene expression and histopathology were studied up to 5 weeks following stroke. A small fraction of systemically transplanted cells were able to integrate in the infarct boundary zone and to survive for at least 30 days post injection. The majority of these cells remained in an undifferentiated state, thus exerting a delayed neuroprotective effect that was associated with a significant sparing of inter‐hemispherical communicating fibers and an enhanced striatal neuronal survival, when compared to sham‐treated controls. This delayed neuroprotective effect was related to a reduction of tissue inflammation and glial scar formation that was visible with both gene and protein analyses. Finally, NPCs‐treated mice showed a progressively enhanced recovery of motor skills associated with stronger grip strength in the right paretic forepaw. Our data highlight the therapeutic potential of NPCs, and the relevance of modulating very delayed degenerative processes in the stroke brain that are intimately associated with both inflammatory and glial responses.
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Hypoxia is a state of deficiency of available oxygen in the blood and bodily tissues. The brain is a main consumer of energy and therefore is particularly sensitive to variations in oxygen level. Hypoxia induces cellular and molecular adaptations involving several transcription factors such as HIF1alpha. Previous in vitro experiments demonstrated that RORalpha is regulated by HIF1alpha in peripheral organs including liver and muscle. RORalpha is a transcription factor which belongs to the nuclear receptor family. Recently, it has been demonstrated that RORalpha is expressed in astrocytes in addition to its well‐known neuronal expression. In the central nervous system, RORalpha has neuroprotective properties. However this neuroprotective function has not yet been associated to the hypoxic response.

We wondered if RORalpha could be implicated in neuroprotective mechanisms triggered by hypoxia in the central nervous system. We thus evaluated the relative contribution of RORalpha in cortical neurons and astrocytes after hypoxia. In this way, we developed an in vitro approach with primary cortical cultures and cocultures of neurons and astrocytes and an in vivo one using the Cre‐Lox recombination system. We crossed Rora‐LoxP mice with either FoxG1‐Cre or Glast‐Cre mice to study the function of RORalpha after hypoxia in vivo in, respectively, cortical neurons and astrocytes. We demonstrated that RORalpha has a neuroprotective function during hypoxia. Then, we showed that this transcription factor is transcriptionnally activated in neurons and astrocytes after hypoxia. We suspect HIF1alpha as being the factor responsible for this regulation. Currently, the target genes of RORalpha involved in its hypoxic function are under investigation.

This work demonstrates that RORalpha is a key molecular player during cerebral hypoxia and that its contribution to the hypoxic response not only implies cortical neurons but also astrocytes.
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Astrocytes are involved in maintaining brain integrity in conditions of disease and injury and are thought to confer neuroprotection during brain ischemia. Since the molecular mechanisms involved in the astrocyte response to ischemia are not yet completely understood, our work is aimed to ascertain the relevance of the endoplasmic reticulum stress response in the astrocyte injury caused by ischemia. Specifically, the work presented here is aimed to analyze the functions of Selenoprotein S in the astrocyte response to ischemia, as this protein is involved in the retrotranslocation step of ER stress.

Differential display analysis of astrocytes exposed to OGD uncovered the upregulation of Selenoprotein S gene during ischemia. Subsequent Northern blot and quantitative RT‐PCR studies showed that OGD‐induced Selenoprotein S mRNA increase was maximum after 4‐hour and returned to control levels following reoxygenation. Astrocyte treatment with thapsigargin or tunicamycin also induced a significant increase of Selenoprotein S expression, indicating that this gene is expressed in astrocytes in the context of the ER‐stress response. siRNA technology was used to assess astrocytic Selenoprotein S functions. This approach caused a prominent diminution of Selenoprotein S expression which had a strong deleterious effect on astrocyte viability, decreasing survival to 4‐hour OGD by 40%. In agreement with Selenoprotein S functions on ER‐stress response, astrocyte survival to thapsigargin or tunicamycin treatment was also intensely diminished by Selenoprotein S siRNA.

In summary we can conclude that Selenoprotein S activation during ischemia has protective functions in astrocytes that might be related to the activation of retrotranslocation machinery.
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### Fradejas N., Pastor M.D., Burgos M., Tranque P., Calvo S. {#sec3-126}

#### Facultad de Medicina. Unversidad de Castilla la Mancha, Albacete, Spain {#sec4-126}

Astrocytes are essential cells to maintain brain integrity during ischemia. We have recently shown that the ER‐stress response is activated in astrocytes during ischemia and is characterized by the expression of high levels of the transcription factor C/EBP homologous protein (CHOP). CHOP upregulation induces astrocyte death by mechanisms still unknown. The aim of this work was to determine whether caspase‐11 which activates both apoptotic and pro‐inflammatory pathways, is implicated in ER stress‐dependent astrocyte death in ischemic conditions.

Our results show that caspase‐11 is upregulated in primary astrocyte cultures following either oxygen and glucose deprivation (OGD) or treatment with the ER‐stress inducers thapsigargin and tunicamycin. Moreover, these same stimuli increased caspase‐11 mRNA levels and luciferase activity driven by a caspase‐11 promoter, indicating that caspase‐11 is regulated at the transcriptional level. mRNA increase is followed by an increment of cleaved caspase 11. Our data also illustrate the involvement of ER stress‐associated CHOP in caspase‐11 regulation, as CHOP overexpression by means of an adenoviral vector caused a significant raise in caspase‐11 mRNA and protein levels. In turn, caspase‐11 suppression with siRNA rescued astrocytes from OGD and ER stress‐induced death, supporting that caspase‐11 is responsible for the deleterious effects of ischemia on astrocytes. Finally, specific inhibitors of caspase‐1 and caspase‐3 significantly reduced astrocyte death, which indicates that both proteases act as death effectors of caspase‐11. In conclusion, our work contributes to clarify the pathways leading to astrocyte death in response to ischemia by defining caspase‐11 as a key mediator of the ER stress response acting downstream of CHOP.
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Ischemic injury leads to increased proliferation of neural stem/progenitor cells in the ipsilateral subventricular zone (SVZ) of the lateral ventricle and angiogenesis in the peri‐infarct area, probably through the vascular endothelial growth factor (VEGF) system. VEGF‐C, a member of the VEGF family, has recently identified as an important trophic factor for neural progenitors in embryonic brain. However, the role of VEGF‐C in the ischemic rat brain after middle cerebral artery occlusion (MCAO) still remains to be clarified. We investigated the spatiotemporal expression of VEGF receptor 3 (VEGFR‐3; Flt‐4)), a receptor for VEGF‐C and VEGF‐D following transient focal ischemic injury. The VEGFR‐3 mRNA expression was increased in the SVZ of the ipsilateral lateral ventricle, and both the ischemic core and the boundary zone adjacent to the ischemic core after focal cerebral ischemia. VEGFR‐3 expressing cells were co‐labeled with the proliferation markers, proliferating cellular nuclear antigen (PCNA) or BrdU, and laminin positive vascular profiles in the ischemic core and peri‐infarct region. In addition to proliferating endothelial cells, many VEGFR‐3 expressing cells in the ischemic core were brain macrophages. A substantial increase of VEGFR‐3 mRNA expression was also noted in the peri‐infarct zone, where VEGFR‐3 expressing cells formed a belt‐like boundary surrounding the ischemic core. The majority of these VEGFR‐3 expressing cells coexpressed glial fibrillary acidic protein (GFAP) and the neural progenitor marker nestin, although some were a subpopulation of brain macrophages. Ischemic injury increased VEGFR‐3 expression in the ipsilateral SVZ of the lateral ventricle, well recognized germinal center, at 3 and 7 days. Most of the VEGFR‐3‐expressing cells in the ipsilateral SVZ were co‐labeled with GFAP and the majority of these VEGFR‐3/GFAP double‐labeled cells coexpressed nestin or the proliferation markers, PCNA or Ki‐67. In addition, a subset of VEGFR‐3‐labeled cells in the ipsilateral SVZ was double labeled with Ki‐67 and the immature neuronal marker, polysialic acid‐neural cell adhesion molecule. These data suggest that the VEGF‐C/VEGFR‐3 axis may be involved in glial reaction in the ischemic brain and possibly mediate coupling of angiogenesis and neurogenesis after ischemic stroke.
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It is well established that ischemia‐preconditioned astrocytes and neurons can protect neurons against ischemia‐induced injury. Since there is evidence suggesting the existence of bi‐directional communications between neurons and astrocytes under physiological conditions, we speculate that preconditioned neurons, like astrocytes, can protect astrocytes from ischemia‐induced injury. More specifically, we hypothesize that preconditioned neurons release protective factor(s) to achieve this aim and such bi‐directional protective communications between neurons and astrocytes play crucial roles under pathophysiological conditions. Here, we demonstrated for the first time that ischemia‐preconditioned medium from neuron (IPcNCM) could significantly increase cell viability, and at the same time decrease LDH release and the percentage of apoptotic cells in ischemic astrocytes. We found that preconditioning of neurons increased the expression of hypoxia‐inducible factor‐1 alpha (HIF‐1alpha) and erythropoietin (EPO), but decreased the expression of REDD1 (Regulated in Development and DNA damage responses 1, also referred to as RTP801 or dig2), a gene closely associated with apoptosis in ischemic astrocytes. The protective effects of IPcNCM are highly associated with these changes. On the other hand, we provided further evidence for a connection between the protective and anti‐apoptotic effects of ischemia‐preconditioned medium from astrocytes (IPcACM) on neurons and the endogenous increase in HIF‐1alpha, EPO and phosphorylation of Bad (B‐cell lymphoma/leukaemia 2‐antagonist of cell death). We conclude from our studies that ischemia‐preconditioned neurons can protect astrocytes against ischemia‐induced injury and that ischemic preconditioning triggers bi‐directional protective communications between neurons and astrocytes.

Supported by NSFC of PRC (30770806, 30570675), Jiangsu Natural Science Foundation (05‐BK2005430‐KY), The Competitive Earmarked Grants of The Hong Kong Research Grants Council (CUHK466907‐KY), The NSFC‐CRG Joint Research Grant, Direct Grant of CUHK (A/C: 4450226‐KY, 4450273‐KY), and Shenzhen‐Hong Kong Innovation Circle Program.
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Magnetic resonance imaging (MRI) was employed to follow the neurodegenerative foci and to monitor the localization of inflammatory cells by magnetically labeled (ultra small paramagnetic iron oxide ‐ tagged antibodies: MACS®) CD4 or CD8 lymphocytes in the ischemia‐reperfusion long‐lived rats (9 and 12 months after 10 min ischemia induced by cardiac arrest; Pluta et al., Acta Neuropathol. 83: 1, 1991). These data were followed by immunocytochemistry of microglia (OX42‐specific) with confocal laser scanning in order to target foci of neuroinflammation.

MRI scanning (wide bore 1.5 T Siemens Avanto Imager) of anesthetized long‐lived post‐ischemic rats showed the following characteristics: a) blood brain barrier (BBB) leakage in the area of the dorsal hippocampus and brainstem‐hindbrain level in basal cerebellum; b) anti‐CD8 magnetic antibodies did not give an apparent signal while anti‐CD4 MACS® antibodies in some cases revealed hypointense areas in the brainstem‐interbrain region (caudoputamen) likely to originate from paramagnetic iron since they were not found in animals not injected with MACS® antibodies; and c) dilation in the retrosplenial area. Immunocytochemistry revealed microglial activation in the long‐lived post‐ischemic rat hippocampus (CA1 and CA3 region). In this structures it was also noted that OX42‐positive granules appear in neuronal stomata stained by NeuroTrace. These observations point to a hampered BBB that in long‐term may still lead to infiltration of immune cell that are predominantly of helper function (CD4+ T cells). This inflammatory processes are backed by microglial activity even up to one year after the ischemic insult. These creeping degenerative phenomena specifically in the hippocampal area may lead to formation of amyloid plaques and Alzheimer\'s type dementia which has already been proposed for this long‐term ischemia survival animal model (Pluta, Curr Neurovasc Res 4: 121, 2007).

This work was supported by COST/ESF and MSEP grant \#143054B to A.P.R.

P‐130 {#sec1-130}
=====
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Focal and diffuse periventricular white matter injuries (PVWMI) are the main histological brain lesions detected in preterm infants. Recent studies shown that children born very preterm were more likely to develop neurological, cognitive and/or behavioral handicaps than children born preterm. Our study analysed different phenotypic expression of glial cells observed in diffuse and focal PVWMI on brain tissue (n=28) obtained from very preterm (24‐30 gestational weeks gw) and preterm (31‐35gw) infants compared to controls. Different antibodies were used on serial sections by single or double labelings for astrocytes \[GFAP, monocarboxylate transporter‐1 (MCT1)\], microglia‐macrophages \[Iba‐1, CD68, CD45, LN3 (MCHII)\], vessels (MCT1) and pre‐oligodendrocytes (Olig2).

1/On hemateine eosine staining the different types of PVWMI were identified as focal and/or diffuse lesions, 2/ In control cases, MCT1 was expressed primarily in vessel walls and at a very low level in astrocytes of very preterm brains. MCT1 labeling increased with age in astrocytes in the white matter of preterm brain. 3/ Diffuse lesions displayed a loss in astrocytic cell bodies and processes associated with a microglial‐macrophage activation. MCT1 labeling was not present in most vessel walls and in astrocytes in PVWMI in very preterm brain whereas some labelling was present in preterm brain. 4/ Focal lesions displayed a high density of macrophages associated with a strong astrogliosis. 5/ Olig2 labeling of preoligodendrocytes decreased in most PVWMI, but it was an inconstant feature as some cases display no decrease. In parallel in the internal capsule of some PVWMI, PS100β positive cell bodies displayed an oligodendrocytic phenotype giving rise to myelin sheets.

This study identifies critical differences in glial phenotypic expressions in diffuse compared to focal lesions in PVWMI.
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Dysregulation of inflammatory activation and neuroprotective activity of glia can lead to neurotoxicity, and could be involved in neurodegenerative changes of Alzheimer disease (AD). Dysregulation could be promoted by physiopathological conditions like hypoxia, which is frequently observed in aging. Hypoxia/reperfusion could result in the production of radical species which can increase their reactivity to Amyloid Beta (Aβ) and proinflammatory factors. We assessed the effect of moderate hypoxia (2% O2, 5% CO2; for 0.5, 2 and 4 h) on the activation of primary astrocytes and the microglial line cell EOC‐20 by 1μg/ml LPS and 10 ng/ml IFNγ in culture, evaluating production of nitric oxide (NO), cell death, protein oxidation and TGFβ. Also, because hypoxia and inflammation could modify the expression of receptors involved in Aβ internalization like Scavenger Receptors (SRs), their expression was assessed. Astrocytes\' NO production increased up to 14‐fold after 4 h of hypoxia+LPS (p\<0.008). In EOC‐20 cells, NO production induced by hypoxia+LPS increased 140‐fold respect normoxic control (p\<0.001). A 2.2‐fold increase compared to normoxic proinflammatory condition for both glial types. However, hypoxia produced a short‐lived potentiation for astrocytes and a persistent potentiation for microglia. Activation of TGFβ but not its total concentration showed a 2.6‐fold increase in astrocytes under inflammatory conditions (p\<0.01). Potentiation by hypoxia was time‐dependent, reaching an 8‐fold increase after 4 h of hypoxia. In contrast, microglial cells showed no difference on TGFβ level or activity. The expression of SRs, which can mediate inflammatory activation of glia, showed that hypoxia potentiated induction of SR‐MARCO by inflammatory factors and inhibited expression of SR‐BI. Finally, whereas cell death and oxidative stress were not significantly increased by hypoxia, inhibitors for TGFβ type‐II receptor or the Smad signaling pathway significantly increased the production of NO and cell death induced by hypoxia+inflammation. TGFβ appears to be responsible for the transient nature of the activation and lack of associated damage, suggesting it contributes to the establishment of a protective mechanism in hypoxia.

Supported by grant FONDECYT 1090353.
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Retinal ischemia is a serious and common clinical problem leading to visual loss in a number of ocular diseases including acute glaucoma, branch retinal artery occlusion, diabetic retinopathy, and hypertensive vascular disease. During the ischemic cascade, inflammatory mediators are activated to cause secondary neuronal injury through the release of cytokines, phospholipases and chemokines. 3‐Hydroxy‐3‐methylglutaryl‐CoA reductase inhibitors (statins) are potent cholesterol‐lowering drugs. Recent data suggest that statin therapy has pleiotropic effects, including protection against acute and chronic neurodegeneration following ischemic stroke, and inflammatory pathologies from the central nervous system. The statin simvastatin has been shown to increase retinal ganglion cell survival after ischemia/reperfusion. Mechanisms mediating this effect are incompletely understood. The aim of this study was to characterize the inflammatory response and the putative statin‐mediated immunomodulatory effect during the acute phase following transient retinal ischemia/reperfusion in the rat eye. We used a model of transient global retinal ischemia in the rat by elevation of intraocular pressure above systolic blood pressure. A single dose of Simvastatin (4 or 8 mg/Kg) was delivered subcutaneously 1 h after lesion. Microglia/macrophages were quantitated by means of immunohistochemistry on retinal slices 3, 6, 12 and 24 h after ischemia. Expression of cytokines was evaluated by means of RT‐PCR and ELISA 3, 6, 12 and 24 h after acute retinal ischemia/reperfusion. A significant increase in the number of microglia/macrophages (260% as compared to controls) was observed 3 h after ischemia, concomitant with a change in morphology and distribution in retinal layers. mRNA expression levels for TNF and IL‐1β and protein levels for TNF were significantly increased 3 h after lesion. Simvastatin treatment altered TNF and IL‐1β expression levels 6 and 12 h after retinal ischemia/reperfusion. The number of microglia/macrophages did not change after statin treatment. Results of this study show a strong inflammatoy response in the early phase after ischemia and support a potential use of statins as therapeutic agents to modulate acute inflammation following transient retinal ischemia/reperfusion.
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Time‐dependent changes in astrocyte morphology and astrocyte membrane properties were studied in the hippocampal CA1 region of 8‐week‐old rats after global cerebral ischemia (GCI) followed by reperfusion for 6 or 24 hours or 3, 7 or 30 days. GCI resulted in a significant reorganization of the CA1 region due to neuronal death, microglial and NG2‐glial proliferation, reactive gliosis and changes in glial morphology. Quantifying the changes in cell numbers showed that 1 month after GCI, the CA1 region mainly consisted of astrocytes, microglia and NG2‐glia, while the number of neurons significantly declined compared to controls. Further, 3D‐confocal morphometry revealed marked differences in astrocyte morphology 1 month after GCI when compared to control rats. The total astrocyte volume (V), the volume of the processes (Vp) and the cell soma volume (Vs) were significantly increased, and, moreover, the ratio of Vs/Vp revealed an enlarged astrocytic soma 3 days and 1 month after GCI. The astrocytic membrane properties, determined by the whole‐cell patch‐clamp technique, were correlated with ongoing apoptosis and proliferation using specific markers for neuronal, glial, apoptotic or proliferating cells. In both sham‐operated rats (control) and those after GCI, astrocytes in the CA1 region displayed passive symmetrical non‐decaying K+ currents with the additional expression of delayed outward K+ rectifier (KDR) and/or inward K+ rectifier (KIR) currents. Depolarization of astrocytes was observed starting 2 hours after GCI, and their membrane capacitance was decreased from the first day of reperfusion. The KIR current density in astrocytes was increased 6 hours after GCI, when apoptotic markers appeared in neurons, while after 1 month of reperfusion, apoptotic markers were detected in astrocytes coinciding with the down‐regulation of Kir 4.1 channel expression, confirmed by Western blotting. Additionally, the presence of hyperpolarization‐activated non‐specific cation channels sensitive to glibenclamide, ZD7288 and a low extracellular Na+ concentration (presumably HCN channels) were detected in astrocytes 1 month after GCI and confirmed by immunohistochemical analysis.

Supported by GACR 305/09/0717, AVOZ50390512, LC554.

P‐134 {#sec1-134}
=====

PERINATAL HYPOXIA AFFECTS NEURONAL AND GLIAL P2X7 RECEPTOR ACTIVITY IN NEONATAL AND ADULT RAT {#sec2-134}
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### Alloisio S.,^1^ Cervetto C.,^2^ Barbieri R.,^1^ Mazzotta M.C.,^2^ Marcoli M.,^2^ Maura G.,^2^ Nobile M.^1^ {#sec3-134}

#### ^1^National Research Council, Genoa, Italy; ^2^University of Genoa, Genoa, Italy {#sec4-134}

Neuronal‐astrocytic interaction appears to be of major importance in the control of glutamate and ATP synaptic level following perinatal hypoxia--ischemia. Among the different ATP specific receptors, an upregulation of P2X7 receptors was reported to be associated to astroglial reactivity observed upon ischemic injury.

Here, we studied P2X7 activity measuring intracellular calcium \[Ca2+\]i dynamic and \[3H\]D‐aspartate (\[3H\]D‐ASP) release in cortical synaptosomes and gliosomes from rats born by natural birth or by caesarean section followed by 15 min of global anoxia. Experiments were performed two or sixty days after delivery to verify the effects of damage early and later in life. The data show that synaptosomial \[Ca2+\]i response induced by the synthetic P2X7 selective agonist (BzATP) was significantly decreased in adult rats subjected to perinatal anoxia, while \[3H\]D‐ASP release was enhanced. Differently, in glial particles the same results were already evident at two days post‐hypoxia and persisted in adulthood. \[Ca2+\]i dynamic and \[3H\]D‐ASP release were not affected when all particles were stimulated by depolarising event (ext. high K+). Altogether, these data show that P2X7 receptor activity could have a protective such as neurodegenerative role in hypoxia/ischemia. To investigate on this double function will be the next step of the study.

This work is supported by Mariani Foundation, Milan (Italy).
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STRUCTURAL TARGETS OF ANOXIA IN MAMMALIAN WHITE MATTER {#sec2-135}
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### Baltan S., Ransom B. {#sec3-135}

#### University of Washington, Seattle, United States {#sec4-135}

Mammalian CNS white matter (WM), although susceptible to ischemia, exhibits significant functional tolerance to anoxia due to the ability of a subset of axons to maintain excitability under anaerobic conditions. We studied the morphological consequences of anoxia in mouse optic nerve (MON), using immunohistochemistry and confocal imaging. WM function was quantitatively measured as the area under the compound action potential (CAP) evoked by supramaximal stimulation. Cellular components of WM were selectively identified by labeling astrocytes with GFAP, oligodendrocytes with APC, oligodendrocytes and their processes with CNPase, myelin with MAG, axonal neurofilaments with SMI‐31, microglia with Iba1, axonal structures with CASPR and glial nuclei with Sytox. During prolonged anoxia (180 min), 30% of MON axons remained functional. Upon reoxygenation, the CAP area recovered further to about 40% of control level. In these MONs, there was a profound loss of astrocyte staining implying that their processes and network organization were disrupted. A remarkable drop in CASPR staining was associated with thinner, shorter and disorganized periaxonal structures. CNPase labeling was either almost completely lost or became more clumped. Consistent with axon function loss, SMI‐31 labeling was significantly reduced. Oligodendrocyte counts and MAG labeling remained relatively unchanged. On the other hand, Iba1 (+) microglial staining increased 3‐5 fold. Our results using immunochemistry reveal that anoxia disrupts astrocyte processes, myelinated process of oligodendrocytes, some axons and nodal organization but spares oligodendrocytes. Anoxia and ischemia seem to produce different patterns of injury in MON. Ischemia, but not anoxia, causes a predominant oligodendrocyte death, and anoxia seems to produce less axonal injury.
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ISCHEMIC INGURY IS ENHANCED IN AN ODDD MOUSE MODEL {#sec2-136}
--------------------------------------------------

### Bechberger J., Bechberger G., Suen M., Kozoriz M., Naus C. {#sec3-136}

#### University of Bristish Columbia, Vancouver, Canada {#sec4-136}

Oculodentodigital dysplasia is a rare human disease which has been termed an autosomal dominant defect. This disorder is characterized by developmental anomalies of the limbs, face, heart, eyes and teeth. Recently analysis of human Connexin 43 (Cx43, *GJA1*) DNA sequences revealed a number of different missense, duplication and frame shift mutations resulting in this phenotype (reviewed by Flenniken et al., 2005). A mouse model of this disorder was recently identified following treatment with the mutagen N‐ethyl‐N‐nitrosourea, resulting in a missense mutation of the glycine animo acid at position 60 converting it to a serine (G60S) (Flenniken et al., 2005).This mouse exhibits the characteristic phenotype as observed in humans. The Cx43 genotype of the mouse contains one mutated allele and one wild type allele (termed: *Gja1^jrt^/+*). Protein levels of Cx43 in the mutant mouse were found to be greatly reduced in the heart and granulosa cells as compared to the normal mouse. Since we have previous shown that removal of Cx43 from astrocytes in the brain results in greater ischemic damage following a stroke, we were interested to determine what effect this mutant would have. Primary cultures of astrocytes from the G60S mutant exhibited a lower level of dye coupling as compared to normal. Location of Cx43 protein was observed as a continual line of small puntate aggregates in the plasma membrane, which is distinct from the larger plaques seen in the normal mouse. Also the astrocytes demonstrated a higher level of hemi‐channel activity with the presence of the mutated Cx43allele as compared to the wild type. Four days after middle cerebral artery occlusion the volume of the infarct was significantly larger than in the normal mouse. We are further investigating if the increase of hemi‐channel activity is responsible for the increase in damage.

The *Gja^jrt^/+* mice were provided by Dr. Janet Roussant at the Center for Modeling Human Disease, Mount Sinai Hospital, Toronto.

This work was funded by the Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation of Canada to C.C.G..N. A Michael Smith Foundation for Health Research Fellowship and CIHR -- UBC MD/PhD studentship award to M.K. C.C.N. holds a Canada Research Chair.
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CONTRIBUTION OF ASTROCYTES TO THE "FRENCH PARADOX" IN THE CNS {#sec2-137}
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### Koizumi S.,^1^ Fujishita K.,^1^ Ozawa T.,^1^ Shibata K.,^1^ Tanabe S.,^2^ Sato Y.^2^ {#sec3-137}
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Polyphenolic compounds, including a large group of flavonoids, are abundant in vegetables, fruits, tea and wine. These compounds are generally known to possess potent antioxidant properties. Despite intake of a high‐fat diet, the strikingly low incidences of coronary heart disease in France as compared with other western countries, the so‐called French Paradox, has been attributed partly to the consumption of red wine, which contains higher levels of polyphenols as compared to other alcoholic beverages. In recent years, studies directed at elucidating the mechanisms underlying the French Paradox have stimulated interest in exploring whether polyphenolic antioxidants can also offer antioxidant benefits for the brain. Here we show that grape polyphenols protect neurons against oxidative stress via astrocytic stimulation. We used grape seed extract (GSE) from Koshu grapes (Vitis vinifera) containing a variety of polyphenols, and performed transcriptome analysis to determine the effects of GSE on primary cultures of astrocytes in the hippocampus. GSE upregulated various mRNAs for cytokines, among which interleukin‐6 (IL‐6) showed the biggest increase after treatment with GSE. The GSE‐evoked increase in IL‐6 mRNAs was confirmed by quantitative RT‐PCR. We also detected IL‐6 proteins by ELISA in the supernatant of GSE‐treated astrocytes. We made an oxidative stress‐induced neuronal cell death model in vitro using a neuron rich culture of the hippocampus. Treatment of the neurons with H2O2 caused neuronal cell death in a time‐ and concentration‐dependent manner. Exogenously applied IL‐6 protected against the H2O2‐induced neuronal cell death, which was mimicked by endogenous IL‐6 produced by GSE‐treated astrocytes. Taken together, GSE acting on astrocytes increased IL‐6 production, which functions as a neuroprotective paracrine, could protect neuronal cells from death by oxidative stress.
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MICROGLIA PROTECT NEURONS AGAINST ISCHEMIA BY SYNTHESIS OF TUMOR NECROSIS FACTOR {#sec2-138}
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### Lambertsen K.L.,^1^ Clausen B.H.,^1^ Babcock A.A.,^1^ Gregersen R.,^1^ Fenger C.,^1^ Nielsen H.H.,^1^ Wirenfeldt M.,^1^ Dagnaes‐Hansen F.,^2^ Bluethmann H.,^3^ Meldgaard M.,^1^ Deierborg T.,^4^ Finsen B.^1^ {#sec3-138}

#### ^1^University of Southern Denmark, Odense C, Denmark; ^2^University of Aarhus, AARHUS, Denmark; ^3^Transgenic Animal Models, Basel, Switzerland; ^4^Lund University, Lund, Sweden {#sec4-138}

Microglia and infiltrating leukocytes are considered major producers of tumor necrosis factor (TNF), which is a crucial player in cerebral ischemia and brain inflammation. We have identified a neuroprotective role for microglial‐derived TNF in cerebral ischemia in mice. We show that cortical infarction and behavioral deficit are significantly exacerbated in TNF‐knock out (KO) mice compared to wildtype mice. By using in situ hybridization, immunohistochemistry and green‐flourescent protein bone marrow (BM)‐chimeric mice, TNF was shown to be produced by microglia and infiltrating leukocytes. Further analysis demonstrating that BM‐chimeric TNF‐KO mice grafted with wildtype BM cells developed larger infarcts than BM‐chimeric wildtype mice grafted with TNF‐KO BM cells provided evidence that the neuroprotective effect of TNF was due to microglial‐ not leukocyte‐derived TNF. In addition, observation of increased infarction in TNF‐p55 receptor (R)‐KO mice compared to TNF‐p75R and wildtype mice suggested that microglial‐derived TNF exerts neuroprotective effects through TNF‐p55R. We finally report that TNF deficiency is associated with reduced microglial population size and Toll‐like receptor 2 expression in unmanipulated brain, which might also influence the neuronal response to injury. Our results identify microglia and microglial‐derived TNF as playing a key role in determining the survival of endangered neurons in cerebral ischemia.
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DETECTION OF MARKERS OF ENDOPLASMIC RETICULUM STRESS IN INFARCTED HUMAN BRAIN AND IN NEWLY‐DEVELOPED IN VITRO MODELS OF OLIGODENDROCYTE ISCHAEMIA {#sec2-139}
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### Kraskiewicz H.,^1^ Ní Mháille A.,^1^ Roemer S.,^2^ Lucchinetti C.,^2^ Fitzgerald U.^1^ {#sec3-139}

#### ^1^National University of Ireland, Galway, Galway, Ireland; ^2^Department of Neurology, Mayo Clinic College of Medicine, Rochester, United States {#sec4-139}

Few therapies exist which can be used successfully in the immediate aftermath of a stroke, with most treatments consisting of 'clot busters'. There is an urgent need to identify other drugs which can reduce early tissue damage and extend the therapeutic 'window' beyond the current period of around 4 hours. The endoplasmic reticulum (ER) stress signalling pathway has been implicated in tissue injury following mid‐ cerebral arterial occlusion in several rodent models of ischaemia. In a single study of post‐mortem human stroke tissue, the Macrae lab in Glasgow detected increased growth arrest and DNA damage 34 protein, a marker of ER stress. Here we expand these studies by presenting immunohistochemical data showing upregulated C/EBP homologous binding protein (CHOP) and X‐box‐binding protein 1 (XBP1) in 4 post‐mortem human stroke tissue samples. These ER stress‐associated markers were detected at all stages of cerebral infarction i.e. acute (n=2), early subacue (n=1) and late subacute (n=1). Highest levels of expression were observed at the infarct penumbra in the earlier stages, with a decrease at later stages. Focusing on oligodendrocyte‐specific effects, in vitro models of oligodendrocyte ischaemia were developed, with the ultimate aim of using these as a 'testing bed' for drugs which modify the ER stress response. Exposure of rat oligodendrocyte precursor cell (OPC) line cultures to cobalt chloride or anti‐mycin A mimicked in vivo effects, in that these treatments caused an induction of markers of hypoxia as well as CHOP, XBP1 and an ER‐resident chaperone glucose‐regulated protein 78, within 4 to 24 hours. To more closely match in vivo conditions, a non‐chemical model based on incubation of OPCs in nutrient‐depleted medium and in a hypoxia chamber with 0.1% oxygen was developed. These conditions also induced markers of hypoxia and activated an ER stress response in treated cells within 4 hours. These data strengthen the case for targeting the ER stress signalling pathway in an effort to develop new early treatments for stroke patients.
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BRAIN INJURY ACTIVATES MICROGLIA THAT INDUCE NEURAL STEM CELL PROLIFERATION AND PROMOTE DIFFERENTIATION OF NEUROSPHERE‐DERIVED CELLS INTO NEURONS AND TO OLIGODENDROCYTES {#sec2-140}
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### Deierborg T., Roybon L., Inacio A.R.L., Pesic J., Brundin P. {#sec3-140}

#### Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Lund, Sweden {#sec4-140}

Brain damage, such as ischemic stroke, enhances proliferation of neural stem/progenitor cells (NSPCs) in the subventricular zone. We have investigated how proliferation of NSPCs changes over time after a lesion in the adult rat brain and studied the effects of microglia derived from an injured brain on NSPCs. To answer that question, we induced brain damage either by experimental stroke or excitotoxic striatal lesions. We isolated NSCPs and analyzed their growth and differentiation when cultured as neurospheres. We found that when we isolated NSCPs during the first 1‐2 weeks following brain injury, they generated more and larger neurospheres than those that we harvested from intact brain. Furthermore, the NSCPs derived from injured brain were more likely to differentiate into neurons and oligodendroglia. In the neurosphere cultures that we generated from injured brains, we observed microglia, which formed a monolayer on the bottom of the culture flasks. When we treated NSPCs with conditioned medium from cultures containing microglia (derived from injured brains) we observed a 10‐fold increase in proliferation of cells in the neurospheres. Our data suggest that following brain injury, such as stroke, activated microglia secrete molecules that regulate the proliferation and differentiation of NSPCs in the subventricular zone.
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A ROLE OF NA+‐K+‐2CL‐ CATION‐CHLORIDE COTRANSPORTERS ON SPINAL PAIN TRANSMISSION {#sec2-141}
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### Yanagidate F.,^1^ He Y.,^2^ Chen G.H.,^1^ Zhang L.,^1^ Kawasaki Y.,^3^ Dohi S.^1^ {#sec3-141}

#### ^1^Gifu University Graduate School of Medicine, GIFU, Japan; ^2^The 2nd Affiliated Hospital of Guangzhou, Guangzhou, China; ^3^Nigata University, Department of Anesthesiology, Niigata, Japan {#sec4-141}

Cation‐chloride cotransporters have been suggested to participate in the modulation of pain transmission at the spinal cord level (Granados‐Sato V et al, Pain, 2005). We examined effects of Na+‐K+‐2Cl‐ cotransporter inhibitor, furosemide, in rat\'s incision model where activation of microglia has been suggested to play a role.

METHODS: We examined pain thresholds of each rat by von Frey filaments for 6 hrs and then once a day until 7 days after the hind paw planter incision. Furosemide was administered intrathecally just before the incision. Rats were terminally anesthetized and perfused transcardially on 4th day after intrathecal furosemide injection. Then the L4‐L5 spinal cord segments and DRGs of each rat were removed, postfixed, and cut for immunohistochemistry. The number of phosphorylated extracellular signal‐regulated kinases (pERK) immunoreactivity (IR) was quantified.

RESULTS: Intrathecal furosemide increased the pain threshold in rats with the planter incision at 20 min, 3 h, 4h, 5h, and on 3 to 7 days. The pERK IR in DRGs of L4 and L5 and spinal cord increased after the incision, and furosemide decreased these changes on 4 days after the incision.

DISCUSSION & CONCLUSION: It is been reported that the incision‐induced activation of microglia on dorsal horn neurons increase with painful stimulation and cation‐chloride cotransporters within glia would affect GABA (Payne J et al, Trends Neurosci, 2003). The present results thus suggest that the effects of intrathecal frosemide observed may be due to activation of GABA which could act to be antinociceptive in incisional pain.

Supported in part by research grants No.19209050 from the Ministry of Education, Science, and Culture of Japan.
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MECHANISMS OF INTERLEUKIN‐1β‐INDUCED GDNF RELEASE FROM RAT GLIOMA CELLS {#sec2-142}
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Glial cell line‐derived neurotrophic factor (GDNF) is highly expressed both in neurons and astrocytes in injured tissues. Astrocytes support neurons by releasing neurotrophic factors including GDNF. It has been reported that various agents including cytokines such as interleukin (IL)‐1β induce GDNF mRNA expression and the release in astrocytes. However, the mechanism behind the GDNF synthesis and release remains unclear. Herein, we investigated the mechanisms of the IL‐1β‐induced GDNF release from rat C6 glioma cells. IL‐1β time dependently stimulated GDNF release from C6 cells. IL‐1β induced the phosphorylation of inhibitor kappa B (IκB), p38 mitogen‐activated protein (MAP) kinase, p44/p42 MAP kinase, stress‐activated protein kinase/c‐Jun N‐terminal kinase (SAPK/JNK) and signal transducer and activator of transcription (STAT) 3. The IL‐1β‐stimulated levels of GDNF were suppressed by wedelolactone, an inhibitor of IκB kinase, SB203580, an inhibitor of p38 MAP kinase, PD98059, an inhibitor of MAP kinase kinase 1/2 or Janus family of tyrosine kinase (JAK) inhibitor, an inhibitor of upstream kinase of STAT3. On the contrary, SP600125, an inhibitor of SAPK/JNK, failed to reduce the IL‐1β‐effect. These results strongly suggest that IL‐1β stimulates GDNF release through the pathways of IκB‐nuclear factor kappa B, p38 MAP kinase, p44/p42 MAP kinase and JAK‐STAT3, but not through the SAPK/JNK pathway in glioma cells.
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SIGNALING PATHWAYS INVOLVED IN NGF‐MEDIATED ANTIAPOPTOTIC EFFECT IN PHOTOSENSITIZED CRAYFISH GLIAL CELLS {#sec2-143}
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#### Southern Federal University, Rostov‐on‐Don, Russian Federation {#sec4-143}

Photodynamic therapy (PDT) is used in neurooncology. It induces oxidative stress that kills cells. However, PDT may damage not only malignant cells, but also healthy neurons and glial cells (GC). Neuroglial interactions mediated by neurotrophins can support survival of neurons and glia in stressful situations. As shown in crayfish stretch receptor that consists of a single neuron surrounded by GC, neurotrophin NGF protects GC but not neurons from PDT‐induced apoptosis and necrosis. In order to study signaling mechanisms involved in NGF‐mediated GC protection, a stretch receptor was photosensitized with alumophthalocyanine Photosens in the presence of 100 ng/ml NGF and inhibitors of some signaling proteins. After next 8 hr it was fluorochromed with propidium iodide and Hoechst 33342 to reveal necrosis and apoptosis. In the present work, tyrosine kinase inhibitor genistein did not influence PDT‐induced death of neurons and GC but prevented the anti‐apoptotic effect of NGF. Thus, tyrosine kinases were involved in NGF‐mediated glia protection. SP600125, a JNK inhibitor enhanced PDT‐induced apoptosis of GC. Hence, JNK showed anti‐apoptotic activity. SP600125 also prevented anti‐apoptotic effect of NGF that suggests JNK involvement in NGF‐mediated protection of GC from PDT‐induced apoptosis. p38 inhibitor SB202190 decreased PDT‐induced GC necrosis indicating p38 involvement in this process. Receptor tyrosine kinases may also initiate the protein kinase B/Akt‐glycogen synthase kinase‐3ß (GSK‐3ß) signaling pathway. Akt inhibition with AktI reduced photoinactivation of neurons as well as necrosis of neurons and GC indicating involvement of Akt in these processes. GSK‐3ß inhibitor TDZD‐8 enhanced PDT‐induced glial apoptosis. Therefore, unlike other cells, PKB/Akt participated in PDT‐induced apoptosis, whereas GSK‐3ß protected glial cells. However, they were not involved in NGF‐mediated GC protection. Thus, tyrosine kinases and protein kinase JNK but not Akt and GSK‐3ß may be involved in the NGF‐mediated anti‐apoptotic signaling cascades in photosensitized GC.

The work was supported by RFBR (grants 05‐04048440 and 08‐04‐01322) and Minobrnauki (grant 2.1.1/6185).
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CHARACTERISTIC RESPONSE OF ASTROCYTES TO PLASMINOGEN TO UPREGULATE TRANSFORMING GROWTH FACTOR BETA 3 (TGFβ3) PRODUCTION/SECRETION THROUGH THE ACTION OF PHOSPHATIDYLINOSITOL 3‐KINASE (PI3K)‐AKT/PKB SIGNALING CASCADE {#sec2-144}
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The effects of microglia‐derived plasminogen (PLGn) on the neurotrophic role of astrocytes were investigated in vitro. The treatment of astrocytes with rat PLGn led to a significant increase in transforming growth factor beta3 (TGFÎ^2^3) in the conditioned medium (CM). This response of astrocytes to PLGn was characteristic and different from that to other stimulators, including lipopolysaccharide, phorbol‐12‐myristate‐13‐acetate, interferon‐gamma, and ATP. In surveying signaling molecules that responds to PLGn in astrocytes, we found that phosphorylation of Akt/PKB is promoted. The pretreatment of astrocytes with an Akt inhibitor prior to PLGn stimulation resulted in a significant decrease in Akt phosphorylation as well as TGFÎ^2^3 amounts in the CM, suggesting an association of Akt with the signaling cascade leading to TGFÎ^2^3 production/secretion. Further survey of other signaling molecules by using various inhibitors revealed that phosphatidylinositol 3 kinase (PI3K) activity is closely associated with TGFÎ^2^3 production/secretion in astrocytes. In fact, PI3K inhibitor clearly depressed the phosphorylation of Akt, indicating that PI3K is localized upstream of Akt. These results suggest that PLGn facilitates the production/secretion of TGFÎ^2^3 in astrocytes through a signaling cascade including PI3K and Akt.
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TRANSCRIPTIONAL AND POST‐TRANSCRIPTIONAL REGULATIONS OF P2X4 RECEPTOR UPREGULATION IN FIBRONECTIN‐STIMULATED MICROGLIA {#sec2-145}
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Microglia are resident immune cells in the CNS that become activated and produce pro‐inflammatory and neurotrophic factors upon activation of various cell‐surface receptors. The P2X4 receptor (P2X4R) is a subtype of the purinergic ion‐channel receptors expressed in microglia. P2X4R expression is upregulated under inflammatory or neurodegenerative conditions and this upregulation is implicated in disease pathology. However, the molecular mechanism underlying upregulation of P2X4R in microglia remains unknown. In the present study, we investigated the intracellular signal transduction pathway that promotes P2X4R expression in microglia in response to fibronectin, an extracellular matrix protein that has previously been shown to stimulate P2X4R expression. We found that in fibronectin‐stimulated microglia, activation of phosphatidylinositol 3‐kinase (PI3K)‐Akt and mitogen‐activated protein kinase kinase (MAPK kinase, MEK)‐extracellular signal‐regulated kinase (ERK) signaling cascades occurred divergently downstream of Src‐family kinases (SFKs). Pharmacological interference of PI3K‐Akt signaling inhibited fibronectin‐induced P2X4R gene expression. Activation of PI3K‐Akt signaling resulted in a decrease in the protein level of the transcription factor p53 via mouse double minute 2 (MDM2), an effect that was prevented by MG‐132, an inhibitor of the proteasome. In microglia pretreated with MG‐132, fibronectin failed to upregulate P2X4R expression. Conversely, an inhibitor of p53 caused increased expression of P2X4R, implying a negative regulatory role of p53. On the other hand, inhibiting MEK‐ERK signaling activated by fibronectin suppressed an increase in P2X4R protein but, interestingly, did not affect the level of P2X4R mRNA. We also found that fibronectin stimulation resulted in the activation of the translational factor eIF4E via MAPK‐interacting protein kinase‐1 (MNK1) in a MEK‐ERK signaling‐dependent manner, and an MNK1 inhibitor attenuated the increase in P2X4R protein. Together, these results suggest that the PI3K‐Akt and MEK‐ERK signaling cascades have distinct roles in the upregulation of P2X4R expression in microglia at transcriptional and post‐transcriptional levels, respectively.
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25‐HYDROXYCHOLESTEROL PROVOKES OLIGODENDROCYTE CELL LINE APOPTOSIS AND STIMULATES THE SECRETED PHOSPHOLIPASE A2 TYPE IIA VIA LXR BETA AND PXR {#sec2-146}
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In several neurodegenerative diseases of the central nervous system, oligodendrocytes are implicated in an inflammatory process associated with altered levels of oxysterols and of inflammatory enzymes, such as secreted phospholipase A2 (sPLA2). In view of the scarce literature related to this topic, we investigated oxysterol effects on these myelinating glial cells. Natural oxysterol 25‐hydroxycholesterol (25OH) altered oligodendrocyte cell line (158N) morphology and triggered apoptosis (75% of apoptosis after 72h). These effects were mimicked by 22(S)‐hydroxycholesterol (1 and 10 μM), which does not activate Liver‐X‐Receptor (LXR), but not by a synthetic LXR‐ligand (T0901317). Therefore, oxysterol‐induced apoptosis appears to be independent of LXR. Interestingly, sPLA2 type IIA (sPLA2‐IIA) overexpression partially rescued 158N cells from oxysterol‐induced apoptosis. In fact, 25OH, 24S‐hydroxycholesterol and T0901317 stimulated sPLA2‐IIA promoter and sPLA2 activity in oligodendrocyte cell line. Accordingly, administration of T0901317 to mice enhanced by two‐fold sPLA2 activity in brain extracts. siRNA strategy allowed to establish that stimulation of sPLA2‐IIA is mediated by Pregnane X receptor (PXR) at high oxysterol concentration (10 μM) and by LXR β at basal oxysterol concentration. Finally, gas chromatography coupled to mass spectrometry established that oligodendrocytes contain oxysterols and express their biosynthetic enzymes, suggesting that they may act through autocrine/paracrine mechanism. Our results show the diversity of oxysterol signalling in the CNS and highlight the positive effects of the LXR/PXR pathway which may open new perspectives in the treatment of demyelinating and neurodegenerative diseases.
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FIBRIN AND FIBRINOGEN CAUSE NEURON NON‐CELL AUTONOMOUS DEGENERATION {#sec2-147}
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### Piers T.M., East E., Pocock J.M. {#sec3-147}
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Microglia are the resident immune cells of the central nervous system (CNS), patrolling the parenchyma returning homeostasis to imbalanced areas via phagocytosis. Excessive microglial activation has been implicated as a causal factor of neuroinflammation and neurodegeneration via persistent release of pro‐inflammatory factors (Gao et al. 2003). Blood brain barrier (BBB) disruption observed in chronic neurological disorders allows influx of blood‐borne proteins including fibrinogen into the CNS parenchyma resulting in deposition of fibrin, implicated in neuroinflammation (Paul et al. 2007). The blood protein influx has been targeted as a potential cause of excessive activation of microglia leading to neurodegenerative signalling cascades and disease progression (Hooper et al. 2009). Here direct exposure of fibrinogen to cerebellar granule cell (CGC) cultures caused significant neuronal death within 24 hours. However an increase in neuronal death after fibrin stimulation was only observed after 48 hours, comparable with the classic microglial activator lipopolysaccharide (LPS). Fibrinogen also has potential as an indirect neurotoxin as it produced an activated microglia phenotype. Supporting this, we show fibrinogen conditioned microglia medium caused extensive CGC death to a level comparable with fibrin or LPS. There was also significant induction of pro‐inflammatory factors from both primary microglia and CGC cultures after exposure to fibrin or fibrinogen. The increase of these factors in CGC cultures was attributed to microglia because leucine methyl ester (LME) depletion of microglia significantly attenuated the response. We propose that both fibrin and fibrinogen have the potential to cause indirect neurotoxicity via a microglia mediated pathway involving pro‐inflammatory factors, but only fibrinogen is directly neurotoxic.
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CALCIUM SIGNALING IN OLFACTORY ENSHEATHING CELLS OF THE DEVELOPING MOUSE OLFACTORY BULB {#sec2-148}
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Olfactory ensheathing cells (OECs) are unique glial cells in the olfactory nerve responsible for the regeneration and guidance of mammalian olfactory axons. The growth promoting properties of OECs appear to be substantially influenced by calcium signaling. We therefore focussed on characteristics of calcium signaling of OECs. Here we present our results from lifetime calcium imaging performed on intact isolated olfactory bulb of postnatal mice (P0‐P7). Two different subtypes of OECs exist in the olfactory nerve: OECs of the outer nerve layer responded to ATP and glutamate released by the olfactory axons upon electrical stimulation. OECs of the inner nerve layer did not evoke calcium signals by ATP, glutamate or electrical stimulation, but were found to develop spontaneous intercellular calcium waves comprising hundreds of OECs. The calcium waves were inhibited by the gap junction blockers carbenoxolon and meclofenamic acid -- a strong indication for calcium wave propagation via gap junctions. However, the waves were not eliminated by the application of tetrodotoxin (TTX). Thus, no support for a direct neuronal influence on these OECs could be obtained. After depletion of the endoplasmic reticulum with cyclopiazonic acid (CPA), the waves disappeared immediately, whereas withdrawal of external calcium had no effect, indicating that calcium from internal stores is required for generating the waves. Both populations of OECs exhibited store‐operated calcium entry (SOCE), a mechanism employed to refill intracellular calcium stores after depletion. SOCE in OECs could be blocked by the SOC channel blocker 2‐APB. Our findings demonstrate the existence of SOCE in OECs as well as spontaneous intercellular calcium waves in the inner OECs mediated by internal calcium release and gap‐junctional coupling.

Supported by DFG Research Training Group GRK 845.
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NEUROTRANSMITTER MODULATION OF SUPEROXIDE PRODUCTION IN MICROGLIA {#sec2-149}
-----------------------------------------------------------------

### Mead E.L., Pocock J.M. {#sec3-149}

#### Institute of Neurology, UCL, London, United Kingdom {#sec4-149}

Microglia, the immune cells of the CNS, are implicated in the production of reactive oxygen species (ROS). Microglia express inducible nitric oxide synthase (iNOS) involved in the production of nitric oxide (NO), and NADPH oxidase which produces superoxide. Both iNOS and NADPH oxidase activities are required for the production of peroxynitrite, a neurotoxic ROS implicated in neurodegeneration. There are five NADPH oxidase isoforms, of which the predominant ROS producing isoform in microglia is believed to be Nox2, which is activated by phosphorylation and translocation of the cytoplasmic p47phox and p67phox subunits to the plasma membrane, where they associate with the catalytic subunits gp91phox/p22phox. There is limited data to suggest that the constitutively expressed isoform Nox1 may also be implicated in the production of intracellular ROS in microglia. Nox1 activation is regulated by the phosphorylation and binding of NOXA1 and NOXO1 to the catalytic Nox1 subunit.

In Microglia it is thought that Nox1 and Nox2 have distinct cellular functions. Here we have show that in the BV2 microglial cell line Nox1 is implicated in the production of intracellular superoxide, which was measured by the reduction of nitro‐blue tetrazolium chloride (NBT) to an insoluble blue formazan precipitate. Stimulation of the BV2 microglia by different cytokines or excitatory and inhibitory neurotransmitters modulated superoxide production in the cells. However, Nox1 protein levels were not affected, whereas mRNA levels were increased. Furthermore, in BV2 cells Nox2 mRNA expression was reduced by neurotransmitter stimulation.

These studies suggest that Nox1 is implicated in intracellular superoxide production in microglia and BV2 cells, and also suggests that Nox1 and Nox2 may be regulated through distinct signalling pathways mediated by both cytokines and neurotransmitters, which may have important implications in different neuropathologies.
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REGULATION OF EXOCYTOTIC PROTEIN EXPRESSION AND CA2+‐DEPENDENT PEPTIDE SECRETION IN ASTROCYTES {#sec2-150}
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### Paco S.,^1^ Margelí M.A.,^1^ Olkkonen V.M.,^2^ Imai A.,^3^ Blasi J.,^4^ Fischer‐Colbrie R.,^5^ Aguado F.^1^ {#sec3-150}

#### ^1^University of Barcelona, Barcelona, Spain; ^2^University of Helsinki, Helsinki, Finland; ^3^The Nippon Dental University, Niigata, Japan; ^4^IDIBELL‐University of Barcelona, Barcelona, Spain; ^5^Medical University of Innsbruck, Innsbruck, Austria {#sec4-150}

Vesicular transmitter release from astrocytes influences neuronal development, function and plasticity. However, secretory pathways and the involved molecular mechanisms in astroglial cells are poorly known. In this study we show that a variety of SNARE and Munc18 isoforms are expressed by cultured astrocytes, with syntaxin‐4, Munc18c, SNAP‐23 and VAMP‐3 being the most abundant variants. Exocytotic protein expression was differentially regulated by activating and differentiating agents. Specifically, proteins controlling Ca^2+^ ‐dependent secretion in neuroendocrine cells were upregulated after long‐term 8Br‐cAMP administration in astrocytes, but not by proinflammatory cytokines. Moreover, 8Br‐cAMP treatment greatly increased the cellular content of the peptidic vesicle marker secretogranin‐2. Release assays performed on cAMP‐treated astrocytes showed that basal and stimulated secretogranin‐2 secretion are dependent on \[Ca^2+^\]~i~. As shown release of the chimeric hormone ANP.emd from transfected cells, cAMP‐induced differentiation in astrocytes enhances Ca^2+^‐regulated peptide secretion. We conclude that astroglial cells display distinctive molecular components for exocytosis. Moreover, the regulation of both exocytotic protein expression and Ca^2+^‐dependent peptide secretion in astrocytes by differentiating and activating agents suggest that glial secretory pathways are adjusted in different physiological states.
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PRION PROTEIN AND STRESS INDUCIBLE PROTEIN 1 MODULATE ASTROCYTE DEVELOPMENT {#sec2-151}
---------------------------------------------------------------------------

### Lima F.R.S.,^1^ Arantes C.P.,^2^ Nomizo R.,^3^ Lopes M.M.,^4^ Hajj G.N.,^4^ Martins V.R.^4^ {#sec3-151}

#### ^1^Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; ^2^Departamento de Bioquímica, Instituto de Química da Universidade de São Paulo, São Paulo, Brazil; ^3^Centro de Tratamento e Pesquisa Hospital A. C. Camargo, São Paulo, Brazil; ^4^Ludwig Institute for Cancer Research Hospital Alemão Oswaldo Cruz, São Paulo, Brazil {#sec4-151}

Prion protein (PrPC) interaction with stress inducible protein 1 (STI1) mediates neuronal survival and differentiation. However, the function of PrPC in astrocytes has not been approached. In this study, we show that STI1 prevents cell death in wild‐type astrocytes in a protein kinase A‐dependent manner while PrPC‐null astrocytes were not affected by STI1 treatment. Remarkably, STI1 inhibits proliferation of both wild‐type and PrPC‐null astrocytes in a protein kinase C‐dependent manner. At embryonic day 17, PrPC‐null astrocytes treated with STI1 do not differentiate from a flat to a process‐bearing morphology, as do wild‐type astrocytes. Furthermore, astrocytes and brain extracts derived from PrPC‐null mice show reduced expression of glial fibrillary acidic protein (GFAP) and increased vimentin and nestin expression when compared to wild‐type, suggesting slower astrocyte maturation in PrPC‐null animals. Conversely, astrocytes and brain extracts derived from prion protein‐over expressing mice (Tg20) show increased expression of GFAP and reduced vimentin and nestin expression when compared to wild‐type, indicating faster maturation of astrocytes in Tg20 animals. Taken together, our data show that PrPC and STI1 are essential to astrocyte development, and act through distinct signaling pathways.
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FM DYE AS A MULTI‐ROLE MODULATOR OF ASTROCYTE STORE‐OPERATED CHANNELS {#sec2-152}
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### Li D., Oheim M., Herault K., Ropert N. {#sec3-152}

#### INSERM U603 ‐ CNRS UMR8154, Paris, France {#sec4-152}

Astrocytic calcium (Ca^2+^) excitability predominantly relies on the mobilization of Ca^2+^ from intracellular Ca^2+^ stores and the subsequent Ca^2+^ influx through store‐operated Ca^2+^ channels (SOCs). Modulating or interfering with astrocyte SOC activity inevitably alters the bi‐phasic Ca^2+^ signals typical for astrocytic signaling. The styryl FM dyes are amphiphilic molecules capable of reversibly partitioning in the lipid membrane. Their cationically charged pyridinium head prevents the dyes from diffusing through the plasma membrane in many types of neuronal cells. By these properties, FM dyes have been extensively used to selectively label cycling synaptic vesicles in an activity‐dependent way. Recently, however, we found that astrocyte FM uptake occurs in an activity‐independent manner. Here, we provide mechanistic evidence that the styryl pyridinium dye FM4‐64, upon its insertion in the plasma membrane, facilitates the opening of astroglial SOCs whereby it penetrates through the channel pore, leading to a non‐endocytic uptake and non‐vesicular labeling. Strikingly, using dual‐color total internal reflection fluorescence microscopy (TIRFM) to simultaneously monitor the FM dye uptake and the membrane‐proximal \[Ca^2+^\]~i~ signaling, we show that FM dye entry releases Ca^2+^ from endoplasmic reticulum stores, suggesting a positive feed‐back signal that maintains SOCs activated and drives a sustained FM dye uptake. The unexpected channel‐mediated astrocytic uptake of the synaptic vesicle marker FM4‐64 highlights the fundamental difference of the sub‐cellular mechanism underlying FM dye handling between astroglia and neurons. Demonstrating FM4‐64 as a polyvalent modulator of astroglial SOCs, this study sets the framework for knowing and using to an advantage the action of FM on astroglial SOCs for modulating and imaging store‐operated channel activity.
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AMMONIA ALTERS MGLUR‐MEDIATED CALCIUM SIGNALING IN HIPPOCAMPAL ASTROCYTES AND NEURONS IN SITU {#sec2-153}
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### Steiner T., Kelly T., Walz C., Rose C.R. {#sec3-153}

#### Institute for Neurobiology, Heinrich‐Heine‐University, Duesseldorf, Germany {#sec4-153}

Glutamate is the main excitatory transmitter in the brain. Its synaptic release evokes intracellular calcium signals which contribute to neurotransmission and synaptic plasticity. Neuronal calcium signals involve activation of ionotropic and metabotropic (mGluR) glutamate receptors, as well as voltage‐gated calcium channels, whereas calcium signals in astrocytes are mainly attributed to activation of PLC‐coupled mGluR1 and mGluR5. In patients with hepatic encephalopathy (HE), a reduction in excitatory neurotransmission has been reported, and was attributed to increases in brain ammonium (NH~4~ ^+^/NH~3~) concentrations. However, the mechanisms by which NH~4~ ^+/^NH~3~ affects glutamatergic neurotransmission are not understood in detail. In the present study, we examined the effects of NH~4~ ^+^/NH~3~ on calcium signaling induced by synaptic stimulation and glutamate receptor activation in neurons and astrocytes.

Calcium transients were measured using Ca^2+^ sensitive fluorescence dyes in CA1 pyramidal neurons and astrocytes of acute hippocampal slices from 20‐22 postnatal days old mice. Passive astrocytes were identified using the fluorescent marker SR101. Addition of 5 mM NH~4~ ^+/^NH~3~ reduced Ca^2+^ transients elicited by synaptic stimulation of Schaffer colleterals in neurons by 55% and in astrocytes by 95%. Also neuronal field potentials were reduced by about 60%. To identify specific GluR involved in synaptically induced Ca^2+^ signals altered by ammonia, we focally applied glutamate receptor agonists. Under control conditions, DHPG (3,5‐Dihydroxyphenylglycin), a selective agonist for mGluR1 and mGluR5, induced transient increases in Ca^2+^ in neurons and astrocytes. Ammonia reduced DHPG‐induced Ca^2+^ transients in both neurons and astrocytes by around 50%. Similarly, NH~4~ ^+^/NH~3~ reduced Ca^2+^ transients mediated by ADP/ATP, which act via metabotropic purinergic receptors. In contrast, Ca^2+^ transients elicited by ionotropic glutamate receptor agonists were not reduced by NH~4~ ^+^/NH~3~.

Taken together, our results demonstrate that NH~4~ ^+^/NH~3~ inhibits intracellular calcium signaling via metabotropic receptors in hippocampal neurons and astrocytes. This inhibition may contribute to the deficits in glutamate transmission observed during HE.

Supported by the DFG (SFB 575, TPC7).

P‐154 {#sec1-154}
=====

CELL DEATH COMMUNICATION VIA CONNEXIN CHANNELS INVESTIGATED IN A C6 GLIOMA CELL MODEL {#sec2-154}
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### Decrock E.,^1^ Van Moorhem M.,^1^ de Vuyst E.,^1^ Wang N.,^1^ de Bock M.,^1^ Vinken M.,^2^ Rogiers V.,^2^ Naus C.C.,^3^ Erneux C.,^2^ Leybaert L.^1^ {#sec3-154}

#### ^1^Ghent University, Ghent, Belgium; ^2^Vrije Universiteit Brussel, Brussels, Belgium; ^3^University of British Columbia, Vancouver, Canada {#sec4-154}

A characteristic feature of astrocytes is their high level of intercellular communication mediated by connexin (Cx) channels, i.e. gap junction channels (GJs) connecting the cytoplasm of adjacent cells and hemichannels (hemi‐GJs) forming a paracrine conduit between the cytoplasm and the extracellular environment. This type of network organization is not only of major importance for their neuronal supportive function but may have detrimental consequences as well, contributing to exacerbation of injury. GJs have been demonstrated to communicate cell death signals from apoptotic to healthy cells, thereby spatially extending apoptosis. Before being incorporated into GJs, hemichannels are normally closed but recent evidence suggests they can be opened by various messengers and conditions, thereby forming a pore through which molecules can enter or leave the cell potentially leading to cell death. The present study was set up to determine the contribution of both Cx channels in the communication of apoptosis towards surrounding cells.

We used an *in situ* electroporation technique to load a localized area of an adherent C6 glioma cell culture, stably transfected with Cx43 (C6Cx43), with the apoptotic agent Cytochrome C (CytC) and found that healthy surrounding cells underwent apoptotic transformation as evidenced by various cell death markers. Further work with wild type cells, inhibitors of GJs and/or hemichannels and Cx43 gene silencing showed that GJs contribute to the spread of apoptosis in a zone next to where apoptosis was triggered while hemichannels also promoted cell death beyond this area. Application of the cell permeable calcium chelator BAPTA‐AM and electroporation loading of an inositol trisphosphate (IP~3~) degrading phosphatase reduced the cell death mediated by GJs as well as hemichannels, suggesting that calcium and IP~3~ are involved in both processes.

We conclude that Cx43 hemichannels can function as an entry route or a leakage pore for pro‐apoptotic messengers, thereby playing a role in communicating apoptotic cell death messages in concert with their GJ counterparts.

P‐155 {#sec1-155}
=====

CALCIUM REGULATION OF CONNEXIN‐43 HEMICHANNEL‐MEDIATED ATP RELEASE IN GLIAL CELLS {#sec2-155}
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### de Vuyst E.,^1^ de Bock M.,^1^ Wang N.,^1^ Decrock E.,^1^ Vinken M.,^2^ Van Moorhem M.,^1^ Rogiers V.,^2^ Naus C.C.,^3^ Evans W.H.,^4^ Leybaert L.^1^ {#sec3-155}

#### ^1^Ghent University, Ghent, Belgium; ^2^Vrije Universiteit Brussel, Brussels, Belgium; ^3^University of British Columbia, Vancouver, Canada; ^4^Cardiff University School of Medicine, Cardiff, United Kingdom {#sec4-155}

Connexin (Cx) hemichannels are closed before being incorporated into gap junctions but can be opened by various stimuli, thereby forming a release pathway for small paracrine messengers. Here, we investigated hemichannel‐mediated ATP release in response to changes of intracellular Ca^2+^ (\[Ca^2+^\]~i~) making use of C6 glioma cells stably transfected with Cx43 and primary glial cells isolated from rat cortex. The involvement of hemichannels was studied with gja1 gene silencing experiments and the exclusion of other release mechanisms. Hemichannel‐related ATP responses appeared when \[Ca^2+^\]~i~ changes, brought about by exposure of the cells to the Ca^2+^ ionophore A23187, were in the 500 nM range while these responses disappeared with larger \[Ca^2+^\]~i~ transients. Ca^2+^‐triggered responses induced by A23187 and also glutamate activated a cascade sequentially involving calmodulin (CaM), calmodulin‐dependent kinase II (CaMK‐II), p38 mitogen activated kinase (MAPK), arachidonic acid (AA), reactive oxygen species (ROS) and NO. This cascade was also activated by stimulation at intermediate points such as activation of CaM with the Ca^2+^‐like peptide (CALP1) or exogenous application of AA, and was also operational in primary glial cell cultures (astrocytes in majority) isolated from rat cortex. The disappearance of hemichannel responses with high \[Ca^2+^\]~i~ was independent of CaM signaling. We conclude that ATP release via Cx43 hemichannels can be invoked by \[Ca^2+^\]~i~ via an intermediate signaling axis that is combined with distinct OFF‐mechanisms that help to limit and control the release process.
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GLYCINE AND L‐SERINE ENHANCE MICROGLIAL CALCIUM FLUXES: A POSSIBLE ROLE FOR NEUTRAL AMINO ACID TRANSPORTERS {#sec2-156}
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### Van Den Eynden J., Notelaers K., Sahebali S., Nelissen K., Smolders I., Brône B., Rigo J.M. {#sec3-156}

#### Hasselt University, Diepenbeek, Belgium {#sec4-156}

Microglial cells are considered as the macrophages of the brain. Besides this immune function, recent data suggest an important role in neuronal development and synaptogenesis, as well as in different neuropathologies.

Glycine is best known as the main neurotransmitter mediating fast inhibitory neurotransmission in the caudal part of the central nervous system. Glycine has also been proposed as an immunomodulatory signal for various immune cells. Several studies suggested that this modulation is dependent on glycine receptors (GlyRs), in general causing an inhibition of immune function. In microglia, it has been shown that astrocyte‐derived glycine modulates microglial activity, although the mechanism is unknown. Our previous work showed that these modulating glycine effects were in fact GlyR‐independent. The aim of this study was to study whether these effects were correlated with changes in calcium signalling, and, if so, to further elucidate the mechanism behind these effects.

Two in vitro models were used: the mouse microglial BV‐2 cell line and primary microglial cultures derived from newborn rats.

Calcium fluxes were induced by ATP and thapsigargin and were measured in a fluorescent plate reader with the calcium indicator Fluo‐3. We found a clear enhancement of calcium fluxes in millimolar concentrations of glycine or L‐serine. This enhancement could be detected after a short time incubation with glycine or L‐serine, arguing against a metabolic mechanism. The effects were not blocked by strychnine, confirming GlyR independency. AIB (2‐amino‐isobutyric acid), a blocker of neutral amino acid transporters could dose‐dependently block the effects, suggesting that uptake of these amino acids is at least part of the process.

By means of glycine immunolabelling and confocal microscopy we could confirm extensive glycine uptake under our experimental conditions.

This study shows that the enhancing effects of glycine and L‐serine on microglial activity are correlated with GlyR‐independent enhancements of calcium fluxes. We hypothesise that these amino acids are taken up by microglial cells and somehow activate intracellular signalling cascades. Further research is necessary to unravel the precise mechanism.
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GABA TRANSPORT‐MEDIATED CALCIUM SIGNALING IN OLFACTORY BULB ASTROCYTES {#sec2-157}
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### Doengi M.,^1^ Coulon P.,^1^ Pape H.C.,^1^ Deitmer J.W.,^2^ Lohr C.^1^ {#sec3-157}

#### ^1^University of Muenster, Muenster, Germany; ^2^University of Kaiserslautern, Kaiserslautern, Germany {#sec4-157}

The communication between neurons and glial cells plays an important role in developmental and regenerative processes as well as in information processing. This takes place, for example, in the glomerular layer of the olfactory bulb, the first relaystation of olfactory information processing. Since GABAergic signaling plays a crucial role in olfactory information processing, we studied the mechanism of GABA‐induced signaling in astrocytes of olfactory bulb slices using confocal Ca^2+^ imaging and 2‐photon Na^+^ imaging. GABA evoked Ca^2+^ transients and Na^+^ transients in astrocytes that persisted in the presence of GABA~A~ and GABA~B~ receptor antagonists, but were greatly reduced by inhibition of GABA uptake by SNAP 5114. GABA uptake‐mediated Na^+^ rises might reduce Na^+^/Ca2^+^ exchange, thereby leading to intracellular Ca^2+^ transients. To test the effect of reduced Na^+^/Ca^2+^ exchange on Ca^2+^ signaling, we used the Na^+^/Ca^2+^ exchange inhibitor KB‐R7943. Application of KB‐R7943 mimicked GABA‐induced Ca^2+^ signaling. Withdrawal of external Ca^2+^ entirely suppressed GABA‐induced Ca^2+^ transients, and depletion of intracellular Ca^2+^ stores with cyclopiazonic acid reduced the Ca^2+^ transients by approximately 90%. This indicates that the Ca^2+^ transients depend on external Ca^2+^, but are mainly mediated by intracellular Ca^2+^ release, in line with Ca^2+^‐induced Ca^2+^ release. Neither activation nor inhibition of ryanodine receptors affected basal Ca^2+^ or GABA‐induced Ca^2+^ transients, whereas the InsP~3~ receptor blocker 2‐APB inhibited the Ca^2+^ transients. The results suggest a novel mechanism of GABAergic signaling, composed of GABA uptake‐mediated Na^+^ rises that reduce Na^+^/Ca^2+^ exchange efficacy, thereby leading to a small Ca^2+^ increase sufficient to trigger Ca^2+^‐induced Ca^2+^ release via InsP~3~ receptors.

Supported by DFG LO779 and SFB 530 TPB1.
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QUANTITATIVE PROTEOMICS YIELDS INSIGHTS INTO THE REGULATION OF CONNEXIN43 BY THE UBIQUITIN PROTEASOME SYSTEM {#sec2-158}
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### Chen V.C., Foster L.J., Naus C.C. {#sec3-158}

#### University of British Columbia, Vancouver, Canada {#sec4-158}

The aberrant expression of the gap junction protein connexin43 (Cx43) is associated with a range of debilitating pathologies including the propagation of stroke damage and the progression of malignant tumors. Using quantitative Cx43 co‐immunoprecipiation, peptide‐level dimethylation and LC‐MS/MS, we have identified components of the ubiquitin‐proteasome system (UPS), a regulatory network implicated in the trafficking and degradation of ion channels and membrane receptors. Amongst the proteins found to associate with Cx43 at gap junction in C6 cells and primary mouse astrocytes, we have identified ring finger protein TRIM, ubiquitin, and unexpectedly, lid components of the (26s) proteasome. Serving as further evidence, we additionally identified the specific sites of Cx43 ubiquitylation and associated K48‐linked polyubiquitin chains, which we speculate serves to regulate the intracellular localization and retrograde turnover of the gap junction protein. Findings presented within this study provide mechanistic insights into the post‐translational regulation and trafficking of the gap junction protein, and more generally will serve as a foundation for future investigations related to aberrant levels of Cx43 in a variety of diseases.

Funded by a grant from the Canadian Institutes of Health Research; V.C.C. holds a Heart & Stroke Foundation of Canada (Post‐doctoral) Junior Personal Award; L.J.F. holds a Canada Research Chair in Organellar Proteomics; C.C.N. holds a Canada Research Chair in Gap Junctions and Disease.
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SPONTANEOUS GLIAL CALCIUM WAVES IN THE RETINA INCREASE WITH AGE {#sec2-159}
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### Kurthnelson Z., Mishra A., Newman E.A. {#sec3-159}

#### University of Minnesota, Minneapolis, United States {#sec4-159}

Intercellular glial Ca^2+^ waves constitute a signaling pathway between glial cells. Artificial stimuli have previously been used to evoke these waves, and their physiological significance has been questioned. We report here that Ca^2+^ waves occur spontaneously in retinal glial cells, both in the isolated retina and in vivo. These spontaneous waves are propagated by ATP release. In the isolated retina, suramin (a P2 receptor antagonist) reduces the frequency of spontaneous waves by 53 percent, and apyrase (an ATP‐hydrolyzing enzyme) reduces wave frequency by 95 percent. Luciferin/luciferase chemiluminescence reveals waves of ATP matching the spontaneous Ca^2+^ waves, indicating that ATP release occurs as spontaneous Ca^2+^ waves are generated. In rats aged 20 days, spontaneous waves occur at a frequency of 0.3 per minute per mm^2^, while in rats aged 120 days, the rate is increased to 1.0 per minute per mm^2^. ATP sensitivity does not increase with age, but the ATP released by evoked waves is 31 percent greater in 120 day old than in 20 day old rats, suggesting that increased ATP release in older animals could account for the higher frequency of wave generation. Simultaneous imaging of glial Ca^2+^ and blood vessels in the isolated retina shows that spontaneous waves cause constrictions in arterioles. Spontaneous intercellular glial Ca^2+^ waves also occur in the retina in vivo, with frequency, speed and diameter similar to waves observed in the isolated retina. Our finding that spontaneous wave occurrence increases with age suggests that wave generation may be related to retinal pathology. Spontaneous Ca^2+^ waves may have a significant impact on retinal physiology as they alter arteriole diameter.
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AMPA receptor stimulation of glia as a mechanism for D‐serine release in the retina {#sec2-160}
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### Sullivan S., Miller R.F. {#sec3-160}

#### University of Minnesota, Minneapolis, United States {#sec4-160}

NMDA receptor activation requires glutamate as well as a coagonist, either glycine or D‐serine. Since the discovery of D‐serine in the nervous system, it has been shown to be primarily localized to astrocytes along with its synthetic enzyme serine racemase, and D‐serine release has been observed in cultured astrocytes. In the retina, D‐serine and serine racemase are colocalized in astrocytes and Müller cells (the principal retinal glia cell), and evidence suggests that D‐serine is the primary coagonist utilized by retinal ganglion cell NMDA receptors. Electrophysiological experiments have shown that light stimulation of the retina can evoke coagonist release, but whether retinal stimulation can specifically cause D‐serine release remains to be elucidated. Here we show that AMPA receptor stimulation of the isolated retina causes D‐serine release and also evokes Ca^2+^ increases in Müller cells. AMPA induced D‐serine release and Müller cell Ca^2+^ increases were partially dependent on Ca^2+^ permeable AMPA receptors and persisted in the absence of neural activity. Collectively, these findings allude to a model where light‐induced glutamate release from bipolar cells could evoke AMPA receptor dependent D‐serine release from Müller cells, which in turn could modulate retinal ganglion cell activity.
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CONNEXIN43 IS INVOLVED IN THE EFFECT OF ENDOTHELIN‐1 ON ASTROCYTE PROLIFERATION AND GLUCOSE UPTAKE {#sec2-161}
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### Herrero‐González S.,^1^ Valle‐Casuso J.C.,^1^ Sanchez‐Alvarez R.,^1^ Giaume C.,^2^ Medina J.M.,^1^ Tabernero A.^1^ {#sec3-161}

#### ^1^Instituto de Neurociencias de Castilla y León (INCYL), Salamanca, Spain; ^2^INSERM U840, Collège de France, Paris, France {#sec4-161}

In previous studies, we showed that endothelin‐1 (ET‐1) increased astrocyte proliferation and glucose uptake. These effects were similar to those observed with other gap junctions inhibitors, such as carbenoxolone (CBX). Because 24‐h treatment with ET‐1 or CBX downregulates the expression of connexin43 (Cx43), the main protein forming astrocytic gap junctions, which can also be involved in proliferation, in this study, we addressed the possible role of Cx43 in the effects of ET‐1. To do so, Cx43 was silenced in astrocytes by siRNA. The knock down of Cx43 increased the rate of glucose uptake, characterized by the upregulation of GLUT‐1 and type I hexokinase. Neither ET‐1 nor CBX were able to further increase the rate of glucose uptake in Cx43‐silenced astrocytes. In agreement, no effects of ET‐1 and CBX on GLUT‐1 and type I hexokinase were observed in Cx43 silenced astrocytes or in astrocytes from Cx43 knock‐out (KO) mice. Our previous studies suggested a close relationship between glucose uptake and astrocyte proliferation. Consistent with this, Cx43‐silenced astrocytes exhibited and increase in Ki‐67, a marker of proliferation. The effects of ET‐1 on retinoblastoma phosphorylation on Ser780 and on the upregulation of cyclins D1 and D3 were affected by the levels of Cx43. In conclusion, our results indicate that Cx43 participates in the effects of ET‐1 on glucose uptake and proliferation in astrocytes. Interestingly, although the rate of growth in Cx43 KO astrocytes has been reported to be reduced, we observed that an acute reduction in Cx43 by siRNA increased proliferation and glucose uptake.
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AGONIST‐INDUCED INHIBITION OF GAP JUNCTIONAL COMMUNICATION IN ASTROCYTES: CX43 DEPHOSPHORYLATION AND PARTNERSHIP {#sec2-162}
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### Tence M., Ezan P., Amigou E., Giaume C. {#sec3-162}

#### INSERM U840, Paris, France {#sec4-162}

Astrocytes are extensively coupled together by gap junctional communication (GJC). This intercellular communication, which in culture is mostly mediated by Cx43 channels, allows the propagation at a distance of signals critical for neuronal activity and survival and constitutes the basis for a coordinated action of astrocytes. GJC is a highly regulated process that is altered in pathological situations. We have previously shown that sphingosine‐1‐phosphate (S1P) and endothelin‐1 (ET‐1), two mediators that increase in brain at sites of injury and inflammation, induced in a few minutes a strong inhibition of GJC in cultured astrocytes. Here, we have studied the molecular mechanisms involved in these effects. For this purpose, we used the scrape‐loading dye transfer technique, immunocytochemistry/confocal microscopy and immunoprecipitation approaches. We found that for both S1P and ET‐1, activation of Gi‐mediated signalling pathway(s) is a prerequisite step for inhibition. This inhibition is accompanied by a dephosphorylation of Cx43 engaged at junctional plaques. This process is mediated by the phosphatase PP2B and depends on Gi activation. Astrocytes expressed occludin, ZO‐1 and ZO‐2 that display rings at cell‐cell contacts and are closely associated with Cx43 as suggested by confocal microscopy. Neither the amount nor the cellular distribution of occludin, ZO‐1 and ZO‐2 seem modified following dephosphorylation of Cx43. Co‐immunoprecipitation experiments demonstrate that Cx43, occludin, ZO‐1 and ZO‐2 belong to same multiprotein membrane complexes. Indeed, the anti‐occludin antibody is able to precipitate Cx43, ZO‐1 and ZO‐2 and anti‐ZO‐1 antibody precipitates both Cx43 and ZO‐2. The amount of Cx43 present in these complexes is increased following treatment with ET‐1. This suggests that, in astrocytes, alteration of GJC implies not only modifications of the phosphorylation status of Cx43 itself but also changes in its molecular interactions with scaffolding partners.
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EFFECTS OF BETA‐AMYLOID PEPTIDE ON ASTROCYTES: STIMULATION OF ENDOZEPINE RELEASE AND CELL PROLIFERATION {#sec2-163}
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### Hachem R.,^1^ Tokay T.,^1^ Masmoudi‐Kouki O.,^2^ Gandolfo P.,^1^ Desrues L.,^1^ Leprince J.,^1^ Castel H.,^1^ Diallo M.,^1^ Amri M.,^2^ Vaudry H.,^1^ Tonon M.C.^1^ {#sec3-163}
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Beta‐amyloid peptide (Aß) is a primary protein component of senile plaques in Alzheimer\'s disease, a neurodegenerative disorder also characterized by an intense proliferation of glial cells. Some data indicate that cerebrospinal fluid of Alzheimer\'s patients exhibits high concentrations of endozepines. All members of the endozepine family, including the octadecaneuropeptide (ODN), derive from the diazepam‐binding inhibitor (DBI), and are considered as the endogenous ligands of benzodiazepine receptors. It has been shown that ODN also interacts with a metabotropic receptor positively coupled to a phospholipase C (PLC) through a pertussis toxin sensitive G protein. Endozepines are exclusively produced by astroglial cells in the central nervous system and we have recently shown that Aß stimulates their release from cultured astrocytes. The aim of this study was to determine the mechanisms involved in the effects of Aß on endozepine release and astrocyte proliferation. We have first observed that Aß induces a transient stimulation of cAMP formation and a sustained activation of polyphosphoinositide turnover. The effects of Aß on intracellular pathways as well as on endozepine release are mediated through activation of N‐formyl peptide receptors (FPR). We demonstrated that both protein kinases A and C are involved in Aß‐ and N‐formyl peptide‐induced endozepine release. In addition, we showed that the stimulatory effect of Aß on endozepine release is dependent on an ATP‐binding cassette transporter. In the second part of the study, we have shown that ODN, like Aß and interleukin‐1ß (IL‐1ß), stimulates astrocyte proliferation in a dose‐dependent manner. Since the release of endozepines induced by Aß precedes that of IL‐1ß, these data suggest that endozepine release might be involved in Aß‐induced IL‐1ß production and cell proliferation. Taken together, these data demonstrate for the first time that astroglial FPR are positively coupled to adenylyl cyclase and PLC, and that Aß stimulates endozepine release from astrocytes through activation of FPR. In addition, our results suggest that the release of endozepines stimulates directly or indirectly, via the production of IL‐1ß, astrocyte proliferation. Identification of the receptors involved in the effect of endozepines deserves further investigations.
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INSULIN‐LIKE GROWTH FACTOR BINDING PROTEINS REGULATE GLIAL CELL BEHAVIOR IN AN IGF‐1‐DEPENDENT AND ‐INDEPENDENT FASHION: IMPLICATIONS IN MULTIPLE SCLEROSIS {#sec2-164}
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### Chesik D.,^1^ Wilczak N.,^1^ de Keyser J.^2^ {#sec3-164}

#### ^1^University Medical Center Groningen, Groningen, Netherlands; ^2^University Hospital of Brussels, Brussels, Belgium {#sec4-164}

INTRODUCTION: Insulin‐like growth factor‐1 (IGF‐1) is an essential factor in proper CNS development and induces differentiation of oligodendrocytes. Due to its myelinogenic property, IGF‐1 possesses therapeutic potential in treating demyelinating diseases such as multiple sclerosis (MS). However, IGF‐1 is under tight regulation by a complex system of IGF binding proteins (IGFBPs).

OBJECTIVE: To characterize the IGF‐system in glial cells in MS brain and investigate regulation of the IGF‐system on glial cell behavior.

METHODS: By means of immunohistochemistry, we analyzed levels of IGF‐1, the type 1 IGF receptor and 6 known IGFBPs in MS brain. Based on expression patterns observed in glial cells in situ, in vitro investigations were conducted to study the effects of the IGF‐system on cell signaling and behavior. To this end, we utilized GTPase pull down assays, Western blotting, immunocytochemistry, flow cytometry, as well as proliferation, survival and migration assays.

RESULTS: Reactive astrocytes and microglia in MS lesions showed upregulation of IGFBP‐2 expression. By comparison, oligodendrocytes demonstrated a prominent upregulation of IGFBP‐1 in MS. In an in vitro model of astrogliosis, reactive cells also expressed high levels of IGFBP‐2 and a protease that degraded this protein. We further demonstrate that IGFBP‐2 does not inhibit IGF‐1 effects on astrocytes yet inhibits IGF‐1 effects on oligodendrocytes. Further, in vitro investigation on oligodendrocytes show divergent effects of IGFBP‐1. While IGFBP‐1 inhibited IGF‐1 effects on oligodendrocyte survival as well as MBP and MAG expression, IGFBP‐1 also exerted IGF‐independent effects on oligodendrocytes mediated through integrin signaling including activation of signaling pathways and enhanced oligodendrocyte migration.

INTERPRETATION: IGFBP‐2 upregulation in astrocytes in MS may target IGF‐signaling to astrocytes and enhance reactive astrogliosis. IGFBP‐2 and IGFBP‐1 inhibit IGF‐1 signaling in oligodendrocytes which may serve to prevent oligodendrocyte differentiation and allow progenitors to migrate and proliferate in order to repopulate MS lesions, a prerequisite for remyelination of damaged tissue.
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INHIBITION OF CONNEXIN 43 HEMICHANNEL RESPONSES WITH HIGH CYTOPLASMIC CALCIUM CONCENTRATIONS IS MEDIATED BY MECHANISMS DIFFERENT FROM CALCIUM ACTIVATION OF HEMICHANNEL RESPONSES {#sec2-165}
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### Wang N., de Vuyst E., de Bock M., Decrock E., Van Moorhem M., Leybaert L. {#sec3-165}

#### Ghent University, Ghent, Belgium {#sec4-165}

Connexin 43 (Cx43) hemichannel (HC) responses can be activated by \[Ca2+\]i changes according to a bell‐shaped response curve with activation of the responses at moderate \[Ca2+\]i elevation (peak below ∼500 nM) and disappearance of the responses (further called inactivation) with \[Ca2+\]i transients peaking above ∼500 nM. We further explored the mechanisms of \[Ca2+\]i‐dependent inactivation. \[Ca2+\]i--triggered HC responses have been demonstrated to involve an intermediate step of calmodulin (CaM) and arachidonic acid (AA) signaling (see abstract & poster of De Vuyst E. et al.). ATP release assays on HC responses triggered in C6 glioma cells stably transfected with Cx43 cells by Ca2+‐independent CaM activation with the peptide CALP 1 demonstrated an S‐shaped concentration‐response curve, indicating that high \[Ca2+\]i related inactivation was absent with this trigger. Dye uptake assays (PI and EtBr) with AA‐triggered responses revealed a similar S‐shaped concentration‐response behavior (half‐maximal activation at ∼330 μM). We next triggered HC dye uptake with AA and combined this trigger with various concentrations (6‐12 μM) of the Ca2+‐ionophore A23187 to induce large (μM) \[Ca2+\]i transients. These experiments demonstrated concentration‐dependent suppression of AA‐triggered HC responses, confirming that high \[Ca2+\]i levels inhibit HC responses. In a next step, we investigated whether the \[Ca2+\]i‐ dependency of HC responses was related to Cx43 phosphorylation. Western blot analysis showed that A23187 concentrations activating HC responses reduced the degree of non‐phosphorylated Cx43 protein (presumably due to the Ca2+‐activated kinases) and that higher A23187 concentrations, that cause HC inactivation, restored the degree of non‐phosphorylated Cx43. A possible explanation for this observation may reside in the activation at high \[Ca2+\]i of a Ca2+‐dependent serine/threonine protein phosphatase such as calcineurin. Inhibition of phosphatase type 2B with 2 μM cyclosporin A indeed reduced the high \[Ca2+\]i‐induced dephosphorylation and furthermore prevented inactivation of the HC responses probed with dye uptake. Our results demonstrate that the modulation of HC responses by \[Ca2+\]i is a bi‐modal process each governed by distinct signaling mechanisms.
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INVOLVEMENT OF PKC/PKD PATHWAY IN UDP‐STIMULATED MICROGLIAL PHAGOCYTOSIS {#sec2-166}
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### Kataoka A., Tozaki‐Saitoh H., Koga Y., Tsuda M., Inoue K. {#sec3-166}

#### Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan {#sec4-166}

The clearance of tissue debris by microglial phagocytosis is one of the crucial components in the maintenance of the brain homeostasis. Recently, it was reported that extracellular UDP stimulates phagocytosis activity of microglia through P2Y~6~ receptor activation. However, the intracellular mechanism underlying these phenomena has not been identified. UDP rapidly induced actin aggregation and active movement of cellular protrusions in microglia leading to enhanced microsphere phagocytosis. We found that UDP‐induced the facilitation of fluorescent microsphere uptake by microglia was effectively inhibited by Go6976, a PKC and PKD (PKCμ) inhibitor, but not by Go6983 which is less sensitive to PKD. Furthermore, we observed rapid phosphorylation of PKD (Ser744/748 and Ser916) after UDP stimulation in a PKC dependent manner. We also found UDP induced phosphorylation of Akt and it was also dependent on PKC/PKD activation. In addition, PI3K inhibitors suppressed the phagocytic effects of microglia and also Akt phosphorylation. Vasodilator‐stimulated phosphoprotein (VASP) which is known to be involved in actin polymerization was also phosphorylated by UDP. It was suppressed by inhibition of PKC/PKD pathway, but not by PI3K/Akt. These data suggest that PKC/PKD pathway control the microglial phagocytosis by independently‐regulating PI3K/Akt and VASP activation.

P‐167 {#sec1-167}
=====

GAIN MODULATION OF ASTROCYTE CA2+ SIGNALLING BY NITRIC OXIDE {#sec2-167}
------------------------------------------------------------

### James L., Bellamy T. {#sec3-167}

#### Babraham Institute, Cambridge, United Kingdom {#sec4-167}

Astrocytes are non‐excitable cells, but express a wide range of neurotransmitter and hormone receptors linked to second messenger signalling pathways. Accordingly, they can detect and respond to messengers released from both the neuronal network and the vasculature, with which they are closely associated.

Nitric oxide (NO) is an atypical, highly diffusible, messenger released by endothelial cells and neurons which binds to its receptor guanylyl cyclase (GC), catalyzing the synthesis of the second messenger cGMP, which in turn engages kinases (PKG), gated/modulated ion channels and phosphodiesterases.

Application of NO to cultured cerebellar astrocytes at physiological concentrations (\< 1 μM) results in intermittent Ca^2+^ spiking after a considerable delay (1‐10 min). These long‐latency spikes were blocked by inhibitors of GC and PKG, but were also blocked by glutamate and ATP receptor antagonists. These experiments suggest that NO acts indirectly; it does not initiate the Ca^2+^ spikes, but acts via upstream receptors.

One possibility is that NO sensitizes the cells to tonic levels of transmitter, that are released under normal culturing conditions, but are unlikely to reach a threshold for triggering global Ca^2+^ oscillations. To test this hypothesis, we co‐applied NO with submaximal concentrations of various neurotransmitter receptor agonists. We found that the probability of a cell responding to an agonist with a global Ca^2+^ signal, the frequency of Ca^2+^ oscillations, and the total Ca^2+^ flux (measured as area under the curve) are significantly enhanced by either ATP or histamine when in the presence of NO. In contrast, glutamate induced Ca^2+^ signalling was unaffected by co‐application of NO. As our cultured cerebellar astrocytes express ionotropic glutamate receptors, but not metabotropic glutamate receptors, NO‐cGMP signalling therefore appears to modulate some aspect of the Gq signalling pathway in a manner that lowers the threshold at which InsP~3~ receptor activation leads to a global Ca^2+^ response. We therefore propose that NO acts as a "gain modulator" of astrocyte Ca^2+^ signalling pathways.
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TYRPHOSTIN AG126 MODULATES TOLL‐LIKE RECEPTOR (TLR)‐ACTIVATED RESPONSES IN MICROGLIA {#sec2-168}
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### Menzfeld C.,^1^ John M.,^2^ Neumann K.,^3^ Tischner D.,^3^ Wienands J.,^3^ Reichardt H.M.,^3^ Luehder F.,^4^ Brueck W.,^3^ Rotshenker S.,^5^ Hanisch U.K.^1^ {#sec3-168}

#### ^1^Institute for Neuropathology, University of Goettingen, Goettingen, Germany; ^2^Institute for Anorganic Chemistry, University of Goettingen, Goettingen, Germany; ^3^Institute of Cellular and Molecular Immunology, University of Goettingen, Goettingen, Germany; ^4^Institute for Multiple Sclerosis Research, University of Goettingen and Gemeinnützige Hertie‐Stiftung, Goettingen, Germany; ^5^Department of Anatomy and Cell Biology, Hebrew University Hadassah Medical School, Jerusalem, Israel {#sec4-168}

Tyrphostins are synthetic protein tyrosine kinase (PTK) inhibitors with a potential to interfere selectively with substrate tyrosine phosphorylation. AG126 revealed anti‐inflammatory properties in diverse *in vivo* settings, and we obtained beneficial effects in a mouse model of multiple sclerosis, i.e. experimental autoimmune encephalomyelitis (EAE). To elucidate basic modes of action, we analysed putatively involved signaling pathways and AG126‐sensitive targets in microglia, considering different mechanisms: We addressed the involvement of PTK inhibition, assuming Bruton\'s tyrosine kinase (BTK) as a candidate. BTK participates in MyD88‐dependent TLR signalling and plays a role in the basal intracellular Ca^2+^ regulation. Similarly, AG126 suppresses MyD88‐dependent proinflammatry cyto/chemokine inductions in microglia, as triggered by several TLR agonists but with a different modulatory profile in the case of TLR4. Moreover, AG126 affects the microglial basal Ca^2+^ level. Because BTK is best characterised in the B cell receptor signalling, various B cell lines were used to address the putative modulatory effect of AG126 on BTK activity. As revealed by comparisons with the BTK inhibitor LFM‐A13 in these *in vitro* assays, the functional profile of AG126 cannot solely be explained by BTK interference. Besides PTK inhibition, we considered some agonistic properties of AG126, based on the structural relatedness to nor‐/adrenaline and the very similar effects of AG126 treatment and adrenergic receptor stimulation on TLR‐induced responses in microglia. Yet our data rule out a direct link. Finally, chemical analysis by nuclear magnetic resonance spectroscopy revealed hydrolysis of AG126 in aqueous solution and suggests that the compound undergoes conversion/metabolization. Therefore, observed AG126 effects in microglial responses may be caused by the respective breakdown products. Taken together, the potent actions of AG126 could be mediated by PTK inhibition, modulation of MyD88 signaling and changes in Ca^2+^ but likely include more than a single molecular target.

Supported by Niedersachsen‐Israel Research Cooperation.
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AUTOCRINE CELL VOLUME REGULATION OF MÜLLER CELLS: INVESTIGATION OF INVOLVED SIGNALING PATHWAYS {#sec2-169}
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### Linnertz R.,^1^ Bringmann A.,^2^ Wiedemann P.,^2^ Reichenbach A.^1^ {#sec3-169}

#### ^1^Paul Flechsig Institute of Brain Research, Leipzig, Germany; ^2^Department of Ophthalmology and Eye Hospital, Leipzig, Germany {#sec4-169}

One important function of Müller cells is the maintenance of the volume homeostasis of the retinal tissue. Swelling of Müller cells was suggested to be involved in development of retinal edema. Hypoosmotic conditions in the presence of inflammatory mediators or under oxidative stress, and during blockade of potassium channels, induce swelling of Müller cells. The aim of our study was to determine whether receptor agonists which evoke a calcium response in Müller cells may prevent the osmotic swelling of Müller cells. In further experiments we investigated the involvement of voltage‐gated sodium and calcium channels in the autocrine regulation of Müller cell volume.

Freshly isolated Müller cells of the rat were perfused with isotonic or hypotonic solution. To determine the volume changes of the cells the cross sectional area of the somata was measured with a laser scanning microscope. We found that vascular endothelial growth factor, heparin‐binding EGF‐like growth factor, neuropeptide Y, atrial natriuretic peptide and erythropoietin prevented the osmotic swelling of the cells. Activation of specific receptors evoked a calcium‐dependent, exocytotic release of glutamate from Müller cells, and subsequent stimulation of glial group I/II metabotropic glutamate receptors. Activation of glutamate receptors evoked an autocrine swelling‐inhibitory purinergic signalling cascade that was calcium‐independent.

We found that the inhibitory effect of the agonists on the osmotic swelling of retinal glial cells was prevented in the presence of inhibitors of voltage‐gated sodium (tetrodotoxin) and T‐type calcium channels (kurtoxin). In contrast, the swelling‐inhibitory effect of glutamate remained unaffected in the presence of the blockers. The present results indicate a functional role of voltage‐dependent calcium channels in the mediation of the calcium influx for the vesicular release of glutamate from Müller cells. The involvement of voltage‐dependent sodium channels suggests that rapid fluctuations of the membrane potential underlie the activation of calcium channels.
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INVOLVEMENT OF CONNEXIN HEMICHANNELS IN DYNAMIC CALCIUM CHANGES AND PERMEABILITY OF BLOOD‐BRAIN BARRIER ENDOTHELIAL CELLS {#sec2-170}
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### de Bock M.,^1^ de Vuyst E.,^1^ Wang N.,^1^ Decrock E.,^1^ Van Moorhem M.,^1^ Culot M.,^2^ Simon A.M.,^3^ Cecchelli R.,^2^ Leybaert L.^1^ {#sec3-170}

#### ^1^Dept. of Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium; ^2^Laboratoire de physiopathologie de la barrière hémato‐encéphalique, Université Lille Nord de France, Lens, France; ^3^Dept. of Physiology, College of Medicine, University of Arizona, Tucson, United States {#sec4-170}

It is well established that endothelial cytoplasmic calcium (\[Ca2+\]i) is an important factor determining blood‐brain barrier (BBB) permeability but little is known concerning the effect of dynamic \[Ca2+\]i changes on BBB function. Here we applied several conditions that trigger Ca2+ waves or oscillations and determined the involvement of connexin (Cx) hemichannels in the induced \[Ca2+\]i changes as well as its effects on BBB function. Immortalized rat brain ECs (RBE4) were used to explore the role of hemichannels in \[Ca2+\]i waves/oscillations while an in vitro BBB model composed of primary bovine capillary EC (BCEC) grown in co‐culture with rat cortical astrocytes was used to confirm the observations in RBE4 and to investigate functional effects on BBB permeability. \[Ca2+\]i was monitored with fluo‐3 and BBB permeability was assessed from the clearance of lucifer yellow added in the compartment facing the ECs. Both RBE4 and BCEC expressed Cx37 and Cx43, while Cx40 was not detectable. Lowering extracellular \[Ca2+\] (\[Ca2+\]e), a known trigger for hemichannel opening, caused Ca2+ waves and oscillations in the ECs that were significantly reduced by the Cx mimetic peptide Gap27. Furthermore, low \[Ca2+\]e induced an increase in BBB permeability that was inhibited by \[Ca2+\]i chelation with BAPTA‐AM, indicating a role for endothelial \[Ca2+\]i changes, and by Gap27 pointing to a role of hemichannels. Exposure of the cells to 0.5 μM bradykinin (BK) induced Ca2+ oscillations but not Ca2+ waves. The number of cells displaying oscillatory \[Ca2+\]i changes was significantly reduced in the presence of carbenoxolone (Cbx) or Gap27 as well as by suramin/PPADS or apyrase, indicating a role for extracellular ATP presumably released via hemichannels. Exposure of the cells to 0.5 μM ATP also induced Ca2+ oscillations, but remarkably, here the number of oscillating cells was not reduced by Cbx or Gap27 suggesting a different oscillation mechanism. At the level of BBB function, BK increased the BBB permeability while ATP had no effect. These observations suggest that the mechanism of Ca2+ oscillations is important in the subsequent BBB opening. We conclude that connexin hemichannels play a role in the generation of Ca2+ waves and oscillations in BBB endothelium and thereby influence BBB function.
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NOVEL CROSS‐TALK BETWEEN ERBB AND ENDOTHELIN RECEPTORS IN CORTICAL ASTROCYTES {#sec2-171}
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### Glisic D., Lehmann C., Engele J. {#sec3-171}

#### University of Leipzig, Institute of Anatomy, Leipzig, Germany {#sec4-171}

ErbB and endothelin receptors as well as their ligands are massively upregulated upon most forms of brain injuries and are consequently considered central to the control of reactive brain processes. A recognized cross‐talk between both systems is the transactivation of ErbB1/EGFR by endothelin receptors. In order to gain further insight into the role of EGFR transactivation in reactive brain processes, we have now studied the interplay of endothelins with the EGFR in more depth. Analysis of the subcellular localization of the EGFR using endosomal as well as lysosomal markers surprisingly demonstrated that stimulation of cultured cortical astrocytes with endothelin‐1 (10 nM; 30 min) prevents internalization and subsequent degradation of ligand‐bound EGFR. Immunoprecipitation of the EGFR followed by Western blotting further unravelled that endothelin‐1 abrogates ligand‐induced EGFR internalization by promoting the formation of "internalization‐deficient" EGFR/ErbB2‐heterodimers. In addition, we demonstrate that ET‐1, but not EGF, also activates c‐Abl kinase, an established negative regulator of EGFR internalization which prevents Cbl‐dependent ubiquitination of the receptor protein. Since receptor internalization profoundly affects the quantity and quality of EGFR signalling, these findings point to endothelins as major regulators of EGFR function in the diseased brain.
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THE ROLE OF ACTIN FILAMENTS AND MICROTUBULES IN CALCIUM‐DEPENDENT AND INDEPENDENT MOTILITY OF MITOCHONDRIA IN CULTURED ASTROCYTES {#sec2-172}
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### Khiroug L., Kremneva E. {#sec3-172}

#### University of Helsinki, Helsinki, Finland {#sec4-172}

Motility of mitochondria is essential for neuronal function, but its relevance for the glial cell signalling is largely unknown. We used kinetic fluorescence imaging, genetic manipulations and pharmacological techniques to characterize calcium‐ and cytoskeleton‐dependent motility of mitochondria in cultured astrocytes dissociated from rat cortex and hippocampus. Mitochondrial "trains" were mostly aligned along microtubules, often orthogonal to actin filaments. Under resting conditions at low intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~), astrocytic mitochondria were highly mobile as they exhibited both axial (presumably along microtubules) and lateral movements in an apparently uncoordinated manner. Ionomycin‐mediated increase in \[Ca^2+^\]~i~ induced a strong but incomplete block of mitochondrial motility. In those cells that were able to restore their \[Ca^2+^\]~i~ to pre‐ionomycin levels, the decrease in mitochondrial motility was also reversible. Disruption of microtubules by preincubation with nocodazole resulted in a complete immobilization of mitochondria, indicating that intact microtubules are an essential requirement of mitochondrial motility. In contrast, manipulations with actin had no effect on mitochondrial motility at resting \[Ca^2+^\]~i~ levels. Remarkably, either depolymerisation of actin with latrunculin B or transfection of cells with the mCherry‐tagged actin resulted in a strong reduction of Ca^2+^‐dependent immobilization of mitochondria induced by the application of ionomycin. These results support a concept in which the Ca^2+^‐independent axial motility of mitochondria along microtubule "rails" is constrained by the Ca^2+^‐sensitive interaction of mitochondria with the actin "railroad ties".
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NOTCH‐1 SIGNALING DURING THE PATHOGENESIS OF AMYOTROPHIC LATERAL SCLEROSIS {#sec2-173}
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### Philips T., Robberecht W. {#sec3-173}

#### Vesalius Research Institute, Flemish Institute of Biotechnology (VIB), Leuven, Belgium, Leuven, Belgium {#sec4-173}

Neurodegenerative diseases such as Alzheimer disease, Parkinson disease and Amyotrophic Lateral Sclerosis (ALS) are characterised by an extensive loss of neuronal cells which is accompanied by so‐called « gliosis »; an inflammatory reaction of non‐neuronal cells that contribute to neurodegeneration. Studies in rodent models of these diseases and other neurodegenerative diseases e.g. experimental ischemic stroke, prove that Notch‐1 signaling plays an important role in mediating the microglial reaction and GFAP+ astrocytic scar formation that occurs during neurodegeneration. The Notch‐1 receptor signaling pathway mediates a wide range of functions with neighbouring cells by direct cell‐cell interaction, mainly during embryonic stages, but also in adulthood. In the central nervous system these receptors mediate cell renewal, cell fate specification and cell differentiation. In this study, we try to unravel the role of Notch‐1 signaling during motor neuron degeneration in ALS using the SOD1G93A mouse; the animal model most widely used to study ALS. In affected humans and SOD1G93A mice a massive activation of both microglia and astrocytes is observed, which can have both a beneficial and a detrimental outcome on the surrounding motor neurons. Firstly, we try to characterise the Notch‐1 signaling pathway in the reactive glia and neurons of ALS mice using Notch signaling reporter lines, and secondly, we try to interfere with Notch signaling in the reactive glial cells and affected motor neurons of SOD1G93A mice by specifically activating or downregulating Notch‐1 signaling in these cell types, both in vitro and in vivo. To this end, we have crossbred SOD1G93A mice with 1) tissue specific Cre mice and 2) mice in which the canonical Notch‐1 pathway can be inhibited after Cre mediated deletion of the presenilin‐1 gamma‐secretase activity or the activity of the CSL protein RBP‐Jk. To activate Notch‐1 activity, we crossbred the tissue specific Cre mice with mice in which the Notch intracellular domain (NICD) is overexpressed after Cre mediated excision of a stop cassette inhibiting NICD transcription. By means of these models, we hope to obtain more insight into the role of Notch‐1 signaling during reactive gliosis and neurodegeneration in a mouse model for Amyotrophic Lateral Sclerosis.
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WHAT IS ENDOPLASMIC RETICULUM STRESS DOING DURING MULTIPLE SCLEROSIS PROGRESSION? {#sec2-174}
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### Mcmahon J.,^1^ Ní Mháille A.,^1^ Mcquaid S.,^2^ Farrell M.,^3^ Cunnea P.,^1^ Dolphin C.,^1^ Samali A.,^4^ Fitzgerald U.^1^ {#sec3-174}

#### ^1^NCBES, NUI Galway, Galway, Ireland; ^2^Belfast Health Trust and Queens University, Belfast, United Kingdom; ^3^Departments of Pathology, Beaumont Hospital and the Royal College of Surgeons in Ireland, Dublin, Ireland; ^4^Department of Biochemistry, NUI Galway, Galway, Ireland {#sec4-174}

Large‐scale measurement of gene expression variation in Multiple Sclerosis (MS) tissue has led to an increasingly complex picture of potential key regulators of the pathological process in MS and while this information is valuable it is often difficult to make meaningful deductions from data sets produced. By viewing changes from the point of view of cell stress, the potential importance of oxidative and nitrative stress has been reported by several labs. More recently, data from ours and the Popko lab has implicated endoplasmic reticulum stress as a potential player. Here we show that ER stress occurs at the earliest stages of myelin destruction, as evidenced by raised levels of the C/EBP homologous protein (CHOP) and immunoglobulin heavy chain binding protein (BiP) at the centre or edge of most biopsy‐derived lesions examined, when compared to surrounding perilesional white matter. We also report the use of laser capture microdissection to obtain measurements of ER stress‐specific transcriptional changes occurring in different areas of diseased post‐mortem MS tissue. Real‐time PCR analysis of RNA isolated from microdissectates demonstrated that CHOP, BiP and activated transcription factor 4 (ATF4) mRNAs were up‐regulated 3‐fold in normal‐appearing white matter compared to non‐MS controls and that CHOP was increased 6‐fold in the perilesion of active plaques when compared to non‐MS samples. Finally, preliminary data from our oligodendrocyte differentiation model hints that BiP may play a role in oligodendrocyte maturation. Using a rat oligodendrocyte precursor cell line maintained in differentiation medium, we showed a near 2.4‐fold induction of BiP mRNA after 7 days. In conclusion, markers consistent with activation of a cellular response to ER stress are present in a variety of cells in newly‐forming de‐myelinated lesions and in later‐stage MS lesions. BiP up‐regulation during oligodendrocyte differentiation implicates this ER‐resident chaperone in oligodendrocyte maturation. How can the differing roles of ER stress in lesion evolution and resolution be reconciled? Are ER stress‐specific responses protective or destructive? Is the nature of the ER stress response cell‐type‐specific? In vitro and in vivo models of de‐ and re‐myelination will be key to defining the role of ER stress in MS progression.
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MODULATION OF MICROGLIAL INDUCED OLIGODENDROCYTE TOXICITY IN MULTIPLE SCLEROSIS {#sec2-175}
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### Sevastou I.G.,^1^ Heales S.J.,^2^ Pocock J.M.^1^ {#sec3-175}

#### ^1^UCL Institute of Neurology, Department of Neuroinflammation, Cell Signalling Laboratory, London, United Kingdom; ^2^UCL Institute of Neurology, Department of Molecular Neuroscience, London, United Kingdom {#sec4-175}

Oligodendrocytes are the principal target of immune attack in multiple sclerosis (MS), where the immune system attacks the myelin sheath, leading to oligodendrocyte demise, compromised axonal salutatory conduction and eventually neuronal degeneration. Microglia are also implicated in MS pathology and are present in lesions in an activated state. The vulnerability of oligodendrocytes to activated microglia has been a subject of debate. Although oligodendrocyte precursor cells (OPCs) have been shown to be very vulnerable to lipopolysaccharide (LPS) induced microglial activation, reports on mature oligodendrocytes have been variable. We show here that LPS activated microglia are detrimental not only to OPCs but also to mature oligodendrocytes co‐cultured with primary microglia. We also show that microglial conditioned medium is not able to induce oligodendrocyte death when collected from microglial monocultures and applied on OPCs or oligodendrocytes in primary culture. Thus co‐culture of the cells is required, pointing towards cell contact or short lived molecules as potential toxic mediators. Factors implicated in microglial induced oligodendrocyte death are thought to be tumour necrosis factor α (TNFα), interleukin 1‐β (IL1‐β), interferon γ (IFNγ) and nitric oxide (NO). We found that inducible nitric oxide sythnase (iNOS) inhibition was at least partially able to reverse toxicity. The reverse of microglial induced oligodendrocyte death was also attempted by blocking pathways of microglial activation such as the Rho‐ROCK pathway and modulation of microglial activation by metabotropic glutamate receptor manipulation. Modulation of the microglial induced oligodendrocyte toxicity could lead to strategies to slow disease progression in MS patients by protecting mature oligodendrocytes from microglial induced death, whilst most importantly enhancing survival of OPCs in MS lesions, where they are recruited to remyelinate neuronal axons.
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MODULATION OF ADENOSINE UPTAKE AND RELEASE BY INHIBITORS OF ERK 1/2 IN CULTURES OF AVIAN RETINAL CELLS {#sec2-176}
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### Dos Santos Rodrigues A., Ferreira J.M., Paes‐de‐Carvalho R. {#sec3-176}

#### Laboratory of Cellular Neurobiology, Department of Neurobiology, Program of Neurosciences, Institute of Biology, Federal Fluminense University, Niteroi, Rio de Janeiro, Brazil {#sec4-176}

OBJECTIVES: Adenosine (Ado) is an important modulator of neuronal survival and differentiation in the CNS. Our previous work showed that Ado transporters are present in cultures of chick retinal cells and that activation of Ado A1 receptors promotes an increase in ERK phosphorylation in glial cultures. Our aim in this work was to study the participation of the ERK pathway in Ado uptake and release by different types of retinal cultures.

METHODS: The uptake was measured after incubation with (^3^H)adenosine for 15 minutes and cell lysis to determine intracellular radioactivity. Basal and glutamate‐stimulated radioactivity released from cells was determined by liquid scintillation spectroscopy.

RESULTS: Ado uptake involves 2 components, one saturable and one linear, in mixed or glial cultures, but the saturable component is much smaller in glial cultures. In glial cultures, ERK inhibition with PD98059 (25 μM) reduced the uptake in 37.1 ± 4.3% (n=4). In mixed cultures, PD98059 (25 μM) or UO126 (10 μM), two MEK inhibitors with different chemical structures, reduced the uptake in 39.1 ± 4.5% (n=5) and 48.6 ± 2.9% (n=3), respectively. U0124 (10 μM), an innactive UO126 analog, was much less effective in inhibiting Ado uptake (17.9 ± 3.4 % vs control, n=3). The analysis of inhibition curves with MEK inhibitors showed that the blockade is observed mainly on the saturable component at both types of culture. Glutamate (Glu) induced the release of purines from mixed cultures (136.9 ± 31.0 % increase vs control, n=3) and this effect was not significantly inhibited by PD98059 (79.6 ± 18.8% increase vs Glu, n=3).

CONCLUSIONS: MEK inhibition dramatically reduces adenosine uptake in mixed neuronal/glial or purified cultures of retinal glial cells, apparently not affecting purine release induced by Glu. Since ERK activity is regulated by stimulation of A1 receptors in the retina, the results suggest that adenosine regulates its own transporter activity via activation of the ERK pathway.
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MICROGLIA PROCESSES BLOCK THE SPREAD OF DAMAGE IN THE BRAIN AND REQUIRE FUNCTIONAL CHLORIDE CHANNELS {#sec2-177}
----------------------------------------------------------------------------------------------------

### Hines D., Hines R., Macvicar B. {#sec3-177}

#### University of British Columbia, Vancouver, Canada {#sec4-177}

Microglia cells exhibit two forms of motility, constant movement of filopodia probing surrounding brain tissue, and outgrowth of larger processes in response to nearby damage. The mechanisms and functions of filopodia sensing and process outgrowth are not well characterized but are likely critical for normal immune function in the brain. Using two photon laser scanning microscopy we investigated microglia process outgrowth in response to damage, and explored the relationship between process outgrowth and filopodia movement. Further, we examined the roles of Cl‐ or K+ channel activation, as well as actin polymerization in these two distinct processes, since mechanistic understanding could provide a strategy to modulate microglia function. We found that volume sensitive Cl‐ channel blockers (NPPB, tamoxifen, DIDS) prevented the rapid process outgrowth of microglia observed in response to damage. In contrast, filopodia extension during sensing was resistant to Cl‐ channel inhibitors, indicating that these motile processes have different cellular mechanisms. However, both filopodia sensing and rapid process outgrowth were blocked by inhibition of actin polymerization. Following lesion formation under control conditions, rapidly outgrowing processes contacted the damaged area and this was associated with a 37% decrease in lesion volume. Inhibition of process outgrowth by Cl‐ channel block, prevention of actin polymerization, or by selectively ablating microglia all allowed lesion volume to increase and spread into the surrounding tissue. Therefore, process outgrowth in response to focal brain damage is beneficial by preventing lesion expansion and suggests microglia represent a front line defence against damage in the brain.

P‐178 {#sec1-178}
=====

GAP JUNCTION COUPLING AMONG OLIGODENDROCYTES IN MOUSE CORPUS CALLOSUM IS LARGELY PROMOTED BY CONNEXIN47 {#sec2-178}
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### Maglione M.,^1^ Tress O.,^2^ Haas B.,^3^ Willecke K.,^2^ Kettenmann H.^1^ {#sec3-178}

#### ^1^Max‐Delbrück‐Center for Molecular Medicine, Berlin, Germany; ^2^Institut für Genetik, Universität Bonn, Bonn, Germany; ^3^INSERM U840, Collège de France, Paris, France {#sec4-178}

Cx32 and Cx47 are the major gap junction proteins expressed by oligodendrocytes, the myelinating cells in the CNS. In addition to their role in cell communication, the expression of these proteins is essential for the formation and maintenance of myelin as it has become evident in mutations. According to previously published ultra structural studies, oligodendrocytes in white matter exhibit gap junctions with astrocytes, but not among each other, while in cell culture experiments, oligodendrocytes form functional gap junctions. We have studied functional coupling among oligodendrocytes and astrocytes in the corpus callosum. Using the patch‐clamp technique we tested for coupling by injection of biocytin, a gap‐junction‐permeable tracer, into oligodendrocytes in acute slices of corpus callosum (postnatal day 10‐15). To identify the coupled cells in the network we combined biocytin labeling with CNPase and GFAP immunostaining, i.e. markers for oligodendrocytes and astrocytes, respectively. On average 61 cells were positive for the tracer detected by biocytin immunostaining with fluorochrome‐conjugated streptavidin. 77% of the coupled cells were positive for the oligodendrocyte marker CNPase, 9% for the astrocyte marker GFAP and 14% were negative for both CNPase and GFAP. In wildtype tissue uncoupled oligodendrocytes could be distinguished from coupled cells by a distinct membrane current pattern that strongly decayed after de‐ or hyperpolarizing voltage steps. In Cx47‐deficient mice, the number of coupled cells was reduced by 80%, while deletion of Cx32 did not reduce the number of coupled cells. Ablation of Cx47 completely abolished coupling of oligodendrocytes to astrocytes. In contrast, in Cx43‐deficient animals, oligodendrocyte‐astrocyte coupling was still present, but coupling to the CNPase‐ and GFAP‐negative cell population was not observed. Oligodendrocytes in Cx32/Cx47 double deficient mice were not coupled at all and showed the distinct current decay of uncoupled oligodendrocytes in response to voltage steps. We conclude that oligodendrocytes in white matter predominantly couple among each other dependent on Cx47 and Cx32 expression. In addition Cx47 is essential for oligodendrocyte‐to‐astrocyte coupling.
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NEURONAL DIFFERENTIATION IS MODULATED BY CONNEXIN43 CARBOXYL TERMINUS {#sec2-179}
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### Santiago M.,^1^ Alcami J.,^2^ Striedinger K.,^3^ Spray D.,^3^ Scemes E.^3^ {#sec3-179}

#### ^1^Biophysics Institute, Rio de Janeiro, Brazil; ^2^Ecole Normale Superiore, Paris, France; ^3^Albert Einstein College of Medicine, Bronx, United States {#sec4-179}

In early embryonic stages of brain development, connexin43 (Cx43) is abundantly expressed in neural stem/progenitor cells and its expression becomes restricted mainly to the astroctytic cell population in the mature brain. Recent studies have indicated that Cx43 plays important, non‐channel, roles during CNS maturation by affecting neural cell migration. Here we evaluated whether Cx43 affected neuronal differentiation. For that we used an in vitro model of neural cell development (neurospheres) to evaluate, through immunocytochemistry, electrophysiology and molecular biology, the degree of neuronal maturation originated from neurospheres derived from wild‐type (WT) and Cx43‐null mice, as well as Cx43‐null neurospheres expressing different Cx43 mutants. Our results indicate that lack of Cx43 induces neuronal differentiation in early embryonic stages of the CNS. The number of neurospheres containing β‐III tubulin (TUB) positive cells and the number of cells displaying inward currents was significantly higher in Cx43‐null that in WT littermate neurospheres. Knockdown of Cx43 with siRNA, increased the number of WT neurospheres with TUB positive cells. Transfection of Cx43‐null neural stem/progenitor cells with Cx43 mutants revealed that Cx43 carboxyl terminus (CT) provides a negative signal for neuronal maturation; the number of Cx43‐null neurospheres with TUB positive cells was reduced following transfection with full‐length Cx43 or with Cx43‐CT, but did not change following transfection of Cx43 lacking the CT. Blockade of gap junctional communication with carbenoxolone did not induce neuronal differentiation in WT neural progenitors. In agreement with these in vitro data, in situ analysis of E16 brains revealed increased TUB expression in germinal zones of Cx43‐null compared to that of WT littermates. Bioinformatics analysis of previously published microarray data obtained comparing whole brains from E19 WT and Cx43‐null embryos also indicated up‐regulation of neuronal differentiation markers in Cx43‐null compared to WT littermates. These results suggest that the carboxyl terminus of Cx43 is a crucial domain for signaling mechanisms involved in neuronal differentiation during embryonic brain development.

NIH‐NINDS: NS054225 to ES.
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THE EFFECT OF HISTAMINE, A TRAUMATIC BRAIN INJURY MEDIATOR, ON THE FUNCTION OF AQUAPORIN‐4 IN ASTROCYTOMA CELLS IN VITRO AND IN RAT BRAIN IN VIVO {#sec2-180}
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Aquaporins influence bi‐directional, transmembraneous water transport and help to regulate cell volume and tissue water homeostasis. AQP‐4, the channel with the highest water permeability, is most abundantly expressed in the brain and predominantly localized on astrocyte endfeet. Its expression rate and polarization change during various central nervous system diseases accompanied by cerebral edema, including stroke, trauma, infections and brain tumors.

After traumatic brain injury, high levels of histamine may participate in the pathophysiology of secondary brain injury. Histaminergic neurons project throughout the entire brain and are activated during brain diseases accompanied by edema. Interfering with histamine signaling influences the outcome after neurological insults in animals. In addition, histamine challenge to an AQP‐4 transfected gastric cell line decreased the fraction of functional membrane‐associated AQP‐4 and attenuated hypotonic cell swelling.

The role between histamine and AQP‐4 functioning is further evaluated. In vitro, AQP‐4 transfected 1321‐N1 cells show a membrane‐restricted expression of naive AQP‐4 and a correlation between AQP‐4 overexpression and increased swelling upon hypotonicity. A rapid decrease of membrane‐associated AQP‐4, with an intracellular accumulation of AQP‐4, is induced upon histamine challenge. In vivo, intracerebroventricular application of histamine dose dependently impairs survival and water homeostasis in the adult rat brain as documented by increased intracranial pressure. Immunohistochemical analyses of control tissue show that AQP‐4 is strictly membrane‐expressed in the entire brain, ICV histamine results in a more granular expression of the water channel typically in ependym cells lining the ventricles. The decreased fraction of functional membrane‐associated AQP‐4 might result in an increased ICP and decreased survival. In this new experimental rat model, intravenous or ICV administered drugs can readily be tested. This ICV histamine injection model is preferable compared to other closed head injury models in anesthetized animals for studying brain water homeostasis because of ethical considerations and the less variable outcome.
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RILUZOLE INDUCE PROLIFERATION OF NG2‐EXPRESSING GLIAL CELLS IN THE RAT AMYGDALA {#sec2-181}
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### Wennström M., Orre K., Tingström A. {#sec3-181}

#### Enheten för Molekylär Psykiatri, Lund, Sweden {#sec4-181}

There is a growing body of evidence indicating that glial pathology and abnormalities in glutamate transmission may contribute to the pathology of major depressive disorder. In our previous studies we have shown that ECS, a rat model of the antidepressant treatment electroconvulsive therapy (ECT) increase the proliferation of NG2+ glial cells, a celltype known to interact with glutamatergic neurons. The proliferative response could possibly be due to the elevated glutamate levels induced by the ECS evoked seizures. The aim of this study is to investigate changes in NG2+ glial cell proliferation in response to Riluzole, a glutamate modulating substance also known to have antidepressant properties.

Male Wistar rats were subjected to a single injection of Riluzole (1, 4 and 15 mg/kg). Two days after the treatment the rats were injected four times with the proliferation marker bromodeoxyuridine (BrdU) (100 mg/kg) at two hours intervals. The animals were transcardically perfused 24 hours after the last BrdU injection. Tissue sections were double stained for BrdU and NG2 and proliferation in the basolateral nucleus of amygdala (BL) was analyzed with fluorescence microscopy.

The total number of BrdU+/NG2+ cells in BL significantly increased in rats treated with 10 mg/kg Riluzole, whereas the cell number at the lower doses, 1 and 4 mg/kg, did not increase significantly.

We conclude that Riluzole, a glutamate modulating substance with antidepressant effects increase the number of newly formed NG2+ glial cells in the rat amygdala.

Further studies investigating the underlying mechanisms are in progress.
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ACTIVE H1‐RECEPTORS PROTECT AGAINST THE HARMFUL EFFECTS OF H2‐RECEPTORS IN A HISTAMINE INDUCED BRAIN EDEMA MODEL {#sec2-182}
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### de Jongh R.,^1^ Smets A.,^2^ Nuydens R.,^3^ Rigo J.M.,^2^ Meert T.^3^ {#sec3-182}

#### ^1^Ziekenhuis Oost‐Limburg, Gent, Belgium; ^2^Universiteit Hasselt, Hasselt, Belgium; ^3^Neuroscience department, Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium {#sec4-182}

After traumatic brain injury (TBI), high levels of histamine may participate in the pathophysiology of secondary brain injury. Histaminergic neurons project throughout the entire brain and are activated during brain diseases accompanied by edema. Interfering with histamine signaling influences the outcome after neurological insults in animals. We developed a histamine induced brain edema model in rats. Intracerebroventricular (ICV) application of histamine dose dependently impairs survival and water homeostasis in the adult rat brain as documented by increased intracranial pressure (ICP). In this new experimental model, selective histamine agonists and antagonists were tested. We show an acute toxic effect of H2‐receptor activity, which disappears when H1‐receptors are activated. We conclude that active H1‐receptors protect against the toxic H2‐effect. This shielding effect of H1‐receptor activity is confirmed in several experiments. Therefore the use of central penetrating H1‐antagonists must be avoided in patients with a suspected elevated histamine concentration in the brain, for example TBI‐patients.
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THE ROLE OF GLYCINE IN OLIGODENDROGLIAL CELL PROLIFERATION {#sec2-183}
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Like for other neurotransmitters, there is growing evidence that glycine, besides its classical role in fast inhibitory neurotransmission, could play a role in paracrine communication within the central nervous system. Studies have shown that inhibitory neurotransmitters can have beneficial effects on neuronal precursor cells with respect to migration, differentiation and cell survival. There has also been evidence suggesting that the myelination process is in part regulated by neurotransmitter receptors. With these and other indications we propose the hypothesis that inhibitory neurotransmitters could play a functional role in oligodendrocytes and their precursors with respect to developmental and repair processes. In that context, glycine receptors (GlyR) and transporters (GlyT) were already described on oligodendroglial cells cultured in oligospheres. However, this was not confirmed either in other culture models or in vivo. With RT‐PCR, Western blot and immunocytochemistry we already confirmed the presence of GlyRs and GlyTs in three different oligodendroglial cell lines (OLN‐93, MO3.13 and HOG). By using whole‐cell patch‐clamp and cell surface protein analysis we looked for the presence of functional GlyR and/ or GlyTs on the cell membrane. Finally, we investigated the effects of glycine on cell proliferation.
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EFFECT OF THE BRAIN PROTECTING AGENT ERYTHROPOIETIN ON ASTROCYTE FUNCTION {#sec2-184}
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Glial cells are increasingly recognized as playing significant roles for repair and regeneration after brain injury. Astrocyte dysfunction, including impaired water and ion transport, may be implicated in several brain disease processes. Most studies on the mechanisms for the neuroprotective effect of Erythropoietin (EPO) have focused on neurons. We speculate that a potent EPO‐mediated protection requires preservation of astrocyte function. To test this we have investigated whether EPO modulate the astrocyte water channel aquaporin 4 (AQP4) function and studied downstream effects of EPO in cultured astrocytes. Previously we showed that glutamate acting on mGluR5, which signals both via intracellular Ca^2+^ increase and via the src‐ERK pathway; increases water permeability of astrocytes via phosphorylation of AQP4. In ischemia, the sustained excessive release of glutamate should therefore increase astrocyte water uptake. We have examined whether EPO antagonizes the effect of mGluR5 activation on astrocyte water permeability. We found that: 1) EPO abolished the increase in AQP4 water permeability caused by activation by the group I mGluR agonist DHPG in rat astrocytes expressing AQP4. 2) EPO interfered with and altered the frequency of mGluR5‐triggered intracellular calcium oscillations in primary astrocytes. 3) Exposure to DHPG significantly increased the rate of rat hippocampal slice swelling in response to hypotonicity. EPO totally abolished the DHPG‐effect on the slice swelling rate. The effects on astrocyte swelling occurred within few minutes. In ongoing studies we have observed other downstream effects of EPO on astrocyte mGluR5 signaling: In primary cultured astrocytes DHPG increases the fraction of phosphorylated ERK1/2. Pretreatment with EPO for 20 min attenuates the effect of DHPG on ERK1/2 phosphorylation, suggesting that modulation of mGluR signaling in astrocytes also is involved in long‐term effects of EPO. Our findings indicate that EPO may, by dynamically affecting mGluR5 regulation of AQP4 water permeability reduce the risk of astrocyte swelling in acute brain insults. Furthermore, preliminary data suggest that EPO modulates astrocyte function via changes in mGluR5 signaling. Thus, astrocyte effects may also contribute to the long‐term neuroprotective effects of EPO.
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DOWNREGULATION OF CONNEXIN43 BY RNA INTERFERENCE UNCOVERS A CYTOSKELETAL PLATFORM INVOLVED IN PROCESS FORMATION AND MIGRATION {#sec2-185}
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### Olk S., Turchinovich A., Grzendowski M., Stühler K., Zoidl G., Dermietzel R. {#sec3-185}

#### Ruhr‐University Bochum, Bochum, Germany {#sec4-185}

BACKGROUND: Connexin 43 (Cx43) is the most abundant gap junction protein of the brain, where it is predominantly expressed in astrocytes. Recent studies imply a role of Cx43 in the regulation of important cellular processes, including migration, proliferation and apoptosis. These mechanisms are considered to impinge on the proteome of the Cx43 expressing cells.

METHODS: To analyze the influence of Cx43 on the astrocytic proteome we used RNA interference to downregulate the Cx43 expression in primary cultures of mouse astrocytes. We applied Difference Gel Electrophoresis (DIGE) to compare siRNA treated astrocytes with control cells. Quantitative immunocytochemistry and Western blotting were applied to verify the results from the DIGE study. Astrocytic morphology was analyzed by confocal laser scanning microscopy. Migration was assessed by a transwell assay.

RESULTS: The differential proteome analysis revealed 15 significantly regulated proteins, out of which 6 are known to belong the group of cytoskeletal members involved in cortical platform formation. Astrocytes treated with Cx43 small interfering (si)RNA showed an increased expression of the cytoskeletal proteins: actin, tubulin, tropomyosin, microtubule‐associated protein RP/EB1 and transgelin and a decreased expression of cofilin‐1. Besides that, GFAP was also found to be regulated. Quantitative immunocytochemistry and Western blotting revealed similar results showing an upregulation of actin, tubulin, tropomyosin, EB1, transgelin and GFAP, and a downregulation of Ser‐3‐phosphorylated cofilin. In addition to the impact of Cx43 silencing on cytoskeletal components, we found phenotypical changes in cell morphology and migratory activity. After down‐regulation of Cx43, astrocytes showed an increased number and an increased length of cell protrusions, while cell size remained equal. Astrocytes migrated faster after Cx43 silencing.

CONCLUSION: Our results provide first mechanistic clues for an understanding of Cx43 interaction with cellular motor activity such as migration and process formation in astrocytes. The next step will comprise the identification of effector proteins to unravel the uncharacterized signaling pathways affected by Cx43.
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PURINERGIC SIGNALING IN BERGMANN GLIAL CELLS {#sec2-186}
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A part from their role in neuronal metabolism and cytoarchitecture, astrocytes are increasingly viewed as active participants in the functioning of the brain. They respond to neural activity, affect network excitability, and can regulate blood flow. Bergmann glial cells constitute radial glia of the cerebellar cortex. Their processes surround Purkinje cell synapses and stellate cell axons in the molecular layer putting them in a position to both respond to and influence cerebellar processing. It has been shown that neuron to astrocyte signalling is mediated by a number of neurotransmitters, including ATP. While the presence of purinergic metabotropic receptors (P2Y) onto Bergmann cells has been well documented, the existence of ionotropic purinergic receptor (P2X) onto this astrocyte type is still unexplored. The superfamily of ATP‐sensitive ionotropic receptors is composed of seven cloned receptor subtypes (P2X1‐7). Unlike other P2X receptors, homomeric P2X7 receptors require high concentration of ATP (∼1 mM) to be activated. They are permeable to Na+, K+ and Ca2+ but, after repeated or prolonged exposure to ATP, they can form a non‐selective pore that allows permeation of large molecules. In the present study, immunostaining with P2X7 receptor antibodies reveal the expression of this receptor in Bergmann cell processes. Using patch clamp recordings from mouse acute cerebellar slices, we found that ATP or BzATP (a potent although non‐selective P2X7 receptor agonist) induced an inward current in Bergmann cells. This current was potentiated when ATP was applied in low Ca2+ and low Mg2+ solution and it was totally abolished in the presence of A‐740003, a new selective P2X7 receptor antagonist. Moreover, ATP or BzATP were unable to induce any inward current in Bergmann cells recorded from P2X7 knock‐out mice confirming that P2X7 receptor are functionally expressed in Bergmann glial cells, where they play a major role in the membrane depolarization elicited by ATP. Finally, adding a calcium dye in the patch pipette, we recorded intracellular Ca2+ Bergmann cells during ATP application and we found that intracellular Ca2+ raises were associated to the P2X7 receptor‐mediated current. These Ca2+ rises persist during the entire application of the agonist and appeared strongly diminished in P2X7 knock‐out mice.
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ANTIDEPRESSANTS ACT ON GLIA CELLS: CALCIUM RESPONSES OF ASTROCYTES TO CITALOPRAM AND FLUOXETINE IN THE MOUSE BRAIN {#sec2-187}
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#### Charité University Medicine Berlin, Berlin, Germany {#sec4-187}

Synaptic transmission is directly influenced by astrocytes, the most numerous cell type in the mammalian brain. An active role for astrocytes in memory processing is more and more recognized, but the role of astrocytes in mood disorders has yet to be elucidated. Also, the pathophysiological basis of major depressive disorder (MDD) and the modes of action of anti‐depressant drugs, especially of serotonin (5‐HT) reuptake inhibitors (SSRIs), are not completely understood.

In order to investigate the role of astrocytes in MDD and the mode of action of SSRIs, we loaded astrocytes in acute slices of the mouse prefrontal cortex with the calcium‐sensitive dye Fluo‐4 and analyzed the astrocyte calcium responses to stimulation with the SSRIs citalopram, fluoxetine or 5‐HT directly.

We found that in acute slices of the mouse prefrontal cortex the SSRIs citalopram and fluoxetine induce calcium signals in a subset of astrocytes also when neuronal signal propagation is inhibited. The calcium transients in individual astrocytes occur delayed and not all at once, in contrast to a classical astrocytic calcium response to ATP or glutamate. These calcium responses were also observed after the application of 5‐HT. Responses to 5‐HT could mostly not be evoked twice. Using pharmacological approaches, we determined glutamate as a substance that leads to the modulation of the 5‐HT‐induced calcium signal in astrocytes.

Thus, responses to stimulation of glutamatergic and serotonergic receptors on astrocytes are functionally interfering. We speculate that this neuron‐glia interaction which may play a role in the disturbed balance of neurotransmitter systems in MDD is modified by citalopram and fluoxetine.
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P2X RECEPTOR‐MEDIATED CURRENTS IN MOUSE HIPPOCAMPAL MICROGLIA AFTER A STATUS EPILEPTICUS {#sec2-188}
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Activation of microglia cells orchestrates inflammatory reactions associated with many brain disorders, including epilepsy. Purinergic signalling plays a critical role in microglia activation yet, membrane currents induced by the activation of purinergic receptors expressed in native microglia have rarely been studied. We previously showed that P2X and P2Y receptor‐mediated currents are up‐regulated in mouse hippocampal microglia after a status epilepticus (SE) induced by systemic injection of kainate. The present study aimed at characterizing in more details the currents evoked by P2X receptor (P2XR) activation in this model of temporal lobe epilepsy.

We performed whole cell recordings of microglia in hippocampal slices from CX3CR1+/eGFP adult mice. In wild type control animals, inward currents induced by bath applications of 1 mM ATP were partially blocked by the selective P2X7R antagonist A‐740003 (10 μM) and greatly potentiated in the absence of external divalent cations. A similar pharmacological profile was observed in P2X4 knockout (KO) mice except that the potentiation induced by divalent‐free external solutions was almost 4 times larger. In P2X7 KO mice, all current densities evoked by ATP were of smaller amplitudes. Forty height hours after induction of SE in wild type mice, current densities evoked by ATP, both in normal and in divalent‐free external solutions, were twice larger than in control mice. In P2X4 KO mice, SE induced an increase of the ATP responses evoked in normal external medium of similar magnitude than in wild type animals and the residual ATP response observed in P2X7 KO mice was also potentiated by SE.

These results indicate that non‐activated hippocampal microglia expresses functional P2X7Rs and that microglia activation by SE is accompanied by an increase of the P2X7R‐mediated responses. They also suggest that P2X4Rs negatively regulate P2X7R‐mediated responses and that another P2XR is also up‐regulated in microglia after SE.
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CELL‐BASED SCREENING OF AQUAPORIN‐4 MODULATORS FOR ASTROCYTE SWELLING IN BRAIN EDEMA {#sec2-189}
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Several studies have provided indirect evidence that aquaporins are involved in various physiological processes and have diverse clinical implications. In particular, many brain alterations such those occurring in stroke, head trauma, tumors and infections result in brain edema, an important neurological problem associated with mortality and morbidity. Recent studies demonstrate a key role of AQP4, strongly expressed in mammalian brain astrocytes, in the formation and the resolution of brain edema suggesting that AQP4 inhibition by pharmacological blockers might provide a new therapeutic alternative to current approaches for the treatment of cerebral edema.

Up today there are neither specific AQP4 inhibitors nor for other AQPs. The purpose of this study was to establish an automatic procedure to screen large commercially available libraries of drugs in order to identify compounds that modulate aquaporin function. We set up a functional assay based on measurement of osmotically‐induced cell volume changes by using the calcein quenching method. Time course of fluorescence changes was analyzed using a commercial 96‐multiwell fluorescence automatic plate reader. This system was validated using astrocyte primary cultures that strongly express endogenous AQP4 as well as AQP4‐transfected cells. Several different collections for a total of 3500 small drug‐like compounds were screened for their effect on AQP‐mediated water transport. These collections also included a set of 400 FDA approved and commercially available drugs. Primary screening yielded about ten compounds that affected water transport activity and/or cell volume regulation in both astrocytes and AQP4‐expressing cells. Selected drugs were then analyzed on AQP4 and AQP1 expressing membrane vesicles by stopped‐flow light scattering. Four molecules were identified that affected to a different degree both AQP4 and AQP1 mediated water transport with EC50 values between 20 and 50 μM. Our data support the fluorescence microplate reader‐based assay as a convenient approach for high‐throughput screening to select AQP‐specific drugs that may provide novel therapeutic strategies for the treatment of brain edema and other water balance disorders.
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N‐Methyl‐D‐Aspartate (NMDA) receptors are co‐activated by glycine and D‐serine which bind to the co‐agonist Glycine B site located on their NR1 subunit. A hypofunction of NMDA receptors may contribute to schizophrenia. Thus, enhancing activity at NMDA receptor‐coupled Glycine B sites may be therapeutically useful, and both glycine and D‐Serine have been clinically evaluated. Herein, their impact upon extracellular levels of amino acids was evaluated using in vivo microdialysis of the frontal cortex (FCX) of freely‐moving rats. Two HPLC separations and fluorescence detections were developed to simultaneously quantify amino acids in 10 min dialysate samples. Aspartate, glutamate, glutamine, glycine, taurine, alanine, citrulline, arginine, tyrosine and GABA were derivatised using naphtalene dicarboxaldehyde/cyanide while phosphoethanol amine, L‐serine and D‐serine were derivatised using O‐phtaldialdehyde/N‐Boc‐cysteine. D‐serine dose‐dependently (10‐160 mg/kg, s.c.) increased extracellular levels of D‐Serine in FCX by 7,000% vs baseline (=100%), without affecting L‐Serine, glycine or other amino acids. Conversely, L‐Serine (10‐160, s.c.) selectively elevated levels of L‐Serine, albeit only by 220%. Glycine (40‐800 mg/kg, i.p.) dose‐dependently elevated glycine levels up to 2,100%, but also elevated taurine (220%). Interestingly, L‐Serine levels were increased (170%), likely reflecting activation of the reversible enzyme serine hydroxymethyl transferase, whereas D‐Serine was suppressed (‐40%). This effect of glycine on D‐serine was reproduced with NMDA (40.0 s.c.), which also increased taurine but did not affect L‐Serine. Reductions in D‐Serine were blocked by pre‐treatment with the competitive NMDA antagonist, CPP, corroborating mediation by NMDA receptors. Interestingly, the inhibitory influence of glycine upon FCX levels of D‐Serine was abrogated in rats neonatally treated with PCP (2.5 mg/kg, s.c., 4 days). Moreover, similar decreases in D‐Serine were provoked in hippocampus, cerebellum, striatum and nucleus accumbens. This novel approach should generate a wealth of information concerning the influence of drugs and pathological states upon extracellular levels of multiple amino acids simultaneously quantified in discrete brain structures.
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EXPRESSION OF RYANODINE RECEPTOR ISOFORMS IN NORMAL AND INJURED RAT SCIATIC NERVE {#sec2-191}
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Ryanodine receptors (RyRs) are intracellular calcium release channels that participate in controlling cytosolic calcium levels. Currently three types of RyR have been identified in different tissues, including brain, but their expression in peripheral nerves has not been reported. Here, we have investigated the expression of the three RyR isoforms in the sciatic nerve. By RT‐PCR, all three RyR subtypes are expressed in the sciatic nerve; RyR1 (45%) is enriched relative to RyR2 (28%) and RyR3 (27%). Using an in situ hybridisation/immunohistochemistry technique, we show that in teased nerves the three isoforms are expressed in both non‐myelinating Schwann cells, which were identified by double‐labeling with GFAP, and myelinating Schwann cells. In myelinating Schwann cells they are present in the perinuclear and internodal cytoplasm of the Schwann cell sheath, but not in the nucleus. Expression is also observed in a majority of the nodes of Ranvier. These results suggest the presence of endoplasmic reticulum or free polysomes throughout the cytoplasm of both types of Schwann cells, where the RyR proteins are synthesized. In addition the localization of mRNA RyR at the nodal region suggests the presence of an RNA transport signal in the 3\'untranslated region of mRNA to ensure localized synthesis of the encoded protein at the nodal region. We also studied the levels of mRNA of RyR isoforms during Wallerian degeneration in transected sciatic nerve by semi‐quantitative RT‐PCR. No change in the levels of expression of RyR1was observed. However, the expression of RyR2 and RyR3 shows a small decrease in the distal and proximal regions of the sciatic nerve respectively.
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FUNCTIONAL CROSS‐TALK BETWEEN THE UROTENSIN II AND THE GABAA RECEPTORS IN ASTROCYTES. POTENTIAL INVOLVEMENT IN CELL PROLIFERATION {#sec2-192}
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### Castel H., Lefebvre T., Desrues L., Diallo M., Dubessy C., Leprince J., Vaudry H., Gandolfo P., Tonon M.C. {#sec3-192}

#### EA4310, Inserm, DC2N, Mont‐Saint‐aignan, France {#sec4-192}

Urotensin II (UII) is a cyclic neuropeptide up to now considered as the most efficient endogenous vasoactive factor in mammals. UII is the endogenous ligand of a seven transmembrane domain receptor coupled to G proteins termed UT receptor. Previous data from our laboratory have demonstrated that UII stimulates astrocyte proliferation and may interact with the glial GABA~A~ receptor (GABA~A~R). The aim of the present study was to investigate the ability of UII to modulate GABA~A~R activity in astrocytes and to characterize whether UII modulates the GABA‐evoked current in CHO cell lines transfected by cDNA encoding both human UT and GABA~A~R subunits. In coculture with neurons, we observed a decreased proliferation rate of astrocytes correlated to the presence of functional expression of GABA~A~R and to hyperpolarized resting membrane potential. Immunohistochemical experiments revealed that UT is expressed in astrocytes, Purkinje neurons and mature granule cells in cerebellum. In coculture, astrocytes were immunopositive for UT whereas the GABA~A~R γ1 subunit was expressed in granule cells but also in astrocytes. In astrocytes, UII (10‐13 -- 10‐7 M) induced an inhibition of the GABA‐evoked chloride current and accelerated its desensitization kinetic. In CHO expressing the human UT (CHO‐UT) and transfected with different GABA~A~R subunit combinations, UII markedly depressed the chloride current amplitude (α~3~γ~2~ \> α~2~β~3~γ~2~ \> α~2~β~1~γ~2~). This effect is characterized by a rapid inhibition after few‐seconds UII perfusion, followed by a run‐down of the GABA‐evoked current. The long‐term modulation was partially blocked in the presence of various kinase and phosphatase inhibitors and was totally abolished in the presence of an inhibitor of dynamin, a protein known to be involved in the internalization process of the GABA~A~R. Altogether, these data show that activation of UT resulted in a rapid and direct inhibition of the GABAergic activity through G proteins, kinase/phosphatase and calcium‐independent mechanisms, followed by a long‐term inhibition due to the GABA~A~R internalization. The UII‐induced prolonged inhibition of the GABA~A~R would play a key role in the initiation of proliferation and astrogliosis in pathophysiological conditions.
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EXTRACELLULAR CGMP CONTROL OF KAINATE RECEPTOR ACTIVATION IN RAT CEREBELLAR ASTROCYTE PROCESSES {#sec2-193}
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### Marcoli M., Cervetto C., Mazzotta M.C., Maura G. {#sec3-193}

#### University of Genova, Genova, Italy {#sec4-193}

Bidirectional signalling between astrocytes and neurons has revealed active astrocyte contribution to the regulation of synaptic transmission: the concept of tripartite synapse (including pre‐ and postsynaptic neuronal partners and astrocyte processes) has changed thinking about neurotransmission. Astrocyte processes are specialized zones expressing machinery for gliotransmitter uptake/release and receptors/channels regulating gliotransmitter release. Processes of astrocytes (gliosomes) can be isolated from the adult brain; in situ maturation of gliosome‐producing astrocytes gives the chance to directly investigate on the astrocyte process functioning in adult brain. While in the cerebellum roles for intracellular cGMP (produced in Purkinje and glial cells following ionotropic glutamate receptors/NOS/sGC pathway activation) have been widely investigated, roles for extracellular cGMP have been scarcely searched for. In the present work we investigate on extracellular cGMP effects on \[3H\]D‐aspartate release from rat cerebellar astrocyte processes.

Briefly, purified gliosomes were prepared from adult rat cerebellum by separation on discontinuous Percoll gradient, preincubated with \[3H\]D‐aspartate and superfused in parallel chambers; \[3H\]D‐aspartate fractional release was measured. AMPA or (S)‐CPW 399 (a full AMPA non‐desensitising receptor agonist) increased \[3H\]D‐aspartate release in a CNQX‐sensitive way; cyclothiazide (inhibiting AMPA receptor desensitisation) greatly increased the AMPA effect. Kainate primarily activated AMPA receptors (as indicated by the cyclothiazide facilitatory effect); blockade of AMPA receptor by GYKI 52466 and preventing kainate receptor desensitization with concanavalin A unmasked the kainate receptor response. Extracellular cGMP inhibited the kainate receptor‐mediated \[3H\]D‐aspartate release, while it was ineffective on the AMPA receptor response. In conclusion, we found that release‐stimulating AMPA and kainate receptors are present on cerebellar astrocyte processes; extracellular cGMP selectively impairs kainate receptor‐mediated responses. It can be hypothesised that cGMP might play roles as an extracellular signal in the control of the astrocyte‐neuron communication in adult rat cerebellar cortex.
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REGULATION OF PANNEXIN1 BY PROTEIN INTERACTION AND REDOX SIGNALING {#sec2-194}
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### Bunse S.,^1^ Locovei S.,^2^ Schmidt M.,^1^ Prochnow N.,^1^ Zoidl G.,^1^ Dahl G.,^2^ Dermietzel R.^1^ {#sec3-194}

#### ^1^Ruhr‐Universität Bochum, Bochum, Germany; ^2^University of Miami, Miami, United States {#sec4-194}

Pannexin1 (Panx1) is able to form hemichannels in the membrane of cells in the central nervous system (CNS). We are interested in the regulatory mechanisms controlling the functional properties of Panx1. Kvß3, a ß‐subunit of potassium channels, was identified as an interaction partner of Panx1 using a Two‐Hybrid system and confirmed by co‐immunoprecipitation. To study the physiological relevance, we examined the influence of Kvß3 on the electrophysiological properties of Panx1 expressed in oocytes of the frog *Xenopus laevis*. As the Kvß subunits are aldo‐reductases responding to changes in the redox state, the influence of reducing agents was tested during voltage clamp recordings on cRNA injected oocytes. TCEP attenuated the currents evoked by depolarization in oocytes expressing only Panx1. This effect was reduced if the agent was applied to cells co‐expressing Panx1/Kvß3. Apparently, Kvß3 exerts a rescue effect on the inhibitory influence of changes in the redox potential on the current of Panx1. Panx1 hemichannels are implied to play an essential role during ischemia. Because redox‐regulation is of importance during this pathogenic process, the ten cysteines of Panx1 were mutated and the functional properties of these mutants determined. The mutations of C40 and C346 led to the formation of constitutively open hemichannels while mutating the extracellular cysteines C66, C84, C245 and C264 resulted in "dead" channels. Our findings may pave the way for a better understanding of the physiological and pathological functions of Panx1 in the CNS.
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HEMICHANNELS MEDIATE CALCIUM OSCILLATIONS DURING ACTIVATION OF SPINAL CORD ASTROCYTES {#sec2-195}
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### Garre J.M., Bukauskas F.F., Bennett M.V.L. {#sec3-195}

#### Albert Einstein College of Medicine, Bronx, New York, United States {#sec4-195}

ATP is released within minutes during inflammatory stimulation of spinal cord astrocytes with FGF‐1. ATP then opens pannexin1 hemichannels (Px1 HCs), mediated by P2X7Rs activation, and hours later connexin 43 hemichannels (Cx43 HCs). Astrocytes are immunopositive to both P2X7R and Px1, as well as Cx43. HCs opened by ATP allow the release of ATP in a regenerative process leading to accumulation of ATP and calcium oscillations in ∼1/2 the activated astrocytes. The oscillations are rapid in onset (\<10 min), and low in frequency (0.2‐0.4/min), and are accompanied by HC mediated increase in membrane permeability (Pm) to ethidium ions (Etd+). The oscillations and Pm increases are diminished by application of apyrase, a soluble ATPase, or carbenoxolone (CBX), a Px1 and Cx43 HC blocker. Non‐hydrolyzable agonists of P2X7R increase Pm faster than does FGF‐1 (\<30 s), and these permeability increases are also diminished by apyrase, which hydrolyzes released ATP, or CBX, or by knocking down Px1 expression with siRNA.

Exogenous ATP evokes an initial short latency increase in \[Ca\]i which decays exponentially (time constant of decay, τ= ∼1 min).

Astrocytes show morphological signs of activation after 5 -- 8 h FGF‐1 treatment. Activated astrocytes exhibit increased basal \[Ca\]i and also show oscillations of higher frequency (1/min). Basal \[Ca\]i is reduced and \[Ca\]i oscillations are completely blocked by pre‐treating astrocytes with an FGF antagonist or apyrase during FGF‐1 treatment or by knocking down Px1 or blocking Cx43 HCs with octanol.

These data demonstrate that ATP release mediates FGF‐1 induced \[Ca\]i oscillations in spinal cord astrocytes. ATP released by opening of Px1 and Cx43 HCs elevates the membrane permeability to calcium and ATP and contributes to the generation of calcium oscillations. These oscillations may be characteristic of and integral to several spinal cord pathologies.
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FUNCTIONAL TASK‐1 CHANNEL IS EXPRESSED IN ASTROCYTES AND OLIGODENDROCYTES OF THE MOUSE OPTIC NERVE {#sec2-196}
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### Bay V., Butt A. {#sec3-196}

#### University of portsmouth, Portsmouth, United Kingdom {#sec4-196}

Tandem Pore Domain K^+^ channels (K~2P~) are accountable for K^+^ 'leak' currents in excitable cells, which play a major role in setting the resting membrane potential (RMP). Here, we have examined the role of TASK‐1 in setting the strongly negative RMP of glia and facilitating their primary function of extracellular K^+^ (\[K^+^\]~out~) regulation. All animals were killed humanely in accordance with the UK Animals (Scientific Procedures) Act (1986). Using immunohistochemistry of the cerebellum and optic nerve, we show that TASK‐1 is differentially expressed in glia, predominantly on the somata of oligodendrocytes and processes of astrocytes. Electrophysiological measurements were performed in isolated optic nerves maintained in a brain slice chamber and whole cell currents were recorded from explanted optic nerve glia. Stimulation of the optic nerve at 20Hz for 120 seconds resulted in a rise in \[K^+^\]~out~and consequent fall in the nerve compound action potential (CAP) amplitude, due to axonal K^+^efflux during action potential propagation. When high frequency stimulation was ended, there was a rapid undershoot in \[K^+^\]~out~ and gradual recovery of \[K^+^\]~out~, both of which are predominantly due to glial K^+^ spatial buffering. Treatment with the TASK‐1 inhibitor anandamide (10 μM), in combination with 100 μM BaCl~2~ to block glial Kir, had two main effects compared to treatment with BaCl~2~ alone: (1) during stimulation, anandamide was neuroprotective and reduced the decline in the CAP and the increase in \[K^+^\]~out~; (2) anandamide significantly decreased the post‐stimulation undershoot in \[K^+^\]~out~, although the recovery of \[K^+^\]~out~and the CAP were not improved. Furthermore, patch clamp analysis of glial whole cell currents in the presence of classical K^+^channel blockers revealed leak currents with anandamide sensitivity. The results demonstrate glial expression of TASK‐1 and support a role for glial TASK‐1 in \[K^+^\]~out~regulation and neuronal excitability.
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INTRACELLULAR CA2+ SIGNALING OF METABOTROPIC GLUTAMATE RECEPTOR 5 IS REGULATED BY THE RECEPTOR PHOSPHORYLATION {#sec2-197}
--------------------------------------------------------------------------------------------------------------

### Zelenina M.,^1^ Nishi A.,^2^ Uematsu K.,^2^ Heiman M.,^3^ Greengard P.,^3^ Aperia A.^1^ {#sec3-197}

#### ^1^Karolinska Institutet, Stockholm, Sweden; ^2^Kurume University School of Medicine, Kurume, Fukuoka, Japan; ^3^The Rockefeller University, New York, United States {#sec4-197}

Metabotropic glutamate receptor (mGluR) 5 is the major mGluR expressed in astrocytes. mGluR5 activation initiates a characteristic oscillatory Ca^2+^ response, which might have various intracellular effects depending on the amplitude and the frequency of the oscillations. At glutamatergic synapses, astrocytes take up glutamate released during neuronal activity. Astrocytes can also release glutamate, modulating neurotransmitter release and neuronal excitability. Both glutamate uptake and glutamate release are regulated by glutamate receptors and intracellular Ca^2+^ signaling. mGluR5 is known to have several potential sites of phosphorylation within its COOH‐terminus and intracellular loops. Here we report that phosphorylation of one of these sites might significantly modulate mGluR5‐activated Ca^2+^ oscillations. We have expressed the wild type and the mutant mGluR5 in HEK293 cells and performed a ratiometric intracellular Ca^2+^ measurements. We found that the mutation of mGluR5 on the phosphorylation site significantly decreases the average number of Ca^2+^ peaks observed in the cells in response to the mGluR5 agonist DHPG. The number of cells that responded to DHPG with Ca^2+^ oscillations (three or more Ca^2+^ peaks) was decreased 2‐fold in the cells expressing the mutant mGluR5, compared to the cells expressing the wild type mGluR5. The decreased Ca^2+^ response in cells transfected with the mutant mGluR5b was not due to an increased internalization of the receptors following the DHPG treatment. Our results suggest that the function of mGluR5 might be modulated by signaling from other types of astrocyte receptors. Via this modulation, glutamate uptake, glutamate release, and other astrocyte functions might be coordinated by several stimuli integrated at the level of mGluR5.

 {#sec1-p-424}
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ASTROCYTES DERIVED FROM NEURAL PRECURSOR CELLS OF WOBBLER MICE INDUCE APOPTOTIC DEATH OF MOTOR NEURONS THROUGH REDUCED GLUTAMATE TRANSPORT {#sec2-198}
------------------------------------------------------------------------------------------------------------------------------------------

### Diana V.,^1^ Ottolina A.,^1^ Botti F.,^2^ Fumagalli E.,^1^ Calcagno E.,^1^ de Paola M.,^1^ Cagnotto A.,^1^ Invernici G.,^3^ Parati E.,^3^ Curti D.,^2^ Mennini T.^1^ {#sec3-198}

#### ^1^Mario Negri Institute for Pharmacological research, Milano, Italy; ^2^University of Pavia, Pavia, Italy; ^3^Fondazione Irccs Neurological Institute, Carlo Besta, Milano, Italy {#sec4-198}

Among the putative factors responsible for motor neuron death in motor neuron diseases (MNDs), excitotoxicity caused by excess of glutamate in the extracellular milieu of the synaptic cleft is a well‐documented contributory pathway. In the present study, we investigated whether cultured astrocytes derived from adult neural precursor cells (NPCs) obtained from the subventricular zone (SVZ) of wobbler mice display metabolic traits of the wobbler astrocytes in situ and in primary culture. We also utilized NPC‐derived astrocytes as a tool to investigate the involvement of astrocytes in the molecular mechanism of MND focusing on the possible alteration of glutamate reuptake. NPC‐derived wobbler astrocytes were characterized by high immunoreactivity for GFAP, significant decrease of glutamate uptake (50%) and reduced immunoreactivity for glutamate transporters GLT1 and GLAST. The consequences of these alterations on motor neurons were studied by plating spinal cord motor neurons derived from healthy mouse embryos on a layer of wobbler NPC‐derived astrocytes. In these conditions, motor neurons showed reduced viability accompanied with morphologic alterations. Suffering motor neurons were caspase‐7 positive, and treatment with the anti‐apoptotic drug V5 increased motor neuron survival. Moreover, purified motor neurons displayed reduced survival when treated with the medium conditioned by wobbler NPC‐derived astrocytes. Glutamate receptor antagonists were able to enhance motor neuron survival. HPLC assay revealed toxic levels of glutamate in the extracellular medium of wobbler NPC‐derived astrocytes and reduced level of intracellular glutamate if compared with controls (p\<0.05). Therefore, our results demonstrate that alteration of astrocyte glutamate homeostasis may play a crucial role in motor neuron degeneration and that cultured astrocytes derived from NPCs may be an in vitro useful model to study the molecular mechanism involved in neurodegeneration.
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THE FATE OF NEURAL PROGENITOR CELLS AFTER TRANSPLANTATION INTO ISCHEMIC BRAIN {#sec2-199}
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### Tsupykov O.,^1^ Poddubna A.,^1^ Kyryk V.,^2^ Kuchuk O.,^2^ Butenko G.,^2^ Skibo G.,^1^ Pivneva T.^1^ {#sec3-199}

#### ^1^Bogomoletz Institute of Physiology, Kyiv, Ukraine; ^2^State Institute of Genetic and Regenerative Medicine, Kyiv, Ukraine {#sec4-199}

It is well known that, neural tissue is vulnerable to ischemic injury and has low regenerative potential. Stem cells therapy is a promising approach in design of therapeutic medicine against ischemic injury. Stem cells are able to find out damaged tissue, migrate to these zones and differentiate to the cell type, which is necessary for recovery lost functions. It is important to identify those cells in recipient tissue for estimation of stem cells transplantation efficacy.

In this study, we identified the fate of neural progenitor cells (NPCs) after their transplantation into ischemic brain tissue. Ischemic brain injury was performed by 20‐minutes occlusion of common carotid arteries in FVB mice. Neural progenitor cells were isolated from medial ganglionic eminences of E12.5 transgenic mice FVB‐Cg‐Tg(GFPU)5Nagy/J. Green fluorescent protein (GFP)‐positive progenitors were suboccipitaly transplanted into ischemic brain after 24 hours of occlusion. Migration and differentiation of GFP‐positive progenitor cells into recipient tissue were studied by immunofluorescent approaches using laser scanning confocal microscope at different time points after transplantation (7, 14, 28, 90 days). The following markers were used for study of NPCs differentiation: GFP, Nestin, NeuN and GFAP.

Transplanted GFP‐positive progenitor cells migrated and integrated into hippocampus, where it has be shown global ischemia leads to irreversible cellular damage. GFP‐positive NPCs differentiated into mature neurons and astrocytes. Moreover, GFP‐positive mature neurons in the hippocampus displayed the morphology of neurons with pyramidal cell bodies, long apical dendrites, and basal axons extending into the alveus. Evidence of synaptic inputs was apparent in the presence of arborized dendrites with spines.

Our data demonstrate that neural progenitors can survive, migrate and differentiate in an adult stroke lesion paradigm for up to 90 days. Obtained data of the study will be an experimental base for using stem cell therapy in ischemic brain injury.
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TRANSCRIPTION FACTOR‐BASED INSTRUCTION OF AN OLIGODENDROGLIAL FATE USING DIRECT PROTEIN TRANSDUCTION {#sec2-200}
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### Stock K.,^1^ Nolden L.,^2^ Edenhofer F.,^2^ Glaser T.,^2^ Bruestle O.^2^ {#sec3-200}

#### ^1^Institute of Reconstructive Neurobiology, Life & Brain Center, University of Bonn and Hertie Foundation, Bonn, Germany; Present Address: Max Delbrueck Center for Molecular Medicine (MDC), Berlin, Germany; ^2^Institute of Reconstructive Neurobiology, Life & Brain Center, University of Bonn and Hertie Foundation, Bonn, Germany {#sec4-200}

During development of the mammalian central nervous system, multipotent neural precursors generate neurons, oligodendrocytes and astrocytes in a time‐ and region‐specific manner. Transcriptional regulators represent key cell‐autonomous signals for neuro‐ and gliogenesis. The transcription factors Olig2, Nkx2.2 and Sox10 are supposed to be involved in directing the glial fate as well as maturation of oligodendrocytes. While Olig2 determines early oligodendroglial lineage commitment, Nkx2.2 and Sox10 participate in terminal differentiation of oligodendrocytes. Generation of oligodendrocytes and their progenitors from embryonic stem cells (ESC) provides interesting prospects for studying oligodendrocyte development, glial pathologies and myelin repair. Here, we explore whether direct protein transduction of transcription factors involved in oligodendrogliogenesis can be employed to modulate oligodendroglial differentiation in neural stem cells (NSC) derived from ESC. Specifically, we generated cell‐permeant variants of the transcription factors Olig2, Nkx2.2 and Sox10 containing the protein transduction domain from the human immunodeficiency virus‐1 transcriptional activator protein (TAT). Mouse ESC‐derived NSC served as a first model system for the functional validation of these proteins. These cells exhibit endogenous expression of Olig2 and Sox10, whereas Nkx2.2 expression is largely absent. Exposure of ESC‐derived NSC to recombinant Nkx2.2 protein and initiation of differentiation resulted in a two‐fold increase in the number of O4‐positive oligodendrocytes. Furthermore, Nkx2.2‐transduced cells exhibited a more mature oligodendroglial phenotype as evidenced by a three‐fold increase in tertiary processes and formation of myelin‐like structures. Comparative viral gene transfer studies showed that in this cell differentiation paradigm the biological effect of Nkx2.2 protein transduction is comparable to that obtained by lentiviral transduction. These observations demonstrate that direct delivery of transcription factors by protein transduction can be used as alternative modality to specify fate decision in differentiating stem cell cultures without genetic modification.

Supported by the BMBF (01GN0502).
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IN VITRO DIFFERENTIATION OF NEURAL STEM CELLS TOWARDS DOPAMINERGIC NEURONS {#sec2-201}
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### Roessler R., Boddeke E. {#sec3-201}

#### University Medical Center Groningen, Groningen, Netherlands {#sec4-201}

We have applied a protocol to differentiate mouse neural stem cells (NSC) towards dopamine (DA) neurons. According to in vivo differentiation pathways, we selected the extrinsic morphogenic factors Sonic hedgehog (Shh), fibrobast growth factor 8 (FGF8) and Wnt‐1 to induce differentiation towards DA neurons. Additionally we overexpressed the transcription factors Lmx1a (LIM homeobox transcription factor 1, alpha) and Msx1 (msh homeobox homolog 1), which are involved in the maturation process of DA neurons, in embryonic neural stem cells isolated from mouse brains. We found a clear increase in tyrosin hydroxylase (TH) positive cells using our in vitro differentiation protocol. However, overexpression of these intrinsic factors combined with extrinsic growthfactors does not cause a significant enhancement of DA cell differentiation. Furthermore, spatial and temporal expression patterns of these extrinsic and intrinsic factors are crucial for the correct differentiation of DA neurons in embryonic brain development. Therefore, we studied the effects of Shh and FGF8 on Lmx1a in a time and concentration dependent manner. Interestingly, we found that high concentrations of Shh and FGF8 provoke an increase in Lmx1a expression 48h and 72h after supplementation. This increased Lmx1a expression was even more pronounced if Shh and FGF8 was applied in combination with the histone deacetylase (HDAC) inhibitor Trichostatin A.
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GENERATION OF FUNCTIONAL ASTROCYTES FROM MURINE EMBRYONIC STEM CELLS {#sec2-202}
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### Kuegler P.B., Baumann B.A., Zimmer B., Kadereit S., Leist M. {#sec3-202}

#### Doerenkamp‐Zbinden Chair for Alternative in vitro Methods, Konstanz, Germany {#sec4-202}

Astrocytes are the most abundant glial cell type in the brain. They are involved both in the maintenance of physiological homeostasis and in inflammatory responses. Research into the cell biology of these cells would benefit from the availability of astrocytes cultures free of other glial contaminants. One approach to obtaining a reliable and reproducible cell culture system is differentiation of the cells from embryonic stem cells (ESC). We present here a method to generate highly astroglial‐enriched cultures from ESC and characterise them for inflammatory signalling responses. During the differentiation of both, embryonic and neural stem cells, astroglial markers (GFAP, S100b, A2B5, CD44) were upregulated while the transient neural markers nestin, NCAM, and bIII‐tubulin were downregulated in the final cultures. The presence of astroglial markers in about 90% of the cells of the culture and the absence of the neuronal markers NCAM and bIII‐Tubulin indicate a successful differentiation process. We demonstrated inflammatory signalling capability of our astrocytes by nuclear factor kB translocation into the nucleus and an increased release of IL‐6 and NO into the supernatant upon stimulation with a proinflammatory cytokine mix. ESC‐derived astrocytes and neural stem cell‐derived astrocytes showed the same response pattern as astrocytes isolated from mouse brain.
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EFFICIENT PRODUCTION OF OLIGODENDROCYTE PRECURSORS FROM HUMAN EMBRYONIC STEM CELLS IN DEFINED SERUM‐FREE MEDIUM {#sec2-203}
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### Sundberg M., Skottman H., Suuronen R., Narkilahti S. {#sec3-203}

#### REGEA ‐ Institute for Regenerative Medicine, University of Tampere and Tampere University Hospital, Tampere, Finland {#sec4-203}

Human embryonic stem cells (hESCs) are a promising source for production of oligodendrocyte precursor cells (OPCs) and oligodendrocytes. These cells can be used for myelin repair in central nervous system deficits such as multiple sclerosis or in traumas such as spinal cord injury. Here, we introduce a new differentiation method for the efficient production of OPCs from hESCs. OPCs were differentiated in defined serum‐free medium supplemented with human growth factors. A broad gene expression analysis revealed that this OPC population expressed Olig1/2, Sox10, PDGFR, Nkx2.2, Nkx6.2, OMG, MBP, and PLP. The OPC population was over 90% positive for NG2 and further maturated into GalC‐ (80%) and O4‐ (45%) positive oligodendrocyte populations. These OPC populations could be purified with NG2+ selection by fluorescence activated cell sorting. In addition, these NG2+ cells maturated into myelin‐forming cells when co‐cultured with neuronal cells. The novelty of this method is that hESC‐derived OPCs expanded in the presence of human growth factors and differentiated on human extracellular matrix proteins that were used as a substitute for matrigel. Further development of this protocol for OPCs differentiation will be useful for therapeutic graft production.
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GLYCANS IN BRAIN DEVELOPMENT: THE NOVEL MONOCLONAL ANTIBODY CLONE 5750 DETECTS A CARBOHYDRATE EPITOPE ON NEURAL PRECURSOR CELLS {#sec2-204}
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### Hennen E.,^1^ Faissner A.^2^ {#sec3-204}

#### ^1^International Graduate School of Neuroscience and Dept. of Cell Morphology and Molecular Neurobiology, Ruhr‐University, Bochum, Germany; ^2^Dept. of Cell Morphology and Molecular Neurobiology, Ruhr‐University, Bochum, Germany {#sec4-204}

Glycosylation is a common modification of proteins and lipids. Elimination of the major classes of glycans has proven lethal during embryogenesis. Therefore, it is accepted that glycosylation is critical for proper protein function. Genetic disruption of various glycosyltransferases that determine distal parts of glycan chains gives rise to viable animals. However, these suffer from significant functional deficits. These findings indicate that glycans serve manifold biological roles, most of which remain to be uncovered. Moreover, since many glycans are linked to cell surface proteins or lipids, they serve as excellent biomarkers at different stages of cellular differentiation.

Here, we introduce the novel monoclonal antibody (mAb) clone 5750 as a new tool to study glycans as well as glycoproteins. When tested in oligosaccharide microarrays, the mAb 5750 was found to bind to carbohydrates belonging to the LewisX (LeX) structural type. LeX, also known as CD15 or SSEA‐1, is involved in cell proliferation and migration in the CNS.

Immunohistochemical analysis of the developing embryo showed a strong correlation of the 5750‐epitope with established neural precursor cell markers such as nestin and RC2. Fluorescent activated cell sorting of embryonic cortical cells confirmed that the 5750‐positive population consists of multipotent neural precursor cells with neurosphere forming capacity. Conversely, the 5750‐negative cell population lacks this property. Hence, mAb 5750 can be used to isolate and select for neural precursor cells. Interestingly, the epitope recognized by mAb 5750 seems to differ from those detected by other anti‐LeX antibodies. We show that the glycans detected by mAb 5750 and by the anti‐LeX mAb 487 (L5) are expressed by different cell populations.

In conclusion, we provide evidence that mAb 5750 permits new insights into the complexity and variability of neural stem and progenitor cell populations.
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ORGANOTYPIC CULTURE: AN EX VIVO APPROACH TO STUDY POSTNATAL MODIFICATION {#sec2-205}
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### Armentano M.,^1^ Aimar P.,^1^ Canalia N.,^1^ Bonfanti L.^2^ {#sec3-205}

#### ^1^University of Turin, Grugliasco (TO), Italy; ^2^National Institute for Neuroscience‐Italy, Turin, Italy {#sec4-205}

Adult neurogenic sites are specialized microenvironments (niches) regulating neurogenesis in restricted brain regions. In the subventricular zone (SVZ), neurogenesis is supported by neural stem cells (NSCs). They are astrocytic cells which proliferate at low rate and contribute transit‐amplifying progenitors which expand to generate neuroblasts (Doetsch, 2003). During the first three weeks after birth, radial glia transform into into SVZ astrocytes, but how this glial population changes remains to be understood (Bonfanti & Peretto, 2007).

We are developing an ex vivo model of forebrain organotypic slices which contain the SVZ, to be employed as an alternative way of investigating the NSC niche. We adapted the original protocol for hippocampal cultures (Stoppini, 1991) to slices containing both neurogenic (SVZ) and non‐neurogenic tissue (striatum, cortex). We extended this ex vivo approach to all ages involved in the SVZ postnatal modifications (0, 5, 13, 21 days from birth). The goal is a systematic study to define ultrastructural/antigenic features of SVZ niche at different time points in vitro (0, 12, 24, 48 hrs), focusing on the different cell types and their three‐dimensional relationships. We show that conditions for these cultures change through the postnatal ages, due to modifications of the non‐neurogenic tissue (Canalia, in preparation). Cell viability and behaviour are different in the SVZ and non‐neurogenic tissue. Proliferation markers (BrdU, PH3) revealed that mitotic activity in the SVZ culture is not affected at any time point considered. We quantified apoptosis (casp3A+ cells) at the light and ultrastructural level. At early in vitro time points (t0‐t6) SVZ cells are more healthy than surrounding tissue. With CD11 marker, we found both highly ramified (quiescent microglia) and fibroblastic (reactive microglia), maybe a possible gliosis resulting from technical procedures. We also started to compare the postnatal modification of glial populations in vivo and in culture.

Our results show that it is possible to get viable organotypic cultures at different ages (first three postnatal weeks) that preserve SVZ cell types and relationships between neurogenic and non‐neurogenic tissue, although changes in the SVZ three‐dimensional arrangement start to occur after 24 hrs in colture.
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ACTIVATED ADULT NEURAL STEM CELLS GENERATE DISTINCT LAMININ/ INTEGRIN INTERACTIONS DURING REGENERATION OF THE SUBEPENDYMAL ZONE NEUROGENIC NICHE {#sec2-206}
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### Kazanis I.,^1^ Lathia J.D.,^2^ Vadakkan T.J.,^3^ Mattson M.P.,^4^ Dickinon M.E.,^3^ Ffrench‐Constant C.^5^ {#sec3-206}

#### ^1^University of Cambridge, Cambridge, United Kingdom; ^2^Lerner Research Institute, Cleveland, United States; ^3^Baylor College of Medicine, Houston, United States; ^4^National Institute on Aging, Baltimore, United States; ^5^MRC Centre for Regenerative Medicine, Edinburgh, United Kingdom {#sec4-206}

The subependymal zone (SEZ) of the lateral ventricles is one of the areas of the adult mouse brain where new neurons are continuously generated from astroglial‐like neural stem cells (NSCs), via rapidly dividing neuronal progenitors. Within this niche, neural stem cells reside in a complex cellular and extracellular microenvironment comprising their own progeny, ependymal cells, numerous blood vessels and various extracellular matrix (ECM) molecules. Here we show that NSCs, which remain relatively quiescent (therefore can be identified as slowly‐dividing BrdU‐retaining cells) in the normal, homeostatic niche, occupy distinct positions in relation to blood vessels and the ventricular wall, compared to their actively dividing progeny. In addition, quiescent NSCs do not contribute to the laminin content of the niche and express low levels of laminin receptors, such as integrin beta1, again in contrast to neuronal progenitors. Interestingly, their behavior is significantly altered during regeneration of the niche, after the ablation of actively dividing progenitors. Although their position within the niche does not change they start modulating their microenvironment by expressing the laminin b1 chain and by upregulating expression of specific laminin receptors prior and in parallel to their mitotic activation. Conclusively, our data demonstrate that adult NSCs retain the ability to respond to environmental queues in vivo and to become more interactive with their microenvironment during periods of activity.
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OLFACTORY ENSHEATHING CELLS ATTRACTANT OF NEURAL PROGENITOR MIGRATION TO OLFACTORY BULB {#sec2-207}
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### He C., Zhu Y. {#sec3-207}

#### Second Military Medical University, Shanghai, China {#sec4-207}

Olfactory ensheathing cells (OECs) are the glial cells that derive from the olfactory placode, envelop olfactory axons in the course of migration from the olfactory epithelium to the olfactory bulb and reside in the olfactory nerve layer and glomerular layer. OECs transplantation as a promising experimental therapy for axonal injuries has been intensively studied, however little is known about their roles in olfactory bulb development. In the present study, we examined the effects of OECs on migration of neural progenitors in rostral migratory stream (RMS). Initially, the neurosphere migration assay showed that OEC‐conditioned medium promoted progenitors migrating from RMS neurospheres in a concentration dependent manner. Moreover, co‐culture of OECs nearby the RMS explants lead to asymmetric migration of explants in different developing stages. Finally, slice assay that mimic the circumstance in vivo revealed that OECs had a chemoattractive activity on RMS neural progenitors. Together, these results demonstrate that OECs attract neural progenitors in RMS through the release of diffusible factors and suggest a previously unknown function for OECs in olfactory development.
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COMBINED IN VIVO BIOLUMINESCENCE AND MAGNETIC RESONANCE IMAGING OF ADHERENTLY CULTURED NEURAL STEM/PROGENITOR CELL IMPLANTS IN BRAIN OF MICE {#sec2-208}
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### Reekmans K.,^1^ Tambuyzer B.,^1^ de Vocht N.,^1^ Bergwerf I.,^1^ Daans J.,^1^ Baekelandt V.,^2^ Jorens P.,^1^ Goossens H.,^1^ Ysebaert D.,^1^ Chatterjee S.,^1^ Van Marck E.,^1^ Van Der Llinden A.,^1^ Berneman Z.,^1^ Ponsaerts P.^1^ {#sec3-208}

#### ^1^University of Antwerp, Wilrijk, Belgium; ^2^Kuleuven, Leuven, Belgium {#sec4-208}

Transplantation of neural stem/progenitor cells (NSPC) is expected to become a supportive therapy for treatment of traumatic and ischemic injuries to the central nervous system (CNS). In order to improve the methods to follow the fate of cells implanted in the CNS, we investigated a multimodal imaging strategy for NSPC implants by real‐time bioluminescence imaging (BLI), magnetic resonance imaging (MRI) and histological analysis. For this, we first derived adherently growing NSPC cultures from ROSA26‐L‐S‐L‐Luciferase transgenic mice, which displayed a uniform morphology and expression profile of membrane and intracellular markers, and which displayed an in vitro differentiation potential into astrocytes and neurons. Next, in order to localise luciferase‐expressing NSPC (NSPC‐LUC) cell grafts in vivo by MRI and post‐mortem by histology, cultured NSPC‐LUC were loaded with 0.96 μm green fluorescent micron‐sized iron oxide particles (f‐MPIO). Using MRI, we were able to detect f‐MPIO particles upon implantation of f‐MPIO‐labelled NSPC‐LUC in the CNS of mice. In addition, in vivo cell viability was monitored reliably by in vivo BLI up to two weeks post‐implantation. Finally, histological analysis revealed an in vivo differentiation potential of f‐MPIO‐labelled NSPC‐LUC mainly into astrocytes, but not into neurons. In addition, all presented results were further validated by histology using enhanced green fluorescent protein (eGFP)‐expressing NSPC‐LUC cultures. In summary, we have developed an experimental procedure to combine in vivo BLI and MRI and have validated it with post‐mortem histological analysis in order to evaluate in vivo survival, localisation and differentiation of adherently cultured NSPC grafted in the CNS of mice.
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CHARACTERISATION OF THE STEM CELL‐LIKE POPULATION FOUND WITHIN HUMAN OLFACTORY MUCOSA {#sec2-209}
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### Lindsay S.L.,^1^ Clark L.,^2^ Sheikh S.,^2^ Barnett S.C.^1^ {#sec3-209}

#### ^1^Division of Clinical Neuroscience, GBRC, University of Glasgow, G12 8TA, Glasgow, United Kingdom; ^2^ENT department, Southern General Hospital, G51 4TF, Glasgow, United Kingdom {#sec4-209}

The peripheral olfactory system undergoes continual neurogenesis throughout life, making it a unique tissue. It is comprised of the olfactory mucosa (OM) which resides in the PNS and the olfactory bulb (OB) which resides in the CNS. The olfactory mucosa (OM) consists of the olfactory epithelium (OE) and the underlying lamina propria (LP). The capability of the OM to repair has been attributed in part to the multipotential stem cells present in the basal layer of the OE. However, we have recently shown that embryonic rat OM contains two stem cell‐like populations; one originating from the OE and the other from the LP. Since transplants of human OM are already ongoing in clinical trials, it is necessary to assess the potential of such tissue as a source of stem cells and focus on whether human OM has similar stem cell populations as described for the rat. Human olfactory biopsies were obtained with ethics approval from nasal/polypectomy surgery. Samples were processed for immunofluorescence or cultured in neurosphere media to promote stem cell‐like proliferation. The staining profile of human and rat mucosa was compared using a panel of markers and similar patterns were found. Culture of human OM resulted in either the generation of neurospheres, akin to that found in the rat and/or a monolayer of cells. The majority of neurospheres were tightly packed with a defined membrane expressing cytokeratin positive cells. In addition, other spheres were found to contain cells positive for nestin, SMA, Stro‐1, GFAP and Thy1.1. Cells derived from spheres were found to undergo differentiation into osteogenic and adipogenic lineage when placed into the appropriate induction medium, suggesting they have mesenchymal stem cell‐like properties. Cells from monlayers had a mixed phenotype expressing both OE and LP markers. Preliminary data using FACS analysis has shown it is possible to isolate Stro‐1 positive cells from these mixed populations. These results suggest that there are similarities between human and rat OM and they each contain distinct cell populations with stem‐cell like properties. Interestingly, there may be a mesenchymal stem‐cell like population which is likely to originate from the LP. These findings highlight the cellular complexity of olfactory tissue as a potential source of stem cells.
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GFAP‐ DELTA POSITIVE CELLS IN THE HUMAN SUBVENTRICULAR ZONE IN RELATION TO REMYELINATION AND SCAR FORMATION IN MULTIPLE SCLEROSIS {#sec2-210}
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### Huitinga I., Kuijpers C., Van Weverswijk A., Van Heerikhuizen J., Coppen E., Hol E., Van Eden C. {#sec3-210}

#### Netherlands Institute for Neuroscience, Amsterdam, Netherlands {#sec4-210}

The pathophysiological process of multiple sclerosis (MS) is characterized by a dynamic interplay of de‐myelination and repair mechanisms. Remyelination represents an important mechanism of repair and occurs in an early stage of the lesion. In a later stage scar formation becomes prominent, which prevents further remyelination. A study was conducted in human post mortem brain (<http://www.brainbank.nl>) to elucidate the role of δ‐GFAP positive progenitor cells in the subventricular zone (SVZ) in these processes in MS. δ‐GFAP is a splice variant of the GFAP gene, the intermediate filament protein commonly expressed in glia and in progenitor cells in the SVZ. δ ‐GFAP alters the cytoskeleton and, thereby, can change motility of the cells (Roelofs et al, Glia 2005). The SVZ was outlined in immunohistochemically stained sections of MS patients and controls on the basis of δ‐GFAP expression at two standard locations along the SVZ. Image analysis, measuring the average thickness of the SVZ and the density of δ‐GFAP‐positive profiles, showed that the thickness had significantly increased in MS patients as compared to controls, both in MS patients with active and with chronic inactive lesions. However, the immunoreactivity of δ‐GFAP was significantly increased in MS patients with active lesions only. Likewise, PCNA expression, a marker for cell proliferation, was significantly increased in MS patients with active lesions only. Double‐stainings of δ‐GFAP with the oligodendrocyte (precursor) markers SOX9, Olig2, O4 and Galc were used to explore the contribution of these δ‐GFAP positive SVZ cells in the development of new oligodendrocytes. The first results point to a contribution of the δ‐GFAP positive cell population as source of oligodendrocytes as well as to astrocytes in and around active lesions.

MS Reseach grant 06‐586.
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TRANSPLANTATION OF EMBRYONIC NEURAL STEM/PRECURSOR CELLS OVER‐EXPRESSING CEND1/BM88 IN A MOUSE MODEL OF ACUTE CORTICAL TRAUMA ENHANCES NEURONAL DIFFERENTIATION {#sec2-211}
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### Thomaidou D., Makri G., Lavdas A., Katsimpardi L., Matsas R. {#sec3-211}

#### Hellenic Pasteur Instute, Athens, Greece {#sec4-211}

The intrinsic inability of the central nervous system to efficiently repair traumatic injuries renders transplantation of neural stem / precursor cells (NPCs) a promising approach towards repair of brain lesions. In this study cultured embryonic day E14.5 (E14.5) mouse cortex NPCs were genetically modified to over‐express the neuronal cell fate determinant Cend1/BM88, known to promote cell cycle exit and neurogenesis both in vitro and in vivo, and were subsequently stereotaxically transplanted in a mouse model of acute cortical injury. Our findings indicate that grafts of both wild‐type and Cend1‐overexpressing NPCs survive 1 month after the lesion and spread in a distance of 350 μm away from the transplantation site without forming tumors. A significant sub‐population of transplanted NPCs express the undifferentiated neural stem cells marker Nestin 1 day following transplantation, while the number of Nestin+ cells gets significantly reduced 1 and 4 weeks following the transplantation. Interestingly, our data demonstrate that, by contrast to wild‐type NPCs, a sub‐population of Cend1‐overexpressing NPCs have the potency to differentiate towards the neuronal lineage 4 weeks after the transplantation. Also, transplantation of Cend1‐overexpressing NSC in the lesion site results to less extensive astrogliosis of the damaged cortical tissue, as well as, a smaller number of transplanted cells differentiating towards the oligodendroglial lineage, as compared to wild‐type NPCs transplantation. Taken together these results support the potential of using NPCs over‐expressing Cend1 for both promoting neurogenesis and reducing astrogliosis in the acute cortical injury mouse model of brain trauma.
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EXPRESSION PATTERN OF GABA RECEPTORS IN SCHWANN CELL‐LIKE DERIVED FROM STEM CELLS {#sec2-212}
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### Faroni A.,^1^ Terenghi G.,^1^ Magnaghi V.^2^ {#sec3-212}

#### ^1^Blond McIndoe Laboratories, Tissue Injury and Repair Group, The University of Manchester, Manchester, United Kingdom; ^2^Department of Endocrinology, Physiopathology and Applied Biology, University of Milan, Milan, Italy {#sec4-212}

Gamma amino‐butyric acid (GABA), the main inhibitory neurotransmitter in the adult central nervous system (CNS), interacts with different receptor types, respectively the ligand‐gated ion channel GABA‐A and the metabotropic GABA‐B receptor. Both GABA‐A and GABA‐B receptor types are expressed in glial cells of the central and peripheral nervous system (PNS), where they are involved in the biology of myelin. Previous in vitro studies showed that GABA receptor ligands modulate the proliferation and expression of myelin proteins in Schwann cells (SC) cultured from neonatal rat sciatic nerves (Magnaghi, 2004). Furthermore, the importance of GABA‐B receptors in peripheral myelination has been analyzed in vivo in GABA‐B1 deficient mice (Magnaghi, 2008). SC play an essential role in peripheral nerve regeneration, but due to their slow growth rate, they are not profitable to a tissue engineering approach for nerve regeneration. Adult stem cells, derived either from adipose tissue (ADSC) or from bone marrow (BM‐MSC), can be differentiated into a SC‐like phenotype and thus potentially be used as SC substitute. The aim of this study was to determine the expression pattern of GABA receptors in these cells following differentiation. By means of immunocytochemistry, RT‐PCR and western blot analysis we found that both BM‐MSC and ADSC express several subunits of GABA‐A and B receptors. Specifically, GABA‐A subunit α2 and β1, GABA B1 and B2 subunits are expressed in BM‐MSC and ADSC and appear to be upregulated in SC‐like differentiated cells. Furthermore, consistent with previous observations made on SC, the localization of these subunits is cytoplasmatic. Altogether our data show that GABA receptors are present in BM‐MSC and ADSC stem cells, where they might be functionally active regulating SC‐like differentiation. Further experiment are direct to analyze whether SC‐like may be a valid tool to improve peripheral nerve repair after injury.
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LONG‐CHAIN FATTY ACID SUPPLEMENTATION OF NEURAL STEM CELLS/NEURAL PROGENITORS CULTURES {#sec2-213}
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### Langelier B., Linard A., Lavialle M., Heberden C. {#sec3-213}

#### INRA, Jouy En Josas, France {#sec4-213}

Rat neural stem cells/neural progenitors (NSC/NP) in culture were analyzed for their lipid and fatty acid contents. Under standard conditions, the cells were characterized by phospholipids displaying a highly saturated profile, deprived of poly unsaturated fatty acids (PUFAs). When cultured in the presence of Arachidonic Acid (AA), or docosahexaenoic acid (DHA), the two main PUFAs present in the brain, the cells easily incorporated them into the phospholipid fraction. When cells were allowed to differentiate in PUFAs‐enriched media, they expressed more connexin 43 and pannexin‐1, and neurons had elongated neurites compared to cells grown in standard conditions. Additions of AA and DHA in the medium resulted in a robust and sustained activation of ERK1/2. The effects of both PUFAs were comparable to the effect of brain derived neurotrophic factor (BDNF). Along with their function as membrane building‐blocks, PUFAs display neurotrophin‐like properties. The mechanism underlying this feature has yet to be revealed.
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BMP7 RELEASE FROM ENDOGENOUS NEURAL PRECURSORS SUPPRESSES GLIOMA STEM CELLS {#sec2-214}
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### Glass R.,^1^ Chirasani S.,^1^ Sternjak A.,^1^ Wend P.,^1^ Momma S.,^2^ Herold‐Mende C.,^3^ Besser D.,^1^ Synowitz M.,^4^ Kettenmann H.^1^ {#sec3-214}

#### ^1^Max Delbrück Center, Berlin, Germany; ^2^Edinger Institut, Frankfurt M., Germany; ^3^Neurosurgery, Universität Heidelberg, Heidelberg, Germany; ^4^Neurosurgery, Charité, Berlin, Germany {#sec4-214}

We have established previously that endogenous neural precursor cells (NPCs) are attracted to experimental gliomas and reduce tumor size. We now report that NPCs constitutively release BMP7 and thereby suppress the tumourigenicity of CD133‐expressing glioma stem cells.

Using an in vivo model we show that glioma‐associated PSA‐NCAM‐positive NPCs express BMP7, but not BMP2 or BMP4. BMP7 is the pre‐dominant BMP in neurosphere cultures and is mainly expressed by PSA‐NCAM‐positive NPCs, but not by differentiating precursor cells or by tumor cells. The NPCs constitutively release BMP7 and induce canonical smad signaling in human glioma stem cells. Neurosphere conditioned media or recombinant BMP7 were applied to murine or human glioma and, BMP‐receptor dependently, reduced the plasma‐membrane expression of CD133, attenuated tumour cell expansion, sphere formation and viability, and induced markers of differentiation. Importantly, exposure of CD133+ murine glioma cells to recombinant BMP7 prior to intracerebral injection prolonged survival in a mouse model. Likewise, BMP signaling evoked by NPC‐conditioned medium in human glioma stem cells prior to intracerebral injection significantly prolonged survival in a mouse model. Finally, we show that BMP7 attenuates the expansion of human glioma stem cells by downregulating the expression of Olig2. Overall, our results show that NPC‐released BMP7 attenuates tumor expansion by suppressing the population of glioma stem cells and point out a role for BMPs as paracrine tumor suppressors in the CNS.
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PROM1 (CD133) IS A MARKER OF DISTRIBUTED GLIAL PROGENITORS IN THE ADULT BRAIN {#sec2-215}
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### Maire C.,^1^ Holmberg Olausson K.,^1^ Ling J.,^1^ Haynes R.,^2^ Learner E.,^1^ Ligon K.L.^3^ {#sec3-215}

#### ^1^Dana‐Farber Cancer Institute, Boston, United States; ^2^Department of Pathology and Neurology, Children\'s Hospital, Harvard University, Boston, United States; ^3^Pathology, Harvard Medical School, Center for Molecular Oncologic Pathology, Dana‐Farber Cancer Institute/Brigham and Women\'s Hospital, Boston, United States {#sec4-215}

Prom1 (Prominin 1 or CD133) is a transmembrane glycoprotein localized in plasma membrane protrusions and is used as a stem/progenitor cell marker in glioblastoma (GBM) and various other cancers. However, numerous controversies remain over its expression and function in the normal and pathological brain and we sought to address this through a more detailed expression analysis. During embryonic development (E12.5‐E18.5), RNA in situ hybridization shows *CD133* is broadly and moderately expressed in the ventricular zone stem/progenitor cells of the entire CNS. Interestingly, in the postnatal period a new and apparently distinct population of *CD133* cells with high level expression (*CD133* ^hi^) appears to arise distributed widely throughout the white and grey matter in both mouse and human brain. The *CD133* ^hi^ distributed population (DP) is the predominant population detected from P14 to adult mouse brain, while *CD133* expression in the SVZ and SGZ is reduced with time. This developmental switch in *CD133* expression corresponds also with a switch in *CD133* isoform expression from the embryo to the adult. Although previously reported to be lineage null, we find that *CD133* ^hi^ DPs express the glial stem/progenitor markers Olig2 (100%) and Sox2 (18%). No co‐localization with Gfap (astrocytes), NeuN (neurons) or NG2 (oligodendrocyte DPs) were noted. In vivo labeling with BrdU shows CD133hi DPs are slowly dividing progenitors but such cells do not respond to injury such as stab wound lesion or irradiation. However, analysis of CD133 expression in the pathologic setting of human cancer shows the presence of an interesting and heterogeneous pattern of expression in GBM but not in MB. In summary our data suggest Prom1 expressing cells might represent a new population of distributed relatively quiescent glial progenitors more likely involved in the origin of gliomas than medulloblastomas.
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IMPAIRED ADULT NEUROGENESIS IN MICE WITH REDUCED CX43 EXPRESSION {#sec2-216}
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### Frahm C. {#sec3-216}

#### University Hospital Jena, Jena, France {#sec4-216}

BACKGROUND: Connexin43 is the main astrocytic gap junction protein in the brain followed by Cx30. A diminished Cx43 expression in cell cultures simulating developmental processes causes a reorganization of purinergic receptors accompanied with impaired cell proliferation and differentiation. Our study was designed to answer the question if reduced Cx43 and Cx30 influences the expression of P2Y1 and P2Y2 receptors and thereby impairs proliferation of neural progenitor cells in the adult hippocampus. To that end, mice with conditional deletion of Cx43 and mice with disruption of astrocytic coupling (created by crossing conditional Cx43‐deficient mice with conventional Cx30 knockout mice) were investigated. C57Bl/6 mice and mice with inserted loxP elements (Cx43fl/fl) served as controls.

RESULTS: Insertion of loxP sites already dramatically down‐regulated Cx43 transcripts and proteins to about 30%, cre recombinase activity leads to a further decrease to 5% transcripts and to no discernable protein expression. Cell proliferation rate of hippocampal progenitors decreased to about 50% in all transgenic mice. Phenotyping of newborn cells revealed a significantly reduced number of mature neurons in Cx43fl/fl exclusively. P2Y1 and P2Y2 mRNA did not significantly vary between all tested groups. The impaired proliferation rate in all transgenic mice is probably due to the strong downregulation of Cx43 which is already present in Cx43fl/fl mice.

CONCLUSION: Our study revealed an impact of Cx43 but not Cx30 expression on adult neurogenesis. Stable expression of P2Y1 and P2Y2 in vivo implicates another mechanism of Cx43 mediated effects on cell proliferation than previously shown in vitro.
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NESTIN, NEUROFILAMENT, BETA‐TUBULIN AND MAP‐KINASE ESPRESSION IS UP AND DOWN MODULATED IN DEX OR ESTRADIOL‐TREATED RAT BONE MARROW MESENCHYMAL STEM CELL CULTURES DIFFERENTIATING TO NEURAL CELL LINE {#sec2-217}
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#### ^1^Dept. of Chemical Sciences, sec. Biochemistry and Molecular Biology, University of Catania, Catania, Italy; ^2^Dept. of Physiological Sciences, University of Catania, Catania, Italy; ^3^Dept. of Biological Chemistry, Medical Chemistry and Molecular Biology ‐ University of Catania, Catania, Italy {#sec4-217}

It\'s well known that bone marrow mesenchymal stem cells (MSCs) are multipotent cells in the bone marrow stromal line, known for their potential to differentiate into several cell types.

In the present study we investigated the effects of dexamethasone (DEX) or estradiol (E~2~) on proliferation and differentiation of rat MSCs in culture, evaluating by western blotting and immunocitochemical analysis some neural proliferative and differentiative markers.

MSCs were harvested from bone marrow of femurs of 4 to 8 month‐old rats. Cytofluorimetric analysis revealed that MSCs were negative for CD45, CD34 and positive for CD90, CD105.

After 24h starvation period, MSC cultures were treated for 48h with DEX 10^‐9^ M or E~2~ 5 x 10^‐9^ M. Qualitative and quantitative analysis were performed by immunocytochemical and western blot analysis respectively for nestin, neurofilament, beta‐tubulin and MAP‐kinase.

Our results show an enhancement of the above mentioned neural markers and MAP‐Kinase in MSCs cultures treated with DEX. E~2~‐treatment increases MAP‐Kinase and beta‐tubulin expression, but it decreases nestin and neurofilament expression.

In conclusion, our results indicate that DEX induces an up modulation of some neural protein expression indicating an its possible role played on differentiation of these MSCs to neural cell line.

Furthermore, these findings show an involvement on signal transduction patways. On the contrary, E~2~treatment induces up and down modulation of nestin, neurofilament, beta‐tubulin and MAP‐kinase expression. Moreover, are in progress experiments on DEX‐growth factors crosstalk on GFAP, vimentin, nestin, PARP and MAP‐Kinase expression in astroglial cell cultures at 15 DIV, in order to compare the different effects evaluated in both in vitro models.
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SVCT2 EXPRESSION AND POLARIZATION IN RADIAL GLIAL CELLS {#sec2-218}
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### Nualart F., Silva‐Alvarez C., Salazar K., Cisternas P. {#sec3-218}

#### Concepcion University, Concepción, Chile {#sec4-218}

Cells transport reduced vitamin C using the sodium‐dependent ascorbic acid cotransporters (SVCT1 and SVCT2). SVCT2 is mainly expressed in the nervous system; however, there are no published studies describing the localization of SVCT2 during central nervous system development. This has impaired the definition of the mechanisms by which radial glial cells take up vitamin C. This lack of information led us to determine the expression and localization of SVCT2 during CNS development. We carried out immunohistochemistry and in situ hybridization studies in embryonic preparations from different mouse brain developmental stages (E11 to E19). Our results indicate that SVCT2 is preferentially localized in the radial glial body at the ventricular edge of the cortex during the neurogenic stage (E12 to E17). A similar distribution pattern was observed in human brain samples at 9 weeks of gestation. Plasmids encoding for SVCT2‐YFP were transfected by intraventricular injection (E14‐15) followed by in utero electroporation. We demonstrated that SVCT2 overexpressed during brain development (E15‐E18) was also polarized to the apical membrane of radial glial cells. These results suggest that radial glial cells take up vitamin C from cerebrospinal fluid.

Supported by Grant CONICYT‐World Bank ACT‐02.
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REGULATION OF EPENDYMOCYTES DIFFERENTIATION BY INSULIN AND MAP KINASE PATHWAY IN VITRO {#sec2-219}
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### Corsi J.M., Meunier A., Aguilar A., Strehl L., Spassky N. {#sec3-219}

#### ENS IFR 36 CNRS/INSERM, Paris, France {#sec4-219}

Ependymocytes are multiciliated cells lining the walls of the brain ventricles. Their ciliary beatings play important roles in cerebrospinal fluid (CSF) propelling and neuroblast migration toward the mouse olfactory bulb. Ependymocytes are derived from neural stem cells (NSCs). Developmental defects in ciliogenesis lead to hydrocephalus. In the adult mice, ependymocytes can generate neuroblasts and astrocytes in response to injury. Thus, deciphering the molecular mechanism regulating ependymocytes differentiation process is of great interest for ciliopathy and neurodegenerative disease therapy. Insulin‐like growth factors (IGFs) exert wide variety actions on NSCs and precursors of each of the major neural lineages: neurons, oligodendrocytes and astrocytes during central nervous system development and in the adulthood, including promotion of proliferation, survival and differentiation. In vivo IGF is produced by neural stem cells and is present in the CSF and IGF receptors are expressed by ependymocytes.

We hypothesized that IGF play a role in ependymocyte differentiation. We set up an in vitro model of NSC differentiation in ependymocytes. We treated NSC with insulin that activates IGF receptors. We observed an increase differentiation of NSCs in ependymocytes in response to insulin. We shown while characterizing the in vitro model of differentiation that cell differentiation was dependent of cell density. Interestingly insulin treatment increases the differentiation process independently of cell density. Insulin acts partially through the activation of the MAP kinase pathway that is involved in many differentiation processes. We treated NSCs with a pharmalogical inhibitor of MEK that is an upstream activator of the MAP kinase ERK1/2. Ependymocyte differentiation was abolished independently of insulin treatment. Our results show that ependymocyte differentiation is regulated in vitro by the activation of the MAP kinase pathway in an insulin dependent and independent manner.
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#### ^1^U894 Lab Glial Plasticity, Paris, France; ^2^U567 UMR8104 Cochin Proteomic Plateform, Paris, France {#sec4-220}

Gliomas are the most frequent primary tumours of the human adult central nervous system, and remain of poor prognosis. Isolation from high‐grade gliomas of tumour cells with stem properties, capability to initiate tumours, and resistance to genotoxic stresses rise novel hopes for the design of efficient therapies. To gain further insights into the molecular pathways that underscore the stem properties of these peculiar tumour cells, we determined the proteomic profiles of glioma‐derived cancer stem cells (gCSC) lines we derived from primary cultures of adult human high‐grade gliomas (n = 4), and of neural stem cells (NSC) we derived from human foetuses (n = 4).

Proteomic profiling using 2D‐DIGE and MALDI‐TOF‐TOF analyses, led to the identification of specific protein patterns for gCSC and NSC groups. 82 proteins were differentially expressed between the two cell groups. 43 were up‐ and 39 down‐expressed in gCSC (threshold ≥ 1,5). Validation experiments included Western blots and immunohistochemical assays. The comparative analysis was extended to gCSC and their tumours of origin. In that case, 42 of the 67 proteins found to be differentially expressed were up‐regulated in stem cells as compared to their tumour tissue of origin. Pertinence of these differentially expressed proteins as gCSC markers, and/or diagnostic tools, is under evaluation. In addition, regulatory networks common and proper to gCSC and NSC are sought for using computational bioinformatics analyses.
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IN VITRO AND IN VIVO CHARACTERIZATION OF POTENTIAL STEM CELLS FROM THE PNS: THE BOUNDARY CAP CELLS {#sec2-221}
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Neural stem cells have the capacity to self‐renew and generate different cell types. Therefore, their engraftment constitutes a promising approach to promote myelin repair of the central nervous system. The neural crest derived boundary cap cells (BC) have been suggested to be pluripotent stem cells from the peripheral nervous system since they differentiate into sensory neurons, smooth muscle and glial cells. These cells express restrictively the transcription factor Krox20 between E10.5 and E15.5. Taking advantage of a Krox20cre x R26RYFP mouse line, which allows the tracing of their progeny, we assessed the multipotentiality of BC‐YFP+ in vitro and in vivo.

In vitro, four hours after isolation, Krox 20‐ YFP (+) BCs harbor an immature phenotype expressing Nestin, Sox 2 and Sox 9. However, Krox20‐YFP (+) cells represent only 5% of the acutely dissociated cells. We therefore established a protocol of amplification of BCs. We showed that BCs, when cultured in NeuroBasal medium supplemented with EGF and FGF, give rise to floating Krox20‐YFP (+) spheres surviving up to 6 passages and still expressing immature markers. These results show that BCs are able to respond to EGF/FGF growth factors in vitro, and suggest their self‐renewal capacity.

In vivo, when grafted in the SVZ, acutely dissociated cells or in vitro amplified Krox20‐YFP (+) cells migrate and differentiate in more mature cells. The majority of in vitro amplified Krox20‐YFP (+) cells migrate along the RMS reaching the OB where they differentiate into NeuN+ neurons. Furthermore, grafted cells migrate in the corpus callosum, the striatum and along the meninges where they give rise to YFP+/GFAP+ astrocytes and YFP+/APC+ cells with an oligodendroglial morphology. Taken together, these results highlight BC\'s stem cell features including a high proliferative capacity in vitro and their neurogenic and gliogenic potential in vivo.

J.T. has a fellowship from NMSS and ARSEP. The work was supported by INSERM.
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ASTROGLIAL NF‐KB REGULATES HIPPOCAMPAL NEUROGENESIS AND SPATIAL MEMORY IN FEMALE MICE {#sec2-222}
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### Bracchi‐Ricard V.,^1^ Quadrato G.,^2^ Dellarole A.,^2^ Levenson J.M.,^3^ Green E.J.,^4^ Grilli M.,^2^ Bethea J.R.^1^ {#sec3-222}

#### ^1^University of Miami Miller School of Medicine, Miami, United States; ^2^University of Piemonte Orientale, Novara, Italy; ^3^University of Wisconsin School of Medicine and Public Health, Madison, United States; ^4^University of Miami, Miami, United States {#sec4-222}

Astrocytes play multiple roles in the central nervous system as support cells to the neurons as well as dynamic partners at the synapse and important players of inflammation. Interestingly the nuclear factor‐kappa B (NF‐kB) family of transcription factors also plays a number of roles from synaptic plasticity to inflammation. Since many neurodegenerative diseases have an inflammatory component and are associated with cognitive deficits we decided to investigate the role of astroglial NF‐kB in learning and memory. We have generated transgenic mice (GFAP‐IkBa‐dn) where NF‐kB signaling is specifically inhibited in astrocytes. To our surprise, we demonstrated that only female transgenic mice, but not males, had robust deficits in hippocampal and extra‐hippocampal‐dependent learning and memory. We also determined that there were significant deficits in LTP and expression of synaptic molecules specifically in female transgenic mice. Since hippocampal neurogenesis participates in spatial memory learning by providing a source of new more excitable neurons we decided to investigate hippocampal neurogenesis in our GFAP‐IkBa‐dn mice. Using BrdU incorporation, we found significantly fewer neuroblasts in the granular layer of the dentate gyrus of female GFAP‐IkBa‐dn mice compared to WT littermates, while the rate of proliferation of hippocampal precursors between the two genotypes was the same. Furthermore no difference was found in the neuronal fate specification rate, both WT and GFAP‐IkBa‐dn mice giving rise at 75% to mature neurons. We also found a significant reduction in the number of calretinin‐positive cells in female transgenic mice. The survival of granule neuroblasts in male transgenic mice was unaffected underlying the gender specific effect of the NF‐kB mutation in astrocytes. These data suggest that astroglial NF‐kB signaling is required for the survival of granule neuroblasts in females. We would like to propose that NF‐kB signaling is differentially regulated in male and female astrocytes under physiological conditions leading perhaps under pathological conditions to the gender difference seen in several neurodegenerative diseases.
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MULTISTEM® PREVENTS MACROPHAGE‐MEDIATED AXONAL DIEBACK FOLLOWING SPINAL CORD INJURY {#sec2-223}
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### Busch S.,^1^ Horn K.,^1^ Cuascut F.,^1^ Hamilton J.,^2^ Lehman N.,^2^ Ting A.,^2^ Mays R.,^2^ Silver J.^1^ {#sec3-223}

#### ^1^Case Western Reserve University, Cleveland, United States; ^2^Athersys Inc., Cleveland, United States {#sec4-223}

Infiltrating macrophages contribute directly to the process of axonal dieback that occurs after spinal cord injury. We have developed an *in vitro* model of the glial scar in which adult rat dorsal root ganglion (DRG) axons are confronted with an increasing gradient of inhibitory proteoglycan and a decreasing gradient of permissive laminin. Growth cones in this environment develop a characteristic dystrophic morphology and, when contacted by activated macrophages added to the culture, undergo significant axonal dieback. Endogenous stem‐like NG2+ progenitor cells can stabilize axons after macrophage‐mediated axonal dieback, but not prevent retraction. In this study, we sought to determine if culturing DRG neurons with MultiStem® (M®), an adult bone marrow‐derived cell product manufactured by Athersys Inc., could prevent macrophage‐mediated axonal dieback, as M® are thought to be immunomodulatory. In the presence of M®, growth cones developed a motile, flattened morphology. Macrophages still contacted these axons, but contacts were generally transient and axonal retraction was prevented. In addition, preincubation of macrophages with M® conditioned media (M®‐CM) prevented axonal retraction, despite extensive contact between axons and macrophages. M®‐CM directly added to the DRG neuron culture also prevented macrophage‐induced axonal retraction. Adult DRG neurons cocultured with mesenchymal stem cells (MSCs) were not protected from macrophage‐induced axonal retraction to the same degree. We confirmed that M® can modulate the effects of macrophages on injured axons *in vivo* using a dorsal column crush model of spinal cord injury. We transplanted M® into the spinal cord immediately following injury and measured the extent of axonal dieback at two, four and seven days post injury. The transplanted M® successfully integrated into the lesioned spinal cord tissue and associated with the endings of injured axons. Seven days post‐lesion, M® transplanted animals showed a significant decrease in the extent of axonal dieback compared to vehicle controls. The transplantation of M® attenuated the dieback normally observed at this time. Therefore, our results suggest that the presence of M® within the injured spinal cord is sufficient to reduce macrophage‐induced axonal dieback *in vivo*.
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NEURAL STEM CELLS OF THE ADULT OLFACTORY BULB ARE MORE RESPONSIVE TO FGF THAN TO EGF {#sec2-224}
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### Delgado A.C.,^1^ Fariñas I.,^2^ Trujillo C.M.^1^ {#sec3-224}

#### ^1^Universidad de La Laguna, la Laguna, Spain; ^2^Universidad de Valencia, Valencia, Spain {#sec4-224}

Neurogenesis persists in specific domains of the adult mammalian brain: the subependymal zone (SEZ) adjacent to the lateral ventricles and the subgranular zone of the dentate gyrus in the hippocampus. Neural stem cells (NSCs) lodged in these regions are cells competent to proliferate, to acquire regional identity, and to produce the different cellular types which are characteristic of the mature nervous system. In the SEZ, derived progeny of these NSCs migrate to the OB where they differentiate into local interneurons. In addition, some authors have recently considered the possibility of local neurogenesis in the adult OB of mammals, supported by NSCs intrinsic to this structure. In this work we aimed at culturing and characterizing adult OB cells that could behave like adult NSCs both in vitro and in vivo. We could detect cells that retained bromodeoxyuridine (BrdU) for over three weeks (BrdU‐label retaining cells or BrdU‐LRC) and that expressed GFAP. These doubled marked cells were located in the SEZ intrabulbar region and they could be considered as local NSCs of the adult OB. To test the potential of these cells in vitro, we dissected the region adjacent to the rostral extension of the lateral ventricle and cells dissociated to the single cell level were plated in neurosphere culture medium containing EGF and FGF. Under these conditions, we obtained numerous neurospheres which were capable of self‐renewal for an extended number of times. Moreover, these cells exhibited multipotency as reflected in differentiation assays in which we used markers for the three major lineages: beta‐III‐tubulin for neurons, GFAP for astrocytes, and O4 for oligodendrocytes. Interestingly, when cells were seeded in the two mitogens, EGF and FGF, separately we observe that FGF is a more efficient mitogen than EGF in contrast to the mitogenic profile of NSCs derived from the SEZ, which proliferate more actively in EGF. These results indicate that NSCs isolated from the OB respond differentially to growth factors.
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GLYCOPROTEIN 130 SIGNALLING IS NOT REQUIRED FOR MAINTENANCE OF ADULT NEURAL PRECURSOR CELLS IN VITRO {#sec2-225}
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### Merson T., Mareels D., Soo P., Kilpatrick T. {#sec3-225}

#### Florey Neuroscience Institutes and Centre for Neuroscience, University of Melbourne, Parkville, Australia {#sec4-225}

Cytokines that belong to the IL‐6 family have been implicated in the maintenance of various stem cell populations. Leukemia inhibitory factor (LIF) has been proposed to regulate the maintenance of neural precursor cells (NPCs) in the embryonic and adult CNS. LIF signals via a heterodimeric receptor complex comprising LIFRβ and gp130, the latter being the common receptor component for all IL‐6 family cytokines. We assessed the consequence of conditional deletion of gp130 upon NPCs derived from the subventricular zone (SVZ) of adult mice. We found that gp130‐deficiency had no influence upon the capacity of primary neurosphere cells to form secondary neurospheres, nor did it alter the growth characteristics of long‐term serially‐passaged neurosphere cultures. Consistent with this finding, we found that stimulating wild‐type primary neurospheres with LIF did not modulate their capacity to generate secondary neurospheres, irrespective of whether EGF or FGF‐2 was used, the duration of exposure or concentration of exogenous LIF used. Under differentiating conditions gp130‐deficient NPCs exhibited a marked deficiency in their capacity to generate astrocytes, of which the vast majority exhibited low‐level expression of GFAP but normal levels of S100β expression. Assessment of the effect of exogenous LIF upon the differentiation of wild‐type neurospheres corroborated this result, demonstrating that LIF acted specifically during NPC differentiation rather than the proliferative phase to increase the production of astrocytes 2.5‐fold relative to untreated cultures. Further we found that BMP4 treatment was unable to substitute for deficient gp130 signalling in potentiating astrocyte production and noggin was unable to abolish the capacity for gp130‐deficient neurospheres to generate astrocytes. Together our results suggest that rather than regulating the clonogenicity of adult NPCs in vitro, gp130 signalling acts to selectively regulate the production of astrocytes during NPC differentiation.
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IMPAIRMENT OF SUBVENTRICULAR ZONE‐DERIVED NEUROGENESIS FOLLOWING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) TARGETING TO THE MOUSE FOREBRAIN {#sec2-226}
-------------------------------------------------------------------------------------------------------------------------------------------------

### Tepavcevic V.,^1^ Alfaro Cervello C.,^2^ Lazarini F.,^3^ Garcia Verdugo J.M.,^2^ Lledo P.M.,^3^ Nait Oumersmar B.,^1^ Baron Van Evercooren A.^1^ {#sec3-226}

#### ^1^Université Pierre et Marie Curie‐Paris 6/Inserm UMR‐S 975 CRICM, CNRS UMR 7225, Paris, France; ^2^Departamento de Biología Celular, Facultad de Ciencias Bioló, Valencia, Spain; ^3^Laboratoire de perception et mémoire, CNRS URA 2182, départment de neuroscience, Institut Pasteur, Paris, France {#sec4-226}

Subventricular zone (SVZ) is the largest germinal zone of the adult brain and it contains multipotential cells capable of generating neurons, astrocytes and oligodendrocytes. It has therefore been hypothesized that SVZ cells may contribute to the central nervous system (CNS) repair during neurodegenerative/demyelinating pathologies. Our aim was to investigate the effect of multiple sclerosis (MS) ‐like pathology on this stem cell niche.

In order to perform the study, we have developed an experimental protocol that reproducibly targeted EAE lesions to the SVZ‐proximal white matter tracts in C57/Bl 6 mice. Immunohistochemistry and electron microscopy (EM) were used to characterize the pathological events in this model consisting of extensive forebrain inflammation, demyelination/remyelination, and axonal injury/degeneration. By evaluating SVZ proliferation and examining different cell types (A, B, C) within this neurogenic niche during the time course of targeted EAE, we show: 1severe reduction in SVZ neuroblast numbers and chain migration resulting into a decrease in olfactory bulb neurogenesis in response to inflammation.2persistence and amplification of type C cells.

Our study suggests that CNS inflammation impairs the SVZ neurogenesis by producing a differentiation block of transit amplifying progenitors. We are currently investigating the consequences of these events on odour discrimination, learning and memory.
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TRANSPLANTED HUMAN NEURAL PROGENITOR CELLS FROM DIFFERENT FOETAL FOREBRAIN REGIONS REMYELINATE THE MOUSE DEMYELINATED SPINAL CORD {#sec2-227}
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### Buchet D., Garcia C., Deboux C., Nait‐Oumesmar B., Baron‐Van Evercooren A. {#sec3-227}

#### INSERM UMR S 975, Paris, France {#sec4-227}

Neural stem/progenitor cells (NPCs) display active proliferation while retaining their ability to generate the three major cell types of the CNS and therefore represent ideal candidates for the treatment of myelin diseases. However, when isolated from human foetal CNS, these cells generally give rise to very limited amounts of oligodendrocytes (OLs), thereby limiting their remyelination potential after grafting. In the present study, instead of isolating hNPCs from the whole foetal brain, we asked whether there might be a forebrain region enriched in OL progenitors (OPCs), and whether isolation of this particular region could increase OL generation both in vitro and in vivo after grafting.

We described for the first time the onset of oligodendrogenesis within the human forebrain, which takes place around 7.5 weeks of gestation. By that time, OPC emergence was restricted to ventral parts of the telencephalon. Cells from this particular area (GE), as well as from dorsal telencephalon (Cortex) and diencephalon (Thalamus), were then isolated to evaluate their oligodendroglial potentials, respectively. In vitro, early OPCs were concentrated in GE, suggesting that hNPCs conserved their regional characteristics after dissociation. We then used two different demyelination models to evaluate remyelinating abilities of hNPCs from each region. After transplantation into the demyelinated spinal cord of adult nude mice, human cells survived for up to one year, migrated extensively within the white matter and generated high amounts (up to 40%) of mature OLs. Although no specific features of these cells could be highlighted according to their territorial origins, we showed that, even after long‐term expansion in vitro, cells from each region displayed high remyelination abilities, through a differentiation process that was much slower than the one described for rodent NPCs. We then took advantage of the adult MBP‐deficient shiverer dysmyelination model to attest for proper compaction of exogenous newly formed human myelin, by electron microscopy. Thus, our study highlights the characteristics of human neural progenitor cells from different forebrain regions at the onset of oligodendrogenesis and emphasizes their most promising potential as a tool for CNS remyelination.
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CHARACTERISATION OF HUMAN MESENCHYMAL STEM CELLS FOLLOWING DIFFERENTIATION INTO SCHWANN CELL‐LIKE CELLS {#sec2-228}
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### Brohlin M.,^1^ Mahay D.,^2^ Novikov L.N.,^1^ Terenghi G.,^2^ Wiberg M.,^1^ Shawcross S.G.,^2^ Novikova L.N.^1^ {#sec3-228}

#### ^1^Department of Integrative Medical Biology, Section of Anatomy, Umeå University, UMEå, Sweden; ^2^Blond McIndoe Research Laboratories, Tissue Injury and Repair Group, The University of, Manchester, United Kingdom {#sec4-228}

Cell based therapies provide a clinically applicable and available alternative to nerve autografts. We have investigated the phenotypic, molecular and functional characteristics of human‐derived MSC (hMSC) differentiated along a Schwann cell lineage. The hMSC were isolated from healthy human donors and the identity of the undifferentiated hMSC was confirmed by the detection of MSC specific cells surface markers. The hMSC were differentiated along a glial cell lineage using an established cocktail of growth factors including glial growth factor‐2. Following differentiation, the hMSC expressed the key Schwann cell (SC) markers at both the transcriptional and translational level. More importantly, we show the functional effect of hMSC on neurite outgrowth using an in vitro co‐culture model system with rat derived primary sensory neurons. The number of DRG sprouting neurites was significantly enhanced in the presence of differentiated hMSC; neurite length and density (branching) were also increased. We also investigated the functional effect in co‐cultures with donors from different age groups.

These results provide evidence that hMSC can undergo molecular, morphological and functional changes to adopt a SC‐like behaviour and, therefore, could be suitable as SC substitutes for nerve repair in clinical applications.
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INVOLVEMENT OF IKAP/ELP1 IN DIFFERENTATION OF OLIGODENDROCYTES {#sec2-229}
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### Cheishvili D.,^1^ Maayan C.,^1^ Ast G.,^2^ Razin A.^1^ {#sec3-229}

#### ^1^Hebrew University, Jerusalem, Israel; ^2^Tel‐Aviv University, Tel‐Aviv, Israel {#sec4-229}

A splice site mutation in the IKBKAP gene coding for IKAP/Elp1 protein causes a neurodegenerative, autosomal‐recessive genetic disorder called Familial dysautonomia (FD). This mutation leads to a shift from constitutive to alternative splicing of exon 20 of the gene, and thus generates a premature stop codon. Both, the exon 20 skipped and inclusion forms are produced in different ratios in most cell types, however in neuronal tissues the skipped isoform is the predominant mRNA product, leading to substantial reduction in the production of the IKAP/Elp1 protein.

FD patients show abnormal development and survival of the sensory and autonomic nervous system associated with demyelination at various loci. The FD condition is also described as a small fiber neuropathy that affects development and survival of unmyelinated and small fiber neurons causing impaired pain, hot and cold appreciation.

We attempt to reveal how IKAP/Elp1 depletion causes this neurodegenerative phenotype. First, we performed microarray analyses to identify genes that show a change in their expression level in FD brain tissue. This analysis revealed a specific decrease in expression of genes involved in oligodendrocyte differentiation and/or myelin formation. The microarray results were verified by Real Time PCR and confirmed on the protein level by Western blotting. Similar results were obtained with brain tissue of an FD mouse model.

These observations prompted us to study the IKAP/Elp1 role in oligodendrocyte development. We established an in vitro system that allowed us to study the effects of IKAP/Elp1 deficiency on the biology of the oligodendrocyte cell in culture. Our findings suggest that the IKAP/Elp1 deficiency in the oligodendrocyte cell line causes downregulation of the genes involved in oligodendrocyte differentiation through deacetylation of histone H3 K9 at the promoters of these genes. The IKAP/Elp1 deficiency showed also a negative effect on adhesion of Oli‐neu cells and distribution of the gangliosides between membrane and cytoplasm. Our results provide a first step towards understanding how the genetic trait in FD brings about the devastating phenotype in FD patients. Further work is required to decipher the significance of our findings in oligodendrocyte development and function in vivo.
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MATURATION DEFECTS OF GLIA PROGENITORS IN VANISHING WHITE MATTER {#sec2-230}
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### Boor I.,^1^ Bugiani M.,^1^ Van Berkel C.,^1^ Scheper G.,^1^ Baron W.,^2^ Goldman S.,^3^ Van Der Knaap M.^1^ {#sec3-230}

#### ^1^VU University Medical Center, Amsterdam, Netherlands; ^2^University Medical Center Groningen, Groningen, Netherlands; ^3^University of Rochester, Rochester, United States {#sec4-230}

Leukoencephalopathy with Vanishing White Matter (VWM) is one of the most prevalent inherited white matter disorders in children and is caused by mutations in the genes encoding the subunits of a complex called eIF2B. Although the defect in VWM resides in a protein complex that is present in all cells, the disease manifests itself in macroglia (astrocytes and oligodendrocytes) mainly. Both cell types are not able to perform their functions properly. Oligodendrocytes do not make enough myelin and astrocytes produce scarce gliosis, resulting in a cavitating leukoencephalopathy. The dysfunction of these glia is probably caused by a maturation defect. Our research is focused on a better characterization of the cell types that are affected in VWM and on defining the defects in macroglia maturation and function. To study the dysfunction of astrocytes we used the so‐called scratch‐wound assay. This is a tissue culture model in which primary astrocytes of VWM patients and control subjects are cultured in confluent monolayers. With the tip of a pipette a scratch is made in this monolayer of cells. The reaction of both VWM and control astrocytes on the damage can be monitored. In addition to astrocytes of VWM patients, we also use control astrocytes in which eIF2B activity has been down‐regulated with so‐called silencing constructs. With the scratch‐wound assay we study possible differences in gliosis between cultures of astrocytes from patients and controls and of silenced and non‐silenced cells. To study the defect in glia maturation we use glia progenitor cells of fetal human brain and maturate them in tissue culture. We are currently investigating whether we can manipulate maturation of these cultured progenitor cells by using the same silencing constructs as we used for primary astrocytes. In this way we can test the hypothesis that silencing of the EIF2B5 gene influences differentiation of glia‐progenitors into mature oligodendrocytes and astrocytes.
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SOX10 IS REQUIRED FOR MULTIPLE STEPS IN SCHWANN CELL DEVELOPMENT {#sec2-231}
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### Finzsch M.,^1^ Schreiner S.,^1^ Stolt C.C.,^1^ Bösl M.R.,^1^ Meijer D.,^2^ Charnay P.,^3^ Tamm E.R.,^4^ Wegner M.^1^ {#sec3-231}

#### ^1^Universitaet Erlangen‐Nuernberg, Erlangen, Germany; ^2^Department of Cell Biology and Genetics, Erasmus MC University Medical Centre, Rotterdam, Netherlands; ^3^INSERM, U784, Ecole Normale Supérieure, Département de Biologie, Paris, France; ^4^Universitaet Regensburg, Regensburg, Germany {#sec4-231}

The HMG domain‐containing transcription factor Sox10 is essential for the development of neural crest cells into cells of the peripheral nervous system. In Schwann cells as neural crest derivatives of the PNS, Sox10 is expressed during specification, lineage progression and differentiation. In mice that carry a spontaneous or a targeted mutation of Sox10 Schwann cells are lost early in development. This confirms a Sox10 requirement during early stages, but also makes it impossible to study additional functions of Sox10 during later stages of Schwann cell development. In order to investigate Sox10 function at these later stages we generated mice that selectively lost Sox10 in the Schwann cell lineage during two distinct time points of development. The use of a Cre‐recombinase under control of Desert Hedgehog regulatory sequences allows the generation of Sox10‐deficient Schwann cell precursors. In order to investigate Sox10 function during Schwann cell terminal differentiation we made use of a Krox20 Cre‐recombinase mediated approach. Mice carrying the Desert Hedgehog mediated Sox10‐deletion show a severe neuropathologic phenotype of the PNS limiting life span to a maximum of 6 weeks. Schwann cell development in these mice is arrested at the immature Schwann cell stage with major differences in the expression pattern of characteristic Schwann cell markers and a total lack of myelination. A Sox10‐deletion during Schwann cell terminal differentiation results in a milder phenotype with unaltered expression of most Schwann cell markers. Strikingly, ultrastructural analysis revealed a significant reduction of the numbers of myelinated axons and the extent of myelination although the animals are viable beyond 4 months of age. Both mouse models thus confirm the continuous significant impact of Sox10 function throughout Schwann cell development and are excellent models for the investigation of Schwann cell‐based peripheral neuropathies in human patients.
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### Takahashi K.,^1^ Noto D.,^2^ Yamada M.^2^ {#sec3-232}

#### ^1^Iou National Hospital, Kanazawa, Japan; ^2^Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan {#sec4-232}

BACKGROUND: Microglia are believed to be only the resident immune cells in the central nervous system (CNS), originating from hematopoietic‐derived myeloid cells and invading CNS during development. However, the detailed mechanisms of differentiation and transformation of microglial cells have not fully understood.

METHODS: Murine primary mixed glial cells and lineage negative bone marrow (LN) cells, defined by the absence of surface markers such as CD3, CD4, CD5, CD8α, CD11b/MAC‐1α, B220, Gr‐1, and TER‐119, were used in this study.

RESULTS: Murine microglial cells showed 2 morphological forms in vitro; small round cells expressing CD11b, Iba1, Triggering receptor expressed on microglia‐2 (TREM2) and MHC class II, and large flat cells expressing only CD11b and Iba1. Moreover, LN cells cultured with primary mixed glial culture cells could differentiate into the only small round microglia‐like cells in spite of the absence of CCR2 and Gr‐1 expression. Addition of M‐CSF to LN cell‐culture allowed proliferation and expression of TREM2 of LN cells, and addition of neutralizing anti‐M‐CSF antibodies suppressed the proliferation of LN cells in spite of expression of TREM2. When LN cells were cultured with M‐CSF, the number of small round cells in the culture was considerably low, indicating that the small round morphology of the immature cells is not maintained in the presence of only M‐CSF. On the other hand, when LN cells were grown in the presence of astrocytes, the small round cells were maintained at a concentration of approximately 30% of the total population.

CONCLUSION: LN cells could differentiate into the small round type but not the large flat type microglia‐like cells. Moreover, not only M‐CSF but also cell‐cell contacts with astrocytes play an important role in microglial differentiation.
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CHARACTERIZATION OF THE CELLULAR INTERACTIONS OCCURRING DURING MYELINATION IN THE CENTRAL NERVOUS SYSTEM {#sec2-233}
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### Dumas L., Heitz C., Moreau‐ Fauvarque C., Livet J., Chédotal A. {#sec3-233}

#### Institut de la Vision UMR S968 Inserm, Paris, France {#sec4-233}

Although many markers of oligodendrocytes, the myelinating cells in the CNS, have been identified, the cellular mechanisms regulating myelination during development and in pathological condition are still largely unknown. To large extent, this is due to the lack of suitable methods allowing one to visualize and follow the same oligodendrocytes during myelination.

We have decided to a use novel molecular and imaging techniques in order to visualize simultaneously many individual oligodendroctes within a normal or demyelinated brain region. This method is based on Brainbow, a transgenic system for stochastic expression of multiple genes, through CRE/Lox recombination, previously used for visualizing axons and neurons. In mice expressing Brainbow constructs under the control of the neuronal promoter Thy‐1, cells express random combinations of three or more spectrally distinct fluorescent proteins. Dozens of hues are created by mixing these three primary colors, providing a spectrum of color labels allowing one to distinguish multiple neighboring cells and their processes in a single tissue sample.

Our aim is to characterize the cellular interactions occurring during myelin formation. Cellular interactions are thought to determine how oligodendrocytes share axonal segments to myelinate. However, such interactions have not been visualized because no technique allows for the labeling of adjacent oligodendrocytes with distinct markers. Understanding the cellular details of the myelination and remyelination process could shed light into myelin disorders. We are generating transgenic mice expressing Brainbow under the control of the oligodendrocyte‐specific promoters PLP and MBP. In parallel, we are crossing mice expressing Brainbow in all cells to PLP:CREERT2 mice. The efficacy of the diverse constructs has been tested by transient transfection in cell lines and purified oligodendrocytes. Multi‐colored oligodendrocytes could be observed in the cultures, thereby demonstrating the feasability of this approach. The morphological changes and behavior of individual oligodendrocytes as well as pairs of adjacent oligodendrocytes is being studied using time‐lapse analysis in slices and dissociated cells.

P‐234 {#sec1-234}
=====

A DUAL ROLE FOR THE TRANSMEMBRANE SEMAPHORIN SEMA6A IN MYELINATION {#sec2-234}
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### Moreau‐Fauvarque C.,^1^ Bernard F.,^2^ Heitz C.,^1^ Zagar Y.,^1^ Dumas L.,^1^ Shao Z.,^3^ Mi S.,^3^ Chédotal A.^1^ {#sec3-234}

#### ^1^Institut de la Vision, UMR_S968 Inserm/UPMC, Paris, France; ^2^Novartis, Basel, Switzerland; ^3^Biogen Idec Inc., Cambridge MA, United States {#sec4-234}

Myelination is a crucial step in brain development and maintenance. The identification of novel proteins selectively expressed by developing oligodendrocytes should help understanding this complex process. Semaphorin is a family of cell‐cell signaling proteins that have been involved in axon guidance. We found that the transmembrane semaphorin 6A is expressed by myelinating oligodendrocytes in the postnatal mouse brain. We are studying the role of Sema6A in oligodendrocytes, in normal and pathological condition using Sema6A deficient mice. To determine if the number of oligodendrocytes and the time‐course of myelination were normal in Sema6A‐deficient mice, we have quantified the number of cells expressing specific oligodendrocyte lineage markers in major forebrain axonal tracts. This revealed a significant but transient reduction of the density of PLP and MAG expressing cells in the anterior commissure, while the density of Olig2 cells was comparable. We next studied the in vitro maturation of oligodendrocytes purified from Sema6A‐/‐ newborn mice. We found that oligodendrocyte differentiation is delayed in oligodendrocytes lacking Sema6A, suggesting a cell‐autonomous function for this protein in myelination.

We next developed myelinating co‐culture of DRGs and oligodendrocytes and found that addition of Sema6A‐Fc protein increased myelination in a dose dependent manner. This pro‐myelinating activity appears to require plexin‐A expression on myelinated axons, with Sema6A acting as a ligand on oligodendrocytes.

Furthermore, a role of Sema6A has been analyzed in a pathophysiological context, in which demyelination is induced by cuprizone. In this model, there is a significant increase of oligodendrocytes expressing Sema6A, starting 3 weeks after the administration of cuprizone, peaking at 4 and then returning to the basal level of expression at 6. Altogether these results suggest that Sema6A play a role in myelination in the central nervous system.

Funded by ARSEP.
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GIAL PROGENITOR NG2 CELLS PROTECT NEURONS IN OGD‐EXPOSED HIPPOCAMPAL SLICES {#sec2-235}
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### Sypecka J., Sarnowska A., Winiarska H., Domanska‐Janik K. {#sec3-235}

#### Medical Research Centre, Warsaw, Poland {#sec4-235}

The fate choice of neural progenitors could be dictated by local cellular environment of adult CNS. And conversely, the presence of progenitor cells might modulate their microenvironment, influencing local biological processes. The aim of our study therefore was to evaluate the effect of hippocampal slice culture on the differentiation of glia‐commited NG2 precursors. Subsequently, we investigated the potential effect of NG2 cells on hippocampal slices subjected to glucose‐oxygen deprivation (OGD, the model of an ischemic injury). Methods. The hippocampal slice culture was established from brains of 7‐day old rats. The NG2 precursors, obtained from old mixed primary culture of neonatal rat hemispheres, were labeled with CMFDA and seeded on hippocampal slices. After 7 days in co‐culture, the cells were stained with neural markers. The OGD‐subjected hippocampal slices were co‐cultured with NG2 cells (indirect contact) for 6 days in the presence of either BrdU or propidium iodide and then immunostained. Results. The NG2 progenitors cultured in neuronal microenvironment differentiated predominantly into oligodendrocytes (altogether 69.7 %, including 7.1 % GalC+). However, a considerable number of the cells differentiated into neurons: TuJ+ (27.1 %) and even MAP‐2+ cells were frequently observed. Moreover, a certain population gathered their progenitor properties, as revealed by Ki67 (5%) and nestin (15.9%) expression. The close vicinity of NG2 cells turned to be neuroprotective for OGD‐injured hippocampal slices: the co‐culture for 48/72 h reduced cell death by ∼30%. Conclusions. The NG2 cells were shown to have intrinsic potency for neurogenesis. In stimulating microenvironment in vitro, they are multipotent, motile, proliferative and express neural stem cell marker. Their presence was shown to be neuroprotective for OGD‐ injured hippocampal slices. The results show the strong mutual neuron‐glia interactions and the crucial role the local cellular environment plays in NSC fate‐decision, what should be taken into consideration in therapeutic approaches.

Supported by MSRHE grant N40101832 /0296
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### Dimou L.,^1^ Laugwitz L.,^1^ Zils C.,^1^ Götz M.^2^ {#sec3-236}

#### ^1^LMU Munich, Munich, Germany; ^2^HelmholtzZentrum, Munich, Germany {#sec4-236}

Many proliferating cells, the majority of which expresses the transcription factor Olig2, exist in the adult brain parenchyma of non‐neurogenic regions. Here we aimed to understand the progeny of this adult progenitor population in different areas of the CNS with and without injury by using an inducible Cre‐recombinase expressed in the Olig2 locus. Upon Tamoxifen (Tam) application, recombination in the adult cortex and cerebellum resulted in reporter gene expression mostly in proliferating NG2+ cells. In contrast, in the spinal cord we mostly labeled postmitotic, mature oligodendrocytes. In the White Matter (WM) of the cortex and cerebellum, the initially labeled population of proliferating NG2+ progenitors generated largely mature oligodendrocytes that showed a morphology typical for myelinating cells and had processes containing myelin proteins. In contrast, in the Grey Matter (GM) of these brain regions these progenitors differentiated into non‐proliferative NG2+ glia, and no myelinating oligodendrocytes could be observed even 6 months after recombination. In order to analyze the repair potential of these progenitors we performed stab wound injury in the cerebral cortex, and saw that Olig2+ cells still only generated postmitotic NG2+ glia, even when neurons and oligodendrocytes had degenerated. Thus, in vivo Olig2‐expressing progenitors appear restricted to an NG2/oligodendrocyte lineage.

Indeed, also after sorting of these cells from injured cerebral cortex, no cells with larger potential, i.e. neurosphere formation, could be observed. We also tested the potential of cultured postnatal NG2/Olig2+ progenitors for neurogenesis by antagonizing the repressor activity of Olig2 and/or expression of the neurogenic fate determinants Pax6 and Ngn2. Interestingly, we could observe some degree of neurogenesis from these OPCs, even though the neurogenic reprogramming effect was clearly lower as observed for astrocytes.

Thus, our results demonstrate some limited reprogramming capacity of OPCs, at least in vitro, and restriction of Olig2+ progenitors to the oligodendrocyte lineage in vivo.
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THE DISTRIBUTION OF TWO TYPES OF OLIGODENDROCYTE PRECURSOR CELL IN DIFFERENT BRAIN AREAS {#sec2-237}
----------------------------------------------------------------------------------------

### Clarke L.E.,^1^ Hamilton N.B.,^1^ Kessaris N.,^2^ Richardson W.D.,^2^ Attwell D.^1^ {#sec3-237}

#### ^1^Department of Neuroscience, Physiology and Pharmacology, UCL, London, United Kingdom; ^2^Wolfson Institute for Biomedical Research, UCL, London, United Kingdom {#sec4-237}

Oligodendrocyte precursor cells (OPCs) generate the oligodendrocytes which myelinate axons during development. In the adult CNS, OPCs are the main proliferating cells in both grey matter and white matter where they continue to generate new oligodendrocytes for months after birth in the mouse. There is evidence that they also generate some protoplasmic astrocytes and even neurons. We have recently shown that rat cerebellar white matter OPCs fall into two classes, one of which expresses voltage‐gated Na^+^ channels (I~Na~) and can generate action potentials on depolarisation, whereas the other type lacks these attributes. To determine how generally relevant these properties are, we recorded from mouse cells expressing GFP in oligodendrocyte lineage cells under the control of the SOX10 or PDGFRα promoter, which had a bipolar or stellate OPC morphology, in white matter (corpus callosum and cerebellar cortex) and grey matter (cerebellar granule cell layer and neocortex) areas. The internal solution was K‐gluconate based. Early in development (P6‐P9) approximately 2/3 of the presumed OPCs expressed I~Na~ in the white matter, although the magnitude of I~Na~ on depolarization from ‐70mV to +10 mV (after subtraction of the linearly scaled capacity transient) was approximately 6 times smaller than the ∼1nA seen in rat OPCs. In contrast, most (∼85%) of the OPCs in grey matter regions expressed I~Na~. In more mature mice (P30‐P36), a smaller fraction (∼30%) of OPCs were found to express I~Na~ in grey matter brain areas, whereas the proportion of cells expressing I~Na~ in the white matter remained about the same. Although the ratio of I~Na~ magnitude to cell input resistance was lower in mouse OPCs than was previously found for rat OPCs, a subpopulation of I~Na~‐expressing OPCs in both the grey and white matter elicited a single regenerative depolarization on injection of depolarising current, and a few white matter OPCs were capable of initiating repetitive action potential‐like depolarizations. These data show that OPCs fall into two classes, one expressing I~Na~ and exhibiting regenerative depolarisations and the other not, suggesting that these two cell types might have different functional roles.
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EFFECT OF NEUREGULIN ON RADIAL GLIAL CELLS DERIVED FROM RAT SPINAL CORD {#sec2-238}
-----------------------------------------------------------------------

### Martens W., Moreels M., Lambrichts I. {#sec3-238}

#### Hasselt University, Diepenbeek, Belgium {#sec4-238}

Radial glial cells have a crucial role in the developing brain and spinal cord during neurogenesis and after birth. They are involved in the support of migrating neurons and act as a progenitor population for astrocytes and neurons. Neuregulin is a glycoprotein, belonging to the family of the epidermal growth factor--like ligands. These growth factors are important for the development and functioning of the central nervous system. It has been demonstrated that neuregulin plays a critical role in the establishment, maintenance, and maturation of cerebral radial glial cells (Schmid et al 2003, Zheng et al 2006). Regarding to astrocytes, it has been found that neuregulin can induce the transformation of cerebellar astrocytes into a radial glia phenotype (Gierdalski et al 2005).

In the present study we investigated the effect of exogenous neuregulin on glial cells in a mixed glial cell culture system. Mixed glial cell cultures were prepared from spinal cords of neonatal rat pups (P3) as described by Moreels et al (2006) and were treated with different concentrations of neuregulin (ranging from 1 ng/ml to 25 ng/ml). After 6‐7 days, cell cultures were fixed and characterised using cell‐specific immunocytochemical markers including GFAP, MBP, nestin and 3CB2.

Treatment with different concentrations of neuregulin (1‐10‐25 ng/ml) increased the number of astrocytes in a dose‐dependent manner. In contrast, the number of radial glial cells decreased after treatment. However, no morphological changes could be observed.

In conclusion, neuregulin has an influence on both radial glial cells and astrocytes. Further research is needed to investigate whether neuregulin promotes the proliferation of astrocytes or the differentiation of radial glial cells into astrocytes.
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THE EXTRACELLULAR MATRIX GLYCOPROTEIN TENASCIN‐C CONTROLS THE ACTIVITY OF DIRECTLY NEUROGENIC PROGENITORS IN THE VENTRICULAR ZONE OF THE MOUSE EMBRYONIC FOREBRAIN {#sec2-239}
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### Kazanis I.,^1^ Ffrench‐Constant C.^2^ {#sec3-239}

#### ^1^University of Cambridge, Cambridge, United Kingdom; ^2^MRC Centre for Regenerative Medicine, Edinburgh, United Kingdom {#sec4-239}

The mammalian brain is a complicated structure formed during embryonic development through multiple divisions of neural stem cells and progenitors which are localized in two distinct proliferative areas around the ventricles. The first is the ventricular zone (VZ), where bipolar neuroepithelial and later radial glial cells divide in order to expand the progenitor population and to generate neurons and glia either directly or via intermediate progenitors. The second is the subventricular zone, where intermediate (basal) pogenitors are dividing in order to generate differentiated cells. Although VZ progenitors seem to be morphologically very similar, an abundance of evidence indicates the co‐existence of multiple sub‐types with different functions and lineage commitment. However, it has proved very difficult to ascribe specific proliferation and differentiation properties to distinct progenitor groups within the VZ. Here, based on the analysis of mice knockout for the glycoprotein Tenascin‐C (TnC), we report data that for the first time correlate an extracellular matrix component with the neurogenic behavior of VZ progenitors. Our results show that TnC acts to specifically block the activity of a fraction of VZ progenitors that exhibit a limited self‐renewing potential and are normally destined to directly produce neurons via asymmetric divisions within the VZ. Furthermore, our data indicate the operation of a novel mechanism underlying the transformation of the VZ from the early neuroepithelial to the mature radial glial dominated composition, that involves the inactivation of specific groups of progenitors, a process observed only in TnC‐rich areas of the mouse forebrain.
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CHRONIC TREATMENT WITH VALPROATE DECREASES NG2 CELL PROLIFERATION IN CORPUS CALLOSUM OF ADULT RAT {#sec2-240}
-------------------------------------------------------------------------------------------------

### Orre K., Wennström M., Tingström A. {#sec3-240}

#### Molecular Psychiatry Unit, Lund, Sweden {#sec4-240}

We have previously shown that chronic treatment with lithium, a commonly used mood‐stabilizing drug, decreases the proliferation of NG2+ glial cells (NG2 cells) in corpus callosum. NG2 cells are a continuously dividing cell type known to be oligodendrocyte precursors and suggested to be involved in regulation of neuronal signalling and axonal outgrowth. Since an increasing number of investigations suggest decreased size and abnormal myelination of corpus callosum of patients with bipolar disorder and NG2 cells are known to be implicated in remyelination, we here investigated how another mood‐stabilizing drug, valproate, affect the proliferation of theses cells in corpus callosum.

Adult male Wistar rats were given control or sodium valproate‐supplemented chow (20g/kg; half dose during the first week) for four weeks. The proliferation marker bromodeoxyuridine (BrdU) was injected during the last three days of treatment. The average concentration of valproic acid in serum was upon perfusion 0.32mM. Immunohistochemical analysis of brain sections was performed to estimate the number of newly born (BrdU‐labeled) NG2 cells in corpus callosum (from ‐2.8 mm to ‐4.52. mm relative to bregma).

We found a significant decrease in the number BrdU+/NG2+ cells in animals treated with valproate compared to control. We conclude that chronic valproate treatment, in accordance with chronic lithium treatment; decrease proliferation of NG2 cells in corpus callosum of adult rats. Further studies investigating the underlying mechanisms and the effect of these drugs on oligogenesis are in process.
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RETINOID METABOLISM AND RETINOIC ACID SIGNALING IN ASTROCYTES AND DIFFERENTIATING NEURAL STEM CELLS {#sec2-241}
---------------------------------------------------------------------------------------------------

### Orsolits B., Vofely G., Hadinger N., Madarasz E., Kornyei Z. {#sec3-241}

#### IEM‐HAS, Budapest, Hungary {#sec4-241}

Retinoic acid (RA) is a widely used as a potent inducer of neuronal differentiation by various multipotent cell populations (embryonic carcinoma cells, embryonic and neural stem cells), *in vitro.*The *in vitro*studies suggest that RA may function as a regulator of neural stem cell fate *in vivo*. This implication is supported by earlier, as well as recent findings on retinoid signaling at sites of both embryonic and postnatal neurogenesis (see poster by Vofely et al.). In the present study, we explore the components of retinoid metabolism/signaling in differentiating neural stem cells as well as in astroglial cells isolated from hGFAP‐GFP mice. Our recent data show, that the key enzymes of RA synthesis, the retinaldehyde dehydrogenases (RALDHs) are upregulated during neuronal differentiation. In line with this, RA production is elevated in the course of neuronal/glial differentiation. Based on earlier findings (Kornyei et al. 2007, FASEB J. 21(10):2496‐509) we monitor vitamin A storing and retinoic acid producing capacity of both cultured and FACS‐sorted astroglial cells.
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EXPRESSION OF ENDOTHELIN RECEPTOR A AND ITS IMPLICATIONS FOR THE INVOLVEMENT IN THE DIFFERENTIATION OF OLIGODENDROCYTES {#sec2-242}
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### Jung K.J.,^1^ Lee H.N.,^2^ Kim D.W.^1^ {#sec3-242}

#### ^1^Chungnam National Univ., Daejeon, Republic of Korea; ^2^Seoul National Univ, Seoul, Republic of Korea {#sec4-242}

Endothelins (ET) produce their biological effects via activation of two receptor subtype, the endothelin A and B receptor. ET receptor A and ET receptor B are widely distributed throughout the body, but each receptor has a unique distribution. However, the exact cellular targets for ET receptors in the development remain to be defined. ET receptor A immunoreactivity is expressed by vascular smooth muscle cells at postnatal 0 (P0) day and then its immunoreactivity is expressed by oligodendrocytes cells at P28 days. ET receptor B immunoreactivity is expressed by astrocyte, ependymal cells, vascular endothelial cells and to a lesser extent in smooth muscle cells at same stages. ET‐1 regulates oligodendrocytes precursor cells differentiation into mature oligodendrocytes in a concentration‐dependent manner. These findings suggest that ET receptor A might regulate remyelination processes in inflammatory demyelinating diseases of the CNS, like multiple sclerosis.
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EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR‐3 mRNA WITHIN THE DEVELOPING FOREBRAIN {#sec2-243}
------------------------------------------------------------------------------------------------

### Lee M.Y., Choi J.S., Shin Y.J., Lee J.Y., Hou Y., Cha J.H., Choi J.Y., Chun M.H. {#sec3-243}

#### College of medicine, The Catholic University of Korea, Seoul, Republic of Korea {#sec4-243}

To define better the putative targets of vascular endothelial growth factor (VEGF)‐C in the developing brain, we have examined temporal and spatial distribution of VEGFR‐3 expression in developing rat forebrain using in situ hybridization and reverse transcriptase‐polymerase chain reaction (RT‐PCR). Messenger RNAs for VEGFR‐3 appeared along most of the ventricular zone of the lateral ventricle as early as embryonic day (E) 13. Messages gradually became restricted to a limited ventricular zone at E20. In co‐expression studies, most of the VEGFR‐3 expressing cells in the ventricular zone of the lateral ventricle coexpressed the neural progenitor marker nestin or the proliferation marker, Ki67. Especially, intense VEGFR‐3 was expressed in the corticostriatal sulcus, where most VEGFR‐3 expressing cells were also immunoreactive for glutamine synthetase, a marker for radial glial cells. Expression of VEGFR‐3 was also observed in the cerebral cortex and hippocampus. In the cortex, expression of mRNA for VEGFR‐3 was detected in the preplate around E15, and in cells of the subplate and cortical plate by E17, in increasingly superficial lamina during early postnatal development. At P14, VEGFR‐3 expression was observed in cortical neurons with highest levels in layer II/III and V, but was absent in the subplate in all cortical regions. Semiquantitative RT‐PCR analysis revealed that VEGFR‐3 signal was consistently observed in the same proportion throughout development of the forebrain. VEGFR‐3 mRNA was also expressed in the subventricular zone of the lateral ventricle and its rostral extension, rostral migratory stream, where VEGFR‐3 mRNA were mainly expressed on glutamine synthetase‐positive glial cells. These data suggest that VEGF‐C may be involved in early developmental processes including the proliferation, differentiation and maturation of specific neuronal populations and glial cells via VEGFR‐3 in the developing rat forebrain.

This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A08‐4288‐A22023‐08N1‐00010A).
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CFM2 : A NEW ACTIN REGULATOR FOR NEURAL PROGENITOR CELL DIFFERENTIATION {#sec2-244}
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### Gay O., Baudier J., Gilquin B., Benaud C., Assard N. {#sec3-244}

#### IRTSV ‐ CEA Grenoble, Grenoble, France {#sec4-244}

Oligodendroglial progenitor cells (OPC) represent 5 to 8% total cells in adult rodent central nervous system (CNS). OPCs regenerate the oligodendrocyte (OL) pool after NCS alteration (caused by traumatic injury, viral infection or auto‐immune response) and possess neuromodulatory functions. OPCs arise from amplifying multipotent progenitors (type C cells) that reside in specific germinative niches in the adult CNS. Differentiation from type C cells to OPCs takes place during cellular migration to the white matter and parenchyma; migration to new environment is a prerequisite for differentiation.

Currently, little is known about the mechanisms that promote differentiation and migration of type C cells.

Comparative genomic analysis allowed us to identify a new gene, cfm2, which is up regulated in type C cells committed to differentiate into the OL lineage.

The small protein Cfm2 (22 kDa) has no obvious functional domain; it is a member of the Cfm family that comprises another protein: Cfm1. Functional implication of neither protein has been studied until now.

Functional analysis reveals that Cfm2 is a new actin cytoskeleton regulator that controls cell shape and migration. Its expression in astrocytoma cell lines (U373) leads to changes in cell migration. We have shown that, in living cells, Cfm2 recruits the actin binding and scaffolding protein FilaminA on the actin cytoskeleton and promotes formation of actin bundles as well as original actin aster‐like superstructures. In neural progenitors grown in vitro, both Cfm2 and FilaminA relocate from the cytoplasm to actin bundles during differentiation. It has been previously shown that, in the developing CNS, FilaminA participates in neuronal progenitors\' migration and differentiation.

Finally, molecular studies on the Cfm2/FilaminA interaction identified two regions on Cfm2 involved in binding FilaminA; this interaction promotes FilaminA oligomerization that leads to FilaminA binding to actin.

These data make Cfm2 a unique protein that regulates FilaminA\'s binding to actin; this may open up new avenues for understanding actin‐based microdynamics connected to neural progenitor migration and differentiation.
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EXPRESSION OF THE 3α‐HYDROXYSTEROID OXIDOREDUCTASE, ENZYME RESPONSIBLE FOR 3α,5α‐TETRAHYDROPROGESTERONE SYNTHESIS, IN THE RAT BRAIN DURING EMBRYONIC AND POSTNATAL DEVELOPMENT {#sec2-245}
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### Gago N.,^1^ Alcala K.,^1^ Mensah‐Nyagan A.G.,^2^ Guerrero H.,^1^ Cardillo E.,^1^ Marcano D.,^1^ Schumacher M.^3^ {#sec3-245}

#### ^1^Universidad Central de Venezuela, Caracas, Venezuela; ^2^Equipe Stéroïdes, Neuromodulateurs et Neuropathologies, Université de Strasbourg, Strasbourg, France; ^3^INSERM UMR 788, Kremlin‐Bicêtre, France {#sec4-245}

We have demonstrated that neural progenitors isolated from newborn rat brain are able, in vitro, to synthesize the neurosteroid 3α,5α‐tetrahydroprogesterone (THP), a neuroactive metabolite of progesterone. We also found that THP stimulates the proliferation of these progenitors through GABA~A~ receptors, which suggests the existence of a paracrine/autocrine control. Recently, we found that the enzyme 3α‐hydroxysteroid oxidoreductase (3α‐HSOR), responsible for the synthesis of THP, was expressed in neurogenic zones of the adult rat brain. The aim of the present work was to bring more anatomical evidence suggesting that THP could contribute to the control of neural progenitor biology in vivo. We have investigated by immunofluorescence the distribution of 3α‐HSOR in the rat brain during embryonic and postnatal development. We used Sprague‐Dawley rats at embryonic days 14, 17 and 20 (E14, E17 and E20), and postnatal rats at 1, 4, 7, 12, 15, and 21 days (P1, P4, P7, P12, P15 and P21). The expression of 3α‐HSOR could be observed at E14 in the ventricular zone (VZ), the olfactory neuroepithelium, and the ganglionic eminences. At E17, the enzyme was expressed in the superficial layers of the cortex, the olfactory bulbs (BO) and the hippocampus. At E20, 3α‐HSOR expression was more widespread and in neurogenic zones the enzyme was observed in the VZ and the subventricular zone (SVZ). During postnatal development, the enzyme expression in neurogenic zones (SVZ, rostral migratory stream, OB and dentate gyrus) increased during the first two weeks and then decreased without disappearing. Concerning the caudal extension of the SVZ (CESVZ), we found that at P1, this structure was composed of a large number of 3α‐HSOR^+^neural progenitors that form radial chains which enter into the corpus callosum (CC). At P21, the CESVZ and the radial chains practically disappeared but isolated 3α‐HSOR^+^cells could be observed in the CC. The enzyme was also expressed in endothelial cells, and showed a dramatic increase of its expression during P12 and P15. 3α‐HSOR^+^vessels were observed within neurogenic zones. These results bring anatomical evidence suggesting that THP could contribute to the control of neural progenitor biology in vivo during brain development.
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ASTROGLIA GENESIS IN VITRO: DISTINCT EFFECTS OF RETINOIC ACID IN DIFFERENT PHASES OF NEURAL STEM CELL DIFFERENTIAION {#sec2-246}
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### Hadinger N., Varga B.V., Berzsenyi S., Környei Z., Madarasz E., Herberth B. {#sec3-246}

#### IEM‐HAS, Budapest, Hungary {#sec4-246}

In the developing CNS, the manifestation of the macroglial phenotypes is delayed behind the formation of neurons. The "neurons first -- glia second" principle seems to be valid for neural tissue differentiation throughout the neuraxis, but the reasons behind are far from clear. In the presented study, the mechanisms of this timing were investigated in vitro, in the course of the neural differentiation of one cell derived NE‐4C neuroectodermal stem and P19 embryonic carcinoma cells. The data demonstrated that astrocyte formation coincided in time with the maturation of postmitotic neurons, but the close vicinity of neurons did not initate astrocyte formation before schedule. All‐trans retinoic acid, a well‐known inducer of neuronal differentiation, on the other hand, blocked effectively the astroglia production if present in defined stages of the in vitro neuroectodermal cell differentiation. According to the data, retinoic acid plays at least a dual role in astrogliogenesis: while it is needed for committing neural progenitors for a future production of astrocytes, it prevents premature astrogliogenesis by inhibiting the differentiation of primed glial progenitors.
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A ROLE FOR THE MAPK/ERK PATHWAY IN OLIGODENDROGLIAL DIFFERENTIATION IN VITRO: STAGE SPECIFIC EFFECTS ON CELL BRANCHING AND PROCESS ELONGATION {#sec2-247}
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### Barradas P.C., Younes‐Rapozo V., Felgueiras L.O.R., Viana N.L., Fierro I.M., Barja‐Fidalgo T.C., Manhães A.C. {#sec3-247}

#### Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil {#sec4-247}

The effect of the MAPK/ERK pathway on oligodendroglial differentiation was studied *in vitro*. Cultures of oligodendrocytes (OL) with 5 or 11 days *in vitro* (div) were treated with the MEK inhibitor PD98059 (PD) observed at the following time points: 30min, 24h and 48h. Oligodendroglia was distinguished by using stage specific markers: NG2 proteoglycan, A2B5, 2\'3\'nucleotide‐cyclic 3\'phosphodiesterase (CNPase) and myelin basic protein (MBP). CNPase+ and MBP+ cell number were classified according to its morphology (phenotype) into different developmental stages: oligodendroglial progenitors (OPC), pre‐oligodendrocyte (PO), immature OL (IO), mature OL (M). Rounded cells, which could not be classified (NC), were also counted. The number of cells per phenotype was submitted to repeated measures ANOVA. At 5div, PD treatment significantly increased the number of NC cells (F=29.9, d.f.=1, p=0.001 for CNPase; F=12.2, d.f.=1, p=0.02 for MBP), which was accompanied by increases in the number of cells with more immature morphologies such as OPC (F=13.0, d.f.=1, p=0.007 for CNPase; F=8.3, d.f.=1, p=0.04 for MBP) and reductions in the number of M cells (F=8.7, d.f.=1, p=0.04 for MBP). At 11div, the PD group presented significantly increased the number of NC cells (F=16.7, d.f.=1, p=0.003 for CNPase; F=55.9, d.f.=1, p=0.002 for MBP), which was accompanied by increases in the number of cells with immature morphologies such as OPC of (F=7.2, d.f.=1, p=0.03 for CNPase) and PO cells (F=20.1, d.f.=1, p=0.01 for MBP), and reductions in the number of M cells (F=6.8, d.f.=1, p=0.03 for CNPase; F=9.1, d.f.=1, p=0.04 for MBP). PD treatment also resulted in changes in the profiles of the distributions of cells phenotypes: The strongest effects were usually observed shortly after treatment, at 30min (F=9.6, d.f.=1.7, p=0.003 for CNPase; F=12.9, d.f.=1.6, p=0.007 for MBP) at 11div. As time progressed, the profiles changed indicating that cells were recovering from treatment. NC CNPase+/MBP+ cells were neither stained by anti‐NG2 nor A2B5, indicating that they were mature cells unable to extend and/or to maintain their processes. These data indicate that the ERK pathway has a role in the branching and elongation of OL processes, with possible consequences for the formation of the myelin sheath.

Support: FAPERJ/CNPq/SR2‐UERJ.
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REST/NRSF FUNCTION IN DEVELOPING OLIGODENDROCYTES {#sec2-248}
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### Levine J.,^1^ Mandel G.,^2^ Evans L.^1^ {#sec3-248}

#### ^1^Suny at Stony Brook, Stony Brook, United States; ^2^HHMI, OHSU, Portland. OR, United States {#sec4-248}

Oligodendrocytes, the myelin‐forming cells of the CNS, are derived from neural stem cells as are neurons and astrocytes. This common lineage is reflected by the phenotypic plasticity of oligodendrocyte precursor cells (OPCs) which can give rise to small numbers of astrocytes and neurons in vivo and can be reprogrammed in vitro to act as multipotential neural stem cells. To understand how the plasticity of OPCs is regulated, we have studied the functions of REST, a DNA‐binding protein that recruits histone‐deacetylases and other chromatin modifying enzymes to DNA. REST binds to a specific DNA sequence known as the RE1 that is found in many neural‐specific genes and normally keeps these genes transcriptionally silent in non‐neuronal cells. The functions of REST during glial differentiation are unknown.

OPCs, oligodendrocytes, and astrocytes in culture express REST mRNA and protein. Glial cells within both the intact and dissociated postnatal rat optic nerve express nuclear REST. REST acts as a functional transcriptional repressor in glial cells and in chromatin‐immunoprecipitation (CHIP) experiments, REST binds to the RE1 of several neural‐ specific target genes. These genes (SCG10, Nav1.2, NF‐M and L1 CAM) are repressed in OPCs as shown by qRT‐PCR. Oligodendrocyte lineage cells infected with viruses expressing either dominant‐negative (dn) REST or REST‐VP16 (a chimeric protein with the DNA binding domain of REST fused to the activation domain of VP16) display multiple changes in the expression of neural specific genes, transcription factors, and cell‐type specific marker antigens as demonstrated by quantitative RT‐PCR, western blot analysis and immunofluorescence. Thus REST plays a role in gene regulation within developing glia.

Perturbing REST function in differentiating OPCs in vitro decreases the expression of oligodendrocyte‐specific proteins and reduces the number of oligodendrocytes that develop. Over‐expression of dnREST or REST‐VP16 in differentiating OPCs causes a significant increase in TUJ1+ cells at the expense of O4+ and MBP+ cells. REST loss‐of‐function, however, has no effect on OPC maturation into process‐bearing GFAP+ cells. These results show that REST function is required for the development of OPCs into oligodendrocytes.
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EXPRESSION OF NEURAL AND ASTROGLIAL MARKERS OF DIFFERENTIATED HUMAN UMBILICAL MESENCHYMAL STEM CELLS IN VITRO {#sec2-249}
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### Tu J., Lu T., Qi H., Wang L. {#sec3-249}

#### Shenzhen Institute of Advanced Technology, Chinese Academy of Science, Key Lab for Biomedical Informatics and Health Engineering, Institute of Biomedical and Health Engineering, Shenzhen, China, Shenzhen, China {#sec4-249}

Human umbilical mesenchymal stem cells (HUMSCs) isolated from Wharton\'s jelly of the umbilical cord can be easily obtained and processed compared with embryonic or bone marrow stem cells. They are capable of giving rise to mesenchymal cells such as osteoblasts and adipocytes in vitro. In this study, we explored the experimental condition of differentiation into neural‐like cells induced by basic fibroblast growth factor (bFGF), sonic hedgehog (Shh) and brain‐derived neurotrophic factor (BDNF) in vitro and to investigate their biological characteristics. HUMSCs were obtained from human umbilical cord of term deliveries. Cells were cultured with Dulbecco\'s modified Eagle\'s medium/F12 for expansion. After the third cell passage, the cells were analyzed with a flow cytometry using the following monocloned antibodies: CD34, CD44, CD45, CD73, CD105 and HLA‐DR. Taking another HUMSC, its basal medium was replaced with neural basal medium supplemented with B27. Cells were cultured for an additional 3 days for preinduction and then the induction medium was replaced with the presence of bFGF, Shh and BDNF. Cells were cultured for another 12 days, fixed, and then analyzed by immunocytochemistry. In our study, we isolated a cell population derived from Wharton\'s jelly, which possesses morphological characteristics similar to those of MSCs isolated from bone marrow. They exhibited fibroblastoid morphology. In the cytometric analysis, HUMSCs were positive for CD44, CD73 and CD105, but were negative for CD34, CD45, and HLA‐DR. The induced HUMSCs developed rounded cell bodies with multiple neural‐like processes. After induction by bFGF, Shh and BDNF, HUMSCs also expressed neuronal marker beta‐tubulin III, neurofilament (NeuF) and astroglial marker glial fibrillary acidic protein (GFAP). This study demonstrates that HUMSCs induced by FGF, Shh and BDNF can differentiate into neural‐like cells in vitro, which may provide a promising therapeutic strategy for the treatment of neural degeneration diseases and spinal cord injury.

This work was supported by National Basic Research Program of China 2009CB526501, National Natural Science Foundation of China Special Funds 30840037 and "Shenzhen‐Hong Kong" Innovation Program SG200810160077A.
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ASSESSING IN VIVO ELECTROPORATION AS A TOOL TO TARGET OLIGODENDROGLIAL PRECURSOR CELLS {#sec2-250}
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### Tognatta R., Dietrich D. {#sec3-250}

#### University Clinic Bonn, Department of Neurosurgery, Experimental Neurophysiology, Sigmud‐Freud‐Str. ‐ 25, 53105, Bonn, Germany {#sec4-250}

We aimed at establishing in vivo electroporation to express transgenes in oligodendroglial precursor cells (OPCs). First, we employed postnatal electroporation to target OPCs with GFP expressing plasmids. Plasmids were injected locally into the dorsolateral subventricular zone (SVZ) (co‐ordinates: 1.3 mm deep, 1.4 mm from lambda, 1.9 mm laterally) of postnatal day 0 (P0) to P2 pups. Mice were analysed for GFP expressing cells (GFP+) between P1 and P15. At all time points hundreds of GFP+ cells were found in the SVZ while outside this area nearly no cells were observed. During the first postnatal days there was a prominent labelling of radial glial cells as identified by long processes leading from the SVZ to the pial surface of the dorsal cortex. At later time points radial glial cells disappeared and cells in the SVZ displayed a more differentiated morphology. However, none of the GFP+ cells within the SVZ or any of the rarely found cells outside the SVZ were expressing NG2. Next, we used in‐utero electroporation to target embryonic precursors. Plasmids were injected into lateral ventricle between E15 and E17. The mice were analysed between P0 and P20. At P0, large numbers of GFP+ cells with simple morphology were found in the SVZ. In addition we observed numerous GFP+ cells with a migratory morphology spreading out radially from the SVZ to the dorsal and lateral cortex and a few neurons lining up in layer 2/3. At P2 and later the number of layer 2/3 neurons dramatically increased and bundles of axons were observed in the corpus callosum and in the subcortical white matter. Additionally, a constant population of GFP+ cells was found in the SVZ. However, in none of the animals we noted OPCs, astrocytes or radial glial cells. In a final series of experiments we electroporated Cre coding plasmids into Cre reporter mice at E17. Intriguingly, in addition to the cells described above we now observed vast numbers of OPCs and astrocytes in the cortex and subcortical white matter. At P20 we also found numerous myelinating oligodendrocytes. Collectively, our experiments suggest that, indeed, OPCs and astrocytes can be successfully targeted by electroporation but that in striking contrast to neurons and to a quiescent cell population in the SVZ, plasmids are only transiently active in OPCs and astrocytes.
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THE FLAVONOID AGATHISFLAVONE INDUCES DIFFERENTIATION IN NEUROBLASTOMA, GLIOBLASTOMA, NEURON‐GLIA CO‐CULTURE AND MOUSE EMBRYONIC STEM CELLS {#sec2-251}
------------------------------------------------------------------------------------------------------------------------------------------

### Costa S.L.,^1^ Souza C.S.,^1^ Silva A.R.,^1^ Granger M.S.,^1^ Pitanga B.S.,^1^ Silva V.D.,^1^ Ribeiro C.S.,^1^ Costa M.D.F.D.,^1^ Bahia M.,^1^ Paulsen B.S.,^2^ El‐Bachá R.D.S.,^1^ Rehen S.K.^2^ {#sec3-251}

#### ^1^Universidade Federal da Bahia, Salvador‐BA, Brazil; ^2^Universidade Faderal do Rio de Janeiro, Rio de Janeiro, Brazil {#sec4-251}

PURPOSE: Cell lines are a renewable and supply of central nervous system cell types and constitute an invaluable resource for studies of news therapeuticals agents against diseases on CNS. In this study, we investigated if the flavonoid agathisflavone (FAB), alone or associated with the all trans retinoic acid (RA) could interfere on cell proliferation and viability, and whether it induces differentiation in human GL‐15 glioblastoma cells, human SH‐SY5Y neuroblastoma cells, rat neuron‐glia co‐culture, and in embryoid bodies (EB) derivated from mouse embryonic stem cells (mES).

EXPERIMENTAL DESIGN: Cell proliferation was measured by 3H‐thymidine incorporation or immunostaining with phosphorylated histone H3; cell viability was determined by MTT test; cell death was evaluated by TUNEL analysis; changes on cell morphology were evaluated after Rosenfeld\'s staining and immunocytochemistry for GFAP, βIII‐tubulin and nestin.

RESULTS: It was demonstrated that FAB wasn\'t toxic to any lineages at the concentrations adopted. The compound alone was able to induce a dose‐dependent inhibition of cell proliferation in neuroblastoma and glioblastoma cells. On the other hand, the same test showed that the FAB didn\'t interfere in proliferation of mES. The TUNEL test revealed that FAB protected ES cells of death. Moreover, it alone was able to induce morphological changes in the cells. It was observed that the majority of tumor derived cells (SH‐SY5Y and GL‐15) treated with 50--100 μM FAB retracted the cell body and emitted thin GFAP or βIII‐tubulin positive processes. A subpopulation of cells showed a star‐like astrocyte phenotype with increased GFAP. As expected, immunohistochemistry staining demonstrated that EBs treated with RA were positive for nestin and βIII‐tubulin. However, we observed that the treatment of EBs with RA in association with FAB, promote a increase of neuronal markers expression as well promoted neuritogenesis. This effect was also observed in tumors and co‐culture of neurons/glial cells.

CONCLUSIONS: These results indicates that the flavonoid FAB present potencial to induces maturation of neurons in co‐cultures, and to promotes neural and/or glial differentiation in mES and human glioblastoma and neuroblastoma cells.

Supported by CNPq, FAPESB and FAPERJ.
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NITRIC OXIDE REGULATES ASTROCYTE DIFFERENTIATION: INVOLVEMENT OF INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) {#sec2-252}
-------------------------------------------------------------------------------------------------------

### Bechade C., Pascual O., Diaz‐Callejo P., Bessis A. {#sec3-252}

#### INSERM U789, Ecole Normale Supérieure, Paris, France {#sec4-252}

Astrocytes are generated from lately differentiated radial glia around birth. This generation depends on both intrinsic and extrinsic factors. We have analysed the role of nitric oxide (NO) in the generation and the differentiation of astrocytes in mouse hippocampus.

To evaluate the involvement of NO in the generation of astrocytes, we depleted NO from brain neonates by injecting carboxy‐PTIO, a nitric oxide scavenger into the ventricle. Analysis of radial glia by immunohistochemistry showed that, in the PTIO injected hippocampus, after 24h, lately differentiated GFAP positive radial glia were markedly altered as shown by their reduced length and decreased density. In contrast, neither early differentiated RC2 positive radial glia nor pyramidal neurons were affected. In addition, six days after injection, the density of GFAP positive astrocytes was significantly decreased in the hippocampus. This showed that NO is necessary for the late differentiation of radial glia and, subsequently, the generation of astrocytes.

In the brain, a significant source of NO is produced by the inducible NO synthase (iNOS) expressed by macrophages and microglia which are, in the neonate hippocampus, closely apposed to radial glia. We hypothesized that NO produced by iNOS is involved in astrocyte differenciation. We, thus, analyzed astrogenesis in the brain of mice lacking iNOS (iNOS‐/‐). As for NO depletion, in iNOS‐/‐ hippocampus, lately differentiated GFAP‐positive radial glia were strongly altered whereas the early differentiated RC2‐positive radial glia and pyramidal neurons were unaffected. After being generated, astrocytes undergo maturation characterized by an increased branching and modifications of their electrophysiological properties. We found that, in adult iNOS‐/‐ hippocampus, branching of astrocytes was reduced, suggesting an immature stage of astrocytes. To test this hypothesis, we performed whole cell recording from astrocytes in acute hippocampal slices. At P7, in wild type slices, 65% of astrocytes were mature based on their linear I/V relationship. In contrast, only 15% of astrocytes recorded from iNOS‐/‐ hippocampus displayed a mature profile.

Our results highligth a novel role of NO produced by iNOS in the production and maturation of astrocytes.
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ESTABLISHMENT OF A HUMAN FETAL BRAIN PROGENITOR‐DERIVED OLIGODENDROCYTE CULTURE SYSTEM AND ITS USE TO STUDY JC VIRUS INFECTION {#sec2-253}
------------------------------------------------------------------------------------------------------------------------------

### Monaco M.C.,^1^ Maric D.,^2^ Major E.O.^1^ {#sec3-253}

#### ^1^Laboratory of Molecular Medicine and Neuroscience, Ninds, NIH, Bethesda, United States; ^2^Laboratory of Neurophysiology, Ninds, NIH, Bethesda, United States {#sec4-253}

Differentiation of human neural progenitor cells into neural cell types offers a versatile model to study the molecular regulation of cellular phenotypes. We previously demonstrated that primary human fetal brain derived multipotential progenitor cells can be differentiated into progenitor‐derived‐neurons (PDN) and progenitor‐derived‐astrocytes (PDA). We have now expanded this cell culture model to direct progenitors in an oligodendrocytic lineage, resulting in progenitor‐derived‐oligodendrocytes (PDO). Differentiation into this lineage was demonstrated by the expression of specific markers such as A2B5, O4, GalC (galactocerebroside) and MBPs (myelin basic proteins). This cell culture model was developed in part as a unique tool to study the cellular tropism of the human polyomavirus, JCV, which is restricted in the brain to multiply within glial cells, particularly the oligodendrocyte resulting in the demyelinating disease progressive multifocal leukoencephalopathy (PML). Unexpectedly, PDO exposed to JCV showed only low levels of infection. To examine whether the receptor for JCV was present, we tested PDO for expression of both the viral receptor alpha 2‐6 linked sialic acid (SA) and the co‐receptor, the serotonin receptor (5HT2aR). While SA was abundant in PDO there was no obvious correlation between percentage of cells expressing JCV receptor and levels of infection. Because JCV receptor expression could not account for the level of susceptibility to infection, we tested the DNA binding protein, nuclear factor I class X (NFI‐X) that is highly expressed in cells susceptible to JCV infection. During differentiation from progenitors to PDO, low level of NFI‐X expression was observed. The use of this cell model to study viral gene regulation in glial cells highlights differences between oligodendrocytes derived from early stages of development compared with mature oligodendrocytes in the adult brain. The demyelinating disease that results from JCV infection, PML, is rarely seen in immune compromised children although the majority of these children have been exposed to the virus. It is possible that fetal oligodendrocytes as compared with adult cells, lack transcription proteins sufficient to support JCV infection, therefore, placing children at less risk for PML than adults.
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OLIG2 OVEREXPRESSION ENHANCES OLIGODENDROGENESIS AND MYELINATION {#sec2-254}
----------------------------------------------------------------

### Wegener A.,^1^ Maire C.,^1^ Toussaint C.,^1^ Wegner M.,^2^ Nait Oumesmar B.^1^ {#sec3-254}

#### ^1^CRICM, Paris, France; ^2^Institüt fur Biochemie, Universität Erlangen‐Nürnberg, Erlagen, Germany {#sec4-254}

Oligodendrocytes are derived from oligodendrocyte precursor cells (OPCs), which arise from specific ventricular domains along the neural axis. During development, OPCs divide, and migrate to their axonal targets, where they differentiate into myelin‐forming cells. The bHLH transcription factors, OLIG2 and OLIG1, were shown to play critical roles in oligodendrocyte development. OLIG2 is required for the commitment of neural stem cells (NSCs) into OPCs, but its function in oligodendrocyte differentiation is still poorly understood.

Here, we investigated whether OLIG2 overexpression in NSCs of subventricular zone (SVZ) could enhance oligodendrogenesis and the onset of myelination in the postnatal mouse brain. For this purpose, we generated double transgenic mice expressing OLIG2 and EGFP in nestin‐expressing stem/progenitor cells in a doxycycline (Dox) inducible manner. We found that OLIG2 overexpression in the postnatal SVZ increases the number of NG2+ cells, and as a consequence increases the number of mature oligodendrocytes in the corpus callosum and olfactory bulb, leading to increased and precocious myelination. We next tested whether OLIG2 overexpression in OPCs could also modify their differentiation into myelinating oligodendrocytes. TetOlig2 mice were crossed with an inducer line expressing the reverse tetracycline activator (rtTA) under the control the Sox10 promoter. In Dox‐induced TetOlig2:Sox10rtTA embryos, OLIG2 overexpression was specifically targeted into PDGF‐Rα+ OPCs. At embryonic stages, we demonstrated that OLIG2 overexpression in OPCs did not modify their proliferation and differentiation rate in the spinal cord. At postnatal stages (P7 and P15), the expression of the transgenes was also detected in CC1+ and MBP+ oligodendrocytes, indicating that OLIG2 overexpression was inducible at all stages of the oligodendrocyte development. Altogether, our data indicate that our transgenic models are value tools to modulate OLIG2 overexpression and to assess its roles in CNS myelination and remyelination.

Supports: French MS Association (ARSEP), NMSS (USA), INSERM.
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DIRECTING ASTROGLIA FROM THE CEREBRAL CORTEX INTO SUBTYPE SPECIFIC FUNCTIONAL NEURONS {#sec2-255}
-------------------------------------------------------------------------------------

### Heinrich C.,^1^ Blum R.,^1^ Tripathi P.,^2^ Sanchez R.,^1^ Götz M.,^2^ Berninger B.^1^ {#sec3-255}

#### ^1^Institute of Physiology, Munich, Germany; ^2^Institute for Stem Cell Research, Munich, Germany {#sec4-255}

Astroglia from the postnatal cerebral cortex can be reprogrammed in vitro to generate neurons following forced expression of neurogenic transcription factors, thus opening new avenues towards a potential use of endogenous astroglia for brain repair. However, in our previous attempts, astroglia‐derived neurons failed to establish a functional presynaptic output, a severe limitation of such an approach. It was therefore also unknown whether neurons instructed from postnatal astroglia can be directed towards distinct subtype identities. Here we show that stronger and more persistent expression of neurogenic fate determinants via silencing‐resistant retroviral vectors directs astroglia to mature into fully functional, synapse‐forming neurons. Importantly, the neurotransmitter fate choice of astroglia‐derived neurons can be controlled by selective expression of distinct neurogenic fate determinants: Forced expression of the dorsal telencephalic fate determinant neurogenin‐2 (Neurog2) directs cortical astroglia in vitro to generate synapse‐forming glutamatergic neurons, while the ventral telencephalic fate determinant Dlx2 induces a GABAergic identity. While reprogramming towards a glutamatergic phenotype occurred very efficiently in more than 70% of all Neurog2‐transduced astroglia, Dlx2‐mediated reprogramming was less efficient. Interestingly, this limitation could be overcome when astroglia were first expanded as neurosphere cells prior to transduction with the GABAergic neuron fate determinant. Significantly, this approach of expansion under neurosphere conditions and subsequent reprogramming with distinct neurogenic transcription factors could also be extended to reactive astroglia isolated from the adult injured cerebral cortex, allowing for the selective generation of glutamatergic and GABAergic neurons. These data show that neuronal reprogramming of astroglia is not restricted to postnatal stages, but can also be achieved from terminally differentiated astroglia of the adult cerebral cortex following injury‐induced reactivation.
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POPULATION STUDIES OF NG2 CELLS IN THE ADULT MOUSE BRAIN {#sec2-256}
--------------------------------------------------------

### Psachoulia K., Young K.M., Rivers L.E., Richardson W.D. {#sec3-256}

#### University College London, London, United Kingdom {#sec4-256}

NG2 cells make up around 4% of all cells in the adult mouse CNS. In the normal healthy brain a subset of NG2 cells is mitotically active and continues to generate differentiated oligodendrocyte (OL) lineage cells (PDGFRA‐‐, NG2‐‐, SOX10+, OLIG2+) for at least 8 months after birth. In the white matter of the corpus callosum (CC) the new cells become myelinating OLs; around 20‐25% of all OLs in the 8 month old CC are generated after P45. In the grey matter of the cerebral cortex the newly differentiated OL lineage cells are not so obviously myelinating ‐ this might simply reflect the fact that axons within the cortex are not closely aligned and fasciculated as in white matter. There is also evidence that NG2 cells might generate a small number of new projection neurons in the adult piriform cortex (primary olfactory cortex).

It seems probable (but as yet unproven) that the newly‐formed OLs myelinate previously unmyelinated axons, of which there are a large number even in the 8‐month old CC (around 70% of axons remain unmyelinated at that age). NG2 cells also generate remyelinating cells in demyelinated lesions produced by gliotoxin injection or EAE. Therefore, changes in the properties of NG2 cells as the brain matures and ages might critically affect normal brain function as well as the ability to repair myelin damage.

We have studied the proliferative properties of the NG2 cell population as a function of age, by cumulative BrdU labelling over a 100 day period. In young adults (P60), 40‐50% of NG2 cells in the CC and cortex incorporate BrdU; in the CC the cell cycle is ∼8 days and in the cortex ∼20 days. In eight month‐old mice (P240), again 40‐50% incorporate BrdU but with a considerably longer cell cycle, ∼60 days in both CC and cortex. Preliminary data suggest that cell cycle dynamics does not change further between 8 and 18 months. The age‐related increases in cell cycle times correlate with reduced rates of differentiation and new OL production. The density of NG2 cells in the CC declined from ∼120 to ∼80 cells/mm2 (14 μm sections) between P60 and 8 months. In the cortex, NG2 cell density remained steady at 70‐80 cells/ mm^2^.

These data raise further questions. Why are there dividing and non‐dividing NG2 cells? What causes age‐related slowing of the cell cycle? What is the requirement for OL genesis in healthy young adults?
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A COMBINED GENOMIC / RNAi APPROACH TO IDENTIFY GENES THAT OVERCOME INHIBITORS OF OLIGODENDROCYTE PRECURSOR CELL DIFFERENTIATION {#sec2-257}
-------------------------------------------------------------------------------------------------------------------------------

### Hofer M.,^1^ Baer A.,^2^ Kotter M.R.^1^ {#sec3-257}

#### ^1^University of Cambridge, Cambridge, United Kingdom; ^2^Medical University Vienna, Vienna, Austria {#sec4-257}

We have recently shown that breakdown products of myelin sheaths accumulating following demyelination contain proteins that are potent inhibitors of remyelination and which may contribute to the failure of myelin repair in these diseases. Furthermore, we were able to show that pharmacological or RNAi based neutralisation of intracellular signal cascades including Fyn‐RhoA‐ROCK and PKC‐signalling that mediate the inhibitory effects of myelin associated inhibitors (MAI) can neutralise the inhibitory effects in vitro. More importantly, pharmacological neutralisation of inhibitory MAI signalling can promote remyelination in vivo. As the processes that mediate the differentiation block of OPCs are still poorly understood, we have developed a system by which the regulatory mechanisms by which MAI inhibit OPC differentiation can be systematically studied.

The system is based on I. A microarray based comparison of OPCs in the presence and absence of inhibitors to identify mechanisms that mediate inhibitory effects of MAI on OPC differentiation, and II. A high‐throughput RNAi transfection system to evaluate the ability of candidate genes to overcome inhibitors of myelin that allows for testing more than 60 RNAi species in primary OPCs per culture and identify their potential to neutralise MAI.
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A CRITICAL ROLE FOR KIR4.1 POTASSIUM CHANNELS IN OLIGODENDROCYTE DIFFERENTIATION {#sec2-258}
--------------------------------------------------------------------------------

### Brasko C., Bay V., Bolton S., Greenwood K., Butt A.M. {#sec3-258}

#### University of Portsmouth, Portsmouth, United Kingdom {#sec4-258}

Differentiation of astrocytes and oligodendrocytes is accompanied by a negative shift in their resting membrane potential (RMP), which we hypothesise is determined by inwardly rectifying potassium channel subtype Kir4.1. Here, we have examined the effects of genetic ablation of Kir4.1 on the maturation and function of oligodendrocytes, using immunolabelling and electrophysiological techniques. Transgenic Kir4.1 knock out and wild type mice were humanely killed in accordance with the Animals (Scientific Procedures) Act 1986. In the absence of Kir4.1, there is a marked depolarization in optic nerve glia in situ and whole cell patch‐clamp analysis in optic nerve explant cultures shows this was due to a massive loss of inward currents. Measurements of the extracellular potassium (\[K+\]out) and the compound action potential (CAP) performed in the isolated, intact optic nerve, show that in the absence of Kir4.1, \[K+\]out is uncorrected and causes conduction block. In addition, we provide evidence that oligodendrocyte differentiation is retarded in the absence of Kir4.1, indicating that myelin disruption is not an indirect effect of disrupted astroglial K+ regulation. In vivo, in Kir4.1 knock out nerves there is a significant decrease in the total number of oligodendrocytes and fewer myelinating cells. Analysis of optic nerve explant cultures indicates a decrease in the proportion of mature oligodendrocytes in Kir4.1 knock out mice compared to wild type and these findings could be replicated using transient transfection techniques to regulate Kir4.1 gene expression. The results provide evidence of a critical role for Kir4.1 in both the specialised glial functions of myelination and \[K+\]out regulation, which are essential for normal CNS function.
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RADIAL GLIA‐LIKE CELLS PERSIST IN THE ADULT RAT BRAIN {#sec2-259}
-----------------------------------------------------

### Gubert F., Zaverucha‐Do‐Valle C., Pimentel‐Coelho P.M., Mendez‐Otero R., Santiago M.F. {#sec3-259}

#### Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil {#sec4-259}

During development, radial glia cells contribute to neuronal migration and neurogenesis, and differentiate into astrocytes by the end of the developmental period. Recently, it was demonstrated that during development, radial glia cells, in addition to their role in migration, also give rise to neuroblasts. Furthermore, radial glial cells remain in the adult brain as adult neural stem cells (NSC) in the subventricular zone (SVZ) around the lateral ventricles (LVs), and generate new neurons continuously throughout adulthood. In this study, we used immunohistochemical and morphological methods to investigate the presence of radial glia‐like cells around the LVs during the postnatal development period until adulthood in rats. In all ages of rats studied, we identified cells with morphological and immunocytochemical features that are similar to the radial glia cells found in the embryonic brain. Similarly to the radial glia, these cells express nestin and vimentin, and have a radial morphology, extending perpendicularly as processes from the ventricle wall. These cells also express GFAP, GLAST, and Pax6, and proliferate. In the brains of adult rats, we identified cells with relatively long processes (up to 600 μm) in close apposition with migrating neuroblasts. Our results showed that the radial glia‐like cells present in the adult rat brain share several morphological and functional characteristics with the embryonic radial glia. We suggest that the embryonic radial glia cells located around the LV walls do not complete their transformation into astrocytes, but rather persist in adulthood.
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MULTIPOTENT NEURAL‐OSTEOGENIC PROGENITORS IN THE NEURAL CREST {#sec2-260}
-------------------------------------------------------------

### Dupin E., Calloni G., Coelho J., Le Douarin N.M. {#sec3-260}

#### CNRS, GIF‐SUR‐Yvette, France {#sec4-260}

Many different cell types of adult vertebrates arise from the neural crest cells (NCC), a cell population that migrates from the neural primordium during embryogenesis. In addition to melanocytes and neurons and glial cells of the PNS, NCC derivatives in the head include chondrocytes, osteocytes and myofibroblasts/smooth muscle cells. In the trunk, these mesenchymal cells arise from mesoderm. How skeletogenic cells become segregated in NCC and whether they arise from multipotent progenitors remain poorly documented. We recently identified multipotent progenitors for PNS cells and chondrocytes in the cephalic quail NCC. Here we have studied the osteogenic progenitors in cranial NCC cultures and investigated whether trunk NCC have osteogenic capacities in vitro.

We show that cranial NCC isolated from 6‐8 somite‐stage quail embryos differentiate in vitro into Runx2‐expressing osteoblasts, either located in the perichondrium around chondrocyte nodules (endochondral‐like) or forming clusters unassociated with chondrocytes (membranous‐like). The perichondrial osteoblasts showed enhanced proliferation and differentiation after treatment with the morphogen Sonic Hedgehog (Shh). We then characterized osteogenic progenitors by in vitro clonal analysis. More than 90% of clonogenic cranial NCC gave rise to osteoblasts and glial cells and showed various degrees of multipotency, including a novel highly multipotent progenitor that yielded glial cells, neurons, melanocytes, myofibroblasts, chondrocytes and osteoblasts. Upon addition of Shh, the frequency of this progenitor raised to 13%. This progenitor is lying upstream of all the other NC precursors known so far and is a likely candidate stem cell able to yield the whole repertoire of NC derivatives.

We also found that trunk NCC isolated from 20‐25 somite‐stage embryos can give rise to osteoblasts in culture, although at lower frequency than their cephalic counterparts. Shh increased perichondrial osteoblast differentiation by trunk NCC.

These results uncover a previously unsuspected prevalence of multipotent progenitors with both neural and osteogenic capacities in the early cranial NCC and reveal that a subset of trunk NCC is able to express osteogenic properties in vitro.
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NOVEL FACTORS NECESSARY FOR OLIGODENDROCYTE DIFFERENTIATION IDENTIFIED BY A GENOME‐WIDE EXPRESSION SCREEN {#sec2-261}
---------------------------------------------------------------------------------------------------------

### Potter G., Petryniak M., Rubenstein J., Rowitch D. {#sec3-261}

#### UCSF, San Francisco, United States {#sec4-261}

Our research is focused on the molecular mechanisms of glia fate acquisition in the developing forebrain and how insights from this process can be applied to enhance treatment of neurological diseases such as multiple sclerosis (MS) and periventricular leukomalacia (PVL). These disorders may be amenable to cell transplantation‐based strategies since remyelination may be achieved by replacing the dysfunctional oligodendrocytes. Current data suggest that transplanted wild‐type OPCs may be inefficient at remyelination, and the molecular cues that direct transplanted precursors towards becoming myelinating oligodendrocytes in‐vivo are still being elucidated. We conducted a genome‐wide expression screen to identify factors that might be involved in oligodendrocyte production or differentiation. Our previous work has shown that the Dlx1&2 homeobox transcription factors repress oligodendrocyte formation in the forebrain. While OPC production is greatly increased in Dlx1&2 mutants, it is nearly abolished in Olig2 knockout mice, and we exploited these phenotypes in a genome‐based microarray strategy for identifying novel genes involved in OPC development. Our embryonic microarray screen has identified approximately 20 genes that are likely candidates to direct progenitor cells to differentiate along the oligodendrocyte lineage. Four of these genes (*Sox10*, *Pdgfra*, *Gpr17*, and *P2rx7*) have been previously characterized as involved in oligodendrocyte production or development, confirming the validity of the screen. The additional genes have yet to be studied in oligodendrocyte development. Based upon *in situ* hybridization analysis of the identified factors, we are further charactering the function of three genes: a novel protein, a putative transcription factor, and a predicted transmembrane signaling protein. We are studying the knock‐down (via RNAi) or over‐expression of these proteins in primary oligodendrocyte cultures and via injection of viral constructs into the corpus callosum of neonatal mice to elucidate their effects upon oligodendrocyte proliferation, differentiation, and myelin‐formation. We will be transplanting OPCs which have been modified for these factors, into *shiverer* mice to evaluate the ability of the modified OPCs to migrate and myelinate.
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SOLUBLE RPTPZETA/PHOSPHACAN REGULATES OPC DEVELOPMENT {#sec2-262}
-----------------------------------------------------

### Maison B.,^1^ Lamprianou S.,^1^ Chatzopoulou E.,^2^ Pauper E.,^1^ Thomas J.L.,^2^ Harroch S.^1^ {#sec3-262}

#### ^1^Institut pasteur, Paris, France; ^2^INSERM U495, Paris, France {#sec4-262}

As we have previous demonstrated a crucial role of RPTPzeta, a receptor type protein tyrosine phosphatase in myelin repair, we have investigated its role during oligodendrogenesis, particularly at the stage of oligodendrocyte progenitor cells (OPC) which are one of the few cell types in which most aspects of proliferation and differentiation can be manipulated in a defined in vitro environment.

We showed that, in RPTPzeta‐deficient mice, the number of proliferating OPC isolated from neonatal cortex and from embryonic spinal cord was increased compared to WT mice. We observed the same results in in vivo studies of the optic nerve. In addition, the proliferation of OPC isolated from WT neonatal cortex was reduced in the presence of conditioned medium derived from RPTPζ‐deficient glial cells, lacking soluble form of RPTPζ, phosphacan. This result indicates that phosphacan acts on OPC by repressing their proliferation.

Searching for the mode of action of soluble RPTPzeta using Fc fusion proteins, we demonstrated that soluble RPTPzeta binds specifically to OPC and that its binding is lost with differentiation. Finally, treatment with soluble RPTPzeta fusion proteins of mixed primary cultures, isolated from WT and RPTPzeta‐deficient neonatal cortex, resulted in an increased of oligodendrocyte differentiation. Evidence that OPC grown in the absence of mitogen, do not divide, but instead differentiate prematurely explains the complex relationship between cell division and the control of differentiation in oligodendrocytes. Thus, we propose that inhibition of proliferation caused by phosphacan is correlated with the increased differentiation observed.
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FGF SIGNALLING AND GLIAL DEVELOPMENT IN THE CHICK SPINAL CORD {#sec2-263}
-------------------------------------------------------------

### Agius E., Soula C., Cochard P. {#sec3-263}

#### Centre de Biologie du Développement, Université Paul Sabatier, Toulouse, France {#sec4-263}

During central nervous development system, various classes of neurons are generated along the entire dorso ventral axis of the spinal cord then glial progenitors are generated from discrete regions of the neuroepithelium. In vivo, Shh and BMPs, secreted respectively in the floor plate and the roof plate of the neural tube have been involved in the neurogenesis. However, if FGF signalling has long been shown to control glial development in vitro, the role of this morphogen is still controversial in vivo. We have used the embryonic chick spinal cord to study the role of FGF signaling regarding the mechanisms controlling glial development. In previous work, we have shown that sulfatase1 is expressed in the ventral spinal cord where it is a new oligodendrocyte lineage marker. Sulfatases are secreted enzymes removing sulphate moieties from heparin sulphate proteoglyans and have been shown to affect activity of various signalling pathway including Wnt, FGF and Shh. In this work, we show that the FGF receptors expression is regionalised in the ventral neuroepithelium and that FGF signalling pathway is activated when glial cells are generated around E6 in the chick spinal cord. In the chick spinal cord. We are currently analysing the relationship between sulfatases expression in the ventral spinal cord, the activity of FGF pathway and gliogenesis.
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VEGF‐C/VEGFR‐3 SIGNALING PROMOTES POSTNATAL DEVELOPMENT OF CEREBRAL INTERNEURONS {#sec2-264}
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### Fontaine R.H.,^1^ Calvo C.F.,^1^ Soueid J.,^1^ Tammela T.,^2^ Mouktine I.,^1^ Jaskowiak A.L.,^1^ Miguez A.,^1^ Zalc B.,^1^ Alitalo K.,^2^ Eichmann A.,^3^ Thomas J.L.^1^ {#sec3-264}

#### ^1^Inserm UMR‐S 975, UPMC, Hôpital de la Salpêtrière, Paris, France; ^2^Biomedicum, Helsinki, Finland; ^3^Inserm U833, Collège de France, Paris, France {#sec4-264}

In the vascular system, VEGF‐C specifically regulates lymphangiogenesis by binding to and signaling through the tyrosine kinase receptor VEGFR‐3. VEGFR‐3 expression is largely restricted to lymphatic endothelial cells but can also be detected in subsets of cells in the central nervous system (CNS) that is devoid of lymphatics. In vitro and in vivo studies in the mouse embryo have shown that VEGF‐C provides trophic support for neural precursor cells, especially for oligodendrocyte precursors of the optic nerve during the early stages of development (Le Bras et al. Nat Neurosci 2006 Mar; 9(3):340‐8). Here, we report the contribution of VEGF‐C/VEGFR‐3 signaling to postnatal neurogenesis. Using Vegf‐c and Vegfr‐3‐lacZ knock‐in mice, as well as a Vegfr‐3::Venus BAC murine line, we show that Vegfr3+ interneurons arise in the septum, striatum, and olfactory bulb during the first two neonatal weeks. These interneurons derive from the subventricular zone (SVZ) of the lateral ventricles, where Vegfr3+ neural precursors are initially localized adjacently to VEGF‐C expressing ependymal cells and neuroblasts. Neurosphere assays show that VEGF‐C promotes the survival of Vegfr3+ neuroblasts that differentiate into inhibitory interneurons. In vivo, VEGF‐C overexpression in the adult forebrain promotes neurogenesis but not angiogenesis. Finally, the conditional deletion of Vegfr‐3 in neural cells in Brn4::cre/Vegfr‐3::lox mice leads to a dramatic loss of interneurons in the basal forebrain and olfactory system. Thus, VEGF‐C/VEGFR‐3 signaling promotes the production of inhibitory interneurons, suggesting that this lymphangiogenic growth‐factor‐receptor system may contribute to the establishment of behavior within the CNS.
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DEGENERATIVE DISEASES, TOXINS AND NEURO‐PROTECTION

P‐265 {#sec1-265}
=====

TISSUE PLASMINOGEN ACTIVATOR (T‐PA) PROTECTS OLIGODENDROCYTE PROGENITOR CELLS FROM APOPTOSIS THROUGH A CYTOKINE‐LIKE EFFECT {#sec2-265}
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### Docagne F.,^1^ Ali C.,^1^ Parcq J.,^1^ Hernangomez M.,^2^ Hommet Y.,^1^ Liot G.,^3^ Vivien D.,^1^ Guaza C.,^2^ Correa F.^2^ {#sec3-265}

#### ^1^INSERM, INSERM‐U919; Université de Caen Basse‐Normandie; GIP Cyceron, Caen, France; ^2^Laboratory of Neuroimmunology, Functional and Systems Neurobiology Dept., Instituto Cajal, Madird, Spain; ^3^CNRS UMR 146, Institut Curie, Orsay, France {#sec4-265}

Oligodendrocyte progenitor cells (OPCs) are of special interest due to their capacity to differentiate into mature oligodendrocytes and promote remyelination, particularly in disorders of the white matter. Death of mature and progenitor oligodendrocytes is an important feature of multiple sclerosis, and also occurs in acute brain diseases such as cerebral ischemia, perinatal hypoxia‐ischemia or head trauma. Opportunity for remyelination depends on the survival, migration and differentiation of OPCs to mature oligodendrocytes. Therefore, limiting the death of these cells is a promising strategy to enhance the capacity of remyelination in disorders where white matter integrity is compromised. Tissue plasminogen activator (t‐PA) is a serine‐protease with effects ranging from synaptic plasticity to control of cell fate in the CNS. The principal objectives of the present study were to investigate whether t‐PA could protect primary cultures of OPCs from apoptosis induced by trophic factor deprivation. We attempted to uncover the molecular mechanisms sustaining this effect and in particular identify the membrane receptors and signalling pathways mediating this action. Here, we show that t‐PA protects cultured OPCs from apoptosis independent of its proteolytic activity or its interaction with previously reported CNS receptors such as the low density lipoprotein receptor related protein or the N‐methyl‐D‐aspartate receptor. Further, we show that t‐PA physically interacts with epidermal growth factor (EGF) receptor, leading to its activation. Anti‐apoptotic effects of t‐PA were reversed by the inhibition of the kinase activity of this receptor, and were mimicked by the EGF‐like domain of t‐PA. Interestingly, PI3K/Akt and Erk1/2 signalling pathways mediate this protective effect and converge to anti‐apoptotic pathways. Overall, this study identifies oligodendrocyte as a target cell for cytokine effects of t‐PA in CNS diseases. These novel findings bring considerable advances in the understanding of the mechanisms of actions of t‐PA, and suggests that t‐PA should not anymore be considered as a simple enzyme, but rather as a pleiotropic protein with cytokine‐like effects.
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TARGETING RESPIRATORY DYSFUNCTION IN ALS: ASTROCYTE REPLACEMENT IN THE CERVICAL SPINAL CORD OF SOD1‐G93A RATS VIA TRANSPLANTATION OF HUMAN GLIAL‐RESTRICTED PRECURSORS (GRPS) {#sec2-266}
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### Lepore A.C.,^1^ Campanelli J.T.,^2^ Rauck B.,^1^ Dejea C.M.,^1^ Rao M.S.,^3^ Rothstein J.D.,^1^ Maragakis N.J.^1^ {#sec3-266}

#### ^1^The Johns Hopkins University School of Medicine, Baltimore, United States; ^2^Q Therapeutics, Salt Lake City, United States; ^3^Invitrogen Corporation, Carlsbad, United States {#sec4-266}

Studies in models of amyotrophic lateral sclerosis (ALS) have suggested that cellular abnormalities are not limited to motor neurons. Given the numerous observations of astrocyte dysfunction in both humans with ALS and in SOD1^G93A^ rodents, a widely studied ALS model, the present study targeted replacement of non‐neuronal cell types for therapeutic benefits via transplantation of human Glial‐Restricted Precursors (GRPs), lineage‐restricted astrocyte precursors derived from human fetal neural tissue. Our previous findings demonstrated that transplantation of rat‐derived GRPs into cervical spinal cord ventral gray matter (in order to target therapy to diaphragmatic function) resulted in therapeutic efficacy in the SOD1^G93A^ rat. Benefits using rat GRPs included extended survival and disease duration, delayed forelimb (but not hindlimb) disease onset, and slowed declines in forelimb grip strength, motor performance and diaphragm compound muscle action potentials (CMAPs) following phrenic nerve stimulation, a functional electrophysiological assay of diaphragm function. These findings demonstrate the feasibility and efficacy of transplantation‐based astrocyte replacement for ALS, and also show that targeted multi‐segmental cell delivery to cervical spinal cord is a promising therapeutic strategy, particularly because of it relevance to addressing respiratory compromise associated with ALS. The present studies have extended this therapeutic approach to transplantation of human GRP analogs. Human GRP transplants robustly survived in both gray and white matter, migrated primarily along white matter tracts, and differentiated into astrocytes in SOD1^G93A^ spinal cord, despite ongoing disease progression. Studies are in progress to examine the therapeutic efficacy of transplanted human GRPs in the SOD1^G93A^ rat model.

The work was supported by: NIH F32‐NS059155 (A.C.L.), The Robert Packard Center for ALS Research (N.J.M.), The ALS Association (NJM), The Maryland Stem Cell Research Fund (NJM).
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BINDING OF THE LYMPHOCYTE‐SPECIFIC TRANSCRIPTION FACTOR SPI‐B TO UNIQUE TARGET SITES ON THE JC VIRUS PROMOTER IN PROGENITOR DERIVED ASTROCYTES {#sec2-267}
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### Marshall L., Jensen P., Ryschkewitsch C., Major E. {#sec3-267}

#### Ninds/NIH, Bethesda, United States {#sec4-267}

Human fetal progenitor derived glial cells were used as a model to study the molecular events that control JC virus (JCV) infection in the brain. JC virus is the etiological agent of the fatal demyelinating disease Progressive Multifocal Leukoencephalopathy that occurs in approximately 5% of AIDS patients, and is an emerging threat for those undergoing immunomodulatory therapies for diseases like Multiple Sclerosis. JCV undergoes a lytic infection in the brain and a latent infection in cells of the immune system. Usage of glial cells as targets for infection allows the analysis of the close relationship between cells of the brain and the immune system. JCV latency is associated with hematopoietic progenitors in the bone marrow and mature B cells in circulation. JCV gene expression is tightly regulated through usage of cellular transcription factors (TF). Because JCV is associated with cells of the immune system and the brain, it is probable that these tissues express common TFs that regulate JCV gene expression in these cells. Spi‐B is expressed at high levels in developing and mature B cells, and is involved in differentiation and maturation of B cells. Nine Spi‐B binding sites have been identified on prototype, including MAD1 and MAD4, and archetype JCV regulatory regions. Three of the potential sites were bound by proteins expressed in the hematopoietic precursor cell line KG1a, the mature B cell line BJAB, and progenitor derived astrocytes (PDA) in electromobility shift assays. Interestingly, one of the potential sites was bound only by proteins expressed in PDAs. Thirty‐three potential Spi‐B binding sites were identified on JCV promoter sequences from 16 clinical PML cases. Twelve of 25 potential sites tested bound proteins expressed in BJAB cells and PDAs. Importantly, 7 of the 25 sites were bound only by proteins expressed in PDAs. These results demonstrate that the lymphocyte‐specific TF Spi‐B is expressed in glial cells and this protein may play an important role in JCV infection in the brain. Future studies will determine the functional consequence of Spi‐B binding on the JCV regulatory region on the outcome of JCV infection in cells of the brain and immune system.
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A POINT MUTATION IN EIF2B5 LEADS TO DELAYED AND ABNORMAL DEVELOPMENT OF BRAIN WHITE MATTER IN A MOUSE MODEL FOR CACH/VWM {#sec2-268}
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### Cabilly Y., Geva M., Assaf Y., Mindroul N., Elroy‐Stein O. {#sec3-268}

#### Tel‐Aviv University, Tel Aviv, Israel {#sec4-268}

Childhood Ataxia with CNS Hypomyelination (CACH) / Vanishing White Matter (VWM) is an autosomal recessive genetic disease caused by mutations in each of the five genes encoding eukaryotic translation initiation factor 2B (eIF2B) subunits. The disease is manifested by loss of motor and cognitive functions which deteriorate upon physiological and environmental stress. The course of the disease is chronic progressive towards death at early adolescence.

We recently generated the first knocked‐in (KI) mouse model for the disease by introducing a point mutation into the mouse genome, leading to R132H replacement in the catalytic subunit of eIF2B. This mutation corresponds to the human R136H mutation that leads to a classical form of the disease.

Overall the symptoms of the KI mice are mild, akin to the late onset form of the human disease, pointing at the potential weight of stress to disease progression. In the absence of any physiological or environmental stress, impairment of motor functions was detectable in the KI mice at 6 weeks of age, but the mice did not develop paralysis. Both Magnetic Resonance (diffusion tensor imaging) and transmission electron microscope (TEM) reveal that the mutation in eIF2B5 primarily leads to delayed and abnormal developmental of the white matter in the brain Internal Capsule (IC), which is critical for motor functions and movement control.
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INTERACTION PARTNERS OF MTMR2 AND MTMR13/SBF2 ‐ TWO MYOTUBULARINS INVOLVED IN DEMYELINATING PERIPHERAL NEUROPATHY {#sec2-269}
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### Locher V.,^1^ Tersar K.,^1^ Berger P.,^2^ Suter U.^1^ {#sec3-269}

#### ^1^Institute of Cell Biology, Department of Biology, ETH Zurich, Zurich, Switzerland; ^2^Molecular Cell Biology, Paul Scherrer Institut, Villigen, Switzerland {#sec4-269}

The myotubularin protein family consists of eight active and six inactive phosphatases specific for phosphoinositides (PI‐3‐P, PI‐3,5‐P~2~) that have been shown to play an important functional role in endosomal sorting. Three myotubularins have been linked to human diseases: Mutated MTM1 is responsible for X‐linked myotubular myopathy, while mutations in MTMR2 or MTMR13/SBF2 lead to Charcot‐Marie‐Tooth disease (CMT) type 4B. Mtmr2 interacts with Sap97/Dlg1 as well as Neurofilament light chain (NF‐L), a protein mutated in CMT type 1F and 2E. In an immunoprecipitation‐based screen we have found that also other intermediate filaments are likely to interact with Mtmr2. Furthermore, we have searched for interaction partners of Mtmr13/Sbf2 to gain further insights into disease‐relevant protein complexes and mechanisms. Using immunoprecipitation as well as yeast two‐hybrid‐based screens, we have identified several promising candidates including other myotubularins and proteins involved in sumoylation.
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NEUROPROTECTIVE EFFECTS OF THE ENDOCANNABINOID 2‐ARACHIDONOYLGLYCEROL ARE MEDIATED BY ABNORMAL‐CANNABIDIOL‐SENSITIVE RECEPTORS ON MICROGLIAL CELLS {#sec2-270}
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### Koch M., Kreutz S., Böttger C., Ghadban C., Korf H.W., Dehghani F. {#sec3-270}

#### Goethe‐University Frankfurt, Frankfurt, Germany {#sec4-270}

Endocannabinoids like 2‐arachidonoylglycerol (2‐AG) have been shown to protect neurons after brain injuries. According to current concepts these neuroprotective effects are due to interactions between 2‐AG and cannabinoid (CB)1 receptors on neurons. On the other hand, CB2‐ and abnormal‐cannabidiol (abn‐CBD)‐sensitive receptors modulate proliferation and migration of microglial cells that become rapidly activated after neuronal injury. Here we investigated the role of abn‐CBD‐sensitive receptor on microglial cells and its contribution to 2‐AG‐mediated neuroprotection. Organotypic hippocampal slice cultures (OHSCs) were chosen as model system. Excitotoxic lesion of OHSCs was induced by NMDA (50 μM) application for 4h and caused neuronal damage and accumulation of microglial cells within the granule cell layer. Lesioned OHSCs were treated with two agonists of the abn‐CBD‐sensitive receptor, abn‐CBD or 2‐AG, two antagonists, 1,3‐dimethoxy‐5‐methyl‐2‐\[(1R,6R)‐3‐methyl‐6‐(1‐methylethenyl)‐2‐cyclohexen1‐yl\]‐benzene (O‐1918) or cannabidiol (CBD) and the CB1 receptor antagonist AM251. Application of both, abn‐CBD or 2‐AG to lesioned OHSC significantly decreased the number of microglial cells and degenerating neurons in the dentate gyrus. Application of O‐1918 or CBD, but not of AM251 reversed these effects. When microglial cells were depleted by preincubation of OHSC with the bisphosphonate clodronate, 2‐AG and abn‐CBD lost their neuroprotective effects. We therefore propose that the endocannabinoid 2‐AG exerts its neuroprotective effects via activation of abn‐CBD‐sensitive receptors on microglial cells.

This study was supported by the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF).
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NEURON‐TO‐GLIA TRANSMISSION OF ALPHA‐SYNUCLEIN: A NOVEL MECHANISM OF GLIAL INCLUSION FORMATION AND IMMUNE RESPONSES IN SYNUCLEINOPATHIES {#sec2-271}
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### Lee S.J.,^1^ Lee H.J.,^1^ Suk J.E.,^1^ Patrick C.,^2^ Bae E.J.,^1^ Cho J.H.,^3^ Rho S.,^3^ Jung J.W.,^1^ Kim K.P.,^1^ Hwang D.,^3^ Masliah E.^2^ {#sec3-271}

#### ^1^Konkuk University, Seoul, Republic of Korea; ^2^UC San Diego, la Jolla, United States; ^3^Postech, Pohang, Republic of Korea {#sec4-271}

Abnormal neuronal aggregation of alpha‐synuclein is implicated in the development of many neurological disorders including Parkinson\'s disease and dementia with Lewy bodies. Glial cells also show extensive alpha‐synuclein pathology and are thought to contribute to disease progression. However, the mechanism that produces the glial alpha‐synuclein pathology and the interaction between neurons and glia in the disease‐inflicted microenvironment remain unknown. Here, we show that neuronal cells release aggregated alpha‐synuclein proteins under various protein misfolding stresses, and that astrocytes take up the neuron‐derived alpha‐synuclein aggregates through endocytosis. Through this neuron‐to‐glia transmission, astrocytes produce alpha‐synuclein inclusions similar to the ones found in human brains. The glial accumulation of alpha‐synuclein through the transmission of the neuronal protein was also demonstrated in a transgenic mouse model expressing human alpha‐synuclein. Furthermore, astrocytes that were exposed to neuronal cell‐derived alpha‐synuclein underwent changes in the gene expression profile reflecting an inflammatory response. Induction of proinflammatory cytokines and chemokines correlated with the extent of glial accumulation of alpha‐synuclein. Together, these results suggest that astroglial alpha‐synuclein pathology is produced by cell‐to‐cell transmission of neuronal alpha‐synuclein aggregates, causing inflammatory responses. This transmission step is thus an important mediator of pathogenic glial responses and could qualify as a new therapeutic target.
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EFFECTS OF MINOCYCLINE ON MICROGLIAL ACTIVATION AND DIFFUSE AXONAL INJURY FOLLOWING TRAUMATIC BRAIN INJURY IN MICE {#sec2-272}
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### Homsi S., Piaggio T., Croci N., Plotkine M., Marchand‐Leroux C., Jafarian‐Tehrani M. {#sec3-272}

#### Université Paris Descartes, Paris, France {#sec4-272}

INTRODUCTION: Minocycline has shown to exert anti‐inflammatory and neuroprotective effects in several animal models of neurodegenerative diseases and acute brain injuries. However, the effect of minocycline on the consequences of traumatic brain injury (TBI) is still not fully investigated. Since neuroinflammation and diffuse axonal injury (DAI) are two consequences of TBI, we investigated the effects of minocycline on the TBI‐induced microglial activation, and axonal accumulation of β‐amyloid precursor protein (β‐APP) as markers of neuroinflammation and DAI (1), respectively.

METHODS: The weight drop model was used to induce TBI in mice (2). Microglial activation and DAI were evaluated by immunohistochemistry using CD11b and β‐APP markers, respectively. Minocycline was administered either 1) three times 5 min (90 mg/kg, i.p.), 3 and 9h (45 mg/kg, i.p.) following TBI (short‐term protocol), or 2) six times 5min (90 mg/kg, i.p.), 3, 9, 24, 36 and 48h (45 mg/kg, i.p.) following TBI (long‐term protocol). The levels of CD11b and β‐APP were evaluated at 24 (short‐term protocol) or 72h post‐TBI (long‐term protocol).

RESULTS: The kinetic studies of post‐TBI microglial activation and DAI showed an increase of CD‐11b immunolabelling as well as an acute axonal accumulation of β‐APP from 6h up to 72h post‐TBI. While minocycline treatment decreased the elevation of post‐TBI CD11b marker in the short‐term protocol (P\<0.05), it was devoid of effect in the long‐term protocol. Besides, minocycline had no significant effect on the TBI‐induced axonal accumulation of β‐APP in none of the protocols used in this study.

CONCLUSION: Treatment with minocycline was able to reduce the TBI‐induced microglial activation in the short‐term protocol. However, it was not able to reduce the traumatic axonal injury suggesting that under our experimental conditions the microglial activation does not affect DAI following TBI.

1\) Stone et al. Brain Res. 2000; 871(2):288‐302.

2\) Hellal et al. J Neurotrauma. 2003; 20: 841‐51.
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REGENERATIVE THERAPY OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY NEUROTROPHIN‐3 TRANSDUCED ES CELL DERIVED MICROGLIAL CELLS {#sec2-273}
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### Lenerz V.,^1^ Beutner C.,^1^ Masgutov R.,^1^ Litwak S.,^1^ Chechneva O.,^1^ Dann A.,^2^ Prinz M.,^2^ Neumann H.^1^ {#sec3-273}

#### ^1^Institute of Reconstructive Neurobiology, University Bonn Life & Brain Center, Bonn, Germany; ^2^Department of Neuropathology, University Freiburg, Freiburg, Germany {#sec4-273}

Multiple sclerosis (MS) is an autoimmune disease, in which the immune system attacks the nervous system. Demyelination of nerve cells in the brain as well as in the spinal cord and inflammation of the tissue are the main pathological hallmarks of the disease. In MS inflammation can be successfully prevented, but regeneration still remains a major challenge.

In this study, we present a novel regenerative approach to mice afflicted by experimental autoimmune encephalomyelitis (EAE), a common mouse model for MS. Microglial precursor cells derived from C57BL/6 embryonic stem cells (ESdM) were intravenously transplanted into EAE‐mice. Injection was performed in mice at ongoing disease after reaching clinical score of 3 at 18 to 20 days after immunization with MOG peptide. ESdMs labeled with green fluorescent protein (GFP) migrated into the EAE spinal cord lesions and slightly improved the disease course. Next, ESdM lentivirally transduced with neurotrophin 3 (NT3), which has been reported to promote restoration of motoric function in rats after spinal cord injury, were transplanted into EAE‐mice. EAE‐mice treated with NT3‐transduced ESdM stably recovered from disease symptoms without any relapses in contrast to control mice treated with phosphate buffered saline. NT3‐transduced ESdM created an anti‐inflammatory cytokine milieu in the spinal cord and promoted axonal sprouting and regeneration. Particularly, the sprouting associated protein GAP43 was only detected by immunocytochemistry in mice treated with NT3‐transduced ESdM, but not control mice.

Thus, genetically modified ESdMs expressing neurotrophin 3 reveal a promising approach for regenerative therapy of EAE in mice.
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CELLULAR IMMUNITY AND PATHOLOGICAL ALTERATIONS IN MS GREY MATTER {#sec2-274}
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### Kinter J.,^1^ Allaman I.,^2^ Schroder K.,^3^ Tschopp J.,^3^ Magistretti P.,^2^ Schaeren‐Wiemers N.^1^ {#sec3-274}

#### ^1^University Hospital Basel, Basel, Switzerland; ^2^Brain Mind Institute, Ecole Polytechnique Fédérale (EPFL), Lausanne, Switzerland; ^3^Department of Biochemistry, University of Lausanne, Epalinges, Switzerland {#sec4-274}

In recent years, grey matter abnormalities as well as damage to neurons and axons have received considerable attention in MS research. Total amount of neuronal/axonal damage accumulating in the MS brain may further be augmented by the formation of grey matter lesions. The extent of axonal pathology has emerged as an important correlate of the clinical deficit in MS patients. Grey matter abnormalities have been linked to several clinical manifestations, such as seizures, fatigue and cognitive dysfunction. However, very little is known about molecular and cellular changes in the grey matter of MS patients. A possibility could be that some of the clinical manifestations in MS might be induced by molecular changes in cortical grey matter of MS patients. For that reason, we ask the question whether a diffuse inflammatory reaction, as observed in the adjacent normal appearing white matter, might be present and is possibly responsible for grey matter pathogenesis.To identify molecular and cellular alterations in the grey matter of MS a pilot microarray study was performed. Normal appearing grey matter from 8 control and 14 MS cases was isolated and subjected to gene expression analysis. Differentially expressed genes in the MS NAGM were identified. Many genes of particular Interleukin signalling pathways were upregulated, indicating an activation of cellular immunity in MS grey matter. Downregulation of several astroglial genes known to be involved in energy metabolism suggests a dysregulation of astrocytic gene expression. Both detected pathways have been recently shown to be interconnected. The interleukin‐mediated disturbance of the energy metabolism within the cortex may be the molecular basis of several clinical manifestations seen in MS. The identification of such pathological alterations in the grey matter will help to understand the pathogenesis of the disease and may serve for developing new therapeutic strategies.
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MODULATION OF ASTROCYTE‐MEDIATED NEUROTOXICITY BY PRION PROTEIN AND STRESS‐INDUCIBLE PROTEIN 1 IN A MODEL OF ALS {#sec2-275}
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### Barbeito A.G.,^1^ Martínez‐Palma L.,^1^ Cassina P.,^1^ Hajj G.N.,^2^ Brentani R.R.,^3^ Barbeito L.,^4^ Martins V.R.^2^ {#sec3-275}

#### ^1^Facultad de Medicina, Montevideo, Uruguay; ^2^Ludwig Institute for Cancer Research, Sao Paulo, Brazil; ^3^Centro de Tratamento e Pesquisa Hospital do Câncer, Sao Paulo, Brazil; ^4^Institut Pasteur de Montevideo, Montevideo, Uruguay {#sec4-275}

The survival of motor neurons depends on the supply of trophic factors produced by neighboring neuronal and non‐neuronal cells. Altered trophic support may be involved in the increased vulnerability and degeneration of motor neurons occurring in Amyotrophic Lateral Sclerosis (ALS). Prion protein (PrP^C^) and the co‐chaperone Stress Inducible Protein 1 (STI1) have been shown to mediate survival of retinal and hippocampal neurons. In the present study, we determined whether the PrP^C^‐STI1 trophic pathway could modulate motor neuron survival since both, PrP^C^ and STI1 were strongly expressed in spinal motor neurons. Importantly, we show that the synthetic STI1~230‐245~ peptide, containing the PrP^C^ binding site, prevented motor neuron death induced by the withdrawal of trophic factors. This effect was dependent on PrP^C^ expression since STI1~230‐245~ was completely devoid of protective effect in motor neurons from PrP^C^‐null mice. In addition, neutralizing antibodies to PrP^C^ and STI1 decreased the survival of motor neurons maintained on the top of astrocyte monolayers. Finally, STI1~230‐245~ peptide prevented motor neuron loss induced by astrocytes expressing the ALS‐linked G93A SOD‐1 mutation, suggesting a protective role of STI1‐PrP^C^ in the disease. In agreement, STI1 but not PrP^C^ was decreased in a subset of degenerating motor neurons in symptomatic SOD1^G93A^ mice. Taken together, our data suggest that PrP^C^‐STI1 complex represents a major trophic pathway in motor neurons, which may lead to novel approaches to halt the progression of ALS.
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CHARACTERIZATION OF LITAF AND ITS ROLE IN CHARCOT‐MARIE‐TOOTH NEUROPATHY {#sec2-276}
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### Somandin C.,^1^ Stendel C.,^1^ Roos A.,^2^ Senderek J.,^1^ Suter U.^1^ {#sec3-276}

#### ^1^Institute of Cell Biology, Department of Biology, ETH Zurich, Zurich, Switzerland; ^2^Institute of Human Genetics, Medical Faculty, RWTH Aachen, AACHEN, Germany {#sec4-276}

Charcot‐Marie‐Tooth (CMT) disease is a clinically and genetically heterogeneous group of inherited peripheral neuropathies characterized by progressive weakness and atrophy of distal limb muscles and sensory loss. Missense mutations in the LITAF gene cause an autosomal dominant demyelinating form of CMT (CMT1C). The function of LITAF, the consequences of LITAF mutations on the protein and the related pathomechanism leading to peripheral nerve demyelination are largely unknown. Expression analysis of LITAF in mice revealed expression in sciatic nerve and up‐regulation of the protein during onset of myelination. To unravel potential functions of LITAF we performed a yeast two‐hybrid screen and a tandem affinity purification assay to identify interaction partners of LITAF. In a more hypothesis‐driven approach, we have investigated a possible impact of LITAF on protein degradation as LITAF may associate with late endosomes/lysosomes. In addition, we are working on LITAF knockout mice and transgenic mice overexpressing a human CMT1C disease mutation to investigate the functional role of LITAF in CMT1C pathophysiology in vivo.
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GLIAL CELL REACTIVITY IN A MOUSE MODEL OF AMYLOID PLAQUE DEPOSITION {#sec2-277}
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### Behrendt G.,^1^ Buffo A.,^2^ Götz M.,^3^ Dimou L.^1^ {#sec3-277}

#### ^1^LMU München, Munich, Germany; ^2^University of Turin, Turin, Italy; ^3^Institute of Stem Cell Research, Helmholtz Zentrum, Munich, Germany {#sec4-277}

Glial cells have many important functions in the intact as well as in the injured brain. We have previously discovered that glial cells react to brain injury of the cerebral cortex by an increase of proliferation as well as an elevation of cells expressing the transcription factor Olig2 (Buffo et al., PNAS 2005). Here we investigated how glial cells react toward a chronic injury such as progressive amyloid plaque deposition (Thy1‐APP/PS1 mice, Radde et al., EMBO 2006).

As the first reaction to amyloid plaque deposition we observed an increase in proliferation around the amyloid plaques already in 3 months old mice. This was mostly due to activation of microglia. At this timepoint astroglial reactivity had also started surrounding the plaques, but reactive astrocytes did not proliferate, as observed after acute brain injury involving disruption of the blood‐brain barrier. Interestingly, the number of Olig2‐expressing cells was not yet up‐regulated in 3 months old Thy1‐APP/PS1 mice, but after 6 months of age. Additionally, we observed myelin defects at the same time in these mice and Olig2 up‐regulation occurred mostly in mature oligodendrocytes. These myelin defects persisted and could not be repaired as demonstrated by fate mapping Olig2‐expressing progenitors using Olig2::CreERTM --mediated genetic labelling (Dimou et al., J. Neuroscience 2008) to follow the progeny of Olig2+ cells prior and after plaque deposition. We therefore propose that myelin aberrations and the failure to repair these may contribute to neuronal deficits observed after amyloid plaque deposition. As repair of myelinating oligodendrocytes in the white matter of the cerebral cortex can also originate from adult neural stem cells, we are now monitoring the progeny of these cells using GLAST::CreERT2‐mediated genetic fate mapping as described in Ninkovic et al. (J. Neuroscience 2007). Results of these experiments will also be presented.
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AAV6 FOR TRANSDUCTION OF HUMAN AND MOUSE MÜLLER GLIA CELLS {#sec2-278}
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### Wijnholds J., Aartsen W.M., van Cleef K., Pellissier L., Blits B., Ehlert E., Vos R., Verhaagen J. {#sec3-278}

#### Netherlands Institute for Neuroscience, Amsterdam, Netherlands {#sec4-278}

Crumbs homolog‐1 (CRB1) is a transmembrane protein that is expressed in Müller cells of the retina. The protein localizes apically adjacent to adherens junctions between Müller cells and photoreceptors. Mutations in the CRB1 gene cause Leber congenital amaurosis (LCA) and progressive forms of retinitis pigmentosa (RP), which lead to blindness at birth or at young adulthood, respectively. Mice lacking CRB1 develop retinal disorganization followed by retinal degeneration, suggesting that CRB1 is required to maintain adhesion between Müller cells and photoreceptors.

We are in progress of developing gene therapy for CRB1. To allow targeting of Müller cells we tested different adeno‐associated viral (AAV) serotypes and ways of administration of AAV. We show that intravitreally applied AAV2/6‐CMV‐GFP can effectively transduce mouse and human Müller cells. Müller cells located near to blood veins are preferentially transduced. Disruption of the inner limiting membrane by collagenase further increases the infection of Müller cells. We show that AAV2/6‐CMV‐GFP injected underneath the retinal inner limiting membrane of human donor eyes infects human Müller cells effectively.

We will present expression of human CRB1 in Crb1 knock‐out mouse retinas.
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BIOLUMINESCENCE IMAGING OF OLIG2‐NEURAL STEM CELLS REVEALS IMPROVED ENGRAFTMENT IN MULTIPLE SCLEROSIS MOUSE MODELS {#sec2-279}
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### Sher F., Boddeke E., van Dam G., Copray S. {#sec3-279}

#### University Medical Center Groningen, Groningen, Netherlands {#sec4-279}

Neural stem cells (NSCs) are considered as a potential source for oligodendrocyte precursor cells (OPCs) to be used in cell based remyelination therapy for multiple sclerosis (MS). A major issue in the potential application of NSC‐based cell replacement therapy for multiple sclerosis (MS) is the question regarding the survival, functional behavior and stability of implanted NSCs over an extended period. To address this issue, we have employed Bioluminescence Imaging (BLI) and Magnetic Resonance Imaging (MRI) as non‐invasive longitudinal in‐vivo techniques to monitor the fate of the implanted NSCs in MS mouse models. We have used the cuprizone demyelination mouse model and NSCs isolated from luciferase‐GFP‐actin transgenic mice. To compare normal NSCs with NSCs that were primed to become oligodendrocytes precursor cells (OPCs) by the induction of Olig2 overexpression (Olig2‐tNSCs) we did stereotactic implantation in the demyelinated corpus callosum of cuprizone‐fed mice. In vivo BLI validated by immunohistochemistry revealed that, after a steep cell loss following implantation during the first 3 weeks, approximately 10% of the Olig2‐tNSCs stably survived for two months after implantation, in contrast to \<1% of the normal NSCs. Immunohistochemistry and electronmicroscopy revealed that the surviving Olig2‐tNSCs in vast majority had differentiated into mature oligodendrocytes and contributed to remyelination.
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GSTA4, A CANDIDATE GENE FOR REGULATION OF NERVE INJURY‐INDUCED NEURODEGENERATION IN THE RAT {#sec2-280}
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### Al Nimer F., Ström M., Lindblom R., Piehl F. {#sec3-280}

#### Karolinska University Hospital, Stockholm, Sweden {#sec4-280}

Reactive oxygen species (ROS) are produced during oxidative events and are highly neurotoxic molecules. ROS are produced by activated microglia after nerve injury and cause damage to DNA, proteins and lipids, the latter in a reaction called lipid peroxidation. 4‐HNE is a product of lipid peroxidation involved in regulation of p53‐induced apoptosis that has been suggested to play a role in a wide range of neurodegenerative diseases, e.g. Alzheimer (AD) and ALS. 4‐HNE is reduced by conjugation with glutathione, a reaction catalyzed by glutathione‐S‐transferases (GSTs). Of the GSTs, Gsta4 has by far the highest catalytic efficiency for 4‐HNE.

In this study we have used a nerve injury model in the rat, ventral root avulsion (VRA), which results in a very proximal injury in the CNS/PNS border that results in the loss of a large proportion of axotomized motorneurons and elicits a local inflammatory response with activation of microglia. In a F2 intercross between DA and PVG, two inbred rat strains that display a two‐fold difference in nerve cell survival, we previously have identified a QTL regulating motorneuron survival, VRA1. The fragment is now fine mapped in a G12 advanced intercross line to a 9 Mb fragment containing 59 genes, among these two GSTS; Gsta2 and Gsta4. A new F2 intercross was set up and material sampled 5 days after injury, just before motorneurons start to degenerate. mRNA expression levels were studied with Affymetrix Rat Exon 1.0 chips with over 27 000 probe sets to get expression data on all known genes and subsequently linkage analysis was performed. Only one transcript, Gsta4, was significantly linked to the VRA1 region making it a likely candidate for observed differences in motorneuron survival. Strain differences in expression have been verified by RT‐PCR and also studied and replicated a model of traumatic brain injury, TBI. Furthermore, microglia obtained from PVG and DA in vitro display even greater strain difference.

In summary, with an unbiased genetic approach we have identified allelic differences in Gsta4 as likely candidate gene for strain differences in neurodegeneration. This protein has been shown to be very efficient in reducing levels of 4‐HNE, implicated in neurodegenerative disorders. Our data support Gsta4 as a candidate gene for regulation of susceptibility to neurodegeneration.
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CONDITIONAL P27 INACTIVATION IN THE ADULT MOUSE RECAPITULATES REACTIVE GLIOSIS {#sec2-281}
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### Vazquez‐Chona F.,^1^ Swan A.,^1^ Defoe D.,^2^ Levine E.^1^ {#sec3-281}
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PURPOSE: Radial retinal (Müller) glia support the survival of photoreceptors and in some species retinal glia regenerate photoreceptors. In humans, the metabolic demands of retinal degenerations can promote reactivity in Müller glia, a state where they become hypertrophic, migratory and mitotic. We are testing the hypothesis that the cell‐cycle inhibitor p27KIP1 (commonly known as p27) is a negative regulator of glial reactivity.

METHODS: To test our hypothesis we used a conditional gene targeting approach. We inactivated p27 in adult mice using the floxed p27 x Actin:CreER line. Classic signaling pathways of glial reactivity and metabolic states of glia were assayed using conventional protein profiling (immunohistochemistry and Western blots) and metabolic profiling (computational molecular phenotyping, CMP).

RESULTS: Global conditional inactivation of p27 results in Müller glial reactivity: (i) upregulation of cytoskeletal proteins including GFAP and VIM; (ii) nuclear displacement and endfeet migration; and (iii) cell‐cycle entry.

CONCLUSIONS: These data provide evidence that p27 inactivation in adult mice is sufficient to promote reactivity in Müller glia, which supports our hypothesis that p27 is a negative regulator of this behavior.
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Amyloid precursor protein (APP) transgenic Tg2576 mice overexpress human APPswedish and develop Abeta plaques in an age‐dependent manner. The Abeta plaque formation is accompanied by a robust glial response and by the expression of both, pro‐ and anti‐inflammatory cytokines, which may contribute to secondary neuronal dysfunction/cells loss. Recently, it was demonstrated that N‐terminally truncated and pyroglutamate‐modified Abeta peptides (pE‐Abeta) act as a seed for Abeta aggregation and for co‐aggregation of non‐modified Abeta peptides. The pE modification of Abeta is catalyzed by the enzyme glutaminyl cyclase (QC) in vitro and in vivo. Here, we show that the chronic application of a QC inhibitor via the oral route reduces pE‐Abeta generation and subsequent plaque formation when applied in young, 6‐month‐old, mice prior to the initial seeding process. Reduced Abeta plaque formation was found to be accompanied by attenuated glial response in brains of Tg2576 mice. On the contrary, when the QC inhibitor was administered to 10‐month‐old Tg2576 mice; i.e. after initial plaque seeding events, there was no effect of QC inhibition on the ongoing plaque formation process. However, the plaque‐associated activation of microglial cells and of astrocytes was considerably reduced as shown by double immunofluorescent labelings and confocal laser scanning microscopy. These observations indicate anti‐inflammatory effects of QC inhibition in brains of Tg2576 mice, which are independent from the plaque formation process.

P‐283 {#sec1-283}
=====

NEURONAL AND GLIAL EXPRESSION OF GLUTAMINYL CYCLASE IN BRAIN {#sec2-283}
------------------------------------------------------------
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Glutaminyl cyclase (QC) converts N‐terminal glutaminyl residues into pyroglutamate (pE), thereby stabilizing these peptides/proteins. Recently, we demonstrated that QC also plays a pathogenic role in Alzheimer\'s disease by generating the disease‐associated pE‐Abeta from N‐terminally truncated Abeta peptides *in vivo*. This newly identified function makes QC an interesting pharmacological target for Alzheimer\'s disease therapy. However, the expression of QC in brain, its cell type‐specific and subcellular localization as well as developmental profiles are not yet known. In the present study QC mRNA expression was found highest in hypothalamus, followed by hippocampus and cortex. In the developmental course, stable QC mRNA levels were detected in hypothalamus from postnatal day 5 to 370. On the contrary, in cortex and hippocampus QC mRNA levels were highest after birth and declined during ontogenesis by 20 to 25%. These results were corroborated by immunocytochemical analysis in mouse brain demonstrating a robust QC expression in a subpopulation of lateral and paraventricular hypothalamic neurons and the labeling of a significant number of small neurons in the hippocampal molecular layer, in the hilus of the dentate gyrus and in all layers of the neocortex. Under basal conditions in the unmanipulated brain QC was exclusively expressed by neurons and localized to the endoplasmatic reticulum, Golgi apparatus and secretory granules, consistent with a function of QC in neuronal protein maturation and/or modification. However, after middle cerebral artery occlusion and following immunotoxic lesions of cholinergic, serotonergic and dopaminergic neurons, QC was also expressed by glial cells in a time and region‐specific manner. Glial QC expression was also observed in primary cultrures from mouse brain. Our results indicate that distinct kinds of lesions induce a glial response which involves QC expression and might, therefore, contribute to amyloidogenesis.
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NEURO‐ AND GLIOTOXICITY OF THE EXCITATORY AMINO ACID BETA‐ODAP INVOLVES IMPAIRED FREE RADICAL DEFENCE {#sec2-284}
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### Van Moorhem M.,^1^ Decrock E.,^1^ de Bock M.,^1^ Wang N.,^1^ de Vuyst E.,^1^ Callewaert G.,^2^ Van Den Bosch L.,^3^ Lambein F.,^1^ Leybaert L.^1^ {#sec3-284}
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Excessive consumption of *Lathyrus sativus* L. seeds (grass pea) can cause neurolathyrism, a disease occurring mainly in developing countries that is characterized by symmetrical spastic paraparesis of the legs with degeneration of motor neurons. The excitatory amino acid β‐N‐oxalyl‐α,β‐diaminopropionic acid (β‐ODAP) present in grass pea is proposed as the cause of the disease, but the mechanism of its action has not been conclusively elucidated. β‐ODAP acts as an agonist of AMPA/KA receptors and metabotropic glutamate (Glu) receptors. It inhibits Na+‐dependent Glu uptake, Glu‐dependent cystine uptake and complex‐I of the mitochondrial electron transfer chain and it alters mitochondrial Ca2+ handling. These effects take place in neurons as well as in astrocytes and result in the accumulation of Glu into the extracellular space, the generation of free radicals and a compromised defence against free radicals. The latter probably play an important role in the pathogenesis as the grass pea that triggers this disease is deficient for methionine and cysteine, two precursors of glutathione that confers antioxidant protection. The aim of the present work was to determine the role of oxidative stress on β‐ODAP‐triggered cell death in motor neurons and glial cells. Neurotoxicity was determined by exposing primary rat spinal motor neurons co‐cultured with astrocytes to β‐ODAP or Glu over 24 h. β‐ODAP and Glu triggered significant cell death but β‐ODAP was more potent when applied at the same concentration. Inclusion of methionine or cysteine in the treatment medium protected the neurons against cell death, suggesting a role for the involvement of oxidative stress in this model. Gliotoxicity was evaluated in a simple model system of C6 glioma cells after applying β‐ODAP or Glu for 24 h and quantifying cell survival/death. Inclusion of cysteine or ascorbic acid in the medium decreased the toxicity of β‐ODAP and Glu, pointing to an oxidative component in the gliotoxicity of these substances. Future work will be directed to determine the contribution of astrocytes in neurotoxicity, i.e. whether gliotoxic effects increase the sensitivity of the neurons for β‐ODAP and Glu. Evidence from other diseases like ALS suggest that this is indeed the case.
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Regulation of proliferation, migration, polarization, and cell shape changes is essential for Schwann cells to ensheath and myelinate axons. There is increasing evidence that Rho GTPases, their regulatory proteins, and their downstream effectors participate in all these events. We have recently shown that mutations in the gene encoding a regulator of Rho GTPase activity, the putative guanine nucleotide exchange factor (GEF) FGD4/Frabin, cause demyelinating hereditary neuropathy (CMT4H) in humans. Our aim now is to clarify the role of Frabin in development, maintenance and regeneration of the peripheral nervous system (PNS) using biochemical, cell biological and i*n vivo* approaches.
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KIAA1985, A PROTEIN MUTANT IN CHARCOT‐MARIE‐TOOTH NEUROPATHY, LINKS PERIPHERAL NERVE MYELINATION TO ENDOSOMAL RECYCLING PATHWAYS {#sec2-286}
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Charcot‐Marie‐Tooth neuropathy (CMT) represents a heterogenous group of inherited disorders of the peripheral nervous system. One form of autosomal recessive demyelinating CMT (CMT4C, 5q32) is caused by mutations in the gene encoding KIAA1985, a protein of so far unknown function. Here we show that KIAA1985 is exclusively expressed in Schwann cells. KIAA1985 is tethered to cellular membranes through an N‐terminal myristic acid anchor and localizes to the perinuclear recycling compartment. A search for proteins that interact with KIAA1985 identified the small GTPase Rab11, a key regulator of recycling endosome functions. CMT4C‐related missense mutations disrupt the KIAA1985/Rab11 interaction. Protein binding studies indicate that KIAA1985 functions as a Rab11 effector, as it interacts only with active forms of Rab11 (WT and Q70L) and does not interact with the GDP locked mutant (S25N). Consistent with a function of Rab11 in Schwann cell myelination, myelin formation was strongly impaired when dorsal root ganglion neurons were co‐cultured with Schwann cells infected with Rab11 S25N. Our data indicate that the KIAA1985/Rab11 interaction is relevant for peripheral nerve pathophysiology and place endosomal recycling on the list of cellular mechanisms involved in Schwann cell myelination.
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INTRA‐VENTRICULAR INJECTION OF 6‐HYDROXYDOPAMINE INDUCES A REGION‐SPECIFIC UPREGULATION OF NESTIN IN RAT ASTROCYTES {#sec2-287}
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The most commonly used toxin‐based Parkinson model is the 6‐hydroxydopamine (6‐OHDA) lesion rat model. Standard models use injections of 6‐OHDA in either the medial forebrain bundle or the substantia nigra, resulting in a sudden, nearly complete loss of the dopaminergic neurons. Intra‐striatal and intra‐ventricular injections cause a partial and progressive loss of dopamine (DA) leading to a long‐lasting DA depletion of the nigrostriatal pathway.

We investigated the effect of bilateral intra‐ventricular 6‐OHDA injections on the morphology and proliferation of astrocytes in the rat brain. Using immunohistochemistry, we compared the expression of the glial marker GFAP, the progenitor marker Nestin, the proliferation marker Ki‐67, and the water channel protein AQP4 in sections from 6‐OHDA lesioned and sham‐operated rats at 4 days and 14 days after the injection.

Four days after the lesion, a strong up‐regulation of GFAP and Nestin in the cortex and the striatum of 6‐OHDA lesioned rats as well as an increase in the number of Ki‐67 positive cells were observed. GFAP expression remained elevated during the sample period, whereas Nestin expression decreased to control levels after 14 days. No obvious changes in the AQP4 expression were detected at any time point.

Additionally, we investigated the effect of DA‐treatment on striatal and mesencephalic astrocytes of mouse in vitro, using immunocytochemistry. No differences in the expression of GFAP, Nestin, AQP4 or Ki‐67 were detected between DA‐treated and untreated astrocytic cultures.

Our data suggest that 6‐OHDA lesions not only affect neurons, but also have an impact on astrocytes. We hypothesize, those astrocytes might undergo de‐differentiation and acquire the potential of progenitor cells in consequence of 6‐OHDA injections. In future experiments we will investigate Pax6 and Sox2 expression in astrocytes of 6‐OHDA lesioned rats with the objective to characterize them cellular as neural or glial precursor cells.
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Pelizaeus‐Merzbacher disease (PMD) and Spastic Paraplegia type 2 (SPG2) are two X linked dysmyelinating disorder of the central nervous system (CNS) related to proteolipid proteins (PLP) mutations. Numerous electrophysiological case reports indicated that the abnormal myelin formation and progressive axonal degeneration observed in PLP mutated patients are associated with abnormalities of nerve conduction. Different transgenic mice mutants with alteration in PLP expression have contributed to understand the pathophysiology of PLP related disorders. The Plp over‐expressing mice (PLOA) have neurological symptoms and CNS pathology similar to that found in PMD patients: motor impairment is clearly present after 3 weeks with two months mean survival. In contrast, the Plp knock‐out mice (PLPKO) manifest a late‐onset ascending axonopathy: mice expressed impairment of motor functions after 12 months with a normal survival.

Longitudinal follow‐up of auditory evaluation and somesthetic evoked potentials have been performed in homozygous (male) and heterozygous (female) PLOA and PLPKO mice mutants in order to correlate the results to those performed in PLP/SPG2 male patients and their mother carrier.

The final purpose of this project is to apply our new electrophysiological tools to examine the long‐range effect of pharmacological substances in therapeutic strategies for myelin repair and neuroprotection.
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Connexins are the proteins forming gap junctions. Six subunits are necessary to form a hemichannel or connexon anchored in the plasma membrane. Two hemichannels of adjacent cells form a gap junction. At present, there are, at least, 20 isoforms of connexins described in humans. Particularly, mutations in Connexin 32 (Cx32) have been associated with the X‐linked form of Charcot‐Marie‐Tooth disease (CMTX), a neurodegenerative illness affecting the peripheral nervous system. There is growing evidence that ATP is being released, under some stimuli, through hemichannels constituted either by connexins or pannexins. Using immunofluorescent methodology we have localized Connexin 32 (Cx32) in Schwann cells of teased nerve fibres from mice sciatic nerve, specifically in the paranodal zones of nodes of Ranvier and in the Schmidt‐Lantermann incisures. We have detected the release of ATP from mechanical and electrical stimulated nerve fibres through the Luciferin‐Luciferase bioluminescent reaction using the Orca II and the ImagEM digital cameras (Hamamatsu). Under these conditions we found the maximal release of ATP in the paranodal zones of Schwann cells. We have expressed the human Cx32 (hCx32) in Xenopus laevis oocytes and we have measured simultaneously the electric currents supported by Cx32 and the release of ATP. We have recorded that hCx32 is permeable to ATP when is forming hemichannels. Five mutations of different regions of the Cx32 molecule have been tested for ATP release and in all mutations tested (hCx32 S26L; hCx32 P87A; hCx32 Del111‐116; hCx32 D178Y and hCx32 R220X) the ATP release was inhibited or completely abolished.

Because Schwann cells express some forms of P2X and P2Y receptors, we hypothesize that, in physiological conditions, Schwann cells release ATP which would act as an autocrine signal. In view of our results the form of CMTX may be due to an impairment of the autocrine purinergic signalling, which should be a key process to maintain Schwann cells in healthy conditions.

Supported by grant SAF2008/732 of MICINN of Spanish Government.
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ADENOSINE A2A RECEPTOR BLOCKADE PREVENTS Aβ‐INDUCED INHIBITION OF GLUTAMATE UPTAKE IN CORTICAL ASTROCYTES {#sec2-290}
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Alzheimer\'s disease (AD) is characterized by a progressive cognitive impairment resulting from an initial synaptic impairment in cortical regions, associated with the accumulation of β‐amyloid peptides (Aβ). Aβ seem to primarily affect glutamatergic (glu) synapses, prompting the hypothesis that glu dysfunction may be associated with the early phases of AD. Therefore, we previously showed that Aβ1‐40 decreases astroglial glutamate uptake as a result of a combined decrease of transporters activity and levels (Matos et al., 2008, Neuroscience 156:898). Since we also found that antagonists of adenosine A2A receptors (A2AR) prevented memory impairment as synaptic loss caused by Aβ (Cunha et al., 2008, Exp Neurol 210:776), we now tested if A2AR affected Aβ‐induced decrease of astrocytic glutamate uptake. Primary cultures of Wistar rat (P3‐P5) brain astrocytes were exposed to CGS21680 (A2AR agonist, 30 nM) and/or SCH58261 (A2AR antagonist, 50 nM) for 15min or 24hrs in the absence or presence of Aβ1‐42 (5 μM, 24hrs) before measuring D‐\[3H\] aspartate uptake, to evaluate the activity of glutamate transporters (Matos et al., 2008). After 15 min incubation, CGS21680 decreased 57.1±3.0% (n=3) D‐aspartate uptake, an effect prevented by SCH58261, which was devoid of effects alone. After 24hrs incubation, the inhibitory effect of CGS21680 was lower (29.3±3.8% (n=3) and was still inhibited (P\<0.05) by SCH58261 (n=3), which was devoid of effect alone. In contrast, SCH58261 was able to attenuate the inhibitory effect caused by Aβ1‐42 treatment; thus, Aβ1‐42 inhibited D‐aspartate uptake by 35.6±5.8% alone (n=5) and by 14.4±4.4% in the presence of SCH58261 (n=3). In parallel, Aβ1‐42 treatment augmented A2AR immunoreactivity in astrocytes, as evaluated by immunocytochemistry. These results show that A2AR control the activity of glutamate transporters in astrocytes and indicate that the tonic activation of these A2AR is involved in the effects of Aβ on glutamate uptake. This strengthens the hypothesis that A2AR‐mediated neuroprotection in AD may be associated with a control of glutamatergic function, involving astrocytes. Similar D‐aspartate uptake studies are currently being carried out in our lab using glial re‐sealed particles ‐ gliosomes.

Supported by FCT.
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INTRODUCTION: One of the severe complications following traumatic brain injury (TBI) is cerebral edema and its effective treatment is of great interest to prevent further brain damage. This study investigated the effects of minocycline, known for its anti‐inflammatory properties, on cerebral edema and its respective inflammatory markers (IL‐1ß, MMP‐9) by comparing different dose regimens, following TBI.

METHODS: The weight drop model was used to induce TBI in mice (1). The brain water content was measured to evaluate cerebral edema. Inflammatory markers were detected by ELISA (IL‐1ß), zymography and Western blot (MMP‐9). Minocycline was administered (45 or 90 mg/kg, i.p.) either once (5 min) or twice (5 min and 3h or 5 min and 6h) following TBI. Cerebral edema and inflammatory markers were evaluated at 6 or 12 post‐TBI.

RESULTS: The kinetic study of inflammatory markers showed an early and transient increase of IL‐1ß, which peaked at 6h post‐TBI, accompanied by a persistent increase of MMP‐9 from 6 to 48h post‐TBI, with a maximum increase between 12 and 48h post TBI. Cerebral edema peaked between 4 and 24h after TBI (2). The single and double administration of minocycline reduced the increase of IL‐1ß and MMP‐9 at 6 and 12h post‐TBI. Minocycline reduced the cerebral edema at 6h post‐TBI only if it was administered twice (5 min, 3h) at the high dose regimen.

CONCLUSION: In this study, we reported an anti‐edematous effect of minocycline after TBI according to a specific treatment regimen. Interestingly, minocycline requires a high dose regimen and a short interval of administration in order to exert an anti‐edematous effect compared to that needed to reduce inflammatory markers (IL‐1ß and MMP‐9) at the acute phase of TBI in mice. These findings emphasize that the beneficial effects of minocycline depend on the treatment regimen following a brain injury.

1\) Hellal et al. J Neurotrauma. 2003; 20: 841--51.

2\) Hellal et al. Neurosci Lett 2004; 357:21--24.
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Huntington\'s disease (HD) is a neurodegenerative disorder caused by the expansion of a polyglutamine (PolyQ) tract in a protein called huntingtin (htt). This expansion leads to the preferential loss of medium‐sized spiny neurons in the striatum despite the widespread expression of both normal and mutant forms of htt in neurons and astrocytes. Little is known about the role of astrocytes in HD pathogenesis because no animal model, besides the fruit fly, is available to directly assess their potential implication in vivo.

To study the involvement of astrocytes in HD in vivo, we first developed a new animal model with a selective expression of mutant Htt by striatal astrocytes using our recently described gene transfer strategy that allows the selective expression of any transgene into astrocytes in vivo (Colin et al., GLIA, 2008). This gene transfer strategy relies on a lentiviral vector pseudotyped with mokola and includes a specific neuronal microRNA target sequence to eliminate residual expression of the transgene in neuronal cells.

We performed stereotaxic injections into the mouse striatum of this lentiviral vector encoding a short fragment (171 aa) of the htt gene with 18 (wild‐type, 171‐18Q) or 82Q (mutant form, 171‐82Q). Immunostaining using 2B4 antibody revealed htt aggregates only in astrocytes expressing 171‐82Q at 4 to 12 weeks after injection and not in neurons. These astrocytes expressing 171‐82Q displayed morphological alterations (hypertrophy, tortuous and shrinked processes) 12 weeks after injection. The expression and function of both glial glutamate transporters GLT‐1 and GLAST gradually and significantly decreased from 4 to 12 weeks post‐injection in astrocytes expressing 171‐82Q compared to those expressing the wild type form (171‐18Q).

We conclude that astrocytes are also a target of mutant htt and that the reduced expression of both astrocyte glutamate transporters induced by mutant htt in vivo may contribute to glutamatergic excitotoxicity and neuronal death in HD.
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Multiple sclerosis is the commonest cause of neurological disability that affects young, Caucasian adults. Here we describe the role of the TAM family of protein tyrosine kinase receptors, and their common ligand, Gas6, during cuprizone‐mediated demyelination in mice. We have previously shown that Gas6 deficiency increases oligodendrocyte loss and microglial activation after three weeks of cuprizone challenge1. We hypothesised that TAM receptor signalling would also influence the extent of recovery in mice after withdrawal of cuprizone. Three groups of 8 week old Gas6 knockout (KO) and wild‐type (WT) mice (n = 3/4 per group per genotype) were subjected to cuprizone challenge for 5 weeks. One group was analysed at this time‐point to provide nadir levels of myelination. The remaining mice were analysed at either two weeks or four weeks post‐cuprizone withdrawal. As we have previously shown, in Gas6 KO mice subjected to cuprizone, demyelination was greater than in control mice as assessed by both luxol fast blue staining and ultrastructure. However, after two weeks of recovery there was no significant difference between genotypes (p \> 0.05), suggesting that remyelination occurs effectively in the absence of Gas6. However, after 4 weeks recovery in the absence of cuprizone, WT mice had remyelinated to a significantly greater extent than Gas6 KO mice (p = 0.04). These data indicate that whilst initial remyelination occurs in the absence of Gas6, continued recovery appears to be compromised. To understand the molecular mechanisms that drive the observed effects, we also examined the effect of exogenous Gas6 in in vitro myelination assays. We found that Gas6 significantly increased myelination in a dose‐dependent manner (p = 0.02), suggesting that TAM receptor signalling could be directly involved in myelination by oligodendrocytes. The failure of Gas6 KO mice to fully remyelinate could thus result from a lack of Gas6 at a critical time during myelin production after injury. To address these issues further, we are currently assessing levels of oligodendrocyte progenitor recruitment, microglial activation, completing a detailed ultrastructural analysis of myelin integrity, as well as assessing later stages of remyelination, following cuprizone challenge in Gas KO mice.

1\. Binder et al (2008). J.Neurosci. 8(20):5195--206.
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Traumatic brain injury (TBI) leads to neuroinflammation regulated transcriptionally and evidenced by edema, cytokine production, matrix metalloproteinase (MMP) activation and leukocyte infiltration. Transcriptional activity is regulated by histone acetylation level. As TBI induces brain histone deacetylation suggesting an activation of histone deacetylases (HDAC), we evaluated the role of HDAC in post‐TBI inflammation. So we studied the effects of valproic acid (VPA), an HDAC inhibitor, in a closed head injury model.

Mice were given VPA (300 mg/kg) or its vehicle i.p. 5 min after TBI induced by weight drop. Neurological deficits were assessed by two tests: grip score measuring the time that mice remained on the string with a maximum of 30 s; string test scoring from 0 (severely impaired) to 5 (normal) evaluating the way mice could hang and move on the string. Cerebral edema was determined by measuring brain water content (BWC). Histone H3 acetylation was evaluated by immunohistochemistry. Levels of mRNA of interleukin‐1β, chemokine receptor CCR2, MMP9 and 12, E and P‐selectin, and the one of the chaperone protein HSP70 were measured by quantitative RT PCR.

At 24 h, TBI led to a reduced brain histone H3 acetylation that was increased by VPA. At 24 h post‐TBI, both grip and string scores were significantly decreased in vehicle‐treated mice, which were improved by VPA (grip: *P*\<0.05; string: *P*\<0.05), demonstrating a neurological recovery‐promoting effect. TBI induced a BWC increase (*P*\<0.05), which was reduced by VPA (*P*\<0.05) demonstrating an anti‐edematous effect. These beneficial effects were associated to a transcripts decrease of IL‐1β, CCR2, MMP9 and 12, E‐ and P selectin (*P*\<0.01) and to an increase in HSP70 mRNA levels (*P*\<0.01).

In conclusion, our results show that VPA post‐treatment promotes beneficial effects in TBI. Therefore, HDAC inhibition may constitute a promising therapeutic strategy for TBI.
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Neuroinflammation is a prominent feature shared by various neurodegenerative diseases and it is important to identify the signal pathways that control the initiation, progression and termination of the inflammatory reaction since a well‐regulated inflammatory process is essential for tissue homeostasis. Protease‐activated receptors (PARs) are cleaved and activated by thrombin and other extracellular proteases which are released during tissue trauma and inflammation. PAR‐1 is the prototypic member of the PAR family and has been shown to be upregulated in several brain pathologies being expressed by neurons and glial cells. Our previous results show that PAR‐1 expression is increased in astrocytes both in vivo and in vitro after treatment with the neurotoxic compound trimethyltin (TMT). Administration of TMT to the rat results in loss of hippocampal neurons and an ensuing gliosis without blood‐brain barrier compromise. TMT caused pyramidal cell damage within 3 days and a substantial loss of these neurons by 21 days post dosing. Marked microglial activation and astrogliosis are evident over the same time period. TMT causes large increase of PAR‐1 immunoreactivity in microglia by day 7 while in untreated controls this receptor is barely detectable. In vitro data show that the administration of the PAR‐1 activating peptides (TRAP6 and TFLLR) inhibits the production of the pro‐inflammatory cytokines TNF‐alpha and IL‐6 in microglial cells treated with lipopolysaccharide (LPS) while promoting the release of the anti‐inflammatory cytokine IL‐10. Our results suggest that PAR‐1 may be involved in the regulation of the inflammatory response in the brain.
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#### ^1^Seoul National University College of Medicine, Seoul, Republic of Korea; ^2^Chungnam National University College of Medicine, Daejeon, Republic of Korea {#sec4-296}

AMP‐activatied protein kinase (AMPK) is a member of the family of serine/threonine kinases and is activated by cellular increases in AMP concentrations under conditions of nutritional/metabolic stress. This is thus often referred to as the fuel gauge of the cell, since it protects the cell against ATP depletion and boosts the energy generation pathway.

Following Kainc acid (KA) injection, excitotoxic damage is found to cause pyramidal cell degeneration in the CA3 region of the hippocampus, and is accompanied by the intense reaction of both astrocytes and microglia. In this study, we examined patterns of phospho‐AMPKα expression in the KA‐treated mouse hippocampus. Western blot analysis revealed that p‐AMPKα expressed in the hippocampus 3days after KA treatment, and was decreased in 7days. p‐AMPKα immunorecativity was observed in migcroglia throughout the CA3 region in parallel with pyramidal cell degeneration. AICAR is reported to activate AMPK in the cell following its conversion to ZMP(a non‐degradable AMP analog) and thus mimics the activity of AMP for activation of AMPK. Recently, AICAR, as anti‐inflammatory properties in glial cells, was found to inhibit expression of pro‐inflammatory cytokines and of iNOS in glial cells. We investigated p‐AMPKα expression in KA‐induced mouse hippocampus by pre‐treatment of AICAR at 3days. According to the neuroprotection by AICAR, it is decreased neuronal cell death and expression of microglia. Therefore we suggest that AICAR activate AMPK and blockade of ROS generation, thereby inhibiting the inflammatory signaling cascade.

Keywords: AMPK, AICAR, Microglia, Kainic acid, Hippocampus
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#### Institute for Neurobiology, Düsseldorf, Germany {#sec4-297}

Ammonium (NH~4~ ^+^/NH~3~) is the leading candidate responsible for the toxic effects observed during hepatic encephalopathy (HE). The mechanism for cellular influx of NH~4~ ^+^ is critically important to understanding the pathology of HE, as accompaning ion influx may contribute to the increased extracellular glutamate concentrations and astrocytic swelling observed during HE. In cultured astrocytes, we found that NH~4~ ^+^ influx via Na^+^, K^+^, Cl^‐^ cotransport (NKCC) evokes large changes in intracellular sodium (\[Na^+^\]~i~) and pH (pH~i~). In the intact tissue, however, the mechanism of NH~4~ ^+^ entry in astrocytes and neurones is unknown. In the present study, therefore, we examined the effects of 5 mM NH~4~Cl on \[Na^+^\]~i~ and pH~i~ in astrocytes and CA1 pyramidal neurones in acute hippocampal slices.

Sodium and pH sensitive dyes (SBFI & BCECF, respectively) were employed to measure \[Na^+^\]~i~ and pH~i~ in astrocytes and neurones in slices from 20‐22 postnatal day old mice. Passive astrocytes were identified using the fluorescent marker SR101. In both astrocytes and neurones, steady‐state \[Na^+^\]~i~ was 13 ‐ 15 mM and pH~i~ was 7.20 ‐ 7.22 under control conditions. In astrocytes, NH~4~ ^+^/NH~3~ increased steady‐state \[Na~+~\]~i~ by 27 ± 8 mM and decreased pH~i~ by 0.18 ± 0.05 pH units, whereas in neurones, NH~4~ ^+^/NH~3~ decreased pH~i~ by 0.27 ± 0.09 pH units in the absence of any increases in \[Na^+^\]~i~. Similar to findings from cultured astrocytes, inhibition of NKCC with 50‐100 μM bumetanide prevented NH~4~ ^+^/NH~3~‐evoked increases in steady‐state \[Na^+^\]~i~ and attenuated the acidifications in astrocytes. In contrast, bumetanide failed to attenuate NH~4~ ^+^/NH~3~‐evoked acidifications in neurones. Furthermore, NH~4~ ^+^/NH~3~‐evoked acidifications in neurones were not sensitive to maneuvers that inhibit the related K^+^, Cl^‐^ cotransporter and K^+^ channels (*i.e.* application of furosemide or low Cl^‐^ solutions in the presence of Ba^2+^ and TEA). However, inhibition of Na^+^, K^+^ ATPase with 15 μM ouabain attenuated the acidifications mediated by NH~4~ ^+^/NH~3~ in neurones.

Taken together the results demonstrate that the mechanism of NH~4~ ^+^ entry differs between astrocytes and neurones. NH~4~ ^+^ influx appears to primarily involve NKCC in astrocytes and Na^+^, K^+^ ATPase in neurones. In addition to NH~4~ ^+^ influx, the accompanying ion influx may contribute to the pathology of HE.

Supported by the DFG (SFB 575, TPC7).
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Zinc (Zn) deficiency is present in many physiological and health problems. Among circumstances involved in Zn deficiency, ethanol consumption appears as a prominent cause. In the CNS substantial amounts of Zn appear accumulated in synaptic vesicles of a particular class of neurons: the Zn enriched neurons very abundant in the telencephalon and cerebral cortex. This is the so called synaptic Zn which is simultaneously released with the neurotransmitter thus exerting a neuromodulator role during synaptic transmission. Neighbour astrocytic processes have to capture the excess of both extracellular Zn and neurotransmitter in order to maintain efficient synaptic transmission between neurons. In this work we analyze the effect of exposure to 30 mM ethanol for 7 days in the ability of cultured rat astrocytes to capture and manage extracellular Zn. Intracellular Zn levels were visualized by using the TSQ Zn fluorochrome, either in normal culture conditions or after supplementary addition of 50 μM ZnSO4 to the culture. Fluorescence was recorded with an Olympus microscope BX50WI, equipped with a Hamamatsu ORCA digital camera controlled with the Aquacosmos software. Basal Zn levels in cultured astrocytes was greatly and significantly lower in ethanol treated cells (about 30% of control cultures). These differences were consistently maintained after addition of extracellular Zn to cell monolayers, resulting in a lower ability to uptake or retain Zn. The Zn was uptaked by the endocytic pathway, as demonstrated by the marker FM1‐43 and was mainly confined to bright organelles that were more abundant in control cells. In conclusion, ethanol impairs astrocyte Zn management resulting in a lower capacity for extracellular Zn intake in resting conditions and after extracellular addition. It has been proposed that an efficient method to palliate Zn deficiency it could be a dietary supplement. Nevertheless, this study suggests that a dietary Zn supplementation may not be enough for recovery of cellular normal function in alcoholic cultured astrocytes.
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Leukodystrophies are rare genetic disorders that affect myelin, the major component of white matter (WM) in brain and spinal cord. Ethiology of the leukodystrophies is broad; while adrenoleukodystrophy (ALD) and metachromatic leukodystrophy (MLD) are lipid storage disorders involving defective metabolism in organelles, Pelizaeus‐Merzbacher disease (PMD) is caused by a defect in the myelination related to mutations or overexpression of the main CNS myelin protein, the proteolipid protein (PLP).

Recently, we have described oxidative damage in spinal cord of Abcd1‐ mice, the mouse model of ALD, one year before clinical symptoms of degeneration (Fourcade et al, 2008). Following the hypothesis that oxidative stress might underlie physiopathogenesis also in other leukodystrophies, we performed oxidative stress and redox proteomics analysis in presymptomatic brain samples of PLP overexpressing mice model of PMD (+plp Tg ‐ 1.5 month homozygous mice) and also in arylsulfatase deficient mice model of MLD (Asa‐/‐ 11 months mice). We found that 4‐Hydroxy‐2‐nonenal (HNE), a marker of oxidative stress from lipooxidative origin, is increased in brain of both mouse models (ASA‐/‐ and +plp Tg). Our work is directed towards identification of protein targets affected by the lipoxidation process, which might constitute valuable biomarkers of disease progression and provide insight into disease physiopathogenesis. The results will set the rationale for therapeutic strategies to prevent or delay oxidative damage in leukodystrophies of different ethiology.
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Alzheimer\'s disease (AD) is the most common form of dementia in the western world affecting millions of people. One of the pathological hallmarks, in addition to extracellular amyloid‐beta (Abeta) plaques and intracellular neurofibrillary tangles, is activated microglia and astrocytes surrounding the plaques resulting in a chronic inflammation. The neuroinflammation seen in AD is believed to be a relatively early event that precedes neurofibrillary tangle formation, but whether it is deleterious or beneficial is under debate. CCAAT/enhancer binding protein (C/EBP) is a transcription factor found in 1987. It is mostly studied in liver and adipose tissue but three of the family members, C/EBPalpha, beta and delta, have lately gained at lot of interest in the CNS due to their involvement in neuroinflammation and their altered expression in patients suffering from AD. In the present study we have analyzed the protein levels of C/EBPalpha and delta in 15.5‐17 months old tgAPPArc‐Swe mice. The brains were dissected into hindbrain, a control region free from amyloid‐beta plaques with low amounts of amyloid precursor protein (APP) and APP metabolism, and forebrain, a brain region containing a lot of APP and amyloid‐beta plaques. Surprisingly, our results show a down‐regulation of C/EBPalpha in both hindbrain and forebrain, whereas C/EBPdelta only show a down‐regulation in forebrain where the plaques are located. To further investigate the impact of the Abeta1‐42 peptide and an ongoing inflammation on C/EBP expression, mixed primary glial cell cultures from rat were used. Cells were treated with 1 microgram/milliliter lipopolysaccharide (LPS), 10 micromolar oligomeric Abeta1‐42 and/or 10 nanogram/milliliter interleukin‐1beta (IL‐1beta) for 3 h and protein levels were analysed. Preliminary results for C/EBPdelta show an increase in protein levels following LPS and IL‐1beta treatment, that was unaffected by co‐treatment with Abeta1‐42. The difference between the two studies might be explained by the conformation of the Abeta1‐42 peptide, where the fibrillar structure may have more impact on C/EBP expression.
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One of the relevant neuropathological aspect associated with several neurodegenerative diseases (ND) is the presence of a large number of reactive astrocytes (astrocytosis). The cause of this activation is still partially unknown. To better understand the specificity of astrocyte activation in ND we quantified their distribution in the brain of patients with different neuropathologies (e.g. Binswanger\'s, Alzheimer\'s and Pick\'s Disease). Brain sections of proven cases were immunostained with antibodies to glial fibrillary acidic proteins (GFAP) and to metallothionein I and II (MT I‐II), both markers which specifically identify normal and reactive astrocytes. We found an increased expression of MT I‐II in various affected brain areas with respect to the elderly control patients. This increase could be related to a natural defence against stress factors in order to protect neurons. Indeed, the major function of MT is related to metal metabolism since they could act as metal modulators mainly for copper and zinc, conferring a protection against oxidative stress generated by metal redox cycling. Strong correlations have been drawn between metal ions (e.g. copper, zinc and iron) and the onset and/or progression of ND. These findings allow for a speculation over the pathological role of the metal ions as one important potential activating factor for MT and as a possible aetiological factor for ND. We argued that changes in the expression of these important, but still, at least in part, enigmatic proteins, in astrocytes might be also the consequence of the brain metal dyshomeostasis which characterizes many ND. Clarification of this issue will aid in the basic understanding of the pathological mechanisms which lead to loss of brain functioning.
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We have performed a therapy trial of a mouse model for Pelizaeus‐Merzbacher disease (PMD, a severe leukodystrophy) which in the majority of cases is caused by toxic overexpression of the Plp1 gene. An appropriate mouse model transgenically overexpressing the Plp1 gene has been characterized in our department and was used to test the potential therapeutic effect of a newly developed anti‐progesterone drug (ZK230211, PA) aimed to lower Plp1 gene transcription. If successful, this may lead to a 'rational therapy' for a subgroup of PMD patients that harbour Plp1 gene duplications.

The study design consisted of three arms: 30 placebo treated wildtypes, 12 placebo‐ and 11 anti‐progesterone‐treated Plp1 transgenic mice. Treatment duration was 10 weeks and started at 21 days of age. Motor function analysis ("grid‐slip test") were performed during therapy. Plp1 mRNA expression levels of total brain in placebo‐treated mutants were 1.8 fold higher than in wildtype reflecting Plp1 overexpression. Plp1 mRNA expression was reduced by 15% in anti‐progesterone‐treated mutants compared to placebo‐treated controls. Wildtype mice performed significantly better in the grid‐slip test than Plp1 transgenic mice. PA‐treated mutants performed significantly better than the placebo controls. Electron‐microscopical quantification revealed an increase in the absolute number of myelinated axons in the corticospinal tract after PA‐treatment compared to placebo controls by approximately 30%. Immunhistochemical analysis demonstrated reduced GFAP, Mac3 and CD3 stainings in the PA treated Plp1 transgenic animals compared to controls indicating reduced inflammatory response.

In summary, our data demonstrate proof‐of‐principle that the progesterone receptor serves as a feasible therapeutical target aiming at lowering toxic Plp1 overexpression and ameliorating the clinical phenotype in a Plp transgenic animal model of PMD.
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Dynamin‐2 (Dnm2) belongs to the family of large mechanochemical GTPases and is highly conserved within vertebrates. The importance of Dnm2 for the endocytotic machinery is most well known. Furthermore, it is implicated to participate in vesicle formation from the trans‐Golgi network, in centrosome cohesion and cytokinesis. Mutations in *DNM2* were shown to result in dominant intermediate Charcot‐Marie‐Tooth disease (CMT) and autosomal dominant centronuclear myopathy (CNM). So far, nineteen dominant mutations within the middle, pleckstrin‐homology and GTPase effector domain of Dnm2 were identified. The functional consequences of the different mutations and their relationship to the different diseases are not known. The aim of this project is the investigation of altered cellular functions of disease‐causing mutations in Schwann cells, neurons and muscle cells.
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Nijmegen breakage syndrome (NBS) is a genomic instability disease caused by hypomorphic mutations in the NBS1 gene. Nbs1 is a component of the Mre11/Rad50/Nbs1 (MRN) complex that acts as a sensor of double strand breaks (DSBs) in the DNA and is critical for proper activation of the broad cellular response to DSBs. Conditional disruption of the murine ortholog of NBS1, Nbn, in the CNS of mice was previously reported to cause microcephaly, severe cerebellar atrophy, and ataxia and white matter damage. Here we show that conditional inactivation of the NBS1 gene has a profound effect on the integrity and the functionality of the microglial cells. Using RT‐PCR analysis and Western blot analysis we have that expression of brain derived growth factor (BDNF), neurotrophic factor‐3 (NT3) and CD‐11b (microglia) were significantly lower in Nbs1‐CNS‐del cerebella. Collectively, our results suggest that Nbs1 inactivation has a profound effect on the integrity and the functionality of the microglia cells suggesting that microglia cells play a crucial role in the etiology and progression of genomic instability disorder.
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Alzheimer\'s disease (AD) is clinically characterized by dementia and pathologically by a progressive loss of neurons, senile plaques, neurofibrillary tangles and vascular deposites of amyloid‐beta peptide (Ab). Recent evidence indicates that inflammation occurs in pathologically vulnerable regions of the AD brain. Recent studies show that Ab may cause direct neuronal damage and death. Cytosolic Phospholipase A2 alpha (cPLA2) is a requisite component in the cascade of events leading to the production of eicosanoids during acute and chronic inflammation. In the central nervous system (CNS), cPLA2 appears to function in maintaining basal cellular physiological processes, based on the fact that arachidonic acid and its metabolites have been implicated in normal CNS physiological processes, including synaptic receptor signal transduction, synaptogenesis, and neurotransmitter release. However, the consequences of elevated activity are not yet clear. The aim of the present study is to examine whether cPLA2 participates in cortical neuron damage induced by aggregated Ab1‐42. Addition of aggregated Ab1‐42 to primary cortical neurons caused a decrease in neuronal viability and induced elevation in cPLA2 activity and expression, as indicated by MTT assay and immunoblot analysis, respectively. The elevation in cPLA2 activity was prevented by pretreatment with DPI (NADPH‐oxidase inhibitor). In addition, increased expression of the apoptotic proteins active caspase‐8 and cleaved caspase‐3, were detected in neuron cultured with Ab1‐42. Addition of antisense, which inhibited cPLA2 expression, to neuron cultures prior to Ab1‐42 treatment prevented the increase in the apoptotic proteins expression and obstructed its damaging effect. Further more, increased expression of amyloid precursor protein (APP), which may accelerate the effect of Aβ was detected in neuron cultured with Ab1‐42. Pretreatment with the cPLA2 antisense prevented the elevation in APP expression induced by Ab1‐42. Our results suggest that cPLA2 is involved in neuronal damage and apoptosis induced by Ab1‐42 and that elevated active caspase‐8, cleaved caspase‐3 and APP may participate in this process.
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We and others demonstrated that fibrates and statins, exerted neuroprotective and pleiotropic effects in experimental models of traumatic brain injury (TBI). As combination of statins and fibrates synergistically enhanced peroxisome proliferator‐activated receptor alpha activation, we hypothesized the combination of both drugs exert more important and/or prolonged beneficial effects in TBI than each one alone. In this study, we examined the effect of the combination of fenofibrate and simvastatin on consequences induced by lateral fluid percussion of the temporoparietal cortex on male Sprague‐Dawley rats.

Simvastatin (37.5mg/kg), fenofibrate (50mg/kg), combination and vehicle were administrated by gavage 1 and 6h after TBI. At 24, 48h, 3 and 7 days, a neurological assessment was done by 2 tests: one for reflexes and sensorimotor responses (ranging from 0=worst to 9=best), and the second untitled beam walking test for motor coordination (ranging from 0=worst to 4=best). Cerebral edema was measured at 24 and 48 h after TBI, and brain lesion at 7 days.

TBI decreased the neurological score at 24 h post‐injury (*P*\<0.001) demonstrating a neurological deficit that persisted at 48 h (*P*\<0.001). Fenofibrate (*P*\<0.05), simvastatin (*P*\<0.01) or their combination (*P*\<0.01) improved the neurological score at 24 h showing a neurological recovery. Even if monotherapies had no more effects on the neurological score since 48 h post‐TBI, combination still promoted an improved neurological score until, at least, 7 days after TBI (*P*\<0.01) demonstrating a longest neurological recovery promoting effect. At 48 h and later after injury, rats receiving the combination showed an improved beam walking score (*P*\<0.05) whereas monotherapies had no effects. TBI led to brain edema at 24 h (*P*\<0.001) that persisted at 48 h (*P*\<0.001). At 24 h, edema was reduced by monotherapies and combination. At 48 h, the combination alone still reduced edema (*P*\<0.05). TBI induced a lesion of 83±8 mm^3^ that was reduced by the combination (36±12 mm^3^, *P*\<0.05), whereas both monotherapies did not reduce it.

This is the first evidence that fenofibrate combined with simvastatin promote long‐lasting and synergistic beneficial effects on neurological recovery, brain edema and lesion after TBI. Our data provides a strong basis for the use of this therapy for TBI treatment.
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The peroxisome proliferator‐activated receptor‐gamma (PPAR‐gamma) belongs to the group of nuclear receptors controlling reproduction, metabolism, development and immune response. Several lines of evidence suggest that PPAR‐gamma agonists may be of potential therapeutic use in brain diseases. Their beneficial effects might be mediated by several mechanisms involving anti‐inflammatory activities as well as direct effects on neural cell types, including neurons and glial cells. The aim of the present study was to unravel the potential beneficial action of PPAR‐gamma agonists on oligodendrocytes (OLs). In previous studies we evaluated the capability of the PPAR‐gamma endogenous (15d‐PGJ2) and synthetic (pioglitazone) agonists to strengthen the intrinsic cellular mechanisms protecting oligodendrocytes (OLs) from inflammatory and oxidative insults, and we found by biochemical approaches that PPAR‐gamma agonists are able to increase the expression of enzymes and molecules deputed to the defense against oxidative insults such as SOD1, catalase and glutathione. Moreover, we also found that PPAR‐gamma agonists were also able to drive OPs toward a differentiating phenotype, which could be instrumental to the promotion of myelination (Bernardo et al., 2009). In recent studies we more closely focused on mitochondria, considered not only as target of stressful events accompanying myelination but also for their role in its progression. In this regard, we pointed out the capability of PPAR‐gamma agonists to increase the expression of the mitochondrial inner membrane protein UCP2, known to decrease mitochondrial production of superoxide. In addition, fluorescence video‐imaging studies on ATP‐induced cytoplasmic Ca2+ transients and on mitochondrial parameters like inner membrane potential and Ca2+ uptake were carried out. These indicated that PPAR‐gamma agonists might sustain myelination through their activities on mitochondria by favoring Ca2+ waves propagation in differentiating OLs. In a clinical perspective, these data contribute to validate the utilization of selected PPAR‐gamma agonists to treat de‐myelinating diseases in which inflammatory events and redox unbalance occur.

This study was supported by ELA foundation, grant number 2007‐034I1.
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Pelizaeus‐Merzbacher disease (PMD), a severe leukodystrophy, is caused by toxic overexpression of the Plp1 gene in the majority of cases. There is no therapy available. cAMP/Calcium signalling is known to increase PLP gene expression in vitro. A NMDA receptor antagonist (MK‐801) lowers PLP gene expression in vivo. Here, we use a transgenic mouse model of PMD overexpressing the Plp1 gene to test the potential therapeutic effect of the class of NMDA receptor antagonists aimed to lower Plp1 gene transcription. This may lead to a 'rational therapy' for a subgroup of PMD patients that harbour Plp1 gene duplications.

We treated the animals over 3 months and started at 21 days of age. A specific motor performance test ("grid‐slip test") to characterize the phenotype of PMD‐mice was designed. The study design consisted of three arms: 15 placebo treated wildtypes, 20 placebo‐ and 20 MK‐801‐treated Plp1 transgenic mice. Regular clinical scoring and motor function analysis were performed at the beginning, the end and twice during therapy. Plp1 mRNA expression levels of total brain as measured by qRT‐PCR in placebo‐treated mutants were 1.8 fold higher than in wildtype. After MK‐801 treatment, Plp1 mRNA expression was reduced by 30% compared to placebo‐treated controls. Increased expression of the inducible cAMP early repressor (ICER) mRNA in the MK‐801 treated animals may explain downregulation of PLP mRNA. Importantly, MK‐801‐treated mutants performed significantly better in the grid‐slip test than the placebo controls. Electron‐microscopical quantification of myelinated axons in the cortico‐spinal tract revealed increased myelin thickness as measured by g‐ratio analysis after treatment. In summary, our data demonstrate proof‐of‐principle that the NMDA receptor serves as a feasable therapeutical target aiming at lowering toxic Plp1 overexpression and ameliorating the clinical phenotype in a Plp transgenic animal model of PMD.
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UBIQUITIN‐PROTEASOME SYSTEM IMPAIRMENT: A PATHOGENIC FACTOR IN X‐LINKED ADRENOLEUKODYSTROPHY? {#sec2-309}
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X‐linked adrenoleukodystrophy is a severe neurodegenerative disorder characterized by progressive demyelination and accumulation of very‐long‐chain fatty acids (VLCFA). The molecular defect is the inactivation of the ABCD1 peroxisomal transporter, whose function is the import of VLCFA into the peroxisomes for degradation. ABCD1 null mice develop a late‐onset neurodegenerative phenotype with axonal degeneration, reactive microgliosis and astrogliosis, starting at around 15 months of age, comparable to the most common X‐ALD phenotype in patients, adrenomyeloneuropathy (AMN). The present study shows a significant decrease of the proteasome activities at all different stages of the disease in spinal cord of ABDC1 null mice. Moreover, in the spinal cord of ABCD1 null mice we found a differential regulation of constitutive proteasome subunits during disease progression, as assessed by microarrays, real‐time PCR and immunohistochemistry. Indeed, proteasome subunits are upregulated in early presymptomatic stages (3 months) and repressed just before disease onset (12 months). Altogether, our data provide evidences involving the ubiquitin proteasome system (UPS) in the pathogenesis of X‐ALD. As UPS is underlying the molecular basis of several neurodegerative diseases, our results might highlight novel targets for therapeutic approaches for adrenoleukodystrophy.
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X‐linked adrenoleukodystrophy (X‐ALD) is the most frequent inherited monogenic demyelinating disease (minimal incidence 1:17,000). X‐ALD leads to death in boys or to motor disability in adults (adrenomyeloneuropathy or AMN). The disease is caused by loss of function of the ABCD1 gene, a peroxisomal ATP‐binding cassette transporter, which function is related to defective ß‐oxidation of very long‐chain fatty acids (VLCFA) in peroxisomes. Therefore, a hallmark of the disease is the accumulation of VLCFA in plasma and tissues. The mouse model for X‐ALD (Ald knock‐out) exhibits a late‐onset phenotype closely related to adrenomyeloneuropathy, with neurodegenerative features beginning at 15 months of age (1,2). Recently, we have found that oxidative damage might be a major contributor to disease pathogenesis in the mouse. Indeed, Abcd1 deficient mice present accumulation of MDAL (malonaldehyde‐lysine), a consequence of lipoxidative damage to proteins, in spinal cords as early as 3.5 months of age. At 12 months, Abcd1‐ mice accumulate additional oxidative damage products arising from metal‐catalyzed oxidation and glycoxidation/lipoxidation to proteins. Importantly, we observed that VLCFA excess is able to generate ROS and decrease reduced glutathione levels. Using gas chromatography/mass spectrometry we have found that the α‐tocopherol analog Trolox is able to reverse oxidative lesions in vitro, thus providing therapeutic hope. In addition, we have treated human fibroblasts with 3 different antioxidants, which are able to prevent C26:0‐ROS production. For this reason, we have decided to treat old Wt and Abcd1‐ mice with a cocktail of these 3 antioxidants, which are able to normalize oxidative lesions in spinal cord. Work on progress aim to determine whether oxidative stress plays a main contributing role to X‐ALD physiopathogenesis.

\(1\) Pujol et al, Hum Mol Genet. 2002 Mar 1;11(5):499--505.

\(2\) Pujol et al, Hum Mol Genet. 2004 Dec1;13(23):2997--3006.

P‐311 {#sec1-311}
=====

MITOCHONDRIA DEPLETION UNDERLYING NEURODEGENERATION IN X‐ALD {#sec2-311}
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X‐linked adrenoleukodystrophy (X‐ALD) is the most frequent inherited monogenic demyelinating disease (minimal incidence 1:17,000). X‐ALD leads to death in boys or to motor disability in adults (adrenomyeloneuropathy or AMN). The disease is caused by loss of function of the ABCD1 gene, a peroxisomal ATP‐binding cassette transporter, which function is related to defective ß‐oxidation of very long‐chain fatty acids (VLCFA) in peroxisomes. Therefore, a hallmark of the disease is the accumulation of VLCFA in plasma and tissues. The mouse model for X‐ALD (Ald knock‐out) exhibit a late‐onset phenotype closely related to adrenomyeloneuropathy, with neurodegenerative features beginning at 15 months of age. Using microarrays, Q‐PCR and Western Blots of mouse spinal cords, we have identified a mitochondria depletion as very early event in the pathogenesis (3.5 months of age). RIP140 (Receptor interacting protein 140), a nuclear co‐repressor of mitochondria biogenesis, is upregulated in spinal cord from Aldko mice. VLCFA are able to induce RIP140 in ex vivo organotypic spinal cord slice culture. We have also observed a mitochondria depletion in the affected white matter of CCALD (Cerebral Childhood ALD) and cerebral AMN compared to control individuals. This depletion is correlated to a higher level of RIP140 in the non‐affected white matter of X‐ALD patients. This could be disease causative, or at least, contribute significantly to the neurodegenerative cascade in X‐ALD physiopathogenesis.

P‐312 {#sec1-312}
=====
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Oxidative stress is a condition in which an imbalance between Reactive Oxygen Species (ROS) production and cellular antioxidant defenses causes damage to proteins, lipids and nucleic acids, possibly leading to cell death. A key player in this process is iron, a metallic ion essential for some biochemical pathways but dangerous when in excess, since its reaction with hydrogen peroxide in the Fenton reaction produces the highly toxic hydroxyl radical. Iron‐induced oxidative stress is thought to play an important role in the pathogenesis of several neurodegenerative disorders. In the central nervous system, astrocytes actively participate in ROS detoxification and in physiological as well as pathological processes, playing either a neurotoxic or a neuroprotective role.

In order to investigate the effects of iron mediated‐toxicity, we employed rat primary cultures of cortical astrocytes. We set up the conditions to control acute iron overload and to evaluate ensuing oxidation of intracellular iron, as well as ROS production. Rapid iron entry (monitored by the quenching of FURA‐2) impaired the reducing potential of the cell and promoted ROS production (monitored by DCFDA), eventually leading to cell death (monitored by the loss of the cytosolic dye and the entry of a dead‐cell indicator). Depletion of intracellular glutathione further increased ROS levels and speeded up cell death.

It is known that proinflammatory cytokines, mainly released by microglia upon a pathological stimulus, induce changes in the astrocyte phenotype, promoting a process known as "activation". We found that this condition was able to protect cultured astrocytes from the effects of iron‐induced oxidative stress. We are currently investigating at the molecular level the differences between resting and "activated" astrocytes in terms of their capability to detoxify iron and ROS, with particular attention to the role of mitochondria.
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STI1 UNCONVENTIONAL SECRETION BY ASTROCYTES IS LIPID DEPENDENT AND ACTIVATES THE ERK SIGNALING PATHWAY {#sec2-313}
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The physiological functions of cellular prion protein (PrPC) are under intense investigation, particularly those associated with brain development. In neurons, the association of PrPC with its ligand, the co‐chaperone Stress Inducible Protein 1 (STI1) induces neuritogenesis and neuroprotection via ERK (Extracellular Regulated Kinase) and PKA (cAMP dependent Protein Kinase) signaling pathways, respectively. Herein, we demonstrated that STI1 can be secreted by astrocytes, even though it lacks a secretory signal sequence. This secretion is independent on the classical secretory pathway mediated by the Golgi apparatus, since Brefeldin A and Monensin had no blocking effect on it. The secreted STI1 is found in both a soluble form and in vesicles/aggregates that can be precipitated by ultracentrifugation. When separated through gel filtration, secreted STI1 was found in four compartments of different size and protein composition. Three of these compartments have a lipid composition, as determined by detergent treatment and labeling with miristic acid‐T\[H\]3, a lipidic precursor. Among the non‐classical lipid‐dependent secretory pathways, STI1 secretion by shedding was ruled out since STI1 was not separated by an isopycnic density centrifugation. On the other hand, STI1 is present in fractions that are positive for transferrin receptor, HSP70, HSP90, PrPC and acetylcholinesterase activity, suggesting an exosome identity. Secreted STI1 is functional, since GFP‐STI1 expressed by transfected astrocytes can bind and be internalized by neurons, activating the ERK1/2 signaling pathway in wild‐type hippocampal neurons but not in PrPC‐null neurons. Taken together these findings indicate that STI1 is secreted by astrocytes in an unconventional, lipid‐dependent pathway. Secreted STI1 acts as a neurotrophic factor whose activity is dependent on the expression of PrPC at the neuronal surface.

Supported by FAPESP, CNPq and HHMI.
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The astrocytes, oligodendrocytes and microglia make up a significant proportion of the cells of the CNS. In recent years, there has been a burgeoning interest in the role of glial cells, in neurodegenerative disease. These cell types have been shown to play diverse roles in neuroinflammation, bioenergetics, signalling and intracellular oxidative balance, amongst others. Studies on Parkinson\'s, Alzheimer\'s, Huntington\'s and prion diseases suggest that the misfolded intra‐ or extra‐cellular proteins that characterize these diseases could interfere with glial cell functions. We are interested in identifying glial cell dysfunctions caused by abnormal protein misfolding, particularly in Huntington\'s disease, which might in turn interfere with neuronal function and survival during disease progression. We have developed an in vitro astrocyte primary cell culture model for genomic and proteomic screening and the testing of more specific hypothesis relating to how glial cells deal with misfolded proteins.
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Toxic metals, including "heavy metals", are individual metals and metal compounds that negatively affect health, even though many of these metals are necessary to support life at trace concentration. Manganese (Mn) is ubiquitously distributed in the environment and, although an essential metal, is a common environmental contaminant. A mounting body of evidence indicates that excessive chronic exposure to Mn participates in the pathophysiological processes of numerous disorders of the central nervous system (CNS) in humans.

In this study, we tested the hypothesis that the "in vitro" exposure of astrocytes with Mn is able to induce the activity and expression of gelatinases A (MMP‐2) and B (MMP‐9), which rapresent important pathogenetic factors in various CNS diseases such as Multiple Sclerosis, Alzheimer disease, Parkinson\'s disease.

Primary cultures of rat astrocyte were exposed to different doses of MnCl2 for 20 h. In another set of experiments, astrocytes were simultaneously exposed to MnCl2 and treated with the antioxidant resveratrol. Culture supernatants collected from astrocytes after incubation at 37°C, 5% CO2 were subjected to gelatin zymography for the assessment of MMP‐2 and MMP‐9 protein levels. Total RNA was extracted from cells and used for RT‐PCR for the assessment of mRNA expression.

Our results indicate that astrocytes constitutively express MMP‐2 mRNA and protein. The exposure of astrocytes to Mn2+ at concentrations ranging between 1‐20 microM, dose--dependently induced levels and expression of both MMP‐2 and MMP‐9. The addition of 50 microM resveratrol inhibited the levels and expression of MMP‐2 as well as MMP‐9 in astrocytes.

These results indicate a possible involvement of heavy metals in those neurological diseases in which environmental factors play a central role. The inhibitory effect of the antioxidant resveratrol on gelatinase production may suggest that Mn neurotoxicity is mediated by reactive oxigen species (ROS), indicating the possible therapeutical use of natural antioxidants in neurological diseases associated with MMP overexpression and ROS production.

Funding in part by the Italian Foundation for Multiple Sclerosis (FISM) to G.M.L. 2005/R/13.
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The neurotoxin MPTP reproduces most of the biochemical and pathological hallmarks of Parkinson\'s disease (PD). In addition to reactive oxygen species (ROS) generated as a consequence of mitochondrial complex I inhibition, microglial activation and microglial NADPH‐derived ROS play major roles in the toxicity of MPTP. However the exact mechanism regulating the microglial response remains to be clarified. Recent data suggest that neuropeptides play a major and unexplored role in neurodegeneration and microglial signaling. The peptide angiotensin II (AII), via type 1 receptors (AT1), is one of the most important inflammation and oxidative stress inducers, and produces ROS by activation of the NADPH‐oxidase complex. Brain, including the basal ganglia, possesses a local angiotensin system, which modulates striatal dopamine release. However, it is not known if AII plays a major role in microglial activation and DA degeneration in PD. In the present study we found that in primary mesencephalic cultures, dopaminergic degeneration induced by the neurotoxin MPTP/MPP+ was amplified by AII and inhibited by AT1 receptor antagonists, and that the effect was mediated by protein kinase C, NADPH‐complex and microglial activation. In mice, AT1 receptor antagonists inhibited both dopaminergic degeneration and early microglial and NADPH activation. AII alone did not induce any significant dopaminergic degeneration. However, AII significantly reduced the dose of MPP+ required to induce the microglial activation and dopaminergic cell death. The brain angiotensin system may play a key role in the self‐propelling mechanism of PD and constitutes an unexplored target for neuroprotection, as previously reported for vascular diseases.
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Neonatal exposure to moderate levels of unconjugated bilirubin (UCB) is associated with an increased risk for minor neurologic dysfunction, that may develop into behavioural and learning problems.^1^ The elaboration of neuronal arborization is dependent on a functional cytoskeleton, strictly regulated by associated proteins such as Tau1 and MAP2. Here we investigate whether UCB interferes with axonal arborization through changes at cytoskeletal dynamics.

Primary cultures of mouse hippocampal neurons were incubated at 1 day‐in‐vitro (DIV) with 50 μM purified UCB plus 100 μM human serum albumin, for 24 h at 37°C, and additionally cultured until 3 DIV. Axon arborization was evaluated in individual neurons electroporated with pCAG‐EGFP. MAP2 and Tau1 expression and localization along the axon were determined by immunostaining with specific antibodies and their binding to microtubules (MT) assessed after extraction of soluble cytoplasmic components prior to fixation. MT polimerization was evaluated in cells electroporated with pCAG‐EB3‐EGFP, a MT plus end‐binding protein 3 (EB3).

Exposure of developing neurons to UCB decreased axonal arborization (10%) mainly by reducing branches number (∼20%, p\<0.05). Physiologically, MT binding of MAP2 is stronger in the cell body and dendrites, while that of Tau is tighter in the axon. However, UCB induced an increased axonal entry of MAP2 (∼30%, p\<0.05) with a higher expression in the apical portion of the axon (\>20%, p\<0.05). Tau1 expression increased after UCB treatment (\>60 %, p\<0.05), namely at the middle and terminal portions of the axon. These results indicate an increased UCB‐induced binding of MAP2 and Tau1 to MT (∼20% and ∼40% respectively, p\<0.05), confirmed by immunostaining following extraction. In addition, UCB reduced the presence of EB3 at the apical portion of the axon (∼30%, p\<0.05), pointing to a deficient polymerization of MT at this level.

Collectively, these data show that exposure of neurons to UCB during early development modifies axonal arborization with specific changes at the MT cytoskeletal dynamics, elucidating part of the mechanisms leading to neuronal abnormalities upon neonatal hyperbilirubinemia.

1\. Soorani‐Lunsing et al. Pediatr Res 2001;50:701--5.

2\. Kwei et al. Neuroreport 1998;9:1035--40.

Funded by FCT‐PTDC/SAU‐NEU/64385/2006 to DB.
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Angiotensin II (AII) plays a major role in the initiation and progression of vascular disease, in which initiates and perpetuates inflammation and activates the NADPH oxidase complex. The brain possesses a local angiotensin system (RAS), and oxidative stress and inflammation are key factors in the pathogenesis and progression of Parkinson\'s disease (PD). The present study shows the presence of angiotensin receptors type 1 (AT1) and 2 (AT2) and NADPH oxidase subunits in dopaminergic neurons, astrocytes and microglia in rat primary mesencephalic cultures. In cultures, treatment with AII (100nM) produced a significant increase in 6‐OHDA‐induced DA cell death, together with a significant increase in generation of superoxide in DA neurons and microglial cells, in the expression of NADPH‐oxidase mRNA, and in the number of reactive microglial cells. These effects were blocked by treatment with AT1 antagonists, NADPH complex inhibitors, or elimination of glial cells. The dopaminergic neurotoxin 6‐OHDA induced a significant increase in angiotensin converting enzyme (ACE) activity and endogenous AII levels in cultured cells. In rats, 6‐OHDA induced dopaminergic cell loss and microglial activation were reduced by treatment with AT1 antagonists. The present data suggest that AII, via AT1 receptors, increases the dopaminergic degeneration process by amplifying the inflammatory response and intraneuronal levels of oxidative stress, and that glial cells play a major role in this process. Manipulation of the brain RAS components may break a vicious circle that potentiates the progression of PD.
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Dynamins (Dnm) are multi‐functional GTPases implicated in several cellular events, including endocytosis, intracellular trafficking, cell signaling and cytokinesis, and are encoded as three isoforms. Mutations in Dnm2 are linked to two different human disorders: a dominant intermediate form of the inherited neuropathy Charcot‐Marie‐Tooth (CMT), and centronuclear myopathy. Since the mechanistic basis of these diseases remains elusive, we ablated Dnm2 in Schwann cells. The importance of Dnm2 for proliferation, differentiation, and cell death will be assessed. Analyses of Schwann cell morphology, differentiation, and myelination may help to elucidate the importance of Dnm2 for Schwann cells and the molecular mechanisms underlying the development of disease.
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BACKGROUND: Alzheimer\'s disease (AD) is the most common cause of dementia. Hallmarks of AD are β‐amyloid (Aβ) plaques, intracellular fibrillary tangles and vascular amyloidosis that can result in reduced perfusion and hypoxia, leading to oxidative stress and brain tissue damage. There is evidence that activated microglia and astrocytes can phagocytose Aβ. Scavenger receptors (SRs) are among the receptors mediating the uptake of fibrillar Aβ by glial cells and could also mediate their activation. However, a decreased pH could lead to the impairment of amyloid clearance by glial cells and thus, enhance neurodegenerative changes.

AIM: To evaluate the effect of pH on the Aβ clearance activity of microglia and astrocytes, we determined the expression of SRs in primary glial cultures by immunocytochemistry and immunoblot. Glial function was evaluated with assays of Aβ phagocytosis.

RESULTS: The incubation on acidic medium (pH 6.9 or 6.5) for 24‐48h led to dramatic morphological changes of microglia and astrocytes and a decrease on adherent microglial cell number. Expression of SR‐BI, SR‐MARCO by microglia exposed to pH 6.5 increased by 123±18% and 151±11% respectively (p\<0.05). Astrocytes expression of SR‐BI also increased by 138±16%, whereas SR‐MARCO decreased by 63.8±13% (p\<0.01). Phagocytosis assays showed that microglia maintained their ability to uptake Aβ at the different pHs (pH 7.4 to 6.5) over time (from 5 h to 6 days). In contrast, phagocytosis by astrocytes decreased by 50% (p\<0.0001) over the same pH range. Co‐localization of Aβ with early endosomes was observed by confocal microscopy.

CONCLUSION: Low pH reduced Aβ uptake by astrocytes, whereas it did not reduce Aβ uptake by microglial cells. However, morphofunctional changes leading to reduced adhesiveness of microglia also resulted in a reduced total clearance. Changes in phagocytosis and on the expression SR suggest that the clearance of Aβ and perhaps also the activation of glial cells may be affected by acidosis.

Supported By: FONDECYT grant 1090353 to RvB.
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Based on our previous results and the fact that calcium play a pivotal role in cellular signalling pathways involved in neurotoxicity iof Aβ, we investigated the effects of oligomeric forms of Aβ1‐42 on the expression of CA2+ proteins, ej., calpain 1 and S100B, in reactive astrocytes. The implications of nuclear factor of activated T cells (NFAT) and nuclear factor kappa of activate Beta cells (NFkβ) in astrocytes, was also analyzed in this study. In rats, anaesthetised with equitesina (0.33 ml/100gr), injections of Aβ(1‐42) oligomers (BACHEM, 2μg) were placed into the posterior cingulate cortex. Control animals were injected with Aβ(42‐1) sequence (2 μg). After 24h and 72h, animals were deeply anaesthetised and perfused with fixative. Injections of Aβ1‐42 oligomers induce reactive astrocytes around the injection sites at an early stage of Aβ toxicity. Reactive astrocytes were also observed around blood vessels and along the subventricular zone of the lateral ventricles. Confocal microscopy image showed reactivity for calpain 1 and S100B proteins expressed in reactive astrocytes, increasing from early stages (24h) of Aβ toxicity to later (72h) time point. S100B protein co‐localized primarily with astrocytes around blood vessels. Calpain positive material has been found in reactive astrocytes at the injection site, in cortical and leptomeningeal blood vessel, and along the subventricular zone of the lateral ventricles. In Aβ‐treated animals, a correlation between NFkβ proteins and reactive astrocytes was observed around the injection site, extending further to hippocampus and to several cortical regions at an earlier (24h) time point. In addition, NFAT immunopositive material was observed in reactive astrocytes, primarily around cortical and leptomeningeal blood vessels, at 72h survival. Control animals showed a light staining for the proteins analyzed in this study, likely caused by mechanical damage, at any time point. These findings suggest that oligomeric forms of Aβ increase the activity of calpain and S100 proteins, increasing intracellular calcium levels in astrocytes and that, mediated astrocytic dysfunction through NFkβ and NFAT signalling pathways.

Supported: Junta de Castilla y León (SAN673/VA14/08; VA030A07).
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Astrocytes, the most numerous cells of the brain, are essential for neuronal activity and are also the fulcrum of the brain diseases such as neurodegenerative processes like Alzheimer\'s disease (AD). Extensive literature points towards a hypertrophic reaction of astrocytes during ageing, neurodegenerative processes and AD. Here, we have studied the astrocytic changes and modifications that appear throughout the progression of AD within the hippocampus. For this we have used an immunohistochemical approach that has allowed us not only to determine the complexity (surface/volume ratio) of the glial cytoskeleton but also their relationship and/or association with one of the major pathological hallmarks of AD: the neuritic plaques. We studied this in a recently developed triple transgenic mouse model of AD (3xTg‐AD) that mimics the temporal evolution and progression of AD.

Surprisingly and apposed to what has been described till now we found that from early ages (3 months of age), it starts to appear an astrocytic atrophy as shown by a reduction in astrocytic volume and surface which translates in a 1.3% decrease in complexity. This atrophy becomes markedly significant at 12 and 18 months of age (5.04% and 8.33% respectively) in the dentate gyrus and at 18 months of age (3.56%) in the CA1 of the hippocampus when we compared 3xTg‐AD to non‐Tg animals. However, we found that whilst this is a generalised process, astrocytes surrounding plaques show a cytoskeleton hypertrophy as revealed by an increase of complexity (7.76%), volume (98.19%) and surface (118.69%) of GFAP labelling. Despite these cytoskeleton morphological changes, the numerical density of astrocytes in both areas remain invariable.

Therefore, our results suggest that there are differential effects of AD on astrocytic subpopulations which will account for the progressive glial and neuronal alterations in synaptic connectivity that appear in AD and that are responsible for the observed mnesic and cognitive impairments.
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In the CNS the transcription factor NF‐kB is a key regulator of inflammation and secondary injury processes. Following trauma or disease, the expression of NF‐kB‐dependent genes is activated, leading to both protective and detrimental effects. Here we show that transgenic inactivation of astroglial NF‐kB (GFAP‐IkBa‐dn mice) resulted in reduced disease severity and improved functional recovery following experimental autoimmune encephalomyelitis (EAE). At the chronic stage of the disease, transgenic mice exhibited an overall higher presence of leukocytes in spinal cord and brain, and a markedly higher percentage of CD8+CD122+ T regulatory cells compared to WT, which correlated with the timing of clinical recovery. We also observed that expression of proinflammatory genes in both spinal cord and cerebellum was delayed and reduced, while the loss of neuronal‐specific molecules essential for synaptic transmission was limited compared to WT mice. Furthermore, death of retinal ganglion cells in affected retinas was almost abolished, suggesting the activation of neuroprotective mechanisms. Our data indicate that inhibiting NF‐kB in astrocytes results in neuroprotective effects following EAE, directly implicating astrocytes in the pathophysiology of this disease.
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KRABBE DISEASE: OPTIONS FOR TREATING THE SEVERE DEMYELINATION IN THE MOUSE MODELS {#sec2-324}
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### Wenger D.,^1^ Luzi P.,^1^ Rafi M.,^1^ Costantino‐Ceccarini E.^2^ {#sec3-324}

#### ^1^Jefferson Medical College, Philadelphia, United States; ^2^Institute of Clinical Physiology CNR, Siena, Italy {#sec4-324}

Globoid cell leukodystrophy (GLD) is a genetic demyelinating disorder caused by the deficiency of galactocerebrosidase (GALC) activity. The disease is characterized by microglial activation, astrogliosis, macrophage infiltration and apoptosis leading to progressive loss of myelin in the CNS and PNS. Treatment of asymptomatic patients is limited to hematopoietic stem cell transplantation which slows the progression but does not result in a cure. Several well‐characterized mouse models of this disease are available. BMT in affected mice results in longer life‐spans with evidence for remyelination in the PNS and CNS. Additional treatments have been tried in the mouse models including gene therapy using AAV‐GALC vectors in brain (high localized expression of GALC activity, improved myelination, little increase in life span) and injection of GALC over‐expressing neural progenitor cells into brain (evidence for transfer of GALC activity from donor cells to oligodendrocytes and improved pathology, little increase in life span). Recruitment of inflammatory cells and increased levels of cytokines and chemokines are present in the CNS of GLD mice. We evaluated the effects of the anti‐inflammatory drugs indomethacin and ibuprofen and a neuroprotective drug minocycline on the progression of the disease in the mouse model. Real‐time quantitative PCR was used to analyze the expression of several markers of immune/inflammatory response. IL‐6, TNF‐a, MIP‐1b, MCP‐1, iNOS, CD11b, CD68, CD4 and CD8 mRNA levels were measured in cortex, cerebellum and spinal cord of untreated and treated affected mice. The pharmacological treatments were compared to BMT, currently the most effective treatment option. The drug treatments were able to significantly extend the life‐spans of the mice and to reduce the levels of most factors studied. However, BMT produced the most dramatic results. The cerebellum responded better than the cortex. In the spinal cord of BMT‐treated mice, factors were normalized faster than the cerebellum, with the exception of CD68. There was a decrease in the number of apoptotic cells in the cerebellum with all treatments, however BMT plus minocycline produced the greatest reduction in the percentage of apoptotic cells. The results of the most promising treatments for this demyelinating disease will be presented.
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NEUROMYELITIS OPTICA AUTOANTIBODIES SPECIFICALLY BIND THE AQUAPORIN‐4 SUPRASTRUCTURES ‐ ORTHOGONAL ARRAYS OF PARTICLES {#sec2-325}
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### Nicchia G.P., Pisani F., Rossi A., Mastrototaro M., Svelto M., Frigeri A. {#sec3-325}

#### University of Bari, Bari, Italy {#sec4-325}

NMO‐IgG is the auto‐antibody specific to the glial water channel aquaporin‐4 (AQP4) associated with neuromyelitis optica (NMO), an autoimmune inflammatory disease. Two AQP4 isoforms (M1 and M23) are encoded by two transcript variants and are characterized by Met 1 and in‐frame Met 23. In the plasma membrane M1 and M23 aggregate to form suprastructures called Orthogonal Arrays of Particles (OAPs). M23 is the OAP‐forming isoform, whereas M1 alone is unable to form OAPs. We recently demonstrated that OAP assemblies are required for NMO‐IgG to recognize AQP4. However, in experiments performed on cells transiently transfected with M1, a significant number of cells was recognized by NMO‐IgG. We hypothesized that the high transcription frequency which characterizes transient transfections, allow the synthesis of M23 from the M1 mRNA through a leaky scanning mechanism and therefore explains the presence of OAP expressing cells recognized by NMO IgG. To confirm our hypothesis we mutated M1 cDNA (M1mut) at the Met23 in order to avoid the leaky scanning mechanism and compared M1 to M1mut cDNA in transient transfection experiments. Our Western blot results demonstrate the additional presence of M23 only in cells transfected with M1 and not with M1mut. Accordingly, by TIRF and BN/SDS‐PAGE we show the presence of OAPs only in cells transfected with M1. Finally, immunofluorescence analysis performed using NMO IgG sera demonstrate the presence of positive cells only in cells transfected with M1 while cells transfected with M1mut were completely negative. We conclude that 1‐ a leaky scanning mechanism is responsible for the synthesis of AQP4‐M23 isoform starting from the M1 mRNA and that this could play an important role in vivo in regulating the ratio M1/M23 in pathophysiological conditions, and 2‐ NMO‐IgG epitope is intrinsic of AQP4 assembled into OAPs and that disassemblies of AQP4‐OAPs can be considered an innovative approach for the treatment of NMO.
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THE LXR AGONIST TO901317 REDUCES PLAQUE LOAD IN APP23 MICE AND STIMULATES PHAGOCYTOSIS OF FIBRILLAR ABETA DEPENDENT ON APOE AND LXRALPHA {#sec2-326}
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### Terwel D.,^1^ Gasparini F.,^2^ Jacobson L.,^2^ Desrayaud S.,^2^ Lerchner A.,^2^ May‐Nass R.,^2^ Reichwald J.,^2^ Staufenbiel M.,^2^ Heneka M.T.^1^ {#sec3-326}

#### ^1^University Clinic Bonn, Bonn, Germany; ^2^Novartis, Basel, Switzerland {#sec4-326}

The finding that ApoE4 is a risk factor for Alzheimer\'s disease (AD) links this disease to lipid metabolism. LXRs are key regulators of lipid metabolism. In order to investigate the role of processes controlled by LXRs in amyloid pathology we treated 13‐month‐old amyloid plaque bearing APP23 mice with the LXR agonist TO901317 (50 mg/kg daily by gavage for a period of 6 weeks). Post‐mortem analysis demonstrated that TO901317 reached brain concentrations of 5 to 10 μM. Insoluble and soluble Aβ levels in the TO901317‐treated APP23 mice were 80% and 40% lower, respectively, than in the untreated animals. APP processing products, however, were unchanged, suggesting that LXR stimulation did not affect Aβ processing but rather clearance or degradation. Surprisingly, treatment of 3‐month‐old APP23 mice for 6 days did not influence Aβ levels, despite achieving similar levels of compound in the brain. In the chronic experiment, levels of ApoE and ABCA1, responsible for ApoE lipidation, were increased at the end of the treatment. Both ApoE and ABCA1 could be shown to localize primarily to astrocytes. Experiments with primary microglia demonstrated that LXR stimulation increased phagocytosis of fibrillar Aβ, dependent on astrocyte conditioned medium. Conditioned medium from ApoE (‐/‐) astrocyte cultures was ineffective and microglia knockout for LXRα did not respond to the drug. We conclude that LXR stimulation increased the ability of the brain to eliminate toxic Aβ species that lead to plaque formation, whereas it does not affect soluble Aβ directly. One of the possible mechanisms is the increased ability of microglia to remove fibrillar Aβ after LXR stimulation, dependent on ApoE derived from and lipidated by astrocytes. Moreover, increased lipidation of ApoE could reduce co‐aggregation of Aβ and ApoE.
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EFFECT OF THE DOWN‐REGULATION OF GLUTAMATE TRANSPORTERS GLAST AND GLT‐1 IN ASTROCYTIC METABOLIC FLUXES: DEPICTING METABOLIC ALTERATIONS IN HUNTINGTON\'S DISEASE {#sec2-327}
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### Amaral A.I.,^1^ Pacheco I.,^1^ Teixeira A.P.,^1^ Déglon N.,^2^ Bonvento G.,^2^ Alves P.M.^1^ {#sec3-327}

#### ^1^Instituto de Tecnologia Química e Biológica ‐ Universidade Nova de Lisboa (ITQB‐UNL), and Instituto de Biologia Experimental e Tecnológica (IBET), Oeiras, Portugal; ^2^CEA, Institut d\'Imagerie Biomedicale (I2BM), MIRCen, Fontenay‐Aux‐Roses, France {#sec4-327}

Impaired glutamate uptake by astrocytes, due to a decreased expression of the glutamate transporters GLAST and GLT‐1, has recently been demonstrated to be an important factor in Huntington\'s disease (HD) pathophysiology (Shin, J.Y., et al. J Cell Biol, 2005; Miller, B.R., et al. Neuroscience, 2008). In addition to clearing synaptic glutamate, these glial glutamate transporters play a key role in the regulation of glucose metabolism (Voutisnos‐Porche et al., Neuron, 2003). The aim of this work was to investigate the consequences of the down‐regulation of GLAST and GLT‐1 in astrocytic energy metabolism, namely to quantify the changes at the level of metabolic fluxes. siRNA lentiviral vectors carrying a GFP reporter gene were used to down‐regulate the expression of GLAST or GLT‐1 in primary cultures of rat cortical astrocytes. A decrease in the expression of the transporters (24% for GLAST and 41% for GLT‐1) was achieved simultaneously with a significant reduction of the specific glutamate uptake rate (‐50% and ‐56% for GLAST and GLT‐1, respectively) compared to control cultures. To investigate the alterations in metabolic fluxes, astrocytes were incubated with a medium containing \[1‐^13^C\] glucose or \[1‐^13^C\] glucose + \[U‐^13^C\] glutamate. Samples of cell supernatant were collected at several time‐points to determine the specific consumption/production rates of glucose, lactate and amino acids and also to determine ^13^C labelling in several metabolites produced from the ^13^C‐labelled substrates. Cell extracts were also performed to analyze the distribution of the ^13^C label in the main intracellular metabolites involved in energy metabolism. Metabolic Flux Analysis (MFA) (Teixeira, A.P., et al. Neurochem Int, 2008) was applied to quantify the alterations in the main metabolic fluxes. The results indicate alterations in glucose uptake rate and in glucose oxidation in siGLAST and siGLT‐1 astrocytes, compared to controls. Furthermore, changes in glutamine synthesis and in the use of branched chain amino acids were also observed when the transporters were down‐regulated. All these variations were integrated and quantified with MFA, providing an important picture of the metabolic alterations that might be associated with HD.
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EXPRESSION OF CHOLINE TRANSPORTER‐LIKE PROTEIN 1 (CTL1) IN THE NORMAL CENTRAL NERVOUS SYSTEM AND IN MULTIPLE SCLEROSIS PLAQUES {#sec2-328}
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### O\'Regan S.,^1^ Meunier F.M.,^1^ Newcombe J.^2^ {#sec3-328}

#### ^1^NBCM CNRS UPR9040, GIF SUR Yvette, France; ^2^NeuroResource, UCL Institute of Neurology, London, United Kingdom {#sec4-328}

Choline transporter‐like 1 (CTL1, also termed SLC44A1, CDw92) is highly expressed in the CNS and also in other tissues. In human normal control white and grey matter, C‐terminal specific CTL1 antibodies label a 55 kDa MW band on immunoblots while CTL1 loop antibodies label a 48 KDa MW band in several types of muscle. At the cellular level, CTL1 mRNA has been localized to oligodendrocytes and specific types of neurons in the brain and spinal cord. In agreement with this, by immunohistochemistry on tissue sections CTL1 protein has been localized in oligodendrocytes and certain groups of neuronal cell bodies including spinal motor neurons. The major cell type observed depends on the individual antibody used. A striking change in CTL1 protein profile on immunoblots occurs in the demyelinating disease multiple sclerosis (MS). A band of about 48 kDa recognized by the CTL1 loop antibodies appears in samples containing MS plaques. In addition, in a subgroup of MS plaques some of these antibodies strongly immunolabel a distinct population of enlarged axons which are most prominent at the edges of these plaques. While some of these differences are likely to be related to the expression of different alternate splice isoforms, there are clearly other changes occurring during CTL1 protein processing. Learning more about the mechanisms inducing CTL1 protein modification and the effect of these modifications on choline transport will shed light on why and how CTL1 undergoes changes in MS.
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GLIA IS LINKED TO SCHIZOPHRENIA SUSCEPTIBILITY THROUGH THE MODULATION OF D‐SERINE CONCENTRATION {#sec2-329}
-----------------------------------------------------------------------------------------------

### Sacchi S.,^1^ Cappelletti P.,^1^ Caldinelli L.,^1^ Martineau M.,^2^ Mothet J.P.,^2^ Pollegioni L.^1^ {#sec3-329}

#### ^1^The Protein Factory, Dept. of Biotechnology and Molecular Sciences, University of Insubria, Varese, Italy; ^2^Institut F. Magendie, Centre de Recherche INSERM, Bordeaux, France {#sec4-329}

Up to now, schizophrenia (SZ) represented a puzzle for neurobiologists as it is a multi‐factorial disorder with both genetic and environmental contributions. Several genes have been associated to SZ, but the still open challenge is to identify their specific mechanisms to develop new targeted treatments. In particular, the genes encoding for D‐amino acid oxidase (DAAO) and its interactor pLG72 have been linked to SZ susceptibility. In the brain, the FAD‐containing flavoenzyme DAAO catalyses the degradation of the gliotransmitter D‐serine, the principal coagonist of the NMDA receptors. DAAO and pLG72 have been proposed to be associated to SZ onset by affecting glutamatergic neurotransmission through the depletion of D‐serine hence supporting the hypothesis of hypoglutamatergia in SZ. We recently showed that both proteins are expressed in human astrocytes where they most likely interact, considering their partial overlapping subcellular distribution and their co‐immunoprecipitation (2). Their in vitro interaction yields a ∼200 kDa complex (2 DAAO homodimers : 2 pLG72 molecules) and results in a time‐dependent loss of enzymatic activity. Noteworthy, the over‐expression of DAAO in human U87 glioblastoma cells decreases the cellular level of D‐serine, an effect which is nulled when pLG72 is co‐expressed: these evidences strongly indicate that pLG72 acts as a negative effector of DAAO. We thus proposed a molecular model for SZ susceptibility: an anomalous hypoexpression of pLG72 yields to an increase of DAAO activity, then to a decrease of D‐serine disposition at the synapse and, as a result, to the hypoactivation of NMDA receptors. Concerning the regulation of DAAO activity, we demonstrated that the interaction with pLG72 increases the sensitivity of DAAO to proteases cleavage, while small sticky ligands (such as benzoate) protect the flavoenzyme from complete degradation because of a tighter interaction with the FAD cofactor and the increase of the holoenzyme form. On the other hand, the addition of the drug chlorpromazine makes DAAO more sensitive to proteolysis. In conclusion, these studies are aimed at the elucidation of the regulation mechanism of human DAAO with the final purpose of providing a complete scenario for the modulation in brain of D‐serine levels and NMDA receptors activity.
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THE PROTECTIVE EFFECT OF PHENELZINE (PLZ), A MONOAMINE OXIDASE (MAO) INHIBITOR, ON FORMALDEHYDE‐INDUCED TOXICITY IN CULTURED ASTROCYTES: CELLULAR AND MOLECULAR MECHANISMS {#sec2-330}
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### Todd K.G., Song M.S., Baker G.B. {#sec3-330}

#### University of Alberta, Edmonton, Canada {#sec4-330}

Reactive aldehydes have been implicated in the etiology of several neurological and psychiatric disorders. Semicarbazide‐senstive amine oxidase, which catalyzes conversion of methylamine to formaldehyde (FA), hydrogen peroxide and ammonia, has been reported to be increased in some of these disorders. FA is extremely reactive and can produce cytotoxicity by cross‐linking with proteins or single stranded DNA. Discovery of effective drugs to neutralize reactive aldehydes, thus reducing aldehyde load and promoting cellular survival, has been the object of considerable recent research. Phenelzine (PLZ), a monoamine oxidase inhibiting antidepressant/antipanic drug, has recently been reported to sequester reactive aldehydes and promote neuronal survival. The neuroprotective capabilities of PLZ have been studied in cultured neurons and *in vivo* in animals but little is known of the effect of aldehdyes and PLZ on glia. Because astrocytes provide amino acids, anti‐ or pro‐inflammatory and trophic factors to neurons, and play an important neuromodulatory role in neuronal activity and fate, it is important to investigate their involvement in the brain\'s response to aldehydes. Thus we examined PLZ\'s effects on FA‐induced astrocyte toxicity.

Results from our study show that FA induces toxicity in astrocytes through multiple death‐related (suppression of AKT) and stress‐related (activation of p38) signals. FA also decreases glutamate transporter expression in astrocytes, thus inhibiting glutamate uptake and phenelzine reverses this FA‐induced decrease of glutamate transport. Presumably, this protective effect is due in part to the sequestration of FA by PLZ. However as PLZ alone enhances glutamate transporter expression and alters levels of amino acids associated with neuro‐ or gliotoxicity, this drug may have other independent effects that affect normal astrocyte function. We also demonstrated that FA increases BDNF release from astrocytes and that PLZ attenuates this release. These data suggest that PLZ can affect astrocytes in several novel ways that may contribute to its observed neuroprotective effects in vivo.

Funds provided by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada and the Davey Endowment for Brain Research.
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THE GFAP ISOFORM (GFAP+1) IS ASSOCIATED WITH ASTROGLIOSIS AROUND PLAQUES IN A MOUSE MODEL FOR ALZHEIMER DISEASE {#sec2-331}
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### Kamphuis W., Kamphuis W., de Groot L., Sluijs J., Dimayuga V., Freriks M., Hol E. {#sec3-331}

#### Netherlands Institute for Neuroscience, Amsterdam, Netherlands {#sec4-331}

INTRODUCTION: In Alzheimer Disease (AD) brains plaques are surrounded by reactive astrocytes with increased expression of the intermediate filament glial fibrillary acidic protein (GFAP). The formation of a gliotic network may have functional consequences for neuronal signalling. The gliotic reaction is dependent on the presence of GFAP. Our lab has identified several GFAP isoforms that differ in their C‐terminal domains, a region of intermediate filament monomers known to affect their characteristics for network formation.

AIM: (i) Are GFAP‐isoforms (GFAPα, GFAPδ, GFAPκ, GFAP+1) differentially expressed during astrogliosis in a transgenic AD mouse model? (ii) The GFAPδ isoform is involved in neurogenesis in the human brain. To assess a potential role of GFAPδ in proliferative activity, the mice were injected with BrdU prior to sacrifice.

RESULTS: Doublestainings for Aβ and the canonical GFAPα isoform showed that already the very first small amyloid deposits trigger an upregulation of GFAPα in the small number of local astrocytes contacting the aggregation. With time, the cortex becomes completely filled with a dense network of GFAPα containing processes surrounding the increasing number of plaques. In contrast to the differential expression in the human brain, GFAPδ completely co‐localizes with GFAPα in both wild‐type and in the transgenic animals. Cortical cells that had incorporated BrdU never immuno‐stained for any of the GFAP isoforms. Antibodies raised against GFAPκ were able to detect this isoform in a cells transfected with the cloned mouse sequence, but no staining was observed in either wild‐type or transgenic mice. Gfap+1 immunostaining was absent in wild‐type animals at all ages. In 6 month and older transgenic mice hypertrophic astrocytes associated with larger‐sized Aβ deposits expressed GFAP+1.

CONCLUSIONS: The GFAP+1 isoform is differentially expressed by hypertrophic astrocytes suggesting an specific function for this particular isoform in astrogliosis triggered by Aβ deposits. Transfection studies with GFAP+1 in combination with GFAP‐α show that GFAP+1 affects the morphology of the resulting network. The precise role of GFAP+1 in astrogliosis will be a topic of further research.
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THE BETA2‐ADRENOCEPTOR AGONIST CLENBUTEROL ACTIVATES ASTROCYTES AND REDUCES AMYLOID‐BETA CONCENTRATIONS AND RAGE EXPRESSION IN RAT CORTEX AND HIPPOCAMPUS {#sec2-332}
---------------------------------------------------------------------------------------------------------------------------------------------------------

### Ryan K.M.,^1^ Mahfoud O.K.,^1^ Jones R.S.,^1^ Harkin A.,^2^ Connor T.J.^1^ {#sec3-332}

#### ^1^Neuroimmunology Research Group, School of Medicine and Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland; ^2^Neuropsychopharmacology Research Group, School of Pharmacy and Pharmaceutical Sciences and Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland {#sec4-332}

Alzheimer\'s disease is a neurodegenerative disease characterized by chronic inflammation and the accumulation of amyloid‐β plaques and neurofibrillary tangles. Noradrenaline acting at β~2~‐adrenoceptors on glial cells has anti‐inflammatory and neurotrophic properties, and it has been suggested that a loss of central noradrenergic tone may contribute to the development of Alzheimer\'s disease by facilitating chronic neuroinflammation and amyloid‐β deposition.

In this study we report that chronic treatment with long‐acting β~2~‐adrenoceptor agonist clenbuterol (30 μg/kg; bid; 14 days) results in a significant induction of GFAP mRNA expression in rat cortex and hippocampus, indicating astrocytic activation. In parallel, clenbuterol treatment reduced amyloid‐β1‐40 and amyloid‐β1‐42 concentrations in both brain regions. We suggest that this reduction in amyloid‐β concentrations occurs due to increased degradation, as opposed to an inhibition of synthesis. In this regard, we demonstrate that clenbuterol induces expression of matrix metalloproteinase‐2 (MMP‐2) in cortex and hippocampus; an enzyme that is known to degrade amyloid‐β. In contrast, we found no evidence that clenbuterol could influence amyloid‐β synthesis, as expression of amyloid precursor protein, α‐secretase (ADAM‐10 or ADAM‐17) or γ‐secretase (Presenillin 1 or 2) were not altered following clenbuterol treatment. Furthermore, clenbuterol treatment significantly reduced expression of the receptor for advanced glycation end products (RAGE) in both hippocampus andcortex; a receptor implicated in mediating amyloid‐β‐induced neurotoxicity.

Ultimately these data indicate that β~2~‐adrenoceptor activation activates astrocytes and limits the actions of amyloid‐β by clearing the protein, and also by reducing expression of RAGE. These results indicate that the β~2~‐adrenoceptor may represent a new target for pharmacological intervention in the treatment of Alzheimer\'s disease.
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THE ROLE OF CASPASE‐1 IN AMYOTROPHIC LATERAL SCLEROSIS {#sec2-333}
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### Molawi K., Meissner F., Zychlinsky A. {#sec3-333}

#### Max Planck Institute for Infection Biology, Berlin, Germany {#sec4-333}

Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerativedisease that can be caused by dominant mutations of Superoxide Dismutase 1 (SOD1). During disease pathogenesis the proinflammatory enzyme Caspase‐1 gets activated. Caspase‐1 serves an essential function in the initiation of inflammation by proteolytically maturing the cytokines Interleukin 1β and Interleukin 18 but can also induce apoptosis.

We demonstrate that Superoxide Dismutase 1 (SOD1) regulates Caspase‐1 activation. In SOD1‐deficient phagocytes, higher superoxide production decreased the cellular redox potential and specifically inhibited Caspase‐1 by reversible oxidation and glutathionylation.

In transgenic ALS mice expressing mutant human SOD1, pathological activation of Caspase‐1 accelerates disease progression suggesting Caspase‐1 activation in microglia. This effect is specifically mediated through the activation of IL‐1β and is independent of other functions of Caspase‐1.
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ALPHA A‐AND ALPHA B‐CRYSTALLIN, NEWLY IDENTIFIED INTERACTION PROTEINS OF PROTEASE‐ACTIVATED RECEPTOR‐2 (PAR‐2), PROTECT ASTROCYTES FROM CELL DEATH {#sec2-334}
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### Reiser G., Li R., Hanck T. {#sec3-334}

#### Otto‐von‐Guericke Universität, Magdeburg, Germany {#sec4-334}

Protease‐activated receptor‐2 (PAR‐2) is a G protein‐coupled receptor activated by trypsin and other trypsin‐like serine proteases. The widely expressed PAR‐2 is involved in inflammation response, but the physiological/pathological roles of PAR‐2 in the nervous system are still uncertain. In the present study, we report novel PAR‐2 interaction proteins, alphaA‐crystallin and alphaB‐crystallin. These 20 kDa proteins have been implicated in neurodegenerative diseases, like Alexander\'s disease, Creutzfeldt‐Jacob disease, Alzheimer\'s disease and Parkinson\'s disease. Results from yeast‐two‐hybrid assay using the cytoplasmic C‐tail of PAR‐2 as bait suggested that alphaA‐crystallin interacts with PAR‐2. We further demonstrate the in vitro and cellular in vivo interaction of C‐tail of PAR‐2 as well as of full‐length PAR‐2 with alphaA(alphaB)‐crystallins. We use pull‐down, co‐immunocipitation and co‐localization assays. Analysis of alphaA‐crystallin deletion mutants showed that amino acids 120‐130 and 136‐154 ofalphaA‐crystallin are required for the interaction with PAR‐2. Co‐immunoprecipitation experiments ruled out an interaction of alphaA(alphaB)‐crystallins with PAR‐1, PAR‐3 and PAR‐4. This demonstrates that alphaA(alphaB)‐crystallins are PAR‐2‐specific interaction proteins. Moreover, we investigated the functional role of PAR‐2 and alpha‐crystallins in astrocytes. Evidence is presented to show that PAR‐2 activation and increased expression of alpha‐crystallins reduced C2‐ceramide‐ and staurosporine‐induced cell death in astrocytes. Thus, both PAR‐2 and alpha‐crystallins are involved in cytoprotection in astrocytes.

 {#sec1-p-728}

CELL MIGRATION
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ROLE AND MECHANISMS OF REACTIVE ASTROCYTE\'S MIGRATION AFTER SPINAL CORD INJURY {#sec2-335}
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### Renault‐Mihara F., Mukaino M., Nakamura M., Toyama Y., Okano H. {#sec3-335}

#### Keio University School of Medicine, Tokyo, Japan {#sec4-335}

Our group recently reported that the limited locomotor recovery spontaneously occurring in the sub‐acute phase of spinal cord injury relies on Signal Transducer and Activator of Transcription 3 (STAT3) signaling in reactive astrocytes. During this phase astrocytes compact the lesion and seclude infiltrated inflammatory cells. Conditional ablation of STAT3 in reactive astrocytes allowed evidencing that STAT3 signaling is required for both in vivo compaction of lesion center and full in vitro astrocyte migration capabilities, thus strongly suggesting that migration of astrocytes, by compacting the lesion center and secluding inflammatory cells, contributes to protect the tissue.

Here we will present current results of ongoing research that aims at identifying 1/ the molecular effectors whereby STAT3 governs intrinsic migration of astrocytes 2/ the nature and origin of the signals that initiate and orientate this migration 3/ the role of this migration.

This research is supported by The Japanese Society for Promotion of Science.
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MICROGLIAL CHEMOTAXIS IS REGULATED BY THE PHAGOCYTE NADPH‐OXIDASE {#sec2-336}
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### Lelli A.,^1^ Cheret C.,^1^ Gervais A.,^1^ Colin C.,^1^ Krause K.H.,^2^ Mallat M.^1^ {#sec3-336}

#### ^1^INSERM UMR 975, UPMC, CRICM, Paris, France; ^2^Laboratoire de Biologie du vieillissement, Geneve, Switzerland {#sec4-336}

Microglia are resident CNS cells affiliated to mononuclear phagocytes. We recently found that microglia express not only Nox2, the catalytic subunit of the phagocyte oxidase, but also Nox1, and that both enzymes contribute to superoxide production in microglia (Cheret et al., J. Neurosci. 2008). CSF‐1 is a mitogenic and chemotactic cytokine produced in the CNS and which signals through binding to the fms tyrosine kinase receptor expressed by mononuclear phagocytes. Here we investigated whether Nox proteins might modulate CSF‐1‐chemotactic or mitogenic signaling in microglial cells purified from the cerebral cortex of one‐day old mice. Using a Boyden chamber assay, we found that CSF‐1‐triggered migration of wild type (WT) microglia was prevented when the cells were treated with pharmacological inhibitors of NADPH oxidases. Similar to WT cells, Nox1‐KO microglia responded to CSF‐1 gradient, whereas CSF‐1 did not stimulate migration of microglia purified from Nox2‐KO mice. In contrast, CSF‐1 treatment of growth arrested microglia triggered cell cycle entry in both WT and Nox2‐KO. These results indicate that Nox2 is required for fms chemotactic signaling but not for fms‐triggered mitogenic response. Our data suggest that Nox2 activity may contribute to migration of microglial cells during normal development or in pathological contexts.

Supported by INSERM, UPMC, Agence Nationale de la Recherche (ANR) and Federation de la Recherche sur le Cerveau (FRC)
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ROLE OF MEGALIN RECEPTOR IN THE BIOLOGY OF OLIGODENDROCYTE PRECURSORS: IMPLICATIONS IN DEMYELINATION {#sec2-337}
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### Ortega M.C.,^1^ Clemente D.,^1^ Cases O.,^2^ Kozyraki R.,^2^ de Castro F.^1^ {#sec3-337}

#### ^1^Grupo de Neurobiología del Desarrollo‐GNDe. Hospital Nacional de Parapléjicos, Toledo, Spain; ^2^Institut de la Vision, INSERM, U592., Paris, France {#sec4-337}

Megalin (also known as LRP‐2 or gp330) is a multiligand receptor involved in the development of the CNS (Willnow et al. 1996). The morphogen Sonic hedgehog (Shh) is one of the ligands that interacts with megalin (McCarthy et al. 2002). Indeed, the knock‐out for Megalin shows similar phenotype than the one for Shh, which suggests close related actions of both factors during development (McCarthy et al. 2002). Previous work of our laboratory demonstrates that the effects of Shh in the migration and proliferation of the oligodendrocyte precursor cells (OPCs) during development could not be exclusively mediated by Patched‐1, canonical receptor for Shh receptor (Merchán et al., 2007). In order to study the role of other receptors for Shh, like megalin, in the biology of OPCs, we have studied:athe spatial‐temporal expression (by immunocytochemistry and real time RT‐PCR) of megalin in the optic nerve at different embryonic stages (mouse E16.5 and E18.5);bstudy of the blockade of megalin (either with a neutralizing antibody of megalin or the LRPs antagonis RAP‐Receptor Associated Protein) in OPCs and its effects in migration and proliferation of these cells;cmegalin participates in the internalization of albumin in astrocytes (Bento‐Abreu et al. 2008), so we have tested the internalization of a Shh::GFP construction in primary cultures of astrocytes, as well as trace the intracellular route of Shh once internalized via megalin;deffect of previously internalized Shh (by astrocytes) in the migration and proliferation of OPCs;etime course of expression of the megalin in the EAE mice model.

Our results show that the blockade of megalin reverts the effects of Shh in migration and proliferation of the OPCs. This suggests a significant role of this receptor in the action of Shh in the biology of OPCs during development and in the pathogenesis of demyelination.

Supported by grants from the following Spanish institutions: Ministerio de Ciencia e Innovación (SAF2007‐65845), Consejería de Sanidad (ICS06024/00) and Consejería de Educación y Ciencia de Castilla‐La Mancha (PAI08‐0242‐3822), FISCAM (G2008‐C8) and Instituto de Salud Carlos III (RD07/0060). MCO is a predoctoral fellow from FISCAM (MOV‐2007_JI/20).
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ROLE OF HSP 25 IN THE REGULATION OF ASTROCYTE RESPONSE TO SPINAL CORD INJURY {#sec2-338}
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### El Mehdi D., Howard R.M., Rane M.J., Whittemore S.R., Gozal E. {#sec3-338}

#### University of Louisville, Louisville, United States {#sec4-338}

Astrocytes play an important role in spinal cord physiology, providing a vital environment to surrounding cells, preserving homeostasis and maintaining blood‐spinal cord barrier. After spinal cord injury (SCI), astrocytes are recruited to the site of injury and drastically alter their phenotype, upregulating intermediate filament proteins and growing thicker processes towards the injury site. These changes appear critical for limiting tissue damage and for the onset of recovery. However at later stages, glial scar formation may impair axonal elongation across the injured area. Therefore, understanding glial response to injury may be critical for interventional strategies to increase recovery. Heat Shock Protein 25 (HSP25), a chaperone protein induced in response to physiological and pathological injury, has multiple functions also playing a role in the regulation of cytoskeletal stability and actin polymerization. We investigated the role of HSP25 in astrocyte process extension, in vivo after moderate SCI in rats, and in vitro in a scratch injury model. HSP25 and phospho‐HSP25 expression were dramatically upregulated at 3 days post‐SCI around the injured site and along blood vessels in GFAPpositive astrocyte processes. HSP 25 and phospho‐HSP25 expression also increased along the scratch in an injury model of cultured rat astrocytes isolated from sham or injured SCI, co‐localizing with cytoskeletal proteins and in the processes extending through the scratch. Our data suggest that HSP25 accumulation in growth cones may limit their expansion while phospho‐HSP25 observed in end‐feet may promote a unidirectional process extension. In summary, HSP25 phosphorylation may act as a key regulator of astrocyte response after injury, directing the pattern of processes extension to seclude damaged area as well as to facilitate astroglial investment of affected vessels, thus providing rapid support to the injured area. Modulating HSP25 expression and phosphorylation in early after SCI may enhance process extension and provide novel therapeutic options to improve recovery.
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ACTIVATION OF THE NRF2 PATHWAY REDUCES TRANSENDOTHELIAL LEUKOCYTE MIGRATION {#sec2-339}
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### Van Horssen J., Drexhage J., de Vries H.E. {#sec3-339}

#### VU University Medical Center Amsterdam, Amsterdam, Netherlands {#sec4-339}

Reactive oxygen species (ROS) play a central role in various stages of multiple sclerosis (MS) lesion development. Long‐term exposure to ROS may induce adaptive responses in brain endothelial cells to counteract an oxidative attack. To identify these cellular adaptations, we studied the effect of ROS on gene and protein expression in brain endothelial cells. Using real‐time quantitative PCR and proteomic techniques we show that superoxide induces differential gene and protein expression in brain endothelium, including molecules involved in redox regulation, among which peroxiredoxin‐1 (Prx1). To further delineate the role of peroxiredoxin‐1in transendothelial monocyte migration, we established a brain endothelial cell line overexpressing peroxiredoxin‐1. Our data show that peroxiredoxin‐1 overexpression protects brain endothelial cells from ROS‐induced cell death and enhances the integrity of the brain endothelial layer. In addition, peroxiredoxin‐1 overexpression reduces adhesion and subsequent transendothelial migration by decreasing endothelial adhesion molecule expression. In parallel, we examined the distribution of antioxidant enzymes, including peroxiredoxin‐1 in control and MS brain tissue. In control sections antioxidant enzymes are expressed by glial cells, however in active demyelinating MS lesions we observed enhanced immunoreactivity in of antioxidant enzymes in hypertrophic astrocytes and myelin‐laden macrophages. Expression of these enzymes is regulated through a nuclear factor‐E2‐related factor (Nrf2), which upon oxidative stress locates to the nucleus, where it activates the antioxidant response element (ARE)‐mediated gene transcription. We examined the effects of Nrf2 activation on transendothelial monocyte migration and adhesion. We show that activation of Nrf2 increases the production of antioxidant enzymes in brain endothelial cells and astrocytes and reduces transendothelial monocyte migration. Our data shows that compounds that activate the Nrf2‐ARE pathway may be a promising therapy for the treatment of neuroinflammatory disorders like MS.
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MOLECULAR REQUERIMENTS OF MICROGLIAL MIGRATION IN ORGANOTYPIC CULTURES OF DEVELOPING QUAIL RETINA {#sec2-340}
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### Carrasco M.C., Navascues J., Martin‐Oliva D., Calvente R., Sierra A., Santos A.M., Ferrer‐Martin R.M., Cuadros M.A., Marin‐Teva J.L. {#sec3-340}

#### Dept. Cell Biology, Univ. Granada, Granada, Spain {#sec4-340}

Cell migration is commonly understood as the movement of individual cells that undergo polarized extension‐contraction cycles coupled with adhesion to and de‐adhesion from the surrounding substrate. Two distinct patterns of migration by mechanisms with different molecular requirements have been described in studies on cancer cell migration. Thus, some cancer cells migrate by a mechanism called mesenchymal migration, which is dependent on matrix‐metalloproteinases (MMPs), tyrosine kinase Src, intracellular protease calpain and integrins but is independent of Rho‐associated kinase (ROCK). Other cells migrate by an alternative mechanism known as ameboid migration, which is dependent on ROCK and independent of MMPs, Src kinase, calpain and integrins. The aim of this study was to analyze whether the mode of migration of microglial cells in developing quail retina resembles the mesenchymal or the ameboid mechanism described in cancer cells. To investigate this issue, we have taken advantage of a new experimental model developed by our group based on organotypic cultures of quail embryo retina (OCQERs). We have previously shown that microglial cells migrate in OCQERs following a pattern similar to that described in the embryonic retina in situ. In the present study, we used OCQERs obtained from embryos at 7 days of incubation, a developmental stage in which microglial migration begins in the central retina. These OCQERs were treated with selective inhibitors of different molecules involved in either mesenchymal or ameboid migration. The inhibitors tested were a broad‐spectrum MMP‐inhibitor (20 μM GM6001) and selective inhibitors of Src kinase (20 μM PP2), ROCK (20 μM Y‐23632) and calpain (10 μM ALLN). A β1‐integrin blocking antibody (JG22 monoclonal antibody) was also tested. This molecular screening showed that microglial cells in the developing retina migrate by a mechanism that has molecular requirements similar to the mesenchymal migration described in tumour cells.

Supported by Grant BFU2007‐61659 from the Spanish Ministry of Science and Innovation.
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INHIBITORY EFFECTS OF OREXIN A ON ATP‐INDUCED MICROGLIAL MIGRATION {#sec2-341}
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### Okuno Y.,^1^ Ifuku M.,^2^ Katafuchi T.,^2^ Noda M.^1^ {#sec3-341}

#### ^1^Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; ^2^Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan {#sec4-341}

The neuropeptides orexin A and orexin B, produced in hypothalamic neurons, are crucial regulator of sleep and wakefulness. Orexins have two types of receptor; OX1R and OX2R. While orexin A has equal affinity at OX1R and OX2R, orexin B has approximately 10‐fold greater affinity to OX2R. They are widely distributed in the central nervous system. Microglia, the immunocompetent cells that activated and migrate to areas of brain injury, express orexin receptors. However the function of orexins in microglia is poorly understood. In the present study, we found that orexin A, but not orexin B, suppressed migration of mouse cultured microglia to adenosine triphosphate (ATP) using time lapse video microscopy system and Boyden chamber. Inhibitory effect of orexin A on ATP‐induced microglial migration was reversed by OX1R antagonist. We also explored the role of orexin A in the regulation of intracellular cAMP. Pre‐treatment of the cells with dibutyryl cyclic AMP (dbcAMP), membrane permeable cAMP, partially mimicked microglial migration. Conversely, inhibition of ATP‐induced microglial migration by orexinA was partially prevented by RpcAMP, a membrane permeable cAMP antagonist, suggesting that orexin A regulate the function of microglial migration via cAMP‐dependent mechanism. Our results may help to understand the novel physiological functions of orexin A and the importance of interplay between orexin A and microglia in brain injury.
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FUNCTIONAL IMPORTANCE OF INOSITOL‐1,4,5‐TRIPHOSPHATE (IP~3~)‐INDUCED INTRACELLULAR CA^2+^ MOBILIZATION FOR GALANIN (GAL)‐INDUCED MICROGLIAL MIGRATION {#sec2-342}
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### Ifuku M.,^1^ Okuno Y.,^2^ Izumi K.,^2^ Katafuchi T.,^3^ Noda M.^2^ {#sec3-342}

#### ^1^Institute of Rheological Function of Food Co., Ltd, Fukuoka, Japan; ^2^Kyushu University Graduate School of Pharmaceutical Science, Fukuoka, Japan; ^3^Kyushu University Graduate School of Medical Science, Fukuoka, Japan {#sec4-342}

Galanin (GAL) is 29/30‐amino‐acid neuropeptide and is up‐regulated following neuronal axotomy or inflammation, therefore may affect the brain immune system. GAL has three types of receptors; GalR1, GalR2 and GalR3. They are widely distributed in the central and peripheral nervous system. Activation of GalR1 and GalR3 couples to inhibition of adenylyl cyclase, while activation of GalR2 primarily couples to activation of phospholipase C and formation of inositol‐1,4,5‐triphosphate (IP~3~). It was reported that rat cultured microglia express mRNA for GalR2 but not for GalR1 and GalR3. However the function of GalR2 in microglia is poorly understood. In the present study, we investigated the effect of GAL on microglial migration and compared the mechanism with that of bradykinin (BK)‐induced migration. GAL significantly increased motility and chemotaxis of rat cultured microglia at the lowest concentration we used (100 pM). The signal cascade of GAL‐induced microglial migration was analyzed pharmacologically, which was partially similar to that induced by BK. It was not dependent on G~i/o~ protein but induced by activation of protein kinase C (PKC), phosphoinositide 3‐kinase (PI3K) and Ca^2+^‐dependent K^+^ currents (I~K(ca)~). However, activation of reverse‐mode of Na^+^‐Ca^2+^‐exchanger (NCX1) was not involved in GAL‐induced microglial migration, unlike in BK‐induced microglial migration. Microglial migration induced by GALP, a GalR2 agonist, was not affected by SN‐6, a specific inhibitor of NCX in reverse mode, while BK‐induced migration was completely blocked by SN‐6. Likewise, nominally free extracellular Ca^2+^ inhibited BK‐induced migration but not GALP‐induced microglial motility. Therefore, we tested if intracellular Ca^2+^ mobilization was involved in GALP‐induced microglial motility. Xestospongin C, an IP~3~receptor antagonist, significantly inhibited GAL‐induced microglial motility. These results indicated that activation of IP3 receptor and increase in intracellular Ca^2+^ were important for GALP‐induced microglial motility. The differences in down‐stream of signal transduction induced by GAL and BK may suggest that GAL and BK control distinct microglial functions in pathological conditions such as lesion and inflammations.
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EFFECTS OF NEUROTROPHINS ON NEURAL CREST AND SCHWANN CELL MIGRATION {#sec2-343}
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### de Bellard M.E.,^1^ Waldheim C.,^1^ Kim L.,^1^ Walker J.,^1^ Ollison L.,^1^ Bronner‐Fraser M.^2^ {#sec3-343}

#### ^1^Csun, Northridge, United States; ^2^Caltech, Pasadena, United States {#sec4-343}

The neural crest is a migratory population of cells that gives rise to a wide range of cell types in the peripheral nervous system of vertebrate embryos. It has been shown that neural crest cells migrate along very specific pathways throughout the embryo. The reason for such specificity is not fully known. During the last years, some known axon pathfinding repellants (ephrinB2, SemaIIIa, Slit2, etc) have been shown to repel neural crest cells as well during their migration through the somites. However, we know very little about the migratory clues that guide the neural crest for the rest of their path. The goal of this study was to find which other molecules are capable of guiding the neural crest. For this purpose we had set out to screen a group of neurotrophic factors that are expressed at the same time that the crest is migrating through the embryo. Our aim was to look at the effect of neurotrophins on neural crest migration and Schwann cell precursors. Experiments by live imaging in special chambers suggest that: a) neural crest cells are attracted to glia derived neurotrophic factor (GDNF) and Heregulinβ1; and b) that Schwann cell precursors increase their speed in the presence of GDNF, NGF, Heregulinβ1 and Macrophage inhibitory factor (MIF). These preliminary data suggests that neural crest and Schwann cells use a variety of neurotrophic factors as guiding clues during their extensive migration in the embryo.

This work was supported by a grant from NIH 5 R01 HD15527‐15, an NIH SCORE grant 2‐SO6‐GM048680‐12A1 and a NMSS fellowship to MEdB FA1383‐A‐1.
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INHIBITION OF 9‐O‐ACETYL GD3‐MEDIATED NEURONAL MIGRATION BY JONES ANTIBODY REDUCES SPONTANEOUS CALCIUM OSCILLATIONS AND LEADS TO P2Y1 RECEPTOR INTERNALIZATION {#sec2-344}
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### Santiago M.F.,^1^ Scemes E.^2^ {#sec3-344}

#### ^1^Dominick P. Purpura Department of Neurosciencce, Albert Einstein College of Medicine, Bronx, USA and Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; ^2^Dominick P. Purpura Department of Neurosciencce, Albert Einstein College of Medicine, Bronx, United States {#sec4-344}

During development, cerebellar granule cells migrate from the external to the internal granular layer guided by radial glial cells. Distinct mechanisms have been implicated in this directional movement, including those involving the ganglioside 9‐O‐acetyl GD3 (9OGD3), which is recognized by the Jones antibody. We have previously demonstrated that binding of Jones to 9OGD3 plays an important role in the gliophilic migration of neuroblasts in vivo. Because, P2Y1 receptors (P2Y1Rs) and Ca2+ signals have also been implicated in the migration process, we evaluated whether such a mechanism was involved in Jones immunoblockade of cell migration. For that, we evaluated the effects of Jones treatement on intracellular Ca2+ signals of Fluo‐3‐AM loaded neuroblasts derived from post‐natal day 6 (P6) cerebellar explants. Our results indicate that neuroblast spontaneous Ca2+ oscillations were greatly reduced in cultures treated with Jones antibody. Blockade of P2Y1R with the specific antagonist MRS2179 caused similar reduction in Ca2+ oscillations as seen with Jones antibody. Immunocytochemistry revealed the presence of 9OGD3 and P2Y1R in virtually all migrating neuroblasts, and pharmacological studies confirmed the presence of functional P2Y1Rs. Migration distances of P6 cerebellar neuroblasts derived from GD3S‐/‐ mice was significantly reduced compared to those of wild‐type (WT) cells and treatment with Jones antibody, MRS2179 or with neuraminidase did not promote further decrease in migration distances of GD3S‐/‐ cells. Thus, these results strongly suggest that neuronal migration is directly dependent on 9OGD3 which may in turn affects purinergic signaling. In this regard, differently from WT neuroblasts treated for 30 min with Jones, neuroblasts treated for 48 hrs did not respond with increase in cytosolic Ca2+ following bath application of the P2Y1 agonist 2MeSADP. This reduction in purinergic receptor responsiveness was paralleled by P2Y1R internalization, as indicated from experiments performed on P2Y1R‐eGFP transfected P6 cerebellar explants. Taken together, our studies suggest that interference with granular cell migration through 9OGD3 signaling leads to reduced spontaneous Ca2+ oscillation and to P2Y1R internalization.

NIH NS052245.
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CCL2‐DRIVEN MONOCYTES REGULATE MIGRATION THROUGH THE GLIA LIMITANS DURING ACUTE VIRAL ENCEPHALITIS {#sec2-345}
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### Savarin C., Ransohoff R., Stohlman S., Bergmann C. {#sec3-345}

#### Cleveland Clinic Foundation, Department of Neuroscience NC‐30, Cleveland, United States {#sec4-345}

Infection of the central nervous system (CNS) with a sublethal neurotropic coronavirus (JHMV) provides a murine model to study both virus‐induced encephalitis and immune mediated demyelination. Despite a prominent influx of monocytes to the CNS, their contribution to virus induced pathogenesis remains unclear. Depletion of both neutrophils and monocytes by the anti‐Gr1 antibody (RB6‐8C5) significantly reduced blood brain barrier (BBB) permeability and correlated with an absence of matrix metalloproteinase‐9 (MMP9) activity. These data suggested a potential role of neutrophils and monocytes in BBB disruption by MMP9 release. CCL2 deficient (CCL2‐/‐) mice were infected to specifically assess the contribution of monocytes in BBB breakdown and facilitating T cell access to the parenchyma. Infected CCL2‐/‐ mice showed a delay in clinical disease compared to wt mice, which correlated with a significant decrease of CNS leukocyte infiltration at early time points. This decrease was mainly due to very limited F4/80+ monocyte accumulation, confirming CCL2 as a potent monocyte attractant. Nevertheless, CNS recruitment of CD4 and CD8 T cells in CCL2‐/‐ mice was similar to wt mice, demonstrating that neither CCL2 nor monocytes are essential for CNS T cell infiltration. Surprisingly, control of virus replication was delayed in mice lacking CCL2 compared to wt mice despite similar T cell recruitment. This delay correlated with retention of leukocytes in the perivascular space at day 5 p.i., implicating monocytes in regulating migration through the glia limitans. Furthermore, no difference in MMPs expression in CCL2‐/‐ mice compared to controls suggested a novel MMP independent role of monocytes in enhancing migration through the glia limitans during acute viral encephalitis.

 {#sec1-p-753}
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FATTY ACID 2‐HYDROXYLASE DEFICIENT MICE: AN ANIMAL MODEL FOR A NEW LEUKODYSTROPHY WITH SPASTIC PARAPARESIS {#sec2-346}
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### Eckhardt M., Meixner M., Meier H., Gieselmann V., Hartmann D. {#sec3-346}

#### University of Bonn, Bonn, Germany {#sec4-346}

Sphingolipids containing 2‐hydroxylated acyl residues constitute a major fraction of myelin lipids. 2‐Hydroxylation of fatty acids is catalyzed by a fatty acid 2‐hydroxylase (FA2H). FA2H deficient mice have been generated and confirmed the essential role of FA2H in synthesis of 2‐hydroxylated sphingolipid in the nervous system. Interestingly, analysis of these mice also demonstrated that FA2H is not responsible in all tissues for synthesis of 2‐hydroxylated sphingolipids. Myelin structure appear normal in these mice, and no signs of hypomyelination or demyelination were observed in young (5‐month‐old) mice. However, 18‐month‐old mice displayed scattered axonal and myelin degeneration in the spinal cord and peripheral nerves. Myelin sheaths in the spinal cord exhibited signs of decompaction with accumulation of undefined material with. Our data suggest that 2‐hydroxylated sphingolipids are dispensable for compact myelin formation, but play an important role in long‐term myelin maintenance and possibly axon‐glial signalling. This conclusion is further supported by the recent identification of mutations in the human FA2H gene associated with a new leukodystrophy with spastic paraparesis \[SPG35; Edvardson et al. (2008) Am. J. Hum. Genet. 83:643‐648\]. We examined FA2H activity of a described mutant FA2H enzyme found in patients (amino acid exchange D35Y) and could show that this mutant exhibit residual activity, which might explain the milder phenotype of the affected individuals, when compared to patients with a splice‐site mutation causing deletion of a major part of the catalytic domain of the enzyme. The suitability of the FA2H knock‐out mouse as an animal model of SPG35 will be discussed.
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MYELIN ALTERATIONS IN ABSENCE OF LYSOPHOSPHATIDIC ACID RECEPTOR LPA1 {#sec2-347}
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### Estivill‐Torrús G.,^1^ García‐Diaz B.,^1^ Matas‐Rico E.,^1^ Gómez‐Conde A.I.,^1^ Riquelme R.,^2^ Varela‐Nieto I.,^2^ Jiménez A.J.,^3^ Leyva L.,^1^ Fernández O.,^4^ Chun J.,^5^ Rodríguez de Fonseca F.^1^ {#sec3-347}

#### ^1^Fundación IMABIS, Hospital Carlos Haya, Málaga, Spain; ^2^Instituto de Investigaciones Biomédicas Alberto Sols (CSIC‐UAM), Madrid, Spain; ^3^Dept. de Biología Celular, Genética y Fisiología, Universidad de Málaga, Málaga, Spain; ^4^Instituto de Neurociencias Clínicas, Hospital Carlos Haya, Málaga, Spain; ^5^Dept. of Molecular Biology, Helen L. Dorris Child and Adolescent Neuropsychiatric Disorder Institute, The Scripps Research Institute, la Jolla, CA, United States {#sec4-347}

The lysophosphatidic acid (LPA) is an endogenous phospholipid acting in multiple processes through specific G‐protein coupled receptors (LPA1‐5). Its signalling pathway is present in the CNS by way of, mostly, LPA1 receptor. Our research group has demonstrated that viable Málaga variant maLPA1‐null mice developed in our laboratory, lacking the LPA1 receptor, exhibit neural precursor reduction and altered differentiation during both cortical development and hippocampal and SVZ adult neurogenesis. Because of the identified influence of LPA in the differentiation of myelinating cells, the maLPA1‐null mouse characterization has been extended to myelinating glia, specifically expressing LPA1 in corresponding way to myelination processes. Thus maLPA1‐null mouse comes out in a new highly attractive model for the study of demyelinating diseases. In absence of LPA1 animals show cortical myelin deficit, mainly observed from the reduced expression of cortical both myelin basic (MBP) and proteolipid (PLP) proteins using immunohistochemistry and western‐blot. The alteration in myelin was also confirmed by electron microscopy, displaying jumbled and spaced myelin fibres, and magnetic resonance spectroscopy, this last showing anomalous choline patterning. In addition, stereological analysis of oligodendrocytes showed a significant myelinating cell reduction when LPA1 lacked. As a possible mechanism involving the oligodendrocyte survival we demonstrated alteration in the intracellular transport of PLP myelin protein that showed intracellular accretion of the protein to the detriment of its membrane emplacement. The present results demonstrate that the absence of LPA1 generates not only a reduction of the number of oligodendrocytes but also a defective production of myelin as well.

The research has been granted by Regional Ministry of Health (SAS, exp.0013/06, 0232/2007 and 0187/2008) and Regional Ministry of Innovation, Science and Enterprise (Research Groups CTS433; CTS 507).
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THE ROLE OF INTEGRIN‐LINKED KINASE IN OLIGODENDROCYTE DEVELOPMENT {#sec2-348}
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### O\'Meara R.,^1^ Michalski J.P.,^1^ Kothary R.^2^ {#sec3-348}

#### ^1^Ottawa Health Research Institute, Ottawa, Canada; ^2^Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada {#sec4-348}

Oligodendrocytes are responsible for the generation of myelin in the central nervous system. Myelin formation involves interactions between the extracellular matrix (ECM) and the β1‐integrin signaling pathway within oligodendrocytes. Integrin‐Linked Kinase (ILK) is associated with the C‐terminus of the β1‐integrin receptor. Recent work suggests that ILK is involved in the stabilization of focal adhesions and transduction of signals received from the ECM via the integrins. The current study will determine the function of ILK in immortalized and primary murine oligodendrocytes. A protein expression profile of the OLI‐neu cell line was evaluated to determine the developmental time period through which these cells progress. Primary oligodendrocytes were isolated from P0‐P2 Ilkfl/fl mice and administered a recombinant TAT‐Cre fusion protein to induce recombination between loxP sites flanking the exons coding for the ILK kinase domain. It was determined that OLI‐neu cells proliferate as oligodendrocyte progenitors, expressing markers such as PDGFRα and NG2. Upon differentiation, OLI‐neu cells begin to express mature markers such as MAG and CNPase. In primary cultures, isolated oligodendrocytes were immuno‐positive for a variety of oligodendrocyte‐specific markers such as PDGFRα, NG2, CNPase, MAG, MBP and O4. The administration of TAT‐Cre fusion protein resulted in the excision of the region between exons 5 and 13 of the Ilk gene. Future work will determine whether the developmental time course of OLI‐neu and primary oligodendrocytes is altered when ILK is perturbed. In OLI‐neu cells, siRNA will be used to knockdown ILK. As well, other factors such as process extension, and changes to focal adhesions will be evaluated. The results of this study will allow for a better understanding of key players involved in the development of oligodendrocytes.

This work was supported by the Multiple Sclerosis Society of Canada.
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A CMT1A MOUSE MODEL WITH 3 TO 4 COPIES OF PMP22 {#sec2-349}
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### Hantke J.,^1^ Wilton D.,^1^ Latouche M.,^1^ Baas F.,^2^ Mirsky R.,^1^ Jessen K.R.^1^ {#sec3-349}

#### ^1^University College London, London, United Kingdom; ^2^Academic Medical Center, Amsterdam, Netherlands {#sec4-349}

Charcot‐Marie‐Tooth disease 1A (CMT1A) is a demyelinating neuropathy due to mutations in the peripheral myelin protein 22 (PMP22). Over 70% of CMT1A patients carry a duplication of the PMP22 gene, which is inherited autosomal dominant with age‐dependent penetrance and variable expressivity but is also frequently found de novo.

Animal models of CMT1A include a rat model with 3 copies of PMP22 and mouse models with 4 (C61 mouse) and 7‐8 copies (C22). Here we report analysis of a novel mouse model called C3 (or amC22) that has 3‐4 copies of PMP22 and originated as a clinically distinct subgroup of the C22 mouse model generated by spontaneous rearrangement of the human transgene.

Behavioural testing included both motor (hanging wire test, rotarod, grid walking, beam walking and foot print analysis) and sensory (Hargreave\'s) tests and was performed in several age groups starting with 1.5 months. Significant differences between wildtype and mutant mice where detected by several tests even in the youngest age group. Examination of nerve pathology revealed marked differences in the degree of demyelination between different types of nerves, with some being almost normal, while others are strikingly affected.

Furthermore, we investigate the role of c‐Jun in the pathology of CMT1A. c‐Jun is highly expressed by immature Schwann cells but down‐regulated in normal adult nerves. In injured nerves Schwann cell c‐Jun is neuro‐protective, and required for Schwann cell dedifferentiation. We find that the level of c‐Jun protein is increased in sciatic nerves of the C3 mouse while Krox20 protein expression is reduced.

Compared to the severe C22 mouse model, the C3 mouse model shows a milder phenotype and may be more representative of the less severe part the human spectrum of CMT1A.
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INFLAMMATORY ACTION AND ADHESIVE PROPERTIES OF MYELIN BASIC PROTEIN PEPTIDE 45‐89 {#sec2-350}
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### Shanshiashvili L.,^1^ Shatirishvili M.,^2^ Kalandadze I.,^3^ Surmava A.,^3^ Ramsden J.,^4^ Mikeladze D.^1^ {#sec3-350}

#### ^1^I.Chavchavadze State University, I.Beritashvili Institute of Physiology, Tbilisi, Georgia; ^2^I.Chavchavadze State University, Tbilisi, Georgia; ^3^I.Beritashvili Institute of Physiology, Tbilisi, Georgia; ^4^Collegium Basilea, Basel, Switzerland {#sec4-350}

Several peptide fragments of myelin basic protein (MBP) are produced in the brain during demyelinating diseases. These small fragments of MBP can trigger either proliferation or damage of glial cells. We have found that continuous (24 h) exposure of mixed oligodendrocyte/microglial cells to peptides 45‐89 derived from citrullinated MBP‐C8 isoforms induces cell death. In contrast, MBP‐C8 at the same molecular concentration is not toxic to oligodendrocyte/microglial cells as detected by the MTT test and trypan blue exclusion method. The loss of oligodendrocyte/microglial cells resulted in the release of cytochrome c from mitochondria, suggesting MBP 45‐89‐induced apoptosis. On the other hand, peptides 45‐89 stimulated the secretion of nitric oxide from microglial cells only via induction of iNOS. The addition of peptide 45‐89 to the microglial cells led to a decrease of the level of the inhibitory protein -- IkB, indicating that activation of the transcription factor NF‐kB is involved in these procesess. We also studied the association of peptides 45‐89 derived from citrullinated MBP‐C8 isoform with the lipid part of the myelin membrane at the microscopic level in a model membrane system using optical waveguide lightmode spectrometry. It was observed low adsorption properties for citrullinated peptide as compared with non‐citrullinated one.

We propose that citrullination (i.e. deimination arginine residues) of myelin basic protein lead to abnormal formation of myelin membranes and peptide fragments. The citrullinated peptide 45‐89 released from modified deiminated MBP activates microglial cells and subsequent generation of nitric oxide induces damage of oligodendrocytes that may be a first step in the initiation of demyelinating disorders.
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AN EPITHELIAL‐LIKE CELL POLARITY IN MYELINATING SCHWANN CELLS {#sec2-351}
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### Tricaud N., Oezcelik M., Suter U. {#sec3-351}

#### Swiss Federal Institute of Technology Zürich, Zürich, Switzerland {#sec4-351}

The myelinating Schwann cell is the myelin‐forming cell of the peripheral nervous system. It is a highly differentiated cell that presents different subdomains, suggesting that this struc tural organization requires a polarization process. We have used the epithelial cell as a model of cell polarization to characterize myelinating Schwann cells polarity. We show that the Schwann cell is formed by two clearly separated domains that contain markers of the basolateral and apical domains of the epithelial cell. So it is likely that similar polarization processes occur in both cell types to build the differentiated cell structure and organization.
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MAMMALIAN DISC‐LARGE 1 REGULATES SCHWANN CELL MYELINATION AND MYELIN SHEATH THICKNESS {#sec2-352}
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### Tricaud N.,^1^ Oezcelik M.,^1^ Jacob C.,^1^ Pereira J.,^1^ Baumann R.,^1^ Cotter L.,^1^ Relvas J.,^2^ Suter U.^1^ {#sec3-352}

#### ^1^Swiss Federal Institute of Technology Zürich, Zürich, Switzerland; ^2^IBMC‐Instituto de Biologia Molecular e Celular, Universidade de Porto, Porto, Portugal {#sec4-352}

In order to maximize conduction velocity, axons are myelinated and the thickness and length of the myelin sheath are carefully adjusted to the axon diameter. In the peripheral nervous system, axons express neuregulin‐1 that stimulates myelination through a glial pathway and a cascade known to lead to AKT activation. Intriguingly neuregulin levels remain high even when the right myelin thickness is reached. The mechanism that allows myelinating Schwann cells to control the stimulation mediated by axons still remains elusive. We show here that the silencing of the cell polarity protein dlg1 in myelinating Schwann cells increases myelin sheath thickness, indicating that dlg1 acts as a repressor of myelination. Indeed dlg1 overexpression prevents Schwann myelination in the sciatic nerve in vivo. As dlg1 also inhibits AKT activation in vivo and in vitro, these results suggest that dlg1 regulates AKT activation in Schwann cells to modulate the axonal stimulation of myelination.
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A ROLE FOR INTEGRIN‐LINKED KINASE IN OLIGODENDROCYTE MEDIATED MYELINATION OF THE CENTRAL NERVOUS SYSTEM {#sec2-353}
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### Michalski J.P., O\'Meara R., Anderson C., Kothary R. {#sec3-353}

#### OHRI, Ottawa, Canada {#sec4-353}

Recent studies have shown integrin‐linked kinase (ILK) to be a major structural binding partner of β1 integrin, an essential component of oligodendrocyte (OL) myelin sheet formation in the central nervous system (CNS). To study the role of ILK in CNS myelination *in vivo* and avoid embryonic lethality associated with ILK deletion, we have created conditional knockout mouse models employing the Cre‐loxP system. Using the Cre recombinase model, recombination of floxed *Ilk*can be controlled spatially and temporally. In the present study, the *Cre*gene is under the control of either the proteolipid protein (*Plp*) promoter or the NG2 promoter, allowing for expression in mature OLs and OL precursor cells, respectively. The Cre recombinase is fused with a mutant estrogen receptor (CreER^T^) which can only enter the nucleus upon activation by tamoxifen and not estradiol. Injection of tamoxifen is required for translocation of Cre into the nucleus and for the excision of the floxed *Ilk* gene.

Initially, we have assessed for expression of Cre in CNS tissues, specifically in the OL lineages, and have determined the efficiency of *Ilk* excision. Staining of CNS tissues with fluoromyelin and MBP show myelin loss specific to the optic nerve of P16 and P4 *Ilk* ^*fl/fl*^;PLP‐CreER^*T*^ tamoxifen injected mice. To begin addressing the question of why there is a loss of myelin marker signal in the optic nerve of P4 mice, total number of mature OLs were counted. No significant difference was observed between *Ilk* ^*fl/fl*^;*PLP‐CreER* ^*T*^ and wild type littermates The deficiency in myelin staining may be related to an inability of the OLs to elaborate processes and properly form myelin membranes, suggesting that ILK may be essential for the early steps in OL‐mediated myelination. Future work is directed towards identifying downstream signalling pathways that are perturbed in the ILK‐deficient OLs.

*Work supported by the MS Society of Canada.*
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CONTROL OF OLIGODENDROCYTE DEVELOPMENT AND MYELINATION BY NEUROTRANSMITTERS IN DEVELOPING NEOCORTICAL SLICES FROM SOX10‐GFP MICE {#sec2-354}
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### Hamilton N., Kessaris N., Richardson W.D., Attwell D. {#sec3-354}

#### University College London, London, United Kingdom {#sec4-354}

Myelination is essential for normal CNS function. Neurotransmitters, released from axons or astrocytes (Stevens et al., 2002; Kukley et al., 2007; Ziskin et al., 2007), have been suggested to influence the proliferation of oligodendrocyte precursors (OPCs) and their subsequent development.

We investigated the control of myelination by neurotransmitters using organotypic cultured neocortical slices from P8 mice in which oligodendrocyte lineage cells express GFP driven by the Sox10 promotor. The difference between the proliferation and death rates of oligodendrocyte lineage cells was assessed from the number of GFP labelled cells present. Myelination was quantified as the ratio of myelin basic protein labelling (using an antibody conjugated to a red fluorophore) to labelling of neurons for neurofilament (using an antibody conjugated to a blue fluorophore). On the day of culturing, no MBP labelling was present. Three days later, a few differentiated MBP‐positive oligodendrocytes were visible, and the intensity of labelling increased rapidly over the following 2 weeks as myelin wrapped around axons. Myelinated axons were visible, running transversely in layers IV‐V of the cortex (the Baillarger bands, corresponding to the line of Gennari in striate cortex), and running vertically through layers I‐III and V‐VI.

Block of GABAA receptors from day 3 to day 14 in culture led to a more than 2‐fold increase in the number of oligodendrocyte lineage cells present and a smaller increase in myelin basic protein, with no change in neurofilament labelling. These data suggest that release of GABA onto OPCs from interneuron axons (Lin & Bergles, 2004; Karadottir et al., 2008) may serve to suppress oligodendrocyte proliferation.

Supported by the Wellcome Trust.
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HISTONE DEACETYLASES 1 AND 2 ARE MASTER REGULATORS OF SCHWANN CELL BIOLOGY {#sec2-355}
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### Jacob C.,^1^ Pereira J.,^1^ Christen C.N.,^1^ Loetscher P.,^1^ Oeçelik M.,^1^ Tricaud N.,^1^ Yamaguchi T.,^2^ Matthias P.,^2^ Suter U.^1^ {#sec3-355}

#### ^1^ETH Zurich, Zurich, Switzerland; ^2^Friedrich Miescher Institute, Basel, Switzerland {#sec4-355}

Schwann cells are the myelinating glial cells of the PNS. At birth, mouse sciatic nerves mature in 2 subsequent phases: 1/ big caliber axons get sorted into a 1 to 1 relationship with Schwann cells, 2/ Schwann cells build a myelin sheath around sorted axons.

In mice where Histone Deacetylases (HDAC) 1 & 2 have been specifically knocked out in Schwann cells, both phases are impaired.

While many big caliber axons are already sorted in a 1 to 1 relashionship with Schwann cells and myelinated in postnatal day (P) 5 wild type control sciatic nerves, in knock‐out nerves most big caliber axons are still organized in bundles or are in 1 to 2 or 1 to 3 relationships with Schwann cells. Although a few axons get successfully sorted, Schwann cell processes wrapped around those are discontinuous. In these animals, only very few Schwann cells manage to built a myelin sheath.

At P10, all mutant Schwann cells are getting encircled and phagocytosed by surrounding fibroblasts to be completely cleared off the nerve by P16. At this end stage where most animals die, no Schwann cell and no perineurial fibroblast are anymore present; instead, we observe a massive invasion of perineurial fibroblasts fasciculating large bundles of naked axons, possibly in attempt to maintain the structure of the nerve.

Animals lacking only HDAC1 or HDAC2 in Schwann cells survive and display no obvious phenotype. In the sciatic nerve of these animals, the HDAC which has not been knocked out is strongly up‐regulated, supporting the hypothesis of compensatory mechanisms.

In Schwann cell cultures, specific knock‐down of a single HDAC without significant up‐regulation of the other HDAC can be achieved by short term use of lentiviral vectors carrying a specific shRNA. Down‐regulation of HDAC1 markedly promotes apoptosis, whereas knock‐down of HDAC2 increases proliferation and prevents the expression of some differentiation markers.

Our study reveals a critical function of HDAC1 and HDAC2 in the differentiation and survival of Schwann cells, and suggests some specific functions of each HDAC, which can be compensated when HDAC1 or HDAC2 are absent. We are currently analyzing the molecular mechanisms of action responsible for these functions.
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SCHWANN CELLS POSESS AN AGE DEPENDENT ABILITY TO PHAGOCYTE MYELIN {#sec2-356}
-----------------------------------------------------------------

### Wicher G.,^1^ Atterby C.,^1^ Jessen K.,^2^ Fex‐Svenningsen A.^3^ {#sec3-356}

#### ^1^Uppsala University, Uppsala, Sweden; ^2^University College London, London, United Kingdom; ^3^Institute of Medical Biology ‐ Anatomy and Neurobiology, Odense, Denmark {#sec4-356}

Phagocytosis by endogenous cells and by macrophages that migrate from blood vessels plays a major role in the clearance of myelin debris and further nerve regeneration in the peripheral nervous system. We have investigated the phagocytotic ability of Schwann cells and found that these cells have the ability to transform to a phagic phenotype actively involved in myelin debris clearance long before the resident and blood borne macrophages have time to act. The phenotype of phagocyting Schwann cells were analyzed by variety of biochemical markers, "specific" for macrophages involved in uptake as well as break down of myelin. In order to delineate, if the cell maturation is necessary for the cells to demonstrate a macrophage‐like phenotype we used several developmental stages of Schwann cells (P1‐adult). A quantitative analysis using a phagocytotic assay, showed age dependent differences in Schwann cell phagic ability. These findings suggest that Schwann cell phagocytosis play crucial role in myelin debris clearance after injury at peripheral nerve and that the phagic activity of the Schwann cells is age dependent.
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DEVELOPMENT AND CHARACTERIZATION OF A MOUSE MODEL OF CHARCOT‐MARIE‐TOOTH DISEASE 4C {#sec2-357}
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### Arnaud E.,^1^ Zenker J.,^1^ de Preux Charles A.S.,^1^ Stendel C.,^2^ Medard J.J.,^1^ Tricaud N.,^2^ Suter U.,^2^ Senderek J.,^2^ Chrast R.^1^ {#sec3-357}

#### ^1^UNIL, Lausanne, Switzerland; ^2^ETH, Zurich, Switzerland {#sec4-357}

Charcot‐Marie‐Tooth disease (CMT4C, OMIM \#601596) is a rare form of autosomal recessive demyelinating neuropathy with an early onset. The clinical manifestations include delayed age of walking, distal weakness, muscle atrophy, reduced nerve conduction velocity and are often associated with progressive scoliosis. Histologically, thin myelin, "giant axons", basal lamina "onion bulb" formation and extended Schwann cell processes are observed on a nerve biopsy. The gene mutated in CMT4C disease, KIAA1985/SH3TC2 was recently identified (Senderek et al, 2003) however the function of the protein it encodes remains unknown.

In order to obtain an insight into the role of SH3TC2 we have decided to characterize the function of its mouse orthologue, Sh3tc2. We have generated knockout mice where we have replaced the first exon of the Sh3tc2 gene with an eGFP cassette. The homozygous Sh3tc2‐/‐ animals develop peripheral neuropathy manifested by decreased motor and sensory nerve conduction velocity and decreased myelin thickness. Transcriptional analysis performed on the endoneurial compartment of developing peripheral nerve isolated from control and Sh3tc2‐/‐ animals revealed a concordant decrease in expression of transcripts encoding myelin proteins and enzymes involved in cholesterol biosynthesis, thus confirming the presence of peripheral neuropathy in the knockout animals. Interestingly, the Gene Ontology based annotation of transcripts varying in the level of expression at least 2‐fold between control and mutant samples revealed changes especially in transcripts encoding genes involved in cell adhesion. We have therefore analyzed in detail the structure of single myelinated fibers of Sh3tc2‐/‐ mice and demonstrated the presence of wider Nodes of Ranvier in the knockout as compared with control littermates.

The successful creation of an animal model of CMT4C disease thus allowed us to study in detail the role of Sh3tc2 in peripheral nerve leading to discovery of its previously unknown role in maintenance of integrity of the Node of Ranvier. Importantly, if confirmed in patients, this observation may lead to improvement in CMT4C diagnostics.
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HYPOMYELINATION CAUSED BY SCAP DELETION IS SLOWLY RESCUED BY EXTRACELLULAR LIPIDS THAT ALTER MYELIN STRUCTURE {#sec2-358}
-------------------------------------------------------------------------------------------------------------

### Verheijen M.,^1^ Camargo N.,^1^ Verdier V.,^2^ Nadra K.,^2^ Luoma A.,^3^ Brouwers J.,^4^ Feltri M.,^5^ Wrabetz L.,^5^ Kirschner D.,^3^ Chrast R.,^2^ Smit A.^1^ {#sec3-358}

#### ^1^Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, Netherlands; ^2^Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland; ^3^Department of Biology, Boston College, Chestnut Hill, United States; ^4^Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands; ^5^Dibit, San Raffaele Scientific Institute, Milan, Italy {#sec4-358}

Myelination requires a massive increase in glial cell membrane synthesis. Here we demonstrate that the acute phase of myelin lipid synthesis is regulated by SREBP cleavage activation protein (SCAP), an activator of sterol regulatory element‐binding proteins (SREBPs). Deletion of SCAP in Schwann cells led to a loss of SREBP‐mediated gene expression, congenital hypomyelination and abnormal gait. Interestingly, aging SCAP mutant mice showed partial regain of function; they exhibited improved gait and produced small amounts of myelin indicating a slow SCAP‐independent uptake of external lipids. Accordingly, extracellular lipoproteins promoted myelination by SCAP mutant Schwann cells. However, SCAP mutant myelin never reached normal thickness and had biophysical abnormalities concordant with abnormal lipid composition. These data demonstrate that SCAP mediated regulation of glial lipogenesis is key to the proper synthesis of myelin membrane. The described defects in SCAP mutant myelination provide new insights into the pathogenesis, and open new avenues for treatment strategies, of peripheral neuropathies associated with lipid metabolic disorders.

P‐359 {#sec1-359}
=====

ABNORMAL MATURATION AND FUNCTION OF ASTROCYTES AND OLIGODENDROCYTES IN VANISHING WHITE MATTER DISEASE {#sec2-359}
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### Bugiani M.,^1^ Boor I.,^1^ Postma N.,^1^ Van Kollenburg B.,^1^ Hol E.,^2^ Scheper G.,^1^ Goldman S.,^3^ Van Der Knaap M.^1^ {#sec3-359}

#### ^1^VU University Medical Center, Amsterdam, Netherlands; ^2^Netherlands Institute for Brain Research, Amsterdam, Netherlands; ^3^Center for Translational Neuromedicine, University of Rochester, Rochester, NY, United States {#sec4-359}

Vanishing white matter disease (VWM) is one one the most prevalent childhood leukoencephalopathies. It is caused by mutations in any of the genes encoding the five subunits of the eukaryotic translation initiation factor eIF2B. Like other white matter diseases, VWM is characterized by progressive cerebellar ataxia and less prominent spastisticy. However, typical to VWM are episodes of major neurological deterioration triggered by minor stresses as fever and mild trauma. Neuropathological features of VWM are also distinctive. The episodes of major deterioration correlate pathologically with the appearance and extension of cystic rarefaction and cavitation of the white matter, in which dysmorphic astrocytes and insufficient gliosis are a major feature. Around cavitated areas, hypomyelination and myelin loss coexist with a striking increase in the density of oligodendrocytes. These findings suggest that a functional impairment and/or a maturation defect of macroglial cells might contribute to the pathogenesis of VWM.

We demonstrate delayed maturation of astrocytes and oligodendrocytes in the brain of 5 VWM patients using immunohistochemistry, Western blot, microarray analysis, and qPCR. We show that astrocytes do proliferate in VWM, but do not reach full maturity and overexpress the delta isoform of the GFAP protein together with the stress protein alpha B‐crystallin, a finding that might explain their abnormal morphology and dysfunction. VWM astrocytes also abnormally express the enzyme galactocerebrosidase, which is typical of normal oligodendrocytes. Oligodendrocytes are immature in VWM, and many fail to go beyond the status of progenitors. However, mRNAs of major myelin proteins are normally detected, although to a lesser degree than in normal controls, suggesting that the myelinogenic program per se is not perturbed in VWM, but expression of myelin proteins is impaired possibly due to an aberrant post‐translational control. This combination of findings is not found in controls and other genetic white matter disorders, and thus appears to be specific of VWM.
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PAN‐GLIAL TRANSCRIPTOMIC CONTINUITY OF THE MYELINATION SUBSTRATE IN THE MOUSE BRAIN {#sec2-360}
-----------------------------------------------------------------------------------

### Iacobas D., Iacobas S., Spray D. {#sec3-360}

#### Albert Einstein College of Medicine, Bronx‐New York, United States {#sec4-360}

We have used 27k cDNA AECOM microarrays to compare the alterations in the myelination (MYE) gene web induced in the mouse brain by total or partial disruption of the gap junction proteins (connexins) Cx43, Cx32 or Cx36. Alterations in Cx43 null (K43) and heterozygous (H43), and in Cx32 null (K32) brains with respect to wildtype were analyzed in neonatal, while those in Cx36 null (K36) and heterozygous (H36) in P10 mice. The most relevant 55 quantifiable myelination out of 7455 distinct unigenes were selected and ranked through the novel Prominent Gene Analysis that considers both interconnectivity and expression stability of the web that can be formed with them. Differences in the myelination substrate were then quantified with respect to the Euclidian distance separating the corresponding gene webs of the profiled brains in a polydimensional space of their weighted undirected graphs. We found that the MYE gene web was profoundly affected and remodeled in the brains deficient in any of these three connexins. The percentages of 39% regulated MYE genes in Cx43 null (23% in Cx43‐/+), 48% in Cx32 null and 19% in Cx36 null (14% in Cx36‐/+) were substantially larger than the about 10% overall expression regulation reported for all quantified genes in these Cx KO brains. However, the alterations in Cx43 and Cx32 null brains were highly similar to each other (correl (K43:K32) = 0.91) but much less similar to those in Cx36 null brain (correl (K36:K32) = 0.09, correl (K36:K43) = 0.10). The substantial changes in the MYE gene webs in brains deficient in Cx43 or Cx36 is interesting because neither of these connexins is expressed in the myelinating oligodendrocytes. Since astrocytes and oligodendrocytes have been reported to form heterotypic gap junction channels, our results support the idea of a pan‐glial transcriptomic continuity of the myelination substrate.
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MYELINATION SUBSTRATE IN IMMORTALIZED OLIGODENDROCYTES IS CONTROLLED BY CONNEXIN‐DEPENDENT TRANSCRIPTOMIC NETWORKS OF CA2+‐SIGNALING AND ENHANCED BY ASTROCYTE PROXIMITY {#sec2-361}
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### Iacobas S., Spray D., Iacobas D. {#sec3-361}

#### Albert Einstein College of Medicine, Bronx‐New York, United States {#sec4-361}

Increasing evidence shows that many reciprocal signaling systems that coordinate the organization and activity of axonal domains with migration, maturation and myelin biogenesis of oligodendrocytes mediate their actions via cytosolic \[Ca^2+^\] transients. We have used high density gene expression arrays and computational methods to identify and quantify the responsible transcriptomic networks through which the intercellular Ca^2+^‐signaling (ICS) gene web controls the myelination (MYE) gene web in immortalized control and differentiated oligodendrocyte precursor (Oli neu) cells. Differentiation of the Oli‐neu line (kind gift of Dr Trotter from Mainz, Germany) into myelin‐associated glycoprotein (MAG)‐positive oligodendrocyte‐like cells was induced by 10 day treatment with 1 mM dibutyryl cAMP (dbcAMP). Oli neu cells were cultured alone or co‐cultured with cortical astrocytes in FalconTM cell culture insert systems that allowed or blocked formation of gap junction channels in addition to permitting exchange of soluble factors via the culture medium. The novel Prominent Gene Analysis (that refines iteratively the functional webs to optimize the interconnectivity and expression stability of the associated genes) was used to select and rank the most relevant MYE and ICS genes and build the corresponding gene webs. Such a web is a polydimensional representation of the 95% confidence expression intervals of the composing genes whose interconnections are proportional to the Pearson pair‐wise correlation coefficients of their expression levels in biological replicas. Thus, differences in the myelination substrate of Oli neu cells in different environments were quantified as Euclidian distances separating the corresponding MYE gene webs. Remarkably, the proximity of astrocytes induced a larger increase of the overall expression level and interlinkage of MYE genes than the differentiating treatment, with different intensities depending on whether astrocytes and Oli neu cells were in contact. In all experimental paradigms, our studies revealed that the topology of the MYE gene web in the Oli‐neu cells is tuned by ICS transcriptomic regulatory networks, with genes encoding the gap junction proteins (connexins) Cx29, Cx45 and Cx47 playing central roles.
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ANALYSIS OF NODES OF RANVIER AND AXON INITIAL SEGMENTS ORGANIZATION IN SCHIP‐1 MUTANT MICE {#sec2-362}
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### Goutebroze L.,^1^ Garcia M.,^1^ Chareyre F.,^2^ Niwa‐Kawakita M.,^2^ Carnaud M.,^1^ Devaux J.,^3^ Giovannini M.,^2^ Girault J.A.,^1^ Martin P.M.^1^ {#sec3-362}

#### ^1^INSERM UMR‐S 839, Paris, France; ^2^INSERM U674, Paris, France; ^3^CNRS UMR 6231, Marseille, France {#sec4-362}

Myelination allows the saltatory conduction of action potentials in vertebrates. It provides an insulating myelin sheath, regularly interrupted at nodes of Ranvier (NR) where voltage‐gated Na+ channels are concentrated. The Na+ channels are localized in the axonal membrane of the nodes where they are part of multimolecular complexes, including several transmembrane adhesion molecules of the immunoglobulins superfamily (IgSF‐CAM) and the cytoskeletal associated proteins ankyrinG and βIV spectrin. These complexes present striking similarities with those identified in the axonal initial segment of neurons (AIS), where action potentials are generated.

SCHIP‐1 is a protein discovered in our laboratory, which is highly enriched in the axonal membrane of NR and AIS and is able to interact with ankyrinG. In order to elucidate the role SCHIP‐1 in NR and AIS and more generally in myelinated fibers, we studied the consequences of the deletion of a functional domain of SCHIP‐1 in mutant mice (Δ10/Δ10) that we have generated. Analysis of peripheral myelinated fibers in SCHIP‐1 mutant mice revealed morphological anomalies of NR and a progressive decrease in their number within the nerve. Additionally, nodal accumulation of some of the NR proteins, including ankyrinG, is progressivly perturbed with age. These results suggest a possible role of SCHIP‐1 in long‐term stabilization of these regions.

Analysis of the clinical phenotype of the mutant mice is underway. Preliminary results indicate that Δ10/Δ10 mice suffer from a mild growth delay and have an abnormal motor coordination.
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LACTATE TRANSPORTERS IN DEVELOPING OLIGODENDROCYTES {#sec2-363}
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### Rinholm J.E.,^1^ Hamilton N.B.,^2^ Ianarelli P.,^2^ Kessaris N.,^2^ Richardson W.D.,^2^ Bergersen L.H.,^1^ Attwell D.^2^ {#sec3-363}

#### ^1^University of Oslo, Oslo, Norway; ^2^University College London, London, United Kingdom {#sec4-363}

In the brain\'s grey matter, astrocytes have been suggested to export lactate to neurons to power their mitochondria. In the white matter, lactate can support axon function in conditions of energy deprivation, but it is not known whether lactate works by preserving energy levels in axons or in oligodendrocytes, the myelinating processes of which are damaged rapidly in low energy conditions. Studies of cultured cells suggest that oligodendrocytes are the cell type in the brain which consumes lactate at the highest rate, in part to produce membrane lipids presumably for myelin. Here we use pH imaging to show that oligodendrocytes in the white matter of the cerebellum and corpus callosum take up lactate via monocarboxylate transporters (MCTs), which we identify as MCT1 by immunocytochemistry and electron microscopy. Using cultured slices of developing cerebral cortex from mice in which oligodendrocyte lineage cells express GFP under control of the Sox10 promoter, we show that a low glucose concentration inhibits myelination. This inhibition is enhanced when lactate uptake is blocked with D‐lactate, and is reduced when exogenous L‐lactate is supplied. These data suggest that oligodendrocytes can take up lactate using MCT1 and use it to support myelination. In CNS diseases involving energy deprivation at times of myelination or remyelination, as occurs in conditions causing periventricular leukomalacia leading to cerebral palsy, in stroke, and in secondary ischaemia following spinal cord injury, lactate transporters in oligodendrocytes may play an important role in minimising the inhibition of myelination that occurs.
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THE MONOCARBOXYLATE TRANSPORTER 8 (MCT8), MUTATED IN PMLD PATIENTS, IS INVOLVED IN THYROID HORMONES TRANSPORT IN OLIGODENDROCYTES {#sec2-364}
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### Capri Y.,^1^ Friesma E.,^2^ Gonthier‐Gueret C.,^1^ Boespflug‐Tanguy O.,^1^ Visser T.,^2^ Vaurs‐Barriere C.^1^ {#sec3-364}

#### ^1^GReD UMR INSERM U931 CNRS6247, Medicine School, Clermont‐Ferrand, France; ^2^Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands {#sec4-364}

The *monocarboxylate transporter 8* (*MCT8*) gene encodes a very efficient thyroid hormone (TH) transporter expressed in various tissues including brain. *MCT8*loss of function mutations are responsible for severe psychomotor developmental retardation and we have recently described in 8 patients that *MCT8*mutations are associated with a severe myelination delay in patients presenting initially with a Pelizaeus‐Marzbacher‐Like disease (PMLD). Indeed, brain MRI imaging of all patients demonstrates a diffuse hypomyelinated pattern in the first years of life which improves with age without clinical improvement. Oligodendrocytes (OLs) myelinate axons in the central nervous system (CNS). Appropriate myelination facilitates normal development and maintenance of axons. Thyroid hormones are known to stimulate OLs differentiation but hypothyroid animals have demonstrated that delayed myelination can occur even in absence of TH. Whether *MCT8*loss of function in *MCT8*mutated patients affects myelination directly *via*T3 transport impairment in OLs and/or indirectly *via*alterations of myelin‐axon interactions remain to be assessed.

Our study of *MCT8*expression during human CNS development has shown that *MCT8*is highly expressed in total foetal brain when myelination is starting (between 28 to 40 weeks of gestation (WG)) compared to the foetal spinal cord or to adult cortex. The study of various OL cell lines has demonstrated a significant *MCT8*mRNA expression in MO3.13, a human oligodendroglioma cell line, in Oli‐neu, a mouse oligodendrocyte cell line, and in mouse primary oligodendrocytes. Moreover, the use of siRNA to silence *hMCT8*expression in MO3.13 markedly decreases T3 uptake by 42.17+/‐4.39%. These preliminary results suggest that TH transport in OLs is in part mediated by MCT8. Complementary experiments studying effects of *mMct8*silencing in Oli‐neu cells onT3 uptake as well as *in situ*hybridization on human fetal brain sections (30 -- 40 WG) will be presented to support *MCT8* implication in OLs *in vivo* and *in vitro* and conclude on whether the delayed myelination observed in *MCT8*patients could result from a defect of TH uptake by the OLs.
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IMPAIRED MOTOR COORDINATION AND CORTICAL HYPOMYELINATION IN HEMOPEXIN‐NULL MICE {#sec2-365}
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### Morello N., Tonoli E., Silengo L., Vercelli A., Altruda F., Tolosano E. {#sec3-365}

#### University, Torino, Italy {#sec4-365}

Hemopexin is a plasma protein with the highest heme binding affinity. We have recently reported that Hemopexin‐null mice show dysregulated iron homeostasis in the central nervous system as they accumulate iron in oligodendrocytes in the basal ganglia and thalamus. Iron loading is not associated to an adequate increase in ferritins, thus resulting in oxidative stress. As iron levels in oligodendrocytes may affect myelinogenesis and, consequently, motor behaviour, we analyzed myelin distribution and motor performance in Hemopexin‐null mice at 2 and 12 months of age.

Myelin‐specific Black‐Gold stain showed a reduction in cortical myelinated fibers in Hemopexin‐null mice compared to wild‐type controls both at 2 and 12 months of age. These results were confirmed by biochemical analysis showing a strong reduction of the myelin binding protein (MBP) expression in the cortex of Hemopexin‐null mice compared to age‐matched wild‐type controls. A decrease in Black‐Gold staining and MBP expression was also observed in the basal ganglia of Hemopexin‐null mice but the difference with wild‐type controls was not as strong as in the cortical regions.

Motor coordination was analyzed with the rotarod test. Hemopexin‐null mice were unable to perform efficiently on the rotarod starting from five months of age. Motor impairment worsened with age, the rotarod mean score being reduced of 16% and 31% in Hemopexin‐null mice compared to wild‐type animals at 6 and 12 months, respectively.

These data demonstrate that hemopexin affects motor performances, likely interfering with myelination and may be explained either by an effect of Hemopexin on oligodendrocyte differentiation or by an effect on myelin synthesis in fully differentiated oligodendrocytes. To discriminate between these possibilities, quantification of oligodendrocytes at different developmental stages is currently under investigation.

Taken together, our data suggest that modulation of Hemopexin expression in brain might be an important factor in the pathogenesis of human neurodegenerative disorders characterized by myelin deficits.
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DOES THE MYELIN AND LYMPHOCYTE PROTEIN MAL PLAY A FUNCTIONAL ROLE IN INTRACELLULAR SCHWANN CELL SIGNALING? {#sec2-366}
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### Schmid D., Schaeren‐Wiemers N. {#sec3-366}

#### University Hospital Basel, Basel, Switzerland {#sec4-366}

The myelin and lymphocyte protein MAL is a raft‐associated membrane protein in compact myelin, predominantly expressed by Schwann cells. As MAL expression in the PNS starts already before myelination, we investigated its function during early postnatal development. Our results show that mice overexpressing MAL manifest a delayed onset of myelination, reflecting that MAL might play a key role in PNS myelinogenesis. Previous studies revealed a reduced expression of the neurotrophin receptor p75 (p75^NTR^), an essential receptor for initiating myelination, in sciatic nerves of newborn MAL‐overexpressing mice. To define whether there is a direct link between the overexpression of MAL and the decreased expression of p75^NTR^, we started to establish different in vitro strategies. Currently, we are establishing proliferating rat Schwann cell cultures, which will be infected with a retroviral construct overexpressing MAL. By qRT‐PCR and quantitative Western blot analysis, the expression level of p75^NTR^will be determined, verifying whether the overexpression of MAL is sufficient to alter p75^NTR^ expression or whether the observed reduced expression of p75^NTR^ in vivo is a consequence of a cascade of events induced by MAL‐overexpression. In parallel, we plan to determine the downstream signaling in Schwann cell cultures of MAL‐overexpressing and wildtype mice by investigating the activation of the phosphatidylinositol 3‐kinase‐Akt (PI3K‐Akt) pathway. As PI3K is known to play an important role in the downstream signaling in Schwann cells for initiation of myelination, an alteration in the activation of the PI3K pathway might explain the delayed onset of myelination in mice overexpressing MAL. After stimulating primary mouse Schwann cell cultures with forskolin, the phosphorylation of Akt (one of the key factor of PI3K activation) is measured. The aim of our studies is to elucidate whether MAL plays a direct role in axon‐glia signaling for myelination.

P‐367 {#sec1-367}
=====

THE MOLECULE HYCCIN, A MEMBRANE PROTEIN INVOLVED IN CENTRAL AND PERIPHERAL MYELINATION, REGULATES INTERCELLULAR ADHESIVE PROPERTIES IN SCHWANN CELLS {#sec2-367}
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### Gazzerro E.,^1^ Chiavarina B.,^1^ Musante V.,^1^ Grandis M.,^2^ Biancheri R.,^3^ Zara F.,^1^ Schenone A.,^1^ Minetti C.^1^ {#sec3-367}
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The disease "Hypomyelination and Congenital Cataract" (HCC) is characterized by evidence of diffuse myelin deficiency on brain MRI and in sural nerve biopsy. In HCC patients, we found three different mutations in hyccin, a novel membrane protein of unknown function.

Histological analysis of sural nerve biopsies from HCC patients showed uncompaction of the myelin sheath, which in some fibers appeared redundant and irregularly folded, suggesting a defect in cell adhesion. To test this hypothesis, we analyzed the adhesive properties of RT4‐D6P2T Schwann cells previously silenced for hyccin transcripts.

A pre‐designed silencing RNA targeted to exon 5 of hyccin coding sequence and a 19 bp scrambled RNA were transfected. The percentage of hyccin mRNA inhibition was equal to 90%, and 70% respectively at 24 and 48 h following the transfection. Notably, when tested in cell aggregation tests, RT4‐D6P2T cells silenced for hyccin displayed a 75% decrease in the number of cellular aggregates. This effect was observed at 24 h and was maintained at 48 h (n=3 exp.). To confirm the specificity of this action, cell aggregation tests were completed in RT4‐D6P2T cells transfected with a eukaryotic vector driving myc‐epitope tagged wild‐type (WT) hyccin. A hyccin mutant, deleted in exon 5, and an expression vector driving Myelin Protein Zero (MPZ) were utilized as respectively negative and positive controls. Hyccin WT overexpression induced a significant increase in the cell aggregate area, while hyccin mutant displayed an effect comparable to the empty vector (hyccinWT: 593000±5030, hyccin del‐ex5: 9970±6800, MPZ: 578000±3632, empty vector: 10500±1857 AU; mean±SE, n=30; hyccin WT versus hyccin mutant p\<0.001).

In complementary experiments, we analyzed hyccin action on intercellular adhesive properties of primary fibroblasts extracted from 3 HCC patients and 3 control subjects. According with our previous results, the number of cellular aggregates was equal to 3.5±0.2 and 42±10, (mean±SE, n=6 experiments) respectively in patients and control cells.

In conclusion, hyccin plays a role in the mechanisms which coordinate Schwann cell‐ to‐cell adhesion. Theses processes are critical for normal myelin compaction and, therefore, could provide a first molecular rationale to the hypomyelination observed in HCC.
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EXAMINATION OF THE ROLE OF ASTROCYTES ON MYELINATION IN VITRO {#sec2-368}
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### Nash B.,^1^ Thomson C.,^2^ Barnett S.C.^1^ {#sec3-368}

#### ^1^University of Glasgow, Glasgow, United Kingdom; ^2^Massey University, Palmerston North, New Zealand {#sec4-368}

One of the characteristic features of multiple sclerosis (MS) is a relative failure to remyelinate demyelinated axons. Some evidence suggests that astrocytes play a role in the myelination capacity of oligodendrocytes, acting either directly on oligodendrocytes or indirectly on their precursors. The mechanisms by which astrocytes positively or negatively regulate this process are relatively understudied, and have yet to be clarified. Astrocytes are required in normal physiological conditions but become 'reactive' in injury and disease, where they undergo proliferation, hypertrophy and increased GFAP expression. Astrocytes have been reported to secrete a wide array of growth factors and cytokines, in normal and disease conditions. We have developed a mixed CNS culture comprised of glia and axons, from the embryonic rat spinal cord, that allows us to follow myelination over time. These cultures are comprised of glia and CNS axons, which interact to produce many myelin internodes interspaced with nodes of Ranvier, suggesting that myelin is formed correctly. We have found that a monolayer of astrocytes acting as a support for the dissociated spinal cord cells promotes myelination by secreting a promyelinating factor(s). Using a panel of factors known to be secreted by astrocytes we have identified potential promyelinating candidates which include ciliary neurotrophic factor (CNTF), a cytokine of the interleukin‐6 family which was particularly potent. It has been reported to be secreted by astrocytes and promotes the survival and proliferation of oligodendrocytes. In addition, levels of CNTF are dramatically increased in cultures of reactive astrocytes suggesting a key role in injury conditions. Here we show that the addition of CNTF to our myelinating cultures (20pg‐2ng/ml), leads to an increase in myelination. Furthermore, CNTF has no effect on myelination when dissociated spinal cord cells are plated on a monolayer of olfactory ensheathing cells. We therefore hypothesise that CNTF has an indirect effect on astrocytes and may induce them to secrete other promyelinating factors.
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THE EFFECT OF DONOR AGE ON THE REMYELINATING POTENTIAL OF OLFACTORY ENSHEATHING CELL TRANSPLANTS IN THE DEMYELINATED CNS {#sec2-369}
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### Coutts D.J.C.,^1^ Humphries C.E.,^2^ Plant G.W.,^2^ Franklin R.J.M.^1^ {#sec3-369}

#### ^1^University of Cambridge, Cambridge, United Kingdom; ^2^University of Western Australia, Perth, Australia {#sec4-369}

Olfactory ensheathing cell (OEC) transplantation is a promising approach to restore myelin around axons in demyelinating conditions of the CNS, such as Multiple Sclerosis. Optimising the remyelinating potential of these transplants is a key step in translating remyelination success in the laboratory into a viable clinical treatment. OECs sourced from donors of different ages have been shown to remyelinate in several in vitro and in vivo models, however the optimal donor age for OEC associated remyelination is unclear. This project directly compared the remyelinating potential of purified OEC transplants from three donor ages in a rat CNS model of demyelination. OECs were sourced from the olfactory bulbs of embryonic, neonatal and adult rats, purified and transplanted into a toxin‐induced model of demyelination in the rat spinal cord. Remyelination efficiency three weeks after transplant was assessed morphologically and by immunostaining. Our results indicate that all donor ages remyelinate, however this process is most efficiently achieved by embryonic OECs.

This work is supported by the Gates Cambridge Trust and the MS Society UK.
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NERVE ROOTS ARE MYELINATED BY OLIGODENDROCYTES IN THE ABSENCE OF PERIPHERAL MYELIN {#sec2-370}
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### Coulpier F.,^1^ Decker L.,^2^ Vallat J.M.,^3^ Halliez S.,^2^ Funalot B.,^4^ Charnay P.,^2^ Topilko P.^2^ {#sec3-370}

#### ^1^INSERM, U784, IFR 36,Plateforme Transcriptome, Paris, France; ^2^INSERM, U784, Paris, France; ^3^CHU Dupuytren, Laboratoire de Neurobiologie, Limoges, France; ^4^CHU Dupuytren, Laboratoire de Biochimie et Génétique Moléculaire, Limoges, France {#sec4-370}

Along the spinal nerves, the interface between central (CNS) and peripheral (PNS) nervous system corresponds to two anatomical structures, the dorsal entry zone (DREZ), where sensory neuron afferents invade the neural tube and the motor exit point (MEP), where motor neuron axons emerge from the neural tube. These structures define a border that is clearly delimited in the adult by the presence of Schwann cells on one side and of oligodendrocytes and astrocytes on the other. Despite numerous studies, the mechanisms that prevent the mixture of these cells populations and restrict the Schwann cells to the PNS and the oligodendrocytes to the CNS remain unknown.

To investigate the implication of Schwann cells in the maintenance of PNS/CNS border we have performed their genetic ablation by using *Krox20* KO mice (*Krox20* ^*Gfp(DT)*^) carrying insertion of diphtheria toxin coding sequence into Krox20 locus. Krox20 encodes zinc finger transcription factor, is express in Schwann cells and play the key function during myelination process. We have shown that in the nerve roots from mutant animals Schwann cells elimination occurs around E16.5 that coincide with *Krox20* activation. Surprisingly, soon after Schwann cells ablation we have observed progressive emigration of oligodendrocytes and astrocytes to the PNS, along the dorsal and ventral roots from spinal and cranial nerves and express Olig2 marker and form compact myelin. In order to elucidate if the presence of ectopic oligodendrocytes is due to the elimination of Schwann cells or the absence of peripheral myelin we have analysed the nerve roots from *Krox20^lacZ/lacZ^* KO mice in which Schwann cells are present but unable to myelinate. In this model we have also observed the presence of myelinated oligodendrocytes and astrocytes in the nerve roots. In both mouse models ectopic oligodendrocytes were never present in the distal part of peripheral nerves.

Recently, we have confirmed these observations in human patient carrying congenital peripheral neuropathy in which Schwann cells are unable to myelinate. Ultrastructure and immunohistochemistry study of the spinal nerve roots from this patient reveal the presence of numerous mature oligodendrocytes and astrocytes. This study highlight on the novel role of Schwann cells in the maintenance of PNS/CNS boundary in mouse and humans.
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PROTEOLIPID PROTEIN ALLEVIATES THE NEUROLOGICAL PHENOTYPE IN A MOUSE MODEL OF DéJéRINE‐SOTTAS SYNDROME CAUSED BY A PROTEIN ZERO MUTATION {#sec2-371}
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### Patzig J.,^1^ Möbius W.,^1^ Nave K.A.,^1^ Martini R.,^2^ Werner H.B.^1^ {#sec3-371}

#### ^1^Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany; ^2^Department of Neurology, University of Würzburg, Würzburg, Germany {#sec4-371}

The most abundant protein of peripheral nervous system (PNS) myelin in all vertebrate clades is an adhesion molecule of the Immunoglobulin superfamily, protein zero (P0). In the central nervous system (CNS), P0 was replaced by the unrelated proteolipid protein (PLP) as the most abundant myelin constituent at the evolutionary transition from fish to tetrapods suggesting that PLP may have partially taken over some P0 function(s). Remarkably, the abundance of PLP, but not of other myelin tetraspans, is greatly increased in the PNS of P0*^null^* mice, which model Déjérine‐Sottas syndrome caused by P0‐mutations with respect to hypomyelination, poor myelin compaction, and impaired nerve conduction. To test whether an increase of PLP‐abundance alleviates the consequences of eliminating P0, we have analyzed mice lacking both P0 and PLP (P0*^null^*\*PLP*^null^*). While we found no indication that the CNS was affected, fewer axons were myelinated in P0*^null^*\*PLP*^null^* sciatic nerves, correlating with an enhanced impairment of motor capabilities. The total number of axons was significantly reduced in phrenic nerves, possibly representing the cause of death before postnatal day 40, much earlier than either background strain. Our results indicate that, in experimental mice, PLP may partially compensate the loss of P0 function in myelin biogenesis, but not in myelin compaction. We suggest that the abundance gain of PLP also alleviates the consequences of P0‐deficiency in neuropathies and in tetrapod CNS myelin.
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HIGH‐LEVEL EXPRESSION OF THE PROTEOLIPIDS PLP AND M6B IS SUFFICIENT TO INDUCE OLIGODENDROGLIAL PROCESS OUTGROWTH IN VITRO AND REQUIRED FOR NORMAL MYELINATION IN VIVO {#sec2-372}
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### de Monasterio‐Schrader P.,^1^ Werner H.B.,^1^ Krämer‐Albers E.M.,^2^ Strenzke N.,^3^ Saher G.,^1^ Möbius W.,^1^ Tenzer S.,^4^ Ohno‐Iwashita Y.,^5^ Moser T.,^3^ Griffiths I.R.,^6^ Nave K.A.^1^ {#sec3-372}

#### ^1^MPI of Experimental Medicine, Goettingen, Germany; ^2^Dept. of Biology, University of Mainz, Mainz, Germany; ^3^Inner Ear Lab, Dept. of Otolaryngology, Center for Molecular Physiology of the Brain, University of Goettingen, Goettingen, Germany; ^4^Institute of Immunology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; ^5^Cellular Signaling Group, Research Team for Functional Genomics, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan; ^6^Department of Veterinary Clinical Studies, University of Glasgow, Glasgow, United Kingdom {#sec4-372}

Myelin biogenesis comprises the outgrowth of glial cell processes and the vast expansion of their surface. Surprisingly, central nervous system myelination by oligodendrocytes is not impaired by null‐mutations affecting its far‐most abundant constituent, proteolipid protein (PLP). In a mass spectrometry‐based screen for myelin‐associated tetraspan proteins we have identified the PLP‐ortholog M6B as a candidate to compensate PLP‐deficiency in myelination. Cryo‐immuno electron microscopy confirmed M6B as a low abundant myelin component. Double‐mutant mice lacking both PLP and M6B remained severely dysmyelinated and died prematurely, while myelination appeared unaffected in single‐mutants. Thus, at least one proteolipid is required for oligodendrocytes to assemble future myelin membrane, presumably within the secretory pathway in which PLP and M6B colocalize. Remarkably, the overexpression of either PLP or M6B induced the formation of cellular processes in an oligodendrocyte precursor cell line (Olineu). The expansion of the myelin sheath requires the continuous addition of membrane components, including an unusually high cholesterol level. Both proteolipids have a high affinity to cholesterol, suggesting that they enrich cholesterol in intracellular membranes to a level that allows myelination. However, only PLP is so efficiently sorted into myelin to determine its cholesterol content in vivo. We suggest that the proteolipid‐dependent enrichment of cholesterol is a key step of myelin membrane biogenesis.
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MYELIN‐SPECIFIC CLAUDINS IN ZEBRAFISH: EVOLUTIONARY AND FUNCTIONAL CHARACTERIZATION {#sec2-373}
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### Schaefer K., Brösamle C. {#sec3-373}

#### University of Munich, Munich, Germany {#sec4-373}

Myelination is a key step in vertebrate evolution, as it allows rapid, saltatory nerve impulse conduction while keeping axon diameters small, permitting compact powerful nervous systems at small metabolic cost. Myelinating glia have evolved specific molecular mechanisms and components to form and maintain their myelin sheath. Claudins are essential components of tight junctions, which form selective permeability barriers across paracellular pathways and function as a fence between apical and basolateral membrane domains in epithelia. In myelin of rodents, Claudins are expressed in autotypic tight junctions of oligodendrocytes (Claudin 11/OSP) and Schwann cells (Claudin 19) and contribute to electrical insulation, presumably by regulating ion flow between interstitium and intramyelinic space. The fence function of Claudins may contribute to compartmentalization of the myelin membrane.

We have identified a teleost specific, novel myelin protein, zebrafish Claudin k (*aka* Claudin 31), which is expressed exclusively in Schwann cells and oligodendrocytes. We show that it localizes to the Schmidt‐Lantermann incisures, the paranodal loops, and the inner and outer mesaxons -- similar to mammalian Claudin 11 and ‐19, which are restricted to the CNS and PNS respectively. Zebrafish possess not only Claudin k but also Claudin 11 and ‐19, which is expressed in CNS and PNS. Are myelin Claudins in teleosts redundant or have they evolved divergent functions? To address this question, we analyzed the phylogenetic relationship of Claudins and are performing knock down experiments in zebrafish larvae.

As a tool to further dissect Claudin k function and myelin biology in general, we have cloned a *claudin k* promoter, that drives strong specific expression in myelinating glia -- in the CNS as well as in the PNS. Using a Tol2‐Gal4‐UAS system with independent driver and responder constructs and optional fluorescent reporters, we are generating a transgenic line expressing membrane‐bound eGFP. Additionally, we express eGFP/mCherry‐Claudin k fusion proteins and are verifying their proper localization to autotypic tight junctions. These lines will allow us to monitor myelination and tight junction formation in vivo and can then serve as a readout for experiments that address myelination and tight junction formation.
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IN TOXIC DEMYELINATION OLIGODENDROGLIAL CELL DEATH OCCURS EARLY AND IS FAS INDEPENDENT {#sec2-374}
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### Hesse A.,^1^ Wagner M.,^2^ Held J.,^2^ Brück W.,^2^ Salinas‐Rieser G.,^3^ Hao Z.,^4^ Waisman A.,^5^ Kuhlmann T.^1^ {#sec3-374}

#### ^1^University Hospital Münster, Münster, Germany; ^2^Department of Neuropathology, University Medical Center, Göttingen, Germany; ^3^DNA Mikroarray Core Facility, University of Göttingen, Göttingen, Germany; ^4^Campell Family Institute for Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada; ^5^1st Medical Department, Johannes‐Gutenberg‐University, Mainz, Germany {#sec4-374}

The molecular mechanisms leading to oligodendroglial cell death in a toxic demyelination model caused by the copper chelator cuprizone are unknown.

Here, we demonstrate that oligodendroglial cell death starts already a few days after initiation of the cuprizone diet and weeks before demyelination is obvious. The oligodendroglial cell death is associated with a dramatic downregulation of myelin genes in the first week of cuprizone diet. In early -- but not in later -- stages, dying oligodendrocytes express activated caspase 3, suggesting a switch from classical apoptotic pathways to caspase 3‐independent mechanisms during the course of the cuprizone diet. The expression levels of FAS in the corpus callosum, a cell death receptor crucial for oligodendroglial cell death in experimental autoimmune encephalomyelitis (EAE), correlate with the expression of activated caspase 3 in oligodendrocytes. However, mice lacking FAS especially in oligodendrocytes are not protected against cuprizone‐induced oligodendroglial cell death, showing that FAS is not necessary for oligodendroglial cell death in the cuprizone model.
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INTEGRIN‐LINKED‐KINASE IS REQUIRED FOR RADIAL SORTING OF AXONS AND SCHWANN CELL REMYELINATION IN THE PERIPHERAL NERVOUS SYSTEM {#sec2-375}
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During development Schwann cells (SCs) interpret different extracellular cues to regulate their migration, proliferation, and the remarkable morphological changes associated with the sorting, ensheathment, and myelination of axons. Although interactions between extracellular matrix (ECM) proteins and integrins are critical to some of these processes, the downstream signaling pathways they control are still poorly understood. Integrin‐linked‐kinase (ILK) is a focal adhesion protein that associates with multiple binding partners to link integrins to the actin cytoskeleton, and is thought to participate in integrin and growth factor mediated signaling. Using SC‐specific gene ablation, we report essential functions for ILK in radial sorting of axon bundles and in remyelination in the peripheral nervous system (PNS). Our in vivo and in vitro studies show that ILK negatively regulates rho/ROCK signaling to promote SC process extension and to initiate radial sorting. ILK also facilitates axon remyelination, likely by promoting the activation of downstream molecules such as AKT/PKB.
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AUTOTAXIN (ATX): A REGULATOR OF OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION {#sec2-376}
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### Fuss B., Afshari F.S., Yuelling L.M., Lister J.A., Bigbee J.W. {#sec3-376}

#### Virginia Commonwealth University, Richmond, United States {#sec4-376}

Autotaxin (ATX), also known as phosphodiesterase Iα/autotaxin (PD‐Iα/ATX) or ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), represents a multi‐functional and multi‐modular protein, which is secreted by a variety of cell types including maturing oligodendrocytes, i.e. myelinating cells of the central nervous system (CNS). Our previous data suggest that ATX, via its well characterized enzymatic lysophospholipase D (lysoPLD) activity, may be crucial for the later stages of oligodendrocyte maturation, i.e. for 1) the progression from a cell with a complex process network to a cell generating large membranous sheets ultimately forming the myelin sheath and 2) the expression of the myelin‐specific protein myelin basic protein (MBP). In addition, a separate functionally active domain, referred to as the Modulator of Oligodendrocyte Remodeling and Focal adhesion Organization (MORFO) domain, was discovered by us and found to mediate anti‐adhesive, i.e. matricellular, properties and to promote morphological maturation of oligodendrocytes, i.e. the progression from a cell extending a simple process network to a cell with an expanded and complex process network. Here, we present data characterizing the role of ATX in myelination in vitro, in DRG‐oligodendrocyte co‐cultures, and in vivo, in the hindbrain of the developing zebrafish. More specifically, our data demonstrate that adding fully functional ATX to DRG‐oligodendrocyte co‐cultures increases the number of MBP‐positive cells that are engaged in the generation of neurite ensheathing segments. Using the zebrafish as an in vivo model system, we could further show that ATX is expressed in the hindbrain of the zebrafish in a spatio‐temporal pattern that is consistent with an expression by developing oligodendrocytes. Most importantly, upon morpholino‐based knock‐down of ATX expression in the zebrafish, an inhibition (or delay) of the appearance of MBP expressing oligodendrocytes was found to occur in the developing hindbrain. Taken together, our data suggest that ATX, likely via the action of its different functionally active domains, regulates CNS myelination in vitro and in vivo.
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OLIGODENDROCYTE PROGENITOR CELL SUSCEPTIBILITY TO INJURY BY UNCONJUGATED BILIRUBIN {#sec2-377}
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### Barateiro A., Leitão Silva S., Vaz A.R., Fernandes A., Brites D. {#sec3-377}

#### CPM/iMed, Lisboa, Portugal {#sec4-377}

Myelination occurs in the last half of gestation and throughout childhood until young adult age. Since oligodendrocytes myelinate CNS axons, their death leads to demyelination resulting in neurological impairments. Interestingly, neonatal jaundice has been associated to neurodevelopment deficits with white matter abnormalities,^1^ suggesting that unconjugated bilirubin (UCB) may compromise myelination. To date, only one study showed that UCB decreases the viability of mature oligodendrocytes.^2^ Hence, we aimed to investigate whether and how UCB determines the demise of oligodendrocyte precursor cells (OPCs).

Mixed glial cultures were obtained from cerebral cortex of neonatal rat pups. At 10 days in vitro (DIV) OPCs were isolated by shaking after dislodging of microglia.^3^ Enriched OPCs cultures were achieved using specific proliferating factors. After 6 DIV cells were treated with 50 μM UCB plus 100 μM of human serum albumin for 4 and 8 h. The purity of OPC cultures was evaluated by immunocytochemistry using antibodies directed to OPCs (A2B5 and O4) and astrocytes (GFAP). Cell viability was assessed by LDH leakage, mitochondrial abnormalities by MitoTracker Red (500 nM) and endoplasmic reticulum (ER) stress by the activity of calcium‐dependent calpain using a specific substrate BOC‐LM‐CMAC (10 μM).

Approximately 80% of our enriched OPCs cultures were A2B5/O4 positive with less than 3% GFAP positive, and the remaining oligodendrocytes in varying stages of differentiation. Exposure of OPCs to UCB increased the release of LDH at 4 (20% or ∼1.7‐fold, p\<0.05) and 8 h (36% or ∼2.2‐fold, p\<0.05). Interestingly, while a decrease in mitochondrial viability (∼0.8‐fold, p\<0.01) was observed at 4 h, enhancement of calpain activity was only detected at 8 h (∼1.5‐fold, p\<0.01) pointing that mitochondrial dysfunction by UCB occurs prior to ER stress.

Our results suggest that UCB exerts cytotoxicity in OPCs through both mitochondrial dysfunction and ER stress cell death pathways in a time‐dependent manner. Targeting OPCs dysfunction by UCB may lead to new therapeutic strategies aimed at preventing abnormal myelination following neonatal jaundice.

1\. Gkoltsiou et al, *Early Hum Dev* 2008;84:829--38.

2\. Genc et al, *Brain Res* 2003;985:35--41.

3\. Chen et al, *Nat Protoc* 2007;2:1044--51.

Funded by FCT‐PTDC/SAU‐NEU/64385/2006 to D.B.
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EVOLUTION OF MYELIN BASIC PROTEIN AS SEEN THROUGH MOLECULES EXPRESSED IN EXTANT TAXA {#sec2-378}
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### Gould R., Gould R. {#sec3-378}

#### University of Illinois at Chicago, Chicago, United States {#sec4-378}

The origins of the vertebrate myelinated nervous system depended on two proteins, myelin basic protein (MBP) and myelin protein zero (MPZ). Both proteins likely originated near the time myelin fibers first developed as neither is present in genome or EST databases of nine extant invertebrates. No MBP homolog and only partial MPZ models are present in the lamprey genome. After MBP first appeared, it evolved quite differently in fishes that use MPZ in both their CNS and PNS compared with tetrapods. Fish MBPs have a smaller exon I and overall identities with mammalian MBPs range from 29‐37% compared with 58‐69% for tetrapods. Although mammals express multiple splice variants; birds, reptiles and amphibians express mainly a single variant which has all exons except exon II. Exon II sequence is limited to mammals. Cartilaginous fishes express the same variant as well as one that lacks exon V. As many teleost fish MBP sequences are present in the EST database (NCBI, translating and counting them show wide variation in expression patterns from two genes for four fish: zebrafish, three‐spined stickleback, flathead minnow and Atlantic salmon. In three of these species small (88‐107 amino acid) isoforms usually lacking exon VI and sometimes VII are common. In teleost fish nervous systems, myelin is not only made with smaller MBP, but also with a small MPZ splice variant that lacks exon 6. The protein has the same extracellular and transmembrane domains. The highly basic tail important for compaction is half the size. Clearly further studies on the properties of myelin sheaths non‐mammalian species, particularly fish will broaden our understanding of the myelination process.
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EXPLORING PARALLELS BETWEEN MOLECULAR CHANGES INDUCED IN PNS BY AGING AND DEMYELINATING NEUROPATHIES {#sec2-379}
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The peripheral nervous system (PNS) is involved in many age‐dependent neurological deficits, including numbness, pain, restless legs, trouble with walking and balance that are commonly found in the elderly. These symptoms generally result from demyelination and/or loss of axonal integrity. However, the precise identity of age‐regulated molecular changes in either neuronal or glial compartments of the nerve is unclear. Interestingly, these deficiencies are also present in inherited neuropathies, where the expressivity of the rapid and early onset phenotypes is undeniably more severe than in normal aging. Nevertheless, especially the molecular changes underlying loss of axonal integrity in neuropathy condition are also poorly understood.

To unravel molecular mechanisms affected by PNS aging, we used wild‐type mice at 17 time‐points from day of birth until senescence (28 months‐old). For the neuropathy study, we focused on 56 day‐old Schwann cell‐specific neuropathy‐inducing mutants, MPZCre/+/LpinfE2‐3/fE2‐3 and MPZCre/+/ScapfE1/fE1 mice, that have, at this age, already developed neuropathic symptoms. Transcriptomes of dissected Schwann cell‐containing endoneurium or sensory neuron‐containing dorsal root ganglia have been analyzed throughout time or genotypes, using Illumina Bead Chips. Following data validation, we identified groups of differentially expressed genes in the development, aging and in the neuropathic mutants, in both glial and neuronal compartments. We detected substantial differences in the dynamics of changes in gene expression during development and aging between these two compartments. Furthermore, considering the above‐mentioned phenotypic similarities, we integrated aging and mutant data. Interestingly, we observed that there are some parallels at the molecular level between processes involved in aging, which leads to less severe and more progressive PNS alterations, and in the rapid onset peripheral neuropathies.

Apart from helping the understanding of molecular alterations underlying age‐related PNS phenotypes, this data should also contribute to the identification of pathways that could be used as targets for therapeutical approaches to prevent complications associated with both aging and inherited forms of neuropathies.
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C‐MAF IS AN IMPORTANT REGULATOR OF MYELINATION IN THE PERIPHERAL NERVOUS SYSTEM {#sec2-380}
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### Wende H., Grossmann K., Reuter K., Garratt A., Birchmeier C. {#sec3-380}

#### MDC Berlin, Berlin, Germany {#sec4-380}

The crucial role of the Neuregulin‐1/ErbB signalling pathway in Schwann cell development and during myelination is well established. However, the transcriptional network activated downstream of Nrg1/ErbB signalling is not fully understood. We therefore performed a genome‐wide expression analysis of sciatic nerves of Krox20‐Cre//ErbB2 conditional mutant mice. We found that a transcription factor of the basic‐region leucine zipper (bZIP) family, c‐Maf, was downregulated in Schwann cells of ErbB2 mutant mice.

c‐Maf is known to control the differentiation of T cells, chondrocytes and lens fibre cells. c‐Maf is also expressed in the central and peripheral nervous system, but its functions in neural cells have not been assessed. In Schwann cells, c‐Maf expression is first detected around E18 and is maintained in the adult. c‐Maf expression is thus initiated at the time Schwann cells start to myelinate, and expression is observed in myelinating, but not in non‐myelinating Schwann cells. c‐Maf mutant mice die shortly after birth. To investigate the function of c‐Maf in the peripheral nervous system, we therefore generated mice carrying a conditional c‐Maf mutant allele. In Wnt1‐Cre or Krox20‐Cre//c‐Maf mutant mice, we observed a pronounced reduction in the myelin thickness of peripheral nerves very similar to that observed in ErbB2 mutant mice. This hypomyelination was accompanied by the formation of tomaculae at the nodes of Ranvier. Comparing the gene expression in sciatic nerves, we found that many of the genes donwregulated in c‐Maf mutants were also downregulated in ErbB2 mutants.

Our results demonstrate that c‐Maf is an important factor in the transcriptional network regulating myelination in the peripheral nervous system that might act downstream of Nrg1/ErbB signalling.
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OLIGODENDROGLIAL EXPRESSION OF DCC IS REQUIRED FOR THE ORGANIZATION OF PARANODAL JUNCTIONS IN VIVO {#sec2-381}
--------------------------------------------------------------------------------------------------
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#### ^1^McGill University, Montreal, Canada; ^2^Université de Montréal, Montreal, Canada {#sec4-381}

Netrin‐1 and its receptor DCC are implicated in oligodendrocytes precursor cells migration during development. In the adult central nervous system, these proteins are expressed in mature myelinating oligodendrocytes. Previous work by our laboratory has established that netrin‐1 and DCC are expressed at the paranodal axoglial junctions of myelinated fibers, and that they are involved in the maintenance of these junctions *in vitro*. Paranodal axoglial junctions are essential for the segregation of myelinated axons into distinct domains and efficient conduction of action potentials. Netrin‐1 and DCC knock out die at birth, which renders the study of myelination *in vivo* impossible in those mice. Furthermore, DCC and netrin‐1 are expressed by both neurons and oligodendrocytes in the adult nervous system. To clarify the role of these proteins *in vivo* in paranode maintenance and to assess whether DCC is required cell autonomously on oligodendrocyte to function in paranodes, we performed intraretinal oligodendrocytes precursor cells transplantation. With this technique, we demonstrated that DCC is required cell autonomously on oligodendrocytes for normal paranodal organization *in vivo*. A better understanding of the processes regulating axoglial junction maintenance can have tremendous importance for our knowledge of demyelinating diseases such as multiple sclerosis.
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THE MAJOR MYELIN‐RESIDENT PROTEIN PLP IS TRANSPORTED TO MYELIN MEMBRANES VIA A TRANSCYTOTIC MECHANISM: INVOLVEMENT OF SULFATIDE {#sec2-382}
-------------------------------------------------------------------------------------------------------------------------------

### Baron W., Klunder B., de Jonge J., Nomden A., Plat A., Maier O., de Vries H., Hoekstra D. {#sec3-382}

#### UMCG, University of Groningen, Department Cell Biology, Section Membrane Cell Biology, Groningen, Netherlands {#sec4-382}

Myelin membranes are sheet‐like extensions of the plasma membrane of oligodendrocytes (OLGs) that can be considered as distinct membrane domains consisting of myelin‐specific lipids and proteins. Myelin biogenesis presumably requires specialized sorting and targeting devices, and indeed our previous data suggest that the myelin membrane displays typical basolateral features. Consistent with the polarized nature of OLGs, we demonstrate here that in cultured OLGs, transcytotic transport of the major myelin resident protein, PLP, is a key element in the mechanism of myelin assembly. Upon biosynthesis, PLP traffics to the myelin sheet via syntaxin‐3 mediated docking at the apical membrane‐like cell body plasma membrane, which is followed by subsequent internalization and transport to the myelin sheet. A similar transcytotic transport from apical to basolateral membrane is observed, when PLP is expressed in polarized HepG2 cells. In both cell types, PLP dynamically partitions into different lateral membrane pools, characterized by a transient insolubility in TX‐100 and CHAPS. By carrying out pulse chase experiments, in conjunction with surface biotinylation and organelle fractionation, we show that following biosynthesis, PLP is transported to the cell body surface in TX‐100 resistant microdomains. At the plasma membrane, PLP only transiently associates with these microdomains, and its lateral dissipation is followed by segregation into CHAPS resistant domains, internalization and transport towards the myelin sheet. Sulfatide triggers PLP\'s reallocation into CHAPS resistant membrane domains, while inhibition of sulfatide synthesis in polarized HepG2 cells inhibits PLP transport from the apical to the basolateral membrane, thus highlighting the role of sulfatide in transcytosis in OLGs.

Taken together, we propose a model in which PLP transport to the myelin sheet proceeds via a transcytotic mechanism, mediated by sulfatide and characterized by a dynamic, i.e., transient partitioning of PLP into distinct membrane domains, involved in biosynthetic and transcytotic transport.

*This work is supported by the Dutch MS Research Foundation.*
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AXONAL DEGENERATION IN MOUSE MODELS OF CMT1X NEUROPATHY {#sec2-383}
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### Sargiannidou I.,^1^ Vavlitou N.,^1^ Markoullis K.,^1^ Kyriacou K.,^1^ Scherer S.S.,^2^ Kleopa K.A.^1^ {#sec3-383}

#### ^1^The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; ^2^Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, United States {#sec4-383}

X‐linked Charcot‐Marie‐Tooth disease (CMT1X) is an inherited primarily demyelinating neuropathy caused by mutations affecting the gap junction (GJ) protein connexin32 (Cx32). Cx32 is expressed in myelinating Schwann cells and oligodendrocytes and a number of Cx32 mutations also cause transient or chronic CNS phenotypes in addition to peripheral neuropathy. Compared to patients with other types of demyelinating CMT, patients with CMT1X develop relatively early axonal dysfunction and degeneration, which correlates best with chronic disability. In order to clarify the cellular mechanisms of selected Cx32 mutants, we generated transgenic mice expressing the human T55I and R75W Cx32 mutations in myelinating cells both on cx32‐wild type and on cx32‐knockout background. Detailed analysis of mutant Cx32 expression, myelination, and axonal pathology was performed. Both mutants were retained in the perinuclear compartment of myelinating cells colocalizing with Golgi (R75W) or with endoplasmic reticulum (T55I) markers and failed to form GJ‐like plaques. The expression and localization of two other GJ proteins in myelinating cells, Cx47 and Cx29, was not altered. In a cx32‐null background both mutants caused a similar pathology as the null allele. They developed progressive demyelinating neuropathy starting after 3 months of age, as well as mild CNS myelination defects. Early axonal changes were detectable in sciatic nerves at 4 months of age, when the degree of abnormal myelination was minimal. Axonal alterations in GJ deficient nerves included reduced neurofilament and other cytoskeletal protein levels, increased paranodal length and accumulation of beta‐amyloid precursor protein (APP), a marker of axonal damage. Sciatic nerve ligation experiments revealed that axonal transport of synaptic proteins was impaired in 4‐month old CMT1X mutant mice compared to wild type littermates. In conclusion, CMT1X mutations result in loss of function in myelinating cells and do not cause trans‐dominant negative effects on other GJ proteins. Axon integrity appears to be compromised directly by the loss of GJs even before overt demyelination, in keeping with the prominent and early axonal involvement in patients with CMT1X.
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ROLE OF LGI AND ADAM PROTEINS IN NERVE DEVELOPMENT AND FUNCTION {#sec2-384}
---------------------------------------------------------------

### Abello G.,^1^ Ozkaynak E.,^1^ Driegen S.,^1^ Sagane K.,^2^ Jeagle M.,^1^ Bermingham J.R.,^3^ Meijer D.^1^ {#sec3-384}

#### ^1^Erasmus MC, Rotterdam, Netherlands; ^2^Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan; ^3^McLaughlin Research Institute, Great Falls, United States {#sec4-384}

Schwann cells (SC) are the most important accessory cells to neurons in the peripheral nervous system (PNS) and are involved in every aspect of nerve structure, function and regeneration. Dr Meijer\'s group has identified a novel SC expressed factor, Lgi4, involved in nerve development and function. The Lgi4 gene is mutated in a natural mouse mutant called Claw Paw, which exhibits delayed axonal sorting and hypomyelination in the PNS. Lgi4 is a member of a small family of secreted proteins mainly expressed in the nervous system. While mutations in Lgi1 have been implicated in epilepsy in humans, virtually nothing is known about the other two members of the family; Lgi2 and Lgi3. These genes are expressed during development in primary sensory neurons, suggesting that they, together with Lgi4, are involved in diverse aspects of development and function of the PNS. Some or all of these functions could be mediated through interaction with members of the Adam (A Disintergin And Metalloprotease) family of transmembrane proteins. It has been demonstrated that Lgi1 binds to the metalloprotease inactive member Adam22. Our recent results have demonstrated that Lgi4, 2 and 3 also bind Adam22. Adam22 mutant mice have a phenotype that resembles that of Lgi4 mutant mice, suggesting a possible interaction during nerve development. The cellular processes and molecular mechanisms that are influenced by this interaction are at present unclear. Therefore, the major aim of this research proposal is to unravel the cellular and molecular mechanisms through which Lgi4‐Adam22 interaction contributes to proper axonal sorting and myelin formation.

Insight into the role of Lgi and Adam proteins in peripheral nerve development will be instrumental in developing novel therapeutic strategies to aid nerve repair and function and, in addition, will inform us about the role these proteins play in eleptogenesis.
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REVERSIBILITY OF CAMP‐INDUCED SCHWANN CELL DIFFERENTIATION {#sec2-385}
----------------------------------------------------------

### Monje P., Soto J., Bunge M., Wood P. {#sec3-385}

#### The Miami Project to Cure Paralysis, Miami, United States {#sec4-385}

Whereas myelinating Schwann cells can de‐differentiate and re‐initiate cell division after nerve injury, the factors controlling de‐differentiation are still elusive. In this study, we have analyzed the possible de‐differentiating effects of different mitogenic factors in isolated adult Schwann cells differentiated by prolonged cAMP treatment. In the absence of neurons, the second messenger cAMP was a key instructive signal for Schwann cell differentiation inducing phenotypic changes associated with the myelinating phenotype. These include an up‐ regulation of myelin‐gene expression (e.g. MAG and P0) and a down‐regulation of non‐myelin gene expression (e.g. p75NGFR and GFAP). In addition, Schwann cells fully differentiated by cAMP failed to initiate S‐phase entry in response to mitogens. Growth factors activating receptor tyrosine kinases (RTKs), including PDGF, FGF, IGF‐1 and neuregulin, failed to induce de‐differentiation of Schwann cells in the presence of cAMP, in spite of activating both MEK‐ERK and PI3‐K‐Akt signaling, two crucial pathways initiated by ligand‐stimulated RTKs. Similarly, serum factors were inactive at inducing de‐differentiation of Schwann cells. However, when cAMP was removed from the culture medium, the cells rapidly down‐regulated the expression of myelin genes, up‐regulated the expression of non‐myelin genes and re‐acquired their ability to enter the S‐phase in response to mitogenic factors, indicating that cAMP‐induced differentiation was not terminal but reversible. Strikingly, Schwann cells were able to undergo multiple cycles of differentiation and de‐differentiation exclusively dependent upon the addition and the removal of cAMP, respectively. In summary, the presence‐absence of cAMP worked as an effective ON‐OFF switch that allowed Schwann cells to shift from a proliferative (non‐differentiated) to a growth arrested (differentiated) phenotype in a reversible manner and independent of RTK signaling or cell proliferation.
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DEVELOPING A 3D CULTURE MODEL OF CNS MYELINATION {#sec2-386}
------------------------------------------------

### Loughlin J., East E., Golding J., Phillips J. {#sec3-386}

#### Open University, Milton Keynes, United Kingdom {#sec4-386}

*In vivo* studies of myelination and demyelination offer only snapshot views of these dynamic processes and do not permit longitudinal study at the cellular level, whilst 2D cultures fail to reproduce many of the most basic features of the complex spatial and mechanical environment in which CNS myelination occurs.

We are developing a 3D myelinating cell culture model that is amenable to continuous observation and controlled manipulation, which will allow us to follow the dynamic process of myelination *in vitro*. Oligodendrocyte precursor cells (OPCs) are isolated from P1‐2 rat pups, seeded into poly‐L‐ornithine‐coated flasks and expanded by treatment with b‐FGF and PDGF. OPCs are recovered and suspended within a neutralized solution of Type‐I rat‐tail collagen. This suspension is then poured into wells of a 24‐well or 96‐well plate, where it sets to form a gel with cells seeded evenly throughout its volume. Gels are 1 to 2 mm thick; sufficient to provide a 3D environment for the cells, yet still permit microscopic monitoring at all depths. Differentiation is triggered by withdrawal of PDGF and bFGF and addition of medium containing triiodothronine, ciliary neurotrophin factor (CNTF) and N‐acetyl cysteine. Within 2 days, expression of MBP is observed in differentiating oligodendrocytes, and, in co‐cultures with neurones, MBP^+^ oligodendrocytes are observed associated with axonal processes. Electron microscopic analysis of cultures that were maintained in differentiation medium for 3 days revealed myelin‐like structures.

Unlike existing 3D *in vitro* systems such as CNS explant cultures or reaggregate CNS cultures, our new system permits live cell imaging and time‐lapse microscopy during myelination. We are developing our model further to include other CNS cell populations and to further optimise myelin formation. This culture system has unique potential to study the dynamics of demyelination and to explore the potential of therapies to enhance remyelination.
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ELECTRON MICROSCOPY OF MYELIN USING CRYOMETHODS {#sec2-387}
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### Möbius W.,^1^ Ruhwedel T.,^1^ Eimer S.,^2^ Nave K.A.^1^ {#sec3-387}

#### ^1^Max‐Planck‐Institute of Experimental Medicine, Göttingen, Germany; ^2^European Neuroscience Institute, D‐37077 Göttingen, Germany {#sec4-387}

Myelin appears in electron microscopy as a multilayered structure of tightly apposed membranes with typical periodicity. It is composed of compact and non‐compact regions with different composition and function. Non‐compact myelin contains organelles as well as cytoskeletal elements. In‐depth morphological analysis is often hampered by the fact that myelin is prone to fixation and embedding artefacts. Therefore, we carried out a comparative study using perfusion‐fixed versus fresh optic and sciatic nerves of mice for cryofixation by high‐pressure‐freezing and subsequent freeze substitution. Morphological features like myelin periodicity, components of non‐compact myelin, membrane contacts and structures at the axon‐glia interface were compared to those of perfusion‐fixed and conventionally embedded samples. Replacing conventional room temperature embedding by freeze substitution already improved the preservation of myelin in fixed samples substantially, resulting in less shrinkage and membrane distortions. Myelin preservation is still superior in fresh frozen and freeze substituted samples compared to prefixed nerves, but damage by handling unfixed nerves and freeze damage become significant sources of artefacts. Despite this potential drawback, cryofixed samples contain morphological information which is often lost during chemical fixation. Based on the structural preservation of cryofixed optic nerves, a 3D reconstruction of early events during myelination will provide new insight into this complex process.

P‐388 {#sec1-388}
=====

LOW IRON AVAILABILITY PRECLUDES DEMYELINATION INDUCED BY CUPRIZONE {#sec2-388}
------------------------------------------------------------------

### Rosato Siri M.V.,^1^ Badaracco M.E.,^1^ Toscano M.A.,^2^ Rabinovich G.A.,^2^ Pasquini J.M.^1^ {#sec3-388}

#### ^1^School of Pharmacy and Biochemistry. UBA, Buenos Aires, Argentina; ^2^Institute of Biology and Experimental Medicine, Buenos Aires, Argentina {#sec4-388}

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) and was previously demonstrated that iron deficiency provides protection for the development of experimental autoimmune encephalomyelitis (EAE). The mechanism of EAE inhibition in iron‐deficient mice likely involves the delivery and metabolism of iron for optimal CD4+ T‐cell development (Grant et al., 2003).

It was described by us that animals under iron deficient (ID) diet exhibit hypomyelination. This myelin disruption was corrected by a single intracranial injection (ICI) of apotransferrin (aTf) (Badaracco et al., 2008).

Our laboratory has focussed on other models of demyelinating disease including those induced by the use of cuprizone (CPZ) in the diet (Adamo et al., 2005).

The aim of this work was to investigate in vivo the effect of an ID in CPZ‐induced demyelination. Pregnant Wistar rats were fed a control diet (40mg Fe/kg) or an ID diet (4‐6 mg Fe/kg) beginning at gestational day five. After weaning rats were fed a 0.6% CPZ diet during 2 weeks and allowed to recovered for another two weeks. Another group of animals under the same conditions were ICI with 350 ng of aTf. Animals were studied at 21, 35 and 49 days of age. It was clearly demonstrated that in the iron deficient rats, CPZ was not able to induce a more severe demyelination tested by different parameters such as myelin staining and immunohistochemical studies using anti NG2, MBP, GFAP and CD11b antibody. It was previously demonstrated by our group that CPZ effects are dependent of microglia activation (Pasquini et al, 2007 ).T cells and regulatory T cells Foxp3, Gata3, Tbet, RORgammat, IL‐27, IL‐10 and Gal‐1 were also analyzed in order to elucidate whether CPZ effects were mediated by T cell‐mediated mechanisms.
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IMPLICATION OF WNT/BETA‐CATENIN SIGNALING PATHWAY IN THE EXPRESSION OF PERIPHERAL MYELIN GENES IN SCHWANN CELLS {#sec2-389}
---------------------------------------------------------------------------------------------------------------

### Makoukji J. {#sec3-389}

#### Univérsité Paris Descartes, Paris, France {#sec4-389}

Wnt/beta‐catenin signaling pathway plays an essential role in the developmental processes, and the correct functioning of the nervous system. Moreover, this pathway is implicated in the progress of neurodegenerative diseases. We studied the regulation of myelin gene expression by Wnt/beta‐catenin signaling pathway in Schwann cells in vitro and in vivo. We showed that the expression of two major peripheral myelin genes MPZ and PMP22 is stimulated when we incubated Schwann cells with Wnt1 ligand or GSK3ß inhibitors (SB216763 and lithium chloride). Actually, lithium chloride (LiCl) activated by 5‐fold MPZ and PMP22 promoters and chromatin immunoprecipitation experiments showed that beta‐catenin binds directly to the TCF/LEF response elements in the promoter region of MPZ and PMP22, in the presence of LiCl. Furthermore, we found that Wnt/beta‐catenin pathway is essential for the basal expression of myelin genes. As a matter of fact, inhibition of major Wnt/beta‐catenin components by dominant negative forms of the receptor Frizzled or Dishevelled, or by siRNA targeting either beta‐catenin or LEF/TCF transcription factors inhibited the expression of myelin genes. In vivo studies showed that the treatment of adult mice with LiCl increased the mRNA and protein expression of myelin genes.

Our findings highlight the importance of Wnt/beta‐catenin signaling pathway in the expression of myelin genes, and open a new strategies in the treatment of demyelinating diseases or nerve injuries by targeting the Wnt/beta‐catenin signaling modulators.
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MORPHOLINO ANTISENS OLIGONUCLEOTIDE DELIVERY TO OLIGODENDROCYTES {#sec2-390}
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### Begou M., Gonthier C., Giraudet F., Depiets B., Vaurs‐Barriere C., Boespflug‐Tanguy O. {#sec3-390}

#### INSERM U931‐ CNRS 6247, Clermont‐Ferrand, France {#sec4-390}

Progress made in inherited dysmyelinating disorders demonstrated that myelination is particularly sensitive to protein dosage. For example, duplications of the entire proteolipid protein gene (*PLP1*) induce in human a severe X linked hypomyelination of the central nervous system, Pelizaeus‐Merzbacher disease (PMD). Over‐expression of PLP in transgenic mice (+PLP Tg mice) provokes a similar disease related to re‐compartmentalization of PLP along with cholesterol in late endosomes inducing oligodendrocytes apoptosis. Restoring physiological levels of PLP protein expression would improve oligodendrocytes survival. Following this hypothesis, the use of antisens oligonucleotides to decrease the PLP toxicity in oligodendrocytes represents a therapeutic approach. However, oligonucleotides as well as gene delivery to oligodendrocytes remains a challenge that has to be first solved. We tested the interest of morpholino antisens oligonucleotide (morpholino) that have proved their efficacity for exon‐skipping in X‐linked muscular dystrophy. For this purpose, we used transgenic mice expressing enhanced EGFP driven by the mouse Plp promoter regulatory elements (proPlp‐EGFP mice) in order to easily follow the delivery and efficacy of EGFP morpholino antisens in oligodendrocytes by fluorescence quantification

In a first *in vitro* approach, we used oligodendrocytes primary cultures from the proPlp‐EGFP mice and observed a fluorescence decrease in morpholino treated cultures compared to control one. We then tested this effect *in vivo* by administrating the EGFP morpholino antisens to proPlp‐EGFP mice using different routes of administration. No significant effect was observed after intraperitoneal and intrathecal administrations of the morpholino. A direct injection of the morpholino in the corpus callosum showed an important decrease of EGFP fluorescence at the injection site which diffuse to some extent laterally and rostrocaudally. The effect of chronic morpholino infusion of morpholino in ventricules using an osmotic pump is currently tested.
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EXPRESSION OF αB‐CRYSTALLIN IN MYELINATING OLIGODENDROCYTES DURING AVIAN RETINAL DEVELOPMENT {#sec2-391}
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### Seo J.H., Sohn H.J. {#sec3-391}

#### Department of Anatomy, School of Medicine and BK21 Chungbuk Biomedical Science Center, Chungbuk National University, Cheongju, Republic of Korea {#sec4-391}

Expression of αB‐crystallin is increased in neurons, oligodendrocytes and astrocytes under the pathologic condition. However, αB‐crystallin expression during normal development of the central nervous system has not been reported. This study aims to clarify that αB‐crystallin is expressed in myelinating oligodendrocytes in the chick retina. Expression of αB‐crystallin was first observed in the E16 retina. Thereafter, it was increased until E20. αB‐crystallin positive cells first appeared in the optic nerve at E14, in the central retina at E16, and in the peripheral retina at E20. In comparison with the previous stage, the number of αB‐crystallin positive cells at E20 was increased in the central retina and the optic nerve. αB‐crystallin‐immunoreactivity (‐IR) was spatiotemporally similar to myelin basic protein (MBP)‐IR. Differential immunostain demonstrated that αB‐crystallin was exclusively expressed in the myelinating oligodendrocyte. Results of this study, together with the reports that oligodendrocytes have low level of antioxidase and αB‐crystallin plays a role as a molecular chaperone, suggest that αB‐crystallin may play a part of protective roles against oxidative stress in myelinating oligodendrocytes.
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EXPRESSION OF THE TYROSINE KINASE RECEPTOR DDR1 IN HUMAN BRAIN MYELIN {#sec2-392}
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### Roig B., Martorell L., Abasolo N., Vilella E. {#sec3-392}

#### Hospital Psiquiàtric Universitari Institut Pere Mata‐IISPV‐Universitat Rovira i Virgili, Reus, Spain {#sec4-392}

Several studies demonstrated the presence of the protein kinase discoidin domain receptor 1 (DDR1) in mouse myelination during neurodevelopment and in a mouse experimentally induced re‐myelination by oral administration of cuprizone. However data on human brain DDR1 expression are scarce. Here, we describe the pattern of expression of DDR1 in the human adult cerebral cortex. Using several immunohistological and in situ hybridization techniques we identified DDR1 in several structures: 1) in myelin and oligodendrocytes in the white matter; and b) in capillary endothelial cells in gray as well as white matter. The most important overall finding in this study was that DDR1 is present in myelin. First we detected the presence of DDR1 mRNA in myelin and second the pattern of DDR1 immunostaining with an antibody against the C‐terminal of the receptor is indistinguishable from, and co‐localized with MBP, a classical myelin protein implicated in the process of myelination in the central nervous system. These observations suggest us that DDR1 could be an important constituent of myelin. Recently we have demonstrated high expression of DDR1 in human whole brain as well as the association between the gene and schizophrenia in a large case‐control population sample. Since defects in myelination are intimately involved in several mental disorders such as schizophrenia, the function of DDR1 in the myelination process warrants further investigation.
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RESPONSE OF HUMAN OLIGODENDROCYTE PROGENITOR CELLS TO GROWTH FACTORS AND AXON SIGNALS {#sec2-393}
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### Cui Q.L.,^1^ Fragoso G.,^2^ Miron V.,^3^ Darlington P.J.,^2^ Mushynski W.E.,^4^ Antel J.,^3^ Almazan G.^2^ {#sec3-393}

#### ^1^Montreal Neurological Institute, Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada; ^2^Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada; ^3^Montreal Neurological Institute, Montreal, Canada; ^4^Department of Biochemistry, McGill University, Montreal, Canada {#sec4-393}

Our objective was to define the capacity of growth factors (GFs) and neurons to enhance growth and differentiation of human fetal and adult oligodendrocyte (OGC) progenitor cells (OPCs).

OPCs were isolated from 15‐18 week human fetal and adult CNS based on A2B5 expression and grown in dissociated cell cultures and defined media (DFM) ± GFs alone or in co‐culture with rat dorsal root ganglia neurons (DRGNs).

The results showed that in dissociated culture and DFM, only 10% of fetal brain cells expressed the transcription factor Olig2 (progenitor cells), while 4% expressed O4 (pre‐oligodendrocytes). The combination of platelet derived growth factor AA (PDGF) with basic fibroblast growth factor (bFGF), as well as the combination of insulin‐like growth factor‐1 (IGF‐1)/brain derived neurotrophin factor (BDNF) increased the number of Olig 2 and O4 cells in the cultures, but only the PDGF/bFGF combination was associated with increased proliferation whereas the BDNF/IGF‐1 effects were mainly via differentiation. In this regard, BDNF/IGF‐1 promoted a highly significant increase in the proportion of GC+/O4+ cells (96%) relative to PDGF/bFGF (46%) or DFM (20%). The BDNF/IGF‐1‐treated GC+/O4+ cells had a more complex morphology compared to the other conditions. The four factors together further enhanced proliferation of Olig2+ (47%) and O4+ (80%) cells but decreased differentiation (42% GC+/O4+ cells). Co‐culturing BDNF/IGF‐1‐treated OPCs with DRGNs further enhanced differentiation (1 % expressed MBP versus \< 0.1% as compared to OPC cultures along). This treatment also enhanced the attachment of oligodendrocytes to and ensheathment of axons.

In contrast to embryonic OPC, 90% of adult A2B5+ cells also expressed O4. These cells had few cellular processes in DFM. Both BDNF/IGF‐1 and PDGF/bFGF enhanced cell morphological complexity, as well as MBP expression (45% and 62%, respectively) as compared to DFM alone (35%). Adult cells co‐cultured with DRGN in presence of BDNF/IGF‐1 gained MBP expression but were less capable of ensheathing axons when compared to the fetal OPCs.

In conclusion, our results demonstrate that growth and differentiation of human OPC are enhanced by selected GF and axonal contact. These in vitro systems provide means to identify additional molecules that promote or inhibit the myelination process.
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DEVELOPMENT OF GLIAL CELLS AND MYELIN IN THE SHARK EMBRYO CHILOSCYLLIUM PUNCTATUM {#sec2-394}
---------------------------------------------------------------------------------

### de Bellard M.E., Rotenstein L., Milanes A., Juarez M., Reyes M. {#sec3-394}

#### Csun, Northridge, United States {#sec4-394}

Glial cells are responsible for a wide range of functions in the nervous system of vertebrates. Sharks are the most ancient living organisms in evolution that exhibit a complex and large central nervous system in addition to a myelinated one. Much is known about the development of glia in other jawed vertebrates, but for elasmobranchs research is just starting to unveil their processes of neurodevelopment. The present work aims to study the development of glial cells in the bamboo shark, Chiloscyllium punctatum, by identifying the expression pattern of several classic glial and myelin proteins. We found that glial markers were present in shark nervous systems starting at the stage 25 of development. In addition, we observed myelinated peripheral nerves as early as developmental stage 32, suggesting that myelin appearance might be an earlier developmental event than previously thought. Partial support for M. Juarez participation on this project was provided by MARC Program, and NIH GM 2 T34 GM008959 to ME Zavala.

This work was partly supported by an NIH/NINDS AREA grant 1R15‐NS060099‐01 and NIH‐MBRS SCORE‐5S06GM048680‐13 to MEdB.
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AXONAL NEUREGULIN 1 TYPE III IS RESPONSIBLE FOR THE ACTIVATION OF NF‐KB IN SCHWANN CELLS DURING MYELIN FORMATION {#sec2-395}
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### Limpert A., Carter B. {#sec3-395}

#### Vanderbilt University, Nashville, United States {#sec4-395}

The formation of myelin requires a series of complex signaling events initiated by the axon to surrounding glial cells, which ultimately respond by wrapping the axon with layers of specialized plasma membrane thereby allowing for saltatory conduction. Activation of the transcription factor NF‐kB in Schwann cells has been suggested to be critical for these cells to differentiate into a myelinating phenotype; however, the mechanisms by which it is activated have yet to be elucidated. Here, we demonstrate that axonal membranes are sufficient to promote NF‐kB activation in cultured Schwann cells and identify neuregulin 1 (NRG1), specifically the membrane bound type III isoform, as the signal responsible for activating this transcription factor. Surprisingly, neither membrane bound type I nor the soluble NRG1 EGF domain could activate NF‐kB, indicating that type III induces a qualitatively unique signal. The transcriptional activity of NF‐kB was significantly enhanced by treatment with Forskolin, indicating these two signals converge for maximal activation. Both ErbB2 and 3 receptors were required for transducing the NRG1 signal, since gene deletion of ErbB3 in Schwann cells or treatment with the ErbB2 selective inhibitor, PKI‐166, prevented NRG1 type III from stimulating NF‐kB. In addition, PKI‐166 blocked the activation of the transcription factor in myelinating neuron/Schwann cell co‐cultures and in vivo, in developing sciatic nerves. Finally, we demonstrate the requirement for NF‐kB activation during myelination in vivo. Intraneural injection into postnatal day 1 rat sciatic nerve of a lentivirus expressing the NF‐kB inhibitor IkBa resulted in reduced NF‐kB activity and decreased myelin formation, based on expression of myelin basic protein. Taken together, these data establish axonal NRG1 type III as the activator of NF‐kB in Schwann cells, which is required for peripheral myelin formation in vivo.
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GLIAL EXPRESSION OF αB‐CRYSTALLIN AND HSP27 IN AVIAN CEREBELLAR DEVELOPMENT {#sec2-396}
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### Sohn H.J., Seo J.H. {#sec3-396}

#### Department of Anatomy, School of Medicine and BK21 Chungbuk Biomedical Science Center, Chungbuk National University, Cheongju, Republic of Korea {#sec4-396}

It is well known that small heat shock proteins play a role as molecular chaperon. However, during normal development of the cerebellum, expression and distribution of HSP27 and αB‐crystallin (αBC) which are small heat shock proteins have not been reported. To verify the protective role of HSP27 and αBC in neurons and glial cells, we examined the expression and distribution of HSP27 and αBC in the developing chick cerebellum using immunoblot, immunohistochemical and double immunofluorescence staining. Expression of both HSP27 and αBC was first identified in the cerebellum of the embryonic day 14 (E14) embryo, and was increased at E18. Double immunofluorescence analysis with myelin‐basic protein (MBP) demonstrated that αBC positive(+) cells were mature myelinating oligodendrocytes. αBC+ cells were observed in the white matter of the E14 cerebellum. At E18, there were a number of αBC+ cells in the white matter and a few cells in the granular layer of the gray matter. On the other hand, HSP27+ cells were observed in the white matter and the Purkinje cell layer at E14. At E18, HSP27+ signals were observed in Purkinje cells and neurons of cerebellar nucleus as well as oligodendrocytes in the white matter and the granular layer. The results that HSP27 and αBC were expressed in specific neurons and glial cells in the developing cerebellum suggest that HSP27 and αBC may be involved in the protective mechanism for the apoptosis of neurons and the physiological stress occurred in oligodendrocyts during cell maturation.
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PRISTANIC ACID AND PHYTANIC ACID, REFSUM DISEASE‐ASSOCIATED BRANCHED‐CHAIN FATTY ACIDS, AFFECT MITOCHONDRIAL FUNCTIONS AND CALCIUM REGULATION OF HIPPOCAMPAL NEURONS, ASTROCYTES, AND OLIGODENDROCYTES {#sec2-397}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Reiser G., Rönicke S., Kruska N. {#sec3-397}

#### Otto‐von‐Guericke Universität, Magdeburg, Germany {#sec4-397}

Pristanic acid and phytanic acid are branched‐chain fatty acids, which play an important role in diseases with peroxisomal impairment, like Refsum disease (MIM 266500), Zellwegers syndrome and alpha‐methylacyl‐CoA racemase deficiency (MIM 604489). Several studies revealed that the toxic activity of phytanic acid is mediated by multiple mitochondrial dysfunctions. However, the action of pristanic acid on brain cells is still completely unknown. The aim of the present study was the analysis of the toxicity of pristanic acid. Therefore, we characterized the influence of pristanic acid on intracellular Ca^2+^ homeostasis, mitochondrial membrane potential, ROS production and cell death in comparison to the better investigated phytanic acid. As a well established model, mixed primary cell cultures from rat hippocampus were used. Here, we exposed astrocytes, oligodendrocytes and neurons in mixed culture to pristanic acid and phytanic acid to analyze cellular consequences. Pristanic acid exerts a strong cytotoxic activity on brain cells, displayed by dramatic Ca^2+^ deregulation, in situ mitochondrial depolarization and cell death. Interestingly, pristanic acid strongly induced generation of reactive oxygen species (ROS), whereas phytanic acid exerts weaker effects on ROS production. In conclusion, pristanic acid as well as phytanic acid induced a complex array of toxic activities with mitochondrial dysfunction and Ca^2+^ deregulation. We observed a great specificity of the mechanism of toxicity of pristanic acid and phytanic acid, whereas palmitic acid at the same concentration did not exert any harm.
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HELPING TO START AND STOP MYELINATION: CSK HAS DUAL REGULATORY FUNCTIONS DURING OLIGODENDROCYTE DEVELOPMENT {#sec2-398}
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### Tzvetanova I.D., Mcclenahan F.K., Colognato H. {#sec3-398}

#### Stony Brook University, Stony Brook, United States {#sec4-398}

Ensheathment of axons by myelinating oligodendrocytes in the CNS is necessary for normal brain development and function. Oligodendrocytes arise from a proliferative and migratory pool of oligodendrocyte progenitor cells (OPCs) that, upon cell cycle exit, differentiate into myelinating oligodendrocytes. Because arrested or incomplete myelination contributes to CNS dysfunction in demyelinating diseases such as Multiple Sclerosis, it is important to identify mechanisms that control OPC cell cycle exit and subsequent differentiation. Here we identify Csk (C‐terminal Src Kinase) as a negative regulator of oligodendrocyte Fyn, a Src‐family kinase critical for myelination. We found that Csk expression and activity was regulated spatially and temporally during oligodendrocyte development. To study Csk function we depleted Csk in rat OPCs in vitro and in vivo using siRNA, as well as generated oligodendrocyte‐specific Csk null mice. Csk loss altered Fyn activity, yet, interestingly, we identified distinct and opposing roles for Csk in early versus late stages of development. Csk depletion in progenitors caused increased proliferation and stalled differentiation; this delayed oligodendrocyte differentiation was also observed in Csk‐deficient mice. A stall in maturation has also been observed in Multiple Sclerosis, where OPCs repopulate lesions but fail to myelinate. These data suggest that, during myelination onset, Csk is a pro‐differentiation factor to control OPC cell cycle exit. In adult mice, however, Csk deletion caused hypermyelination, suggesting that Csk also contributes to myelination arrest. Although there was no change in the number of mature oligodendrocytes, Csk deletion caused increased expression of myelin basic protein, as well as increased myelination in the cortex, cerebellum and spinal cord. Further analysis of myelin ultrastructure using transmission electron microscopy revealed increased numbers of myelin wraps such that the G‐ratio was significantly decreased. Small caliber axons were preferentially hypermyelinated in Csk mutant animals. Thus we identify Csk as a novel regulator of oligodendrocyte development with two roles: generating appropriate numbers of oligodendrocytes at the onset of myelination and terminating wrapping during myelination.
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DELETION OF ASTROCYTE CONNEXIN 43 AND 30 LEADS TO A DYSMYELINATING PHENOTYPE AND HIPPOCAMPAL CA1 VACUOLATION {#sec2-399}
------------------------------------------------------------------------------------------------------------

### Lutz S.E., Zhao Y., Gulinello M., Lee S., Schwartz G., Raine C.S., Brosnan C.F. {#sec3-399}

#### Albert Einstein College of Medicine, Bronx, United States {#sec4-399}

Astrocytes are coupled via gap junctions (GJ) comprised of connexin 43 (Gja1) and Cx30 (Gjb6) that facilitate intercellular exchange of ions. Astrocyte connexins also form heterotypic GJ with oligodendrocytic somata and lamellae. Loss of oligodendrocyte gap junctions results in oligodendrocyte and myelin pathology. However, whether loss of astrocyte GJ affects oligodendrocytes and myelin is not known. To address this question, mice with astrocyte‐targeted deletion of Cx43 and global loss of Cx30 (double knock‐out, dKO) were studied using western blotting, immunohistochemistry, electron microscopy, and functional assays. Commencing around post‐natal day 23 and persisting into old age, we found widespread pathology of white matter tracts comprising vacuolated oligodendrocytes and intramyelinic edema. In contrast, gray matter pathology was restricted to the CA1 region of the hippocampus, and consisted of edematous astrocytes. No differences were observed in synaptic density or total NeuN+ cells in the hippocampus, or olig2+ cells in the corpus callosum. However, in dKO mice, fewer CC1‐positive mature oligodendrocytes were detected, and western blotting indicated reduced myelin basic protein. Pathology was not noted in mice expressing a single allele of either Cx43 or Cx30. When compared with single connexin knock‐outs, dKO mice were impaired in sensorimotor (rotarod, balance beam assays) and spatial memory tasks (object recognition assays). In addition, mice deficient in astrocyte Cx43 and Cx30 exhibited a trend towards more severe pathology when subjected to experimental autoimmune encephalomyelitis, a model neuroinflammatory disease, and had elevated production of cytokines such as IL‐6 in response to an interleukin‐beta challenge. We conclude that loss of astrocytic GJ can result in white matter pathology that has functional consequences in physiologic and pathophysiologic processes.
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THE ROLE OF THE INTERACTIONS BETWEEN Aβ AND BASEMENT MEMBRANES IN THE PATHOGENESIS OF ALZHEIMERS DISEASE {#sec2-400}
--------------------------------------------------------------------------------------------------------

### Carare R.O.,^1^ Andrews A.L.,^1^ Jennings L.J.,^2^ Sidhu B.,^1^ Wyttenbach A.,^1^ Weller R.,^1^ Nicoll J.A.R.^1^ {#sec3-400}

#### ^1^University of Southampton, Southampton, United Kingdom; ^2^GE Healthcare UK, Chalfont, United Kingdom {#sec4-400}

Aβ accumulates in the brain in Alzheimer\'s disease. As the artery walls age, they become stiffer and perivascular elimination of Aβ fails with accumulation of Aβ in blood vessel walls. One of the routes for elimination of Aβ is by the interstitial fluid drainage pathway along basement membranes of capillary and artery walls. We aim to clarify the mechanisms involved in the perivascular drainage of Aβ. Firstly, we studied the pattern of drainage of Aβ from the brains of naïve mice. Secondly, we characterised the type of interactions between components of basement membranes and soluble Aβ.

MATERIALS AND METHODS: Recombinant Aβ40 and Aβ42 were processed to their non‐aggregated forms. Samples were scanned at an atomic force microscope. Naïve BalbC mice received a stereotaxic injection of solubilised Aβ40 (100 μM) into the left striatum. Mice were sacrificed 5 mins after the injection, and brains were processed for immunocytochemistry. Using confocal imaging and Zeiss Image Analysis, we studied the pattern of distribution of Aβ in relation to the cerebral vasculature. Surface plasmon resonance (Biacore) was employed to assess the binding affinity between Aβ and the laminin and agrin components of basement membranes. Serial injections of Aβ40 and Aβ42 were made over flow cells that contained laminin or agrin or a control agent. Results were analysed using BiaEvaluation software.

RESULTS: Atomic force microscopy confirmed the monomeric state of Aβ used in the experiments. Within 5 minutes of its injection, monomeric Aβ40 diffuses in the extracellular spaces of the grey matter and is distributed along the walls of blood vessels. Soluble, monomeric Aβ40 and Aβ42 bind to laminin and agrin. In the presence of agrin, Aβ42 commenced aggregation. We propose that the elimination from the brain of Aβ, is impaired due to blood vessel ageing; this leads to a disturbance of the homeostasis of the neuronal environment. Understanding the interactions between Aβ and the blood vessel walls enables the design of therapeutic interventions that could change the interactions between Aβ and basement membranes and facilitate the drainage of Aβ and other potentially toxic metabolites from the brain.
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GLIAL‐MEDIATED NEUROVASCULAR COUPLING IN THE NORMAL AND DIABETIC RETINA {#sec2-401}
-----------------------------------------------------------------------

### Mishra A., Newman E.A. {#sec3-401}

#### University of Minnesota, Minneapolis, United States {#sec4-401}

Functional hyperemia is the phenomenon by which local neuronal activity induces increases in local blood perfusion to provide for the heightened energy demands of the active neurons. This is a fundamental aspect of healthy brain function and disruption of the response is seen in many pathological conditions in both the brain and the retina, including diabetic retinopathy. Yet, the cellular mechanisms underlying functional hyperemia are not well understood. Recent evidence suggests that glial cells are important mediators of neurovascular coupling and our lab has previously demonstrated in the rat retina that light and glial stimulation evoke both vasodilations and vasoconstrictions. We showed that nitric oxide (NO) is an important modulator involved in the generation of bi‐directional vasomotor activity ‐ low levels of NO result in a primarily vasodilatory response while high levels result in increased vasoconstriction. We have now investigated the loss of functional hyperemia in diabetic retinopathy. Several groups have reported reduced functional hyperemia in the retinas of diabetic patients. We tested whether a similar reduction occurs in a streptozotocin‐treated rat model of type I diabetes. Indeed, we found that both the incidence and magnitude of light‐evoked vasodilations are reduced in the diabetic retina. In some cases, vessel responses in diabetic retinas are followed by or consist entirely of vasoconstrictions. Application of 1400W and aminoguanidine, two specific inhibitors of inducible NO synthase (iNOS), reverse this deficit in functional hyperemia. A similar change in vasomotor responses is observed in response to glial stimulation by uncaging of Ca^2+^; the incidence and magnitude of glial‐evoked vasodilations are reduced and those of vasoconstrictions are increased in the diabetic retina. Glial‐evoked vasomotor responses are also restored to control levels by treatment with aminoguanidine. These results indicate that abnormally high NO levels resulting from iNOS upregulation alter glia‐to‐vessel signaling and could underlie the loss of functional hyperemia in diabetic retinopathy.

Supported by NIH grant EY004077 and Leducq Foundation.
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ASTROGLIAL CONNEXINS AND BLOOD‐BRAIN BARRIER INTEGRITY {#sec2-402}
------------------------------------------------------

### Cohen‐Salmon M.,^1^ André P.,^2^ Cisternino S.,^2^ Thomas M.A.,^3^ Doutremer S.,^3^ Quenech\'du N.,^3^ Giaume C.^4^ {#sec3-402}

#### ^1^INSERM, Paris, France; ^2^INSERM U705, Paris, France; ^3^LPPA College de France, Paris, France; ^4^INSERM U840, Paris, France {#sec4-402}

The functional activity of the brain depends on the maintenance of the blood‐brain barrier (BBB), which isolates circulation from brain tissues but permits a continuous supply of oxygen and energetic substrates from the blood. BBB disruption is involved in many pathological processes, including neurodegenerative diseases. BBB is constituted of endothelial cells surrounded by astrocytes which play a crucial role in the BBB organization and functioning. Astrocytes communicate each other through gap junction channels (GJC) allowing direct exchanges of ions and small molecules (\<1kDa). Connexins (Cx) are the proteins forming GJC. In astrocytes GJC are composed by Cx30 and Cx43. Both Cx are highly enriched in astrocyte perivascular extensions called endfeet, closely located at the outer surface of blood vessel walls. Such molecular and structural specializations underlay networks of communicating perivascular astrocytes. The precise role of astrocyte Cx at the gliovascular interface is largely unknown. Here, we tested whether Cx30 and Cx43 play a role for BBB development/maintenance. Physical BBB integrity was tested on adult mouse models deleted for Cx30 and/or Cx43, by Horse Raddish Peroxidase (HRP) immunohistodetection after intrajugular injection, to localize BBB disruptions, and by in situ carotid perfusion of radiolabeled sucrose, to quantify the BBB permeability.

Deletion of Cx30 and/or Cx43 resulted in about 10 to 20 areas of HPR leakage per brain. HRP leaks were mainly observed in the cortex and olfactory bulbs, and concerned all type of vessels. In contrast, no leak was observed in C57Bl6 control mice. Quantification of BBB integrity in the whole brain, showed a small but significant elevation (p 0.02) of the brain vascular volume of sucrose in double mutant mice as compared to wild‐type mice. Altogether, these results suggest that deletion of astrocyte connexins weakens BBB, and may predispose to BBB leakage in a brain vascular pathological context.
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NANOPARTICLE NEURODELIVERY INCREASE IN A MODEL OF CHRONICALLY ALTERED BBB (MDX MOUSE) {#sec2-403}
-------------------------------------------------------------------------------------

### Kahn Z., Chretien F., Gherardi R., Cadusseau J. {#sec3-403}

#### INSERM U955, Créteil, France {#sec4-403}

As a trojan horse mechanism likely supports neurodelivery of infectious particles within monocytes/macrophages, we currently investigate the biodistribution and brain translocation of inert nanosized particles after i.m. injection. Brain is considered as efficiently protected from circulating elements by blood brain barrier (BBB). The present study aimed at evaluating the influence of BBB integrity in nanoparticle neurodelivery by comparing mice with chronically altered BBB (mdx) and normal controls (C57Bl6).

Fluorescent 500nm sized fluorescent particles (20 μL) were injected in both tibialis anterior muscles of mdx and C57 mice. At D21 and D90 post‐injection, brains were removed, hemispheres separated and treated either for macrophage/microglia (MM) extraction or histology. MM were extracted using CD45‐coupled magnetic beads (Miltenyi) and sorted according to their CD11b expression. Sorted cells were thereafter microscopically analyzed on cytospins for their fluorescent bead (fb) content.

At D21 the number of fb within MM was sixfold higher in mdx compared to C57 (49,5 fb per 50.10^3^ cells versus 8,3 per 50.10^3^). At D90 there was a further twofold increase of fb incorporation in mdx mice (96 fb per 50.10 cells).

Additionally there was a significantly higher proportion of both CD45^+^ or CD11b^+^ cells in mdx brains compared to C57 brains. Mdx brain sections, immunostained for CD11b, showed i) increase of their total number (35%), ii) dramatic alteration of their morphological phenotype (short processes encompassing blood vessels) iii) irregularly distribution throughout the parenchyma with large areas completely devoided of microglial elements and striking association with blood vessels for 83% of mdx microglia versus 12% for C57 microglia.

Chronically altered BBB is associated with both increased neurodelivery of inert particles and increased/altered microglia.
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LOCAL CELL PROLIFERATION IN DIRECT RETINAL BRAIN TARGETS UPON ENUCLEATION IN THE ADULT MOUSE {#sec2-404}
--------------------------------------------------------------------------------------------

### Cuyvers A., Smolders K., Van Brussel L., Arckens L. {#sec3-404}

#### K.U.Leuven, Leuven, Belgium {#sec4-404}

Gradually more evidence is emerging on the associations between neural and vascular plasticity. When metabolic activity in the visual cortex increases, e.g. by rearing in an enriched environment, the brain responds with compensatory angiogenesis. To investigate whether angiogenesis also occurs to support plastic changes as a result of sensory deprivation we investigated the effect of monocular enucleation on vasculature in the visual system of the mouse.

To identify newly formed endothelial cells within the vascular network, adult monocularly enucleated mice received daily injections of 5‐bromo‐2‐deoxyuridine (BrdU), maximally one week prior to sacrifice. Immunohistochemistry revealed BrdU‐labeled and thus newly formed cells after 7 days of enucleation in different subcortical visual structures, such as the contralateral superior colliculus and contralateral lateral geniculate nucleus, the ipsilateral medial preoptic area and ipsilateral retrochiasmatic area, left and right optic tract and the optic chiasm. On the contrary, no newly formed cells were apparent in the visual cortex. Local cell proliferation only appeared to occur within direct retinal targets, as verified by intraocular WGA‐HRP injections. This particular pattern of cell proliferation is not visible in mice sacrificed after 2, 14, 21 or 31 days of enucleation. We thus have established a specific time frame in which these new cells are formed.

Fluorescent double staining with glial, neuronal and endothelial markers has revealed that most of these newly formed cells are microglia, but also that a lot of the cells are associated with the vascular system.

These data suggest the occurrence of vascular and glial changes within 1 week as a response to sensory deafferentation in different subcortical structures of the mouse visual system.
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IMPAIRING ASTROCYTIC COUPLING MODIFIES ODOR‐EVOKED MAPS RECORDED BY FUNCTIONAL OPTICAL IMAGING IN THE OLFACTORY GLOMERULI {#sec2-405}
-------------------------------------------------------------------------------------------------------------------------

### L\'Heureux B.,^1^ Martin C.,^1^ Giaume C.,^2^ Pain F.,^1^ Gurden H.^1^ {#sec3-405}

#### ^1^IMNC lab, CNRS UMR8165, Orsay, France; ^2^Inserm 840 Collège de France, Paris, France {#sec4-405}

Functional imaging techniques such as BOLD‐fMRI (Blood Oxygen Dependent functional Magnetic Resonance Imaging) are widely used to map activity in the human brain. Functional signals have their origins in the vascular compartment and do not inform directly on neuronal activity. Thus, there is a need to understand mechanisms linking functional signals to activities of pre‐ post‐ synaptic neurons, interneurons and astrocytes at the synaptic triad.

Intrinsic optical signals imaging (IOSI) is widely used to map sensory‐evoked activity in rodents including odor‐evoked maps in the olfactory bulb (OB) in vivo. IOSI is a well described technique based on signals produced by changes in light scattering and absorption during activation. Like in BOLD, local changes in light absorption are due to blood oxygenation level, blood volume and flow. We have previously reported that IOS in the olfactory glomeruli, the functional units of the OB, are directly triggered by presynaptic glutamate release and astrocytic uptake. Knowing that gap junctions constituted of connexins (Cx) are necessary for inter‐astrocytic communication, we further explored the molecular routes linking local cellular activity to imaging signals by the detailed analysis of IOS in Cx‐knock out (Cx‐KO) vs wild‐type (WT) mice. First, we showed by immunochemistry that Cx30, but not Cx43, are mainly expressed in the olfactory glomeruli (see also L. Roux\'s poster on astrocytic coupling in this meeting). Then, we used IOSI to compare odor‐evoked activation maps from Cx30‐KO (n=6) and WT mice (n=6). Our results indicate that the spatial extent of the glomerular activation is different in these strains: analyzing dose (increased odor concentration) ‐ response (IOS amplitude, time course and surface) maps, we observed significant changes in the threshold of activation in Cx30‐KO, resulting in a higher number of activated glomeruli. These results confirm that the link between synaptic activity and functional imaging in olfactory glomeruli is provided by astrocytes (see also C. Martin\'s poster in this meeting for glucose processing). Astrocytic coupling regulates the triggering of optical signals rising from the vascular compartment and the number of odor‐activated glomeruli.

Support: ANR‐06‐NEURO‐004‐01 Astroglo; CNRS Ph‐D fellowship for B. L\'Heureux.
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LABELING OF PERIVASCULAR PHAGOCYTES BY BLOOD‐BORNE HRP IN THE SAMP10 BRAIN {#sec2-406}
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### Lee E.Y.,^1^ Suh Y.H.^2^ {#sec3-406}

#### ^1^Dept. of Anatomy, School of Medicine, Chungbuk National University, Cheongju‐City, Republic of Korea; ^2^Dept. of Pharmacology, School of Medicine, Seoul National University, Seoul, Republic of Korea {#sec4-406}

The present study examined the uptake of blood‐borne horseradish peroxidase (HRP) by perivascular cells in the senescence‐accelerated mouse prone‐10 (SAMP10) and senescence‐accelerated mouse resistant‐1 (SAMR1) brains. The following ages of the animals were studied: 3 month‐old SAMP10 and SAMR1 for young group, 12‐14 month‐old SAMP10 for aged group, and 12‐14 month‐old SAMR1 for age‐matched control. HRP solution was injected to a tail vein of the animal. At two hours after injection animals were transcardially perfused with 4 % paraformaldehyde and 1 % glutaraldehyde mixture. Brain sections made with a vibrating microtome were stained using DAB solution. Reaction products of HRP were frequently and intensely labeled in the perivascular cells along the microvasculature, especially in the young SAMP10 brain. Electron microscopy revealed that the reaction products were evident in the endothelium of the microvasculature, as well as in the perivascular phagocytes of arterioles or venules. In the aged SAMP10, the number of perivascular cells showing HRP‐reaction products was lower than in the young SAMP10. In addition, the intensity of HRP staining was very weak in the aged SAMP10 brain compared to young SAMP10. Further, the perivascular cells of aged SAMP10 brain contained abundant foamy vacuoles or lipid droplets. In both young and aged SAMR1 brains, HRP‐labeled perivascular phagocytes were very occasionally found. In conclusion, the present results showed age‐related decrease of the uptake of blood‐borne HRP by perivascular phagocytes in SAMP10 brain, which suggests microvascular barrier function may be altered with aging.
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BLOCKADE OF THE METABOTROPIC GLUTAMATE RECEPTOR MGLUR5 DOES NOT AFFECT NEUROVASCULAR COUPLING IN ADULT SPRAGUE‐DAWLEY RATS {#sec2-407}
--------------------------------------------------------------------------------------------------------------------------

### Calcinaghi N.,^1^ Jolivet R.,^1^ Wyss M.T.,^2^ Zunzunegui C.,^1^ Gasparini F.,^3^ Buck A.,^2^ Weber B.^1^ {#sec3-407}

#### ^1^Institute of Pharmacology & Toxicology, University of Zurich, Zurich, Switzerland; ^2^Pet Center, University Hospital Zurich, Division of Nuclear Medicine, Zurich, Switzerland; ^3^Novartis Institutes for Biomedical Research, Basel, Switzerland {#sec4-407}

Activation of the metabotropic glutamate receptor mGluR5 has been reported to affect neurovascular coupling in the somatosensory cortex of Wistar rats (Zonta et al, 2003) and to trigger Ca2+ transients in astrocytes of FVB mice (Wang et al, 2006). The authors hypothesize that activation of the metabotropic glutamate receptor mGluR5 on astrocytes triggers astrocytic Ca2+ transients which in turn lead to the production and release of vasoactive prostaglandin E2 by astrocytes (Takano et al, 2006) and that blocking mGluR5 disrupts the hemodynamic response upon neuronal activation. Similar results have been obtained in the murine olfactory bulb (Petzold et al, 2008). Even though mGluR5 was shown to be expressed in astrocytes (van den Pol, 1995) this receptor is primarily neuronal (Ferraguti and Shigemoto, 2006), a fact that is not in favour of a specific involvement of mGluR5 in neurovascular coupling. Here, we report that blockade of mGluR5 by i.v. injection of the mGluR5 antagonist 6‐methyl‐2‐(phenylethynyl)‐pyridine (MPEP) does not affect neurovascular coupling in the somatosensory cortex of adult Sprague‐Dawley rats as measured by optical spectroscopy and laser speckle imaging. Likewise, replacing MPEP by M‐MPEP, 2‐methyl‐6‐(phenylethynyl)‐pyridine, a specific mGluR5 antagonist 5 times more potent than MPEP, does not affect neurovascular coupling. Finally, simultaneous beta‐probe experiments with the radiotracer 11C‐ABP688 ‐ that binds with high specificity to mGluR5 (Wyss et al, 2007) ‐ show that an mGluR5 receptor occupancy of up to 60% does not alter the hemodynamic response. Additionally, CNQX, a potent antagonist of AMPA/Kainate receptor, was tested (injected i.v. as reported in Takano et al., 2006) in a separate set of experiments and a clear inhibition of hemodynamic components was observed.

Taken together, these results suggest that mGluR5 does not play a significant role in neurovascular coupling in adult Sprague‐Dawley rats. Multiplicity of input factors control astrocytic Ca2+ levels and alternative astrocytic glutamate‐related pathways are currently under investigation.
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TWO‐WAY EFFECTS OF FRACTALKINE IN THE DAMAGE OR SURVIVAL OF HAIR CELLS IN THE CORTIS ORGAN {#sec2-408}
------------------------------------------------------------------------------------------

### Sun S.,^1^ Li H.W.,^1^ Xue Z.,^1^ Wang T.F.,^1^ Li W.,^1^ Sun M.Z.,^1^ Yan X.K.,^1^ Liu S.F.,^1^ Lu N.,^1^ Feng Y.^2^ {#sec3-408}

#### ^1^EENT hospital, Fudan University, Shanghai, China; ^2^Institute of Neurobiology, Fudan University, Shanghai, China {#sec4-408}

Fractalkine, as an exclusive ligand for CX3CR1 expressed on microglia, has recently been reported to be released out by neurons, and induce microglial activation as a neuron‐to‐glia signal in the rodent brain. However, the exact role of this chemkine was not determined in the auditory nervous system. Our preliminary data reported that microglia‐like cells were presented in the Corti\'s organ. Then, we demonstrated that the microglia‐like cells were OX‐42 immunoreactive and they were activated in the inner ear following neomycin administration. In our recent in vivo studies, the increased level of CX3CR1 but not fractalkine in the inner ear of mice was observed by real‐time PCR. On the other hand, CX3CR1 expression were increased and co‐localized with OX‐42 positive cells (microglia‐like cells) in the Corti\'s organ compared with control group after injury. During in vitro studies, the basilar membranes cultured with neomycin were examined by immunohistochemistry. The number of hair cells was decreased. However, fractalkine completely co‐localized with myosinVIIA, a hair cell marker, and its immunoreactivity dramatically increased in the survival hair cells, while there was few OX‐42 or CX3CR1 positive cells on the cultured organ. Furthermore, when the basilar membrane cultured with different concentrations of exogenous fractalkine, the lower dose promote the survival of hair cells, however, the higher induced cells death. These results suggest two‐way effects of fractalkine in the damage or survival of hair cells and fractalkine‐to‐CX3CR1 signal may be involved in neomycin induced hearing loss.
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IMMUNOHISTOCHEMICAL CHARACTERIZATION OF PECULIAR OLIGODENDROCYTES IN THE LIZARD RETINA {#sec2-409}
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### Romero‐Alemán M.M.,^1^ Monzón‐Mayor M.,^1^ Yanes C.M.,^2^ Santos E.^2^ {#sec3-409}

#### ^1^University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain; ^2^University of La Laguna, la Laguna, Spain {#sec4-409}

The lizard retina is avascular, myelinated and shows peculiar oligodendrocytes displaying loose myelin sheaths in the nerve fiber layer (NFL) (Santos et al., J Neurobiol 2006 66:1115‐1124). For further characterization of this glial type, we have performed an immunohistochemical study in the lizard retina from the onset of myelination at late embryonic stages (E39) to adults using specific markers for the oligodendroglial line as the transcription factors Nkx2.2 and Olig2, as well as for astrocytes (GFAP), for the p75 neurotrophin receptor (p75NTR) and for the vesicular glutamate transporter 1 (VGLUT1). At E39, putative developing oligodendroglial cells are Nkx2.2+, Olig2+ and GFAP‐ in the NFL. By contrast, oligodendroglial cells in the adult NFL are Nkx.2.2‐, GFAP‐, Olig2+, p75NTR+ and VGLUT1+. A subpopulation of retinal ganglion cells in the ganglion cell layer and punctate staining in the inner plexiform layer are both, p75NTR+ and VGLUT1+. In addition, p75NTR+ putative horizontal cells and VGLUT1+ putative amacrine cells are observed in the inner nuclear layer. These data suggest that the transcription factor Nkx2.2 is mainly expressed in developing oligodendroglial cells whereas the Olig2 persists in mature oligodendrocytes. Moreover, a subpopulation of peculiar oligodendrocytes in the NFL seem to express both, p75NTR and VGLUT1, although their role and significance remains to be ascertained.

Supported by the Spanish Ministry of Education (BFU2007‐67139).
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RETINAL MICROGLIAL RESPONSE TO PHOTODEGENERATION INDUCED BY BRIGHT‐LIGHT EXPOSURE {#sec2-410}
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### Cuadros M.A., Santos A.M., Calvente R., Ferrer‐Martin R.M., Carrasco M.C., Sierra A., Martin‐Oliva D., Marin‐Teva J.L., Navascues J. {#sec3-410}

#### Universidad de Granada, Granada, Spain {#sec4-410}

The response of microglia to retinal photoreceptor degeneration after bright light exposure was studied by mean of several microglial markers (anti‐CD45, anti‐F4/80 anti‐SRA anti‐CD68). BALB/c mice were exposed to bright light (10,000 lux) for 7 hours and were then kept in complete darkness for 6, 12, 18, 24, 36, 48 or 72 hours and 10 days. Several methods confirmed that extensive degeneration, focused mainly on the Outer Nuclear Layer (ONL), occurred in light‐exposed retinas. First, a considerable thinning of the ONL of treated retinas was observed in semithin sections. Second, the number of free nucleosomes, an indicator of cell degeneration that was quantified by ELISA, was increased after photodegeneration. Third, the TUNEL technique revealed that most of the degenerating nuclei were in the ONL, where the photoreceptor nuclei are located. In addition, transmission electron microscope images also showed numerous degenerating nuclei in the ONL. Therefore, the light exposure procedure induces extensive cell death, nearly always photoreceptor cells, in the retina.

Diverse observations revealed that retinal microglial cells are activated in light‐exposed retinas:1They migrated to the region of early injury (ONL and subretinal space).2Retinal microglia transformed from more or less ramified cells to rounded cells with short thick processes.3Retinal microglia also showed immunophenotypic changes. Specifically, microglial cells increased the expression of anti‐CD45, anti‐F4/80, anti‐SRA and anti‐CD68 in response to photoreceptor cell death. In retinas obtained ten days after light exposure microglial cells still showed certain degree of activation: while their anti‐CD45 and anti‐F4/80 labelling were still strong, the expressions of CD68 and SRA molecules had returned to normal levels.

Activated macrophage/microglial cells, therefore, accumulate in affected regions and may play some role in the degeneration that occurs after light exposure. The nature of this role has yet to be elucidated.

Supported by grants BFU2007‐61659 from the Ministry of Science and Innovation (Spain) and P07‐CVI‐03008 from the "Junta de Andalucia".
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EFFECTS OF IBUDILAST ON MORPHINE TOLERANCE {#sec2-411}
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### Kalso E., Lilius T., Rauhala P. {#sec3-411}

#### University of helsinki, Helsinki, Finland {#sec4-411}

Opioid analgesics are effective in relieving pain but they can cause serious adverse effects. In long term use development of tolerance and dependence can also be major problems. Activation of microglia by opioids has been suggested as one mechanism for opioid induced adverse effects. Most of the evidence so far suggests a role for microglial activation in hyperalgesia and tolerance. Ibudilast, an inhibitor of glial activation and PDE enzyme, has shown potential in the treatment of neuropathic pain and opioid withdrawal. Because glial cell activation could also be involved in the development of opioid tolerance, we studied the antinociceptive effects of ibudilast and morphine in thermal nociceptive tests. Different models of co‐administration of ibudilast and morphine were studied. Antinociception was assessed in male Sprague‐Dawley rats using the hot plate and tail‐flick tests. The effects of ibudilast on acute morphine‐induced antinociception, induction of morphine tolerance and established morphine tolerance were studied. Systemic ibudilast produced some antinociception with dose‐limiting central nervous system depression. It had an additive antinociceptive effect when combined with systemic morphine. Co‐administration of ibudilast with morphine did not attenuate the development of morphine tolerance. However, in morphine tolerant rats, ibudilast partly restored morphine‐induced antinociception. It is concluded that ibudilast has a modest antinociceptive effect of its own and it is effective in restoring but not in attenuating morphine tolerance. Its potential in clinical use warrants further study.
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IMAGING NEUROINFLAMMATION WITH POSITRON EMISSION TOMOGRAPHY : THE QUEST FOR PROBES TARGETING THE TRANSLOCATOR PROTEIN 18 KDA {#sec2-412}
----------------------------------------------------------------------------------------------------------------------------

### Dolle F.,^1^ Boisgard R.,^1^ Damont A.,^1^ Van Camp N.,^1^ Kuhnast B.,^1^ Chauveau F.,^1^ Boutin H.,^2^ Hantraye P.,^3^ Tavitian B.^1^ {#sec3-412}

#### ^1^CEA, I2BM, SHFJ, Orsay, France; ^2^Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom; ^3^CEA, I2BM, MIRCen, Fontenay Aux Roses, France {#sec4-412}

Microglia activation is considered as the predominant cellular response to inflammation within the central nervous system. This process is characterized by a drastic change in the morphology of microglial cells and by their notable overexpression of the peripheral benzodiazepine receptor (PBR or as recently renamed TSPO 18 kDa). The radiolabelling of PK11195 with the positron‐emitter carbon‐11 in the mid eighties paved the way for the current concept of PET‐imaging of neuroinflammation using TSPO 18 kDa radioligands. \[11C\]PK11195 is still today considered as the compound of reference, but suffers from several drawbacks, limiting its dissemination and wider clinical use. Besides the short half‐life of carbon‐11 (20.38 min), the main problems are its rather low brain uptake, a high level of non‐specific binding (both leading to a poor signal‐to‐noise ratio) and an extensive binding to plasma proteins, which appear to complicate severely quantitative analysis of the receptor density. Since over two decades, extensive efforts have been undertaken to design and synthesize new radioligands circumventing some of the limitations observed with PK11195 \[1\]. These structures belong to different chemical classes: benzodiazepines, isoquinoline‐3‐carboxamides, quinoline‐2‐carboxamides, N‐benzyl‐N‐(2‐phenoxyaryl)acetamides, vinca minor alkaloids, alpidem derivatives (imidazo\[1,2‐a\]pyridin‐3‐ylacetamides and biosteric structures) and 2‐aryl‐8‐oxodihydropurines.

This chemistry‐orientated presentation first aims to compile most of the structures reported so far for the imaging of the TSPO 18 kDa. It will also present preliminary results of a comparative pharmacological evaluation by autoradiography of three newly designed fluorine‐18‐labeled ligands, DPA‐714 (a pyrazolo\[1,5‐a\]pyrimidineacetamide), PBR111 (an imidazo\[1,2‐a\]pyridineacetamide) and FEDAA1106 (a N‐benzyl‐N‐(2‐phenoxyaryl)‐acetamide) in a rodent model of acute neuroinflammation (unilateral striatal AMPA injection).

\[1\] Chauveau et al. Eur. J. Nucl. Med. Mol. Imag. (2008), 35, 2304--2319.
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AGE‐DEPENDENT DIFFERENTIAL PHENOTYPIC CHANGES OF GLIAL CELLS BY SYSTEMIC INFLAMMATION {#sec2-413}
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### Wu Z., Nakanishi H. {#sec3-413}

#### Kyushu University, Faculty of Dental Sciences, Fukuoka, Japan {#sec4-413}

Systemic inflammation induces age‐dependent differential cytokine responses by glial cells through the secretion of pro‐inflammatory molecules by leptomeningeal cells. Both microglia and astrocytes in the proximity of the leptomeninges produce anti‐inflammatory cytokines including IL‐10 and TGF‐β1 in the young adult adjuvant arthritic (AA) rats. In contrast, glial cells in close proximity to the leptomeninges in middle‐aged AA rats produce IL‐1β, COX‐2 and microsomal prostaglandin synthase‐1, but less IL‐10 and TGF‐β1. IL‐1β and PGE~2~ caused a marked loss of tight junction proteins in the leptomeninges. IL‐1β was found to enhance NMDA‐induced responses. On the other hand, IL‐10 and TGF‐β1 protected tight junction proteins against deleterious effects of IL‐1β and PGE~2~. Furthermore, TGF‐β1 was found to play an essential role in the increased number of stem/progenitor cells in the leptomeninges during systemic inflammation. Therefore, systemic inflammation can switch the differential phenotypes of activated glial cells in an age‐dependent manner. Non‐primed glial cells in the young rat brain are activated to be a protective phenotype upon systemic inflammation. On the other hand, primed glial cells in middle‐aged rat brains are activated to express harmful phenotype upon systemic inflammation.
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MICROGLIA TOLERATE REPORTER GENE‐MODIFIED AUTOLOGOUS, BUT NOT ALLOGENEIC, MESENCHYMAL STEM CELL IMPLANTS IN THE CENTRAL NERVOUS SYSTEM OF IMMUNE COMPETENT MICE {#sec2-414}
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### Tambuyzer B.R.,^1^ Bergwerf I.,^1^ de Vocht N.,^1^ Reekmans K.,^1^ Daans J.,^1^ Ysebaert D.,^2^ Chatterjee S.,^1^ Van Marck E.,^2^ Van Der Linden A.,^1^ Berneman Z.,^2^ Ponsaerts P.^1^ {#sec3-414}

#### ^1^University of Antwerp, Antwerp‐Wilrijk, Belgium; ^2^Antwerp University Hospital, EDEGEM, Belgium {#sec4-414}

Microglia are the so‐called gatekeepers of the central nervous immunology and presumably key role players in the recognition of foreign material within this environment. Therefore cell transplantation, besides its possible clinical relevance, provides an excellent tool to in‐depth dissect microglial responses upon specific changes in their proximity. We transplanted autologous mesenchymal stem cells (MSCs), in vitro genetically engineered to express two reporter genes EGFP and Luciferase, into the brain of immune competent mice. This setup was compared to allogeneic MSC transplantation and followed up to 4 weeks in vivo using bioluminescence imaging. Whereas reporter gene‐modified autologous MSCs survived up till 4 weeks, the allogeneic grafts were eliminated rapidly after 2 weeks as monitored by their decreasing luminescence signal. Histology of post‐transplantation brains revealed a strong microglial reaction (CD11b) at week 1 for all grafts. This reaction persisted until the elimination of allogeneic MSCs, but declined over time for autologous EGFP/Luciferase‐expressing MSCs probably resulting in their survival. At all time points MSCs were identified by their Sca‐1 expression. No other inflammatory cells -- e.g. T cells, B‐cells, NK‐cells, dendritic cells, granulocytes -- could be detected at the site of implantation. To further exclude T‐cells from the site of allograft rejection, well‐known for their role in allorecognition in the peripheral immune system, we performed murine IFN‐γ ELISPOT assays. Hereby, splenocytes from cell‐implanted animals were restimulated in vitro with the allogeneic MSCs. No memory T cells were detected from mice receiving an intracerebral transplant of allogeneic MSCs, whereas intramuscularly transplanted allogeneic MSCs did evoke such a T‐cell response. This striking observation could be confirmed in other strains as well. From our data, we conclude that allogeneic but not reporter gene‐modified autologous MSCs are rejected after intracerebral transplantation in immune competent mice. This process is mediated mainly by activated microglia without overt T‐cell involvement.
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MICROGLIA/NEURON INTERACTIONS IN A MURINE MODEL OF 6OHDA‐INDUCED DOPAMINERGIC NEURODEGENERATION {#sec2-415}
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### Virgone A.,^1^ Jurdic P.,^2^ Domenget C.,^2^ Honnorat J.,^1^ Nataf S.,^1^ Touret M.^1^ {#sec3-415}

#### ^1^Inserm U 842 Neuro‐oncologie et Neuro‐inflammation, Lyon, France; ^2^Endocrinologie Moléculaire et Différenciation, laboratoire de Biologie Moléculaire et Cellulaire UMR 49, Ecole Normale Supérieure, Lyon, France {#sec4-415}

Striatal injection of the neurotoxic compound 6 hydroxydopamine (6‐OHDA) has been widely used to induce dopaminergic neurodegeneration in rat models of Parkinson\'s disease. In contrast, systemic intoxication by MPTP (1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine) is preferred in mice and was shown to induce a robust inflammatory reaction along with a substantial loss of dopaminergic neurons. In the present work, we set up a model of 6 OHDA‐induced dopaminergic neurodegeneration in mice and assessed neuroinflammation and neuron/microglia interactions in the substantia nigra. 6‐OHDA was administrated in the striatum of C57Bl/6 female mice (n = 34) and both functional rotation test and immunohistochemical analyses were performed at different time points post‐injection (p.i.) (day 4, day 7, day 14 or day 21 p.i.). Functional alterations of the apomorphine‐induced rotation test were found to peak on day 7 post‐injection. At this time point, a mean 29% ± 2,6 loss of TH (tyrosine hydroxylase)‐immunopositive dopaminergic neurons was observed in the pars compacta ipsilateral to the injection. In parallel, microglial density as assessed by CD11b immunostaining rose by a mean factor of 3.3 and de novo expression of MHC class II molecules was observed on a sub‐population of microglial cells residing in the pars compacta. By performing double staining experiments we were able to evidence direct microglia/neuron interactions suggesting that microglial neuronophagia occurs in the pars compacta of injected mice. This model is currently used to assess microglial functions and microglia/neuron interactions in Dap‐12 knock‐in mice.
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ALLEVIATION OF NEUROTOXICITY BY MICROGLIAL HUMAN SIGLEC‐11 {#sec2-416}
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### Wang Y., Neumann H. {#sec3-416}

#### Institute of Reconstructive Neurobiology, Bonn, Germany {#sec4-416}

Sialic acid‐binding immunoglobulin superfamily lectins (Siglecs) are emerging as important regulators of the immune system. The recently discovered Siglec‐11 has immunoreceptor tyrosine‐based inhibitory motifs in the cytosolic domain, which interact with protein tyrosine phosphatase‐1 (SHP‐1) and/or SHP‐2, known to be involved in anti‐inflammatory signaling of microglia upon tyrosine phosphorylation. Siglec‐11 binds specifically to alpha 2‐8‐linked sialic acid, but the ligand molecule modified by 2‐8‐linked sialic acids and recognized by Siglec‐11has not been identified. Expression of Siglec‐11 as a human‐specific gene was found on microglia.

We analyzed whether Siglec‐11 participates in the immune regulation of microglia. We observed gene transcription and expression of Siglec‐11 splice variant 2 in human brain microglia by RT‐PCR, Western blot and immunohistochemistry. As a vitro study model, primary murine microglial cells were genetically modified by a lentiviral vector to express human Siglec‐11. Stimulation of Siglec‐11 by cross‐linking antibodies decreased gene transcription of the proinflammatory mediators interleukin‐1 β (IL1‐β) and nitric oxide synthase‐2 (NOS2). The polysialylated neuronal cell adhesion molecule (PSA‐NCAM) as a putative ligand of Siglec‐11 was detected on microglia and neurons. Co‐culture of Siglec‐11 expressing microglia and neurons demonstrated neuroprotective function of Siglec‐11. Neuronal cell body density and neurite density as determined by staining with specific antibodies directed against β‐tubulin‐III was higher in co‐cultures with Siglec‐11 expressing microglia than those with a control vector expressing microglia. Neuroprotective effect was dependent on sialic acid residues on neurons, but independent on sialic acid residues on microglia.

Thus, data demonstrate that human Siglec‐11 ectopically expressed in murine microglia reduces pro‐inflammatory cytokine transcription. Siglec‐11 expressed in microglia interacts with the sialylated glycocalyx of neurons and alleviates microglial neurotoxicity.
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PLASMA FIBRONECTIN ‐ AN ENDOGENOUS DAMP SIGNAL FOR TOLL‐LIKE RECEPTOR 4 ON MICROGLIAL CELLS {#sec2-417}
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### Scheffel J., Van Rossum D., Regen T., Brück W., Hanisch U.K. {#sec3-417}

#### University of Goettingen, Goettingen, Germany {#sec4-417}

Toll‐like receptors (TLRs) belong to the family of pattern recognition receptors recognizing an assortment of evolutionary conserved microbial structure motifs. Expressed by innate immune cells, such as microglia, TLRs trigger complex gene activations and functional mechanisms of host defence. In addition to LPS -- a common microbial agonist -- TLR4 may also accept endogenously derived agonists, i.e. molecules which are produced, released or structurally modified upon cell and tissue injury. Serving as damage‐associated molecular patterns (DAMPs), these factors induce similar emergency responses as triggered under infectious conditions in order to initialize or enhance antimicrobial protection, wound healing and repair. We now demonstrate that plasma fibronectin (FN) can serve as a DAMP signal for microglial cells utilizing the CD14/MD2/TLR4 pathway with associated MyD88 signalling. TRIF, the second intracellular adopter protein for TLR4, also provides contributions. However, no IFNß induction could be observed. We ruled out that trapped endotoxin as a confounding contaminant in FN preparations is responsible for the effects. Moreover, we found that FN can efficiently compete with LPS for TLR4. Microglial cells react in a ligand‐specific manner to stimulations with either LPS or FN, resulting in individual consequences for intracellular signalling events, induced gene patterns and the release of cyto/chemokines. The ligand‐specific response to FN is apparently also achieved by recruitment/involvement of accessory receptor/signalling elements, such as integrins, which may enrich and modulate the TLR4 signaling. Interestingly, this mechanism requires the conformational flexibility of FN, suggesting that the matrix‐crosslinked protein is invisible for microglia. Our findings indicate a role for a TLR4‐centered signaling in the activation of microglia by plasma‐derived proteins upon vascular impairment. This novel mechanism of sharing TLR(4) as a central binding and signaling unit could be an example for a common principle in DAMP signal recognition and supports the emerging concept of plasma factor‐driven microglia responses in CNS damage.

Supported by DFG (SFB/TRR43).
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### Diestel A.,^1^ Troeller S.,^2^ Spencer‐Haensch C.,^1^ Berger F.,^3^ Katharina Rose Luise S.^2^ {#sec3-418}

#### ^1^Charité Universitätsmedizin Berlin, Berlin, Germany; ^2^Deutsches Herzzentrum Berlin, Berlin, Germany; ^3^Deutsches Herzzentrum Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany {#sec4-418}

BACKGROUND: Hypothermia is induced in a variety of clinical conditions such as stroke, cardiac arrest and perinatal asphyxia and to protect the immature brain during complex pediatric cardiac surgery. Despite widespread interest in clinical applications of hypothermia, the cellular mechanisms of hypothermia‐induced neuroprotection have not yet been clearly understood. Therefore this study aimed to elucidate the cellular effects of clinically relevant hypothermia and rewarming on functional characteristics of microglial cells.

METHODS: Microglial cells were exposed to a dynamic cooling and rewarming protocol. For stimulation microglial cells were treated with 1 μg/ml LPS. Immunocytochemistry (IB4 and F‐actin) and time lapse video microscopy (SlideReactor) were performed to analyze morphological changes. Cell viability, activity and proliferation were assessed by MTT assay and cytokine release by ELISA.

RESULTS: Hypothermia led to morphological changes from ramified to amoeboid cell shapes. Twenty‐four hours after hypothermia and rewarming, microglial cells were again ramified. Moreover, we found enhanced cell activation 2 h after rewarming accompanied by increased phagocytosis. Interestingly hypothermia and rewarming led to time‐dependent up‐regulation of the anti‐inflammatory cytokines IL‐10 and IL‐1ra in stimulated microglial cells. Furthermore we found reduced proliferation and time‐dependent down‐regulation of the pro‐inflammatory cytokines TNF‐alpha, IL‐1ß and MCP‐1 in these cells compared to normothermic control cells after LPS stimulation.

CONCLUSION: Hypothermia and rewarming activate microglial cells and shift the balance of cytokine release in stimulated microglial cells towards the anti‐inflammatory cytokines. This may represent a new cellular mechanism of hypothermia‐induced neuroprotection. Although the total effects of hypothermia in humans are complex, understanding the mechanisms on the cellular level will lead to a better overall understanding and potentially more accurate prognosis of how hypothermia will modify patient outcome.

P‐419 {#sec1-419}
=====

ROLE OF ELECTROACUPUNCTURE ON ACTIVATION OF SPINAL GLIA {#sec2-419}
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### Feng Y.,^1^ Sun S.,^2^ Zhang F.,^1^ Guan F.,^1^ Wang T.P.,^3^ Chen B.Y.,^1^ Zhang Y.Q.^4^ {#sec3-419}

#### ^1^Institute of Neurobiology, Department of Neurobiology and Integrative Medicine, Shanghai, China; ^2^Central Medical Lab, Eye Ear Nose and Throat Hospital, Fudan University, Shanghai, China; ^3^Deparment of Acupuncture and Moxibustion, Wuhan, China; ^4^Institute of Neurobiology, Shanghai, China {#sec4-419}

Activated glia play a major role in mediating behavioral hypersensitive state following peripheral inflammation. Electroacupuncture (EA) is well known to relieve persistent inflammatory pain. Our present study revealed that electroacupuncture played different roles between normal and hypersensitive state. EA at the "Huantiao" (GB30) and "Yanglingquan" (GB34) acupoints (100/2 Hz alternation, 1‐2‐3 mA, 30 min) delivered to the ipsilateral hindpaw, repeatedly on day 1, 3, 5, and 7 post‐ monoarthritis (MA) or sham MA, then spinal astrocytic activation was examined. In normal saline‐induced sham MA rats, EA produced moderate increase in GFAP expression on the spinal cord, compared to sham EA or normal rats. However, in CFA‐induced MA rats, EA markedly suppressed MA‐induced up‐regulation of GFAP on the spinal dorsal horn, suggesting that EA can bi‐direct regulate spinal glial function. These results may raise a good reason for why EA does better effect for analgesia in inflammation pain.
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CD38 FACILITATES RECOVERY FROM TRAUMATIC BRAIN INJURY {#sec2-420}
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### Levy A.,^1^ Bercovich‐Kinori A.,^1^ Alexandrovich A.,^2^ Tsenter J.,^2^ Trembovler V.,^2^ Lund F.E.,^3^ Shohami E.,^2^ Stein R.,^1^ Mayo L.^1^ {#sec3-420}

#### ^1^Dept. of Neurobiology, Tel Aviv University, Tel Aviv, Israel; ^2^Department of Pharmacology, Hebrew University, Jerusalem, Israel; ^3^Dept. of Medicine, Div. of Allergy, Immunology and Rheumatology, Univ. of Rochester, Rochester NY, United States {#sec4-420}

Traumatic brain injury (TBI) is a major cause of death and disability worldwide. It causes progressive tissue atrophy and consequent neurological dysfunctions. TBI is accompanied by neuroinflammation, a process mediated largely by microglia. CD38 is an ectoenzyme that promotes transmembrane signaling via the synthesis of potent calcium mobilizing agents (cADPR, ADPR and NAADP) or via its receptor activity. CD38 is expressed in the brain in various cell types including microglia. In previous studies we showed that CD38 regulates microglial activation and response to chemokines. In view of the important role of neuroinflammation in TBI and the effects of CD38 on microglial responses, the present study examines the role of CD38 in the recovery of mice from closed head injury (CHI), a model of focal TBI. For this purpose, CD38‐deficient and wild‐type (WT) mice were subjected to a similar severity of CHI and the effect of the injury on neurobehavioral and cognitive functions was assessed by the Neurological Severity Score (NSS) and the Object Recognition Test, at various time points post‐injury. The results show that recovery after CHI (as indicated by the NSS) was significantly lower in CD38‐deficient mice than in WT mice and that the object recognition performance after injury was significantly impaired in injured CD38‐deficient mice compared with WT mice. In addition, we also observed that the amount of activated microglia/macrophages at the injury site was significantly lower in CD38‐deficient mice compared with WT mice. Taken together, our findings indicate that CD38 plays a beneficial role in the recovery of mice from CHI and that this effect is mediated, at least in part, via the effect of CD38 on microglia responses.
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PROTEOMIC ANALYSIS OF PKCEPSILON‐DEPENDENT ASTROCYTE ACTIVATION {#sec2-421}
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### Burgos M.,^1^ Lubec G.,^2^ Pedro T.^1^ {#sec3-421}

#### ^1^University of Castilla‐la Mancha, Albacete, Spain; ^2^Universität FÜR Kinder UND Jugendheilkunde, Medizinische Univerität Wien, Vienna, Austria {#sec4-421}

A growing body of evidence assigns astrocytes a capital regulatory role on brain immunity. Upon activation, astrocytes can release cytokines as well as other inflammatory molecules that affect neuronal survival in many neuropathologies. On the other hand, PKCepsilon (PKCε) is a kinase implicated in the activation of several cell types with immune functions. Central proinflammatory mediators such as NFκB are downstream targets of this kinase, and macrophages lacking PKCε show a defective activation in response to bacterial infections. Therefore, PKCε may be a crucial regulator for the progression of inflammation and immune‐mediated disorders.

Our laboratory analyzes the implication of PKCε in astrocyte activation in response to pro‐inflammatory stimuli. In previous studies we have demonstrated the implication of PKCε in the morphological transformation associated to astrogliosis. We also found that PKCε affects calcium homeostasis in astrocytes through the upregulation of voltage‐gated calcium channels. The present work examines the effects of astrocytic PKCε at the proteomic level. An adenoviral expression system allowed comparison of primary astrocyte cultures overexpressing PKCε with viral‐infection controls. The proteomics technique applied was based on two‐dimensional gel electrophoresis coupled with mass spectrometry. From the 549 spots unambiguously detected and quantified, 18 spots showed a differential expression when comparing PKCε‐overexpressing astrocytes and controls. Identification of the differential spots using a mass spectrometry apparatus Nano‐LC‐MS/MS (HCT) showed proteins implicated in inflammation such as Hsp60, 14‐3‐3ε or CRYAB; as well as other metabolic, chaperone, cytoskeletal and signalling proteins. These results underline that PKCε expressed in astrocytes participate in multiple processes, including signalling cascades implicated in neuroinflammation. Therefore astrocytes could modulate through PKCε activation the progression of neurological disorders such as Alzheimer disease, Parkinson syndrome or multiple sclerosis.

Supported by grants MOV‐2006/JI‐07 from FISCAM and SAN06‐010 from JCCM.

P‐422 {#sec1-422}
=====

ACTIVATION OF OLIGODENDROGLIAL TNFR1 BY MICROGLIA‐DERIVED TNF IS REQUIRED FOR LIPOPOLYSACCHARIDE TOXICITY TO DEVELOPING OLIGODENDROCYTES {#sec2-422}
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### Li J., Kim S., Steelman A., Koito H. {#sec3-422}

#### Texas A&M University, College Station, United States {#sec4-422}

Neuroinflammation and increased production of tumor necrosis factor (TNFα) within the central nervous system has long been implicated in many neurological diseases including white matter disorders periventricular leukomalacia and multiple sclerosis. However, the exact role of TNFα in these diseases and how it mediates oligodendrocyte death remain unclear. Previously we demonstrated that lipopolysaccharide selectively induces death of developing oligodendrocytes (preOLs) through induction of TNFα in mixed glial cultures (Li et al, 2008 *J Neurosci* 28: 5321‐30). Here we report that activation of oligodendroglial TNFR1 by microglia‐derived TNFα is required for LPS toxicity to preOLs. Using highly purified primary cells, we found that microglia, but not astrocytes, responded robustly to LPS and produced TNFα in a concentration‐dependent manner. Immunocytochemical analyses of LPS‐stimulated mixed glial cultures further revealed that microglia were the source for TNFα. Moreover, microglia from TNFα‐deficient mice were unable to kill preOLs in mixed glial cultures. The LPS‐triggered, microglia‐dependent death of preOLs was completely abrogated in mixed glial cultures prepared from TNF receptor 1 (TNFR1) knockout mice. GFP‐labeled preOLs, seeded into wildtype and TNFR1‐/‐ mixed glial cultures, underwent the same degree of death upon LPS treatment, demonstrating a requirement for oligodendrocglial TNFR1 in the toxicity. In pure preOLs, neither recombinant TNFα nor conditioned media from LPS‐treated mixed glia caused preOL death, suggesting the importance of active intercellular interactions in mediating oligodendroglial cell death. Taken together, our results demonstrate an essential role for oligodendroglial TNFR1 in preOL death under inflammatory conditions and imply that selected targeting of oligodendroglial TNFR1 may be beneficial in preventing OL damage in white matter diseases.
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IKK BETA‐MEDIATED MYELOID CELL ACTIVATION EXACERBATES INFLAMMATORY RESPONSE AND INHIBITS FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY {#sec2-423}
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Traumatic injury in the spinal cord is usually followed by massive infiltration/activation of innate immune cells such as neutrophils. Several studies on the role of these innate immune cells indicate that neutrophil infiltration exacerbates spinal cord injury (SCI) by upregulating putative neurotoxic mediators such as reactive oxygens species, cytokines, and proteases in the injured spinal cord. However, other studies with neutrophil‐depleted animals argue that neutrophil activation after SCI actually plays neuroprotective roles. Thus, the *in vivo* role of neutrophils activation in SCI remains to be elucidated. In this study, we tried to elucidate the *in vivo* role of neutrophil activation in SCI using myeloid cell‐specific Ikk beta conditional knockout (cKO; LysM‐Cre/Ikk beta^f/f^) mice. In these mice, Ikk beta gene is specifically deleted in myeloid cells including neutrophils and macrophages, and, therefore, IKK/NF‐kappa B‐dependent activations of these cells are compromised *in vivo*. We found that neutrophil and macrophage infiltration after SCI was significantly reduced in the cKO. In addition, the SCI‐induced proinflammatory gene expression was reduced in the cKO mice compared to control mice. The reduced neuroinflammation in the cKO mice accompanies with attenuation in neuronal loss, axonal damage, and behavioral deficit in motor activity. Our study revealed that SCI‐induced expression of CXCL‐1 (KC), a potent neutrophil‐attractant, was reduced in the cKO at early time point, which may be responsible for the reduced neutrophil infiltration in the cKO mice. Conclusively, our data demonstrate that IKK/NF‐kappa B‐dependent neutrophil and macrophage activation potentiates neuroinflammation and neuronal damage after SCI.
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We have previously reported that polyinosinic‐polycytidylic acids \[poly(I:C)\], a synthetic toll‐like receptor 3 (TLR3) agonist, induce Schwann cell activation, which exerts neurotoxic effects on sensory neurons. In this study, we investigated the effects of vasoactive intestinal peptide (VIP), a neuropeptide implicated in nerve regeneration, on TLR3‐induced Schwann cell activation. VIP receptors VPAC1 and VPAC2 were constitutively expressed in rat Schwann cells. VIP pretreatment inhibited TLR3‐induced inducible nitric oxide synthase (iNOS) gene expression and NO production in Schwann cells. Studies on the intracellular signal transduction pathways indicate that the VIP effect is mediated by protein kinase A activation. VIP also inhibited the poly(I:C)‐induced p38 activation that is responsible for the iNOS gene expression in Schwann cells. Finally, VIP inhibited dorsal root ganglion neuronal cell death caused by NO produced in activated Schwann cells. Taken together, our data suggest that VIP exerts a neuroprotective effect by inhibiting neurotoxic Schwann cell activation.

P‐425 {#sec1-425}
=====
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The ABC transporter P‐glycoprotein (P‐gp; ABCB1) is highly expressed at the blood‐brain barrier and enables multi‐drug resistance of the central nervous system. P‐gp actively pumps harmful compounds such as drugs and molecules involved in inflammation out of the brain endothelium. Here we demonstrate that brain vascular P‐gp expression and function is strongly decreased during the chronic neuroinflammatory disease multiple sclerosis (MS) and models thereof. In vivo, the efflux functionality and expression of brain endothelial P‐gp in an animal model for MS, experimental allergic encephalomyelitis (EAE) was significantly impaired. Strikingly, microvascular P‐gp expression is decreased in both MS and EAE lesions and its disappearance coincided with the presence of surrounding infiltrated lymphocytes. Our data strongly suggest that CD4+ T cells are the major inflammatory cell type that induce brain endothelial P‐gp malfunction by triggering a novel NF‐kB signaling pathway through intracellular adhesion molecule‐1 (ICAM‐1). CD4+ T cell binding to ICAM‐1 via LFA‐1 results in NF‐kB activation impairing P‐gp function whereas inhibition of NF‐kB activation restores endothelial P‐gp function. Our study provides first evidence that immune cells reduce specific protection mechanisms of the brain endothelium, which will prevent transport of harmful compounds out of the brain under pathological conditions and thereby aggravate neuroinflammation. Restoring P‐gp function might therefore be regarded as a future neuroprotective strategy in neuroinflammatory disorders.
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Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS. The animal models of MS, collectively known as experimental autoimmune encephalomyelitis (EAE), can be elicited by immunizing with CNS tissue or with components of CNS myelin.

Activation of microglia/ peripheral macrophages has been illustrated in acute and chronic MS/ EAE lesions, and importantly also in remote projection areas and histologically normal appearing white matter. Since microglia activation occurs at early disease stages, and is associated with elevated expression of the peripheral benzodiazepine receptor (PBR), PET imaging of microglia activation using PBR‐specific radioligands could offer a valuable tool for disease monitoring.

EAE was induced in Lewis rats by injecting a fragment of myelin basic protein (MBP). MBP68‐86 in saline (0.5 mg/ml) was emulsified with complete Freund\'s adjuvant (CFA), followed by injection of the emulsion (0.1 ml) into the hind footpads. Control rats were injected with a saline/CFA emulsion.

MicroPET and/or biodistribution studies of control and EAE rats were carried out 11‐12 days post immunization. Rats were injected with \[18F\]DPA714, followed by a 60 min scan. At the end of scan, rats were sacrificed, and the radioactivity content of selected organs was measured.

EAE induction using the aforementioned protocol results in an acute disease with extensive neuroinflammation in the spinal cord. Biodistribution and PET studies of EAE and control rats revealed no statistically significant differences in radioactivity uptake values in peripheral organs. Conversely, a 4‐fold higher uptake of \[18F\]DPA714 was measured in spinal cords of EAE rats compared to those of controls.

Importantly, the particular architecture of the spinal cord and the uptake of \[18F\]DPA714 in the vertebrae exerted significant partial volume effect, which misrepresented the differential radioactivity uptake in the spinal cords of EAE vs. control rats using conventional 2D OSEM reconstruction algorithm. Nevertheless, this difference was revealed using 3D OSEM‐MAP reconstruction.

Using \[18F\]DPA714, microglia activation in spinal cords of EAE‐induced rats could be monitored by PET. To the best of our knowledge, this is the first illustration of spinal cord lesions by PET molecular imaging using PBR ligands.
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Activated glial cells secrete inflammatory factors that have been implicated in several neurological diseases. In CNS inflammation, microglia and astrocytes interact with respect to the regulation to local innate immune reactions. However, up to now the knowledge about microglia‐astrocyte interaction under repeated inflammatory stress is relatively scarce.

Therefore, in this work, we investigated activation of primary astrocytes under sequential stimulation conditions. For a first stimulus of primary astrocytes, we used conditioned medium of the microglia‐like cell line BV‐2, which has been activated with LPS. Microglia are a major source of cytokines such as IL1ß and TNFα which are potent activators of astrocytes. Alternatively a more defined proinflammatory cytokine mix which contained TNFα, IL1ß and IFNγ was applied as primary stimulus. In both cases, activated astrocytes expressed higher levels of several genes linked to inflammation. In particular, mRNA of some pattern recognition receptors (PRRs) was upregulated significantly. This altered phenotype may be important in chronic inflammation and leads to the question whether pre‐activated astrocytes react in a different way to a secondary stimulus which targets PRRs or cytokine receptors. Therefore, we used microglia‐conditioned medium or several PRR‐ligands, respectively, as secondary stimulus. As readouts we used NF‐κB activation as receptor‐proximal signal and cytokine (IL‐6) secretion as more distal event. We found reactivity of astrocytes towards a secondary stimulus was increased. Pre‐stimulated astrocytes were activated at lower concentrations of secondary stimulus compared to non‐prestimulated cells. This finding might be crucial for the understanding of CNS host response and its pharmacological modulation.
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During mouse optic nerve development, FGF‐2 exerts a motogenic and chemoatractive effect on the migration of oligodendrocyte precursor cells (OPCs), which is mediated by FGFR1 and down modulated by the extracellular matrix protein Anosmin‐1 (Bribián et al., 2006). This protein, present in OPCs and in optic axons (Bribián et al., 2006; Clemente et al., 2008), has a potent role in OPC adhesion during optic nerve development, limiting the migratory capabilities of these cells (Bribián et al., 2008). The permissive environment that allow migration of OPCs during development, should be present in demyelinating diseases, including multiple sclerosis (MS), to produce an effective remyelination (Dubois‐Dalcq et al., 2005). In both MS and EAE, the molecular environment associated to the demyelinated areas change during the course of the demyelination, and OPC migration into the lesioned regions (and therefore remyelination) occurs only at the first stages of its progression but it is limited or inhibited at the last ones (Chang et al., 2002; Wolswijk, 2002). Although there are some reports about the presence of FGF‐2 in the cerebrospinal fluid of MS patients (Sarchielli et al., 2008), there are not histological evidences about that. In the present study, we analyze the distribution of FGF‐2, FGFR1 and Anosmin‐1 in human samples of MS and in EAE to elucidate if these molecules are related with the pathogenesis of demyelination and putative remyelination. In addition, cortical astrocytic cultures were grown in presence of IL‐1β and TNF‐α cytokines to elucidate if the expression of FGF‐2 and/or its receptor FGFR1 were up‐regulated in a pro‐inflammatory environment. Finally, we analyze if the chemotactic effects of FGF‐2 and Anosmin‐1 in OPC migration observed in embryos are functionally conserved in OPCs from the mature CNS.

Funded by MEC (SAF2007‐65845), Consejería de Sanidad (ICS06024/00) y Consejería de Educación y Ciencia de Castilla‐La Mancha (PAI08‐0242‐3822), FISCAM (G‐2008‐C8) and ISCIII (RD07‐0060‐2007).
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Upon any type of central nervous system (CNS) injury microglia become rapidly activated, a process which has long been thought to bedetrimental for neuronal survival. However, recent findings suggest that microglia display neuroprotective properties in various CNS pathologies.

In the present study we determined the effect of microglia depletion on excitotoxicity‐induced neurodegeneration using mouse organotypic hippocampal slice cultures. Treatment of slice cultures with 10‐50 μM N‐methyl‐D‐aspartic acid (NMDA) induced a region‐specific increase in neuronal cell death with CA1 neurons being most vulnerable to NMDA‐exposure, followed by CA3 and DG neurons, respectively (CA1\>CA3\>DG). This selective neuronal vulnerability correlated with activation of local microglia and was most pronounced in CA1 but almost absent in DG. Furthermore, ablation of microglia by treatment of slice cultures with liposome‐encapsulated clodronate (Lip‐CL), and subsequent exposure to NMDA, resulted in severely enhanced neuronal cell death in the CA3 and DG region.

Particularly, the resistance of DG and CA3 neurons to NMDA‐induced toxicity in presence of ramified microglia and the increased vulnerability of these neurons in absence of microglia suggest that ramified microglia contribute to the protection of neurons under pathological conditions.
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Insult to the central nervous system (CNS) mounts an innate immune response, in which microglia and astrocytes become activated. This response is critical for the induction of inflammatory cytokines and chemokines, which serve to recruit leukocytes to the injury site. The activation of glial cells and the entry of leukocytes may promote repair and regeneration processes in the damaged CNS, but may also cause additional pathology. To better understand these processes, it is important to study the mechanism of signalling in glial responses to injury. The glial response and leukocyte infiltration may involve a wide range of signals including pro‐inflammatory cytokines, such as type I interferons (IFNα/β), which are known to regulate innate immune responses against viral infections. IFNα/β signal through a receptor (IFNAR), which involves activation of STAT1/2 and interferon regulatory factor‐9 (IRF9), leading to activation of interferon stimulated genes including IRF7. The induction of IFNα/β is enhanced by IRF7. The aim of this study was to examine the involvement of IFNα/β signalling in the mouse hippocampus following transection of entorhinal afferents. Axonal injury induced up‐regulation of IRF7 and IRF9 in hippocampus measured by quantitative real‐time PCR. Double immunofluorescent co‐localization studies showed that IRF7 was induced in Mac‐1/CD11b positive macrophages/microglia in hippocampus after axonal transection. In addition, IRF7 mRNA was detected in FACS‐sorted microglia from lesion‐reactive hippocampi. The induction of IRF7 and IRF9 mRNAs did not occur in mice lacking IFNAR and so was IFNα/β‐dependent. Furthermore, lack of IFNα/β signalling resulted in increased leukocyte infiltration into the lesion‐reactive hippocampus. In mice lacking IFNα/β signalling, the fold induction of CCL2 and CXCL10 mRNA, but not TNFα and IL‐1β, were reduced. Our findings indicates the involvement of IFNα/β signalling in injury‐induced glial responses in the CNS, and provides additional information about innate signaling in inflammatory responses after CNS injury.
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Microglia are resident myeloid‐derived antigen presenting cells (APC) of the brain. In contrast to other organs, where terminally differentiated populations of resident APC outnumber colonizing precursors, most microglia remain in an undifferentiated immature state. Although the differentiation process of monocyte‐derived APC has been extensively studied, little is known about microglia differentiation.

We therefore exposed primary microglia from adult rhesus macaques to the prototypic dendritic cell differentiation (DC) regime of GM‐CSF + IL4 (G4). Such microglia acquired an expression profile of cell surface molecules reminiscent of DC, i.e. strongly reduced CD14 expression and enhanced expression of CD83, CD86, CD209 and MHCII. However, these cells proved to be poor APC for Tcells when used in mixed lymphocyte reactions. Furthermore, G4‐microglia did not produce pro‐inflammatory cytokines in response to Toll like receptor (TLR)‐mediated activation, irrespective of the TLR ligand used. This in marked contrast to GM‐CSF‐differentiated microglia or monocyte‐derived DC generated from the same donors. Multiplex analysis revealed that, in contrast to alternatively activated macrophages where TLR responses are skewed towards the production of anti‐inflammatory cytokines, G4‐microglia produced no detectable cytokines at all in response to TLR stimuli. To our surprise, NF‐kappaB activation and translocation to the nucleus were found intact upon TLR engagement. We will present data further elucidating the cell signaling cascade in G4‐microglia.

The apparent paradox between cellular phenotype and the absence of a pro‐inflammatory response to TLR activation was unique to microglia and might have implications in neuroinflammatory disorders as well as in neuro‐oncology where intrathecal production of GM‐CSF and IL4 has been reported earlier.
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#### Ben Gurion University, Department of Clinical Pharmacology, Faculty of Health Sciences, Beer‐Sheva, Israel {#sec4-432}

Bradykinin (BK), a nanopeptide, is known as a powerful mediator of peripheral inflammation. BK\'s effects are mediated through two kinin receptor subtypes, the B2 receptor, which is constitutive and is expressed by many cell types, and the B1 receptor, which is inducible and formed de novo under pathological conditions. It has been shown that kinins and their receptors are highly expressed in the brain under pathophysiological conditions such as inflammation. Brain inflammation includes activation of glial cells and release of inflammatory mediators such as prostaglandins, cytokines and free radicals. The role of bradykinin in the regulation of brain inflammation is not clear.

Previous results from our lab showed that in primary mixed glial cells, BK (B2 receptor agonist) has a short term stimulatory effect on the release of the inflammatory mediators, prostaglandin E~2~ (PGE~2~) and nitric oxide. However, Lys‐Des‐Arg~9~‐BK (B1 receptor agonist) has an inhibitory effect on inflammatory mediators production. The aim of this study was to investigate the long term regulation of primary astrocyte prostaglandin synthesis by BK and B1 receptor stimulation. Long --term exposure of astrocytes to BK increased basal PGE~2~ release by 100‐700 %, dose dependently, whereas long --term exposure to B1 receptor agonist dose dependently decreased basal PGE~2~ release by 30‐90 %. In lipopolysaccharide (LPS) induced cells, BK also enhanced PGE2 production by 10‐40 %, and B1 agonist decreased PGE~2~synthesis compared to LPS. The effects of both kinins on PGE~2~ synthesis were completely abrogated by actinomycin D, a transcription inhibitor and by cycloheximide, a translation inhibitor, suggesting de novo synthesis of proteins. Western blot for cyclooxygenase species (COX‐1 and COX‐2), that are responsible for the synthesis of PGE~2~, showed that treatments with BK in basal and LPS stimulated cells, increased COX‐2 protein levels about 2 fold, while treatment with B1 receptor agonist decreased COX‐2 protein back to control levels. Neither of the kinins altered COX‐1 protein levels in basal and LPS‐treated cells.

Our results imply, for the first time, a long term, dual role of kinins in regulation of inflammatory mediators in astrocytes.

This research was supported by the Israel Science Foundation (grant No. 349/07).
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#### University of Alberta, Edmonton, Canada {#sec4-433}

Microglia are the resident immune cells of the brain. During CNS disturbances, they are activated to take part in mounting of the inflammatory responses which can determine the survival of nearby cells. We have previously shown that the phenotype of activated microglia depend on the surrounding neurochemical environment they have been exposed to. Here, we investigate the effects of aging and its associated changes in brain chemistry on microglial activation. There is increasing evidence suggesting age as a factor that affects microglial phenotype, but a comprehensive comparison ranging from fetal to aged microglia has not been performed. We isolated primary microglial cultures from embryonic, neonatal (1 day old), young (2‐3 months old), 6‐8 months old, 9‐11 months old, and 14‐16 months old rats. We activated these microglia with adenosine 5′‐triphosphate (ATP) and examined the changes in their morphology, as well as their cellular and released effectors. We found that microglia derived from different age groups appear morphologically distinct. In addition, microglial phacocytosis, glutamate uptake, and release of nitric oxide, tumor necrosis factor‐α, and brain‐derived neurotrophic factor all showed age‐related differences. We found that these differences in microglial effectors contribute to their differential toxicity to neuronal cultures. The age‐dependent differences may be due to the differential expression of purinergic receptors, which we found are also different between the age groups. Altogether, we conclude that ATP induced an array of activation responses in microglia that are dependent on the age of rats they are derived from.

Funding acknowledgement: Canadian Institues of Health Research, Heart & Stroke Foundation of Canada, and Davey Endowment for Brain Research.
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INTRODUCTION: Molecules employed by CNS cells to locally modulate immune cells have not been fully elucidated. Programmed cell death‐1 (PD‐1) is a co‐inhibitory receptor expressed on activated immune cells. The interaction between PD‐1 and one of its ligands (PD‐L1/2) suppresses immune responses. PD‐L1 has been observed on immune cells, but also on epithelial and endothelial cells. Multiple sclerosis (MS), an inflammatory disease of the CNS, is characterized by astrocyte and microglia activation, immune cell infiltration, and oligodendrocyte injury. Experiments performed in an MS animal model (experimental autoimmune encephalomyelitis (EAE)) have shown that PD‐L1 or PD‐L2 blockade leads to an earlier onset and increased severity of the disease. Although, PD‐1 and its ligands were observed on infiltrating immune and CNS cells in EAE and MS, which cell types express these molecules have not been completely resolved.

OBJECTIVE: Our goal is to assess the expression of PD‐L1 and PD‐L2 by human CNS cells and to establish whether these molecules could locally contribute to modulate immune responses.

APPROACH AND RESULTS: Human primary CNS cultures were either kept under basal conditions or stimulated with pro‐inflammatory cytokines (IFN‐gamma, TNF‐alpha, IL‐1beta) respectively mimicking healthy vs. MS CNS environment. Human primary cultures of brain cells expressed barely detectable PD‐L1 and PD‐L2 levels, at the mRNA (RT‐PCR) and protein levels (flow cytometry and immunocytochemistry). Following pro‐inflammatory cytokine treatments, we observed an increased expression of both PD‐L1 and PD‐L2 on these cells, especially PD‐L1 on astrocytes and oligodendrocytes, while brain endothelial cells up‐regulated preferentially PD‐L2. Blocking PD‐L1 expression in astrocytes using siRNA led to enhanced alloreactive CD8 T cell responses (proliferation and cytokine production).

CONCLUSION: Our results show that PD‐L1 and PD‐L2 are basally expressed by human brain cells, but that such expression is boosted in a pro‐inflammatory environment. Moreover, CNS‐provided PD‐Ls molecules immuno‐modulate CD8 T cell responses. We are currently evaluating whether PD‐Ls are upregulated in MS lesions.
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The neurotransmitter noradrenaline (NA) can reduce inflammatory responses in both microglia and astrocytes, and is neuroprotective against inflammatory and excitotoxic mediated damage. Perturbation of endogenous NA levels could therefore contribute to or exacerbate pathology in neurological diseases or conditions. In contrast, treatment designed to elevate brain NA levels may be of value in the treatment of Multiple Sclerosis. To test these interrelated hypothesis, we first examined the effects of manipulating central NA levels on development of clinical signs in experimental autoimmune encephalomyelitis (EAE). Female C57Bl6 mice were treated with the selective neurotoxic DSP4 to lesion noradrenergic neurons in the Locus coeruleus (LC), and then immunized with MOG 35‐55 peptide to develop EAE. Assessment of clinical signs showed that DSP4 treatment led to an exacerbation of clinical signs. In a second set of studies, we tested if raising brain NA levels would attenuate clinical signs. Mice with EAE were given either the NA precursor L‐DOPS, which is directly converted to NA in brain by the enzyme L‐aromatic amino acid decarboxlyase (L‐AAAD), or the NA selective reuptake inhibitor Atomoxetine. Treatment with L‐DOPS slowed the progression of clinical signs when given to mice before the peak of disease; and was accompanied by a reduction in inflammation in brain. To determine if endogenous noradrenergic signaling is perturbed in EAE, we stained sections from control and EAE mice with antibodies to Tyrosine Hydroxylase (TH) to mark LC neurons, and to GFAP to monitor astrocyte activation. In the area of the LC we observed decreased intensity of staining for TH, which appeared to be weaker in cells closest to the IVth ventricle. In this region we also saw significant increases in GFAP staining. These data demonstrate that changes in noradrenergic signaling occur in EAE which may contribute to evolution of clinical disease. Treatments designed to raise brain NA levels may therefore be of benefit in MS patients.
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α‐Synuclein has been known to be a key player of the pathogenesis of Parkinson\'s disease, and has recently been detected in extracellular biological fluids and shown to be rapidly secreted from cells. The penetration of α‐synuclein into cells has also been observed. In the present study, we observed that DL‐threo‐1‐phenyl‐2‐decanoylamino‐3‐morpholino‐1‐propanol (PDMP), a glucosyltransferase inhibitor, and proteinase K inhibited the internalization of extracellular monomeric α‐synuclein into BV‐2 cells, and addition of monosialoganglioside GM1 ameliorated the inhibition of α‐synuclein internalization in PDMP‐treated BV‐2 cells. Furthermore, inhibition of clathrin‐, caveolae‐, dynamin‐dependent endocytosis did not prevent the internalization of α‐synuclein, but disruption of lipid raft inhibited it. Inhibition of macropinocytosis and disruption of actin and microtubule structures also did not inhibit the internalization of α‐synuclein. In addition, we further confirmed these observations by coculture system of BV‐2 cells and α‐synuclein overexpressed SH‐SY5Y cells. These findings suggest that extracellular α‐synuclein is internalized into microglia via GM1 as well as hitherto‐unknown protein receptors in clathrin‐, caveolae‐, dynamin‐ independent, but lipid‐raft dependent manner. Elucidation of the mechanism involved in internalization of α‐synuclein should aid the development of new treatments of α‐synuclein‐related neurodegenerative diseases.
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Brain inflammation accompanied with brain injury has been considered as a cause of delayed neuronal death. However, most inflammation studies have focused at the times when neuronal death was detected. Thus, it is necessary to evaluate behavior of inflammatory cells from early injury state and their effect on neurons. When ATP was injected into the substantia nigra pars compacta (SNpc), within 3 h, not only dopaminergic neurons but Iba‐1+ microglia died in the core, and morphologically activated thick process‐bearing microglia arranged around the injury sites. At 2 d, round Iba‐1+ cells were detected in the penumbra, and densely filled the core and penumbra at 7d. The round Iba‐1+ cells considered blood monocytes since they highly expressed CD45, a marker of monocytes. Interestingly, iNOS protein was hardly detected in brain sections obtained at any times after ATP‐injection although IL‐1 beta was detected in Iba‐1+ cells in penumbra from 3 h to 1 d, and ED‐1 (a marker of phagocytic activity) in Iba‐1+ cells in both core and penumbra from 3 d to 7 d. Interestingly, however, the number of dopaminergic neurons did not decrease from 3 h to 7 d despite of activated microglia and vigorously infiltrated monocytes. In the cortex, similar results were obtained: ATP induced acute death of neurons and microglia in the core, and infiltration of round‐shaped Iba‐1+ cells without further increase in neuronal damage. These results suggest that blood monocytes as well as microglia participate in brain inflammation. However, both types of cells express limited kinds and amounts of inflammatory mediators at least in ATP‐injected brain, and do not cause delayed neuronal death.
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Many experimental studies have documented important role of cytokines during different types of neuropathy and their potential to induce or facilitate neuropathic pain. Interleukin‐6 (IL‐6) is a proinflammatory cytokine involved as a key signal molecule in the neuronal and immune responses to nerve injury. A biological effect of IL‐6 is mediated by two signal‐transducing receptors: glycoprotein 130 (gp130) and IL‐6 receptor (IL6r). The gp130 receptor is a transmembrane glycoprotein and integral part of STAT3 signaling pathway.

We have investigated immunohistochemical localization of IL‐6, gp130, IL6r and activated STAT3 in both ipsilateral and contralateral lumbar (L4‐5) and cervical (C7‐8) dorsal root ganglia (DRG) following chronic constriction injury (CCI) of sciatic nerve. Immunostaining for glutamine synthetase (GS) and ED‐1 were used for detection of satellite glial cells (SGC) and macrophages, respectively. In addition, in situ hybridization was used to prove IL‐6 synthesis in DRG. Twenty eight male rats were operated on triple unilateral ligation of right sciatic nerve (CCI) and allowed to survive for 1, 3, 7 and 14 days. All surgical procedures were performed aseptically under deep anesthesia by a xylazine and ketamine. To test neuropathic pain induction, withdrawal threshold of mechanoallodynia and thermal hyperalgesia was measured by Dynamic plantar aesthesiometer (UGO BASILE) and Plantar test (UGO BASILE), respectively.

Immunohistochemical and in situ hybridization results revealed that besides neurons SGC of DRG associated with injured nerve are source of IL‐6 protein. Bilateral elevation of immunostaining for IL‐6r in SGC was detected only in L4‐5 DRG 1 week from CCI. In contrast to naïve DRG, enhanced immunoreactivity for gp130 and STAT3 was present in SGC of both C7‐8 and L4‐5 DRG following unilateral CCI. The results suggest that unilateral nerve injury used as neuropathic pain model induces synthesis of IL‐6 and its IL‐6r in the SGC of DRG associated with injured nerve. Therefore, biological effects of IL‐6 during neuropathic pain are probably driven by IL‐6r, because gp130 and activated STAT3 are expressed by SGC of both cervical and lumbal segments.

Supported by GACR 309/07/0121 and MSM0021622404.
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Multiple Sclerosis is a chronic inflammatory disease of the central nervous system (CNS). Studies of the histopathology of the demyelinated lesions characteristic of MS (Lucchinetti et al., 2000; Raine and Scheinberg, 1988) have revealed heterogeneity at the cellular and molecular level, which might reflect the diversity of the clinical disease course. In previous studies, we identified molecular changes in MS normal appearing white matter (NAWM) of post‐mortem tissue (Graumannn el al.,2003; Zeis et al., 2008), where we demonstrated that the MS brain is mounting a global defence against oxidative stress as well as anti‐inflammatory mechanisms. Additionally, in a single‐case study, we showed earliest molecular changes in white matter surrounding an actively demyelinating lesion during the first manifestation of MS, pointing towards a more widespread pathological process taking place in MS white matter. To get more insights into the possible molecular changes in early stages of MS, we are studying the differential gene expression pattern in formalin‐fixed paraffin‐embedded (FFPE) MS NAWM biopsies. In a pilot study, we compared the gene expression patterns of matched fresh‐frozen as well as 6, 12 and 24h formalin‐fixed and paraffin‐embedded MS NAWM tissue. We could show that from all analyzed genes, about 50% showed no fixation dependent changes. Therefore, gene expression analysis of MS NAWM of biopsies from early MS patients is feasible, and will enable us to identify differences between molecular alterations in early and late phase of the disease, as well as possible differences between the newly discovered MS pattern types.
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Microglial cells, like other macrophages, can commit to diverse reactive phenotypes in order to adapt and alter responses to exogenous as well as endogenous challenges and environmental conditions. Their activities may also change during development and CNS tissue maturation. We established a technique to isolate microglia at various time points (from birth to adulthood) and to keep cells in culture for an extended time period with the possibility of repeated harvests. These preparations comprise whole brain as well as distinct CNS regions including spinal cord. Cells were analyzed for functional properties such as induction of cyto‐ and chemokines in response to stimulation of TLR1/2, TLR4 and TLR6/2 with microbial and putative endogenous agonists. While the functional readouts of the cultures remained stable during the time in vitro, marked differences were observed depending on the time points (animal age) of preparation. Profiles of functional properties over the postnatal period (compared to P0 microglia) revealed, for example, drastic but temporary decreases or increases in inducible amounts of the proinflammatory cytokine TNFα and the neutrophil‐attracting chemokine CXCL1. Similar profiles were obtained with microglia of Iba1‐GFP‐transgenic and C57BL/6 wildtype mice. Studies were also extended to NMRI wildtype mice to assess differences between inbred and outbred strains. The characteristic time courses suggest that microglial properties were not simply overwritten by the culture conditions but rather indicate dramatic reorganization of the TLR signaling in microglia as the surrounding tissue matures, e.g. by forming myelin sheets. Accompanied by in vivo approaches data are alternatively discussed as to systemic versus CNS‐specific factors and mechanisms which could instruct and underlie the microglial behavior. Taken together, this method could complement in vivo and acute ex vivo studies by allowing for cell‐specific experimental manipulations and response monitoring.

Supported by the DFG (SFB/TRR43).
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Immune homeostasis in the central nervous system (CNS) is maintained by resident microglial cells. Clearance function of microglia is essential for CNS tissue homeostasis. Debris clearance is mediated by triggering receptor expressed on myeloid cells‐2 (TREM2) and signal immunoregulatory protein‐β1 (SIRPβ1), both being microglial phagocytic receptors associated with the ITAM‐signaling adaptor molecule DAP12.

SIRPβ1, TREM2 and DAP12 gene transcripts were up‐regulation in embryonic stem cell derived microglia (ESdM) subsequent to treatment by interferon‐α (IFNα), interferon‐β (IFNβ) or lipopolysaccharides (LPS). Phagocytosis of aggregated amyloid‐β1‐42 (Aβ) under the same conditions revealed an increase in internalized Aβ. Lentiviral knock down of DAP12 decreased phagocytosis of aggregated Aβ compared to a control vector.

To mimic an acute or chronic, systemic infection, LPS or IFNα were injected i.p. in C57BL/6 mice. SIRPβ1, TREM2 and DAP12 gene transcription in the CNS showed a time depend response: at short term treatment IFNα increased transcription of all three phagocytosis associated genes, while after long term treatment over several weeks, the same gene transcript levels were decreased. Following LPS treatment all analyzed genes were up‐regulated independent on the time period of treatment.

Functional role of TREM2 was analyzed in TREM2‐deficient mice challenged by systemic and chronic LPS application. LPS was injected i.p. twice a month over a 2 months period in 4 months old TREM2‐/‐ mice, which were analyzed afterwards at the age of 6 months. Substantia nigra sections were studied by catecholaminergic staining and revealed substantial axonal damage in LPS‐treated TREM2‐/‐ mice compared to age matched wildtype controls. The LPS‐treated TREM2‐/‐ mice showed sustained formation of axonal spheroids, while very mild symptoms of axonal damage were detected in phosphate buffered saline (PBS)‐treated TREM2‐/‐ mice, but not in LPS or PBS challenged wildtype controls.

Our data demonstrate an effect of inflammation on microglial phagocytosis and on SIRPβ1, TREM2 and DAP12 gene transcription in the CNS, along with an increased degeneration of nigrostriatal axons in TREM2‐/‐ deficient mice.
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Microglia activation is a prominent feature in many neuroinflammatory disorders. Unrestrained activation generates a chronic inflammatory environment that might lead to neurodegeneration and autoimmunity. Extracellular adenosine modulates cellular activation through adenosine receptor (ADORA)‐mediated signaling. There are four ADORA subtypes that can either increase (A2A and A2B receptors) or decrease (A1 and A3 receptors) intracellular cyclic AMP levels. The expression profile of ADORA subtypes thus orchestrates the cellular response to extracellular adenosine.

We have investigated the expression of ADORA subtypes in non‐activated and Toll‐like receptor (TLR)‐activated primary rhesus monkey microglia. Activation induced an up‐regulation of A2A and a simultaneous down‐regulation of A3 receptor (A3R) levels. As a consequence, ADORA‐mediated inhibition of TLR‐induced TNFα and IL‐12p40/p70 production was much stronger in activated than in non‐activated microglia. This could be attributed to an increase in A2AR‐mediated signaling and involved suppression of NF‐κB activation. By using combinations of subtype‐specific agonists and antagonists we found that in non‐activated microglia, A2AR‐mediated inhibitory signaling was effectively counteracted by A3R‐mediated signaling. In activated microglia, the decrease in A3R‐mediated signaling sensitized them to A2AR‐mediated inhibitory signaling.

In conclusion, we report a differential, activation state‐specific expression of ADORA in microglia and uncover a role for A3R as dynamically regulated suppressors of A2AR‐mediated inhibition of TLR‐induced responses. These findings contribute to our understanding of how inhibitors of cellular activation are regulated themselves, and can have relevance for therapeutic intervention in neuroinflammatory disorders where ‐chronic‐ microglia activation often is an unwanted feature.
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Nerve Growth Factor (NGF) is essential for sensory neurons of the peripheral nervous system and seems to have opposite effects when administered peripherally or intrathecally (i.t.). We synthesized several NGF like peptides, one of these, L1L4, reduced neuropathic behaviour induced by spared nerve injury (SNI) of the sciatic nerve. We investigated the effects of 7 days i.t. continuous infusion of NGF or L1L4 or ACSF on neuroglial network in the spinal cord related to neuropathic behaviour. Allodynic and hyperalgesic behaviour was investigated by Von Frey filament and thermal Plantar test on day 0, day 3 after SNI and day 10, at the ending of treatment. We evaluated on lumbar spinal cord the expression of the inflammatory microglial marker Iba1, and the hallmark of reactive astrocytosis GFAP. To evaluate the injury and neurotrophin effects on neuroglial network, we analyzed the expression of glial (GLT1) and neuronal (EAAC1) glutamate transporters and glial glycine (GlyT1) transporter. Moreover, to map glutamate and GABA synaptic pattern, we analyzed in the dorsal horn the expression of glutamate (vGLUT) and GABA (vGAT) vesicular synaptic transporters and glutammic acid decarboxilase (GAD). NGF and L1L4 treated animals showed reduced allodynia and thermal hyperalgesia, compared to ACSF treated animals. Treatment with NGF or L1L4 significantly reduced Iba1 and GFAP levels compared to ACSF group. Moreover NGF and L1L4 treatment restored the decreased expression of glial transporters evident in ACSF group. In these neuropathic animals, the reduction of glial transporters was counterbalanced by a net increase of the neuronal glutamate transporter, lacking in NGF or L1L4 treated animals. Marked changes of GABAergic synaptic compartment with increased expression of synaptic GABAergic markers, were detected in neuropathic ACSF rats, these were reverted by i.t. NGF or L1L4 treatment. No changes were revealed on glutamatergic synaptic compartment in both groups. Our results indicate that i.t. NGF or L1L4 administration reverses inflammatory and neuro‐glial morpho‐molecular changes occurring in neuropathic animals, suggesting a potential role of i.t neurotrophin administration as anti‐inflammatory tool, and in restoring synaptic pattern in the spinal cord and determining analgesia in neuropathic pain.
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Nerve Growth Factor (NGF) plays a key role in the well‐being of several classes of central nervous system neurons and determining functional neuroglial networks. This factor is produced by a plasmin dependent proNGF/mNGF conversion; the mature form is undetectable because degraded by metalloproteinase (mainly MMP9). To evaluate the effect of endogenous NGF increase on neuroglial network in the spinal cord in a rat model of neuropathic behaviour induced by spared nerve injury (SNI), we investigated the effects of 7 days continuous intrathecal (i.t.) infusion of MMP9 inhibitor (GM6001 ‐ GM), tPA inhibitor (Neuroserpin ‐ NS) and ACSF. Allodynic and hyperalgesic behaviour was investigated by Von Frey filament and thermal Plantar test on day 0, day 3 after SNI and day 10, at the ending of treatment. By in situ zymography we evaluate MMP9 proteolytic activity, then we analyzed the expression of NGF and his precursor pro‐NGF. We measured the expression of the reactive astrocytosis marker GFAP. To evaluate the injury and effects of inhibitors on neuroglial network, we analyzed the expression of glial (GLT1) and neuronal (EAAC1) glutamate transporters and glial glycine (GlyT1) transporter. In the dorsal horn we analyzed glutamate and GABA synaptic pattern, by imaging the expression of glutamate (vGLUT) and GABA (vGAT) vesicular synaptic transporters and glutammic acid decarboxilase (GAD). The in situ zymography showed a net decrease of MMP9 activity in the spinal cord in GM and NS treated animals compared to ACSF group, these results were paralleled by a net increase of NGF and a decrease of proNGF in inhibitors treated group compared to ACSF one. GM and NS treated animals showed reduced allodynia and thermal hyperalgesia. Treatment with both inhibitors significantly reduced GFAP levels. GM and NS treatment restore the decreased expression of glial glutamate and glycine transporters. In neuropathic animals was detected a net increase of neuronal glutamate transporter, lacking in GM and NS treated groups. Iinhibitors treatment revert the changes of GABAergic synaptic compartment characterized by increase of axonal and synaptic GABA related markers, detected in neuropathic rats. These results suggest that endogenous NGF can have anti‐inflammatory properties and play a role in managing homeostatic synaptic pattern.
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Many neurodegenerative diseases are underpinned by a dysregulated inflammatory response in the central nervous system (CNS). However, it is imperative that this process is tightly controlled. The inappropriate or chronic deployment of the inflammatory system can lead to a loss of its protective and reparative function and its emergence as a destructive force in pathogenic processes such as multiple sclerosis (MS) and Alzheimer\'s disease.The Notch pathway is implicated in many aspects of the CNS development and functions. More recently, the Notch pathway has been identified to be involved in inflammatory events of the CNS. In an attempt to understand the implication of this pathway on astrocytes, we have characterized of the Jagged‐Notch‐Hes pathway under inflammatory conditions. LPS exposure induced an upregulation of Jagged1 expression on astrocytes. To address the role of Jagged1 in the modulation of inflammation, we used a siRNA mediated silencing of Jagged1 (siRNA J1). siRNA J1 induced important variations on the Notch pathway components like Hes1, Hes5, Notch3 and RBP‐Jκ. The inhibition of Jagged1 expression repressed the mRNA expression of genes known as hallmarks of the gliosis like GFAP and endothelin(B) receptor. On activated astrocytes, the inhibition of Jagged1 induced important anti‐inflammatory effects. The siRNA J1 decreased the LPS induced iNOS expression and NO production. LPS induced pro‐inflammatory cytokines, like IL1β, IL1α and TNFα, are also decreased. The inhibition of Jagged1 induced a modulation of the JAK/STAT/SOCS signalling pathway. Most interestingly, the siRNA J1 decreased the LPS induced translocation of NFκB p65 and this could be correlated to the phosphorylation of IκBα. We finally showed that the induced effects are at least partially dependent on RBP‐Jκ, Hes1 and Hes5. These results suggest that during inflammatory and gliotic events of the CNS, Jagged1/Notch signalling sustains the inflammation mainly through NFκB and in part through JAK/STAT/SOCS signalling pathways. Our results show that Jagged1 plays an important role in the control of inflammatory reactions and could thus allow to develop new therapeutic strategies helping to diminish the gliosis and the inflammatory response in the CNS.
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The use of neural progenitor (NP) cells has become a subject of high therapeutic interest for neurodegenerative diseases. Recent reports demonstrated anti‐inflammatory activities of progenitor cells in models of multiple sclerosis as well as global ischemia.

In inflammatory conditions, neural progenitors are able to control inflammatory processes. NPs reduce the activity of several inflammatory cytokines in their local environment, particularly on lymphocytes and microglial cells.

During inflammatory events, microglial cells produce chemokines, which attract NPs to the site of brain injury. In this environment, NPsinteract with microglial cells and modulate their activation. The understanding of this dialog is crucial to set up efficient stem cell‐ based replacement therapy and to define new treatments for neuro‐inflammation.

To investigate the role of NPs on the modulation of microglial activity, we use mouse neurospheres. NPs are exposed to LPS to mimic inflammatory conditions. Under these inflamed conditions, we show an increase of the proportion of NP cells in the neurospheres. This increase of NPs is noticeable by an up‐regulation of the stem cell marker Prominin1. The supernatant of these treated neurospheres is used to modulate microglial activity.

We show that microglial cells, cultured with neurospheres‐conditioned medium under inflammatory conditions, produce less pro‐inflammatory compounds such as TNF‐α, NOS2 and CCL2. By serial dilutions of the conditioned medium, we show that the anti‐inflammatory effect is concentration‐dependant.

Moreover, we observe a production of anti‐inflammatory molecules by neural stem cells as early as 3 hours after activation with LPS. These molecules, identified as proteins, act on the inflammatory status of microglial cells.

All these data enforce the concept of the involvement of neural progenitors, via the release of specific proteins, in the modulation and control of neuro‐inflammatory reactions in the CNS.
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Neuro‐inflammation plays a crucial role in numerous neuro‐pathologies (e.g. ischemia, hypoxia, AIDS dementia, chronic pain) and neurodegenerative diseases (e.g. Parkinson\'s disease, Alzheimer\'s disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington\'s disease, Creutzfeldt‐Jacob disease). Microglial cells are the intrinsic immune cells of the brain and are strongly involved in neuro‐protection as well as in neuro‐degeneration. Thus, the implication of microglia on neuro‐inflammatory processes is of key interest in view of developing new therapeutic approaches.

Nowadays, microglial cell lines or primary microglia isolated from embryonic or new‐born animals are widely used as in vitro microglial models. However, embryonic or new‐born primary microglia are not completely mature and therefore are not a suitable model for research on the field of neuro‐degenerative diseases where aging is crucial.

In the present study, we provide a new protocol which opens the possibility to isolate and culture an essentially pure population of microglia from adult mouse brain. Moreover, our protocol is simple and can be applied to any wild‐type or mutant mouse line of interest.

The isolation is based on a new procedure which combines gradient centrifugation and a culture selection process. At least 2 weeks are required from sacrificing the animal until harvesting the first microglia. At the end of the protocol, microglial cells form a non‐adherent floating cell layer that can be easily harvested and replated.

As seen in vivo, the primary microglia isolated from adult mice proliferate, and can therefore be kept in culture for long periods of time. Furthermore, these cells had the same morphology and molecular and electrophysiological characteristics as in situ microglia. They have microglial potassium currents and channels and are positive for microglia markers such as CD11b, F4/80 and Griffonia simplicifolia isolectin B4. They are also capable of phagocytosis and can produce NO and pro‐inflammatory cytokines such as TNF‐α in response to proinflammatory stimuli.
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Recent studies demonstrate that mitochondrial dysfunction and subsequent free radical production are involved in MS lesion development and progression. Mitochondrial dysfunction might occur as a response to demyelination and/or inflammation, since demyelination raises the energy demand and could thereby affect the number, distribution and activity of mitochondria. In addition, inflammatory cells produce proinflammatory cytokines and reactive oxygen species that have deleterious effects on mitochondria. In this study we have investigated the distribution of mitochondria, the cellular expression of mitochondrial proteins and mitochondrial enzyme activity in various MS lesion stages by (immuno)histochemical and biochemical techniques. We observed a significant increase in the number of mitochondria in astrocytes and axons in MS lesions, particularly in inflammatory lesions. The activity of complex IV is strikingly upregulated in astrocytes in MS lesions compared to control white matter and, to a lesser extent, NAWM. To unravel the functional role of enhanced mitochondrial activity in astrocytes we isolated primary astrocytes from NAWM and MS lesions. Astrocytes were probed with JC‐1 and MitoTracker Red CM‐H2Xros, to study mitochondrial membrane potential and mitochondrial H2O2 production. Mitochondrial membrane potential was markedly decreased in MS lesion derived astrocytes, whereas mitochondrial H2O2 production was increased. Finally, we demonstrate increased expression of the mitochondria‐specific anti‐oxidants peroxiredoxin 3 and thioredoxin 2 in astrocytes in MS lesions, as well as increased expression of the mitochondrial stress protein mtHSP70 in astrocytes in MS lesions, indicating the occurrence of ongoing mitochondrial oxidative stress and upregulation of an endogenous defence mechanism against oxidative damage to mitochondria in astrocytes in MS lesions.

Together, our data indicate the occurrence of severe mitochondrial changes in astrocytes in MS lesions and astroglial cells derived from MS lesions.
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Several years ago a highly significant inverse relationship was found between stress‐axis activity and severity of MS (Huitinga et al., Ann. Neurol. 2004). With funding from the Dutch Foundation for MS Research, a follow‐up study of 30 female MS brain donors was performed to further determine what pathological mechanisms may underlie this observation. In this new donor population, it was again found that low cortisol levels are associated with more severe MS. Analysis of the neuropathological reports of all MS brain donors indicated that increased demyelination and decreased remyelination was present in donors with severe MS and low cortisol. The opposite was seen in donors with relatively mild MS and high cortisol levels.

Our results emphasize the importance of high cortisol levels in overcoming MS inflammation. To identify glucocorticoid driven mechanisms responsible for less severe MS, studies are ongoing to compare donors with low cortisol and severe MS versus those with high cortisol and mild MS for expression of genes relevant for microglia activation, immunosuppression, demyelination and remyelination. Preliminary data indicate that microglia in normal appearing white matter of MS patients have an altered activation status as compared to white matter of healthy controls. Interestingly, high levels of cortisol push the microglia phenotype towards a more beneficial one. In contrast, low cortisol levels in MS lead to a microglia phenotype that may render normal appearing white matter more vulnerable for MS lesion development.
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CCAAT/enhancer binding protein delta (C/EBPdelta) is a transcription factor of the C/EBP family which can regulate the expression of proinflammatory genes such as COX2, NOS2, IL‐1beta or IL‐6. It has been proposed to act as a key amplifier in the toll‐like receptor (TLR)‐mediated inflammatory response (Litvak et al, 2009, Nat Immunol). Previous studies have shown the astroglial expression of C/EBPdelta but the microglial expression of C/EBPdelta remains virtually unexplored.

In this report, using murine primary cultures and BV2 cells we clearly demonstrate that C/EBPdelta is expressed by microglia and it is upregulated in microglial activation. Lipopolysaccharide (LPS) upregulates C/EBPdelta in microglia in a time‐ and concentration‐dependent manner, both at mRNA and protein levels. The LPS‐induced C/EBPdelta upregulation in microglia is mimicked by TLR2, 3 and 9 agonists, but not by interferon gamma, and is prevented by an inhibitor of ERK activation. Streptavidin‐agarose pulldown assays show that C/EBPdelta from activated microglia binds to the cyclooxygenase‐2 promoter and by immunoprecipitation we demonstrate that C/EBPdelta forms complexes with C/EBPbeta isoforms in activated microglia. Finally, systemic injection of LPS or kainic acid induces the upregulation of C/EBPdelta in the CNS. Preliminary data show the presence of C/EBPdelta in the nuclei of activated microglia in these in vivo models.

This study, together with previous studies from our group on the expression of C/EBPbeta (Ejarque‐Ortiz et al, 2007, Glia) and C/EBPalpha (Ejarque‐Ortiz et al, 2007, J Neurosci Res) in glial activation show that the various members the C/EBP family of transcription factors have specific patterns of expression in astroglial and microglial activation. These results also point to C/EBPdelta as a putative key regulator of proinflammatory gene expression in microglial activation.
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A powerful inflammatory reaction of microglia and macrophages accompanies tau‐induced neurodegeneration in brains of transgenic rodent models of human tauopathy. We have characterised a transgenic rat model expressing human truncated non‐mutated tau (t151‐391) on the genetic background of the spontaneously hypertensive rat (SHR). Transgenic rats develop neurofibrillary tangles, axonopathy and inflammation in the brainstem and the spinal cord, causing progressive motor impairment. To find out how the genetic background can alter neurodegenerative and inflammatory pathways, we back‐crossed the SHR transgenic line (SHR 72) to the Wistar‐Kyoto (WKY) strain background, creating the WKY 72 line.

Immunohistochemical staining revealed the same type, localisation and density of neurofibrillar pathology in the brain of both transgenic lines. In WKY 72 and SHR 72 rats, there was a marked activation of microglia positive for inflammatory markers (CR3, CD68, CD45, CD4) in the areas of neurofibrillar pathology. Genetic background did not influence the intensity of tau‐induced neuroinflammation. However, we observed substantial differences in the MHCII expression. Most of the activated microglia in the WKY 72 brainstem were MHCII‐positive, while in SHR 72 rats only a small sub‐group of the activated microglia expressed MHCII. We examined different parts of the MHCII molecule: RT1B alpha and beta chain and RT1D -- all displayed a similar pattern: they were upregulated in WKY 72 rats but not in SHR 72.

The most pronounced function of MHCII is presenting antigens to CD4‐positive lymphocytes. However, despite of limited infiltration of CD45‐positive leucocytes from blood vessels into the brain parenchyma, there was no prominent presence of CD4‐positive lymphocytes in WKY 72 or SHR 72 brainstems. The role of microglial MHCII expression in our model remains to be elucidated in future experiments.

This work was supported by research grants APVV‐0631‐07 and LPP‐0363‐06.
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Gluthatione (GSH) is a ubiquitous intracellular peptide with diverse functions that include detoxification, antioxidant defense, maintenance of thiol status and modulation of cell proliferation. Disturbance in the cellular redox balance, due to enhanced ROS production and/or impaired antioxidant defense, eventually leads to oxidative alterations of biological macromolecules, such as proteins, lipids and nucleic acids. These events produce cellular malfunction and eventually cell death. For brain, oxidative stress has been connected with the loss of neurons during the progression of neurological diseases like Parkinson\'s disease (PD), Alzheimer\'s disease (AD), Huntington\'s disease (HS), stroke and other neuroinflammatory diseases. Astrocytes are known to be an important source of neuronal GSH. Astrocytes highly express antioxidant responsive elements (ARE)‐driven genes in response to oxidative stress. Our main goal is to understand the effects of microglial activation on astrocytes expression of GSH, γ‐glutamyl‐cystein ligase (GCL) and other enzymes activated by Nrf2. We exposed astrocytes to microglial‐conditioned medium (MCM) and analysed the content of GSH and the activity of GCL, the rate‐limiting enzyme in GSH synthesis. Briefly, microglial cultures were stimulated with different doses of LPS for 24h. Next, astrocyte cultures were exposed to MCM for 24 or 72 h. A down regulation of GSH was observed when astroglia were cultured in MCM using 10 ng/ml of LPS whereas higher concentrations 100‐1000ng/ml elevated the GSH levels in astroglia at 24 h post‐exposure. After 72 h no stimulatory effect but a decrease on GSH levels in MCH cultured astroglia was observed even for the higher concentrations of LPS. When a blocking antibody against TNF‐α was used, the effects of MCM on GSH levels were prevented, suggesting an involvement of this cytokine both in the up‐ and down‐regulation of the antioxidant system in astrocytes.
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Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS), characterized neuropathologically by multiple focal lesions scattered throughout the CNS. Normally, the blood‐brain barrier (BBB) prevents the entrance of circulating molecules and immune cells into the CNS by the presence of tight junctions. The BBB also acts as a molecular barrier through the presence of specific endothelial efflux systems (multi‐drug resistance pumps, MDRs) A loss of integrity of the BBB has been described for a variety of neuroinflammatory diseases like MS, but so far data on MDR protein expression and function at the BBB under pathological conditions and the downstream effect on brain homeostasis is lacking. Since MDRs are essential in removing detrimental compounds from CNS tissue, loss of expression or function could contribute to the tissue damage observed in MS. We therefore investigated, in various well‐characterized post‐mortem MS lesions, the expression pattern of different MDR efflux transporters (MRP‐1, ‐2 and BCRP) in various lesion stages. Interestingly, reactive astrocytes and infiltrating myelin‐laden macrophages in MS lesions displayed enhanced MDR protein immunoreactivity compared to normal appearing white matter and white matter from non‐neurological patients. Remarkably, no changes in endothelial expression of MDR transporters were observed. In vitro expression and functionality assays for MRP‐1 showed increased mRNA levels and substrate‐specific activity in PolyI:C stimulated, reactive human astrocytes, as well as in astrocytes isolated from human MS lesion material. Together, our results suggest a novel role for MDR efflux transporters on astrocytes during neuroinflammation. Expression of MDR efflux transporters on reactive astrocytes in the immediate vicinity of MS lesions suggests a compensatory mechanism in which astrocytes function as a second barrier when the BBB is compromised. Modulation of MDR transporter function or expression at the BBB might provide a novel therapeutic strategy in MS pathogenesis.

Keywords: MDR efflux transporters, Blood‐Brain Barrier, Multiple Sclerosis, Astrocytes
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Multiple sclerosis (MS) is a chronic, progressive, degenerative disorder of the central nervous system, characterized by inflammation‐mediated demyelination, failure of remyelination and axonal loss. Since growing body of experimental evidence indicates that galectins may play a critical role in the modulation of chronic inflammatory disorders and autoimmunity, we hypothesize that galectins might contribute to some of the pathological processes underlying MS.

We examined expression of galectins 1 and 9 in post‐mortem brain tissue from MS patients and control patients without neurological diseases. Western blot analysis showed significant increase in expression of galectin 1 in chronic active and, to lesser extend, inactive lesions as compared to control tissue. Galectin 9 expression was significantly increased in both chronic active and inactive lesions. Furthermore, higher levels of both galectins are observed in post‐mortem cerebrospinal fluid (CSF) from MS patients as compared to CSF of non‐demented controls.

Immunohistochemistry study revealed that not only inflammatory, but also glial cells express galectins. While high levels of galectin 1 expression were detected in activated astrocytes and microglia in chronic active lesions, only moderate levels were detected in inactive lesions. Quiescent, non‐activated astrocytes and microglia from control tissue showed very low levels of galectin 1 staining. Galectin 9 wasn\'t detected in control astrocytes and very faint staining was observed in activated astrocytes in chronic active and inactive lesions. However, both ramified microglia from control tissue and foamy macrophages in chronic active lesion were highly positive for galectin 9. Oligodendrocytes were negative for any of these two galectins.

In this first extensive study of galectins expression in MS, we showed that higher levels of galectins 1 and 9 were present in lesions and CSF of MS patients as compared to controls. Higher expression was due not only to inflammatory cells but also activated astrocytes and microglia. Given the role of these glycan binding proteins in cell‐matrix (fibronectin) and intercellular interactions as well as their anti‐inflammatory effects in animal model of MS, we speculate that galectin 1 and 9 are potential candidates for new therapeutic strategies in MS.
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Neuroinflammation, in which reactive glial cells are involved, has been repeatedly suggested to play a key role in the development of neurodegenerative diseases. A significant effort is performed to test and develop anti‐inflammatory drugs that could inhibit neuroinflammation as a possible therapy in these diseases. Our main objective is to study the role of CCAAT/enhancer binding protein (C/EBP) β and δ and their interaction with NF‐κB transcription factors, specifically p65, in neuroinflammation and neurotoxicity induced by reactive glial cells. We believe that C/EBPs could be a therapeutic target to act against neuroinflammation and that their inhibition could have a neuroprotective effect.

We used primary cultures of mouse embryonic cortical neurons and cultures of BV2 (murine microglial cell line) or mouse primary microglia. As a model of neuroinflammation, we induced neuronal death in neuronal‐microglial cocultures using LPS/IFNγ to activate microglia (NO and TNFα production, iNOS and COX2 expression, p65, C/EBP β and δ nuclear expression). The lack of specific pharmacological inhibitors of C/EBPs makes it difficult to study their role in neuroinflammation. As several in vitro studies show the anti‐inflammatory effect of plant flavonoids in activated macrophages and microglial cells, we determined the anti‐inflammatory and neuroprotective effect of the flavonoid chrysin in our model of neuroinflammation, as well as the possible involvement of C/EBPs and NF‐κB in its mechanism of action. Chrysin pretreatment inhibited the inflammatory phenotype in LPS/IFNγ‐treated BV2 and primary microglial cells. In addition, when we pretreated the cocultures with chrysin we observed a significant neuroprotection. These effects occurred in the presence of a selective decrease in C/EBPδ expression without any effect on C/EBPβ and p65 expression. Moreover, chrysin pretreatment resulted in a decrease of C/EBPβ DNA binding.

We are showing for the first time that the inhibition of C/EBPδ expression protects from neurotoxicity induced by reactive glial cells. Our results suggest that C/EBPs are a possible therapeutic target to be considered in the treatment of neurodegenerative processes occurring in the presence of neuroinflammation.

P‐456 {#sec1-456}
=====

MODULATION OF GLIAL INFLAMMATORY RESPONSE BY HISTONE DEACETYLASE INHIBITORS {#sec2-456}
---------------------------------------------------------------------------

### Boraso M., Lotterio I., Rubisse S., Picerno E., Corsini E., Galbiati V., Galli C.L., Marinovich M., Viviani B. {#sec3-456}
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Histone deacetylase inhibitors (HDACi) have currently entered clinical trials for hyperproliferative disorders due to their pro‐apoptotic and anti‐inflammatory effect, but still very little is known about their activity towards non‐tumorous cells. In the present study we evaluated whether the HDACi, Trichostatin A (TSA), induces cytotoxicity and regulates the inflammatory response in a neural model of inflammation in vitro. To this purpose, primary glial cells were exposed to lipopolysaccharide (LPS) 10 ng/ml, with or without TSA. Cytokines release was measured by ELISA and/or by appropriated biological assay. TSA did not affect glial viability at any of the concentrations used (0.01‐200 nM), but it dose‐dependently enhanced LPS‐induced release of both Interleukin‐1β (IL‐1β) and Tumor Necrosis Factor‐α (TNF‐α) from glial cells, and significantly reduced the production of the anti‐inflammatory cytokine Interleukin‐10 (IL‐10). Both astrocytes and microglia contributed to this effect. This unexpected effect occurred only in glial cells and was maximal at 10 nM, whereas TSA significantly reduced the release of pro‐inflammatory cytokines from LPS‐stimulated primary macrophages. The enhancement of TNF‐α release from glia was maximal when LPS and TSA (0.1‐100 nM) were applied simultaneously, but it was less pronounced if glia was pre‐treated for 1h with TSA and TNF‐α was measured by biological assay. Biological assays differ from ELISA, since they detect only the cytokines that have been processed to be biologically active. These results suggest that TSA enhances LPS‐induced release of pro‐inflammatory cytokines but also interferes with the proteolytic cleavage of pro‐TNF‐α to its mature form. The pro‐inflammatory setting triggered by TSA is specific for glial cells, suggesting that histone acetylation may partecipate in sustaining the inflammatory response associated with a variety of neurodegenerative/neurotoxic conditions.

This work is supported by EC grant LSH‐CT‐2006‐037‐498.
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The phagocytic function of microglia is critical for the clearance of apoptotic cells and cellular debris during development and following cerebral injuries, diseases and infections. Phospholipase D (PLD), which hydrolyzes phosphatidyl choline to phosphatidic acid (PA) is stimulated following activation of phagocytic receptors, and we have established its importance in the phagocytic process in macrophages (Corrotte et al. Traffic 2006, 7: 365‐377). Both PLD isoforms, PLD 1 and PLD 2 are involved, but probably have complementary roles. We have also observed that the GTPase Ral A is activated during phagocytosis and positively regulates phagocytosis, and we hypothesized that this effect may be mediated through PLD. To test this possibility, we examined the interaction between Ral A and the PLD isoforms during phagocytosis in a macrophage cell line RAW 264.7 following stimulation of the Fc receptor. In macrophages transfected with dsRed‐Ral A and GFP‐PLD1 or GFP‐PLD2, Ral A colocalized with PLD1 and PLD2 at the phagocytic cup during phagosome formation. Immunoprecipitation of the PLD isoforms from stimulated macrophages also indicated that the PLD isoforms can interact with Ral A during phagocytosis. In addition, using an interference RNA strategy to reduce endogenous levels of Ral A, PLD activity was also found to be inhibited. Taken together, these data provide evidence that a pathway including Ral A and PLD is involved in the regulation of the phagocytic process in macrophages.
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*Neospora caninum* is an intracellular protozoan that causes spontaneous abortion in cattle and neurological disorders in dogs. The general immunological response to this parasite has been described as predominantly Th1‐type; however, glial cells in infected primary cultures release IL‐10 and IL‐6, but not IFN‐gamma. This profile suggests a protective response of glia in order to avoid inflammatory damage of nervous tissues. The goal of this study was to investigate the effects of pro‐inflammatory cytokines in primary cell cultures of rat astrocytes and microglia infected with *N. caninum*. Cells were treated with varying concentrations of IFN‐gamma or TNF‐alpha and infected with parasite tachyzoites 24 h after treatment. Lactate dehydrogenase (LDH) activity was measured as an indicator of viability. Infected cultures revealed a significant increase of LDH activity 72 h post‐infection. The same effect was observed following TNF‐alpha treatment. Moreover, treatment with 50, 150 and 300 IU/mL of IFN‐gamma reduced the number of tachyzoites in cultured cells by 41.5, 54.9 and 61.5%, respectively. When infected cells were treated with 50, 150 and 300 IU/mL of TNF‐alpha, parasites number decreased by 30.2, 38.8 and 31.7%, respectively. In control cultures, TNF‐alpha treatment did not affect nitrite level, whereas IFN‐gamma increased it. A significant reduction in nitrite levels was observed in INF‐gamma treated / infected cells, evidencing an inhibitory effect on nitric oxide (NO) production. These results suggest a synergic mechanism involving glial cells and *N. caninum* that reducing inflammatory cytokines effects, allows parasite survive and protect neuron environment.
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INTRODUCTION AND OBJECTIVES: For over two decades, the peripheral benzodiazepine receptor (PBR or TSPO 18 kDa), are clearly recognised and proposed as early biomarkers of neuroinflammation, supporting extensive efforts into the design of radiolabelled ligands for Positron Emission Tomography (PET) imaging. The 3‐isoquinolinecarboxamide \[11C\]PK11195, in spite of its low brain uptake and its high level of non‐specific binding, is still today the most widely used radioligand. Numerous PK11195 challengers are currently under development \[1\] but an attractive chemical class of structures, truly underinvestigated to date, are the indoleacetamides. Within this class, we have labeled SSR180575 \[2\] with carbon‐11, and pharmacologically evaluated it in a rat model of neuroinflammation (unilaterally, AMPA‐induced, striatum‐lesioned rats) with PET.

METHODS: SSR180575 was labeled with carbon‐11 at its N‐methylindole function using \[11C\]methyl triflate. \[11C\]SSR180575 was purified by HPLC (Zorbax® SB‐C‐18) and formulated for i.v. injection. PET‐imaging was performed on a Focus 220 Concorde and includes control kinetics and displacement experiments with PK11195 and SSR180575 (1 mg/kg).

RESULTS: Starting from a 55 GBq cyclotron‐produced \[11C\]carbon dioxide batch, 4.5‐5.0 GBq of \[11C\]SSR180575, \> 99% radiochemically pure and ready‐to‐inject, were obtained within 25 minutes. Specific radioactivities ranged from 50 to 90 GBq/μmol. In PET experiments, \[11C\]SSR180575 showed a higher contrast between the lesioned area and the corresponding area in the intact contralateral hemisphere when compared to \[11C\]PK11195 (ratio ipsi/contra at 20 min post‐injection: \[11C\]SSR180575 : 2.7, n = 4; \[11C\]PK11195, 1.7, n = 5). Furthermore, \[11C\]SSR180575 was displaced by PK11195 or SSR180575. Immunohistochemical analyses correlate with PET‐imaging and showed strong activation of microglia in and around the lesion.

CONCLUSION: The decay‐corrected overall yields for the preparation of \[11C\]SSR180575) were 19.1‐21.2% (n=10). Dynamic μPET studies in rats demonstrate the potential of \[11C\]SSR180575 to image neuroinflammation.

\[1\] Chauveau et al. Eur. J. Nucl. Med. Mol. Imag. (2008), 35, 2304--2319.

\[2\] Ferzaz et al. J. Pharmacol. Exp. Ther. (2002), 301, 1067--1078.

P‐460 {#sec1-460}
=====

INFLAMMATION AND HEPATIC ENCEPHALOPATHY: IBUPROFEN RESTORES LEARNING ABILITY AND MOTOR ACTIVITY IN RATS WITH CHRONIC LIVER FAILURE {#sec2-460}
----------------------------------------------------------------------------------------------------------------------------------

### Rodrigo R., Cauli O., Piedrafita B., Felipo V. {#sec3-460}

#### Centro de Investigación Príncipe Felipe, Valencia, Spain {#sec4-460}

Patients with hepatic encephalopathy show altered cognitive and motor (hypokinesia) impairment. Rats with chronic liver failure due to portacaval shunt (PCS), reproduce these impairments. These rats show decreased ability to learn a conditional discrimination task in a Y maze which seems to be due to reduced function of the glutamate‐nitric oxide‐cGMP pathway in brain.

Increased extracellular glutamate in substantia nigra pars reticulata (SNr) is responsible for hypokinesia in PCS rats. The mechanisms by which liver failure leads to increased extracellular glutamate in SNr remain unclear. Inflammation seems to act synergistically with hyperammonemia to induce neurological alterations in hepatic encephalopathy. It is therefore possible that inflammation‐associated alterations may contribute to cognitive and motor alterations in hepatic encephalopathy.

The aim of the present work was to assess whether treatment with an anti‐inflammatory, ibuprofen, is able to restore the function of the glutamate‐nitric oxide‐cGMP pathway in cerebral cortex in brain in vivo and/or learning ability and normalize extracellular glutamate in SNr and/or to improve hypokinesia in PCS rats.

We show that PCS rats have increased levels of IL‐6 and increased activities of cyclooxygenase and of inducible nitric oxide synthase (iNOS) in cerebral cortex, indicating the presence of inflammation.

Chronic treatment with ibuprofen normalizes cyclooxygenase and iNOS activities but not IL‐6 levels. Moreover, ibuprofen normalizes the function of the glutamate‐NO‐cGMP pathway in cerebral cortex in vivo and restores completely the ability of rats with chronic liver failure to learn the Y maze task. Chronic treatment with ibuprofen completely also normalizes the amount of the glutamate transporters GLT‐1 and EAAC‐1 and significantly reduces extracellular glutamate in SNr of PCS rats. Moreover, ibuprofen, completely eliminates hypokinesia, restoring normal motor activity.

This supports the idea that inflammation is a main contributor to the cognitive impairment and the induction of hypokinesia in hepatic encephalopathy. Moreover, these data point to the possible therapeutic utility of decreasing inflammation, by safe procedures, in the treatment of the cognitive and motor deficits in patients with hepatic encephalopathy.
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Astrocytes are key components of the innate neuroimmune system sensitive to pro‐inflammatory stimuli. There is a need to clarify the mechanisms of astrocyte activation, as they can play both beneficial and deleterious influences on neuronal survival. The nuclear factor of activated T‐cells (NFAT) is a family of transcription factors with a prominent role in the activation of cells with immune functions. Activation of gene transcription by NFAT requires translocation to the nucleus from the cytoplasm, which is induced by calcium dependent‐calcineurin. Previous studies, including our own, have shown NFAT expression in astrocytes; suggesting that NFAT may be a central factor for astrocyte activation in neuroinflammatory pathologies. Therefore, in the present work we have examined the possible regulation of the NFATc3 isoform in hippocampus of mouse brains after kainic acid administration, a model of astrogliosis associated to excitotoxicity. We found that kainic acid injection in mice hippocampus induced a time‐dependent expression of NFATc3 in specific regions. NFATc3 was detected by immunohistochemistry 4 to 7 days after injections, and its expression was almost restricted to CA3/CA4 areas of the hippocampus ipsilateral to the injection site. Co‐localization studies identified NFATc3 within a subset of GFAP‐expressing cells (reactive astrocytes), whereas it was absent from microglia and neurons. Interestingly, NFATc3 distribution was closely related to areas positively stained with Fluoro‐Jade C, indicative of neuronal degeneration. Even though immunohistochemistry analysis revealed a cytoplasmic subcellular localization of kainic‐induced NFATc3, RT‐PCR analysis detected a dramatic up‐regulation of the specific NFAT‐regulated gene Rcan1.4, as well as the NFAT targets COX‐2 and IL‐6, within 6 h after kainic injection. Western blotting confirmed Rcan1.4 protein induction in the ipsilateral hippocampus, with the highest expression 24 h after injections. Altogether, our results identify a population of NFATc3‐expressing astrocytes in the proximity of degenerating neurons in a model of excitotoxicity. This work raises the potential role of NFAT in astrocyte activation in a neuroinflammatory environment with consequences for neuronal survival.

Supported by JCCM grant SAN06‐010.
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Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) with an inflammatory and a neurodegenerative component. The neuropoietic cytokine leukemia inhibitory factor (LIF) is expressed in MS lesions, but its effect on lesion development is far from understood. LIF is suggested to be an interesting candidate for MS therapy, as it has neuroprotective properties and may also promote survival of myelinating oligodendrocytes. However, therapeutic administration of LIF is complicated by its limited abitility to cross the blood‐brain barrier and its pleiotropic actions outside the CNS. To circumvent these problems, we used lentiviral vectors to achieve a stable expression and secretion of LIF in the CNS of adult mice. Gene therapeutic expression of LIF in the CNS significantly reduced immune‐mediated demyelination and ameliorated EAE symptoms with enhanced efficacy compared to systemic treatment. These findings demonstrate that local LIF production is a promising therapeutic option to limit lesion progression in neuroinflammatory disease.

P‐463 {#sec1-463}
=====

ONCOSTATIN M IS A POTENT INDUCER OF CNS INFLAMMATION {#sec2-463}
----------------------------------------------------

### Slaets H.,^1^ Hendriks J.,^1^ de Vries H.,^2^ Van Den Haute C.,^3^ Baekelandt V.,^3^ Stinissen P.,^1^ Hellings N.^1^ {#sec3-463}

#### ^1^Hasselt University, Diepenbeek, Belgium; ^2^VU University Medical Center, Amsterdam, Netherlands; ^3^Katholieke Universiteit Leuven, Leuven, Belgium {#sec4-463}

The neuropoietic cytokine oncostatin M (OSM) is expressed in MS lesions, but its function during CNS lesion development is unknown. We have induced local expression of OSM in the CNS of C57Bl/6J mice by means of lentiviral vectors. Our data demonstrate that at sites of OSM expression, tissue remodelling occurs and an irregular deposition of the basement membrane protein laminin is detected. Further analysis demonstrated that local OSM expression disrupts several aspects of the blood‐brain barrier (BBB): large perivascular spaces were found between the inner and outer basement membranes, expression of the tight junction protein ZO‐1 was altered and serum leaks into the CNS parenchyma. In addition, local OSM expression induced an upregulation of adhesion molecules on endothelial cells of the BBB. Moreover, OSM‐expression was accompanied by an upregulation of MHCII molecules and an infiltration of T‐cells and macrophages/microglia into the brain. This is the first study demonstrating that local OSM expression in the healthy CNS is sufficient to induce several aspects characteristic of neuroinflammation.
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Studies of human microglia are exceptional as these cells are difficult to access in a pure and inactivated form. In the present study we show a rapid procedure to isolate, sort and culture microglia with high purity from human post‐mortem brain tissue. The techniques that were used are based on density gradients and cell surface expression of CD11b and intensity of CD45 expression, as elucidated in cell populations derived from human blood, choroid plexus and corpus callosum white matter. Tissue was obtained from the Netherlands Brain Bank (<http://www.brainbank.nl>). Because in vitro stimulation of monocyte‐derived macrophages results in polarized cells with different pro‐ and anti‐inflammatory properties, we tested whether microglia may polarize as well. We therefore stimulated cultured primary human microglia with IL‐4, as we recently demonstrated that IL‐4 induced expression of the immune inhibitory molecule CD200R and mannose receptor (MR), markers of alternatively activated macrophages. Although microglia expressed low CD200R and MR, expression was not up‐regulated by IL‐4. This was in contrast to human choroid plexus macrophages where IL‐4 increased both CD200R and MR expression. We currently investigate the expression of the IL‐4 receptor and the glucocorticoid receptor and the effects of glucocorticoids on microglia cell polarization.

MS Research grant 02‐496. <http://www.nin.knaw.nl>
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Chronic neuroinflammation is believed to play a major role in Alzheimer\'s disease (AD). It has been shown that the level of neuroinflammation in AD also correlates to the level of cognitive impairment. Evidence indicates that the transcription factor CCAAT enhancer binding protein (C/EBP) family is involved in the inflammatory response in AD. The C/EBP family has at least six family members C/EBP alpha‐zeta. They all have a highly conserved basic‐leucin zipper domain at the C‐terminus. They form homo‐ or hetero‐dimers within their family but have also been known to form dimers with NFkappaB. Many genes involved in neuroinflammation can be regulated by C/EBP. This includes genes coding for the inflammatory cytokines IL‐1, IL‐6 and TNFalpha. Previously it has been shown that the expression of C/EBP beta and delta mRNA are induced by inflammatory stimuli in astrocytes and microglia cells whereas C/EBP alpha mRNA expression is inhibited.

Increased C/EBP delta in activated astrocytes surrounding Abeta plaques in AD brains has also been reported. In addition, our group has previously shown that C/EBP activity is blocked in mixed glial cells following treatment with Abeta. In the present study we wanted to further investigate the signaling pathways involved in the regulation of C/EBP expression and activity during inflammatory conditions. Our data indicates that the p38 MAP kinase pathway, as well as the JNK pathway, is involved in the regulation of C/EBP levels after activation of the Toll‐like receptor 4 in glial cells.
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Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterised by the selective destruction of motor neurons in the brainstem and spinal cord. So far, the mechanisms underlying the progressive nature of ALS still remain elusive and no effective treatment has been developed. Nevertheless, recent studies evidenced that neuroinflammation plays a relevant role in ALS and the influence of cell‐types involved may hold clues for the development of future therapeutic strategies.

In this context, we have examined the possibility to use mesenchymal stem cells (MSCs) isolated from the bone marrow in cellular therapies of ALS. In vitro, MSCs can be differentiated into cells with neuroprotective and immunomodulatory properties. Our group demonstrated that, in vivo naïve MSCs grafted into the spinal cord of ALS‐symptomatic rats (hSOD1G93A) migrate to the site of degeneration and differentiate into astrocytes, providing neuroprotection, preserving motor function, extending survival and decreasing excessive inflammation.

Therefore, we investigated further the underlying mechanisms leading to this beneficial outcome, focussing on the crosstalk between MSCs and microglial cells. Thus, we examined the neuroprotective capacities of MSCs and their impact on inflammatory processes as well as the effect of inflammation on the migration‐capacity of MSCs and their adaptation‐ and differentiation‐profile after being grafted into ALS‐animals.

In accordance with the results obtained in vivo, in vitro‐experiments demonstrated that primary microglia exposed to mediators released by naïve MSCs show an attenuated response to lipopolysaccharid treatment, known to trigger a robust inflammatory reaction.

In the near future, we are eager to extend our study to additional animal models presenting a local and robust inflammation within a short time frame, which combined with stem cell grafting, will allow us to study the direct influence of inflammation on stem cell recruitment as well as the beneficial effects provided by grafted MSCs.

This work was supported by the National Fund for Scientific Research (F.N.R.S., Belgium) and by the Queen Elisabeth Medical Foundation (Belgium). SS is recipient of Marie‐Curie Fellowship (EURON MEST‐CT‐2005‐020589) and EH is Research Director of the F.N.R.S.
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The cross‐talk between microglia and astroglia is a key mechanism in the pathogenesis of several neurodegenerative disorders. Upon nervous injury, microglia become activated and release mediators which influence neighbour neuronal and astroglial cells. In particular, astroglial cells are thought to adapt the expression of proteins involved in glutamate handling, a process that could putatively participate in the development or progression of excitotoxic insults.

We herein hypothesized that soluble mediators released by activated microglia induce changes in the expression of astroglial metabotropic glutamate receptors (mGluRs), which we previously showed to be implicated in the control of glutamate transmission by astrocytes. In this aim, an in vitro model was designed where microglial cells cultivated from neonatal rat cerebral cortex were activated with lipopolysaccharide. After 48 hours, real‐time quantitative PCR (q‐PCR) were performed to validate the activation state of microglia. In parallel, the conditioned media from these cells were transferred to primary cultures of astrocytes which were then examined after 72 hours. Quantitative PCR were realised on these astroglial cultures to evaluate the effects of this inflammatory environment on the expression of mGluR3 and mGluR5, the two principal subtypes identified on glial cells.

We evidenced a robust microglial activation by lipopolysaccharide as shown by concentration‐dependent increases in transcripts of the pro‐inflammatory enzymes iNOS and COX‐2, and the cytokines TNFα, IL‐1β, or IL‐6. The conditioned medium collected from these activated microglia was found to induce an opposite regulation of the glutamate receptors on astrocytes, as mGluR3 was upregulated while mGluR5 was downregulated.

We conclude that activated microglia release diffusible factors which differentially affect the astroglial expression of mGluR 3 and 5. Because these receptors are thought to contribute to the control of glutamate handling and since these receptors activate distinct signaling cascades, our future objective is to understand the molecular mechanisms supporting these regulations and to investigate the impact on excitotoxic events which affect neurodegenerative disorders.
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Microglial cells are the prime effectors in immune and inflammatory responses of the CNS. During pathological conditions, the activation of these cells helps restore CNS homeostasis. However, chronic microglial activation endangers neuronal survival through the release of various proinflammatory molecules and neurotoxins. Thus, negative regulators of microglial activation have been considered as potential therapeutic candidates to target neurodegeneration, such as that in Alzheimer\'s and Parkinson\'s diseases. Crocetin and Crocin (an analog of Crocetin) are carotenoid pigments isolated from *Gardenia jasminoides* Ellis. Crocetin has been reported to have antiatherosclerosis and antioxidant effects. Crocin, the digentiobiosyl ester of Crocetin has also been reported to have an antioxidant effect against oxidative stress‐induced death of neurons and to inhibit the formation of peroxidized lipids. The aim of this study was to examine whether Crocetin and Crocin could exert anti‐inflammatory effects on microglial activation. Crocetin reduced LPS‐induced nitric oxide (NO) release from primary cultured microglial cells. Crocin inhibited LPS‐ and amyloid beta/IFN‐induced NO release from microglial cells. Both Crocetin and Crocin protected microglial cells against LPS‐induced cytotoxicity. In addition, Crocetin and Crocin significantly reduced the LPS‐induced production of TNF‐α. These results suggest that Crocetin and Crocin may provide neuroprotection by attenuating microglial inflammatory responses.
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Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder affecting upper and lower motoneurons. Since immune disbalance is known to be an important manifestation of the disease we were particularly interested in following the immune cells labeled by paramagnetic nanoparticles in the familial ALS rat model, hSOD‐1G93A. To this end T2‐ or T1‐ weighted MRI protocols were used with a mini surface coil placed over the skull of the anesthetized animal in a 1.5 T wide bore magnet. Foci of neuroinflammation were also checked by immunocytochemistry of microglia (ED1 and OX42) and astocytes (GFAP) and confocal laser scanning.

It was confirmed with Gd‐DTPA contrast that the blood brain barrier (BBB) is compromised at the interbrain level. This justified the study of immune cell infiltration by i.v. injectong the rats with magnetically labeled antibodies against helper CD4+ or cytolytic CD8+ killer T cells. By combined T1, T2 and T2\* weighted imaging of ALS rat brains CD4+ lymphocyte infiltration was observed in the brainstem‐midbrain region while the CD8+ cells were more confined to the brainstem region. Immunocytochemistry revealed reactive astrocytes in the vicinity of dilated lateral ventricles, and microglial activation (OX42) in the ALS rat hippocampus and brainstem. In the latter structures it was also noted that OX42‐positive granules appear or a homogeneous cytoplasmic stain occurs in neurons labelled by NeuroTrace. Moreover, macrophage antigen ED1 showed a colocalization with SOD1 overexpressing cells in the ALS brainstem. Comparison of MRI of labelled CD4+ vs. CD8+ lymphocytes revealed the cellular inflammatory mechanism in ALS. The appearance of the MRI signal from the latter T cell type points to the mechanism of BBB disruption as suggested from a recent study on the role of CD8+ T cells in a model of multiple sclerosis (Suidan et al., PLoS ONE 3(8): e3037). The fusion/phagocytic role of microglia in these inflammatory processes is indicated by the colocalization of ED1 and OX42 immunocytochemical markers with SOD1 and NeuroTrace markers, respectively. Further studies are necessary to understand the ethiopathologic mechanisms beneath the different patterns of interaction of microglia with neurons.

This work was supported by COST/ESF and MSEP grant \#143054B to A.P.R.
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Neurodegeneration is associated with mitochondrial damage and activated microglia. Macrophage and microglia activation shows two basic responses: Classic activation leading to inflammation and toxicity and alternative activation leading to wound healing and attenuation of inflammation. Metabolic and immunological profiles of macrophages are interdependent. Classical activation is associated with glycolysis and oxygen independent, while the alternative pathway is linked to fatty acid oxidation. Neurodegeneration causing proteins like mutant huntingtin (Huntington Disease) or mutant SOD1 (Amyotrophic Lateral Sclerosis) are ubiquitously expressed, including in microglia. Furthermore expression of the mutant SOD1 in microglia is associated with an acceleration of disease progression. Microglia hence are an important target for anti‐degenerative therapies. We hypothesize that mitochondrial dysfunctions change the immunological profile of microglia with detrimental effects for the CNS.

We incubated primary mouse microglia with mitochondrial toxins known to induce neurodegeneration in animals (3‐Nitropropionic acid, Malonate and Rotenone) and then stimulated them either towards classic activation (LPS), alternative activation (IL‐4), or alternative activation with subsequent classic activation. We quantified TNF‐alpha, IL1‐beta, IL6 (classic activation cytokines) and IGF‐1 and arginase activity (alternative activation). Mitochondrial toxins did not affect classic activation, but inhibited the alternative activation. The toxins also abolished the inhibitory effect of the alternative activation on the classic activation. This suggests that mitochondrial dysfunction in microglia cells inhibit the alternative response and thereby exacerbate neuroinflammation. To reconstitute the alternative microglia response might therefore be a novel strategy to halt disease progression.
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Major depression is often accompanied by an imbalance of the immune system. The antidepressant treatment electroconvulsive therapy (ECT) has been shown to alter plasma cytokine levels as well as the number and activity of blood born immune cells. However, whether there is an interaction between these peripheral changes and the ECT‐induced processes such as cellular plasticity within the brain, has to our knowledge not yet been investigated.

We have previously shown that electroconvulsive seizures (ECS), an animal model of ECT, cause increased glial cell activation in several limbic areas. This glial cell activation is seen as altered glial cell morphology, as well as an upregulation of classical inflammatory markers, such as major histocompatibility complex class II (MHC II) on microglia and nestin in astrocytes.

The traditional view of neuroinflammation as a strictly detrimental process is challenged by recent studies. Activated microglia have proved to be neuroprotective in several models of CNS injury, and a new study has demonstrated that CD4‐T cell activity is required for maintaining cellular plasticity in the adult hippocampus.

In our current study, we have investigated whether there is an increased adhesion to the blood vessels of blood born immune cells following repeated ECS. Adult rats received one ECS daily for 10 consecutive days and were then perfused at different time points after the last ECS‐treatment. Brain sections were immunostained for ED2 that labels monocytes and macrophages, and cd4 that is expressed by T helper cells, regulatory T cells, monocytes, macrophages and dendritic cells.

Our preliminary results demonstrate an increased number of both ED2‐ and cd4‐expressing cells adhered to the lumen of the blood vessels in hippocampus. The majority of these cells display a large and irregular morphology, typical of macrophages. No ED2‐positive cells were detected outside the vessels but a subpopulation of cd4‐labeled cells was seen in the parenchyma, here with a morphology resembling resting microglial or dendritic cells.

Our observations indicate that there might be a cross talk between the altered peripheral immune response and the increased cellular plasticity following ECS. Further studies to characterize the nature of these processes are underway.
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A proinflammatory status in the central nerve system has been observed to increase progressively during ageing, which could contribute to the pathogenesis of ageing‐related neurodegenerative disorders, such as Alzheimer\'s disease, Parkinson\'s disease and amyotrophic lateral sclerosis. Matrix metalloproteinases (MMPs) are a growing family of zinc‐bound proteases having a wider substrate repertoire with specific processing of bioactive molecules, such as cytokines, chemokines, adhesion molecules, cell surface receptors and growth factors, to serve both pro‐ and anti‐inflammatory roles. In our study, we collected 3, 10 and 18‐month old MMP‐12 deficient and wild‐type control mice, isolated microglia from aged mouse brains and cultured microglia derived from new‐born mice. We used quantitative RT‐PCR to measure inflammatory gene transcripts, ELISA to quantify the cytokine secretion in the conditioned cell culture medium, and MMP‐12 activity assay to analyze MMP‐12 in the brain at a functional level. We observed that both gene transcript and enzyme activity of MMP‐12 were significantly up‐regulated during ageing. Compared to wild‐type control mice, there was a significantly higher level of inflammatory gene transcripts, such as TNF‐alpha, in 18‐month old MMP‐12 deficient mouse brains. Accordingly, transcripts of inflammatory genes, such as TNF‐alpha and CCL‐2, were increased in the microglia isolated from 18‐month old MMP‐12 deficient mouse brains as compared to the age‐matched wild‐type controls. Interestingly, we did not observe the significant difference of inflammatory gene transcripts and lipopolysaccharide‐induced TNF‐alpha secretion in cultured MMP‐12 deficient and wild‐type microglia. Thus, we concluded that MMP‐12 deficiency exaggerates neuroinflammation in aged brain, which does not support the application of MMP‐12 inhibitors in the therapy of age‐associated neurodegenerative disorders.
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INTRODUCTION AND OBJECTIVES: The peripheral benzodiazepine receptor (PBR or TSPO 18 kDa) is expressed by microglial cells in many neuropathologies involving neuroinflammation. \[11C\]PK11195 is today the most widely used radioligand for the in vivo imaging of PBR using PET, and this in spite of its low brain uptake and its high level of non‐specific binding. Numerous PK11195 challengers are currently under investigation \[1\], and of particular interest are the N‐benzyl‐N‐(2‐phenoxyaryl)‐acetamides, a series which includes \[11C\]PBR28 \[2\]. A fluorine‐containing analogue, namely 6‐fluoro‐PBR28 (N‐(2‐methoxybenzyl)‐N‐(6‐fluoro‐4‐phenoxypyridinyl‐3‐yl)acetamide), has been labeled with the longer half‐life positron‐emitter fluorine‐18 and pharmacologically evaluated it in a rat model of neuroinflammation (unilaterally, AMPA‐induced, striatum‐lesioned rats) with PET.

METHODS: 6‐Fluoro‐PBR28, as well as the corresponding precursors for labeling were synthesized from 4‐chloro‐3‐nitropyridine. 6‐Fluoro‐PBR28 was labeled with fluorine‐18 by nucleophilic heteroaromatic substitution using K\[18F\]F‐Kryptofix®222, purified by HPLC (Waters Symmetry® C‐18) and formulated for i.v. injection. PET‐imaging was performed on a Focus 220 Concorde and includes control kinetics and displacement experiments with PK11195 and non‐labeled 6‐fluoro‐PBR28 (1 mg/kg).

RESULTS: Starting from a 37 GBq cyclotron‐produced \[18F\]fluoride batch, 3.3‐3.7 GBq of 6‐\[18F\]fluoro‐PBR28, \> 99% radiochemically pure and ready‐to‐inject, were obtained within 90 minutes. In PET experiments, 6‐\[18F\]fluoro‐PBR28 showed a higher contrast between the lesioned area and the corresponding area in the intact contralateral hemisphere when compared to \[11C\]PK11195 (ratio ipsi/contra at 60min post‐injection: 6‐\[18F\]fluoro‐PBR28 : 2.2; \[11C\]PK11195, 1.5). Furthermore, 6‐\[18F\]fluoro‐PBR28 was displaced by PK11195 or 6‐fluoro‐PBR28. Immunohistochemical analyses correlate with PET‐imaging and showed strong activation of microglia in and around the lesion.

CONCLUSION: Dynamic μPET studies in rats demonstrate the potential of 6‐\[18F\]fluoro‐PBR28 to image neuroinflammation.

\[1\] Chauveau et al. Eur. J. Nucl. Med. Mol. Imag. (2008), 35, 2304--2319.

\[2\] Ferzaz et al. J. Pharmacol. Exp. Ther. (2002), 301, 1067--1078.
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DIFFERENTLY ACTIVATED MACROPHAGES IN MS: IMPLICATIONS FOR AXONAL DAMAGE {#sec2-474}
-----------------------------------------------------------------------

### Vereyken E., Heijnen D., Moeton M., Teunissen C., Dijkstra C. {#sec3-474}
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It is widely recognized that macrophages play an important role in the pathogenesis of multiple sclerosis (MS), having both beneficial and detrimental effects. Several studies have found correlations between macrophages and axonal damage in MS lesions. A correlation was observed between number of infiltrating macrophages and axonal damage, as viewed with both APP and axonal transections. Links between macrophages and axonal regeneration have also been found. Macrophage infiltration corresponded with an upregulation in expression level of growth‐associated protein‐43, a marker for axonal growth. Different subtypes of macrophages exist with different functions in immune response and tissue repair. Two extremes are classically activated (CA) macrophages, which can be cytotoxic, and alternatively activated (AA) macrophages, which can be growth promoting. Indications that both types of macrophages are present in MS lesions have been found. Here we investigate the effects of differentially activated macrophages on neuronal integrity.

Differently activated macrophages were generated by 2 day exposure to either LPS and IFN‐gamma to induce CA macrophages, or IL‐4 to induce AA macrophages. 2 day old mouse primary neuron cultures were exposed to differently activated macrophages and the effect on the number of neurons and morphology was determined.

FACS analysis was used to determine macrophage phenotype. MAC‐1, iNOS and F4/80 were found to be higher expressed by CA macrophages compared to AA macrophages, while MR and E‐cadherin were mainly found on AA macrophages. AA macrophages were significantly more attracted towards neuronally conditioned medium compared to CA macrophages. When neurons were exposed to CA macrophages a consistent reduction in the number of neurons was found compared to neurons exposed to AA macrophages. Also the number of processes, as measured by β‐tubulin staining, was decreased more after exposure to CA macrophages compared to AA macrophages. Moreover, CA macrophages were more efficient in phagocytosing neurons compared to AA macrophages. The capacity of the CA and AA macrophages to phagocytose was similar, since beads were phagocytosed in similar numbers by both CA and AA macrophages.

In summary, CA macrophages appear to be more damaging to neurons compared to AA macrophages.
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MICROGLIAL EXPRESSION OF MOLECULES RELATED TO ANTIGEN PRESENTING MECHANISM DURING THE RECOVERY PHASE OF ACUTE EAE {#sec2-475}
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In spite of the number of articles published, the antigen presentation mechanism in the CNS is still not fully understood. Two signals are involved: the first is provided by the engagement of major histocompatibility complex (MHC), class I or class II, with their receptor TCR in lymphocytes; the second demands the participation of different co‐stimulatory molecules, such as CD28, CTLA‐4 and their receptors B7.1 and B7.2. Specific T cell activation and deactivation are achieved through this signalling which is of vital importance to modulate the immune response associated to some diseases as experimental autoimmune encephalomyelitis (EAE). In this study we used the acute monophasic EAE model induced by the immunization of Lewis rat with myelin basic protein, to study the temporal expression of molecules involved in the antigen presenting mechanism and the nature of cells responsible of this expression, along the different phases of EAE evolution, with special emphasis to the role played by microglial cells. During the inductive phase (from score 0,5 to score 2), progressive increase in both MHC‐class I and MHC‐class II expression was found mainly in Iba1+ microglial cells. This expression reached maximum levels at the peak of the disease (score 3) and decreased gradually during the recovery phase (from score 2R to score 0), although levels were not comparable to controls, even at longer survival times. In contrast, whereas expression of the co‐stimulatory molecule CD28 in T cells was present during all the phases of EAE, expression of both B7.2 in microglia and CTLA‐4 in lymphocytes, were observed around blood vessels and was higher during the recovery phase than during the inductive phase and the peak. In conclusion, our results indicate that, in this acute EAE model, microglial cells are closely involved in the modulation of T cell activation and deactivation: whereas in the inductive phase, the microglial expression of co‐stimulatory molecules is scarce, in the recovery phase is higher suggesting that microglial cells may play a key role in the termination of the immune response by inhibiting T cell function through a B7.2/CTLA‐4 signalling.

Supported by Fundació Marató TV3, Fundación Alicia Koplowitz, the Spanish Ministry of Science and Innovation (BFU2008‐04407/BFI) and COST Neuroinfnet.
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The interplay of glial cells within the central nervous system is crucial to maintain the physiological function of the brain. Glia activation is a process characterized by increased proliferation, morphological alterations and modulation of gene expression, playing either detrimental or protective role in the progression of many neurodegenerative diseases. In this context the interplay between astrocytes, the most abundant glial cells in the brain, and microglial cells, the key cellular mediators of neuroinflammatory processes, is managed via secretion of biologically active molecules, such as pro‐inflammatory cytokines.

We carried out a detailed characterization of the process of activation in pure cultures of rat cortical astrocytes and we identified the different phenotypes that are induced upon administration of various stimuli (e.g. IL1beta, TNFalpha and INFgamma). Moreover, we investigated the effect of lypopolysaccharide (LPS) on the expression of markers of activation (i.e. the release of IL6, PGE2, and NO, and the induction of iNOS and COX2) in either pure astrocytic cultures or cocultures of astrocytes and microglia.

We used this model to investigate the effects of amyloid beta, the peptide that accumulates in the brain of AD patients and reported to affect astrocytic phenotype in vitro. While the activation of microglia with LPS is able to recruit astrocytic activation as well, preliminary evidence suggests that amyloid beta induces microglial activation, but it has no effect on astrocytes. Further investigation is aimed at characterizing the specific activated phenotypes of astrocytes and microglial cells, as well as the signal transduction pathways responsible for such phenotypical changes.
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In healthy CNS, astrocytes are responsible for maintaining tissue homeostasis and ensure proper functioning of neuronal networks. However, under various severe and chronic neuropathological conditions, astroglial cells may gain cytotoxic properties and participate in neuroinflammation processes. The prominent characteristics of astrocyte activation (termed astrogliosis) are: hypertrophy accompanied by enhanced GFAP expression, production of pro‐inflammatory and cytotoxic cytokines, as well as other toxic molecules, like ROS and arachidonic acid metabolites. Therefore astrogliosis modulation is an attractive target for neuroprotective therapies.

To study the signaling events in activated, pro‐inflammatory astrocytes, we employed a model of "reactive astrogliosis *in vitro*" based on primary rat astrocyte cultures stimulated with the mix of pro‐inflammatory cytokines (IL1 beta, IFN gamma and TNF alpha). Cytokine cocktail activated all MAPK kinases: ERK1/2, p38 and JNK, JAK/STAT (JAK1/2 and STAT1, 3,5) and NFkappaB signaling pathways followed by cellular hypertrophy, rearrangement of astrocyte cytoskeleton, nitric oxide production and expression of mRNA for *il‐6* and *trail*.

We previously demonstrated that a widely used immunosuppressant and calcineurin inhibitor FK506 potently reduced gliosis *in vivo* and improved recovery in a rat stroke model (Zawadzka and Kaminska Glia, 49:36‐51, 2005). In the present study, FK506, as well as another calcineurin inhibitor cyclosporin A, reduced the astrocyte hypertrophy and decreased the level of activated p38 MAPK, however, these drugs did not affect iNOS expression stimulated by cytokines. Interestingly, FK506 was also able to reduce the activation of p38 in astrocytes exposed to hydrogen peroxide implicating potential of this drug in counteracting some effects of oxidative stress observed during ischemic reperfusion or neuroinflammation. JAK/STAT inhibitors decreased phosporylation of JAK1/2, STAT1 and 3 induced by cytokine mix. Active STAT proteins may be involved in regulation of target genes, including those encoding inflammatory cytokines, MMPs and inflammation mediators, thus the results raise a promise of potential use of these compounds to inhibit intracellular signal transduction leading to inflammatory responses.
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Microglial activation plays a critical role in inflammatory responses associated with many brain pathologies, including ischemia, Alzheimer\'s and Parkinson\'s diseases. The mobilization of microglia to sites of injury represents a crucial step for restoring brain homeostasis. Accumulating evidence suggests that, among the signalling molecules released from the injured neurons, nucleotides represent the early signals responsible for microglial recruitment to the site of injury. It has been demonstrated that extracellular ATP or ADP induce chemotaxis of cultured microglia through the activation of nucleotide sensitive receptor P2Y12.

To investigate whether different microglial phenotypes could modulate their motility in response to ADP by affecting the expression of P2Y12 and other purinergic receptors such as P2Y1, we analysed the effect of a long term exposure to lipopolysaccharide (LPS), IFN‐gamma and transforming growth factor‐beta (TGF‐beta) on the expression of P2Y12 and P2Y1.

To this aim, primary mixed glial cultures were exposed to different inflammatory mediators for 24 h. After this time, microglial cells were harvested and analysed for purinergic receptor expression. and migratory activity.

We found that both receptor subtypes are expressed in microglial cells from unstimulated primary mixed glial cell cultures, being the P2Y12 the most abundantly expressed. The exposure of mixed glial cultures to TGF‐beta increased both P2Y12 and P2Y1 mRNAs while LPS exposure reduced their levels. IFN‐ gamma had no effect on receptor expression.

Next, we analysed the influence of these mediators on the ADP‐induced migration. By pharmacological means, we confirmed that both receptors are involved in microglial migration induced by ADP. In line with the effect on receptor expression, TGF‐beta significantly increased ADP‐induced migratory activity of microglia while IFN‐gamma slightly decreased it. Lastly, cells harvested from LPS stimulated mixed glial cells virtually lost all their migratory capabilities.

These findings confirm a central role for P2Y12 and P2Y1 in microglial migration and suggest that modulation of purinergic receptors by cytokines and inflammatory mediators represent a further important mechanism affecting microglial behavior.
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Growing evidence indicates that the functional state of microglial cells, the brain resident macrophages, differs according to the pathological conditions that trigger their activation. In particular, activated microglial cells can express sets of Kv subunits which sustain delayed rectifying potassium currents (Kdr) and modulate differently the proliferation rate or the ability of microglia to release nitric oxide and reactive oxygen species. We recently reported that hippocampal microglia is in a particular activation state after a status epilepticus (SE; Avignone et al. 2008) and the present study aimed at identifying which of the Kv channels are functionally expressed by microglia in this model of activation.

SE was induced by systemic injection of kainate in CX3CR1eGFP/+ mice in which microglia is fluorescent. Whole cell recordings of activated microglia were performed in acute hippocampal slices prepared 48h after SE. Microglial cells expressed Kdr currents which were characterized by a potential of half‐maximal activation near ‐25 mV, prominent steady‐state and cumulative inactivations. Kdr currents were almost completely abolished by the broad spectrum antagonist of potassium channels 4‐Aminopyridine (1 mM). In contrast, tetraethylammonium (TEA) at a concentration of 1 mM, known to block Kv3.1, Kv1.1 and 1.2 subunits, only weakly reduced Kdr currents. However, at a concentration of 5 mM which should also affect, Kv1.3 and 1.6, TEA inhibited almost half of the Kdr conductance. Alpha‐dendrotoxin, which selectively inhibits Kv1.1, 1.2 and 1.6, reduced only a small proportion of Kdr currents, indicating that channels formed by homomeric assemblies of these subunits are not important contributors of Kdr currents. Finally, 50 nM agitoxin‐2 strongly inhibited the current indicating that Kv1.3 containing channels, probably heteromers, predominantly determined Kdr currents in activated microglia after SE.

P‐480 {#sec1-480}
=====

CYCLIC GMP‐MEDIATED PATHWAYS REGULATE GLIAL REACTIVITY {#sec2-480}
------------------------------------------------------

### Prado J.,^1^ Pifarre P.,^1^ Giralt M.,^2^ Molinero A.,^2^ Hidalgo J.,^2^ Garcia A.^1^ {#sec3-480}

#### ^1^Instituto de Biotecnología y Biomedicina, Depto de Bioquímica y Biología Molecular, UAB, Barcelona, Spain; ^2^Instituto de Neurociencias, Unidad de Fisiología Animal, UAB, Barcelona, Spain {#sec4-480}

Brain injury elicits a potent inflammatory response, comprising recruitment of inflammatory cells, reactive gliosis and release of pro‐inflammatory cytokines and inflammatory mediators (NO, reactive oxygen species) that can inhibit neurite outgrowth and affect cell survival. The major target for NO in the CNS is the predominantly soluble guanylyl cyclase (NO‐GC) and its product cyclic GMP (cGMP), the recognized mediator of important regulatory actions of NO in synaptic plasticity and brain development. The NO‐cGMP‐protein kinase G (PKG) pathway has been also implicated in neuronal survival. We have previously demonstrated that astroglial NO‐GC activity is regulated by neuroinflammatory agents in vitro and in vivo. Furthermore, we recently showed that cGMP via PKG induces rearrangement of actin and GFAP filaments in cultured astrocytes leading to stellation and enhanced motility. In the present study we have examined if cGMP regulates the glial inflammatory response in vivo using a well characterized brain injury rat model of cryogenic lesion to the cortex. Animals were treated with zaprinast (ZAP), a cGMP phosphodiesterase (PDE) inhibitor, at a dose of 10 mg/ Kg i.p. 2 hours before the lesion and 24 and 48 hours post‐lesion and were sacrificed 3 days post‐lesion. Results show that ZAP greatly enhances reactive astrogliosis induced by cryolesion as manifested by a significant increase in GFAP immunoreactivity around the lesioned area and increased GFAP protein levels. On the other hand, recruitment and activation of microglia/macrophages (rounded lectin‐positive cells) was decreased in ZAP‐treated animals suggesting a reduced microglial response. In agreement with this, the microglial surface marker CD11b that shows increased expression in activated microglia presented significantly lower levels in ZAP‐treated compared to saline‐treated animals. Additionally, ZAP significantly reduced protein oxidative stress and the number of cells stained for the apoptosis marker TUNEL. These results indicate that cGMP‐PDE inhibitors may exert neuroprotective effects in the CNS by regulating glial inflammatory responses.

This work was supported by grants from MEC SAF2005‐00671 to JH and SAF2007‐64164 to AG.
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We have previously shown that inflammatory compounds that induce reactivity and NOS‐2 expression in glial cells (LPS, IL‐1β, β‐amyloid peptides) down‐regulate astroglial NO‐sensitive guanylyl cyclase (GCNO) in vitro and in vivo. Here we show that the decrease in GCNO activity and β1 subunit protein induced by LPS (10 ng/ml, 24h) in cultured rat cerebellar astrocytes is prevented by inhibitors of proteasome activity (MG132, 5 μM; lactacystin, 10 μM) but not by inhibitors of other proteases (calpain inhibitor, 25 μM; ICE inhibitor II, 100 μM; leupeptin, 5 μM). Furthermore, immunocytochemistry and confocal laser microscopy revealed that in LPS‐treated cells a strong GCNO β1 immunoreactivity was present in nuclear aggregates. GCNO β1 co‐localized with 20S proteasomes and ubiquitin in clastosomes, nucleoplasmic substructures involved in ubiquitin‐proteasome‐dependent nuclear proteolysis, but not with other proteasome‐enriched structures such as promyelocytic leukaemia protein bodies (PML) and splicing speckles. In untreated astrocytes clastosomes were scarce and GCNO β1 immunoreactivity presented a diffuse pattern in the cytoplasm and to a lesser extend in the nucleus. A similar distribution was observed in cells co‐treated with LPS and the proteasome inhibitor MG132, reported to prevent clastosome assembly. Co‐treatment with the protein synthesis inhibitor cycloheximide, that prevents LPS‐induced down‐regulation of GCNO, also inhibited clastosome formation, in agreement with the reported ability of LPS and other immunostimulants to induce expression of proteasome components in the nuclei. This is the first demonstration of an LPS‐induced translocation of GCNO β1 to the cell nucleus and its co‐localization with components of the nuclear proteolytic machinery, indicating a mechanism for inflammation‐induced down‐regulation of GCNO.

This work was supported by a SAF2004‐01717 grant (Spain).
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Microglia are immunocompetent cells capable of releasing potentially cytotoxic molecules such as proinflammatory cytokines, upon injury and disease.^1^ Equally, activated microglia contribute to CNS homeostasis by phagocytosis of cellular debris.^2^

Since unconjugated bilirubin (UCB) increases proinflammatory cytokine secretion by both astrocytes and microglia^3^ we aimed to assess the sequence of events involved in microglia activation by UCB. Primary cultures of rat microglia were incubated from 15 min to 24 h with 50 μM UCB plus 100 μM human serum albumin, at 37°C. Phagocytic capacity was evaluated by the uptake of fluorescent microspheres. NF‐κB nuclear translocation was assessed by immunocytochemistry. MAPKs (p38, ERK1/2) activation and upregulation of COX‐2 and RAGE were determined by Western blot. Apoptosis was estimated by measuring caspase 3, 8 and 9 activities.

UCB led to activation of p38 and ERK1/2, peaking between 15‐30 min (∼1.3‐fold, p\<0.05) followed by NF‐κB nuclear translocation (∼1.4‐fold, p\<0.05) at 1 to 2 h of exposure. These events precede the already observed release of proinflammatory cytokines. Interestingly, an increase in microglia phagocytosis was only observed at 4 h (∼1.5 ‐fold, p\<0.05). From this point on, onset of apoptosis occurs based on the activation of caspases‐3, ‐8 and ‐9 achieving a maximum increase at 12 h (∼2.3‐fold, p\<0.05). A COX‐2 increased expression was noticed from 12 to 24 h of UCB exposure (∼1.15‐fold, p\<0.01 and ∼1.14‐fold, p\<0.05, respectively) indicating its involvement in microglial inflammatory response. RAGE expression is also induced at 12 and 24 h (∼1.1‐fold, p\<0.05 and ∼1.14‐fold, p\<0.05, respectively), reinforcing microglial activated state and suggesting that other cells might aggravate microglial response via RAGE engagement.

These data suggest that microglia, when facing UCB, could initially play a repair role by removing dead cells before developing a predominantly proinflammatory response. Thus, modulation of microglial activation may be a promising target in hyperbilirubinemia.

^1^Kim and De Vellis, J Neurosci Res 2005; 81:302--13.

^2^Napoli and Neumann, Neurosci 2009;158:1030--38.

^3^Brites et al., J Perinatol 2009;29:S8--13.

Funded by FCT‐POCTI/SAU/MMO/55955/2004, FCT‐PTDC/SAU‐NEU/64385/2006 and FEDER to DB.
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NITRIC OXIDE MEDIATES INFLAMMATION‐INDUCED APOPTOTIC FEATURES AND NEURONAL DYSFUNCTION AT AN EARLY STAGE OF NEURODEVELOPMENT {#sec2-483}
----------------------------------------------------------------------------------------------------------------------------

### Vaz A.R., Leitão Silva S., Barateiro A., Falcão A.S., Fernandes A., Silva R.F.M., Brito M.A., Brites D. {#sec3-483}

#### CPM/iMed.UL, Lisbon, Portugal {#sec4-483}

The inflammatory response is essential for survival in response to tissue injury or infection, but it can also cause neuronal damage.^1^ In fact, activated microglia in vitro is characterized by production and secretion of proinflammatory products such as nitric oxide (NO) and cytokines,^2^ which are known mediators of neuronal apoptosis.^3^ Moreover, in premature babies, inflammatory mediators can contribute to brain injury and poor neurodevelopmental outcomes.^4^ Here, we investigated the role of NO in apoptotic pathways and cell dysfunction upon exposure of poorly differentiated neuronal cells to pro‐inflammatory cytokines.

Neurons at 3 DIV were incubated with recombinant tumor necrosis factor (TNF)‐alpha and interleukin (IL)‐1beta (50 ng/mL each). In sister experiments, cells were co‐incubated with 100 microM L‐NAME, an inhibitor of nitric oxide synthase. NO production was evaluated by Griess method, activities of caspases‐3, ‐8 and ‐9 were determined by specific substrates cleavage and the truncated form of Bid (tBid) was assessed by Western blot after 4 h incubation at 37°C. Cell function was evaluated by MTT test following 24 h exposure.

The results obtained showed that TNF‐alpha and IL‐1beta induce a 2‐fold increase in the activation of caspases ‐3, ‐8 and ‐9 (p\<0.01), a ∼50% elevation of NO production (p\<0.05) and a nearly 15% rise in the generation of tBid (p\<0.05), together with a ∼27% decline in MTT reduction (p\<0.01). Moreover, L‐NAME prevented the cytokine‐induced activation of caspases by ∼50% (p\<0.05), the NO release by ∼60% (p\<0.05), and the generation of tBid by ∼60% (p\<0.01), whereas MTT metabolism was recovered by ∼70 % (p\<0.01).

These data show that exposure of immature neurons to pro‐inflammatory cytokines compromises cell viability, triggering intrinsic and extrinsic apoptotic pathways and NO production. Our results also suggest that novel therapies intended to downregulate the exacerbated generation of NO may prove useful in the prevention of the noxious effects of inflammation in premature babies.

^1^Konsman JP et al. Clin Sci (Lond) 2007;112:1--25.

^2^Combs CK et al. J Neurosci. 2001;21:1179--88.

^3^Blomgren K et al. Apoptosis 2007;12:993--1010.

^4^Ikonomidou C et al. Brain Dev 2009 \[Epub ahead of print\].

Funded by FCT‐POCTI/SAU/MMO/55955/2004, FCT‐PTDC/SAU‐NEU/64385/2006 POCI 2010 and FEDER to DB.
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MINOCYCLINE PROMOTES REMYELINATION IN AN IN VITRO MODEL OF DEMYELINATION {#sec2-484}
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#### University of Lausanne, Lausanne, Switzerland {#sec4-484}

Brain inflammation plays a central role in numerous brain pathologies, including multiple sclerosis (MS). Microglial cells and astrocytes are the effector cells of neuroinflammation. They can be activated by agents such as interferon‐g (IFN‐g) and lipopolysaccharide (LPS). Aggregating brain cultures exposed to a repeated treatment (3 fold) with IFN‐g (50 U/ml) and LPS (5 ug/ml) were used as an in vitro model of demyelination. Demyelination could be due to either the direct effect of IFN‐g and LPS on oligodendrocytes or the IFN‐g and LPS‐induced inflammatory response. We investigated the involvement of microglial reactivity in demylination and remyelination by using minocycline, an antibiotic known to block microglial reactivity.

Changes in myelination were examined by measuring the expression of myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG) at the mRNA level by quantitative RT‐PCR and at the protein level by Western blotting and immunohistochemistry. To evaluate brain inflammatory reactions, microglia were stained with isolectin B4 (IB4), quantitative RT‐PCR was used to determine the expression of tumor necrosis factor‐a (TNF‐a), interleukin‐6 (IL‐6), and inducible NO synthase (iNOS).

The repeated treatment with IFN‐g and LPS caused demyelination, as indicated by a decrease in MBP and MOG expression. It also activated microglial cells, and up‐regulated TNF‐a, IL‐6, and iNOS expression. Although minocycline did not affect the IFN‐g‐ and LPS‐induced up‐regulation of TNF‐a, IL‐6, it decreased the number of IB4‐labeled microglial cells. Furthermore, minocycline did not prevent demyelination, whereas it strongly increased MBP expression one week after the end of the demyelinating treatment.

In conclusion, the present results show that minocycline promoted remyelination after IFN‐g‐ and LPS‐induced demyelination, presumably due to its effects on microglial cells.
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#### ^1^Centre for Brain Repair & Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom; ^2^Neuroimmunology Branch, Ninds, National Institutes of Health, Bethesda, United States; ^3^Bioinformatics Neuroscience Group, Ninds, National Institutes of Health, Bethesda, United States; ^4^MRC Centre for Regenerative Medicine, Centres for MS & Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom {#sec4-485}

In its most fundamental sense, inflammation is the body\'s mechanism to protect against injury and promote repair. However, many chronic diseases are associated with and caused by inflammation. Multiple sclerosis (MS), the most common neurological disease disabling young adults, is characterized by areas of chronic demyelination, indicating areas where remyelination seen in the early stages of disease has failed. MS is an inflammatory disease, and this inflammation has two opposing effects; it causes the demyelination that characterizes the disease but also promotes subsequent remyelination. This latter effect can be examined by retinal transplantation of oligodendrocyte precursor cells (OPCs). Intravitreous injections of zymosan (12.5 mg/ml) have previously been found to stimulate an inflammatory response in the retina and enhance myelination by transplanted cells. The aim of this project is to identify specific factors from inflammation that can help to promote remyelination. Using the zymosan model of retinal inflammation, tissue and RNA samples of retina were collected comparing zymosan injections and saline injections over the full inflammatory response (0, 3, 7, and 14 days post‐injection). A RNA microarray gene screen was conducted using the Illumina platform, and the inflammatory response assessed via histology. Four candidate factors were identified and tested for their effects on OPC proliferation and differentiation, and myelination in cerebellar slice cultures. Two of the factors tested have been found to significantly promote both OPC differentiation and myelination in vitro. Studies are currently being conducted to validate the potential of these factors to promote and support myelination in vivo.
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NADPH OXIDASE AND MICROGLIAL ACTIVATION IN 6‐OHDA‐INDUCED DEGENERATION OF DOPAMINERGIC NEURONS {#sec2-486}
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### Guerra M.J., Rodriguez‐Pallares J., Parga J.A., Muñoz A.M., Rey P., Labandeira‐Garcia J.L. {#sec3-486}
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Cell death induced by 6‐OHDA is thought to be caused by ROS (reactive oxygen species) derived from 6‐OHDA autooxidation and also by the direct effect of 6‐OHDA on the mitochondrial respiratory chain. However, the process has not been totally clarified. In rat primary mesencephalic cultures, we observed a significant increase in dopaminergic cell loss 24 h after administration of 6‐OHDA (40 μM), and a significant increase in NADPH subunit expression, microglial activation and superoxide anion/superoxide‐derived ROS in dopaminergic cells, that were significantly decreased by the NADPH inhibitor Apocynin. Low doses of 6‐OHDA (10 μM) did not induce a significant loss of dopaminergic cells or a significant increase in NADPH subunit expression, microglial activation or superoxide‐derived ROS. However, treatment with the NADPH complex activator Angiotensin II caused a significant increase in all the latter. Forty‐eight hours after intrastriatal 6‐OHDA injection in rats, there was still no significant loss of dopaminergic neurons although there was an increase in NADPH subunit expression. The results suggests that in addition to the autooxidation‐derived ROS and a direct inhibition of the mitochondrial respiratory chain, early microglial activation and NADPH‐oxidase‐derived ROS act synergistically with 6‐OHDA and constitute a relevant and early component of the 6‐OHDA‐induced cell death.
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Autoantibody responses against Neurofascin (Nfasc) are implicated in the development of axonal pathology in multiple sclerosis (MS). We have now analysed the Nfasc‐specific response in sera from 113 patients with clinically definite MS, 21 patients with clinically isolated syndrome \[CIS\], 41 patients with other neurological diseases \[OND\] and 18 healthy controls \[HC\] by flow cytometry using live cell lines transfected with neuronal (Nfasc186) or glial (Nfasc155) isoforms of the protein. Compared to HC, no significant responses to Nfasc155 were detected in either PPMS or OND, but reactivity was increased in patients with CIS (p = 0.0217), RRMS (p = 0.0053) and SPMS (p = 0.0213), whereas reactivity to Nfasc186 was increased significantly in only RRMS (p = 0.0170) and SPMS (p = 0.0413). To investigate the pathogenic potential of these autoantibodies, Nfasc reactive immunoglobulins were purified from patient plasma by immunoaffinity chromatography and their ability to mediate axonal loss and/or perturb myelin formation was assessed using an in vitro myelinating culture system derived from dissociated embryonic rat spinal cord. Isotype/subclass usages within the Nfasc‐specific repertoire was heterogeneous although most patients exhibited both IgM and IgG responses (IgG2\>IgG1\>\>\>IgG3). In the presence of fresh serum as a source of complement all Nfasc‐specific autoantibody preparations derived from MS patients were found to mediate the rapid and selective destruction of myelin in vitro accompanied by a reduction in the number of mature oligodendrocytes (p\<0.005). In the presence of complement half of the MS samples also mediated a loss of axons (p\<0.005). In addition, half the samples analysed were also found to mediate a complement‐independent effect that although had no axonal effect, significantly inhibited myelination (p\<0.005). Collectively, these data confirm that a subset of patients with MS develop autoantibody responses to Nfasc that can actively partake in disease pathogenesis by mediating axonal injury and/or disrupting (re)myelination. Identification of epitopes targeted by clinically relevant autoantibodies within this functionally heterogeneous response repertoire will provide tools to aid diagnosis/prognosis and improve patient management.
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The nervous system is constantly infiltrated by blood‐derived sentinels known as perivascular macrophages. Their immediate precursors have not yet been identified in situ and the mechanism that governs their recruitment is mostly unknown. Here, we provide evidence that CD68+GR1-- monocytes can give rise to perivascular macrophages in mice suffering from endotoxemia. After adhesion to the endothelium, these monocytes start to crawl, adopt a rod‐shaped morphology when passing through capillaries, and can manifest the ability to proliferate and form a long cytoplasmic protuberance. They are attracted in greater numbers during endotoxemia by a combination of vasoregulatory molecules, including TNF (tumor necrosis factor), interleukin‐1β, and angiopoietin‐2. After a period of several hours, some of them cross the endothelium to expand the population of perivascular macrophages. Depletion of adherent monocytes and perivascular macrophages can be achieved by injection of anti‐angiopoietin‐2 peptide‐Fc fusion protein. This study extends our understanding of the behavior of monocytes at the blood--brain interface and provides a way to block their infiltration into the nervous tissue under inflammatory conditions.
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One of the key mediators of (neuro)inflammation is the pleiotropic transcription factor NFkB. Canonical NFkB activation consists of stimulus‐induced translocation of the factor from the cytoplasm to the nucleus, where the transactivation ability of the NFkB dimer can additionally be modified by posttranslational modifications. Here, we have investigated how signals from β2‐adrenergic receptors, which are abundantly present in the central nervous system (CNS), modulate NFkB‐dependent gene expression in astrocytes, one of the most important cellular mediators of innate immunity in the CNS.

We have observed that combined treatment of human 1321N1 astrocytes with the NFkB activator TNFalfa and the β‐adrenergic agonist isoproterenol synergistically induced expression of the prototypical NFkB‐dependent cytokine IL6. The effect of isoproterenol was cAMP‐dependent and mediated by the β2‐subtype. Using pharmacological inhibitors we showed that the synergy was dependent on the IKK2 and PKA kinases. Further research, using IL6 promoter point mutants, identified CREB and NFkB as the transcription factors involved downstream. Concomitantly, the synergy was inhibited upon silencing of CREB or the NFkB subunit p65 using siRNA. Additionally, we observed that simultaneous induction with isoproterenol and TNF led to combined recruitment of CREB and p65 to the native IL6 promotor, followed by cooperative recruitment of the cofactor CBP. Interestingly, the synergy was a gene‐specific process, occurring at the COX2 and IL6 promotors, but not at other typical NFkB‐dependent promoters such as IL8, ICAM, VCAM or IkB. Competition for the limited cofactor CBP by CREB and NFkB is usually regarded as one of the main mechanisms of CREB‐induced NFkB inhibition. However, our results indicate that on promoters with a particular stereospecific arrangement of CREB and NFkB binding sites, the opposite effect can occur, and CREB and NFkB can cooperate to recruit CBP, activating gene transcription.

In view of the importance of NFkB in neuroinflammatory processes and the abundance of β2‐ARs in the CNS, our observations might have important physiological consequences.
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SUPPRESSION OF NEURODEGENERATION BY MODULATION OF GLIAL GENE EXPRESSION: ROLE OF INTERFERON REGULATORY FACTOR 3 {#sec2-490}
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### Lee S., Suh H.S., Zhao M.L., Choi N., Belbin T., Brosnan C., Tarassishin L. {#sec3-490}

#### Albert Einstein College of Medicine, Bronx, United States {#sec4-490}

The balance between proinflammatory and immunoregulatory cytokines in the local inflammatory milieu may determine the outcome towards neurodegeneration or neuroprotection. In a number of human neurological diseases, activation of microglia and astrocytes with overproduction of cytotoxic and proinflammatory cytokines may contribute to neurodegeneration. We have shown that the transcription factor interferon regulatory factor 3 (IRF3) plays a critical role in the innate antiviral immune response against viruses such as HIV and HCMV in human glia. IRF3 is essential in the glial expression of IFNβ, and potentiates the induction of numerous antiviral genes that are stimulated by IFN (ISGs). Unexpectedly, we observed that overexpression of IRF3 via adenovirus‐mediated gene transfer not only increased the expression of IFNs and ISGs but also differentially regulated the expression of many cytokine and chemokine genes. For example, while increasing the expression of IP‐10, IL‐13, IL‐10 receptor and IL‐1 receptor antagonist (IL‐1ra), IRF3 suppressed the expression of others including IL‐1α, IL‐1β, TNFα, GROα and IL‐8. Inducible nitric oxide synthase expression was also suppressed. In particular, there was a persistent and potent anti‐inflammatory effect of IRF3 on the IL‐1 axis: while IL‐1 and IL‐1 receptor (RI) were suppressed, IL‐1ra was potently increased. These changes were notable in cells activated by inflammatory cytokines and toll‐like receptor ligands (poly I:C and LPS), as well as in unstimulated cells, which showed low level gene induction by adenoviral vector only. Since IL‐1 signaling crucially contributes to proinflammatory glial activation and neurotoxicity, these data suggest that IRF3 gene therapy may inhibit neuroinflammation but promote neuroprotection. In addition, IRF3 may also suppress the known immunogenic and inflammatory side effects of the adenoviral vector. The inhibition of IRF3‐independent (but NF‐κB‐dependent) genes by IRF3 is novel and indicates a presence of an as yet undefined cross‐talk between the IRF3 and NF‐κB pathways. Powerful induction of innate immune response genes in combination with suppression of neurotoxic cytokines makes IRF3 a unique candidate for gene therapy for neurological disorders.
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Glial cells (microglial cells and astrocytes) are the cellular components of the brain immune system. During aging, both microglia and astrocytes are activated, display morphometric changes and produce proinflammatory cytokines. In addition, in response to proinflammatory stimuli, primed microglia overproduce proinflammatory cytokines which trigger neuronal death and cognitive disorders. In this context, limiting the activation of glial cells and the production of proinflammatory cytokines seems very relevant. N‐3 polyunsaturated fatty acids (n‐3 PUFA) are promising micronutrients due to their anti‐inflammatory properties. However two parameters are influent on brain n‐3 PUFA content, especially on long chain n‐3 PUFA such as docasahexaenoic acid (DHA): firstly our western diet is characterized by a growing unbalance between n‐6 and n‐3 PUFA that restrains n‐3 PUFA and secondly during aging brain n‐3 PUFA decreased. This decrease can be restored by food supplementation. The aim of this study was to determine the effects of brain n‐3 PUFA content on glial morphometry during aging in mice. We used Fat‐1 model mice that carried a gene from the roundworm C. elegans. Hence, these mice can add a double bond into an unsaturated fatty‐acid hydrocarbon chain and convert n‐6 to n‐3 PUFA. The brain n‐3 PUFA content was determined by gas chromatography in hippocampus of fat‐1 and wild type mice aged 4.5 and 23 months. We evaluated glial activation by immunostaining of astrocytes (GFAP marker) and microglial cells (Iba1 marker). Images were captured with a confocal microscope in the Dentate Gyrus (DG), CA1 and CA3 of the median hippocampus. Morphometry of astrocytes and microglial cells was analysed using a three‐dimensional reconstructing Imaris software and process length and diameter were measured. DHA was higher in fat‐1 mice as compared to wild type mice at 4.5 and 23 months of age. Changes in morphometry of glial cells were associated to DHA content in hippocampus. These data suggested that increased brain DHA limited the aged‐associated changes of glial cells.
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Indoleamine 2,3‐dioxygenase (IDO) is a multifunctional immune molecule typically expressed in macrophages and dendritic cells activated by IFNγ. IDO is tolerogenic in that IDO expression suppresses CD8 CTL responses to viral infection and tumor. Downstream products of IDO‐mediated tryptophan metabolism such as quinolinic acid have been widely implicated in neurodegeneration due to their NMDA agonist activity. We have previously shown that IDO is induced in human glial cells by IFNγ and toll‐like receptor ligands, poly I:C and LPS, and contributes to innate antiviral response against intracellular pathogens such as HIV. Less is known about the immune modulatory role of IDO in glial cells. In this study, we hypothesized that IDO inhibits glial immune activity by suppressing cytokine and other inflammatory mediator production. We further hypothesized that the anti‐inflammatory and neuroprotective effect of IDO might be mediated by the downstream metabolites of the kynurenine pathway of tryptophan metabolism, such as 3‐hydroxyanthranilic acid (HA). Primary cultures of pure or mixed human microglia, astrocyte and neurons were activated by cytokines or TLR ligands and the role of IDO on the expression of inflammatory mediators was examined by siRNA‐mediated knock down of IDO. In addition, the effect of HA was directly examined. The results were analyzed by microarray, real‐time PCR, western blot, ELISA and immunocytochemistry. They show that IDO exerts anti‐inflammatory effects by suppressing glial inflammatory gene expression. Furthermore, HA suppresses cytokine and chemokine as well as nitric oxide synthase gene expression by human glia. Interestingly, HA appears to mediate the anti‐inflammatory effects in astrocytes in part by inducing antioxidant enzymes such as heme oxygenase‐1 (HO‐1). These results together reveal an unsuspected aspect of IDO biology, i.e., neuroprotection via antioxidant mechanisms. The results with HA have therapeutic implications for human neuroinflammatory diseases.

Supported by NIH grants RO1MH55477, T32NS007098 and P30AI051519.
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IGF2R is a type 1 transmembrane glycoprotein that functions to degrade insulin‐like growth factors and participates in the trafficking of lysosomal enzymes. IGF2R is an imprinted gene, and has been implicated in several disorders such as cancer. Little is known about the role of IGF2R in infectious diseases and inflammation. In this report, we studied the expression and immunoregulatory role of IGF2R in CNS inflammatory disorders such as HIV encephalitis (HIVE). Immunohistochemistry was used to examine the expression of IGF2R in human CNS. Double labeling for IGF2R and cellular/viral markers including CD45RB, GFAP, CD68 and HIV‐1 p24 was performed to examine the cellular expression. The role of IGF2R was examined by RNAi in primary cultures of human microglia infected with VSVg‐env pseudotyped HIV‐1 or activated by cytokines, TLR ligands or mannose‐6‐phosphate. In addition, we adopted stable IGF2R knockdown melanoma cell line (MeWo cells) for IGF2R functional study. The results were obtained by immunocytochemistry, real‐time PCR, western blot and ELISA. The results show that IGF2R is robustly expressed in activated glia in HIVE, particularly in microglia. In in‐vitro studies using microglia and MeWo cells, we show that IGF2R promotes HIV‐1 expression, and modulates the production of cytokines and chemokines. We also find that IGF2R is upregulated by IFN gamma. Together, these results demonstrate a novel role for IGF2R in modulating viral infection and CNS inflammation. These findings have implications for the pathogenesis of HIV‐associated CNS disorders.

Supported by K01 NIH MH94705, R01 MH55477, P30 AI051519, and Einstein CFAR pilot project.
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NG2 is a high molecular weight chondroitinsulfate proteoglycan found on the surface of oligodendrocyte precursor cells (OPCs) in the adult central nervous system (CNS). In vitro, NG2 plays a role in cell migration and proliferation of several cell types, modulates responses to the growth factors PDGF‐AA and bFGF, and is essential in maintaining OPCs in an undifferentiated state. Several studies have shown that insults of the CNS, including inflammation in Multiple Sclerosis, result in rapid accumulation of NG2 at the site of injury. Importantly, the accumulation of NG2 may be detrimental to disease outcome because it may inhibit axonal outgrowth and impair remyelination. Remarkably, despite these potentially averse effects of NG2 accumulation on regenerative processes in the CNS, the cellular sources and mechanisms responsible for NG2 upregulation in response to CNS injury are not well defined.

We have studied the regulation and function of NG2 in experimental autoimmune encephalomyelitis (EAE), a commonly used animal model of Multiple Sclerosis. Western blotting and real‐time PCR demonstrated that both NG2 protein and mRNA are upregulated during EAE. In addition, immunohistochemistry (IHC) showed that NG2 is abundantly present at peak disease surrounding the infiltrating leukocytes in the spinal cord. Potentially both OPCs and infiltrating macrophages could contribute to the upregulation of NG2, and indeed, *in vitro*, both OPCs and macrophages upregulate NG2 mRNA and protein in response to various cytokines. To investigate the function of this increase in NG2 expression in response to CNS injury we subjected NG2 knockout mice to EAE. Surprisingly, although the onset and maximum severity of disease were unaffected by the absence of NG2, the NG2 knockout mice showed improved recovery in the remitting phase of EAE. Subsequent flow cytometric analysis and IHC indicated that this effect might be due to a reduction in antigen presenting dendritic cells in the CNS resulting in reduced demyelination and axonal damage. Thus, both OPCs and macrophages are likely to contribute to increases in NG2 as a result of CNS injury, which appears to affect antigen presenting dendritic cell numbers and augments axonal damage and demyelination.
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Evidence is mounting that microRNAs (miRs), and miR‐155 in particular, play an important role in immune responses and inflammation. For example, it has been demonstrated that activated macrophages express large amounts of miR‐155. In the central nervous system the monocyte‐macrophage function is performed by microglial cells (MC). Yet, it remains to be established whether these cells also express a functional miR‐155.

Murine MC (BV2‐cell line) were stimulated by various concentrations of the TLR4 agonist LPS (1 ‐ 1000 ng/ml) or the TLR2 agonist PAM3CSK4 (PAM, 0.01‐1 μg/ml) for 6h and 24h. Supernatants were collected and IL‐6/TNF‐α production was assessed by ELISA. Furthermore, qPCR was performed to monitor the expression of miR‐155. Next, primary MC were isolated from adult C57/BL6 mice (WT) and age‐matched miR‐155‐/‐ mice. IL‐6/TNF‐α production was determined following LPS(100 ng/ml) or PAM (1 μg/ml) stimulation for 24h. For statistical analysis, the student\'s t‐test was used and a p‐value ≤0.05 was considered significant. Fold‐changes in miR‐155 expression were determined according to the 2‐ΔΔCt method.

At both 6h and 24h, a significant increase in TNFα production was already observed at 10 ng/ml LPS in BV‐2 cells, while a significant increase of IL‐6 production required at least 100 ng/ml. Also, PAM treatment resulted in a dose‐dependent increase of IL‐6 and TNF‐α especially at 24h with 1 μg/ml. With respect to the miR‐155 expression, a similar dose‐dependent increase was observed following LPS (max ∼12‐fold at 1 μg/ml at 6h and 24h) or PAM (max ∼7‐fold at 1 μg/ml at 24h) stimulation.

Next, we isolated primary MC form WT and miR‐155‐/‐ mice. As expected, primary MCs from WT, but not miR‐155‐/‐ mice, clearly expressed miR‐155. Intriguingly, however, both IL‐6 as well as TNF‐α production by primary MC from miR‐155‐/‐ mice was markedly diminished compared to WT mice.

Our data imply that MC express miR‐155 and that in these cells miR‐155 is required for the production of pro‐inflammatory cytokines. This suggests that modulation of inflammation by altering the expression of miR‐155 may become a target for future therapeutic applications in various neurodegenerative diseases (e.g. Alzheimer\'s disease).
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AGE RELATED CHANGES IN CNS‐IMMUNE SYSTEM INTERACTIONS: IMPLICATIONS FOR AGE‐SPECIFIC RISK AND TREATMENT OF NEUROLOGIC DISORDERS {#sec2-496}
-------------------------------------------------------------------------------------------------------------------------------

### Davis D., Puntambekar S.S., Almolda Ardid B., Sloniowski S., Ethell I.M., Carson M.J. {#sec3-496}

#### University of California Riverside, Division of Biomedical Sciences and Center for Glial‐Neuronal Interactions, Riverside, United States {#sec4-496}

Microglia are the tissue macrophage of the CNS able to rapidly respond to insults occurring within the CNS. Systemic inflammation induced outside the CNS can also lead to microglial activation. Here we find that systemic inflammation induced by intraperitoneal LPS injection leads to widespread microglial activation accompanied by a small transient influx of peripheral macrophages. Unlike, microglial activation induced by injection of LPS directly into the CNS, intraperitoneal injection of LPS did not lead to robust proinflammatory activation of microglia. Rather, we observed induced expression of selected members of the TREM family of immunomodulatory receptors that may be indicative of alternative anti‐inflammatory activation responses. Because microglial phenotype is highly plastic and readily modulated by environmental cues, we also examined microglial phenotype and responses to systemic inflammation as a function of normal development and extreme aging. We, and others have hypothesized that during early childhood, the brain has a unique profile of susceptibility to systemic inflammation because this timeframe corresponds to the period of active brain development and experience driven synapse formation. In addition, within the CNS, age‐related changes in the phenotype and function of microglia have been hypothesized to contribute to the onset and progression of age‐linked neurodegenerative disorders such as Alzheimer\'s disease. Here, using flow cytometry and dual immunohistochemical/in situ hybridization, we demonstrate that (1) basal microglial phenotype displays increasing regional diversity as a function of healthy aging (2) macrophage influx into the CNS caused by LPS‐induced systemic inflammation decreases with age (3) microglial responses to systemic inflammation are more robust during early post‐natal development than after CNS maturation is complete. Taken together, these data contribute to the growing literature demonstrating differential age‐linked CNS susceptibility to insults associated with neurodevelopmental disorders, neurodegeneration and responses to therapeutic intervention.

These studies have been supported by NIH, DOD, Dana Foundation and UCR Biomed PIC Grant program.
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EXTRACELLULAR MATRIX AND ADHESION MOLECULES
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ROLE OF PINCH1 AND PINCH2 IN SCHWANN CELL BIOLOGY {#sec2-497}
-------------------------------------------------

### Goncalves A.F. {#sec3-497}

#### ETH Zurich, Zurich, Switzerland {#sec4-497}

PINCH (Particularly interesting new cysteine‐histidine‐rich protein) is part of an intracellular molecular complex designated IPP (Pinch, ILK, Parvin). This complex is targeted to the cell membrane and integrates signals from integrins, and growth factor tyrosine kinase receptors. There are two known PINCH proteins, PINCH1 and PINCH2, which have been previously reported to play both distinct and compensatory roles in the homeostasis of multiple cell types. In this study we use specific gene ablation in order to report essential functions for PINCH 1 and 2 in radial sorting of axon bundles and in peripheral nervous system myelination. Our in vivo and in vitro experiments show that PINCH negatively regulates Rho/Rho kinase signaling to regulate SC process extension and initiating radial sorting. PINCH also appears to modulate IGF‐1 expression and signaling during these early stages of PNS myelination.
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TISSUE TRANSGLUTAMINASE PLAYS A PIVOTAL ROLE IN ASTROCYTE‐FIBRONECTIN INTERACTIONS: A NOVEL THERAPEUTIC TARGET TO COMBAT ASTROGLIOSIS? {#sec2-498}
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### Van Dam A.M., Van Strien M., Fratantoni S., Breve J., Drukarch B. {#sec3-498}

#### VU University Medical Center, Amsterdam, Netherlands {#sec4-498}

An important neuropathological feature of Multiple Sclerosis (MS), but also other chronic lesions within the brain, is the formation of an astroglial scar. Firm interaction of the astrocytes with extracellular matrix proteins is likely to be involved in astrogliosis. Indeed, an increased appearance of various extracellular matrix proteins, such as fibronectin, at the lesion sites in MS has been described. This astrogliosis represents a major mechanical impediment to remyelination and axonal regeneration in MS.

Tissue Transglutaminase (TG2) is a multifunctional enzyme, well known for its protein crosslinking activity. At the cellular level, TG2 has been implicated in adhesion and migration of fibroblasts and monocytic cells onto extracellular matrix proteins, in particular fibronectin. These data suggest a pivotal role of TG2 in cell‐matrix interactions. As we observed that TG2 is present in astrocytes in active MS lesions, we questioned whether TG2 plays a role in astrocyte‐fibronectin interactions in vitro.

To this end, intracellular and surface expression of TG2 in primary cultured rat astrocytes was studied. We observed that inflammatory mediators, present in the CNS of MS patients regulate TG2 production in and surface expression on astrocytes. Indeed, combinations of IFNγ, TNFα and IL‐1β synergistically enhanced TG2 production in primary cultured rat astrocytes. Moreover, TG2 surface expression on astrocytes was elevated after cytokine exposure of the cells and found to be functionally active. In line with these observations, we observed that adhesion of astrocytes onto fibronectin is, at least partly, mediated by TG2 as determined by siRNA studies and pharmacological inhibition of TG2 activity.

We conclude that astroglial TG2 is upregulated by inflammatory mediators. This TG2 is clearly involved in the interaction of astrocytes with the extracellular matrix protein fibronectin. Considering the role of fibronectin in glial scar formation, our data implicate that TG2 can contribute to astrogliosis and thereby possibly impair regeneration of the central nervous system during MS or other chronic brain lesions.
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EXPRESSION OF HYALURONIC ACID RECEPTORS IN SCHWANN CELLS AND GLIAL CELL‐LIKE DIFFERENTIATED STEM CELLS {#sec2-499}
------------------------------------------------------------------------------------------------------

### Ouasti S., Tirelli N., Kingham P. {#sec3-499}

#### Manchester University, Manchester, United Kingdom {#sec4-499}

Hyaluronic acid (HA) is a ubiquitous glycosaminoglycan, present at high levels in the pericellular neuronal matrix. Previous studies suggest that HA plays a crucial role in astrocyte function and glial scar formation following CNS injury. HA interacts with both cell surface receptors, CD44 and RHAMM (receptor of hyaluronan‐mediated motility; CD168), during morphogenesis and tissue regeneration. However, data are lacking on the relation between the function of peripheral glial cells, and the regulation of the expression of both CD44 and RHAMM. In order to provide a thorough study on the HA‐related motility of peripheral glial cells, we investigated CD44 and RHAMM expression of primary adult Schwann cells and adipose derived stem cells (ADSC) differentiated into a Schwann cell phenotype.

Schwann cells were cultured from adult rat sciatic nerve and ADSC were obtained from rat visceral fat. ADSC were isolated from the mature adipocytes by centrifugation and enriched following differential adhesion to tissue culture plastic. The cells were treated with a mixture of glial growth factors to induce expression of Schwann cell markers. RT‐PCR, immunocytochemistry and Western blotting experiments revealed that CD44 was expressed by all the different cell types whereas RHAMM was not expressed by undifferentiated stem cells, but up‐regulated when differentiated into a Schwann cell phenotype. RHAMM was also expressed by primary adult Schwann cells. Immunostaining data revealed that CD44 was mostly localised around the cell body, whereas RHAMM was mainly present on the cytoplasmic elongations of both the primary Schwann cells and the differentiated ADSC. Preliminary western blotting analysis uncovered three RHAMM isoforms of 52, 75 and 85kDa, with an up‐regulation of the ‐85kDa isoform for the ADSC differentiated into a Schwann cell phenotype.

We are currently studying the effect of HA on glial and stem cell motility and proliferation, and the individual contributions of the two receptors. These results will indicate the importance of HA in mediating glial cell function during peripheral nerve regeneration and have implications for therapeutic repair strategies.
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FIBRONECTIN IN REMYELINATION: DO ASTROCYTES SECRETE PATHOLOGICAL MULTIMERS IN MULTIPLE SCLEROSIS? {#sec2-500}
-------------------------------------------------------------------------------------------------

### Stoffels J.,^1^ Zhao C.,^2^ de Jonge J.,^1^ Nomden A.,^1^ Stancic M.,^1^ Hoekstra D.,^1^ Franklin R.,^2^ Baron W.^1^ {#sec3-500}

#### ^1^Department of Cell Biology, Section Membrane Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; ^2^MRC Centre for Stem Cell Biology and Regenerative Medicine and Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom {#sec4-500}

In demyelinating diseases, such as multiple sclerosis (MS), failure of remyelination by oligodendrocyte precursor cells (OPCs) is associated with changes in the expression of extracellular matrix molecules, such as fibronectin. In vitro, fibronectin is known to inhibit myelin‐sheet formation by oligodendrocytes. To further investigate a role for fibronectin in remyelination, we characterised fibronectin expression in MS lesions and in two toxin‐induced demyelination models of the rat central nervous system (CNS).

Using immunohistochemistry and Western blot, we detected persistent upregulation of fibronectin expression in both active and inactive MS lesions. In the toxin‐induced demyelination models, fibronectin expression was upregulated at demyelination and downregulated at remyelination. Interestingly, fibronectin expression was multimeric in MS lesions, but dimeric, possibly not multimeric, in toxin‐induced demyelination. Detection of cellular fibronectin splice variant expression at RT‐PCR and immunohistochemistry suggests that some CNS cells produce fibronectin in demyelination. This was confirmed by double immunohistochemistry and in situ hybridisation on toxin‐induced demyelinating lesions, identifying astrocytes, marcophages/microglia and endothelial cells to express fibronectin (mRNA), but not oligodendrocytes. In addition, cultured astrocytes and, to a lesser extent, endothelial cells were shown to produce fibronectin. Moreover, multimeric fibronectin, as detected in MS lesions, was formed upon stimulation with inflammatory mediators.

Fibronectin expression by various cell types in toxin‐induced demyelination coincides with the recruitment of OPCs, whereas downregulation of fibronectin expression coincides with the onset of differentiation of myelinating OPCs. This suggests that dimeric fibronectin plays a role in the regulation of recruitment of OPCs, but requires downregulation for their differentiation. In MS, persistent expression of multimeric fibronectin might therefore well be implicated in remyelination failure. More functional research is required to further elucidate mechanisms of fibronectin‐mediated effects on remyelination and its persistent expression in MS. This can benefit development of a remyelinating therapeutic strategy.
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MORPHOLOGICAL ANALYSES OF THE PERIPHERAL NERVOUS SYSTEM IN MICE DEFICIENT FOR PERLECAN, A BASEMENT MEMBRANE PROTEOGLYCAN {#sec2-501}
------------------------------------------------------------------------------------------------------------------------

### Bangratz M.,^1^ Davoine C.S.,^1^ Fontaine B.,^2^ Nicole S.^2^ {#sec3-501}

#### ^1^Inserm, UPMC Univ Paris 06, UMR_S975, Paris, France; ^2^Inserm, UPMC Univ Paris 06, UMR_S975; AP‐HP, Paris, France {#sec4-501}

Perlecan is a ubiquitous heparan sulphate proteoglycan (HSPG) secreted into basement membranes (BM) with crucial role in cell adhesion, growth factor signaling, and BM maintenance. A lack of perlecan resulting from hypomorphic mutations leads to Schwartz‐Jampel syndrome (SJS), a recessively inherited human disorder characterized by permanent and generalized muscle stiffness with muscle hyperactivity at EMG. To understand the pathophysiological mechanism responsible for muscle hyperactivity in SJS, we developed a mouse model with perlecan deficiency mimicking SJS. We showed that the muscle hyperactivity recorded in SJS mutant mice was composed of neuromyotonic discharges that originated from the distal part of peripheral nerves. Neuromyotonic discharges were recorded in mice modeling demyelinating peripheral neuropathy such as the P0 ‐/‐, Pmp22 ‐/‐, Trembler‐J, and Pmp22‐overexpressing mice. Since perlecan is highly expressed in the nerve BMs including perineurium and endoneurium, we explored the nerve morphology in our adult SJS mutants deficient for perlecan.

We confirmed the lack of perlecan in the mutant nerve BMs. No major changes in the expression or organization of BM components (laminin‐α2), transmembrane receptors (dystroglycan) or cytoskeletal proteins linked to BM (utrophin) were seen in the proximal sciatic nerves. A small increase of agrin expression, another HSPG found in BMs, was seen, which could functionally compensate for perlecan loss. Neurofilament or MBP analyses did not detect major axonal loss or demyelination events. Ultrastructural analyses showed an increase of endoneurial space with an abnormal shape of axons and a higher proportion of smaller axons compared to control mice. However, no major changes in myelination were observed in adult mutant mice compared to controls, according to the normal electrophysiological characteristics of PNS recorded in our mutant mice. To pursue our investigation, we explored in more details the distal extremities of PNS, near the neuromuscular junction. We will show our immunofluorescence analyses of the mutant distal myelinated‐unmyelinated junctions found in motor terminal arborization branches, which are a site particularly vulnerable to spontaneous impulse generation in the PNS.

INSERM, AFM, ANR Maladies Rares, UPMC
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BILATERAL QUANTITATIVE CHANGES OF LAMININ‐1 IN THE DORSAL AND VENTRAL ROOTS FOLLOWING UNILATERAL CHRONIC CONSTRICTION INJURY OF SCIATIC NERVE ‐ AN IMMUNOFLUORESCENCE TISSUE ARRAY {#sec2-502}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Dubový P., David M., Svizenska I., Klusakova I. {#sec3-502}

#### Masaryk University Medical Faculty, BRNO, Czech Republic {#sec4-502}

Bilateral changes of immunofluorescence for laminin‐1 (lam‐1) were investigated in the rat spinal nerve roots (L4‐L5) following neuropathic pain induction by unilateral sciatic nerve ligature. Induction of neuropathic pain was confirmed in experimental animals by behavioral tests of mechanical allodynia and thermal hyperalgesia. Dorsal and ventral roots of naïve rats displayed lam‐1 immunostaining in the basal laminae on outer surface of Schwann cell/axon units, perineurial sheaths and blood vessels. Significantly higher brightness of immunofluorescence for lam‐1 was observed in the ventral than dorsal roots removed from naive rats as well as those operated on sciatic nerve ligature and surviving fro 1 or 3 days. Chronic constriction injury of sciatic nerve for 7 and 14 days results in reduction of different levels of immunofluorescence brightness between dorsal and ventral roots. In comparison to naïve and sham‐operated animals, apparent bilateral decrease of immunofluorescence brightness for lam‐1 was found in both dorsal and ventral roots 7 days after unilateral nerve injury. Although the pattern of lam‐1 alterations in both ipsi‐ and contralateral roots was similar, changes of immunofluorescence were more evident in ipsilateral than contralateral roots. The results indicate that quantitative changes of immunofluorescence for lam‐1 are present bilaterally in proximal segments of peripheral nerve far from unilateral chronic constriction injury inducing neuropathic pain. This suggests a possible mechanism for misbalance alongside the afferent and motor axons, the involvement of which in neuropathic pain induction is assumed.

Supported by MSM0021622404.
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EXPRESSION OF COLLAGEN XXVIII IN UNMYELINATED SCHWANN CELLS AND AT NODES OF RANVIER {#sec2-503}
-----------------------------------------------------------------------------------

### Fichard‐Carroll A.,^1^ Carroll P.,^1^ Wagener R.,^2^ Grimal S.^1^ {#sec3-503}

#### ^1^Institut des Neurosciences de Montpelier, Montpellier, France; ^2^Center for Biochemistry, Cologne, Germany {#sec4-503}

Collagen XXVIII is a secreted protein expressed essentially in the peripheral nervous system where it was first described in the basal lamina surrounding a sub‐population of Schwann cells. We carried out a detailed analysis of the localisation of collagen XXVIII in the adult mouse. This collagen is highly‐concentrated at the nodes of Ranvier on myelinated fibres and is evenly distributed in the basal lamina surrounding unmyelinated Schwann cells. A strong expression is also observed around certain terminal Schwann cells associated with the peripheral sensory nerves ending both in skin and muscle. This specific pattern of expression suggests an important role for collagen XXVIII in peripheral glial cell biology.
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A SIGNALLING PATHWAY THAT INHIBITS OLIGODENDROCYTE DIFFERENTIATION INDUCED BY THE EXTRACELLULAR MATRIX MOLECULE TENASCIN C {#sec2-504}
--------------------------------------------------------------------------------------------------------------------------

### Czopka T.,^1^ Von Holst A.,^1^ Ffrench‐Constant C.,^2^ Faissner A.^1^ {#sec3-504}

#### ^1^Dept. of Cell Morphology & Molecular Neurobiology, Ruhr‐University, Bochum, Germany; ^2^Centre for Multiple Sclerosis Research, MRC Scottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom {#sec4-504}

Oligodendrocytes are the myelin‐forming cells of the central nervous system. Their differentiation evolves stepwise from bipolar progenitors to immature oligodendrocytes bearing multiple processes and ends with membrane sheath‐bearing mature oligodendrocytes. This process coincides with the upregulation of myelin gene expression. We investigate the impact of extracellular matrix (ECM) components as spatiotemporal cues for oligodendrocyte development. We have previously shown that astrocyte‐derived Tenascin C (Tnc) is a major functional component of astrocyte‐derived ECM, which inhibits the expression of myelin basic protein (MBP) in oligodendrocytes. Here, we investigated the signalling mechanisms that are elicited by Tnc and that mediate delayed MBP‐expression. In a candidate approach, we investigated whether molecules that are known to be involved in oligodendrocyte differentiation also partake in Tnc‐signalling. We show that Tnc interfered with activation of phosphaditylinositol‐3‐kinase signalling, which in turn proved to be required for effective differentiation. Tnc associates with lipid rafts in oligodendrocyte membranes, in conjunction with the cell adhesion molecule Contactin (Cntn1) and the tyrosine kinase Fyn. siRNA‐mediated depletion of Cntn1 abolished the Tnc‐dependent inhibition of maturation. Tnc stimulation also impeded the activation of the tyrosine kinase Fyn in a Cntn1‐dependent manner. Furthermore, Tnc reduced the expression of the signal transducer and RNA‐binding molecule Sam68. Over‐expression of Sam68 in oligodendrocytes promotes their differentiation as determined by increased MBP‐expression. Sam68 bound directly to MBP mRNA, which indicates a regulatory mechanism that may mediate Tnc‐dependent repression of the MBP‐gene.

In summary, our study uncovers a signalling pathway for Tnc and provides novel insights into the complexity of cellular environments for timing of differentiation.

The authors thank the Ministry for Research and Technology (BMBF, Grant 01GN0503 to AF) and the International Graduate School of Neuroscience (IGSN) for support.
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INVESTIGATING THE UNIQUE HEPARAN SULPHATE PROTEOGLYCAN PROFILES OF OLFACTORY ENSHEATHING CELLS AND SCHWANN CELLS AND THEIR ROLE IN ASTROCYTIC BOUNDARY FORMATION {#sec2-505}
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### Higginson J.,^1^ Thompson S.,^2^ Santos‐Silva A.,^1^ Guimond S.,^2^ Turnbull J.E.,^2^ Barnett S.C.^1^ {#sec3-505}

#### ^1^University of Glasgow, Glasgow, United Kingdom; ^2^University of Liverpool, Liverpool, United Kingdom {#sec4-505}

The formation of a glial scar, following central nervous system (CNS) injury, is widely considered to be a major factor in inhibiting CNS repair mechanisms. The cells responsible for this are astrocytes and their stress response is characterised by reactive astrocytosis/proliferation, boundary formation and increased GFAP expression. Previous work has shown that when astrocytes are in contact with Schwann cells both in vitro and in vivo this astrocytic stress response can be observed and a boundary between the two cell types is formed, however this is not seen when astrocytes are in contact with olfactory ensheathing cells (OECs). Furthermore we have shown that the molecular component mediating this effect is secreted by Schwann cells and is sensitive to FGFR1 inhibition and is also critically dependent upon the integrity of heparan sulfate proteoglycans (HSPGs). This indicates that FGF/HSPG interactions differentially regulate the astrocyte stress response in OECs compared with Schwann cells, implying fundamental differences exist in the HSPG profile secreted by these two cell types. In this study we have examined these differences by purifying HSPGs from the conditioned media of OECs and Schwann cells and carrying out compositional analysis, which indicated variation in the structure of the secreted HS between the two cell types. To identify the specific heparan sulphate sidechains responsible for boundary formation, a panel of heparans chemically modified to remove specific sulphate moieties were screened for their ability to induce boundary formation. These compounds demonstrated variant abilities to induce boundary formation between OECs and astrocytes, suggesting a complex interplay between sulfation patterns and activity. In addition, conditioned media was depleted with proteases to investigate whether a protein constituent is required for boundary formation. Work will be described in which the signalling pathways responsible for inducing the astrocytic response were investigated by measuring the activation of FGFR1 and downstream MAPK activity. These results support the accumulating evidence that OECs are distinct from Schwann cells and may have advantages over them for transplant‐mediated repair of CNS injury.
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SIMVASTATIN, A HYDROXYMETHYLGLUTARYL‐COENZYME A REDUCTASE INHIBITOR, EXERTS NEUROLOGICAL RECOVERY‐PROMOTING AND ANTI‐EDEMATOUS EFFECTS ASSOCIATED WITH A DECREASE OF ICAM‐1 EXPRESSION AFTER TRAUMATIC BRAIN INJURY {#sec2-506}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Beziaud T., Chen X.R., Palmier B., Plotkine M., Marchand‐Leroux C., Besson V.C. {#sec3-506}

#### Université Paris Descartes, Paris, France {#sec4-506}

Traumatic brain injury (TBI) leads to a deleterious neuroinflammation evidenced by brain edema, matrix metalloprotease (MMP) activation, cytokine production, and leukocyte parenchyma infiltration. It has been demonstrated that inhibition of hydroxymethylglutaryl Coenzyme A reductase by statins mediates anti‐inflammatory effects. This led us to study the effect of simvastatin on the consequences caused by TBI.

TBI was induced by lateral fluid percussion of the temporoparietal cortex on male Sprague‐Dawley rats. Simvastatin at 37.5 mg/kg or its vehicle (0.5% methylcellulose) were administered by gavage 1 and 6h after brain injury. At 24h, a neurological assessment was done by two tests: one for reflexes and sensorimotor responses (ranging from 0=worst to 9=best), and the second untitled beam walking test for motor coordination (ranging from 0=worst to 4=best). Brain edema was measured by the brain water content (BWC). Thereafter, the effect of simvastatin on ICAM‐1, an adhesion molecule involved in the leukocyte parenchyma infiltration, was evaluated by immunohistochemistry, and the effect on MMP 9 activity by zymography.

At 24h post‐injury, TBI decreased both the neurological (5.9±0.4 *vs* 9.0±0.0 for sham‐operated rats, *P*\<0.001) and beam walking scores (1.8±0.4 *vs* 3.7±0.2 for sham‐operated rats, *P*\<0.001), demonstrating a neurological deficit. Simvastatin improved both scores (7.0±0.3 and 2.7±0.4, *P*\<0.05), demonstrating neurological recovery‐promoting effects. TBI also induced a brain edema (81.5±0.6% *vs* 79.5±0.1% for sham‐operated rats, *P*\<0.001) that was reduced by simvastatin (79.9±0.1, *P*\<0.01), showing an anti‐edematous effect. Moreover, TBI led to ICAM‐1 staining, which was decreased by simvastatin (*P*\<0.05). However, simvastatin failed to reduce MMP 9 activity induced by TBI.

Our results show that simvastatin promotes neurological recovery and exerts anti‐edematous effect after TBI. These beneficial effects are not associated with a decrease in MMP9 activity but could be mediated, partly, by the decrease of ICAM‐1 expression.
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DIFFERENTIAL ACCUMULATION OF CHONDROITIN SULFATE PROTEOGLYCANS AND LAMININS DURING DE‐ AND RE‐MYELINATION AND THEIR FUNCTIONAL ROLES {#sec2-507}
------------------------------------------------------------------------------------------------------------------------------------

### Lau L., Cua R., Döring A., Silva C., Sloka S., Stirling D., Yong V.W. {#sec3-507}

#### University of Calgary, Calgary, Canada {#sec4-507}

Remyelination is a critical repair process in demyelinating disorders such as multiple sclerosis (MS). While remyelination occurs spontaneously in many MS patients, it is often incomplete and insufficient to restore function. This failure may be attributed to the presence of a glial scar, a well‐studied phenomenon in the context of axonal injury but whose role in demyelinating injury has yet to be understood. Components of the glial scar, including chondroitin sulfate proteoglycans (CSPGs), are deposited in MS lesions. CSPGs impede axonal regeneration, but little is known about their role in remyelination. Further, laminins have previously been shown to promote the morphological differentiation of oligodendrocytes in culture but its role in remyelination has not been investigated. Hence, we tested the novel hypothesis that CSPGs and laminins accumulate differentially during de‐ and re‐myelination to dictate the extent of remyelination.

A lysolecithin‐induced demyelinating/remyelinating model was used to characterize deposition and clearance of CSPGs and laminin in the lesion microenvironment. Animals were euthanized at 7, 14 and 21 days post‐injection (dpi). Demyelinated lesions and subsequent remyelination were confirmed with luxol fast blue stain, toluidine blue stain, and electron microscopy. Corresponding with periods of demyelination (7‐14dpi), increased CSPG RNA and protein levels were observed. CSPGs were subsequently cleared prior to remyelination at 21dpi. Conversely, increased laminin RNA and protein levels persisted through later stages of remyelination suggesting a permissive role of laminins.

The functional roles of CSPGs and laminins were assessed on isolated adult oligodendrocyte precursor cells (OPCs) cultured on various substrates. While laminin promoted OPC maturation, CSPGs significantly inhibited. Interestingly, CSPG inhibition was overcome with the further addition of laminin or with the addition of enzymes to degrade CSPG substrates. Ongoing work is focused on CSPG clearance in vivo while retaining laminin expression with the overall aim to promote remyelination. In summary, this study has identified novel and differential roles of CSPGs and laminin during de‐ and re‐myelination.
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A 3‐DIMENSIONAL MATRIX MODEL FOR THE STUDY OF NERVE REGENERATION {#sec2-508}
----------------------------------------------------------------

### Mantovani C.,^1^ Shawcross S.,^1^ Terenghi G.,^1^ Wiberg M.^2^ {#sec3-508}

#### ^1^The University of Manchester, Manchester, United Kingdom; ^2^University of Umea, UMEA, Sweden {#sec4-508}

Despite the improvements in the manufacture of biomaterials and fabrication of artificial nerve conduits, autologous nerve grafts remain the standard procedure for bridging gaps in nerve integrity that result from peripheral nerve injuries. The alternative strategies of tissue engineering constructs for nerve regeneration have yet to prove fully their functional superiority to autologous nerve grafts. The major advantages of autologous nerve grafts are the presence of the basal lamina and extracellular matrix molecules which provides physical guidance for regenerating axons, and of Schwann cells (SC) which are a source of essential neurotrophic factors and adhesion molecules.

The goal of this study was to develop a three‐dimensional (3D) in vitro co‐culture system comprising dorsal root ganglia (DRG) neurons and SC that closely resembles the peripheral nerve regeneration process in vivo in order to study, in a controlled micro‐environment, all the variables that modulates the outgrowth of neurites and results their myelination. SC were obtained fromnerve bipsies and compared to the behaviour of mesenchymal stem cells (MSC) and adipose stem cells (ADSC) differentiated (dMSC or dADSC) into SC‐like cells. Different matrices, such as growth factor‐enriched Matrigel™, pure Hydrogel™ and chitosan sponges were tested as 3D support media for theinteractions between neurons glial cells.

The seeded 3D structures were incubated for varying periods of time and analysed by immunosatining for neuronal,glial, myelin and extracellular matrix marker, using confocal microscopy to examine the neurite growth and cellular interactions.

This system provides the setting mimicking the in vivo regeneration conditions, and offer the possibility to study the interactions between the two types of differentiated stems cells, dMSC and dADSC, and the DRG neurons and to unlock the potential of differentiated stem cells to act as substitutes for SC in the construction of a biologically functional, clinically useful synthetic nerve graft.
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ADHESION TO THE EXTRACELLULAR MATRIX IS REQUIRED FOR INTERLEUKIN‐1‐INDUCED SIGNALLING PATHWAYS IN ASTROCYTES {#sec2-509}
------------------------------------------------------------------------------------------------------------

### Summers L., Kielty C., Pinteaux E. {#sec3-509}

#### University of Manchester, Manchester, United Kingdom {#sec4-509}

The extracellular matrix (ECM) is a critical component of the central nervous system (CNS) that regulates brain homeostasis. However, the ECM is degraded after acute CNS injury, and is deposited around the lesion site during inflammation and recovery. The pro‐inflammatory cytokine interleukin‐1 (IL‐1) is a key mediator of neuroinflammation. Importantly, mechanisms of IL‐1 / ECM cross‐talk, known to occur during peripheral inflammation, have not been studied in acute brain injury. The aim of this study was to investigate whether adhesion to key ECM molecules modulates IL‐1β actions in astrocytes.

Primary rat astrocytes attached, spread and formed focal adhesions when plated onto plasma fibronectin, the cell binding fragment of fibrillin‐1 or laminin 111. Using RGD peptides and specific integrin‐blocking antibodies, we demonstrated that integrin subunits β1, α4 and α5 supported adhesion to these ECM molecules.

IL‐1β‐induced activation of extracellular‐regulated kinase 1/2 (ERK1/2) was significantly increased in cells plated onto ECM, implying higher levels of MEK activation. Conversely, IL‐1β‐induced inhibition of RhoA was enhanced when cells were attached to ECM molecules. IL‐1β‐induced RhoA inhibition was accompanied by loss of focal adhesions and morphological changes, which were prevented by pre‐treatment with the MEK inhibitor U0126.

In conclusion, we showed that attachment to ECM regulates IL‐1ß‐induced RhoA and ERK1/2 activation in astrocytes, leading to astrogliosis. Ongoing studies aim to identify the key signalling elements involved in ECM regulation of IL‐1‐induced signalling pathways, which may lead to novel treatments for neuroinflammatory disorders.
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ETHIDIUM BROMIDE‐INDUCED DEMYELINATION IN THE SCIATIC NERVE OF DIABETIC RATS {#sec2-510}
----------------------------------------------------------------------------

### Bondan E.F.,^1^ Custódio P.R.,^2^ Lallo M.A.,^1^ Bentubo H.D.L.,^2^ Graça D.L.^3^ {#sec3-510}

#### ^1^Universidade Paulista (UNIP); Universidade Cruzeiro do Sul (UNICSUL), SãO Paulo, Brazil; ^2^Universidade Cruzeiro do Sul (UNICSUL), SãO Paulo, Brazil; ^3^Universidade Federal de Santa Maria, Santa Maria, Brazil {#sec4-510}

After local ethidium bromide (EB) injection in the peripheral nervous system no destruction but rather intoxication of Schwann cells (SC) is observed. As hyperglycemia found in diabetes is also known to disturb the integrity and functioning of SC, the aim of this study was to observe the behaviour of these cells facing a double challenge (the EB gliotoxic action and hyperglycemia induced by the streptozotocin diabetogenic model) in order to see if they still maintain their survival capacity or the ability of reconstructing myelin sheaths. Adult male Wistar rats were divided into 4 groups: I‐ diabetic rats injected with 1 microliter of 0.1% EB in the sciatic nerve; II‐ diabetic rats injected with 1 microliter of 0.9% saline solution; III‐ diabetic rats with no EB injection; and IV‐ non‐diabetic rats injected with 1 microliter of 0.1% EB solution. Induction of diabetes mellitus was performed 10 days earlier using a single intraperitonial injection of 50 mg/kg streptozotocin solution. The animals were euthanatized at 3, 7, 14, 21 and 31 days after intraneural injection and nerve sections were collected for transmission electron microscopy studies. In non‐diabetic rats from group IV, SC showed signs of EB intoxication 3 days after, with cytoplasmic vacuolization and rejection of their myelin sheaths. The sheaths showed condensation of the outer lamellae and progressive vesiculation leading to segmental demyelination. Myelin debris were removed by macrophages within the endoneurium distended by edema and mast cells were abundant in all lesions. From 14 days following EB injection, supernumerary SC were seen in the endoneurium expanded by numerous collagen fibers as well as thin myelin sheaths indicating remyelination, which was very advanced by 31 days. No evidence of either primary demyelination or loss of the neuroglia was found in rats from groups II and III. Diabetic rats from group I presented delayed activities from both macrophages and remyelinating SC, with huge amounts of myelin‐derived membranes in the extracellular space, many demyelinated fibers, few thinly remyelinated axons, even at 31 days post‐injection, and absence of mast cells. These results show that SC outstanding potential to remyelinate after EB gliotoxic damage was clearly compromised by the short‐term diabetic state.
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The ubiquitin‐proteasome system (UPS), lysosomes and autophagy are essential protein degradation systems for the regulation of a variety of cellular physiological events including the cellular response to injury. It was recently reported that axonal degeneration by traumatic insults or retrieval of nerve growth factors is mediated by the UPS and autophagy. In the peripheral nerves, axonal degeneration after injury is accompanied by myelin degradation which is tightly related to the reactive changes of Schwann cells called dedifferentiation. In this study, we examined the role of the UPS, lysosomal proteases and autophagy in the early phase of Wallerian degeneration of injured peripheral nerves. We found that nerve injury induced an increase in ubiquitin conjugation and lysosomal‐associated membrane protein‐1 expression within one day without any biochemical evidence for autophagy activation. Using an ex vivo explant culture of the sciatic nerve, we observed that inhibiting proteasomes or lysosomal serine proteases prevented myelin degradation, whereas this was not observed when inhibiting autophagy. Interestingly, proteasome inhibition, but not leupeptin, prevented Schwann cells from inducing dedifferentiation markers such as p75 nerve growth factor receptor and glial fibrillary acidic protein in vitro and in vivo. In addition, proteasome inhibitors induced cell cycle arrest and cellular process formation in cultured Schwann cells. Taken together, these findings indicate that the UPS plays a role in phenotype changes of Schwann cells in response to nerve injury.
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Segmental demyelination is a prominent feature of the symmetric polyneuropathy of diabetic patients, probably due to Schwann cell disturbance. The mechanism of disturbance may be related to the fact that Schwann cells are a primary target of polyol pathway abnormalities strongly linked to the hyperglycemia found in dabetes mellitus. As Schwann cell and oligodendrocyte remyelination in the central nervous system (CNS) is a well known event in the ethidium bromide (EB) demyelinating model, the aim of our investigation was to observe the behaviour of both cells after local EB injection in the brainstem of streptozotocin diabetic rats. Adult male Wistar rats were used and some received a single intravenous injection of streptozotocin (50 mg/kg), being submitted 1 month later to a single injection of 10 microlitres of 0.1% EB or 0.9% saline solution into the cisterna pontis. Ten microlitres of 0.1% EB were also injected in non‐diabetic rats. The rats were anaesthetized, perfused through the heart from 7 to 60 days after EB or saline injection and brainstem sections were collected and processed for light and transmission electron microscopy studies. Comparison between the final balance of myelin repair in diabetic and non‐diabetic rats at 60 days was assessed using a semi‐quantitative method for documenting the extent and nature of remyelination in semithin sections from the EB‐induced lesions. Diabetic rats presented delayed macrophagic activity and lesser remyelination in comparison to non‐diabetic rats. Although oligodendrocytes were the major remyelinating cells in the brainstem, Schwann cells invaded EB‐induced lesions, first appearing at 11 days in non‐diabetic rats and by 15 days in diabetic rats. Results indicate that long‐term streptozotocin‐induced diabetes hindered both oligodendrocyte and Schwann cell remyelination (mean remyelination scores of 2.64 ± 0.63 for oligodendrocytes and 0.73 ± 0.3 for Schwann cells) in comparison to non‐diabetic rats (3.47 ± 0.78 and 1.40 ± 0.84, respectively).

P‐513 {#sec1-513}
=====

ULTRASTRUCTURAL STUDY OF THE EFFECTS OF CYCLOSPORINE IN THE BRAINSTEM OF WISTAR RATS SUBMITTED TO THE ETHIDIUM BROMIDE DEMYELINATING MODEL {#sec2-513}
------------------------------------------------------------------------------------------------------------------------------------------

### Bondan E.F., Lallo M.A. {#sec3-513}

#### Universidade Paulista (UNIP), São Paulo, Brazil {#sec4-513}

Several studies on the biology of demyelination and remyelination in the central nervous system (CNS) have been made based on the use of the gliotoxic agent ethidium bromide (EB). In this experimental model, it was noted the presence of lymphocytes during the process of myelin loss and removal after EB injection, as well as an intense macrophagic activity in the damaged areas. Immunosuppressive agents have been broadly used in toxic and immune‐mediated experimental demyelination, as well as in several demyelinating diseases characterized by immunologic involvement and expression of autoimmunity. The aim of this investigation was to study the cellular processes involved in CNS repair after local EB injection under an attempt of pharmacological interference with the immunomodulating agent cyclosporine (CsA) in the rat brainstem remyelinating process. Thirty male Wistar rats, 4 to 6 months old, were used and divided into 4 groups ‐ I (n=2), including animals taken as histologic controls; II (n=8), constituted of animals injected with 10 microlitres of 0.1% EB into the cisterna pontis; III.E (n=16), of animals equally injected with EB, but treated with CsA; and III.C (n=4), including animals injected with 10 microlitres of 0.9% saline solution and treated with CsA. Rats from groups III.E and III.C were daily treated with CsA using 10 mg/kg by intraperitoneal route in the first week and, thereafter, 3 times a week, with a minimal interval of 48 hours. The animals were anaesthetized and submitted to intracardiac perfusion with 4% glutaraldehyde in 0.1 M Sorensen phosphate buffer (pH 7.4) from 15 to 31 days post‐injection, collecting brainstem sections for light and transmission electron microscopy studies. Group II presented conspicuous macrophages and non‐degraded myelin debris, as well as demyelinated axons, oligodendrocyte or Schwann cell remyelinated axons, groups of infiltrating pial cells, hypertrophic astrocytes and few lymphocytes. No evidence of primary demyelination or loss of neuroglia was found in rats from group III.C. Tissue repair of EB‐induced lesions in group III.E was similar to that of group II, but with the presence of a much higher density of oligodendrocytes near remyelinating areas.
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Multiple Sclerosis (MS) is a chronic neuroinflammatory disease resulting in severe disabilities of mainly the sensory and motor systems. A neuropathological hallmark of MS is the loss of myelin and oligodendrocytes (ODCs) leading to impaired axonal transport. As a mechanism of restoration, spontaneous myelin repair occurs in MS giving rise to so‐called shadow plaques. However, this remyelination is only partially successful as most ODC progenitor cells (OPCs) remain in an undifferentiated state which results in a failure to generate myelinating ODCs.

Tissue transglutaminase (TG2) is a multifunctional enzyme that is mainly known for its protein cross‐linking and GTPase activities. Among other functions, TG2 has been shown to play a role in cell differentiation. Moreover, a link between TG2 and myelination has been suggested for peripheral Schwann cells.

In light of the alleged role in both differentiation and myelination, we hypothesize that TG2 is involved in myelin formation by ODCs and could thereby stimulate (re)myelination. To this end, rat OPCs were cultured *in vitro* and studied throughout development. Our data show that TG2 expression is dramatically elevated during the early stages of OPC development. When TG2 activity is pharmacologically inhibited, the number of ODCs producing myelin‐like membranes as well as the formation of myelin sheets was significantly decreased, indicating that TG2 is involved in myelin formation possibly via reduced cell differentiation. Additionally, we pursued to study the role of TG2 activity in remyelination *in vivo*. To this end, TG2 knockout and wild‐type mice were fed with 0.2% cuprizone for 35 days to induce demyelination. Subsequent remyelination of the corpus callosum was studied by proteolipid protein (PLP) in situ hybridization. Our data showed a clear reduced amount of PLP expressing ODCs in TG2 knockout mice compared to wild‐type mice at 5 and 10 days after finishing the cuprizone diet. Furthermore, by using a Rotarod, we showed that TG2 knockout mice were motorically impaired at both time points.

We conclude that TG2 is essential for myelination by ODCs *in vitro* and *in vivo*. The reduced remyelination by TG2 knockout mice is related to disturbed motor behaviour, and may thus be functionally relevant. We therefore postulate that TG2 could be of therapeutic interest for MS.
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The therapeutic transplantation of olfactory ensheathing cells (OECs) is being trialled in humans for spinal injury regeneration and other neural disorders. However in humans and in animal models of these therapies, the results have been limited or inconsistent. One reason for the variation in results is that it is often assumed that OECs are a uniform population of cells that have the same characteristics, and are therefore uniformly suitable for neural regenerative therapies. We have now used time‐lapse imaging of OEC interactions to examine in detail the behavioural characteristics of anatomical and developmental subpopulations of OECs. We have found that OECs are a heterogeneous population of cells with fundamental differences in their behaviour and migration. Not only were peripheral OECs significantly different from OECs derived from the olfactory bulb, but OECs from different anatomical regions of the olfactory bulb displayed vastly different characteristics. These behaviours were consistent with their proposed roles in vivo with OECs from the olfactory bulb display a mix of adhesion, repulsion or indifference following cell‐cell contact. Consistent with our previous findings, lamellipodial waves along the shaft of the OEC processes are always associated with initiating cell‐cell contact and mediating the resultant behaviours of both peripheral and central OECs. These results have important implications for the use of OECs in neural regeneration therapies as it is clear that OECs are not a uniform population of cells. Instead, these cells display distinct behavioural differences depending on their topographical location and age. These differences in cell origin and behaviour are likely to contribute to the variations in OEC transplantation outcomes.
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Microglia appears to be a major cellular contributor of post‐ischemic inflammation. These cells have been designated to participate to neuronal damage extension through the production of several harmful and cytotoxic components. However, recent experimental evidences indicate that microglia under certain circumstances could be neuroprotective and could also promote neurorestorative events through the production of neurotrophic factors. In this context, in order to clarify the role of microglia, our study was designed to repress microglial activation and to determine the effect of this strategy on neuroplastic changes.

This study was performed on Wistar rats subjected to a photothrombotic stroke model. Microglia/macrophages activation, BDNF production and localization were studied during one month after the onset of ischemia. Synaptogenesis and axonal growth were respectively assessed by synaptophysin and growth associated protein 43 (GAP‐43) expression. The inflammatory response was modulated by the mean of PARP‐1 inhibition using a single injection of 3‐aminobenzamide (3‐AB, 90 mg/kg, i.p.) since PARP‐1 has been shown to play a key role in the induction of post‐ischemic inflammatory events.

Our data showed that focal photothrombotic ischemia triggers a marked and rapid microglial activation associated with a significant increase in BDNF production. In addition, ischemia induces a long term increase in the expression of the neuronal plasticity proteins GAP‐43 and synaptophysin. Following 3‐AB treatment, despite no differences in term of infarct volume between vehicle and treated animals, PARP‐1 inhibition was linked to an early and very robust decrease in microglial activation accompanied with a significant reduction in BDNF production. Interestingly, the almost absence of microglia at early time points in treated ischemic animals was associated with a significant down regulation of GAP‐43 and synaptophysin expression. Taken together, our results argue in favour of a beneficial role for microglia in brain neuroplasticity stimulation and suggest that post‐stroke anti‐inflammatory strategy should be considered with caution.
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Developmental origin of myelinating cells in optic chiasm and nerves is a region in 3rd ventricle epandyma. These cells migrate into the chiasm and nerves by time and myelinate ganglionic cell axons in a caudal to rostral manner. Neurogenesis potential and multipotency of epandymal cells in adult rat 3rd ventricle was described recently. Regarding to the vulnerability of optic apparatus, particularly optic chiasm and nerves in multiple sclerosis and anatomical vicinity of optic chiasm and 3rd ventricle, it was tried to determine if multipotent cells reside in the epandymal layer of 3rd ventricle are mobilized in response to the experimental demyelination of the optic chiasm and nerves?

In this study remyelination pattern in longitude of optic chiasm and subsequent proximal nerves were investigated. Scrutinizing of demyelination and remyelination processes, were accomplished by Visual Evoked Potential recording. Cell tracing carried out using BrdU administration prior to the gliotoxin injection. Special myelin staining was down on serial 5 micron coronal sections and demyelination extension and remyelination intensity were assessed.

We profited from an improved demyelination model which is able to built‐in optic chiasm and nerves simultaneously following injection of lysolecithin into the chiasm without undesirable distribution. Electrophysiological study revealed that demyelination was considerable in days 7 and 14 and an incomplete remyelination occurred in 28 days post induction (dpi) which then confirmed by histological studies. Interestingly, we histologicaly showed that remyelination took place more in caudal part of chiasm than in rostral part and proximal optic nerves while these different regions were demyelinated with same amounts. Studies on sagittal sections showed short trains of BrdU+ cells near the 3rd ventricle. BrdU+ cells were seen in walls of 3rd ventricle 2 dpi which then decreased by time. These observations in lesion site were reversed. Nestin expression was increased in walls of 3rd ventricle and reached to a maximum level in day 7 post lesion and then was sustained with lower expression even 60 dpi.

3rd ventricle multipotent epandymal cells may play a role in respond to existence of demyelinating insult in optic chiasm and nerves and may participate in reconstruction of the lesion.
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The sought for effective strategies for improving axonal regeneration after peripheral nerve reconstruction is a key goal in regenerative medicine. Since Schwann cells play a key role in nerve regeneration, we have studied the variations of the gliotrophic NRG1/ErbB signalling pathway during posttraumatic nerve regeneration obtained by different reconstruction paradigms: crush lesion, end‐to‐end neurorrhaphy, end to side neurorrhaphy and muscle‐vein‐combined tubulization.

Methods and results: in all experimental groups, repaired nerves were withdrawn at 0‐7‐14‐28 days postoperative and processed by polymerase‐chain‐reaction (PCR) analysis. Results showed that NRG1/ErbB signalling pathway is activated differently after different types of nerve reconstruction in order to create a favourable environment that stimulates SC survival, proliferation and mobility. While activation of only NRG1 (crush) or NRG1 and ErbB3 (end‐to‐end and end‐to‐side coaptation) are sufficient to support the signalling pathway though with different kinetics of mRNA expression; the additional up‐regulation of ErbB2 was observed when a nerve defect was repaired by muscle‐vein‐combined tubulization.

Conclusion: our results showed the involvement of the NRG1\'s autocrine/paracrine trophic loop during the early phases of nerve regeneration following different types of nerve injuries. The results obtained using muscle‐vein‐combined tubulization were particularly interesting and suggested that the NRG1‐mediated autocrine and/or paracrine trophic loop is activated by axonal damage and is shared by both Schwann cells and skeletal muscle fibers. Altogether, our results suggest also that NRG1/ErbB signalling pathway might represent a promising therapeutic target for improving posttraumatic nerve regeneration and recovery.
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Scar formation that develops after traumatic injury acts as a barrier to tissue repair. In the nervous system, the scar consists mainly of reactive astrocytes, develops within hours after injury and correlates with areas of vascular rupture. Activated astrocytes upregulate inhibitory chondroitin sulfate proteoglycans (CSPGs), such as neurocan, phosphacan and versican, and induce further increase of blood‐brain barrier (BBB) permeability. Although reactive astrocytosis occurs at sites of vascular damage, the link between leakage of blood proteins and regulation of scar formation remains unknown. Here we show that the blood protein fibrinogen induces glial scar formation and increases BBB permeability via the TGF‐β/Smad signaling pathway. After traumatic brain injury in the cortex, fibrinogen deposition correlates with reactive astrocytosis. Genetic or pharmacologic depletion of fibrinogen using fib‐/‐ mice or the anti‐coagulant ancrod reduces reactive gliosis, CSPG expression and BBB permeability. Fibrinogen treatment of pure primary astrocytes induces neurocan RNA and protein expression. In an in vitro BBB model of endothelial and astrocyte co‐culture, fibrinogen treatment in the astrocyte compartment increases endothelial cell permeability. Stereotactic injection of fibrinogen into mouse cortex is sufficient to induce astrogliosis with increased neurocan expression and BBB leakage. TGF‐β and EGF are known inducers of reactive gliosis. Fibrinogen does not activate EGF receptor in astrocytes and inhibition of the EGF receptor signaling pathway has no effect on fibrinogen‐induced astrocyte activation. In contrast, fibrinogen induces phosphorylation of Smad2/3 in primary astrocytes, and inhibition of the TGF‐β receptor pathway abolishes the fibrinogen‐induced upregulation of neurocan and increase of BBB permeability. These results identify fibrinogen as an important contributor to glial scar formation, provides evidence that upregulation of CSPGs is induced by vasculature rupture and points to TGF‐β as a molecular link between BBB disruption and reactive gliosis.

Supported by NIH/NINDS R01 grant NS052189 and NS051470 to KA, and the German research Foundation (DFG) postdoctoral fellowship to CS.
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Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system (CNS). While the majority of currently used MS medications target the inflammatory aspects of the disease, treatments to induce remyelination and axonal regeneration are lacking. Our research is focused on approaches to increase remyelination. Given the increasing evidence that activated monocytoid cells (macrophages and microglia) have roles in CNS repair through mechanisms such as the scavenging and clearance of debris, we sought first to identify medications that could stimulate monocytoid cells. Using cytokine production by human microglia as the initial screen, we tested a collection of 1040 compounds already in clinical use for various indications and found a single medication (henceforth referred to as Compound Mstim), which stimulated the production of TNF‐α. To facilitate the transition to a mouse model in vivo, we found that Compound Mstim similarly increased the activity of macrophages cultured from the bone marrow of mice. Moreover, the increase in activity of cultured mouse macrophages by Compound Mstim was enhanced by simultaneous treatment with another agent known to have effects on monocytoid cells: macrophage‐colony stimulating factor (M‐CSF). We next produced demyelination of the mouse spinal cord by the local injection of the lipid‐disrupting agent lysolecithin into the dorsal column of the T3/T4 region. Three days after, significant demyelination in the spinal cord was accompanied by elevation of several markers of monocytoid activity, including CD68, toll‐like receptor‐2, cytokines (TNF‐α, IL‐1α), and scavenger receptor proteins (MSR‐1 and Fcrl). Importantly, the systemic injections of the combination of Compound Mstim and MCSF further elevated these monocytoid markers. Ongoing experiments are aimed at defining whether a faster rate of clearance of myelin debris and remyelination result. If so, the regimen of clinically used medications to stimulate the benefits of inflammation has potential applications to conditions such as MS to facilitate myelin repair.
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Astrocytes perform many functions in the adult brain and even act as neural stem cells after brain injury or in regions where neurogenesis persists into adulthood. This raises the question of the cellular and molecular differences between neural stem cells and parenchymal astrocytes. Interestingly, both neural stem cells and parenchymal astrocytes contact the basement membrane by their endfeet. Here we set out to determine the role of basement membrane derived polarity signals for astrocytes and adult neural stem cells.

We first examined the influence of BM‐mediated signaling by conditional deletion of b1‐integrin, one of the major BM receptors in the CNS. Strikingly, conditional deletion of b1‐integrin in glia, but not neurons, at postnatal stages resulted in partial reactive gliosis. In the absence of any injury, blood‐brain barrier alterations or cell death, b1‐integrin‐deficient astrocytes developed the hallmarks of reactive astrocytes comprising astrocyte hypertrophy, up‐regulation of GFAP, vimentin and Tenascin‐C, etc. This reaction was further accompanied by a non‐cell autonomous activation of microglial cells. As, however, neither reactive astrocytes nor microglia initiated proliferation as observed after brain injury, we refer to this reactivity as 'partial' reactive gliosis. Indeed, proliferation was rather impaired in the adult neural stem cell niche as well as after brain injury.

To understand the down‐stream effector of b1‐integrin we examined the role of the small Rho‐GTPases cdc42. While conditional deletion of cdc42 with the same Cre line did not result in partial reactive gliosis, implying different down‐stream events in this response, we observed pronounced defects in astrocyte polarization towards a scratch wound injury in vitro and towards a stab wound site in vivo. Notably, while cdc42 did not phenocopy b1‐integrin deletion in eliciting the partial reactive gliosis, its deletion in adult neural stem cells resulted in similar defects in proliferation and self‐renewal as observed upon b1‐integrin deletion.

These data imply b1‐integrin in astrocytes as a signal to initiate and possibly maintain a quiescent, non‐reactive state, as well as a signal to promote proliferation of stem cells and reactive astrocytes.
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A paradigm of mouse spinal cord lesion and its associated fluorescence imaging protocol were developed to study in vivo how various cell populations synergize to repair injured spinal cord. Using a non‐invasive two‐photon microscopy approach, we characterized the interactions between lesioned axons and blood vessels at high resolution. For the first time, dynamics of both vascular and axonal networks could be described simultaneously in injured spinal cords of living animals for up to 4 months. Surviving injured axons initiated early explorative sprouting with recurrent elimination of some of their extensions. This regenerative potential then led into complete reconnection of the lesion site within two months. Vascular response was rather transient with up‐regulation of vessels density mainly in the first two weeks. Neurovascular interactions were meanwhile maximal, and neo‐vessels exerted potent growth stimulating action on neighboring axons. Likely due to their geometry as well as their strong plasticity, vessels did not guide axon sprouts toward the lesion, ultimately promoting misrouted trajectories. Nevertheless, early treatments with VEGF antibodies which inhibited the post‐traumatic increase in neovessels density subsequently increased Wallerian Degeneration and slowed the regeneration process. Altogether our data are consistent with a beneficial effect of angiogenesis in a traumatic context. If reconnection is a stochastic event dependent on axon sprouts density, stimulation of angiogenesis should thus be considered as an interesting therapeutical approach.
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The *conus papillaris* (*CP*) is a highly vascularized and pigmented structure typical of the reptilian eye, and it is homologous to the avian *pecten oculi* (*PO*). The most accepted function of these structures is the nutrition of the avascular retinas of these vertebrates. Previous studies by our group have shown that the lizard *CP* has blood‐brain barrier (BBB) properties, similarly as the avian *PO* and the mammalian retina and optic nerve head (ONH). Regrowth of retinal ganglion cell (RGC) axons occurs after optic nerve (ON) transection in the lizards *G. galloti* (Lang et al., 2002, 2008). The nutrition of the surviving RGCs should be maintained during the regenerating process. We used electron microscopy and immunohistochemical techniques in the adult and regenerating *CP* (0.5, 1, 3, 7 and 9 months postlesion) of the lizard *Gallotia galloti* in order to analyse its changes and understand the role of the *CP* in the regenerating process. The endothelium was cells continuous, Pax2^‐,^ Vim^+^, p75NTR^+^and GluT‐1^+^, whereas the perivascular cells were GluT‐1^‐^. Moreover, Pax2^+^/GFAP^+^ astrocytes were detected at the *CP* base. Interestingly, relevant changes were observed at 0.5 months postlesion (mpl) as vasodilation with lost of endothelial cells (ECs) microfolds and presence of abundant luminal debris; an increase in the number of macrophages and mastocytes as well as upregulation of GFAP in astrocytes and reactive pigmented cells (PCs). From 3 mpl onwards, the ultrastructure of the CP showed a partial recovery since upregulation of GFAP in reactive astrocytes, as well as abnormal neoangiogenesis in the CP‐ON junction persisted. At all surviving periods studied, GluT‐1 staining of the endothelium was unchanged suggesting maintenance of the BBB properties in the *CP* during the regeneration process. These data suggest that the endothelium of the *CP* is the site of the BBB, induced by the PCs as homologue to avian pecteneal cells, and the pericytes which provide vascular stability.

Supported by: MEC BFU2007‐67139/BFI.
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We have previously described the spontaneous regeneration of retinal ganglion cell axons after transection of the adult lizard (Gallotia galloti) optic nerve (ON) by immunohistochemical methods. In the present study, our purpose was to elucidate the ultrastructural features underlying this process. Thus, we performed an ultrastructural study of the ON at 0.5, 1, 3, 6, and 12 months postlesion (mpl). The main findings were1Large reactive astrocytes with extensive processes filled with gliofilaments were found at all periods studied, despite large reinnervation of the optic tectum already occurs at 6 mpl..2Reactive astrocytes, appeared as the main glial subpopulation in removing cell debris and they accumulated lipid droplets in their cytoplasm for long periods..3At early stages, mitotic cells are sparsely seen, and most likely correspond to local glial cells..4From 6 mpl onwards, thick regenerated axon bundles were seen among still abundant cell debris..5By 12 mpl, some of the regenerated axons had developed a well defined myelin sheath, indicating that axonal regeneration is also accompanied by some degree of remyelination. Altogether, these results support previous immunohistochemical findings and also complement the understanding of the regeneration process.

Supported by the Spanish Ministry of Education (BFU2007‐67139/BFI).
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In previous studies we have demonstrated the ability of retinal ganglion cell axons to regrow after optic nerve (ON) transection in the adult lizard Gallotia galloti (Lang et al., 98,02). In the present study, we analised the changes on Müller glia during the ontogeny (E32 until adult) and during optic nerve regeneration (0.5, 1 3, 9, 12 months postlesion, mpl). For that purpose we used immunohistochemical techniques to detect astroglial markers as vimentin (Vim) and GFAP, and the proliferating cell nuclear antigen (PCNA). Vim+ Müller glia endfeet were firstly observed at E33 in the peripheral retina (PR) and from E35 onwards in the central retina (CR). At E35‐E37, we observed GFAP‐/PCNA+ cells in the middle region of the inner nuclear layer (INL), where Müller cell bodies are presummably located. In postnatals and adults, Müller glial cells showed PCNA‐ nuclei and GFAP+ enfeets. At 0.5‐1 mpl, Müller glia enfeets looked hypertrophied and upregulated both, GFAP and Vim, whereas their somata were also Vim+. In addition, GFAP‐/PCNA+ cell bodies were observed in the retinal nerve fiber layer, inner nuclear layer and the outer nuclear layer. From 3 mpl onwards, Vim staining gradually returned to levels similar to controls whereas GFAP staining showed a gradual increase in in Müller cells processes and endfeets. We conclude that 1) Vim+ and GFAP+ intermediate filaments are mainly located in Müller glia endfeets providing mechanical support to the retina. 2) After ON transection, Müller glial cells in the experimental retina became hypertrophied, proliferanting and showed upregulation of Vim and GFAP.

Lang D et al.,(1998). Glia 23:61--74.

Lang D et al., (2002). J. Neurobiol 52: 322--335.
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Enhancement of endogenous oligodendrocyte regeneration is a promising strategy for repair in demyelinating diseases. Myelin injury induces several factors, including those that could either enhance or inhibit oligodendrogliogenesis. We have previously shown that bone morphogenic protein (BMP) signaling is upregulated in the subventricular zone during demyelination and that BMP4 inhibits oligodendrogliogenesis by decreasing adult neural precursor cell (NPC) proliferation and oligodendrocyte differentiation in vitro. Here, we examine the in vivo effects of modulating BMP signaling on proliferation and lineage commitment during demyelination. For these studies, we used the cuprizone‐induced model of demyelination. Immunohistochemistry showed increased BMP signaling in the corpus callosum (CC) (p\<0.05) during demyelination as observed by phosphorylated SMAD1/5/8 immunoreactivity. We found that p‐SMAD 1/5/8 co‐localised primarily with Olig2+ cells in the CC and that these double positive cells were significantly increased (p\<0.001) during demyelination. Intraventricular infusion of BMP4 during demyelination significantly increased p‐SMAD 1/5/8 immunoreactivity by 1.5‐fold in the midline corpus callosum (p\<0.05). Noggin infusion during demyelination decreased p‐SMAD 1/5/8 immunoreactivity in the corpus callosum, but this effect was not significant. The BMP4 infusion during demyelination resulted in significant increases in proliferation (p\<0.005) in the midline CC. In addition, BMP4 infusion increased the numbers of Olig2+ cells (p\<0.0001) and Olig2+/BrdU+ cells (p\<0.0001) in the CC. These findings demonstrate that BMP signaling is increased in the CC during demyelination and that BMP signaling can be further increased by BMP4 infusion during demyelination, as indicated by p‐SMAD 1/5/8 immunoreactivity. Surprisingly, the increase in BMP signaling resulted in a significant increase in oligodendrocyte numbers in the CC. We are currently examining further how modulation of BMP signaling impacts myelin pathology during demyelination and myelin repair.
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A GENE REGULATORY NETWORK INVOLVING PROSPERO, NOTCH, TNF AND NFKB UNDERLIES A GLIAL‐REPAIR‐RESPONSE TO CNS INJURY {#sec2-527}
-----------------------------------------------------------------------------------------------------------------

### Kato K., Forero M., Fenton J., Hidalgo A. {#sec3-527}

#### University of Birmingham, Birmingham, United Kingdom {#sec4-527}

Glia cells proliferate in response to central nervous system (CNS) injury in mammals, known as the glial repair response (GRR). This results in spontaneous remyelination and limited recovery, revealing a tendency of the CNS to repair itself. The GRR presents a golden opportunity to understand how cells know when normal organism structure is compromised and how to attain it again.

Here we show that glia proliferate upon injury in the *Drosophila* larva and this requires the genes *prospero* and *Notch*, which maintain each other\'s expression through a positive feed‐back loop. Activation of Notch in *prospero* mutants induces tumorous glial proliferation, consistently with Notch promoting and Prospero inhibiting cell cycle progression. As a result, in normal larvae glia do not divide. Upon injury, TNF is released activating NFkB in glia. In *TNF*/*eiger* mutants, the GRR is abrogated and NFkB is less activated. Conversely, activation of NFkB by overexpression of TNFR associated factor *Traf6*/*dTRAF2* induces glial proliferation. The *prospero* and *TNF*/*eiger* double mutants abolish the GRR more severely than single mutants, suggesting that upon injury TNF/Eiger triggers cell division of Prospero‐positive glia. Our data suggest that Notch and Prospero keep glial cells on the brink to divide and upon injury TNF/Eiger stimulates glial proliferation by activating NFkB/Dorsal. A positive feed‐back loop between Prospero and NFkB restores the initial conditions in glia.

Our findings reveal a mechanism that enables glia to respond to changes in their environment to maintain appropriate CNS structure. An evolutionarily conserved mechanism may enable the proliferation of transplanted or endogenous glial progenitors to enable repair upon CNS damage also in humans.
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Microglial cells have been studied using tomato lectin histochemistry during the ontogeny (from E35 to adults) and after optic nerve (ON) axotomy (0.5, 1, 3, 6, 9 and 12 months postlesion, mpl) in the lizard Gallotia galloti. These cells were firstly observed at E35 in the ON head and from E37 onward in the entire ON showing different soma morphology, ranging from ameboid to ramified types. The latter type was the most abundant in the adult lizard. The location and distribution pattern of the different Lectin+ microglial types during the ontogeny indicates that they are of mesodermic origin and reach the nervous parenchyma through different pathways: the vitreous humour, the blood vessels, the piamater amd the hypothalamic ventricle. After ON axotomy, the number of Lectin+ microglia/macrophages increased. At 0.5 mpl, many stained cells bearing vacuoles were detected at the lesion site, and numerous ameboid lectin+ microglia/macrophages were observed in the rest of the ON whereas ramified cells were undetected. At 1 mpl, lectin+ cells were stained in the ventricular zone and mainly in the vitreous humour. Our data suggest that these cells migrate into the retina from the vitreal surface as may occur during development. At 3 mpl, numerous lectin+ cells were detected in the retinal nerve fiber layer and there was a massive migration of ameboid cells from the blood vessels to the nervous parenchyma. At 9 mpl, numerous ameboid cells were still observed in the ON. We conclude that 1) The migration pathways are similar during both, the ontogeny and the regeneration. 2) Ameboid microglia/macrophages are recruited to the lesion site during the regeneration. 3) The presence of ameboid microglia/macrophages after long surviving periods support the idea of a slow regeneration process in the lizard visual system.
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Postlesional reorganization of the Central Nervous System involves local reactive gliosis processes that modify both neuronal and astroglial functions. The analysis of cellular effects at remote cortical sites might contribute to a better understanding of the processes of reorganization and functional recovery following injury. Reactive proliferative response was investigated in the cerebral cortex of adult Cebus apella monkeys, at sites proximal and remote to a surgical lesion. The cortical distribution of nuclear incorporation of immunoreactive (IR) bromodeoxyuridine (BrdU) and specific cellular markers were analyzed. Animals (N=6) were housed under controlled conditions, according to NRC (1996) regulations for animal care. The project was approved by the institutional ethical committee. Typical local GFAP and vimentin immunoreactive astrogliosis was observed in the lesion zone of prefrontal‐ and striate cortex injured monkeys. Lesion of the prefrontal cortex increased the number of BrdU‐IR cell nuclei in frontal and parietal regions, compared with intact animals. The striate cortex lesion produced a similar local effect, but included frontal, parietal and temporal cortical regions. In conclusion, following both types of injury, the reactive response of BrdU nuclear incorporation involved cortical supragranular layers and spread to functionally interrelated cortical areas, suggesting that it would involve direct cortico‐cortical connections.
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Mobilization of endogenous stem cells from the subventricular zone (SVZ) recently appeared as a promising strategy to promote brain repair. Indeed, in case of brain injury, SVZ‐derived cells migrate to lesioned areas in a spontaneous repair attempt. However, this process is too limited to allow efficient cell replacement and functional recovery. Thus it appears necessary to promote SVZ progenitor cell mobilization, i.e. proliferation, exit from RMS, migration and differentiation.

The glycoprotein Reelin plays crucial role during cortex development; in the adult, it is still expressed in the olfactory bulb (OB) where it induces a shift in the migration mode of neural progenitors, allowing them to detach from the rostral migratory stream (RMS) and invade the OB. We hypothesized that ectopic expression of Reelin near the SVZ might stimulate the exit of its progenitors and increase their recruitment.

We used two models of Reelin secreting cells and grafted them in brains areas surrounding SVZ. We detected an increase in the number of endogenous SVZ‐derived cells in periventricular white matter tracts. In an inducible mouse transgenic model over‐expressing Reelin in the adult forebrain, we showed that RMS was slightly disorganised and that some neural progenitor cells detached and escaped from the RMS. Therefore Reelin appears as a good candidate for brain repair since it allows detachment in vivo, of the SVZ cells from their niche and colonisation of adjacent fibre tracts.

In vitro results revealed that Reelin regulates the maturation of cultured SVZ cells without influencing their phenotypic fate, Moreover we could also show, in vivo, that in case of injury, Reelin is over‐expressed by neurons surrounding cortical ischemic lesion compared to contralateral cortex.

Taken together all these results argue that Reelin could be part of the spontaneous repair process of the brain and may be beneficial for brain repair by detaching SVZ cells from their niche and accelerating their maturation.
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Astrocytes remove neurotransmitters, maintain extracellular and intracellular ion homeostasis, and influence neuronal transmission. In response to neural injury, astroglia is activated and undergoes morphological changes like hypertrophy. Reactive astrocytes are responsible for the formation of the glial scar, which affects the functional recovery of the CNS following an insult and may change the physiological properties of the tissue like its capacity for glutamate uptake. This leads to the question, if reactive gliosis results in alterations in the expression pattern of glial glutamate transporters GLT1 and GLAST. We employed organotypic slice cultures to monitor morphological changes in astrocytes over time and their expression of GLT1 and GLAST in response to tissue damage.

Reactive gliosis in mouse organotypic slice cultures was induced by either ATP (1 mM) or a radial scratch wound through the hippocampal CA1 region. The number and diameter of GFAP‐labelled astrocytic processes was determined in injured tissue versus controls. In a second set of experiments the influence of each treatment on the expression of GLT1 and GLAST was studied employing immunohistochemistry.

In response to ATP treatment, the number and diameter of primary GFAP‐labelled astrocytic processes increased 3‐4 days after treatment indicating reactive gliosis. This hypertrophy recovered to control levels after 6‐7 days post‐incubation. Similarly, the number and diameter of GFAP‐positive astrocytic processes increased 3‐4 days following mechanical injury. However, in response to mechanical injury, the number and diameter of astrocytic processes continued to increase for at least 3 more days (i.e. 6‐7 days post‐incubation) indicating an irreversible gliosis.

Irrespective of hypertrophy, the staining patterns of GLT1 and GLAST were not altered by ATP. In contrast, mechanical injury increased the glutamate transporter expression in glial cells surrounding the injury site. Labelling for glutamate transporters mainly increased within the cell‐bodies of both, GFAP‐positive and negative astroglial cells.

While hypertrophy and increased GFAP labelling seem to be general properties of reactive glia, expression levels of glial glutamate transporters depend on the induction protocol.
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The p75 neurotrophin receptor (p75NTR) is expressed in neurons and in a wide variety of glial populations (review in Gragnolini and Friedman, 2008 Trends in Neurosci 31:99‐104). The aim of this study is to characterize the glial cells expressing p75NTR in the optic nerve (ON) of adult lizard and to analyze their response after optic nerve transection. Using immunohistochemical methods, we detected in adult p75NTR+ cells co‐expressing astrocyte markers as GFAP, glutamine sintase (GS) and vimentin (Vim). After ON transection, reactive astrocytes in the lesion site showed upregularion of GFAP and Vim but not of p75NTR. Moreover, a subpopulation of reactive tomato‐lectin+/p75NTR+ microglia/macrophages were observed at the lesion site. These data indicate that the p75NTR is expressed in astrocytes, and in a subpopulation of reactive microglia/macrophages although it does not seem to be involved in reactive astrogliosis unlike occurs in mammals. Finally and due to the ONT endothelial cells have been shown to express p75NTR in the lizard, we suggest a possible role in manteining the blood‐brain barrier integrity, especially under inflammatory conditions, as has been suggested in mice (above review).

This study was supported by the Ministry of MEC‐ BFU2007‐67139/BFI.
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The role of glia in remyelination is well studied in inflammatory demyelinating diseases such as models of multiple sclerosis. Similar studies of glial response and white matter repair have not been undertaken in the setting of ischemic stroke, in which infarcts form white matter lesions and predispose axons to degradation. In this study we used a subcortical white matter stroke model in the mouse to study the regenerative response of oligodendrocyte precursor cells (OPCs) following demyelination secondary to ischemia. Infarcts were induced by direct microinjection of vasoconstrictor endothelin‐1 (ET‐1) into the subcortical white matter below forelimb motor cortex of adult mice. Immunohistochemical studies showed maximum oligodendrocyte apoptosis takes place at day 1, and apparent myelin loss occurs starting at 6 days after ET‐1 injection. Concurrent axonal damage in the stroke site was detected by neurofilament staining as well as electron microscopy. Importantly, subcortical stroke induced prominent activation of GFAP + astrocytes and their distribution persisted in the peri‐infarct region. Hyaluronan, an astrocyte secreted extracellular matrix protein implicated in glial scars, was deposited in high levels in the stroke site. Furthermore, subcortical stroke induced an immediate yet transient immune reaction, as IBA‐1 + microglia/macrophages infiltrated the ischemic white matter. In order to assess the OPC regenerative response, we used BrdU labeling during the first week after stroke and determined the fate of BrdU + cells in early and late time points. The subcortical stroke triggered early expansion and differentiation of NG2 + OPCs, however the number of BrdU incorporated oligodendrocytes declined approximately 50% between day 7 and day 28 after stroke. These data suggest that the oligodendrocytes produced in response to white matter stroke are not necessarily supported during the later stages of recovery. Ongoing studies are utilizing differential mitotic labeling indicators and transgenic reporter mice to define the time course, differential potential and fate of newly born OPCs after subcortical stroke.
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Myelin sheathes the majority of the nerve fibers in central nervous system. It provides a milieu for nerve fibers by which they can conduct salutatory impulses. In this way, neurons can transport different signals independently from each others in a nerve which contains parallel and longitudinal fibers like spinal cord and optic nerves. Myelin is destroyed in young women more than young men by Multiple Sclerosis (MS). Also, it has been observed that the spontaneous remyelination occurs following demyelination in some parts of brain with a rapid rate. Oligodendrocyte precursor cells (OPC) which present in adult CNS can proliferate and differentiate into mature myelinating oligodendrocyte following injuries. Proliferative effect of androgens on male OPCs is more than that of estradiols in female. In this study, we tried to compare demyelination and remyelination processes between males and male castrated rats.

The optic nerve and chiasm received 2 μl lysolecithin 1%. Luxol fast blue staining was used as a histological method. Using a semi‐quantitative RT‐PCR technique, the changes in expression of MBP, Olig2 and GFAP genes, respectively as the markers of adult oligodendrocytes, OPCs and reactive astrocytes, were evaluated at days 2, 7, 14, 28 and 60 post lesions. Maximum demyelination was observed in day 14 in both males and castrated‐males. The extension of demyelination was reversed during days 28 to 60. On the other hands, measured remyelination extension in days 28 and 60 post lesion in males was more than that in castrated rats. Gene expression studies showed decreased expression of MBP and increased expression of Olig2 and GFAP in days post lesion. Following lesion induction in castrated animals, the expression of MBP, Olig2 and GFAP was lower than control male rats.

We observed that the extent of demyelination in castrated male rats was increased in compared to the uncastrated ones, while brain endogenous potential of remyelination was higher in control male rats. Our results support neuroprotective effects of androgens on contribution of endogenous potential of brain in lesion remyelination. Our findings provide new insight for the cause of different susceptibility of male and females for MS disease.
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We have recently shown that *semaphorins (Semas) 3A* and *3F* levels are altered in Multiple Sclerosis (MS) tissue. These semaphorins act respectively as chemorepulsive and chemoattractive OPC guidance cues during development. In MS brain, *Semas 3A* and *3F* are overexpressed by glial cells in inflammatory demyelinating lesions, and some oligodendroglial cells in the surrounding white matter express their receptors. In addition, *Semas 3A* and *3F* are up‐regulated in cortical neurons in the gray matter. Following demyelinating lesions in the rat cortico‐spinal tract, the same expression pattern was detected, with the difference that a higher percentage of cells express *Sema3F* in the spinal cord compared to *Sema3A* (Williams et al., 2007). We suggest that semaphorin overexpression after a demyelinating event could influence OPC migration, hence remyelination efficacy.

To get further insight into the functional role of these guidance cues, we first checked on tissue sections and on a purified population of adult OPC (FACS‐sorted from *PDGFRα::GFP* adult CNS) that adult OPC express Sema3A and Sema3F receptors, and we have seen that this expression is up‐regulated after demyelination. In parallel we over‐expressed Sema3A and Sema3F through lentiviral gene transfer before inducing a demyelinating lesion in the same location in the mouse spinal cord dorsal columns, then quantified OPC recruitment and remyelination.

Over‐expression of Sema3A delays OPC recruitment into a demyelinated lesion, whereas over‐expression of Sema3F accelerates it. These effects are likely to be due to chemorepulsion/attraction respectively, as shown by controls for proliferation and apoptosis. Influence on remyelination capacity is currently analyzed.

These data suggest that guidance molecules Semas 3A and 3F might be involved in MS lesions oligodendroglial content and remyelination outcome. In the long run, controling guidance molecules levels could open promising avenues for therapeutic strategies in MS, aimed at favouring myelin repair.

P‐536 {#sec1-536}
=====

OPTIC NERVE HEAD AXON‐ASTROCYTE INTERACTION IN A REGENERATION MODEL {#sec2-536}
-------------------------------------------------------------------

### Parrilla M., Lillo C., Lara J.M., Herranz‐Martín S., Aijón J., Velasco A. {#sec3-536}

#### INCyL, Salamanca, Spain {#sec4-536}

Astrocytes play a fundamental role in axon guidance processes. Adult fish peripheral retina is continuously adding new cells, including retinal ganglion cells (RGC). Furthermore, RGC axons are able of regenerating after a lesion. Due to this, fish optic nerve head (ONH) has become an excellent model to study the interaction between newly formed axons and astrocytes in a regeneration process. We have analysed some of the astrocyte molecules implicated in the guidance and reorganization of axons during the regeneration process and we have characterised the newly formed astrocytes.

For this purpose, we used control and injured goldfish with two different type of lesions: a cryo‐lesion (CL) of the retina periphery and a optic nerve (ON) crush (CR). These animals were sacrificed from 2 to 120 days (d) post‐injury. We used electron microscopy and double immunofluorescence analyses with antibodies to label astrocytes (Pax2, GFAP, GS, S100 and cytokeratin), dividing cells (PCNA) and growing axons (Zn8).

The elimination of young axons (Zn8+) after CL results in a decrease of Pax2 immunolabeling at 2‐7d which is restored at 15‐21d. However, after CR a higher number of Zn8+ growing axons reappeared rapidly at 7d and the Pax2+ cells number increases. In both cases, there is an increase of PCNA+ cells, and many of them are Pax2+. In non‐lesioned animals, there are no GS+ cells in the ONH, but we detected them after both kinds of lesions. In the limit between the retina and the ONH, next to the retinal pigmented epithelium, we found GFAP+/GS+/S100+ astrocytes at 15‐30d after both kinds of lesion. Also, at early regeneration stages (7‐15d), and only after CR, we detected a striking presence of Pax2+ cells in the retina and an increase of cytokeratin labelling in the ONH. These two labelling were absent in the CL animals. The ONH labelling, after both kinds of lesions, is restored to normal conditions at 90‐120d.

In conclusion, two different injuries produce a notable astrocyte reaction and the apparition of new astrocytes in the ONH which are involved in the axon guidance and packing to restore the visual system.

Support: Grupos de Excelencia Junta de Castilla y León, Fundación MMA, Red de Terapia Celular de Castilla y León, JCyL (SA005B07), Fundación Alicia Koplowitz.
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Models of remyelination for research into Multiple Sclerosis currently rely on either extrapolation from in vitro models of developmental myelination or in vivo experimentation. Both have limitations. Remyelination after pathology poses very different challenges to myelination occurring in in vitro co‐culture systems, due to tissue and cell destruction creating a less conducive environment. In vivo models, although essential, are laborious, time consuming and costly in terms of expense and animals.

We have developed an ex vivo model of remyelination in the mouse, based on the initial work of Birgbauer et al., 2004 (1) in the rat. We take brain and spinal cord slices from mice of postnatal day 0‐3, and grow them in culture for 10 days, to allow myelination to occur. We then demyelinate the slices with the addition of Lysolecithin (LPC) to the culture medium. Demyelination is complete after 24 hours. Extensive remyelination occurs after another 10‐14 days. Immunohistochemistry for CASPR (contactin associated protein) shows the formation of paranodes both initially and in remyelination, indicating mature myelin sheaths. The internodal lengths are significantly shorter in remyelination than in initial myelination in our system‐ pathognomonic of remyelination. We developed a semi‐automated system to quantify myelination using a ratio of immunofluorescent staining for Myelin Basic Protein (MBP) to Neurofilament (NF). We tested the model with a variety of compounds that are known to positively or negatively influence remyelination including PDGF, FGF, Neuroregulins, and the gamma‐secretase inhibitor DAPT (a notch pathway inhibitor) to determine how faithfully the model reflects in vivo remyelination.

We are using this model as a moderately high throughput system to test compounds potentially useful for remyelination. In addition, by combining transgenic, virus and shRNA technology, we will be able to manipulate gene expression and study the effects on remyelination in a simple model, relatively quickly and in real time.

\(1\) Birgbauer E, Rao TS, Webb M. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res. 2004 Oct 15;78(2):157--66.
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Agrin is a heparan sulfate proteoglycan (HSPG) and is primarily expressed in both neurons and glial cells of the embryonic mouse brain. During development, agrin is shown to be implicated in several events, such as neurogensis, axonal elongation and construction of the blood‐brain barrier (BBB) by binding growth factors on the surface of astrocytes. In this study, we examined the spatio‐temporal expression patterns of agrin in murine injured brain by in situ hybridization and immunohistochemistry.

Agrin mRNA was upregulated in the region surrounding the necrotic tissue after brain injury. Time course study showed the highest level of the signal intensity at 7 days. Immunohistochemical study revealed that agrin is detected in GFAP‐positive reactive astrocytes and microvessels surrounding necrotic tissue after brain injury. Therefore, we next employed immunoelectron microscopy to examine the localization of agrin in detail. Agrin was shown to localize to the basal lamina of microvessels in addition to the reactive astrocytes. Then, we investigated the expression patterns of agrin and growth factors by double labeling in situ hybridization after brain injury. Agrin mRNA was coexpressed with mRNAs for FGF2 and pleiotrophin, showing that both agrin and growth factors are produced by the reactive astrocytes after brain injury. Taken together, it is suggested that agrin is implicated in the reconstructive process after brain injury, such as guidance of regenerating axons and reconstruction of vascular system and BBB, by trapping growth factors on the surface of the reactive astrocytes and the basal lamina of microvessels.
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EXPLORING THE REQUIREMENT OF CDK2 FOR NORMAL WHITE MATTER DEVELOPMENT AND MYELIN REPAIR {#sec2-539}
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### Caillava C.,^1^ Vandenbosch R.,^2^ Jablonska B.,^3^ Kaldis P.,^4^ Berthet C.,^4^ Gallo V.,^3^ Malgrange B.,^2^ Belachew S.,^2^ Baron Van Evercooren A.^1^ {#sec3-539}

#### ^1^INSERM UPMC, Paris, France; ^2^Developmental Neurobiology Unit, Liege, Belgium; ^3^Center for Neuroscience Research, Washington, United States; ^4^National Cancer Institute, Frederick, United States {#sec4-539}

The developmental progression from oligodendrocyte progenitor cell (OPCs) to mature myelinating oligodendrocytes entails a complex sequence of events. In the present study, we focused on early events including proliferation and cell cycle withdrawal which are crucial steps for effective differentiation. Type 2 cyclin‐dependent kinase (Cdk2) controls G1/S transition in eukaryotic cell cycle. It was shown to be dispensable during embryonic development since Cdk2‐null mice develop normally until adulthood. Previous work showed that Cdk2 controls OPC cycle progression and is down‐regulated in adult OPC in vitro.

To assess the requirement of Cdk2 for oligodendrogenesis and myelin development, we analyzed the adult corpus callosum with antigenic markers for distinct stages of oligodendroglial maturation. We also assessed quantity and quality of myelin by western blot and electron microscopy (EM) and found no difference between wild‐type and Cdk2 null mice. We next used a model of focal lysolecithin (LPC)‐induced demyelination of the corpus callosum in order to challenge the role of Cdk2 in OPC and neural precursor cells (NPC) proliferation following demyelination. Seven days after LPC injection, we showed that Cdk2 deletion impairs the proliferation of cells that are able to give rise to oligodendrocytes both in the SVZ and LPC lesion. Two to three weeks after LPC injection, immunohistochemistry indicates that oligodendrocytes are more mature in the lesion in the absence of Cdk2 and that remyelination is faster as assessed by EM.

Altogether, our data provide evidence that Cdk2 does not appear to be essential for developmental myelination, suggesting a compensatory effect in neonatal OPCs. However, Cdk2 seems to be involved in cell cycle kinetics of adult NPC/OPC following demyelination. Our data indicate that, by promoting proliferation, Cdk2 may delay adult oligodendrocyte differentiation and suggest that Cdk2 could be a target of interest to stimulate myelin repair.
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ANALOGY BETWEEN ASTROCYTE‐LIKE STEM/NICHE CELLS OF ACTIVATED SEZ AND REACTIVE ASTROCYTES WITHIN THE STRIATUM OF ADULT RAT BRAIN {#sec2-540}
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### Mazurova Y.,^1^ Guncova I.,^1^ Rudolf E.,^1^ Latr I.^2^ {#sec3-540}

#### ^1^Fac. of Med. in Hradec Kralove, Charles Uni. in Prague, HRADEC KRALOVE, Czech Republic; ^2^Faculty Hospital, Hradec Kralove, HRADEC KRALOVE, Czech Republic {#sec4-540}

Astrocytes are intimately involved in all physiological and pathological processes in CNS. Protracted neurodegenerative process within the striatum induced by the quolinic acid (a model of Huntington\'s disease) represents a severe long‐lasting damage (followed from 3 days to 6 months) which invokes the immediate reaction not only in the striatum but also in the subependymal zone (SEZ). The process results in a reparative gliosis, i.e. the up‐regulation of reactive astrocytes within the striatum, and in characteristic enlargement of the SEZ based on the proliferation of stem/niche astrocyte‐like cells. Interestingly, the common feature of both activated astrocytic cells in these completely different locations is a time‐limited intensive reexpression of nestin and vimentin (VIM) and the relationship of these intermediate filaments (IF) to the GFAP. However, the speed and partly also results of these changes are strictly regionally specific depending on a local microenvironment. We can summarize that: (1) reactive astrocytes within the striatum express transitionally (for few weeks) nestin, significantly VIM (for few months) and the both IF are subsequently replaced by GFAP which demonstrates gradual maturation of reactive astrocytes; (2) in the SEZ, nestin+ cells and then also VIM+ cells form networks markedly related to clumps of multiplied neuronal cells; although also here the coexpression of VIM and GFAP is found, only later (in 6 mo survivors) the expression of GFAP markedly prevails in outer part of the SEZ; however, never the VIM+ astrocytes forming a scaffold for clusters of neuronal cells become fully differentiated, i.e. expressing only GFAP. Very interesting findings are also related to S100B which consequent overexpression by activated astrocytic cells in both locations. Our findings document a link between regionally specific astrocytes based on their common origin (from radial glia -- esp. by VIM‐expression), and moreover, also the persistence of silent glial precursors which activation repeats briefly the prenatal gliogenesis. However, the continuation and results of this process are influenced and strictly limited by the microenvironment specific for each brain region, especially in adulthood.

Supported by the Research project of the Ministry of Education of CR, MSM0021620820.
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SCHWANN CELL C‐JUN REGULATES GLIAL SUPPORT FOR SURVIVAL OF PNS NEURONS AFTER INJURY {#sec2-541}
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### Latouche M.,^1^ Wilton D.,^1^ Arthur‐Farraj P.,^1^ Dacosta C.,^2^ Mitter R.,^2^ Turmaine M.,^1^ Raivich G.,^1^ Behrens A.,^2^ Mirsky R.,^1^ Jessen K.R.^1^ {#sec3-541}

#### ^1^UCL, London, United Kingdom; ^2^Cancer Research, London, United Kingdom {#sec4-541}

The ability of neurons to survive and regenerate after injury or disease depends strongly on their surrounding glial cells. The Schwann cells, the glial cells of peripheral nerves, allow much more effective neuronal regeneration to take place than their counterparts in the CNS. Therefore, identification of Schwann cell regulators of nerve response to injury and pathology is critical for understanding and helping the process of neuronal survival and regrowth. We recently identified the transcription factor c‐Jun as one of these regulators (Mirsky and Jessen 2008 Glia Vol 56 No.16 Pages 1552‐1565). The absence of c‐Jun in Schwann cells after nerve injury leads to dramatic impairment in functional recovery and axonal regeneration.

We show here that this absence of regeneration is associated with a striking loss of dorsal root ganglion sensory neurons following Wallerian degeneration. Large sensory neurons with myelinated axons and small sensory neurons with unmyelinated axons are both affected to an extent that has not been reported in previous studies. Transcriptome analysis of the distal stump of sciatic nerves 7 days after transection in mice lacking Schwann cell c‐Jun and in control mice was performed using microarray. This allowed us to identify 160 genes which are abnormally regulated in the absence of c‐Jun in Scwhann cells after injury. The corresponding proteins constitute candidate glial regulators of the neuronal response to injury. The expression of the most promising candidates has been further studied in the nerve in response to injury and in cultured Schwann cells, both at the RNA and at the protein level. This has allowed us to unravel part of the mechanisms underlying Schwann cell support to neurons following injury.
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SCHWANN CELL C‐JUN IS ESSENTIAL FOR PERIPHERAL NERVE REGENERATION {#sec2-542}
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### Wilton D.,^1^ Arthur‐Farraj P.,^1^ Latouche M.,^1^ Turmaine M.,^1^ Behrens A.,^2^ Mirsky R.,^1^ Raivich G.,^1^ Jessen K.^1^ {#sec3-542}

#### ^1^UCL, London, United Kingdom; ^2^Cancer Research UK, London, United Kingdom {#sec4-542}

Nerves in the PNS unlike their counterparts in the CNS are able to spontaneously regenerate following injury. One of the key factors facilitating this is the plasticity of the Schwann cell. Following nerve injury and associated Wallerian degeneration Schwann cells demyelinate and de‐differentiate back to a phenotype similar to that seen in the perinatal nerve. This enables the Schwann cell to provide trophic support to the neurons and a permissive surface for re‐growing axons. Several genes expressed by the Schwann cell have been shown to drive the formation of the de‐differentiated phenotype. One of these is the transcription factor c‐Jun which is expressed by the immature Schwann cell during development and then down regulated at the onset of myelination (Parkinson et al., 2008 J. Cell Biol. Vol 181 No.4 Pages 625‐637). Following nerve injury c‐Jun levels increase and in its absence demyelination and de‐differentiation are delayed (Mirsky and Jessen 2008 Glia Vol 56 No.16 Pages 1552‐1565).

In this report we show that Schwann cell c‐Jun is required for successful peripheral nerve regeneration to take place. In the absence of c‐Jun Schwann cells fail to adopt the de‐differentiated phenotype following nerve injury and show a reduced expression of proteins known to have a key role in regeneration. There is a marked reduction in the initial rate of axonal regeneration but perhaps more surprisingly functional recovery as denoted by footprint analysis and response to painful stimuli is absent even up to 10 weeks after sciatic injury. This is reflected in a significant reduction in the number of myelinated axons present in the nerve and an inability of motor and sensory neurons to re‐innervate target muscles.
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ABLATION OF PROLIFERATING NG2 CELLS (POLYDENDROCYTES) AFTER LPC‐INDUCED DEMYELINATION {#sec2-543}
-------------------------------------------------------------------------------------

### Suzuki R., Nishiyama A. {#sec3-543}

#### University of Connecticut, Storrs, United States {#sec4-543}

Polydendrocytes or NG2 cells constitute a fourth major glial cell type in the mammalian central nervous system (CNS) that is distinct from neurons, mature oligodendrocytes, astrocytes, or microglia. They can be identified by the expression of NG2 proteoglycan and are found to evenly and abundantly populate throughout the gray matter and white matter both in the developing and mature CNS. Recent studies using Cre/loxP fate mapping provided direct evidence that endogenous polydendrocytes give rise to oligodendrocytes in vivo, and supports the notion that they play a key role in remyelination of demyelinated lesions. To elucidate the role of polydendrocytes after demyelination, we generated transgenic mouse lines in which polydendrocytes can be ablated. The NG2BAC modification approach was used to drive the expression of the thymidine kinase gene from herpes simplex virus (HSV‐TK) specifically in NG2‐expressing cells, so that proliferating cells that express HSV‐TK can be ablated by ganciclovir (GCV) treatment. Lysolecithin (LPC) was injected stereotactically into the corpus callosum of adult NG2TKBAC transgenic mice following GCV treatment, and BrdU was injected between 1 and 3 days after LPC injection. Animals were sacrificed 6 days after LPC injection and processed for immunohistochemical analyses. In the transgenic mice, there was a 4‐fold reduction of APC‐positive oligodendrocytes in the corpus callosum compared with wild‐type mice. In addition, the number of BrdU positive cells in the SVZ of the transgenic mice was 2.5‐fold lower than in wild type mice despite the lack of NG2 expression among BrdU+ cells in the SVZ. Additional experiments are conducted to determine whether this is caused by migration of NG2‐negative SVZ cells into the corpus callosum, which subsequently upregulate NG2 expression and are ablated by GCV.
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PDGFRA/ NG2 CELLS GENERATE OLIGODENDROCYTES IN A MURINE EAE MODEL {#sec2-544}
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### Tripathi R.,^1^ Rivers L.,^1^ Jamen F.,^2^ Richardson W.D.^1^ {#sec3-544}

#### ^1^University College of London, London, United Kingdom; ^2^CNRS Institut de Neurobiologie Alfred Fessard, Gif‐sur‐Yvette, France {#sec4-544}

Multiple sclerosis (MS) is a debilitating disease with widespread demyelination in the CNS. The etiological cause of myelin destruction is unknown, as is the reason behind the failure of lesions to repair completely despite the presence of oligodendrocyte progenitors (OLPs) that are capable of generating myelinating oligodendrocytes. To address the fate of PDGFRA+ OLPs during MS‐like pathology we induced experimental autoimmune encephalomyelitis (EAE) in Pdgfra‐Cre(ERT2) : Rosa26‐YFP mice by immunising with emulsified MOG peptide and complete Freund\'s adjuvant. Pertussis toxin was also injected with the initial innoculum. Tamoxifen was administered approximately two weeks prior to EAE induction. In these mice, tamoxifen activates Cre and turns on YFP expression in PDGFRA+ cells and all of their progeny.

A progressive worsening of locomotion was noted in EAE mice beginning at day 11 post immunisation, with some mice showing a relapsing‐remitting phenotype. Unexpectedly, a small but significant improvement in locomotor scores was recorded in mice of both sexes that had received tamoxifen compared to vehicle‐only controls.

Following induction of EAE, immuonohistochemistry revealed demyelinating plaques at all spinal levels and a robust inflammatory response, accompanied by a large increase in YFP+ cells. About 70% of YFP+ cells co‐labelled for NG2. PDGFRA+ cells generated very few astrocytes; only 1‐2% of YFP+ cells were also GFAP+. As expected, a large proportion (90‐95%) of YFP+ cells in naïve and EAE tissue were also OLIG2 immunoreactive. Generation of mature oligodendrocytes (OLs) by PDGFRA+ cells was confirmed by co‐immunolabelling for CNPase.

5‐10% of the YFP+ cells did not label for OLIG2 or other macroglial markers (GFAP and S100beta). To attempt to identify these cells we used a battery of antibody markers including IBA1, CD45, ILB4, collagenase IV and F4/80. A small number of YFP+ cells co‐labeled with IBA1 indicating they were microglia/macrophages. These YFP+/IBA1+ cells within the CNS could be peripherally derived.

Hence, PDGFRA/ NG2 cells in the adult CNS are capable of generating OLs not only in the normal adult CNS but also under disease conditions such as EAE.
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REJUVENATING REMYELINATION IN THE AGEING CNS {#sec2-545}
--------------------------------------------

### Rist J.M.,^1^ Shadrach J.L.,^2^ Wagers A.J.,^2^ Franklin R.J.M.^1^ {#sec3-545}

#### ^1^Cambridge Centre for Brain Repair & Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom; ^2^Department of Stem Cell and Regenerative Biology, Harvard University, Joslin Diabetes Center & Harvard Stem Cell Institute, Boston, United States {#sec4-545}

Remyelination is a spontaneous regenerative process in the central nervous system. Adult stem/precursor cells, the oligodendrocyte precursor cells (OPCs), are recruited to the site of demyelination, where they differentiate into mature oligodendrocytes that can restore an intact myelin sheath to the demyelinated axons. As most other regenerative processes, remyelination efficiency declines with age. This decline has been attributed to systemic changes with age, but also intrinsic alterations in ageing OPCs.

The effects of ageing on remyelination should therefore be taken into account when trying to devise remyelination‐enhancing strategies for diseases like Multiple Sclerosis (MS) that may last several decades. However, it is not clear whether endogenous aged OPCs are amenable to pharmacological manipulation, or whether we should instead focus on transplantation of exogenous young OPCs to enhance remyelination.

In this study, we investigated whether the exposure to a young systemic environment can rejuvenate the process of remyelination in aged mice. We used the model of heterochronic parabiosis, in which an old mouse is exposed to the blood circulation of a young mouse, and assessed the remyelination of a toxin‐induced focal demyelinated lesion in the spinal cord of the old mouse.

Our results suggest that exposure to a young systemic environment can partially reverse the age‐associated decline of remyelination efficiency by increasing the rate of differentiation of OPCs into myelinating oligodendrocytes. This provides a proof of principle that the age‐associated changes in remyelination are reversible and thus validates the approach of targeting endogenous OPCs to achieve enhanced remyelination as a potential therapy for MS.
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ASTROCYTE ALIGNMENT INCREASES NEURITE OUTGROWTH IN A 3D CELL CULTURE MODEL {#sec2-546}
--------------------------------------------------------------------------

### East E., Blum de Oliveira D., Golding J., Phillips J. {#sec3-546}

#### The Open University, Milton Keynes, United Kingdom {#sec4-546}

Repair of CNS injury is hindered by the glial scar that forms around implanted graft devices. The glial scar is composed of a 3‐dimensional (3D) unaligned meshwork of reactive astrocytes that form a physical and physiological barrier, so whilst axons readily enter and traverse the bridging graft, they rarely exit the graft and re‐integrate with the host parenchyma. Previous studies have shown that alignment of astrocytes growing in monolayer directs and enhances the growth of neurites over their surface. The aim of this work was to develop a 3D culture system in which the effect of astrocyte alignment on neurite growth could be modelled in a more spatially relevant environment.

3D cell alignment was achieved by co‐culturing primary rat astrocytes, neural fibroblasts and DRGs for 3 days in rectangular tethered collagen gels. In this system the cells generate forces that contract the restrained gels, forming a central region in which cells align with the axis of principal strain. The gels also contain well‐defined unaligned areas used as controls. Gels were fixed and stained for GFAP, βIII‐tubulin and Hoechst. Astrocyte alignment (aspect ratio) and neurite length were measured and mapped. Astrocyte alignment was significantly greater in the central region of the gels when compared to the control areas (P\<0.01). Additionally, neurites in aligned regions grew in an orientated manner following the direction of astrocyte processes, compared to the random orientation of neurite growth in unaligned regions. Furthermore, neurites in aligned regions were significantly longer than those in unaligned areas (P\<0.01). Expression of GFAP and neurocan mRNA did not differ between aligned and non‐aligned gel regions. In control gels without astrocytes neurites were of similar lengths in both aligned and unaligned regions.

In conclusion, alignment of astrocytes was sufficient to enhance the length and orientation of neurites in a 3D environment, a more clinically relevant model than conventional 2D culture for many investigations of glial‐neuronal interaction. This suggests that manipulation of reactive astrocyte alignment *in vivo* should create a more permissive environment for regenerating axons, and that implantation of bioengineered devices containing aligned astrocytes may be a promising strategy to promote CNS repair.
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RAF/ERK SIGNALLING IN SCHWANN CELLS IS SUFFICIENT TO INDUCE SCHWANN CELL DEDIFFERENTIATION IN VIVO {#sec2-547}
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### Napoli I., Noon L.A., Parrinello S., White I., Woodhoo A., Lloyd A.C. {#sec3-547}

#### MRC Laboratory for Molecular Cell Biology, London, United Kingdom {#sec4-547}

The Peripheral Nervous System (PNS) displays the remarkable property of regeneration and complete nerve repair following injury. In a series of coordinated events, known collectively as Wallerian Degeneration, the myelin sheath breaks down and axons degenerate. As part of this process Schwann cells dedifferentiate and reenter the cell cycle producing a pool of precursor like cells, which can then redifferentiate upon axonal regrowth. This regenerative phase requires clearance of myelin and axonal debris, a process that requires the activation of an inflammatory response with macrophages recruitment to the region of tissue damage.

Previously, we have shown that Ras/Raf/Erk pathway is capable of driving the dedifferentiation of Schwann cells in vitro and that activation of ERK is sustained in Schwann cells following nerve transection in vivo (Harrisingh et al., Embo J, 2004). To address whether ERK activation is sufficient to drive Schwann cell dedifferentiation in vivo and the effect of this specific signal on the biology of the peripheral nerve, we have generated a transgenic mouse model in which we can induce the activation of Raf kinase specifically in Schwann cells in the adult nerve. To date, we have observed that activation of Raf in these mice is sufficient to drive Schwann cell dedifferentiation and demyelination of peripheral nerves in vivo. The effects are dramatic, with severe impairment of motor function. Interestingly, the phenotype of peripheral nerve degeneration is reversible with the period of dedifferentiation determined by the period of ERK activation. Moreover, we found that activation of ERK signaling in the Schwann cells was sufficient to induce an inflammatory response and macrophage infiltration along the entire nerve.

We believe this mouse model provides a powerful system to study the regulation of PNS degeneration and regeneration.

Moreover it will be useful to identify the cellular response downstream to the Schwann Cells dedifferentiation and proliferation, the hallmark event in neuropathies.
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THE TSPO LIGAND ETIFOXINE IMPROVES PERIPHERAL NERVE REGENERATION AND FUNCTIONAL RECOVERY {#sec2-548}
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### Girard C.,^1^ Liu S.,^2^ Cadepond F.,^1^ Adams D.,^3^ Lacroix C.,^3^ Baulieu E.E.,^1^ Schumacher M.,^1^ Schweizer‐Groyer G.^1^ {#sec3-548}

#### ^1^Inserm, le Kremlin‐Bicêtre, France; ^2^Institut Pasteur, Paris, France; ^3^APHP Hôpital de Bicêtre, Kremlin‐Bicêtre, France {#sec4-548}

Etifoxine is already used as an anxiolytic drug in human medicine. It binds to the Translocator Protein 18kDa‐TSPO which is active in apoptosis, proliferation, respiration of mitochondria and steroidogenesis, processes which could be active in neuroprotection and regeneration.

In the peripheral nervous system, spontaneous regenerative processes occur after a traumatic injury or in case of peripheral neuropathies, but the recovery is slow and often incomplete. At present, no efficient treatment is available. To test the effect of etifoxine on peripheral nerve regeneration, we used two in vivo models of traumatic injury (freeze‐injury or complete section of a rat sciatic nerve) and the PC12 cell model for some studies.1We showed by immunohistological and electron microscopic studies that chronic injection of etifoxine promoted a better regeneration of axons at the level and downstream of the lesion after freeze‐injury, and that axonal growth was stimulated by a factor of two in the silicone guide tube used in the complete section model. In PC12 cells in the presence of NGF, neurite outgrowth was also stimulated by etifoxine, an effect even stronger than that obtained with other TSPO ligands.2The number of activated macrophages in the freeze‐injured nerve was markedly decreased after chronic etifoxine injection. This effect appeared earlier in the proximal than in the distal stump of the injured nerve. Etifoxine injection also exerted a marked effect on the expression of inflammatory cytokines. Etifoxine significantly decreased TNF‐alpha mRNA expression in both stumps of the nerve, whilst IL‐1beta mRNA expression was predominantly blunted in the proximal stump.3Functional tests (walking track test, automated grid walk task assay and nerve pinch test showed that both motor and sensory function recovery were accelerated after chronic treatment with etifoxine.

In conclusion, this molecule, which easily enters nervous tissues, remarkably improves nerve regeneration and functional recovery and is already used for adjustment of anxiety disorders in human, offers promise for the treatment of peripheral nerve injuries and neuropathies.
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BALANCING FORM AND FUNCTION: THE INFLUENCE OF TOPOGRAPHY ON NEURONAL GROWTH IN THE GENERATION OF A 3D GRAFT FOR THE TREATMENT OF SPINAL CORD INJURY {#sec2-549}
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### Donoghue P.,^1^ Cortese B.,^2^ Lamond R.,^1^ Gigli G.,^2^ Riehle M.O.,^3^ Barnett S.C.^1^ {#sec3-549}

#### ^1^Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; ^2^National Nanotechnology Laboratories, Distretto Tecnologico, Universita del Salento, Lecce, Italy; ^3^Centre for Cell Engineering, University of Glasgow, Glasgow, United Kingdom {#sec4-549}

A consequence of spinal cord injury (SCI) is the loss of function in regions distal to the site of injury, highlighting the inability of the central nervous system (CNS) to undergo competent regeneration. A particular caveat to functional repair is the formation of a glial scar -- a physical and molecular barrier to regeneration -- which inhibits axonal outgrowth. Advanced therapies envisaged for the repair of SCI utilise a combinatorial treatment approach; including bridging the area of injury via the grafting of artificial implants and cellular transplantation, and pharmacological intervention to counteract the inhibitory scar environment. However, axons entering a cellular graft are often disorganised and fail to exit, necessitating a guidance system.

Our aim is to develop a 3‐dimensional scaffold, embossed with an aligned micropattern and filled with appropriate cells suitable for transplantation into a spinal cord lesion to guide and support functional repair as part of an advanced integrated therapy. Previous studies using myelinating dissociated rat embryonic spinal cord cells plated on a monolayer of astrocytes generating an environment similar to intact CNS have shown that micropatterned 2D constructs (ϵ‐polycaprolactone, polydimethylsiloxane) can be used to provide a suitable growth substrate for promoting axonal alignment and remyelination. We plan to adapt this micropattern for use in 3D scaffolds, the parameters of which will be optimised for beneficial cell growth and structural stability i.e. alignment of pores, groove dimensions, etc. Ultimately this would enable development of a cell‐seeded, biodegradable, physical transplant for the treatment of SCI. This work investigates how alterations to the topography important for cell viability in the 3D scaffold affect the ability of the micropattern to influence cell growth. Data will be shown of the effects of these topographical alterations in a 2D environment on glia‐axonal interactions initially, before gradual development of 3D constructs. Preliminary data indicating cell viability within the 3D construct model will also be shown.
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IMMUNOHISTOCHEMICAL INVESTIGATION OF GLIAL REGENERATION FOLLOWING CEREBELLAR INJURY IN RAT {#sec2-550}
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### Adorjan I., Bindics K., Galgoczy P., Kalman M. {#sec3-550}

#### Semmelweis University, Budapest, Hungary {#sec4-550}

The astroglial structure of the cerebellar cortex composed of the astrocytes in the granular layer, the Bergmann glia\'s cell bodies situated in the Purkinje cell layer and their processes extending to the meningeal surface in the molecular layer. The highly organized structure of these parallel processes provide a base of comparison to observe the events following traumatic injury as it was stab wound in this case. We examined the glial fibers by immunohistochemistry of intermediate filaments such as GFAP and nestin. The GFAP is characteristic of the mature glial elements, i.e the astrocytes and Bergmann glial processes. The nestin is typical of immature neuroepithelial cells during development or subsequent to lesions. By means of these markers we could establish different stages during the healing‐process. The following changes were observed: a) by the second postoperative day (POD2) nestin expressed in the somata of Bergmann‐glia and the nestin‐expression was culminating at POD 7 b) GFAP‐immunopositive fibers appeared at POD 4 and GFAP‐immunopositivity increased parallel to the decrease of nestin‐immunopositivity during the second postoperative week c) nestin‐immunoreactive astrocytes appeared throughout in the cortex d) in case of long term survival (14‐21 days) the Bergmann‐glial fibers were rearranged with newly formed processes perpendicular to the meningeal surface.Current experiments of BrdU immunohistochemisty showed proliferating cells located in the Purkinje cell layer that suggests a new stem cell niche situated in the cerebellum.

Present study was funded by the Hungarian Science Fundation; Grant number: OTKA 2006/K60930.
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SCHWANN CELL P75NTR LIMITS NEUROTROPHIN‐DEPENDENT SENSORY AXON REGENERATION INTO THE SPINAL CORD {#sec2-551}
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### Scott A., Ramer M. {#sec3-551}

#### University of British Columbia, Vancouver, Canada {#sec4-551}

Following spinal cord injury, the p75 neurotrophin receptor (p75NTR) has been primarily characterized by its inhibitory role in regenerating axons, while the effect of non‐neuronal expression of p75NTR remains largely unknown. Following peripheral nerve injury, Schwann cells are a source of neurotrophins, which act on their respective tropomyosin‐related kinase receptors (Trks) to promote axonal growth. However, Schwann cells also upregulate p75NTR, unlike neurons which maintain considerably low p75NTR expression. Thus, we hypothesized that glial p75NTR could act to sequester neurotrophins and prevent neurotrophin‐dependent axonal regeneration and plasticity. Schwann cells isolated from p75‐/‐ (exon III) mice better supported neurite outgrowth from p75+/+ neurons in vitro, an effect which was dependent upon Schwann cell‐derived NGF and NT‐3. These results were recapitulated in in vivo experiments, in which peripheral nerve grafts from p75‐/‐ mice were more readily invaded by injured p75+/+ dorsal column axons than were p75+/+ grafts. Injury to sensory axons within the Schwann cell‐containing dorsal roots resulted in functional regeneration in p75‐/‐ mice, but not p75+/+ mice. Regeneration was again dependent upon endogenous neurotrophins, given that treatment of Trk‐Fc chimeras prevented regeneration in p75‐/‐ mice. To distinguish between effects of neuronal and Schwann cell p75NTR, we transplanted dissociated eGFP‐expressing p75‐/‐ neurons into rhizotomized rat DRGs and found that unlike in p75‐/‐ mice, regeneration halted at the PNS:CNS interface. These results show that it is glial p75NTR expression that limits regeneration by restricting endogenous neurotrophin availability.
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CNS INJURY: DEVELOPMENT OF A NOVEL IN VITRO MODEL {#sec2-552}
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### Boomkamp S.,^1^ Lewis R.,^2^ Riehle M.,^2^ Barnett S.^1^ {#sec3-552}

#### ^1^Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8QQ, United Kingdom; ^2^Centre for Cell Engineering, University of Glasgow, Glasgow G12 8QQ, United Kingdom {#sec4-552}

Damage to the central nervous system (CNS) as a result of nerve injury or disease significantly impacts the ability of the CNS to communicate and may lead to a host of debilitating symptoms and, ultimately, loss of neuronal function with the formation of an astrocytic scar. Currently there are few valid *in vitro* cellular models to evaluate the pathological consequences of CNS injury, and most research in this field is based on time‐consuming, involved and severe animal studies.

We aim to create a reliable *in vitro* model of spinal cord injury using a recently developed mixed CNS culture system, which mimics intact CNS tissue. These primary rat CNS cultures produce a carpet of spinal cord axons that, upon culture on a monolayer of neurosphere‐derived astrocytes, form myelin internodes and nodes of Ranvier. As these show the correct location of nodal proteins, correct myelin formation is assumed. When mature myelinated axons appeared, the cultures were axotomised, resulting in detectable areas of damage, and the axonal outgrowth and regeneration were assessed over time.

Following recovery of the axotomised cells for a minimum of 5 days, large cells positive for glial fibrillary acidic protein (GFAP, an astrocyte marker) could be visualised within the induced lesions, also characterised by axonal boundaries. These reactive astrocytes co‐localised with increased nestin expression besides intrinsically synthesised chondroitin sulphate proteoglycans, suggesting an astrocytic response, and the formation of features typical of a glial scar.

In order to achieve a more organized topology allowing easier measurement of axonal outgrowth, 2.5‐dimensional, micro‐engineered constructs are currently being developed to align axons prior to axotomy. The substrates contain grooves micro‐engineered to have widths of 5.25 μm to 100 μm and adjustable depths. Previous studies have shown that axons align along the smaller grooves and become myelinated by the glia. These cultures lend themselves to the study of glia/axonal interactions in a reproducible manner and allow a more straightforward assessment of regeneration of the lesioned axons. Work is in progress to evaluate their use to study axonal regeneration and combinatorial therapeutic approaches which may promote CNS repair.
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NOVEL MECHANISMS OF MAG SIGNALING IN CORTICAL NEURONS: A ROLE FOR PTEN {#sec2-553}
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### Perdigoto A.L.,^1^ Chaudhry N.,^2^ Filbin M.,^2^ Carter B.^1^ {#sec3-553}
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Injured neurons in the central nervous system (CNS) fail to regenerate partly due to the presence of myelin, a major source of axon growth‐inhibitory ligands. One such inhibitor is myelin‐associated glycoprotein (MAG), which has been shown to bind to the Nogo‐p75 (or TROY) receptor complex, resulting in activation of the GTP binding protein Rho. However, recent studies suggest that MAG may signal through alternate mechanisms, independent of the Nogo‐p75 receptor complex. We were interested in determining how MAG regulates axonal growth in cortical neurons, since injury to the corticospinal tract can result in permanent loss of motor control. We found that cortical neurons exposed to soluble MAG (MAG‐Fc) exhibited a 43% reduction in neurite outgrowth. However, when plated on MAG expressing CHO cells, embryonic (E17) or postnatal (P2) cortical neurons exhibited a dramatic 89% reduction in process outgrowth, relative to those plated on control CHO cells. Moreover, neither the p75 receptor nor its intracellular signaling partner TRAF6 were required for the inhibition of neurite outgrowth by membrane bound MAG, based on analysis of p75‐/‐ and traf6‐/‐ cortical neurons plated on the MAG‐CHO cells. Several studies have shown that Rho GTPase signaling is required for the inhibitory effects of MAG; however, we found that the Rho inhibitor C3 or the Rho kinase (ROCK) inhibitor Y27632 only partially reversed the effects of membrane bound MAG on cortical neurons. In contrast, both inhibitors could fully restore neurite outgrowth in cerebellar granular neurons plated on MAG‐CHO cells. In an effort to determine other signals downstream of membrane bound MAG in cortical neurons, we considered the lipid phosphatase PTEN. Knockdown of PTEN expression by shRNA in cortical neurons resulted in significant, although not complete, reversal of neurite outgrowth inhibition by MAG‐CHO cells. We are currently evaluating the activation of PTEN by MAG and analyzing whether PTEN and Rho GTPase are acting in the same or disparate pathways to mediate the inhibition of neurite outgrowth in cortical neurons.
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Following injury of the adult mammalian CNS, neuronal regeneration is sparse and occurs only rarely to a functionally relevant extent. This is thought to be due to neuron‐intrinsic determinants and growth inhibitors of white matter substances as well as glial scar constituents. Recent experimental evidence suggests an involvement of the transcription factor NF‐κB, commonly known for its anti‐apoptotic action in the immune system, in neuronal survival and myelin differentiation processes.

Here, we investigated the role of the NF‐κB subunit RelA in survival and axonal regeneration of mouse retinal ganglion cells (RGCs) after axotomy of the optic nerve (ON). In native retina, RelA was expressed in Müller glia, which surround and trophically support RGCs. In the ON, strong RelA immunoreactivity was detected in the soma and myelin sheets of CAII‐positive oligodendrocytes (ODCs). Conditional RelA knock out animals lacking RelA in neurons and glia displayed no obvious phenotype of retina and ON as investigated histologically and by optometric measurement of visual function.

Complete ON crush injury, as verified histologically and by an immediate and complete visual loss, induced RelA phosphorylation in the ON within 5 hours after injury, suggesting NF‐κB activation in ODCs. Four weeks post injury, the number of surviving RGCs was slightly increased in RelA knock out animals (48.7% ± 2.1%) compared to controls (41.5% ± 1.1%; *p* \< 0.05).

Regeneration studies using anterograde pre‐ and post‐injury tracing techniques and axonal growth markers (GAP‐43) indicated highly stimulated axonal regeneration in perilesional areas of RelA knock out animals. Four weeks after injury, axonal growth into the proximal ON was elevated on average 5‐fold compared to control animals (*p* \< 0.005). Translesional regeneration was significant in RelA knock out animals, and enhanced about 16‐fold over controls, which displayed only few bridging axons in marginal aspects of the lesion.

Our observations suggest that the lack of RelA promotes neuroprotection and pro‐regenerative processes may be due to interference with growth‐inhibitory signals from CNS ODCs. Ongoing investigations in ODC‐specific RelA knock out mice will further help to define the role of RelA in ODC‐dependent axonal growth inhibition in the mature CNS.
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In the present study we analyzed the mechanical and thermal algesimetry, wind‐up responses, and the astroglial and microglial immunoreactivity after graded spinal cord contusion. Adult Sprague‐Dawley rats were anesthetized, and after dorsal laminectomy (T8‐T9) the exposed subjacent spinal cord was injured using the Infinite Horizon contusion device, applying a force of 100, 150 and 200 kilodynes (KD). Intact animals were used as controls. Thermal pain sensitivity was evaluated using the thermal plantar algesimeter, by measuring the withdrawal latency to heat stimulus (Hargreaves et al 1998); whereas mechanical nociceptive thresholds of the hindlimbs were determined using the electronic von Frey unit (Bioseb, France), and measuring the force applied until hindpaw withdrawal. Wind‐up evoked responses to repetitive electrical stimulation (1Hz, 16 pulses, 1 ms) were recorded from the right tibialis anterior muscle using a protocol modified from Solano et al (2002). At 60 days postsurgery, rats were perfused, the spinal cord removed and processed. Histological sections were immunostained against GFAP and Iba1 to measure astroglial and microglial immunoreactivity, respectively.

In intact animals the withdrawal thresholds to mechanical stimulus averaged 19g, and to thermal stimuli occurred at about 13s. After spinal cord injury, the thresholds lowered to mean values of 10g and 8s, respectively, indicating the development of hyperalgesia. All contusioned rats showed significantly higher wind‐up responses than intact animals. GFAP‐ and Iba1‐immunoreactivity was increased in injured cords. These results suggest that endogenous glia reactivity is involved in nociceptive abnormalities observed after spinal cord injury.

This research was supported by grants from the Ministerio de Educación y Ciencia (SAF2006‐0862), and Fundació La Marató de TV3 (Project \# 070210), Spain.
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Following a traumatic damage of the spinal cord, the increasing reactivity in astrocytes and microglia leads to the diffusion of inflammatory factors and axon outgrowth inhibiting molecules that difficult regeneration. Methylprednisole (MPSS) is currently the treatment for SCI, but there exist controversial results on functional recovery in patients due to their undesidered side effects. Experimental data has recently demonstrate that erythropoietin (EPO) may be used as alternative neuroprotector agent after SCI by already unknown mechanisms. In the present study we have evaluated the astroglial and microglial responses after graded spinal cord contusion, and their modulation by EPO and MPSS. The spinal cord of adult Sprague‐Dawley rats were contusioned using the Infinite Horizon (IH) contusion device, applying a force of 100, 150 or 200 kilodynes (KD) considering from mild (100 KD) to severe (200 KD) injury (n=14). To assess the astroglial and microglial responses in relation to the force applied, histological sections were immunostained against GFAP and iba‐1 respectively and the immunoreactivity grade measured at 60 dpo. The same sections were used to evaluate the amount of spared tissue. Histological results showed an increase in the response of both astrocytes and microglia, and a decrease in the percentage of spared tissue in relation to the force applied (62±6%, 47±4% and 33±6% respectively). In addition, a differential morphology was observed in microglia from a ramified shape to an ameboid morphology depending on the severity of the injury. In order to analyse the effect of MPSS and EPO we performed the treatment on two groups of rats subjected to a severe contusion. One group received MPSS (n=10) (30 mg/kg; i.v.) in a single dose after the injury, and the other received EPO (n=10) (6000 IU/kg; i.v.) after the injury, and two days per week during the first month, injured control animals received vehicle. We found that both drugs reduced two folds the increase of glial response and increased the percentage of spared tissue in the epicentre of the injury with 52±6% by MPSS and 60±5% by EPO. These results suggest that there is a correlation of glial response with the severity of the spinal cord injury, and that even in a severe injury, EPO and MPSS are able to reduce both astrocyte and microgial response.
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Multiple sclerosis (MS) is a chronic degenerative and debilitating disease of the central nervous system (CNS) characterized by inflammation and demyelination. Despite the improved relapse management provided by immune modulating treatments, progression of the handicap in MS patients remains. Indeed none of these drugs address the long term progression and disability that results from axonal degeneration. Therapies targeting myelin repair processes to protect axons from further damage are urgently needed for not only stopping but reversing disease progression. Olesoxime (TRO19622) is the lead compound of the Trophos\' proprietary cholesterol‐oxime compound family of mitochondrial pore modulators. Preclinical studies have demonstrated that the compounds promote the function and survival of neurons under stress conditions through interactions with the mitochondrial permeability transition pore. Interestingly olesoxime has been shown to accelerate axon regeneration and remyelination in the peripheral nervous system after sciatic nerve crush. This regeneration / remyelination process was associated with functional recovery of conduction velocities in motor axons (Bordet et al., JPET 322:709‐720, 2007). In this study, we test its ability to promote myelination in vitro using a combination of rodent CNS culture preparations.

Results indicate that in vitro treatment with olesoxime dose‐dependently accelerates oligodendrocyte progenitor cell (OPC) differentiation from neural progenitors derived from neonatal murine subventricular zone. Using purified OPCs from neonatal rat cortex, we demonstrated that olesoxime directly promoted OPC maturation while it had no effect on OPC survival or proliferation. Importantly treatment with olesoxime strongly enhanced myelination in co‐cultures of dorsal root ganglion neurons and OPC as demonstrated by the increased presence of myelin basic protein positive‐myelinated internodes. Olesoxime is currently under evaluation in two animal models of CNS demyelination and remyelination. Positive preclinical evidence of its efficacy in these models will provide the necessary proof of concept to motivate further development of this class of compounds for treatment of MS.
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Following disease or injury, the central nervous system (CNS) fails to regenerate competently, resulting in functional deficits and the formation of a glial scar which, due to the presence of growth‐inhibitory molecules represents a physical and molecular barrier to axonal regeneration. Cell transplantation has long been considered a possible therapy to promote CNS repair, and transplantation of glial cells (eg. olfactory ensheathing cells ((OECs)) and Schwann cells) results in axonal in‐growth into the graft, but these axons are unaligned with limited capacity to exit the graft. Therefore, any strategy aimed at promoting CNS repair must enable the alignment and outgrowth of axons as well as their remyelination to promote functional recovery. We aim to design a biodegradable polycaprolactone (PCL) micro‐ patterned scaffold seeded with glial cells for transplantation into a CNS lesion to promote axonal alignment, their exit from the graft and subsequent myelination. Since these scaffolds are required to support CNS tissue, we use an established co culture of axons and glia from the embryonic rat spinal cord to mimic the intact CNS. These cultures form a dense layer of axons which become myelinated by oligodendrocytes to form internodes of myelin and nodes of Ranvier with correctly located nodal proteins. Previous studies have shown that a 2D construct with a series of micro grooves at 5 μm depth can be used as a suitable growth substrate to enhance axonal alignment in vitro, although with time the cultures became over‐confluent and disorganised on the surface furthest from the topographical cues. Thus, we aim to determine the optimal depth of groove which will promote axonal alignment and myelination of a long term culture, which we intend to seed with OECs or Schwann cells. Although these cells are efficient at promoting the in‐growth of axons there have been no studies on how they affect endogenous oligodendrocytes. For this reason the axonal/glial co culture will be incubated with various concentrations of Schwann cells and OECs to access their effects on myelination. These studies should allow us to determine the optimum paradigms for developing an effective treatment for spinal cord injury.
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Spinal cord injury (SCI) results in permanent loss of motor, sensory and autonomic functions. A significant part of the tissue damage and functional loss may be preventable as it is the result of secondary events triggered by the trauma. However, an effective treatment eliminating the secondary damage after spinal cord injury is still missing. AlphaB‐ crystallin (CRYAB), a small heat shock protein with anti‐inflammatory and pro‐survival features, has been recently showed to mediate protection and avoid functional deficits and demyelination in EAE, a mouse model of multiple sclerosis. Despite its beneficial properties in CNS disease, no study has addressed the expression and role of CRYAB in SCI yet. We assessed by QPCR the mRNA levels for CRYAB in uninjured and injured spinal cord and observed that CRYAB mRNA levels are not up‐regulated in the injured spinal cord until 21 days after lesion, when most of the mechanisms that contribute to the secondary damage are already switched off. Interestingly, mice given with daily administration of CRYAB for seven days, starting one hour after lesion, showed a robust improvement in functional recovery assessed using the Mouse Basso Scale (BMS) as compared with their PBS counterparts. Significant differences in BMS score started at day 3 after lesion and remained significantly enhanced until day 28, the end of the follow up. Histological analysis revealed that CRYAB promoted a significant increase in tissue sparing and neuronal survival, further demonstrating its protective role in SCI. This is the first study providing evidence that CRYAB is able to promote functional recovery and neuroprotection after SCI. CRYAB could therefore be valuable for the treatment of acute SCI in humans for which there are currently no effective pharmacological approach yet.
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Gal‐1 has been associated with many extracellular and intracellular functions. Extracellularly require the carbohydrate‐binding properties, and has the potential to bind various surface receptors on a variety of cell types as well as extracellular matrix proteins,causing cell proliferation or apoptosis, modulating cell adhesion and inducing cell migration. Intracellularly, Gal‐1 can regulate cell transformation and cell motility. The proliferation of neural stem cells is enhanced by carbohydrate binding by extracellular Gal‐1 (Ishibashi et al.,2007). We investigated the participation of galectin‐1 in demyelination‐remyelination after feeding for 6 weeks with a diet containing 0,2% cuprizone (CPZ) to 8 week old gal‐1 KO and wild type (WT) mice of the 120 Sv strain. One group of animals was killed immediately after withdrawal of CPZ and the other was mantained for one extra week with normal control diet before death.

The study was carried out by immunohistochemical evaluation of specific myelin markers such as MBP and CNP, histological evaluation using myelin staining and biochemical analysis of myelin lipids. Lgals1‐/‐ showed a significantly lower degree of demyelination and remyelination than Lgals1+/+ (P\<0,05). The response of astrocytes (GFAP+) and microglial cells (CD11b+) to CPZ was much smaller in these animals than in WT mice. We also studied the temporal profile of endogenous Gal‐1 expression in a CPZ‐induced demyelination model. In normal brain, Gal‐1 expression was observed only in the SVZ while in the demyelinated brain, Gal‐1 expression was markedly upregulated in the SVZ. The temporal profile of Gal‐1 expression was correlated with the neural progenitor cell proliferation in the SVZ of the demyelinated brain. Double‐labeling studies revealed that Gal‐1 was localized predominantly in both reactive astrocytes and SVZ astrocytes. By contrast, in KO Gal‐1 mice in the SVZ there is an inhibited neurogenesis. These results explained the lack of spontaneous remyelination after withdrawal of CPZ and suggest that Gal‐1 is one of the principal regulators of adult SVZ neurogenesis.
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Regeneration of myelin sheaths is an important therapeutic strategy currently investigated to ease the devastating consequences of diseases associated with demyelination in the central nervous system. The process of remyelination, which is mediated by an adult stem/precursor cell population (OPCs, oligodendrocyte progenitor cells), can occur spontaneously but it is prone to failure in disease where it is most required. The reasons for the failure are not fully understood. A presence of myelin breakdown products that accumulate following demyelination and which are able to inhibit OPC differentiation and thus impair remyelination could play an important role.

In order to investigate the intracellular regulation of the OPC differentiation block we have adopted an in vitro assay in which primary rat OPCs are plated on myelin membrane preparations. Here we show that contact with myelin modulates PKA‐p38‐CREB signaling. Increasing intracellular cAMP levels by either db‐cAMP or inhibition of phosphodiesterase 4 is able to neutralise the inhibitory effects of myelin on OPC differentiation. Finally, treatment of young adult rats in which demyelination has been induced by stereotactic administration of ethidium bromide to the caudal cerebellar peduncle with the phosphodiesterase 4 inhibitor rolipram is able to enhance remyelination in vivo.
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Axon regeneration in adult CNS is limited by the presence of inhibitory proteins associated with myelin. Blocking PKC activity pharmacologically attenuates the ability of CNS myelin to inhibit neurite outgrowth. The intracellular signaling mechanisms underlying the remyelination inhibition in CNS are still largely unknown. Here, we provide histological and functional evidence that protein kinase C (PKC) is a key component in the signaling pathways that inhibit myelin repair. Considering the vulnerability of optic apparatus, particularly optic chiasm and nerves in Multiple Sclerosis (MS) we used this area for local induction of demyelination. We stereotaxically injected 2 μl lysophosphatidyl choline (LPC) %1 in male C57BL/J mouse chiasm. Intracerebroventricular daily injection of a PKC inhibitor (GO6976) 2.5 nmol/ mouse was done for 14 days post lesion. Demyelination and remyelination pattern in the longitude of optic chiasm were investigated by histological evaluation using Luxol fast blue staining and Electrophysiological study using visual evoked potentials. Demyelination extension and remyelination intensity were measured by image J and Scion image soft wares respectively. Visual evoked potential delay was qualified with biochart soft ware. In LPC treated animals demyelination was most marked at days 3 and 7 post lesion, and incomplete remyelination occurred at day 14 post lesion. Less demyelination was observed in day 3 post lesion in animals treated with PKC inhibitor with inhanced remyelination at days 7 and 14. Our findings were confirmed by histological evaluations.

In conclusion, inhibition of PKC activity could represent a potential therapeutic approach for stimulating the remyelination process in the context of MS.
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The concentration of different signaling molecules, timing and interaction between transcriptional activators and repressors control the differentiation of oligodendrocyte progenitor cells (OPCs) into functional oligodendrocytes both during the development and in the mature CNS. One apparently important factor in this network is the Nkx2.2 transcription factor, since the number of MBP expressing oligodendrocytes in the CNS of Nkx2.2^‐/‐^ mice is reduced during development before the mice die early postnatally. Since Nkx2.2 is expressed by adult OPCs and up‐regulated during remyelination in the mature CNS, Nkx2.2 is also likely to be important for the remyelination process.

This study aims to investigate the role of Nkx2.2 during remyelination as a response to chemical‐induced demyelination in mice and to identify Nkx2.2 target‐genes and clarify, whether Nkx2.2 represses or activates the expression of its target genes in mice. Demyelination was induced by feeding young adult mice with 0.4% cuprizone in standard diet for 6 weeks. After ingestion, cuprizone induces general demyelination of telencephalic structures, such as corpus callosum and neocortex. The influence of Nkx2.2 on the remyelination process is investigated in Nkx2.2^+/‐^ and littermate Nkx2.2^+/+^ mice by scoring of luxol fast blue and MBP stained myelin, and the amount of Nkx2.2 expressing OPCs and NogoA expressing oligodendrocytes among un‐treated, cuprizone treated, and remyelinated cuprizone treated mice. The Nkx2.2 target genes are identified by use of mRNA expression microarray and ChIP‐on‐chip technique in parallel studies. Based on the predicted target genes, Nkx2.2 appears to regulate its own expression directly and indirectly by the Gli2 transcription factor, Nkx2.2 also appears to regulate the expression of some of the oligodendrocyte specific markers and pathways involved in formation of myelin.

The results obtained so far, indicate that Nkx2.2 does play a role during remyelination in the mature CNS.

P‐564 {#sec1-564}
=====

Retinoic acid receptor signalling promotes CNS remyelination {#sec2-564}
------------------------------------------------------------

### Huang J.K., Jarjour A.A., Zhao C., Williams A., Bauer J., Ffrench‐Constant C., Franklin R.J.M. {#sec3-564}

#### Department of Veterinary Medicine, University of Cambridge, Cambridge UK CB3 0ES MRC Centre for Regenerative Medicine, The University of Edinburgh, Queen {#sec4-564}

In multiple sclerosis (MS), the natural ability for resident oligodendrocyte precursor cells (OPCs) to differentiate and regenerate lost myelin sheaths, a process called remyelination, becomes progressively impaired. While current treatments aim to suppress the active inflammatory and immune responses associated with the disease, no therapeutic approach has yet been taken to enhance the regenerative ability of OPCs, due in part to the insufficient information on factors that can stimulate OPC differentiation. Here, we establish a comprehensive gene expression profile of CNS remyelination by performing laser capture microdissection and microarray analysis over three distinct phases of remyelination: OPC activation, oligodendrocyte differentiation, and myelination from experimentally demyelinated rat white matter tracts. We found the retinoic acid receptor, RXR‐gamma, was highly expressed during the OPC differentiation phase of CNS remyelination. RT‐PCR and in situ hybridisation revealed its expression by oligodendrocyte lineage cells and macrophages during remyelination. Administration of the retinoid X receptor agonist, 9 cis‐retinoic acid, promoted oligodendrocyte differentiation in cultured oligodendrocytes, and resulted in a significant increase in myelination in oligodendrocyte‐neuron co‐cultures and in experimentally demyelinated rats. Our data suggest the enhancement of retinoid X receptor signalling promotes CNS remyelination, and might be a useful therapeutic strategy to treat demyelinating diseases.
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The role of microglia, the resident macrophages of the brain, in brain tumor biology is not well understood. Despite their potent capability of killing tumor cells, microglia seem to support tumor growth rather than suppress it. Clinical data suggest that a higher grade of microglial infiltration into brain tumors correlates with worse prognosis. A better understanding of this tumor supporting phenotype of microglia and putative ways to stimulate microglia to recover anti‐tumor properties could pave the way for new immunotherapeutical approaches. Here we report for the first time that human microglia, isolated from brain tumor specimen, secrete factors that support tumor migration in a 3D collagen invasion assay. On the other hand, a stimulation of human microglia with the TLR‐3 agonist poly(I:C), but not with any other TLR agonist, leads to a phenotype that suppresses tumor cell growth, as shown by viability assays. Furthermore, this stimulation leads to the secretion of factors that exert a cytotoxic and an anti‐migratory effect on tumor cells, as shown by 2D wound healing and 3D collagen invasion assays. In summary, these data show that human microglia isolated from tumor tissue have a tumor supporting phenotype that can be switched to a tumor killing phenotype by application of a proper stimulus.
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Malignant gliomas remain the most devastating childhood and adult tumors of the central nervous system. Although adult and pediatric gliomas are histologically indistinguishable, they differ in location, behavior and molecular characteristics. This implies that the molecular pathways and pathophysiology of malignant gliomagenesis in these two populations are distinct. Such differences between adult and pediatric gliomas may predict different therapeutic responses. Therefore, accurate genetically engineered models of adult and pediatric gliomas may help understand the biology of these tumors and evaluate therapeutic agents in preclinical studies. It has been proposed that gliomas arise only from the SVZ in mice during development. Here we demonstrate that in adult mice PDGF‐induced gliomas arise not only from cells of the SVZ but also from the cortex and cerebellum. Development of gliomas in different location occurs not only when targeted not only nestin positive but also GFAP positive cells. Our work demonstrates a versatile and highly reproducible adult mouse model of glioma, which can be easily incorporated into pre‐clinical studies.
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The search of effective targets for glioma therapy has been hampered by the lack of integrative approaches that take into account the relative contributions of several mechanisms or pathways involved in cell death. We report such an integrative, experimental‐ and systems biology‐assisted approach that facilitated the characterisation of a mechanism of lysosomal cell death and determination of a therapeutic target. TNF‐α‐resistant glioma cells were efficiently and specifically killed by a combination of TNF‐α, LPS and IFN‐γ (TLI) whereas none of these factors alone was toxic. Treatment of tumor cells with TLI induced production of peroxynitrite in glioma cells and not in astrocytes. It altered the lysosomal sphingolipid degradation pathway at the step of ceramide degradation, inducing death concomitant to ceramide lysosomal accumulation. Blockade of acid ceramidase by a inhibitor was toxic not only for glioma cells but also for astrocytes, indicating that specificity in killing relies on the target cells capacity to produce peroxynitrite. Hints for a specific target were provided by a mathematical modeling of the ceramide pathway in tumor cells and astrocytes, revealing striking differences in sphingosine‐1‐phosphate (S1P)‐dependent vesicular transport and in the ceramide recycling (salvage) pathway. This latter is favored in astrocytes whereas S1P production is favored in glioma cells, pointing to sphingosine kinase as a key molecule. As observed with TLI, treatment with a sphingosine kinase inhibitor led to lysosomal maturation blockade, lysosomal enlargement and permeabilization, alteration in mitochondrial potential and final death in tumor cells, not in astrocytes. We hypothesise that interruption of S1P production leads to a blockade in lysosomal recycling. Upon continuous fusion of incoming membranes, lysosomes start to increase in size and become unstable, suggesting that S1P signals are required for their maturation and hence their size regulation. Apoptotic or necrotic death would ensue, depending on the degree of permeabilisation and mitochondria involvement. Inhibition of sphingosine kinase furthermore induced cell death in human glioma cells and human glioma stem cells without altering human astrocytes, making this enzyme a very attractive therapeutic target.
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COGNITIVE STATUS OF PATIENTS AFTER RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA‐‐A HALF YEAR FOLLOW‐UP STUDY {#sec2-568}
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### Yang H. {#sec3-568}

#### Ruikang hospital, Chinese Traditional Medical University, Nanning, China {#sec4-568}

BACKGROUND: Cognitive dysfunction is common in patients who develop radionecrosis after receiving radiotherapy for nasopharyngeal carcinoma (NPC). However, the continuing impact of early‐stage of post radiotherapy on cognitive dysfunction remains unclear. The authors found a significant association between the severity of cognitive impairment and the time course of post radiotherapy.

OBJECTIVES: To investigate sequential changes of cognitive function in NPC patients at early‐stage of post radiotherapy with neuropsychological and neurophysiological tests.

PATIENTS AND METHODS: Firstly, seventy two patients with NPC who received radiotherapy and 36 age‐, gender‐ and education‐matched control subjects were evaluated by a battery of neuropsychologic tests of cognitive function and tested by P300 auditory event‐related potentials (P300). Secondly, to follow up patients\' neuropsychologic tests of cognitive function and P300 testing at just completed radiotherapy, third month of post radiotherapy and 6th month after radiotherapy; Third, to carry out comparisons of patients\' cognitive data and P300 values in all tests respectively.

RESULTS: There diffuse pattern of postradiation cognitive deficits was found in neuropsychological tests. The longer follow‐up, the more cognitive domains dyfunction were involved. The time course of post radiotherapy was correlated significantly with the severity of cognitive deficits both in neuropsychologic tests of cognitive function and P300 testing.

CONCLUSION: Both neuropsychological and neurophysiological results demonstrated a relatively diffuse pattern of postradiation cognitive deficits characterized by persistent impairment in NPC patients during half‐year follow‐up.
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Less than 3% of patients diagnosed each year for glioblastoma in Western countries will survive more than 5 years. Therefore, this brain tumour remains one of the most lethal forms of human cancer. Although glioblastomas rarely spread outside the nervous system, they infiltrate crucial structures in the brain, preventing curative surgical resection. Radiation and chemotherapy offer only modest benefits and remain essentially palliative. However, a promising new approach to treat glioblastoma suggests targeting cancer stem cells.

The cancer stem cell hypothesis proposes that cancers derive from a small fraction of cancer cells (SLCCs) that constitute a reservoir of self‐sustaining cells with the exclusive ability to self‐renew and maintain the tumour. SLCCs might participate to the resistance of brain tumours to radiotherapies, their recurrence and their aggressiveness. Recent works have indeed identified SLCCs in close proximity to brain endothelial cells, and targeting the tumour vasculature depleted brain tumours from the SLCC sub‐population. However, little is known about these cancer stem cells and their bidirectional interactions with tumour endothelial cells, and more work is required before we develop treatments that selectively target malignant stem cells and their niches.

To this aim, we cultured brain endothelial cells alone or in the presence of glioma stem cells, separated by a semi‐porous filter allowing soluble interactions. This project benefits from two original cellular models: SLCCs isolated from human glioma biopsies, based on their expansion ability in a minimum growth medium, and human brain endothelial cells that recapitulated the properties of the blood‐brain barrier. First, we observed that SLCCs exhibit a constitutive activation of the mTor pathway, and that blocking its activity through rapamycin can efficiently alter their self‐renewal properties. Furthermore, brain endothelial cells modulate partially the mTor signalling nexus in SLCCs. Our project now focused on exploring the mechanisms by which brain endothelial cells might modulate the stem cell properties through the mTor signalling axis.

Overall, we expect our project to better understand the nature of bidirectional communication within the tumour vascular niche.
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REDUCED EXPRESSION OF GAP JUNCTION PROTEIN CX43 IN GRADE IV GLIOBLASTOMA: BIOLOGICAL SIGNIFICANCE OF LOCALIZED HIGH EXPRESSION {#sec2-570}
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### Sin W.C.,^1^ Bechberger J.,^1^ Lampe P.D.,^2^ Naus C.C.^1^ {#sec3-570}

#### ^1^The University of British Columbia, Vancouver, Canada; ^2^Fred Hutchinson Cancer Research Center, Seattle, United States {#sec4-570}

Connexins are a family of transmembrane proteins that form gap junction channels to allow the exchange of materials, including amino acids, calcium ions and ATP, between cells. They are widely believed to co‐ordinate growth control by permitting intercellular communication to occur. As glioblastomas are widely believed to arise from cells of glial origin, we therefore investigated the expression levels and distribution of connexin43 (Cx43), the most abundant gap junction protein in astrocytes, in 2 human glioma tumor tissue microarrays encompassing normal brain tissue and hundreds of glioma tissue samples ranging from grade I to IV, with grade IV corresponding to the most aggressive glioblastoma. Previous analysis with limited glioma tumor sample size showed that Cx43 was either downregulated in high grade glioma tumors, or no correlation was found. In addition, several lines of evidence suggest the reduction of Cx43 levels may contribute to increased proliferation rate in aggressive tumors. Our preliminary results using a well‐tested anti‐Cx43 antibody showed a correlated decrease of Cx43 expression with higher tumor grades. In our tumor arrays, grade I/II tumors often have the highest Cx43 expression while grade III/IV glioblastoma have lower Cx43 expression, confirming the reduced expression of Cx43 in high‐grade gliomas. When the arrays were investigated in detail to examine Cx43 staining in the tumor core, we found pockets of cells within the grade IV tumors expressing high levels of Cx43. For instance, strong Cx43 staining was observed in the perivascular areas within the tumor core. Our results confirm the heterogeneity in glioma tissues and that Cx43 may have a role in dissemination of tumor cells in glioma invasion, in addition to its well characterized growth suppression.

Supported by the Canadian Institute of Health Research. CCN holds a Canada Research Chair.
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### Huillard E.,^1^ Mehta S.,^2^ Kesari S.,^2^ Alberta J.A.,^2^ Kane M.,^2^ Stiles C.D.,^2^ Rowitch D.H.^1^ {#sec3-571}

#### ^1^University of California, San Francisco, San Francisco, United States; ^2^Dana‐Farber Cancer Institute, Boston, United States {#sec4-571}

Gliomas are the most common type of primary brain tumor in adults and comprise a leading cause of cancer‐related death. Recent studies suggest that glioma might arise from the transformation of persistent neural stem or progenitor cells of the adult brain, and that common molecular mechanisms underlie both normal development and gliomagenesis. We previously reported that the bHLH transcription factor Olig2, which has critical roles in oligodendrocyte development, is expressed in progenitor cells in human glioma samples, and that Olig2 function is required for glioma formation in a genetically relevant mouse model. We are currently investigating the mechanisms by which Olig2 regulates tumorigenesis, which may relate to the specific genetic/oncogenic background in tumor progenitors cells. Evidence will be presented suggesting that certain roles for Olig2 in tumorigenic CNS precursors are context dependent.
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IN VIVO TWO‐PHOTON MICROSCOPY FOR MONITORING BRAIN VASCULARISATION DURING GLIOBLASTOMA PROGRESSION {#sec2-572}
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### Stanchi F., Rougon G., Debarbieux F. {#sec3-572}

#### IBDML, Marseille, France {#sec4-572}

Glioblastoma multiforme (GBM) is the most aggressive and vascularised form of glioma, the most frequent primary tumour affecting the central nervous system (CNS). The prognosis for GBM is usually very poor and currently available therapies can only slightly increase the average survival of patients. To generate new and more effective treatments, it is necessary to establish animal models reflecting at best the complex interactions between GBM cells and their natural environment but also to set‐up in vivo modalities to assess non‐invasively the efficacy of treatments at a cellular level.

A two‐photon microscopy protocol was thus developed to monitor in vivo the progression of GBM tumours grafted into the CNS of nude mice. A spheroid of the human GBM line U87 modified to stably express green fluorescent protein (GFP) is thus injected approximately 200 micrometers below the brain surface after craniotomy. A glass window is cemented above the disclosed brain, allowing repeated visualization of the same animal without need for further surgery. Tumour growth and angiogenesis are then observed at regular intervals after highlighting blood vessels by intravenous injection of rhodamine‐conjugated dextran. Single green tumor cells can thus be localized in their red microvascular environment over a depth of 500‐800 μm and their fate can be studied over several weeks.

It is therefore possible to provide a detailed in vivo characterization of GBM growth, invasion and angiogenesis under various pharmacological conditions. As this technique applies to any glioma cell line, implantations of GBM cells of different origins (hence different gene expression profiles), or implantations of genetically modified GBM cells (e.g. stable gene silencing) give access to the role of specific genes during tumour progression in physiological conditions.
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Glioblastomas are the most common primary CNS tumors in adults. Despite intense efforts, treatment of glioblastomas remains elusive. Deregulation of the erbB1 signaling is one of the most frequent anomalies encountered in these tumors, which indicates that the erbB receptor family is a promising target for molecular therapy. However, data on erbB signaling in glioblastomas are still sparse. Therefore, we undertook a comprehensive analysis of erbB receptor expression in a panel of nine glioblastomas that were compared to control cortices, using quantitative RT‐PCR, western blot analysis and immunohistochemistry. The expression profile of the eleven EGF peptide‐encoding genes was also evaluated. We determined the distribution patterns oferbB receptors among the main neural cell types that are present in these tumors, particularly the putative tumoral stem cell population. Quantitative analysis showed that erbB1 signaling and erbB2 receptors exhibited highly variable deregulation profiles among tumors, ranging from under‐ to overexpression, while erbB3 and erbB4 were down‐regulated. Immunohistochemistry revealed an important inter‐ and intra‐tumoral heterogeneity in all four erbB expression profiles. However, each receptor exhibited a distinct repartition pattern among the GFAP‐, Olig2‐, NeuN‐ and CD133‐positive populations. Interestingly, while erbB1 immunoreactivity was only detected in small subsets of CD133‐positive putative tumoral stem cells, erbB3 immunoreactivity was prominent in this cell population thus suggesting that erbB3 may represent a new potential target for molecular therapy.
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DIPEPTIDYL PEPTIDASE‐IV ENZYMATIC ACTIVITY AND GROWTH PROPERTIES OF HUMAN GLIOMA CELLS {#sec2-574}
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### Busek P., Stremenova J., Krepela E., Sedo A. {#sec3-574}

#### Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic {#sec4-574}

Molecules exhibiting dipeptidyl peptidase (DPP)‐IV enzymatic activity including canonical DPP‐IV, fibroblast activation protein (FAP), DPP7, 8 and 9 are serine proteases that cleave a number of biologically active peptides and have been implicated in cancer pathogenesis. We previously detected increased DPP‐IV expression and enzymatic activity in human astrocytic tumors correlating with WHO tumor grade (Stremenova et al 2007, Int J Oncol). The aim of the present study was to evaluate the function of DPP‐IV enzymatic activity in human glioma cells.

DPP‐IV enzymatic activity, DPP‐IV, FAP, DPP8 and DPP9 mRNA expression and their changes during the culture propagation were evaluated and related to the growth properties in 13 primary cell cultures derived from WHO grade IV astrocytomas. The effect of DPP‐IV on the proliferation, cell cycle and motility was also assessed using human glioma cell lines transfected to inducibly express DPP‐IV.

Primary cell cultures displayed varying morphology and differed in the DPP‐IV enzymatic activity and rate of proliferation. DPP‐IV activity positively correlated with the DPP‐IV and FAP mRNA expression. There was an association of higher cell surface DPP‐IV enzymatic activity with both higher population doubling time and slower migration, which was however not statistically significant. Additionally, in 3 out of 4 primary cell cultures propagated for extended period of time, there was a negative relation between the cell growth and DPP‐IV enzymatic activity in individual passages.

In transfected U373 and T98G glioma cell lines, DPP‐IV overexpression lead to decreased growth, a decrease of cells in S phase of the cell cycle and a G2/M cell cycle block. Cells highly expressing DPP‐IV also exhibited decreased migration and adhesion.

Together, the apparent growth inhibitory effect of DPP‐IV in transfected glioma cell lines was not clearly evident in primary cell cultures. However, participation of more molecules such as FAP on the DPP‐IV enzymatic activity in primary cell cultures may explain these seemingly contradictory results.

Supported by grants MSMT 0021620808 and GAUK 257896.
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Stem cells are defined by their intrinsic capacity to self‐renew and differentiate. Cancer stem cells (CSC) retain both of these features and the associated molecular pathways. Therapeutic targeting of CSC requires understanding the deregulations taking place in the molecular pathways that underscore their stem properties.

One of them is the canonical Wnt signalling pathway. It plays a central role in modulating the balance between stemness and differentiation in adult stem cell niches such as the hair follicles, the mammary gland and the intestinal crypt. Accordingly, mutations in genes encoding Wnt pathway downstream components induce constitutive Wnt signalling and underlie tumorigenesis in these tissues.

Q‐PCR analysis of G‐protein coupled receptors transcripts, expressed by four distinct cancer stem cell lines we derived from primary cultures of adult human glioma (gCSC), revealed a rich expression of Wnt receptors Frizzled (Fzd), particularly Fzd 1, 3 and 7. In addition, exposure of gCSC to temozolomide, an alkylant used in glioma chemotherapy, induced enhanced levels of Dickkopf‐1 (Dkk1) mRNAs, an endogenous Fzd inhibitor.

The functionality of the Wnt‐beta‐catenin pathway was verified by transfecting gCSC with a beta‐catenin reporter gene. Cell treatment with Wnt3a, a Fzd ligand, resulted in a dose‐dependent increased expression of the reporter gene. This stimulation was amplified in the presence of lithium chloride known to inhibit GSK3beta‐induced beta‐catenin lysosomal degradation. Expression of the endogenous Fzd inhibitor Dickkopf‐1 (Dkk1), using plasmid transfection or exogenous addition of recombinant protein Dkk1, inhibited in a dose‐dependent manner, Wnt3a effect on beta‐catenin reporter gene expression.

Our results indicate that Wnt‐beta‐catenin pathway does not seem involved in the control of gCSC self‐renewal or survival. However, its activation induces the expression of Snail, ACTA2 and Vimentin while inhibiting the expression of E‐cadherin. Such a protein signature is typical of the epithelial‐mesenchymal transition (EMT), associated with the acquisition of migration/invasion properties.

Taken altogether, our results demonstrate that Wnt‐beta‐catenin signalling is functional in gCSC. Further investigations will analyze its role in glioma progression.
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### Leprince P.,^1^ Junier M.P.,^2^ Bentaib A.^1^ {#sec3-576}

#### ^1^GIGA Neuroscience, Univ of Liège, Liège, Belgium; ^2^Inserm U894, Glial Plasticity Laboratory, Neuropathology dept of Sainte‐Anne Hospital, Paris, France {#sec4-576}

One of the main functions of adult astrocytes is to provide energy to neighboring neurons through release of lactic acid making glycolysis a major metabolic pathway in those cells. Other biosynthetic activities in astroglial cells, in particular during development and in astroglial tumors, also require the diversion of metabolic intermediates of the glycolytic pathway as building blocks for amino acids, fatty acids and nucleotides synthesis. Pyruvate kinase, the last enzyme of the glycolytic pathway, plays a major role in regulating the level of those intermediates. It is present in brain cells as two splice variants PKM1 and PKM2. The latter is an allosteric enzyme that is tightly regulated by the levels of various effectors, and whose expression is limited to proliferating cells during brain development and to cancer cells. Through a proteomic analysis, we first showed in vitro that astrocytes progenitors, mature astrocytes and cancerously transformed astrocytes from the mouse cerebellum and/or the cortex produce different levels of the PKM1 and PKM2 enzymes. Further characterization revealed new PKM isoforms in the transformed cells. These new isoforms have a lower molecular weight and isoelectric point than PKM1 or 2, and are recognized by anti‐PKM1/2 antibodies. Sequence information has been obtained for some of them. The distribution of the different PK isoenzymes during development of the glial population of the cerebellum and in various glial tumor cell lines is investigated through the use of specific anti‐PKM1 and anti‐PKM2 antibodies and quantitative PCR analysis, with the aim to unravel the possible role of these isoenzymes in metabolic maturation of glial cells and tumour growth.
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TUMORIGENICITY IS INDEPENDENT OF DIFFERENTIATION IN GLIOBLASTOMA STEM CELLS {#sec2-577}
---------------------------------------------------------------------------

### Balasubramaniyan V.,^1^ Bhat K.P.,^2^ Wang S.,^3^ Gumin J.,^4^ Sai K.,^3^ Lang F.,^4^ Aldape K.D.,^2^ Colman H.^3^ {#sec3-577}
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The majority of gliobastoma are resistant to standard therapy. Recent evidence suggests that several primary brain tumors including glioblastoma are driven by a rare fraction of cells with stem cell properties termed cancer stem cells that may underlie treatment resistance. However, the molecular mechanisms regulating glioma stem cell (GSC) maintenance, self‐renewal, and their relation to treatment resistance are unknown. Our prior analysis of gene expression data from glioblastoma (GBM) tumors has identified a mesenchymal gene expression signature associated with decreased survival and treatment resistance. In the current study, we have isolated and characterized multiple glioma stem cell (GSC) neurosphere cultures from human glioblastoma tumor samples and compared their properties. All of these GSC cultures demonstrated the key properties of self‐renewal, multilineage differentiation and tumor initiation. Surprisingly however, we found that both neurosphere and tumor initiation ability were retained after both short term and long term differentiation. Under differentiating conditions, GSC cells expressed both neural lineage and stem cell markers, highlighting the aberrant differentiation mechanisms in these tumor cells compared to normal neural stem cells. GSCs maintained under adherent differentiating conditions continued to proliferate and initiate tumor formation with efficiencies similar to GSCs maintained under proliferating (neurosphere) conditions. Taken together, our data indicate that self‐renewal and tumor initiating capacity of GSCs is independent of the differentiation state. These findings provide additional experimental evidence that oncogenesis is linked to alterations in normal differentiation pathways and suggest that therapeutic approaches targeting differentiation pathways in GSCs will have to overcome these differences to negatively affect tumorigenicity of GSCs.
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### Takahashi H., Inoue A., Harada H., Yano H., Ohnishi T., Tanaka J. {#sec3-578}

#### Ehime University Graduate School of Medicine, Toon, Japan {#sec4-578}

There is a growing body of evidence showing the existence of cancer stem cells (CSCs) in malignant brain tumors, and these CSCs are supposed to play pivotal roles in tumor initiation, growth and recurrence.

In this study, we isolated and characterize a subgroup of cancer stem‐like cells from human glioblastoma cell line, U251, which may represent the tumor‐initiating subpopulation of cells. By culturing U251 cells in serum‐free medium with epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and platelet derived growth factor‐AA (PDGF‐AA) for 1∼2 weeks, some U251 cells formed neurosphere‐like aggregates. These spheres expressed CD133, a marker of cancer stem cell, and other stem cell markers. Such spheres were well similar with embryonic stem cells in abilities of self‐renewal, and differentiation into neuron‐like cells in vitro. These cells could develop solid tumors when grafted subcutaneously into nude mice. To investigate the migration and invasion activities of sphere cells, we used organotypic brain slice co‐culture system. Although cells co‐cultured with brain slice migrated on the slice surface, and invaded into a deeper site, sphere cells possessed much higher migration and invasion activities compared with U251 parental cells by up‐regulation of one of matrix metalloproteinase (MMP) family, which may contribute to tumor metastasis.

Therefore, the MMP may be useful as a novel tumor biological and prognostic marker, and its inhibition may be a potential therapeutic target for glioblastoma.
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### Calzolari F., Appolloni I., Malatesta P. {#sec3-579}

#### Istituto Nazionale per la Ricerca sul Cancro; Università di Genova, Genoa, Italy {#sec4-579}

High grade gliomas are aggressive and mostly incurable brain tumors, which often display deregulated PDGF signaling activity. We have generated a mouse model of glioma formation and progression by overexpressing PDGF‐B in embryonic neural progenitor cells, in vivo. These PDGF‐induced gliomas display immature oligodendroglial features and possess a remarkable long‐term in vivo tumor‐propagating potential. Our analysis of the development and progression of these tumors is focused on the role of the transcription factor Olig2, a central regulator of neural stem cell biology, which is commonly overexpressed in human gliomas. Loss‐of‐function experiments have revealed that Olig2 is strictly required for the self‐renewal of glioma cells, in culture. Furthermore, the stable silencing of Olig2 completely abolishes the in vivo tumorigenic potential of PDGF‐B‐induced gliomas, establishing Olig2 as a central regulator of malignancy in this model system.
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Gliomas represent the most common primary tumours of the central nervous system. The annual incidence of gliomas is 5 cases for 100 000 people. Glioblastomas which is the most malignant form account for approximately more than 50% of glial tumours. Lack of curative traitment implicates a poor prognosis with a median survival between 12‐15 months. In the past decade, a sub‐population of CD133+ tumoral cells with characteristics of stem cells has been identified in glioblastomas. These cells are able to long‐term self renew and initiate new tumour when transplanted in immunocompromised mice. They are multipotent and generate astrocytes and neuronal‐like cells after differentiation. Moreover they appear to be more chemo and radioresistant than tumoral CD133‐ cells.

As a first step to understand the mechanisms by which tumoral stem cells self‐renew or generate more committed progenitors, we have derived 4 different cultures from glioblastoma samples using neurosphere technique. The majority of cells express stem cell markers such as Nestin, CD133, BLBP and Sox2. After differentiation by growth factor removal, these cells generate neuron‐like and glial cells expressing β‐3‐tubulin, GFAP and GalC. Cytometer cell sorting in 96 wells plate was used to isolate 3 clonal stem cell lines. Whereas these lines were isolated from one single cell, they rapidly become heterogeneous as evidenced by the expression of various cell lineage markers. Current work is in progress to explore the presence of asymmetric division in these cell lines.
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Glioblastomas are highly aggressive brain tumours without available curative treatment. Cancer cells with stem cell properties have been isolated from these tumours. Our study aims to find new molecules able to interfere with the growth of stem cells isolated from human glioblastomas and to decipher their mechanism of action. Thus, we are developing cell based and target based assays for high throughput screening of chemical libraries. Hits are validated by establishing dose/response curves and active molecules are tested for their specificity of action using classical cancer cell lines and non‐cancerous cells. Finally, gene expression studies will be performed to provide foundation for insights into the mechanism of action of the selected molecules.
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Cerebral tumors represent 2% of human adult cancers with an increase in frequency of 1 to 3% per year. The diversity of biomolecular mechanisms involved in glial tumoral cell proliferation and brain tissue invasion explains disease recur in most patients. It is now clearly established that cyclin‐dependent kinases (CDK) hyperactivity is one of the processes underlying hyperproliferation and tumoral growth. Among the CDK inhibitors already characterized, Meridianins and Variolins, both extracted from marine organisms, present an inhibitory activity associated to cytotoxic effects. From these observations, hybrid compounds named Meriolins have been synthesized to get better specificity and more efficient anti‐proliferative activity1,2. In the present study, we have tested the ability of a series of Meriolins to inhibit the proliferation of the human anaplasic astrocytoma cell line SW1088. Cells were treated during 48 hours in the absence or presence of increasing concentrations of Meriolins (10‐11 -- 10‐5 M). Our results show that among the 31 compounds tested on tumoral cell proliferation, 16 are effective at nano‐ or micromolar levels. The Meriolin 3, 5, 15 and 16 are particularly potent with IC50 values of 0.034, 0.031, 0.046 μM and 0.16 nM, respectively. Flow cytometry studies revealed that Meriolin 5 exhibited pro‐apoptotic activities whereas Meriolin 15 inhibited cell cycle. The more effective compounds are currently tested on the U87 glioblastoma human cell line. The effect of Meriolin 5 and 15 on SW1088‐ and U87‐derived tumors in Nude mice are under investigation. Taken together, our data strongly suggest that Meriolins represent a promising class of CDK inhibitors which may deserve new therapeutic options in the treatment of glial tumors.

^1^Bettayeb et al. (2007) Cancer Res. 67:8325--8334.

^2^Echalier et al. (2008) J. Med. Chem. 51:737--751.
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#### University of Cambridge, Cambridge, United Kingdom {#sec4-583}

INTRODUCTION: Glioblastoma (GBM) is a highly heterogenous brain tumour in terms of cellular composition. In normal brain, NG2 expressing cells have active cell cycle, high migration ability and play a role in blood vessels formation. However, it is not known in details if NG2 cells exist and play a functional role in the neoplastic process. We hypothesised, based on the characteristics of NG2 expressing cells in normal brain, that NG2 expressing cells in glioblastoma (GBM) are potential candidates to be cancer maintaining cells.

METHODS: GBM cell lines (GLs) were derived from fresh clinical samples under serum‐free (SF) conditions according to our Cambridge Protocol (Fael Al‐Mayhani et al.; 2009). Cells were analysed and sorted using FACS. Comparative studies on NG2+ and NG2‐ cells were conducted in vitro and in vivo. Molecular studies were performed using expression microarray and comparative genomic hybridization (CGH).

RESULTS: Microarray data showed that genes associated with neural precursors (NG2, Olig2 and PDGFRa) were expressed by all GLs and the majority of GBM tumours tested (n=147).

In vitro data showed that NG2+ cells isolated from GLs exhibit high level of growth, proliferation and clonogenic potentiality compared to NG2‐ cells.

NG2+ cells exhibit higher level of tumour formation in vivo compared to NG2‐ cells.

Array CGH demonstrate that both NG2 populations have typical GBM cytogenetic profile (e.g. Ch7 gain and Ch10 loss), however, NG2+ cells exhibit significant additional abnormalities.

The observed behaviour of NG2+ cells appears to be explained by a genetic signature represented by panels of genes involved in cell cycle and proliferation.

CONCLUSION: Genes associated with neural precursors are widely expressed by GBM tumours and GLs. NG2 expressing cells in GBM exhibit high levels of growth, proliferation and clonogenicity in vitro and tumour formation in vivo. The expression of NG2 by GBM cells appears to identify a functional phenotype of cells able to maintain tumour growth.
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ROLE OF THE UROTENSIN II AND UT PROTEIN PARTNERS IN GLIOMA CELL MIGRATION {#sec2-584}
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### Lecointre C., Morin F., Jarry M., Le Joncourt V., Desrues L., Schouft M.T., Lefebvre T., Vaudry H., Tonon M.C., Langlois O., Proust F., Gandolfo P., Castel H. {#sec3-584}

#### Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), IFRMP23, University of Rouen, Mont‐Saint‐aignan, France {#sec4-584}

Urotensin II (UII) is considered as the most potent vasoactive peptide. UII and its receptor UT are highly expressed in cardiac and vascular tissues, and UII has been found to exert a potent vasoconstrictor effect in various species. Although the genes encoding UII and its receptor UT are expressed in the central nervous system, little is known regarding the functions of the urotensinergic system in the brain. It has been shown that UII stimulates neoangiogenesis from brain microvessels and acts as a chemoattractant stimulating migration of human monocytes. We have demonstrated the presence of functional UT in cortical glial cells and mRNA expression of UII and its receptor has been previously reported in human glioblastoma cell lines. The aim of the present study was to identify protein partners of UT that may participate in the UII‐mediating effects in glioma development. By means of Western blot, FACS and immunohistochemistry, we showed that UT is expressed in both cytosolic and plasma membrane compartments in anaplasic astrocytoma SW1088 cell line. In these cells, UII induced a transient activation of the phospho‐ERK1/2 cascade and regulated glioma cell morphology. To investigate the mechanism of action of UII development and neoangiogenesis, we identified UT protein partners by using the yeast two‐hybrid strategy. Therefore, we have screened a human brain cDNA library with the cytosolic tail of human UT as bait. Until now, several proteins have been clearly characterized as interacting UT partners, including the filamin A, well known to be involved in cell migration. We demonstrated by using transwell migration assay that UII stimulated SW1088 cell migration in a dose‐dependent manner. Preliminary results showed that UT and Filamin A are co‐expressed in SW1088 and invading cells of fresh cultured human glioma explants. This work is currently extended through examination of the role of UT and UT partners in migration, invasion and neoangiogenesis of astrocytoma cells *in vitro* and *in vivo*.
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INTERACTIONS OF BRAIN TUMOR CELLS WITH IMMUNE AND ENDOTHELIAL CELLS {#sec2-585}
-------------------------------------------------------------------

### Vallières L. {#sec3-585}

#### Laval University Hospital Research Center, Québec, Canada {#sec4-585}

Macrophages can promote the growth of some tumors, such as those of the breast and lung, but it is unknown whether this is true for all tumors. Contrary to this possibility, I will present evidence that macrophages can attenuate the growth of brain tumors by an unconventional mechanism in a new model of transgenic mice allowing for temporal depletion of macrophages. I will also discuss how studying the effects of dexamethasone on tumor‐infiltrating immune cells has led to the identification of a vascular destabilization factor, angiopoietin‐2, as a potential therapeutic target for brain tumors.
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DO ALL GLIAL TUMORS OF THE CHILD CONTAIN TUMOR‐INITIATING CELLS? {#sec2-586}
----------------------------------------------------------------

### Dubleumortier S.,^1^ Bessette B.,^1^ Varlet P.,^1^ Surena A.L.,^1^ Cadusseau J.,^2^ Tavares S.,^1^ Villa C.,^1^ Miquel C.,^1^ Daumas‐Duport C.,^1^ Grill J.,^3^ Sainte‐Rose C.,^4^ Puget S.,^4^ Chneiweiss H.,^1^ Junier M.P.^1^ {#sec3-586}

#### ^1^UMR 894 Inserm ‐ Paris 5 University ‐ Glial Plasticity laboratory ‐ Sainte‐Anne Hospital‐, Paris, France; ^2^Inserm U841, Créteil, France; ^3^Institut Gustave Roussy, Villejuif, France; ^4^Department of neurosurgery, Hospital Necker, Paris, France {#sec4-586}

Recent isolation of tumor initiating cells (TIC) having some of the properties of neural stem cells in medulloblastomas and adult gliomas opens novel insights in the development and therapeutic resistance of primitive brain tumors. Data being scarce for pediatric gliomas, we aimed at isolating TICs from these tumors.

Presence of cells with TICs characteristics, ability to grow in vitro under the form of floating spheres (FS), endowment with self‐renewal and clonal properties, expression of molecular markers of neural stem/progenitor cells, were sought for from 57 pediatric tumors biopsies out of 81 collected from the surgical room.

No FS were observed in non‐tumoral tissue‐derived cultures up to 30 DIV (days in vitro), while medulloblastoma‐derived cultures contained FS within 10 DIV, as expected. FS development was more frequent in grade II to IV glioma than in pilocytic astrocytomas and gangliogliomas (86% versus 56%). Their presence was nevertheless highly variable within a given glioma sub‐type (40 to 100%). In all cases pediatric gliomas‐derived FS self‐renewed slowly (≥10 DIV). FS exhibiting extended self‐renewal capabilities akin to neural stem cells (\>7 self‐renewals) were more frequent in grade II to IV glioma than in pilocytic astrocytoma and ganglioglioma (≥60%, n=10 versus ≤20%, n=22). An even proportion of ependymomas generated cells behaving either as neural progenitors (≤7 self‐renewals) or stem cells. 0.1 to 7.5 % of the cell formed colonies in methylcellulose‐containing medium. Cells expressing the embryonic stem cell and/or neural stem cell markers SSEA4, Nanog, Sox2, and Bmi1 were observed within the FS. TIC‐like cells derived from a ganglioglioma and a grade II astrocytoma grew in an EGF‐dependent manner and most of them resisted to a 5 Gray gamma‐irradiation. Finally, preliminary data indicates genomic anomalies within child glioma‐derived FS and their ability to generate in vivo a tumor with histological characteristics of the initial tumor\'s patient.

The findings show that TIC‐like cells can be isolated from glial tumors of the child regardless of their malignancy. They are however not present in a systematic manner in all tumors of a given glioma sub‐type. Work under way includes further characterization of their karyotype, and of their capability to generate a tumor in vivo.
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DELAYED PROGRESSION OF C6‐DERIVED GLIOMA AFTER DOXYCYCLINE‐MEDIATED INDUCTION OF RECOMBINANT GLT‐1 EXPRESSION {#sec2-587}
-------------------------------------------------------------------------------------------------------------

### Hermans E., Vanhoutte N., Maloteaux J.M. {#sec3-587}

#### Université catholique de Louvain, Brussels, Belgium {#sec4-587}

Gliomas are known to release excitotoxic concentrations of glutamate, a process thought to contribute to their malignant phenotype through enhanced autocrine stimulation of their proliferation and destruction of the surrounding nervous tissue. A model of C6 glioma cells in which expression of the high affinity glutamate transporter GLT‐1 can be manipulated both in vivo and in vitro was used in order to investigate the consequences of increasing glutamate clearance on tumour progression. Non‐induced cells showed modest glutamate uptake and in the presence of L‐cystine, these cells tend to release substantial amounts of glutamate. Overnight exposure to doxycycline increased D‐\[^3^H\]‐aspartate uptake, reaching similar capacity as observed in cultured astrocytes. Efficient clearance of exogenously applied glutamate was evidenced in these cells, even in the presence of L‐cystine. These cells were grafted in the striatum of Wistar rats and doxycycline was administered after validation of tumour development by magnetic resonance imaging. Both GLT‐1 expression examined by immunohistochemistry and glutamate transport activity measured on synaptosomes appeared robustly increased in samples from doxycycline‐treated animals. Moreover, these rats showed extended survival times as compared to vehicle‐treated animals, an effect that was consistent with volumetric data revealing delayed tumour growth. As constitutive deficiency in glutamate clearance at the vicinity of brain tumours is well established, these data illustrate the potential benefit that could be obtained by enhancing glutamate transport by glioma cells in order to reduce their invasive behaviour.

Supported by the Fonds National de la Recherche Scientifique (FNRS) and by the Télévie, Belgium. EH is Research Director of the FNRS.
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PROTEOMIC PROFILING OF HUMAN HIGH‐GRADE OLIGODENDROGLIOMAS POINTS TO DEREGULATION OF THE PI3K/AKT SIGNALING PATHWAY {#sec2-588}
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### Thirant C.,^1^ Varlet P.,^2^ Miquel C.,^2^ Lacombe J.,^2^ Chafey P.,^3^ Broussard C.,^3^ Lions S.,^1^ Camoin L.,^3^ Chneiweiss H.^1^ {#sec3-588}

#### ^1^U894 Lab Glial Plasticity, Paris, France; ^2^Department of Neuropathology, Ste Anne Hospital, Paris, France; ^3^U567 UMR8104 Cochin Proteomic Plateform, Paris, France {#sec4-588}

Oligodendrogliomas (ODG) are diffuse infiltrating primary tumours of the human adult central nervous system. They have an overall survival time of 5 years. Chemosensitivity of a subset of ODG stresses out the need for biomarkers discriminating between eventual ODG sub‐groups. To identify such biomarkers, we took advantage of recent advances in protein dye labelling, 2D‐DIGE technique, and development of sophisticated mass spectrometry instrumentation for protein identification. Tissue samples from a total of 25 well‐characterised human high‐grade ODG were used. Intra‐patient control samples were obtained by separating the tumoral tissue (TT) from the low‐infiltrated parenchyma (LIT) through micro‐dissection of frozen tissues (6 cases). 2D‐DIGE analyses revealed 223 spots differentially expressed in TT vs. LIT. Further tandem mass spectrometry (MALDI TOF‐TOF) analysis of spots extracted from the gels identified 97 proteins of interest. 52 of these proteins were significantly up‐ and 45 down‐expressed in TT vs. LIT (threshold ? 1.5). Validation experiments included Western blots and immunohistochemical assays. They first revealed a protein signature exhibiting restricted over‐expression in ODG tumour cells as compared to other gliomas or normal CNS tissues, constituted by : the intermediate filament alpha‐internexin, protein disulfide isomerase A6, Ubiquitin‐activating enzyme 1, and the ATP‐dependent DNA helicase II. Further functional bioinformatics analysis revealed interconnections between 90 of the 97 identified proteins, which converge to two intra‐cellular signalling pathways nodes: c‐Myc, a Wnt‐beta catenin target and Akt. WB and IHC assays showed an over‐activation of Akt and over‐expression of c‐Myc in ODG tumoral tissue. Our results suggest that intra‐cellular pathways, well known to participate in cancerous transformation of epithelial cells, may also participate to ODG pathogenesis.
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USING MICROGLIA AS VEHICLES IN GENE THERAPY AGAINST GLIOMA {#sec2-589}
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### Bouzier‐Sore A.K.,^1^ Miraux S.,^1^ Bouchaud V.,^1^ Ribot E.,^1^ Franconi J.M.,^1^ Mornet S.,^2^ Duguet E.,^2^ Voisin P.^1^ {#sec3-589}

#### ^1^RMSB Center, Bordeaux, France; ^2^ICMCB, Bordeaux, France {#sec4-589}

In the case of a brain‐developing tumor, it has been observed that the tumor is highly infiltrated by microglia that could thus be used as vehicles to target it. Microglia were transfected with the TK‐GFP gene (with a HSP70 promoter) and internalized VUSPIO (Versatile Ultra Small Paramagnetic Iron Oxides) were used to track them in the brain. We check if VUSPIO internalization could lead to a cellular stress, thus inducing non‐specific activation of the suicide gene. We also determined the MR properties of the VUSPIO, as well as their detection limit, to establish whether this strategy could be used for in vivo cell tracking studies. Finally, the functionality of the TK gene was checked in vivo, by following the glioma progression when gancyclovir treatment was performed.

Transfected microglia phagocytosis of fluorescent VUSPIO was visualized by microscopy. VUSPIO repartition (intra or extracellular) and their potential toxicity were check by flow cytometry. The possible cellular stress induced by VUSPIO internalization was studied by immunohistochemistry and flow cytometry. Then, MR images were obtained both in vitro, on tubes containing VUSPIO‐loaded microglia to characterize MR properties, and in vivo, to localize the loaded transfected microglia in the tumor. Finally, both glioma cells and loaded transfected microglia were stereotaxically injected in rat brain and the development of the glioma was followed with/without gancyclovir treatment by MRI.

Fluorescent microscopy showed that VUSPIO were efficiently internalized by microglia. After cytometric analysis, contribution of free particles to total signal was shown to be negligible and the particles non‐toxic. The immunohistochemistry indicated that VUSPIO internalization does not lead to cellular stress since only heat shock induces the suicide gene activation. VUSPIO relaxivity r2 was 224 mM‐1.s‐1. Such result could generate very high contrast between loaded and unloaded cells on T2‐weighted imaging. In vivo, 5000 gathered microglia were enough to be detected. When both C6 cells and transfected microglia were present in the brain, no tumor was able to develop under gancyclovir treatment.

The present findings show that transfected microglia are a good candidate to carry both a suicide gene for cell therapy and nanoparticles for cell tracking.
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REGULATION OF CELL DIFFERENTIATION IN MERLIN NULL TUMOURS {#sec2-590}
---------------------------------------------------------

### Doddrell R., Hanemann C.O., Parkinson D.B. {#sec3-590}

#### Peninsula Medical School, Plymouth, United Kingdom {#sec4-590}

The relationship between normal cell differentiation and how this process is undone by genetic changes causing tumourigenesis is a key issue in cancer biology. The merlin gene encodes a cytoskeleton‐associated protein controlling cell‐extracellular matrix interactions and proliferation. Loss of merlin causes neurofibromatosis type 2 (NF2) a condition characterised by the development of multiple Schwannomas. We want to understand the process that follows Merlin loss and the mechanisms that cause abnormal de‐differentiation and proliferation of Schwann cells in these tumours. We have previously shown that the zinc finger transcription factor Krox‐20 acts as a master regulator of Schwann cell differentiation regulating differentiation, proliferation and survival of cells. Using an in vitro Schwannoma model, we have studied both regulation of Krox‐20 and the effects of enforced Krox‐20 expression on control and merlin null primary human Schwann cells. Our data demonstrates whilst Krox‐20 remains effective in driving myelination in these cells Merlin loss impairs the ability to induce Krox‐20 in response to in vitro signals. This finding defines what may be the key event in Schwann cell de‐differentiation and proliferation in Merlin null tumours. During normal myelination in vivo, Krox‐20 is activated by the transcription factors Oct‐6, Brn‐2, Sox‐10 and NFATc3/c4 acting on the myelinating Schwann cell element (MSE) upstream of the Krox‐20 proximal promoter. Western blotting and immunocytochemistry show that levels of Sox‐10 are reduced in Merlin null cells, providing a possible mechanism for the inability of these cells to maintain their differentiated state and that this reduction may be due to increased activity of the p38 MAP kinase pathway. Loss of Merlin also impairs the ability of Schwannoma cells to induce Oct‐6 in response to cAMP. Using siRNA to eliminate Merlin expression and dominant negative constructs to impair wildtype Merlin function we are currently confirming these results in rat Schwann cells.
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GAMMA‐LINOLENIC ACID INHIBITS CELL MIGRATION IN A C6 GLIOMA SPHEROID‐BRAIN SLICE MODEL {#sec2-591}
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### Miyake J., Colquhoun A. {#sec3-591}

#### University of São Paulo, São Paulo, Brazil {#sec4-591}

Gamma‐linolenic acid (GLA) is known to inhibit tumour cell proliferation in both in vitro and in vivo conditions. It has also been reported to inhibit cell migration in glioma cells grown on plastic in vitro. The aim of the present study was to identify the effects of GLA upon C6 rat glioma cell proliferation and migration in an in vitro model. C6 cells were grown as spheroids and then placed on rat brain slices and grown in the presence of 150 μM GLA or albumin vehicle. Spheroids were grown for 24‐48 hours in order to study the effects of GLA upon cell proliferation, apoptosis and migration/invasion in this model, which contains both brain cells and extracellular matrix and mimics more closely the in vivo environment. The methods used included (i) analysis of mitosis on 4% formaldehyde‐fixed H/E stained sections to obtain the mitotic index, (ii) TUNEL labelling to obtain the apoptotic index and, (iii) analysis of the number of migrating cells and the distance migrated from the edge of the spheroid. The mitotic index was decreased by 39% in the GLA‐treated spheroids. The presence of GLA also led to a 44% increase in the apoptotic index, determined by TUNEL labelling. The apoptosis:mitosis ratio changed from 6.34 in control conditions to 15.45 in the presence of GLA. Finally, in the presence of GLA, while the absolute number of cells migrating out of the spheroids did not change significantly the distance migrated from the spheroid was decreased by 32%. These findings show that in addition to its inhibitory effects on cell proliferation and its stimulatory effects on apoptosis, GLA can inhibit glioma cell migration/invasion in a brain slice model. These findings are important indicators that GLA may also have anti‐migratory properties in vivo and further work in this area is ongoing in our laboratory.

Financial support: FAPESP, CNPq, CAPES.
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GLIOBLASTOMA TUMOUR INITIATING CELLS DEMONSTRATE VEGF BUT NOT PDGF AUTOCRINE SIGNALLING {#sec2-592}
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### Kenney‐Herbert E., Ball S., Al Fael M., Watts C. {#sec3-592}

#### Brain Repair Centre, Cambridge, United Kingdom {#sec4-592}

INTRODUCTION: PDGFRα, VEGFR2 and their respective endogenous agonists PDGFAA and VEGF are over expressed in glioblastoma, suggesting the importance of autocrine signalling in tumourigenesis. We have derived Tumour initiating cell (TIC) lines, under serum free conditions, from glioblastoma samples and used them to investigate the contribution of putative PDGFAA and VEGF autocrine signalling in TIC proliferation.

METHODS: RT‐PCR was used to determine the presence of PDGFA, PDGFRα, VEGF and VEGFR2 transcripts and translation of PDGFAA and VEGF was investigated by ELISA. Inhibitory antibodies to PDGFAA and VEGF, and extra cellular PDGFAA and VEGF were applied to our cell lines and their effects on cell proliferation were assessed by MTS assay. Western blotting was used to determine the effects of VEGF inhibitory antibodies on phosphorylation of ERK1 and 2.

RESULTS: TICs derived and maintained under serum free conditions secrete VEGF. Many, but not all, of the same cells also expressed the receptor VEGFR2. Anti‐VEGF antibodies lead to a reduction in TIC proliferation in a concentration dependant manner in TIC lines which express VEGFR2 at early passage. Where VEGFR2 was lost over passage response to anti‐VEGF antibodies was also lost. In responsive TICs there was a reduction in ERK1 and 2 phosphorylation when cells were cultured with anti‐VEGF antibodies. Exposure to a high concentration of VEGF did not increase TIC proliferation further. When we repeated our experiments with PDGF we found that the ligand was secreted by only two of our TIC lines. Inhibition of PDGF had no effect on TIC proliferation and neither did exposure to a high concentration of PDGFAA.

CONCLUSION: VEGF autocrine signalling has a role in TIC proliferation where as PDGFAA signalling does not. These experimental data correlate with individual patient responses in clinical trials and suggest the possibility of using cancer stem cells to individualise cancer therapy in the future.
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TARGETING MYOSIN II ACTIVITY BLOCKS GLIOMA MIGRATION EVEN IN THE PRESENCE OF PRO‐MIGRATORY SIGNALS {#sec2-593}
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### Ivkovic S., Beadle C., Canoll P., Rosenfeld S.S. {#sec3-593}

#### Columbia University, New York, United States {#sec4-593}

The propensity of glioblastoma multiforme (GBM) to invade brain renders all standard therapies for this disease ineffective. EGFR signalling is well‐known to stimulate cell migration, and it is abnormally active in over 50% of patients with GBM. However, treating patients with EGFR inhibitors, such as erlotinib or gefitinib, has not provided universal or durable responses. We hypothesize that the multiple pro‐migratory cytokines, which are found in GBMs, circumvent blockade of any one pathway by stimulating other pathways that are at least partially redundant. However, these pathways converge on the molecular motor myosin II, which we had previously shown is indispensible in driving glioma migration. We therefore propose that myosin II is non‐redundant, and that blocking its activity should block glioma invasion regardless of how over‐active upstream pro‐migratory signal transduction cascades are. In order to test this hypothesis, we have generated a unique rat model of GBM, by infecting glial progenitor cells in the subcortical white matter with two retroviruses, which encode for: PDGF‐GFP and EGFR‐Red. The latter is a fusion protein which signals in a ligand‐dependent manner. The resulting tumors have all the histologic features of human GBM, and consist of green, PDGF‐GFP+ and red, EGFR‐Red+ cells. By contrast, injecting rats with the EGFR‐Red‐encoding retrovirus alone drives the infected glial progenitors to diffusely invade white matter, in a pattern consistent with gliomatosis cerebri. We have examined the migratory patterns of EGFR‐Red+ and PFGF‐GFP+ cells in brain slices from tumor‐bearing rats using time‐lapse microscopy. Consistent with our hypothesis, we find that while gefitinib completely blocks migration of EGFR‐Red+ cells in our model of gliomatosis, it has only a minimal effect in the GBM model. By contrast, treating glioma slices with blebbistatin---a highly specific allosteric inhibitor of myosin II---abolishes virtually all glioma cell motility, even in the presence of exogenous pro‐migratory cytokines in large excess.

Our results thus indicate that while glioma invasion can overcome the inhibition of individual signal transduction pathways that are frequently abnormal in these tumors, it remains highly sensitive to a myosin II targeting strategy.

P‐594 {#sec1-594}
=====

M2 RECEPTOR ACTIVATION AFFECTS SURVIVAL AND PROLIFERATION OF HUMAN GLIOBLASTOMA CELLS {#sec2-594}
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### Tata A.M.,^1^ Ferretti M.,^1^ Fabbiano C.,^2^ Pacini L.,^2^ Ricordy R.,^3^ Augusti Tocco G.,^1^ Calogero A.^2^ {#sec3-594}

#### ^1^University of Rome La Sapienza, Roma, Italy; ^2^University of Rome La Sapienza, Polo Pontino, Latina, Italy; ^3^CNR, Roma, Italy {#sec4-594}

The potential involvement of acetylcholine and muscarinic receptors in different pathologies among which cancer emerged in recent years and is becoming a relevant issue for the development of new therapeutic approaches. Muscarinic receptors expressed in several primary and metastatic tumors appear to be implicated in their growth and propagation, suggesting that the use of muscarinic antagonists could be considered as a possible tool in cancer therapy. Although it is known that patients with cerebral tumors often show altered levels of ACh in their cerebrospinal fluid, the role of ACh and muscarinic receptors in brain tumours has been poorly investigated. In the present work we have characterized the cholinergic effects on cell growth and survival in two different glioblastoma cell lines (U251MG and U87MG) and in primary cultures obtained from different human biopsies. We have demonstrated by RT‐PCR and immunocytochemistry that muscarinic receptor subtypes are differentially expressed in glioblastoma cells. Furthermore 3\[H\]‐thymidine incorporation experiments and FACS analysis demonstrated that M2 agonist arecaidine causes a decrease of glioma cell proliferation and the clonogenic ability was also inhibited in both cell lines, indipendently by the arecaidine doses and by the serum concentrations. The inhibitory effect of arecaidine on cell growth is reversible, as the cells recover proliferation after muscarinic agonist removal. Analysis of cell survival by trypan blue and Hoechst staining has also showed that cell death is significantly enhanced in arecaidine treated cells. Apoptosis induced by arecaidine is completely reverted by the M2 antagonist gallamine, confirming that arecaidine effects in glioma cells are mediated by M2 receptor subtype. Indepentendly of p53 status or p16 delections, similar results have been obtained in primary cultures obtained from 5 different glioma biopsies after 50 micromolar of arecaidine treatment. It is relevant that this arecaidine concentration didn\'t affect survival of normal human and mouse astrocytes.

In conclusion we show for the first time that ACh and M2 receptors, play an important role in the modulation of glioma cell growth and survival.

This project is supported by Cofin‐Prin 2007.
